<SEC-DOCUMENT>0001104659-25-016492.txt : 20250224
<SEC-HEADER>0001104659-25-016492.hdr.sgml : 20250224
<ACCEPTANCE-DATETIME>20250224160154
ACCESSION NUMBER:		0001104659-25-016492
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20250224
DATE AS OF CHANGE:		20250224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND
		CENTRAL INDEX KEY:			0001171471
		ORGANIZATION NAME:           	
		IRS NUMBER:				030426532
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285118
		FILM NUMBER:		25656889

	BUSINESS ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
		BUSINESS PHONE:		6302451046

	MAIL ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm256178d3_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Mon Feb 24 14:02:25 UTC 2025 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:chi="http://www.calamos.com/20250221" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title> CALAMOS CONVERTIBLE OPPORTUNITIES &amp; INCOME FUND - 1171471 - 2025</title></head><body><!-- BannerFile="tm256178d3_taggedsupp.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm256178-3/tm256178-3_424b5seq1" -->        <div style="display:none">
        <ix:header><ix:hidden><ix:footnote id="FN20241227085021755_187" xml:lang="en-US">Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</ix:footnote>
<ix:footnote id="FN20241227085021755_186" xml:lang="en-US">Based on the NAV calculated on the close of business on the last business day of each calendar quarter.</ix:footnote>
<ix:footnote id="FN20241227085021754_184" xml:lang="en-US">Based on high and low closing market price per share during the respective quarter and does not reflect commissions.</ix:footnote>
<ix:nonNumeric name="dei:DocumentType" contextRef="C_20250221to20250221" id="Fxbrl_20240919125318801">424B5</ix:nonNumeric><ix:footnote id="FN20250220102555114" xml:lang="en-US">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</ix:footnote>
<ix:footnote id="FN20250220102606193" xml:lang="en-US">Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</ix:footnote>
<ix:footnote id="FN20250220102621370" xml:lang="en-US">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#8220;Plan Agent&#8221;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 72 of the accompanying prospectus.</ix:footnote>
<ix:footnote id="FN20250220102635233" xml:lang="en-US">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</ix:footnote>
<ix:footnote id="FN20250220102650866" xml:lang="en-US">Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."</ix:footnote>
<ix:footnote id="FN20250220102706306" xml:lang="en-US">Reflects estimated dividend expense on $133 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</ix:footnote>
<ix:footnote id="FN20250220102723737" xml:lang="en-US">"Other Expenses" are based on estimated amounts for the current fiscal year.</ix:footnote>
<ix:footnote id="FN20250220103616902" xml:lang="en-US">The example includes sales load and estimated offering costs.</ix:footnote>
<ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20250221to20250221" id="Fdei_EntityCentralIndexKey20250220111616860">0001171471</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20250221to20250221" id="Fdei_AmendmentFlag20250220111629827">false</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="chi-20250221.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:CommonSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240801to20241031"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-08-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241031"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-10-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240501to20240731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240201to20240430"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240430"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231101to20240131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-11-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-01-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230801to20231031"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231031"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230430"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230430"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221101to20230131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241101to20250131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2025-01-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250131to20250131"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-01-31</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20250221to20250221"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171471</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2025-02-21</xbrli:startDate>
        <xbrli:endDate>2025-02-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="SHARES"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="Usd_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20250220110000597_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110000597_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110000597_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110000597_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110000597_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77" toRefs="FN20241227085021755_187"/><ix:relationship fromRefs="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74" toRefs="FN20241227085021754_184"/><ix:relationship fromRefs="Fxbrl_20250220173757676" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220173816108" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20250220173824060" toRefs="FN20241227085021755_186"/><ix:relationship fromRefs="Fxbrl_20240919013753357" toRefs="FN20250220102555114"/><ix:relationship fromRefs="Fxbrl_20240919014039282" toRefs="FN20250220102606193"/><ix:relationship fromRefs="Fxbrl_20240919014057551" toRefs="FN20250220102621370"/><ix:relationship fromRefs="Fxbrl_20250220100703613_xbrl_20240919014412199" toRefs="FN20250220102635233"/><ix:relationship fromRefs="Fxbrl_20250220100708341_xbrl_20240919014500055" toRefs="FN20250220102650866"/><ix:relationship fromRefs="Fxbrl_20240919014525346" toRefs="FN20250220102706306"/><ix:relationship fromRefs="Fxbrl_20240919014544330" toRefs="FN20250220102723737"/><ix:relationship fromRefs="Fxbrl_20250220100757437_xbrl_20240919020822143" toRefs="FN20250220103616902"/><ix:relationship fromRefs="Fxbrl_20250220100757437_xbrl_20240919020814123" toRefs="FN20250220103616902"/><ix:relationship fromRefs="Fxbrl_20250220100757437_xbrl_20240919020804439" toRefs="FN20250220103616902"/><ix:relationship fromRefs="Fxbrl_20250220100757437_xbrl_20240919020758346" toRefs="FN20250220103616902"/></ix:resources></ix:header></div><div>
  <p style="margin:0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><strong>Filed pursuant to Rule&#160;<span style="-sec-ix-hidden:Fxbrl_20240919125318801">424(b)(5)</span></strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><strong>File No.&#160;333-285118</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Prospectus Supplement<br/>(To Prospectus dated February&#160;21, 2025)</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><ix:nonNumeric id="Fxbrl_20240919013421858" name="dei:EntityRegistrantName" contextRef="C_20250221to20250221">Calamos Convertible Opportunities and Income Fund</ix:nonNumeric></strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Up to 17,435,035 Common Shares</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Calamos Convertible Opportunities and Income Fund (the "Fund," "we," "us," or "our") has entered into a distribution agreement dated February&#160;24, 2025 (the "Distribution Agreement") with Foreside Fund Services, LLC (the "Distributor"), relating to the Fund's common shares of beneficial interest ("common shares") offered by this prospectus supplement and the accompanying prospectus. The Distributor has entered into a sub-placement agent agreement dated February&#160;24, 2025 (the "Sub-Placement Agent Agreement") with UBS Securities LLC (the "Sub-Placement Agent"), relating to the Fund's common shares offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sub-Placement Agent Agreement, we may offer and sell up 17,435,035 of our common shares, no par value per share, from time to time through the Sub-Placement Agent, as the sub-placement agent for the offer and sale of the common shares.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Under the Investment Company Act of 1940, as amended (the "1940 Act"), the Fund may not sell any common shares at a price below the current net asset value of such common shares, exclusive of any distributing commission or discount. The Fund is a diversified, closed-end management investment company that commenced investment operations in June&#160;2002. Our investment objective is to provide total return through a combination of capital appreciation and current income.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Our common shares are listed on the Nasdaq Global Select Market ("Nasdaq") under the symbol "CHI." As of January&#160;31, 2025, the last reported sale price for our common shares was $11.37 per share. As of January&#160;31, 2025, the last reported net asset value for our common shares was $10.25 per share.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Sales of our common shares, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be "at the market" as defined in Rule&#160;415 under the Securities Act of 1933, as amended (the "1933 Act"), including sales made directly on the Nasdaq or sales made to or through a market maker other than on an exchange.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Distributor will be entitled to compensation of 1.00% of the gross sales price per share for any common shares sold under the Distribution Agreement. Out of this commission rate, the Distributor will compensate the Sub-Placement Agent at a rate of 0.80% of the gross proceeds of the sale of the Fund's common shares sold through the Sub-Placement Agent. In connection with the sale of the common shares on our behalf, the Distributor may be deemed to be an "underwriter" within the meaning of the 1933 Act and the compensation of the Distributor may be deemed to be underwriting commissions or discounts.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investing in our securities involves certain risks, including the risks associated with the Fund's use of leverage. You could lose some or all of your investment. See "Risk Factors" beginning on page&#160;41 of the accompanying prospectus. Shares of closed-end investment companies frequently trade at a discount to their net asset value and this may increase the risk of loss to purchasers of our securities. You should consider carefully these risks together with all of the other information contained in this prospectus supplement and the accompanying prospectus before making a decision to purchase our securities.</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">Prospectus Supplement dated February&#160;24, 2025</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">This prospectus supplement, together with the accompanying prospectus, sets forth concisely the information that you should know before investing. You should read the accompanying prospectus and this prospectus supplement, which contain important information, before deciding whether to invest in our securities. You should retain the accompanying prospectus and prospectus supplement for future reference. A statement of additional information, dated February&#160;21, 2025 as supplemented from time to time, containing additional information, has been filed with the Securities and Exchange Commission ("Commission") and is incorporated by reference in its entirety into this prospectus supplement and the accompanying prospectus. This prospectus supplement, the accompanying prospectus and the statement of additional information are part of a "shelf" registration statement that we filed with the Commission. This prospectus supplement describes the specific details regarding this offering, including the method of distribution. If information in this prospectus supplement is inconsistent with the accompanying prospectus or the statement of additional information, you should rely on this prospectus supplement. You may request a free copy of the statement of additional information, request a free copy of our annual and semi-annual reports, request other information or make shareholder inquiries, by calling toll-free 800.582.6959, by sending an e-mail request to <span style="text-decoration:underline">prospectus@calamos.com</span>, or by writing to the Fund at 2020 Calamos Court, Naperville,&#160;Illinois 60563. The Fund's annual and semi-annual reports also are available on our website, free of charge, at www.calamos.com, which also provides a link to the Commission's website, as described below, where the Fund's statement of additional information can be obtained. Information included on our website does not form part of this prospectus supplement or the accompanying prospectus. You can review documents we have filed on the Commission's website (<span style="text-decoration:underline">http://www.sec.gov</span>) for free.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Our securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong>TABLE OF CONTENTS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Prospectus Supplement</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellspacing="0" cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%">
  <tr style="vertical-align:bottom">
    <td style="padding-right:0.7pt;padding-bottom:4pt">&#160;</td>
    <td style="border-bottom:black 1pt solid;padding-right:0.7pt;padding-bottom:4.5pt;text-align:right;width:59px"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Page</strong></span></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#a_001"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Prospectus Supplement
    Summary</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_001"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-1</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#a_002"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Capitalization</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_002"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-2</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#a_003"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Summary of Fund Expenses</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_003"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-2</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#a_004"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Market and Net Asset Value
    Information</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_004"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-4</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#a_005"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Use of Proceeds</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_005"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-5</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#a_006"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Plan of Distribution</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_006"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-6</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#a_007"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Available Information</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#a_007"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUP-6</span></a></td></tr>

</table>




<p style="margin:0">&#160;</p>




<p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><strong>Prospectus</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<table cellspacing="0" cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_002"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Prospectus Summary</span></a></td>
    <td style="padding-right:0.7pt;text-align:right;width:59px"><a href="#ana_002"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">1</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_003"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Summary of Fund Expenses</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_003"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">20</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_004"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Financial Highlights</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_004"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_005"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Market and Net Asset Value
    Information</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_005"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_006"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Use of Proceeds</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_006"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_007"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_007"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_008"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Investment Objective and
    Principal Investment Strategies</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_008"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_009"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Leverage</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_009"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">33</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_010"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Interest Rate Transactions</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_010"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">40</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_011"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Risk Factors</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_011"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_012"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Management of the Fund</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_012"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">59</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_013"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Closed-End Fund Structure</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_013"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">62</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_014"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Certain Federal Income
    Tax Matters</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_014"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">63</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_015"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Net Asset Value</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_015"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">70</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_016"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Dividends and Distributions
    on Common Shares; Automatic Dividend Reinvestment Plan</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_016"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">72</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_017"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Description of Securities</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_017"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">77</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_018"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Rating Agency Guidelines</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_018"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">82</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_019"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Certain Provisions of
    the Agreement and Declaration of Trust and By-Laws,&#160;Including Antitakeover Provisions</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_019"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">83</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_020"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Plan of Distribution</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_020"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">86</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_021"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Custodian, Transfer Agent,
    Dividend Disbursing Agent and Registrar</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_021"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">88</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_022"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Legal Matters</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_022"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">88</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:White">
    <td style="padding-right:0.7pt"><a href="#ana_023"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Independent Registered
    Public Accounting Firm</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_023"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">88</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-right:0.7pt"><a href="#ana_024"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Incorporation by Reference</span></a></td>
    <td style="padding-right:0.7pt;text-align:right"><a href="#ana_024"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">88</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>You should rely only on the information contained or incorporated
by reference in this prospectus supplement and the accompanying prospectus in making your investment decisions. We have not authorized
any other person to provide you with different or inconsistent information. If anyone provides you with different or inconsistent information,
you should not rely on it. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or solicitation
of an offer to buy any securities in any jurisdiction where the offer or sale is not permitted. The information appearing in this prospectus
supplement and in the accompanying prospectus is accurate only as of the dates on their covers. Our business, financial condition and
prospects may have changed since such dates. We will advise investors of any material changes to the extent required by applicable law.</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt"><tr style="vertical-align:top;text-align:left"><td style="text-align:center;width:100%">i&#160;</td></tr></table></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING
STATEMENTS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">This prospectus supplement, the accompanying prospectus and the statement
of additional information contain "forward-looking statements." Forward-looking statements can be identified by the words "may,"
"will," "intend," "expect," "estimate," "continue," "plan," "anticipate,"
and similar terms and the negative of such terms. By their nature, all forward-looking statements involve risks and uncertainties, and
actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially
affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the
public markets and other factors discussed in our periodic filings with the Commission. Currently known risk factors that could cause
actual results to differ materially from our expectations include, but are not limited to, the factors described in the "Risk Factors"
section of the accompanying prospectus. We urge you to review carefully that section for a more detailed discussion of the risks of an
investment in our securities.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Although we believe that the expectations expressed in our forward-looking
statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our
future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject
to inherent risks and uncertainties, such as those disclosed in the "Risk Factors" section of the accompanying prospectus. All
forward-looking statements contained or incorporated by reference in this prospectus supplement or the accompanying prospectus are made
as of the date of this prospectus supplement or the accompanying prospectus, as the case may be. Except for our ongoing obligations under
the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking
statements contained in this prospectus supplement, the accompanying prospectus and the statement of additional information are excluded
from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;).</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt"><tr style="vertical-align:top;text-align:left"><td style="text-align:center;width:100%">ii&#160;</td></tr></table></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong><span id="a_001"></span>PROSPECTUS SUPPLEMENT SUMMARY</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>The following summary contains basic information about us and our
securities. It is not complete and may not contain all of the information you may want to consider. You should review the more detailed
information contained in this prospectus supplement and in the accompanying prospectus and in the statement of additional information,
especially the information set forth under the heading "Risk Factors" beginning on page&#160;41 of the accompanying prospectus.</i></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The Fund</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund is a diversified, closed-end management investment company,
with total managed assets of $1.2 billion as of January&#160;31, 2025. We commenced operations in June&#160;2002 following our initial
public offering. Our investment objective is to provide total return through a combination of capital appreciation and current income.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Adviser</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Calamos Advisors LLC (the "Adviser" or "Calamos")
serves as our investment adviser. Calamos is responsible on a day-to-day basis for investment of the Fund's portfolio in accordance with
its investment objective and policies. Calamos makes all investment decisions for the Fund and places purchase and sale orders for the
Fund's portfolio securities. As of January&#160;31, 2025, Calamos managed approximately $40.4 billion in assets of individuals and institutions.
Calamos is a wholly-owned subsidiary of Calamos Investments LLC (&#8220;CILLC&#8221;). Calamos Asset Management,&#160;Inc. is the sole
manager of CILLC.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund pays Calamos an annual fee, payable monthly, for its investment
management services equal to 0.80% of the Fund's average weekly managed assets. "Managed assets" means the total assets of the
Fund (including any assets attributable to any leverage that may be outstanding) minus the sum of liabilities (other than debt representing
financial leverage). &#8220;Net assets&#8221; does not include any assets attributable to any leverage that may be outstanding or other
debt representing financial leverage. See "Management of the Fund" on page&#160;59 of the accompanying prospectus.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The principal business address of the Adviser is 2020 Calamos Court,
Naperville,&#160;Illinois 60563.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The Offering</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund has entered into a distribution agreement dated February&#160;24,
2025 (the &#8220;Distribution Agreement&#8221;) with Foreside Fund Services, LLC (the &#8220;Distributor&#8221;) relating to the common
shares offered by this prospectus supplement and the accompanying prospectus. The Distributor has entered into a sub-placement agent agreement
dated February&#160;24, 2025 (the "Sub-Placement Agent Agreement") with UBS Securities LLC (the "Sub-Placement Agent"),
relating to the Fund's common shares offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms
of the Sub-Placement Agent Agreement, we may offer and sell up to 17,435,035 of our common shares, no par value per share, from time to
time through the Sub-Placement Agent, as the sub-placement agent for the offer and sale of the common shares.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Our common shares are listed on the Nasdaq Global Select Market ("Nasdaq")
under the symbol "CHI." As of January&#160;31, 2025, the last reported sale price for our common shares was $11.37.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Sales of our common shares, if any, under this prospectus supplement
and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be "at the market"
as defined in Rule&#160;415 under the 1933 Act, including sales made directly on the Nasdaq or sales made to or through a market maker
other than on an exchange. Our common shares may not be sold through agents, underwriters or dealers without delivery or deemed delivery
of a prospectus and a prospectus supplement describing the method and terms of the offering of our securities. Under the 1940 Act, the
Fund may not sell any common shares at a price below the current net asset value of such common shares, exclusive of any distributing
commission or discount (the &#8220;Minimum Price&#8221;).</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt"><tr style="vertical-align:top;text-align:left"><td style="width:33%">&#160;</td><td style="width:34%;text-align:center">SUP-1</td><td style="width:33%;text-align:right">&#160;</td></tr></table></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:left">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Use of Proceeds</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Unless otherwise specified in this prospectus supplement, we currently
intend to use the net proceeds from the sale of our common shares in this offering primarily to invest in accordance with our investment
objective and policies (as described under "Investment Objective and Principal Investment Strategies," beginning on page&#160;25
of the accompanying prospectus) within approximately three months of receipt of such proceeds. Such investments may be delayed if suitable
investments are unavailable at the time or for other reasons. We may also use proceeds from the sale of our securities (i)&#160;to retire
all or a portion of any short-term debt we incur in pursuit of our investment objective and policies, (ii)&#160;to redeem any outstanding
senior securities, and (iii)&#160;for working capital purposes, including the payment of interest and operating expenses, although there
is currently no intent to issue securities primarily for these purposes. A delay in the anticipated use of proceeds could lower returns,
reduce our distribution to common shareholders and reduce the amount of cash available to make dividend and interest payments on preferred
shares and debt securities, respectively.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><span id="a_002"></span>CAPITALIZATION</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund may offer and sell up to 17,435,035 of our common shares, no par value per share, from time to time through the Sub-Placement Agent as sub-placement agent under this prospectus supplement and the accompanying prospectus. There is no guarantee that there will be any sales of our common shares pursuant to this prospectus supplement and the accompanying prospectus. The table below assumes that we will sell 17,435,035 common shares at a price of $11.37 per share (the last reported sale price per share of our common shares on Nasdaq on January&#160;31, 2025). Actual sales, if any, of the Fund's common shares under this prospectus supplement and accompanying prospectus may be greater or less than $11.37 per share, depending on the market price of the Fund's common shares at the time of any such sale and/or the Fund's net asset value ("NAV") for purposes of calculating the Minimum Price. The Fund and the Distributor will determine whether any sales of the Fund's common shares will be authorized on a particular day; the Fund and the Distributor, however, will not authorize sales of the Fund's common shares if the per share price of the shares is less than the Minimum Price. The Fund and the Distributor may elect not to authorize sales of the Fund's common shares on a particular day even if the per share price of the shares is equal to or greater than the Minimum Price, or may only authorize a fixed number of shares to be sold on any particular day. The Fund and the Distributor will have full discretion regarding whether sales of Fund common shares will be authorized on a particular day and, if so, in what amounts.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table sets forth our capitalization:</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="margin:0pt 0 0pt 0.5in;text-align:justify;font:10pt Times New Roman, Times, Serif"><span style="font-family:Symbol;font-size:10pt">&#183;</span> on a historical basis as of October&#160;31, 2024 (audited);</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in">&#160;</p><p style="margin:0pt 0 0pt 0.5in;text-align:justify;font:10pt Times New Roman, Times, Serif"><span style="font-family:Symbol;font-size:10pt">&#183;</span> on a pro forma as adjusted basis to reflect issuance of 171,090 of our common shares through the Fund&#8217;s dividend reinvestment plan at an average price of $11.16 and the sale of 507,000 of our common shares at an average price of $11.48 and after deducting the aggregate commission and fees of $58,178; and</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in">&#160;</p><p style="margin:0pt 0 0pt 0.5in;text-align:justify;font:10pt Times New Roman, Times, Serif"><span style="font-family:Symbol;font-size:10pt">&#183;</span> on a pro forma basis as further adjusted to reflect (1)&#160;the assumed sale of 17,435,035 common shares at $11.37 per share (the last reported sale price of the Fund's common shares on Nasdaq on January&#160;31, 2025), in an offering under this prospectus supplement and the accompanying prospectus, and (2)&#160;the investment of net proceeds assumed from such offering in accordance with the Fund's investment objective and policies, after deducting the assumed aggregate commission of $1.98 million (representing an estimated commission to the Distributor of 1.00% of the gross proceeds of the sale of the Fund's common shares, out of which the Distributor will compensate the Sub-Placement Agent at a rate of 0.80% of the gross sales proceeds of the sale of the Fund's common shares sold through the Sub-Placement Agent).</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom"><td style="font-size:10pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td colspan="2" style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Actual</td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td colspan="2" style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">As Adjusted</td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td colspan="2" style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">As Further Adjusted</td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:61%;font:10pt Times New Roman, Times, Serif">Loans(1)</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">227,000,000</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">253,000,000</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">253,000,000</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif">Preferred Shares</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">132,750,000</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">132,750,000</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">132,750,000</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif">Common shares, no par value per share, unlimited shares authorized, 76,312,702 outstanding (actual) shares, 76,990,792 shares outstanding (as adjusted) and 94,425,827 shares outstanding (as further adjusted)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">805,601,157</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">813,330,859</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,011,567,207</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Accumulated distributable earnings (loss)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">(46,394,719</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">(46,394,719</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right">46,394,719</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">Net assets applicable to common shareholders</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">759,206,438</td><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">766,936,140</td><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">965,172,488</td><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt">Total Capitalization</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">1,118,956,438</td><td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">1,152,686,140</td><td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">1,350,922,488</td><td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"><tr style="vertical-align:top"><td style="width:0.5in"/><td style="width:0.25in">(1)</td><td>Figures do not reflect additional structural leverage related to certain securities lending programs, which were $88 million and $62 million as of October&#160;31, 2024 and January&#160;31, 2025, respectively.</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_003"><strong>SUMMARY OF FUND EXPENSES</strong></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div>
        <ix:nonNumeric id="Fxbrl_20250220173537613" name="cef:PurposeOfFeeTableNoteTextBlock" contextRef="C_20250221to20250221" escape="true">
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds and preferred stock dividend payments, as a percentage of our average net assets as of January&#160;31, 2025, and not as a percentage of gross assets or managed assets.</p>
        </ix:nonNumeric>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">By showing expenses as a percentage of average net assets, expenses are not expressed as a percentage of all of the assets we invest. The table and example are based on our capital structure as of January&#160;31, 2025. As of January&#160;31, 2025, the Fund had $315 million in borrowings outstanding, $133 million in outstanding mandatory redeemable preferred shares and additional structural leverage of $62 million, collectively representing 36.4% of managed assets.</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20240919014218635" name="cef:ShareholderTransactionExpensesTableTextBlock" contextRef="C_20250221to20250221" continuedAt="F20250220135400855" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
                <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font-size:10pt">&#160;</td>
                <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="white-space:nowrap;width:87%;font:10pt Times New Roman, Times, Serif;text-align:left">Sales Load (<ix:nonNumeric id="Fxbrl_20250220101540204" name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="C_20250221to20250221" escape="true"><span style="font-size:10pt;font-family:Times New Roman">as a percentage of offering price</span></ix:nonNumeric>)</td>
                <td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="white-space:nowrap;width:9%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919013753357" name="cef:SalesLoadPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.00</ix:nonFraction></td>
                <td style="white-space:nowrap;width:2%;font:10pt Times New Roman, Times, Serif;text-align:left">%(1)</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Offering Expenses Borne by the Fund (as a percentage of offering price)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><ix:nonFraction id="Fxbrl_20240919014039282" name="cef:OtherTransactionExpensesPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%(2)</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Dividend Reinvestment Plan Fees (per sales transaction fee)(3)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919014057551" name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="C_20250221to20250221" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">15.00</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
      <div style="display:none">
        <ix:continuation id="F20250220135400855" continuedAt="F20250220101712508">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt">

            <tr style="vertical-align:top;text-align:left">
              <td style="width:33%">&#160;</td>
              <td style="width:34%;text-align:center">SUP-2</td>
              <td style="width:33%;text-align:right">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240919014335769" name="cef:AnnualExpensesTableTextBlock" contextRef="C_20250221to20250221" continuedAt="F20250220135418508" escape="true">
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Annual Expenses</td>
                <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Percentage of Average Net<br/>Assets Attributable to<br/>Common Shareholders</td>
                <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:82%;font:10pt Times New Roman, Times, Serif">Management Fee(4)</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100703613_xbrl_20240919014412199" name="cef:ManagementFeesPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.26</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Interest Payments on Borrowed Funds(5)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100708341_xbrl_20240919014500055" name="cef:InterestExpensesOnBorrowingsPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.18</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Preferred Stock Dividend Payments(6)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919014525346" name="cef:DividendExpenseOnPreferredSharesPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.70</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif">Other Expenses(7)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919014544330" name="cef:OtherAnnualExpensesPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.09</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Total Annual Expenses</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919014558478" name="cef:TotalAnnualExpensesPercent" contextRef="C_20250221to20250221" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.23</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>

          </table>
        </ix:nonNumeric>
        <div style="display:none">
          <ix:continuation id="F20250220135418508" continuedAt="F20250220101757418">
            <div>&#160;</div>
          </ix:continuation>
        </div>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20250220130952583" name="cef:ExpenseExampleTableTextBlock" contextRef="C_20250221to20250221" continuedAt="F20250220135432050" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Example:</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares (including an assumed total sales load or commission of 1.00%), assuming (1)&#160;total annual expenses of 4.23% of net assets attributable to common shareholders; (2)&#160;a 5% annual gross return; and (3)&#160;all distributions are reinvested at net asset value:</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="font-size:10pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">1 Year</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">3 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">5 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">10 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left">Total Expenses Paid by Common Shareholders(8)</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100757437_xbrl_20240919020758346" name="cef:ExpenseExampleYear01" contextRef="C_20250221to20250221" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">52</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100757437_xbrl_20240919020804439" name="cef:ExpenseExampleYears1to3" contextRef="C_20250221to20250221" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">137</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100757437_xbrl_20240919020814123" name="cef:ExpenseExampleYears1to5" contextRef="C_20250221to20250221" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">223</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220100757437_xbrl_20240919020822143" name="cef:ExpenseExampleYears1to10" contextRef="C_20250221to20250221" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">445</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="display:none">
        <ix:continuation id="F20250220135432050" continuedAt="F20250220134623691">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20250220101712508">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(1)&#160;Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(2)&#160;&#160;Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(3)&#160;Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#8220;Plan Agent&#8221;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page&#160;72 of the accompanying prospectus.</p>
        </div>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20250220101757418">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(4)&#160;The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(5)&#160;Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(6)&#160;Reflects estimated dividend expense on $<span style="color:#212529;background-color:white">133 </span>million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(7)&#160;<ix:nonNumeric id="Fxbrl_20250220173700770" name="cef:OtherExpensesNoteTextBlock" contextRef="C_20250221to20250221" escape="true"><span style="font-size:10pt;font-family:Times New Roman">"Other Expenses" are based on estimated amounts for the current fiscal year.</span></ix:nonNumeric></p>
        </div>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20250220134623691">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(8) The example includes sales load and estimated offering costs.</p>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt">

            <tr style="vertical-align:top;text-align:left">
              <td style="width:33%">&#160;</td>
              <td style="width:34%;text-align:center">SUP-3</td>
              <td style="width:33%;text-align:right">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The purpose of the table and the example above is to help investors understand the fees and expenses that they, as common shareholders, would bear directly or indirectly. For additional information with respect to our expenses, see "Management of the Fund" on page&#160;59 of the accompanying prospectus.</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_004"><strong>MARKET AND NET ASSET VALUE INFORMATION</strong></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Our common shares are listed on the Nasdaq under the symbol "CHI." Our common shares commenced trading on the New York Stock Exchange ("NYSE") in June&#160;2002. On July&#160;2, 2012, the common shares ceased trading on the NYSE and commenced trading on the Nasdaq.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Our common shares have traded both at a premium and a discount to net asset value or NAV. We cannot predict whether our shares will trade in the future at a premium or discount to NAV. The provisions of the 1940 Act generally require that the public offering price of common shares (less any underwriting commissions and discounts) must equal or exceed the NAV per share of a company's common stock (calculated within 48 hours of pricing). Our issuance of common shares may have an adverse effect on prices in the secondary market for our common shares by increasing the number of common shares available, which may put downward pressure on the market price for our common shares. Shares of common stock of closed-end investment companies frequently trade at a discount from NAV. See "Risk Factors &#8212; Market Discount Risk" on page&#160;57 of the accompanying prospectus.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20250220173742357" name="cef:SharePriceTableTextBlock" contextRef="C_20250221to20250221" escape="true">
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table sets forth for each of the periods indicated the high and low closing market prices for our common shares on the Nasdaq, the NAV per share and the premium or discount to NAV per share at which our common shares were trading. NAV is shown for the last business day of each quarter. See "Net Asset Value" on page&#160;70 of the accompanying prospectus for information as to the determination of our NAV.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Market Price</strong></span><strong><span style="font-size:10pt"><sup>(1)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">Net Asset<br/>Value at<br/>Quarter</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Premium/<br/>(Discount)<br/>to Net Asset<br/>Value</strong></span><strong><span style="font-size:10pt"><sup>(3)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Quarter Ended</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">High</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Low</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>End</strong></span><strong><span style="font-size:10pt"><sup>(2)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">High</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Low</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:35%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2025</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20241101to20250131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.28</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20241101to20250131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.19</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20250131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.25</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20241101to20250131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">22.85</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20241101to20250131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.59</ix:nonFraction></td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">October 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110000597_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20240801to20241031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.01</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110000597_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20240801to20241031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.91</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110000597_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20241031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.04</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110000597_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240801to20241031" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">18.20</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110000597_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240801to20241031" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">13.13</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">July 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20240501to20240731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.02</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20240501to20240731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.04</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20240731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.95</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240501to20240731" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">20.24</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240501to20240731" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">11.61</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">April 30, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20240201to20240430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.54</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20240201to20240430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.55</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20240430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.74</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240201to20240430" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">14.21</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240201to20240430" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.46</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20231101to20240131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.71</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20231101to20240131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.74</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20240131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.00</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231101to20240131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">12.00</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231101to20240131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.41</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">October 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20230801to20231031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.32</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20230801to20231031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.00</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20231031" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.99</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230801to20231031" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">15.20</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230801to20231031" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.56</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">July 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20230501to20230731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.36</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20230501to20230731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.90</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20230731" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.51</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230501to20230731" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.21</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230501to20230731" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.53</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">April 30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20230201to20230430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.34</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20230201to20230430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.21</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20230430" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.94</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230201to20230430" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">16.91</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230201to20230430" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.49</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74" name="cef:HighestPriceOrBid" contextRef="C_20221101to20230131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.09</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75" name="cef:LowestPriceOrBid" contextRef="C_20221101to20230131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.51</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76" name="us-gaap:NetAssetValuePerShare" contextRef="C_20230131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.61</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221101to20230131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">15.03</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221101to20230131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.89</ix:nonFraction></td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Source: Fund Accounting Records.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(1)&#160;Based on high and low closing market price per share during the respective quarter and does not reflect commissions.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(2)&#160;Based on the NAV calculated on the close of business on the last business day of each calendar quarter.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(3)&#160;Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</p>
          </div>
        </ix:nonNumeric>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt">

            <tr style="vertical-align:top;text-align:left">
              <td style="width:33%">&#160;</td>
              <td style="width:34%;text-align:center">SUP-4</td>
              <td style="width:33%;text-align:right">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The last reported sale price, NAV per common share and percentage premium to NAV per common share on January&#160;31, 2025, were $<ix:nonFraction id="Fxbrl_20250220173816108" name="us-gaap:SharePrice" contextRef="C_20250131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.37</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20250220173757676" name="us-gaap:NetAssetValuePerShare" contextRef="C_20250131" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.25</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20250220173824060" name="cef:LatestPremiumDiscountToNavPercent" contextRef="C_20250131to20250131" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.93</ix:nonFraction>%, respectively. As of January&#160;31, 2025, we had <ix:nonFraction id="Fxbrl_20250220173807622" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">76,312,702</ix:nonFraction> common shares outstanding and managed assets of approximately $1.2 billion.</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20250220125827307" name="cef:OutstandingSecuritiesTableTextBlock" contextRef="C_20250131to20250131" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table provides information about our outstanding securities as of January&#160;31, 2025:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Authorized</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Held by the<br/>Fund or for<br/>its Account</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Outstanding</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:61%;font:10pt Times New Roman, Times, Serif"><ix:nonNumeric id="Fxbrl_20250220104219855" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember" escape="true"><span style="font-size:10pt;font-family:Times New Roman">Common Shares</span></ix:nonNumeric></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Unlimited</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023157161" name="cef:OutstandingSecurityHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023219489" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">76,312,702</ix:nonFraction></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20250220104257935" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember" escape="true"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series C</span></ix:nonNumeric></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023628137" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,340,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023450849_xbrl_20240919023157161" name="cef:OutstandingSecurityHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023450849_xbrl_20240919023219489" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,340,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20250220104319367" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember" escape="true"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series D</span></ix:nonNumeric></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023652285_xbrl_20240919023628137" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,320,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023652285_xbrl_20240919023450849_xbrl_20240919023157161" name="cef:OutstandingSecurityHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023652285_xbrl_20240919023450849_xbrl_20240919023219489" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,320,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20250220104346871" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember" escape="true"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series E</span></ix:nonNumeric></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023654297_xbrl_20240919023628137" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,330,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023654297_xbrl_20240919023450849_xbrl_20240919023157161" name="cef:OutstandingSecurityHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023654297_xbrl_20240919023450849_xbrl_20240919023219489" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,330,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20250220104402295" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember" escape="true"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series G</span></ix:nonNumeric></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023655942_xbrl_20240919023628137" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,320,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023655942_xbrl_20240919023450849_xbrl_20240919023157161" name="cef:OutstandingSecurityHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240919023655942_xbrl_20240919023450849_xbrl_20240919023219489" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember" unitRef="SHARES" scale="0" decimals="0" format="ixt:num-dot-decimal">1,320,000</ix:nonFraction></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
     <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><span id="a_005"></span>USE OF PROCEEDS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Sales of our common shares, if any, under this prospectus supplement
and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221;
as defined in Rule&#160;415 under the 1933 Act, including sales made directly on the Nasdaq or sales made to or through a market maker
other than on an exchange. There is no guarantee that there will be any sales of our common shares pursuant to this prospectus supplement
and the accompanying prospectus. Actual sales, if any, of our common shares under this prospectus supplement and the accompanying prospectus
may be less than as set forth below in this paragraph. In addition, the price per share of any such sale may be greater or less than the
price set forth below in this paragraph, depending on the market price of our common shares at the time of any such sale. As a result,
the actual net proceeds we receive may be more or less than the amount of net proceeds estimated in this prospectus supplement. Assuming
the sale of the remaining 17,435,035 common shares offered under this prospectus supplement and the accompanying prospectus at the last
reported sale price of $11.37 per share for our common shares on the Nasdaq as of January&#160;31, 2025, we estimate that the net proceeds
of this offering will be approximately $196 million after deducting the estimated sales load and our estimated offering expenses.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Unless otherwise specified in this prospectus supplement, we currently
intend to use the net proceeds from the sale of our common shares in this offering primarily to invest in accordance with our investment
objective and policies (as described under "Investment Objective and Principal Investment Strategies," beginning on page&#160;25
of the accompanying prospectus) within approximately three months of receipt of such proceeds. Such investments may be delayed if suitable
investments are unavailable at the time or for other reasons. We may also use proceeds from the sale of our securities (i)&#160;to retire
all or a portion of any short-term debt we incur in pursuit of our investment objective and policies, (ii)&#160;to redeem any outstanding
senior securities, and (iii)&#160;for working capital purposes, including the payment of interest and operating expenses, although there
is currently no intent to issue securities primarily for these purposes. Pending such use of proceeds, we anticipate that we will invest
the proceeds in securities issued by the U.S. government or its agencies or instrumentalities or in high quality, short-term or long-term
debt obligations. A delay in the anticipated use of proceeds could lower returns, reduce our distribution to common shareholders and reduce
the amount of cash available to make dividend and interest payments on preferred shares and debt securities.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt"><tr style="vertical-align:top;text-align:left"><td style="width:33%">&#160;</td><td style="width:34%;text-align:center">SUP-5</td><td style="width:33%;text-align:right">&#160;</td></tr></table></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong><span id="a_006"></span>PLAN OF DISTRIBUTION</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund has entered into the Distribution Agreement with Foreside
Fund Services, LLC pursuant to which the Fund may offer and sell up to 17,435,035 common shares, from time to time, through the Distributor
in transactions that are deemed to be "at-the-market" as defined in Rule&#160;415&#160;under the&#160;1933 Act. In accordance
with the terms of the Distribution Agreement, the Distributor will use its best efforts to sell the common shares. The minimum price on
any day at which common shares may be sold will not be less than the Minimum Price, which will be equal to the then current net asset
value per common share plus the per common share amount of the commission to be paid to the Distributor. The Fund and the Distributor
will determine whether any sales of common shares will be authorized on a particular day. The Fund and the Distributor, however, will
not authorize sales of common shares if the price per share of the common shares is less than the Minimum Price. The Fund and the Distributor
may elect not to authorize sales of common shares on a particular day even if the price per share of the common shares is equal to or
greater than the Minimum Price, or may only authorize a fixed number of common shares to be sold on any particular day. The Fund and the
Distributor will have full discretion regarding whether sales of common shares will be authorized on a particular day and, if so, in what
amounts.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Distributor may enter into sub-placement agent agreements with
one or more selected dealers. The Distributor has entered into the Sub-Placement Agent Agreement with UBS Securities LLC pursuant to which
the Fund may offer and sell the common shares offered by this prospectus supplement and the accompanying prospectus, from time to time,
through the Sub-Placement Agent, as sub-placement agent for the offer and sale of the common shares. In accordance with the terms of the
Sub-Placement Agent Agreement, the Sub-Placement Agent will use its reasonable best efforts to sell the common shares.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Sub-Placement Agent will provide written confirmation to the Distributor
following the close of trading on the day on which common shares are sold under the Sub-Placement Agent Agreement. Each confirmation will
include the number of shares sold on the preceding day, the time of sale, the gross sales price per each common share sold and the compensation
payable by the Distributor to the Sub-Placement Agent in connection with the sales.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Fund will compensate the Distributor with respect to sales of the
common shares at a commission rate of 1.00% of the gross proceeds of the sale of common shares. The Distributor will compensate the Sub-Placement
Agent for its services in acting as sub-placement agent in the sale of common shares out of this commission at a rate 0.80% of the gross
proceeds of the sale of common shares sold under the Sub-Placement Agent Agreement. There is no guarantee that there will be any sales
of the common shares pursuant to this prospectus supplement and the accompanying prospectus. Calamos will pay the expenses of the offering
(other than the applicable commissions, which will be paid by the Fund) subject to the reimbursement provision set forth in the Summary
of Fund Expenses section of this prospectus supplement.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Settlement for sales of common shares will occur on the first trading
day following the date on which such sales are made, unless otherwise agreed to in writing by the Fund, the Distributor and the Sub-Placement
Agent, in return for payment of the net proceeds to the Fund. There is no arrangement for funds to be received in an escrow, trust or
similar arrangement.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">In connection with the sale of the common shares on the Fund's behalf,
the Distributor may be deemed to be an "underwriter" within the meaning of the&#160;1933 Act, and the compensation of the Distributor
may be deemed to be underwriting commissions or discounts.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Distributor has agreed to provide indemnification and contribution
to the Sub-Placement Agent and Fund against certain civil liabilities, including liabilities under the&#160;1933 Act, under the Sub-Placement
Agent Agreement and Distribution Agreement, respectively. The Fund has agreed to provide indemnification and contribution to the Distributor
against certain civil liabilities, including liabilities under the&#160;1933 Act, under the Distribution Agreement.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The offering of the common shares pursuant to the Distribution Agreement
and the Sub-Placement Agent Agreement will terminate upon the earlier of (1)&#160;the sale of all common shares subject to the Distribution
Agreement or the Sub-Placement Agent Agreement or (2)&#160;termination of the Distribution Agreement or the Sub-Placement Agent Agreement
by any party thereto upon five days' written notice to the other party thereto.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The Sub-Placement Agent, its affiliates or their respective employees
hold or may hold in the future, directly or indirectly, investment interests in the Fund. The interests held by the Sub-Placement Agent,
its affiliates or their respective employees are not attributable to, and no investment discretion is held by, the Sub-Placement Agent,
its affiliates or their respective affiliates.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The principal business address of the Distributor is Three Canal Plaza,
Suite&#160;100, Portland, ME 04101. The principal business address of the Sub-Placement Agent is 1285 Avenue of the Americas, New York,
NY 10019.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong><span id="a_007"></span>AVAILABLE INFORMATION</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">We are subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the 1940 Act and are required to file reports, including annual and
semi-annual reports, proxy statements and other information with the Commission. These documents are available on the Commission's website
at <span style="text-decoration:underline">www.sec.gov</span>.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">This prospectus supplement and the accompanying prospectus do not contain
all of the information in our registration statement, including amendments, exhibits, and schedules. Statements in this prospectus supplement
and the accompanying prospectus about the contents of any contract or other document are not necessarily complete and in each instance
reference is made to the copy of the contract or other document filed as an exhibit to the registration statement, each such statement
being qualified in all respects by this reference.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Additional information about us can be found in our registration statement
(including amendments, exhibits, and schedules) on Form&#160;N-2 filed with the Commission. The Commission maintains a website (http://www.sec.gov)
that contains our registration statement, other documents incorporated by reference, and other information we have filed electronically
with the Commission, including proxy statements and reports filed under the Exchange Act.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-size:10pt"><tr style="vertical-align:top;text-align:left"><td style="width:33%">&#160;</td><td style="width:34%;text-align:center">SUP-6</td><td style="width:33%;text-align:right">&#160;</td></tr></table></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>






</div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm256178d2_basepros.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm256178-3/tm256178-3_424b5seq1" --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Base Prospectus</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>$200,000,000</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Calamos Convertible Opportunities and Income
Fund&#160;</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Common Shares<br/>
Preferred Shares<br/>
Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos Convertible Opportunities and Income Fund (the "Fund,"
"we," "us," or "our") is a diversified, closed-end management investment company that commenced investment
operations in June&#160;2002. Our investment objective is to provide total return through a combination of capital appreciation and current
income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer, on an immediate, continuous or delayed basis, up to $200,000,000
aggregate initial offering price of our common shares (no par value per share), preferred shares (no par value per share) or debt securities,
which we refer to in this prospectus collectively as our securities, in one or more offerings. We may offer our common shares, preferred
shares and debt securities separately or together, in amounts, at prices and on terms set forth in a prospectus supplement to this prospectus.
You should read this prospectus and the related prospectus supplement carefully before you decide to invest in any of our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer our securities directly to one or more purchasers, through
agents that we or they designate from time to time, or to or through underwriters or dealers. The prospectus supplement relating to the
particular offering will identify any agents or underwriters involved in the sale of our securities, and will set forth any applicable
purchase price, fee, commission or discount arrangement between us and such agents or underwriters or among the underwriters and the basis
upon which such amount may be calculated. For more information about the manner in which we may offer our securities, see "Plan of
Distribution." Our securities may not be sold through agents, underwriters or dealers without delivery or deemed delivery of a prospectus
supplement and a prospectus.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our common shares are listed on the Nasdaq Global Select Market under
the symbol "CHI." As of January&#160;31, 2025, the last reported sale price for our common shares was $11.37 per share. As of
January&#160;31, 2025, the last reported net asset value for our common shares was $10.25 per share.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investing in our securities involves certain risks, including
the risks associated with the Fund's use of leverage. You could lose some or all of your investment. See "Risk Factors"
beginning on page&#160;41 of this prospectus. Shares of closed-end investment companies frequently trade at a discount to their net
asset value and this may increase the risk of loss to purchasers of our securities. You should consider carefully these risks
together with all of the other information contained in this prospectus and any prospectus supplement before making a decision to
purchase our securities.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation
to the contrary is a criminal offense.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Prospectus dated February&#160;21, 2025</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus, together with any accompanying prospectus supplement,
sets forth concisely the information that you should know before investing. You should read the prospectus and prospectus supplement,
which contain important information, before deciding whether to invest in our securities. You should retain the prospectus and prospectus
supplement for future reference. A statement of additional information, dated the same date as this prospectus, as supplemented from time
to time, containing additional information, has been filed with the Securities and Exchange Commission ("SEC" or the "Commission")
and is incorporated by reference in its entirety into this prospectus. You may request a free copy of the statement of additional information,
request a free copy of our annual and semi-annual reports, request other information or make shareholder inquiries, by calling toll-free
800.582.6959, by sending an e-mail request to prospectus@calamos.com, or by writing to the Fund at 2020 Calamos Court, Naperville,&#160;Illinois
60563. The Fund's annual and semi-annual reports also are available on our website, free of charge, at www.calamos.com, which also provides
a link to the Commission's website, as described below, where the Fund's statement of additional information can be obtained. Information
included on our website does not form part of this prospectus. You can review documents we have filed on the Commission's website (http://www.sec.gov)
for free.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our securities do not represent a deposit or obligation of, and are
not guaranteed or endorsed by, any bank or other insured depository institution and are not federally insured by the Federal Deposit Insurance
Corporation, the Federal Reserve Board or any other government agency.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 0.7pt; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 0.7pt; padding-bottom: 4.5pt; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_002">Prospectus Summary</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_002">1</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_003">Summary of Fund Expenses</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_003">20</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_004">Financial Highlights</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_004">21</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_005">Market and Net Asset Value Information</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_005">24</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_006">Use of Proceeds</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_006">24</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_007">The Fund</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_007">25</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_008">Investment Objective and Principal Investment Strategies</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_008">25</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_009">Leverage</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_009">33</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_010">Interest Rate Transactions</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_010">40</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_011">Risk Factors</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_011">41</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_012">Management of the Fund</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_012">59</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_013">Closed-End Fund Structure</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_013">62</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_014">Certain Federal Income Tax Matters</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_014">63</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_015">Net Asset Value</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_015">70</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_016">Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment
    Plan</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_016">72</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_017">Description of Securities</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_017">77</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_018">Rating Agency Guidelines</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_018">82</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_019">Certain Provisions of the Agreement and Declaration of Trust and By-Laws,&#160;Including
    Antitakeover Provisions</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_019">83</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_020">Plan of Distribution</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_020">86</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_021">Custodian, Transfer Agent, Dividend Disbursing Agent and Registrar</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_021">88</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_022">Legal Matters</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_022">88</a></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-right: 0.7pt"><a href="#ana_023">Independent Registered Public Accounting Firm</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_023">88</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.7pt"><a href="#ana_024">Incorporation by Reference</a></td>
    <td style="padding-right: 0.7pt; text-align: right"><a href="#ana_024">88</a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>You should rely only on the information contained or incorporated
by reference in this prospectus and any related prospectus supplement in making your investment decisions. We have not authorized any
other person to provide you with different or inconsistent information. If anyone provides you with different or inconsistent information,
you should not rely on it. This prospectus and any prospectus supplement do not constitute an offer to sell or solicitation of an offer
to buy any securities in any jurisdiction where the offer or sale is not permitted. The information appearing in this prospectus and in
any prospectus supplement is accurate only as of the dates on their covers. Our business, financial condition and prospects may have changed
since such dates. We will advise you of any material changes to the extent required by applicable law.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING
STATEMENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus, any accompanying prospectus supplement and the statement
of additional information contain "forward-looking statements." Forward-looking statements can be identified by the words "may,"
"will," "intend," "expect," "estimate," "continue," "plan," "anticipate,"
and similar terms and the negative of such terms. Such forward-looking statements may be contained in this prospectus as well as in any
accompanying prospectus supplement. By their nature, all forward-looking statements involve risks and uncertainties, and actual results
could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual
results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and
other factors discussed in our periodic filings with the Commission. Currently known risk factors that could cause actual results to differ
materially from our expectations include, but are not limited to, the factors described in the "Risk Factors" section of this
prospectus. We urge you to review carefully that section for a more detailed discussion of the risks of an investment in our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we believe that the expectations expressed in our forward-looking
statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our
future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject
to inherent risks and uncertainties, such as those disclosed in the "Risk Factors" section of this prospectus. All forward-looking
statements contained or incorporated by reference in this prospectus or any accompanying prospectus supplement are made as of the date
of this prospectus or such accompanying prospectus supplement, as the case may be. Except for our ongoing obligations under the federal
securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements
contained in this prospectus, any accompanying prospectus supplement and the statement of additional information are excluded from the
safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the "1933 Act").</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS SUMMARY</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>The following summary contains basic information about us and our
securities. It is not complete and may not contain all of the information you may want to consider before investing in the Fund. You should
review the more detailed information contained in this prospectus and in any related prospectus supplement and in the statement of additional
information, especially the information set forth under the heading "Risk Factors" beginning on page&#160;41 of this prospectus.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund is a diversified, closed-end management investment company.
We commenced operations in June&#160;2002 following our initial public offering. As of January&#160;31, 2025, we had $1.2 billion of total
managed assets, including $133 million of outstanding mandatory redeemable preferred shares ("MRP Shares" or "MRPS").
As of January&#160;31, 2025, the Fund had utilized $315 million of the $430 million available under the Amended and Restated Liquidity
Agreement (the "SSB Agreement") with State Street Bank and Trust Company ("SSB" or "State Street") ($253
million in advances outstanding, and $62 million in structural leverage consisting of collateral received from counterparties to securities
lending transactions through SSB in connection with securities on loan), representing 25.6% of the Fund's managed assets as of that date,
and had $133 million of MRP Shares outstanding, representing 10.8% of the Fund's managed assets. Combined, the borrowings under the SSB
Agreement and the outstanding MRP Shares represented 36.4% of the Fund's managed assets. Structural leverage refers to borrowings under
the liquidity agreement in respect of which the Fund's interest payments are reduced or eliminated by the Fund's securities lending activities.
See "Leverage." Our fiscal year ends on October&#160;31. Our investment objective is to provide total return through a combination
of capital appreciation and current income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 4; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Adviser</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos Advisors LLC (the "Adviser" or "Calamos")
serves as our investment adviser. Calamos is responsible on a day-to-day basis for investment of the Fund's portfolio in accordance with
its investment objective and policies. Calamos makes all investment decisions for the Fund and places purchase and sale orders for the
Fund's portfolio securities. As of January&#160;31, 2025, Calamos managed approximately $40.4 billion in assets of individuals and institutions.
Calamos is a wholly-owned subsidiary of Calamos Investments LLC ("CILLC"). Calamos Asset Management,&#160;Inc. is the sole manager
of CILLC. As of January&#160;31, 2025, approximately 22% of the outstanding interests of CILLC was owned by CAM and the remaining approximately
78% of CILLC was owned by Calamos Partners LLC (&#8220;CPL&#8221;) and John P. Calamos,&#160;Sr. CAM was owned by John P. Calamos,&#160;Sr.
and John S. Koudounis, and CPL was owned by John S. Koudounis and Calamos Family Partners,&#160;Inc. (&#8220;CFP&#8221;). CFP was beneficially
owned by members of the Calamos family, including John P. Calamos,&#160;Sr.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund pays Calamos an annual management fee, payable monthly in
arrears, for its investment management services equal to 0.80% of the Fund's average weekly managed assets. "Managed assets"
means the total assets of the Fund (including any assets attributable to any leverage that may be outstanding) minus the sum of accrued
liabilities (other than debt representing financial leverage). "Net assets" does not include any assets attributable to any
leverage that may be outstanding, or other debt representing financial leverage. See "Management of the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The principal business address of the Adviser is 2020 Calamos Court,
Naperville,&#160;Illinois 60563.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Offering</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer, from time to time, in one or more offerings or series,
together or separately, up to $200,000,000 of our common shares, preferred shares or debt securities, which we refer to, collectively,
as the "securities." We may sell our securities through underwriters or dealers, "at the market" to or through a market
maker into an existing trading market or otherwise directly to one or more purchasers or through agents or through a combination of methods
of sale. The identities of such underwriters, dealers, market makers or agents, as the case may be, will be described in one or more supplements
to this prospectus. The securities may be offered at prices and on terms to be described in one or more supplements to this prospectus.
In the event we offer common shares, the offering price per share of our common shares exclusive of any underwriting commissions or discounts
will not be less than the net asset value per share of our common shares at the time we make the offering except as permitted by applicable
law. To the extent that the Fund issues common shares and current shareholders do not participate, those current shareholders may experience
a dilution of their voting rights as new shares are issued to the public. Depending on the facts, any issuance of new common shares may
also have the effect of reducing any premium to per share net asset value at which the shares might trade and the market price at which
the shares might trade.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, the Fund does not intend to offer any additional preferred
shares or debt securities (collectively, "senior securities"), but reserves the right to do so in the future.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer our securities directly to one or more purchasers, through
agents that we or they designate from time to time, or to or through underwriters or dealers. The prospectus supplement relating to the
relevant offering will identify any agents or underwriters involved in the sale of our securities, and will set forth any applicable purchase
price, fee, commission or discount arrangement between us and such agents or underwriters or among underwriters and the basis upon which
such amount may be calculated. See "Plan of Distribution." Our securities may not be sold through agents, underwriters or dealers
without delivery or deemed delivery of a prospectus and prospectus supplement describing the method and terms of the applicable offering
of our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Proceeds</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless otherwise specified in a prospectus supplement, we currently
intend to use the net proceeds from the sale of our securities primarily to invest in accordance with our investment objective and policies
within approximately three months of receipt of such proceeds. Such investments may be delayed if suitable investments are unavailable
at the time or for other reasons. We may also use proceeds from the sale of our securities (i)&#160;to retire all or a portion of any
short-term debt we incur in pursuit of our investment objective and policies, (ii)&#160;to redeem any outstanding senior securities, and
(iii)&#160;for working capital purposes, including the payment of interest and operating expenses, although there is currently no intent
to issue securities primarily for these purposes. A delay in the anticipated use of proceeds could lower returns, reduce our distribution
to common shareholders and reduce the amount of cash available to make dividend and interest payments on preferred shares and debt securities,
respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 5 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends and Distributions on Common Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund intends to distribute to common shareholders all or a portion
of its net investment income monthly and net realized capital gains, if any, at least annually.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund currently intends to make monthly distributions to common
shareholders at a level rate established by the Board of Trustees. The rate may be modified by the Board of Trustees from time to time.
Monthly distributions may include net investment income, net realized short-term capital gain and, if necessary to maintain a level distribution,
return of capital. The Fund may at times in its discretion pay out less than the entire amount of net investment income earned in any
particular period and may at times pay out such accumulated undistributed income in addition to net investment income earned in other
periods in order to permit the Fund to maintain a more stable level of distributions. As a result, the distributions paid by the Fund
to holders of common shares for any particular period may be more or less than the amount of net investment income earned by the Fund
during such period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will seek to establish a distribution rate that roughly corresponds
to the Adviser's projections of the total return that could reasonably be expected to be generated by the Fund over an extended period
of time, although the distribution rate will not be solely dependent on the amount of income earned or capital gains realized by the Fund.
Calamos, in making such projections, may consider long-term historical returns and a variety of other factors. If, for any monthly distribution,
net investment income and net realized capital gains were less than the amount of the distribution, the difference would be distributed
from the Fund's assets. In addition, in order to make such distributions, the Fund might have to sell a portion of its investment portfolio
at a time when independent investment judgment might not dictate such action. The Fund's final distribution for each calendar year will
include any remaining net investment income undistributed during the year and may include any remaining net realized capital gains undistributed
during the year. The Fund's actual financial performance will likely vary significantly from quarter to quarter and from year to year,
and there may be extended periods of up to several years when the distribution rate will exceed the Fund's actual total returns. The Fund's
projected or actual distribution rate is not a prediction of what the Fund's actual total returns will be over any specific future period.
See "Certain Federal Income Tax Matters &#8212; Federal Income Taxation of Common and Preferred Shareholders" and "Dividends
and Distributions on Common Shares; Automatic Dividend Reinvestment Plan &#8212; Dividends and Distributions on Common Shares" below
for a discussion of the short- and long-term implications associated with Fund distributions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As portfolio and market conditions change, the rate of distributions
on the common shares and the Fund's distribution policy could change. To the extent that the total return of the Fund exceeds the distribution
rate for an extended period, the Fund may be in a position to increase the distribution rate or distribute supplemental amounts to shareholders.
Conversely, if the total return of the Fund is less than the distribution rate for an extended period of time, the Fund will effectively
be drawing upon its net assets to meet payments prescribed by its distribution policy. The rate may be modified by the Fund's Board of
Trustees from time to time without prior notice to the Fund's shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net realized short-term capital gains distributed to shareholders will
be taxed as ordinary income for federal income tax purposes and net realized long-term capital gain (if any) will be taxed for federal
income tax purposes at long-term capital gain rates. To the extent the Fund distributes an amount in excess of the Fund's current and
accumulated earnings and profits, such excess, if any, will be treated by a shareholder for federal income tax purposes as a tax-free
return of capital to the extent of the shareholder's adjusted tax basis in their shares and thereafter as a gain from the sale or exchange
of such shares. Any such distributions made by the Fund will reduce the shareholder's adjusted tax basis in their shares to the extent
that the distribution constitutes a return of capital on a tax basis during any calendar year and, thus, could potentially subject the
shareholder to capital gains taxation in connection with a later sale of Fund shares, even if those shares are sold at a price that is
lower than the shareholder's original investment price. To the extent that the Fund's distributions exceed the Fund's current and accumulated
earnings and profits, the distribution payout rate will exceed the yield generated from the Fund's investments. There is no guarantee
that the Fund will realize capital gain in any given year. Distributions are subject to recharacterization for federal income tax purposes
after the end of the fiscal year. See "Certain Federal Income Tax Matters."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Fund's Automatic Dividend Reinvestment Plan, unless
a shareholder is ineligible or elects otherwise, all dividends and capital gain distributions on common shares are automatically reinvested
in additional common shares of the Fund. However, an investor can choose to receive dividends and distributions in cash. Since investors
can participate in the automatic dividend reinvestment plan only if their broker or nominee participates in our plan, you should contact
your broker or nominee to confirm that you are eligible to participate in the plan. See "Dividends and Distributions on Common Shares;
Automatic Dividend Reinvestment Plan &#8212; Automatic Dividend Reinvestment Plan."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Policies</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Primary Investments.</i> Under normal circumstances, the Fund invests
at least 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span>
The portion of the Fund's assets invested in convertible securities and non-convertible income securities will vary from time to time
consistent with the Fund's investment objective, changes in equity prices and changes in interest rates and other economic and market
factors, although, under normal circumstances, the Fund will invest at least 35% of its managed assets in convertible securities. The
Fund invests in securities with a broad range of maturities. See "Investment Objective and Principal Investment Strategies &#8212;
Principal Investment Strategies."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Securities.</i> The Fund is not limited in the percentage
of its assets invested in convertible securities, and investment in convertible securities forms an important part of the Fund's principal
investment strategies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under normal circumstances, the Fund will invest at least 35% of its
managed assets in convertible securities. A convertible security is a debt security, debenture, note or preferred stock that is exchangeable
for an equity security (typically common stock of the same issuer) at a predetermined price (the "conversion price"). Depending
upon the relationship of the conversion price to the market value of the underlying security, a convertible security may trade more like
an equity security than a debt instrument. The Fund may invest in convertible securities of any rating. See "Investment Objective
and Principal Investment Strategies &#8212; Principal Investment Strategies &#8212; Convertible Securities."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Synthetic Convertible Instruments.</i> The Fund may invest in "synthetic"
convertible instruments. A synthetic convertible instrument is a financial instrument (or two or more securities held in tandem) that
is designed to simulate the economic characteristics of another instrument (i.e., a convertible security) through the combined economic
features of a collection of other securities or assets. Calamos may create a synthetic convertible instrument by combining separate securities
that possess the two principal characteristics of a true convertible security, i.e., a fixed-income security ("fixed-income component",
which may be a convertible or non-convertible security) and the right to acquire an equity security ("convertible component").
The fixed-income component is achieved by investing in fixed-income securities such as bonds, preferred stocks and money market instruments.
The convertible component is achieved by investing in warrants or options to buy common stock at a certain exercise price, or options
on a stock index.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may also invest in synthetic convertible instruments created
by third parties, typically investment banks. Synthetic convertible instruments created by such parties may be designed to simulate the
characteristics of traditional convertible securities or may be designed to alter or emphasize a particular feature. Traditional convertible
securities typically offer the opportunity for stable cash flows with the ability to participate in capital appreciation of the underlying
common stock. Traditional convertible securities are exercisable at the option of the holder. Synthetic convertible instruments may alter
these characteristics by offering enhanced yields in exchange for reduced capital appreciation, additional risk of loss, or any combination
of these features. Synthetic convertible instruments may include structured notes, equity-linked notes, mandatory convertibles and combinations
of securities and instruments, such as a debt instrument combined with a forward contract. The Fund's holdings of synthetic convertible
instruments are considered convertible securities for purposes of the Fund's policy to invest at least 35% of its managed assets in convertible
securities and 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities. See
"Investment Objective and Principal Investment Strategies &#8212; Principal Investment Strategies &#8212; Synthetic Convertible Instruments."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-Convertible Income Securities.</i> The Fund will also invest
in non-convertible income securities. The Fund's investments in non-convertible income securities may have fixed or variable principal
payments and all types of interest rate and dividend payment and reset terms, including fixed rate, adjustable rate, zero coupon, contingent,
deferred, payment in kind and auction rate features. See "Investment Objective and Principal Investment Strategies &#8212; Principal
Investment Strategies &#8212; Non-Convertible Income Securities."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>1</sup> This is a non-fundamental policy and may be changed by
the Board of Trustees of the Fund provided that shareholders are provided with at least 60 days' prior written notice of any change as
required by the rules under the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 7 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>High Yield Securities.</i> A substantial portion of the Fund's assets
may be invested in below investment grade (high yield, high risk) securities for either current income or capital appreciation or both.
These securities are rated Ba or lower by Moody's Investors Service,&#160;Inc. ("Moody's") or BB or lower by Standard&#160;&amp;
Poor's Financial Services, LLC, a subsidiary of The McGraw-Hill Companies,&#160;Inc. ("Standard&#160;&amp; Poor's") or are unrated
securities of comparable quality as determined by Calamos, the Fund's investment adviser. The Fund may invest in high yield securities
of any rating. The Fund may, but currently does not intend to, invest up to 5% of its managed assets in distressed securities that are
in default or the issuers of which are in bankruptcy. Non-convertible debt securities rated below investment grade are commonly referred
to as "junk bonds" and are considered speculative with respect to the issuer's capacity to pay interest and repay principal.
Below investment grade securities involve greater risk of loss, are subject to greater price volatility and are less liquid, especially
during periods of economic uncertainty or change, than higher rated securities. See "Investment Objective and Principal Investment
Strategies &#8212; Principal Investment Strategies &#8212; High Yield Securities."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Foreign Securities.</i> Although the Fund primarily invests in securities
of U.S. issuers, the Fund may invest up to 25% of its net assets in securities of foreign issuers in developed and emerging markets, including
debt and equity securities of corporate issuers and debt securities of government issuers. A foreign issuer is a foreign government or
a company organized under the laws of a foreign country. See "Investment Objective and Principal Investment Strategies &#8212; Principal
Investment Strategies &#8212; Foreign Securities."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Options Writing.</i> The Fund may seek to generate income from option
premiums by writing (selling) options. The Fund may write (sell) call options (i)&#160;on a portion of the equity securities (including
equity securities obtainable by the Fund through the exercise of its rights with respect to convertible securities it owns) in the Fund's
portfolio and (ii)&#160;on broad-based securities indices (such as the Standard and Poor's 500<span style="font-size: 10pt"><sup>&#174;</sup></span>
Index ("S&amp;P 500") or the MSCI EAFE<span style="font-size: 10pt"><sup>&#174;</sup></span> Index ("MSCI EAFE"), which
is an index of international equity stocks) or certain ETFs (exchange-traded funds) that trade like common stocks but seek to replicate
such market indices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, to seek to offset some of the risk of a potential decline
in value of certain long positions, the Fund may also purchase put options on individual securities, broad-based securities indices (such
as the S&amp;P 500 or the MSCI EAFE), or certain ETFs that trade like common stocks but seek to replicate such market indices. See "Investment
Objective and Principal Investment Strategies &#8212; Options Writing."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Rule&#160;144A Securities.</i> The Fund may invest without limit
in certain securities ("Rule&#160;144A Securities"), such as convertible and debt securities, that are typically purchased in
transactions exempt from the registration requirements of the 1933 Act pursuant to Rule&#160;144A under that Act. Rule&#160;144A Securities
may only be sold to qualified institutional buyers, such as the Fund. Any resale of these securities must generally be effected through
a sale that is registered under the 1933 Act or otherwise exempted or excepted from such registration requirements. Under the supervision
and oversight of the Fund's Board of Trustees, Calamos will determine whether Rule&#160;144A Securities are liquid. Typically, the Fund
purchases Rule&#160;144A Securities only if Calamos has determined them to be liquid. If any Rule&#160;144A Security held by the Fund
should become illiquid, the value of the security may be reduced and a sale of the security may be more difficult. See "Investment
Objective and Principal Investment Strategies &#8212; Principal Investment Strategies &#8212; Rule&#160;144A Securities."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Loans.</i> The Fund may invest in loan participations and other
direct claims against a borrower. The corporate loans in which the Fund may invest primarily consist of direct obligations of a borrower
and may include debtor in possession financings pursuant to Chapter 11 of the U.S. Bankruptcy Code, obligations of a borrower issued in
connection with a restructuring pursuant to Chapter 11 of the U.S. Bankruptcy Code, leveraged buy-out loans, leveraged recapitalization
loans, receivables purchase facilities, and privately placed notes. The Fund may invest in a corporate loan at origination as a co-lender
or by acquiring in the secondary market participations in, assignments of or novations of a corporate loan. By purchasing a participation,
the Fund acquires some or all of the interest of a bank or other lending institution in a loan to a corporate or government borrower.
The participations typically will result in the Fund having a contractual relationship only with the lender not the borrower. The Fund
will have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the participation
and only upon receipt by the lender of the payments from the borrower. Many such loans are secured, although some may be unsecured. Such
loans may be in default at the time of purchase. Loans that are fully secured offer the Fund more protection than an unsecured loan in
the event of non-payment of scheduled interest or principal. However, there is no assurance that the liquidation of collateral from a
secured loan would satisfy the corporate borrower's obligation, or that the collateral can be liquidated. Direct debt instruments may
involve a risk of loss in case of default or insolvency of the borrower and may offer less legal protection to the Fund in the event of
fraud or misrepresentation. In addition, loan participations involve a risk of insolvency of the lending bank or other financial intermediary.
The markets in such loans are not regulated by federal securities laws or the Commission.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 8 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other Securities.</i> The Fund may invest in other securities of
various types to the extent consistent with its investment objective. Normally, the Fund invests substantially all of its assets to meet
its investment objective. For temporary defensive purposes, the Fund may depart from its principal investment strategies and invest part
or all of its assets in securities with remaining maturities of less than one year or cash equivalents; or it may hold cash. During such
periods, the Fund may not be able to achieve its investment objective. There are no restrictions as to the ratings of debt securities
acquired by the Fund or the portion of the Fund's assets that may be invested in debt securities in a particular ratings category. For
more information on the types of derivatives that the Fund invests in, see "Investment Objective and Principal Investment Strategies
&#8212; Principal Investment Strategies" in this prospectus and "Investment Objective and Policies" in the statement of
additional information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Leverage by the Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund currently uses, and may in the future use, financial leverage.
The Fund has obtained financial leverage (i)&#160;under the SSB Agreement that allows the Fund to borrow up to $430 million and (ii)&#160;through
the issuance of four series of MRP Shares with an aggregate liquidation preference of $132.75 million, as described in greater detail
below. The Fund's outstanding MRP Shares include 1,340,000 Series&#160;C MRP Shares, with an aggregate liquidation preference of $33,500,000
and a mandatory redemption date of September&#160;6, 2027; 1,320,000 Series&#160;D MRP Shares, with an aggregate liquidation preference
of $33,000,000 and a mandatory redemption date of August&#160;24, 2026; 1,330,000 Series&#160;E MRP Shares, with an aggregate liquidation
preference of $33,250,000 and a mandatory redemption date of May&#160;24, 2027; and 1,320,000 Series&#160;G MRP Shares, with an aggregate
liquidation preference of $33,000,000 and a mandatory redemption date of September&#160;9, 2029. The Series&#160;C, Series&#160;D, Series&#160;E,
and Series&#160;G MRP Shares are to pay monthly cash dividends initially at rates of 4.24%, 2.45%, 2.68%, and 6.24%, respectively, subject
to adjustment under certain circumstances. Additional details regarding the SSB Agreement and the MRP Shares are included under "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of January&#160;31, 2025, the Fund had utilized $315 million of
the $430 million available under the SSB Agreement ($253 million in advances outstanding, and $62 million in structural leverage consisting
of collateral received from counterparties to securities lending transactions through SSB), representing 25.6% of the Fund's managed assets
as of that date, and had $133 million in liquidation preference of MRP Shares outstanding, representing 10.8% of the Fund's managed assets.
Combined, the proceeds of borrowings and structured leverage under the SSB Agreement and the current liquidation preference of outstanding
MRP Shares represented 36.4% of the Fund's managed assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may make further use of financial leverage through the issuance
of additional preferred shares or may borrow money or issue additional debt securities to the extent permitted under the 1940 Act and
under the SSB Agreement. As a non-fundamental policy, the Fund may not issue preferred shares or borrow money and/or issue debt securities
with an aggregate liquidation preference and aggregate principal amount exceeding 38% of the Fund's managed assets measured at the time
of borrowing or issuance of the new securities. However, the Board of Trustees reserves the right to issue preferred shares or debt securities
or borrow to the extent permitted by the 1940 Act. See "Leverage." The holders of preferred shares or debt, if any, on the one
hand, and the holders of the common shares, on the other, may have interests that conflict with each other in certain situations. See
"Description of Securities &#8212; Preferred Shares" and "Certain Provisions of the Agreement and Declaration of Trust
and By-Laws,&#160;Including Antitakeover Provisions."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because Calamos' investment management fee is a percentage of the Fund's
managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage
the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional
use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would
require approval by the Board of Trustees of the Fund. In considering whether to approve the use of additional leverage through those
means, the Board would be presented with all relevant information necessary to make a determination whether or not additional leverage
would be in the best interests of the Fund, including information regarding any potential conflicts of interest. For further information
about the Fund's financial leverage, see "Use of Leverage by the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 9 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For further information about the effects of the Fund's financial leverage
and an illustration of the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by borrowings
and other uses of leverage under the Fund's financing package, see "Effects of Leverage." For further information about leveraging,
see "Risk Factors &#8212; Fund Risks &#8212; Leverage Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Interest Rate Transactions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to seek to reduce the interest rate risk inherent in the Fund's
underlying investments and capital structure, the Fund, if Calamos deems market conditions favorable, may enter into over-the-counter
interest rate swap, cap or floor transactions to attempt to protect itself from increasing dividend or interest expenses on its leverage.
The use of interest rate swaps and caps is a highly specialized activity that involves investment techniques and risks different from
those associated with ordinary portfolio security transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In an interest rate swap, the Fund would agree to pay to the other
party to the interest rate swap (which is known as the "counterparty") a fixed rate payment in exchange for the counterparty
agreeing to pay to the Fund a payment at a variable rate that is expected to approximate the rate on any variable rate payment obligation
on the Fund's leverage. The payment obligations would be based on the notional amount of the swap.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In an interest rate cap, the Fund would pay a premium to the counterparty
to the interest rate cap and, to the extent that a specified variable rate index exceeds a predetermined fixed rate, would receive from
the counterparty payments of the difference based on the notional amount of such cap. There can be no assurance that the Fund will use
interest rate transactions or that, if used, their use will be beneficial to the Fund. Depending on the state of interest rates in general,
the Fund's use of interest rate swap or cap transactions could enhance or harm the overall performance of the common shares. See "Interest
Rate Transactions."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conflicts of Interest</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conflicts of interest may arise from the fact that Calamos and its
affiliates carry on substantial investment activities for other clients, in which the Fund does not have an interest. Calamos or its affiliates
may have financial incentives to favor certain of these accounts over the Fund. Any of their proprietary accounts or other customer accounts
may compete with the Fund for specific trades. Calamos or its affiliates may give advice and recommend securities to, or buy or sell securities
for, other accounts and customers, which advice or securities recommended may differ from advice given to, or securities recommended or
bought or sold for, the Fund, even though their investment objectives may be the same as, or similar to, the Fund's investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Situations may occur when the Fund could be disadvantaged because of
the investment activities conducted by Calamos and its affiliates for their other accounts. Such situations may be based on, among other
things, the following: (1)&#160;legal or internal restrictions on the combined size of positions that may be taken for the Fund or the
other accounts, thereby limiting the size of the Fund's position; (2)&#160;the difficulty of liquidating an investment for the Fund or
the other accounts where the market cannot absorb the sale of the combined position; or (3)&#160;limits on co-investing in negotiated
transactions under the 1940 Act. See "Investment Objective and Principal Investment Strategies &#8212; Conflicts of Interest."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fund Risks</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="color: #231F20">An investment in the Fund is subject to
risks, and you could lose money on your investment in the Fund. There can be no assurance that the Fund will achieve its investment objective.
You should not consider investing in the Fund if your investment objective differs from the Fund's investment objective or if you are
not willing to accept the principal risks associated with an investment in the Fund. The risks associated with an investment in the Fund
can increase during times of significant market volatility. Your investment in the Fund is not a deposit in a bank and is not insured
or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. </span>The principal risks are presented in
alphabetical order to facilitate finding particular risks and comparing them with other funds. Each risk summarized below, including Management
Risk, Portfolio Selection Risk, Equity Securities Risk, Emerging Market Risk and Foreign Securities Risk, among others, is considered
a "principal risk" of investing in the Fund, regardless of the order in which it appears.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 10 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>American Depositary Receipts Risk.</i> The stocks of most foreign
companies that trade in the U.S. markets are traded as ADRs. U.S. depositary banks issue these stocks. Each ADR represents one or more
shares of foreign stock or a fraction of a share. The price of an ADR corresponds to the price of the foreign stock in its home market,
adjusted to the ratio of the ADRs to foreign company shares. Therefore while purchasing a security on a U.S. exchange, the risks inherently
associated with foreign investing still apply to ADRs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Antitakeover Provisions.</i> The Fund's Agreement and Declaration
of Trust and By-Laws include provisions that could limit the ability of other entities or persons to acquire control of the Fund or to
change the composition of its Board of Trustees. Such provisions could limit the ability of shareholders to sell their shares at a premium
over prevailing market prices by discouraging a third party from seeking to obtain control of the Fund. These provisions include staggered
terms of office for the Trustees, advance notice requirements for shareholder proposals, and super-majority voting requirements for certain
transactions with affiliates, converting the Fund to an open-end investment company or a merger, asset sale or similar transaction. Holders
of preferred shares have voting rights in addition to and separate from the voting rights of common shareholders with respect to certain
of these matters. Holders of any preferred shares, voting separately as a single class, have the right to elect at least two Trustees
at all times. See "Description of Securities &#8212; Preferred Shares" and "Certain Provisions of the Agreement and Declaration
of Trust and By-Laws,&#160;Including Antitakeover Provisions." The holders of preferred shares or debt, if any, on the one hand,
and the holders of the common shares, on the other, may have interests that conflict with each other in certain situations, including
conflicts that relate to the fees and expenses of the Fund. For more information on potential conflicts of interest between holders of
common shares and holders of preferred shares, see "Fund Risks &#8212; Leverage Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Holdings Risk.</i> To the extent the Fund holds cash positions,
the Fund risks achieving lower returns and potential lost opportunities to participate in market appreciation which could negatively impact
the Fund's performance and ability to achieve its investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Contingent Liabilities Risk.</i> Entering into derivative contracts
in order to pursue the Fund's various hedging strategies could require the Fund to fund cash payments in the future under certain circumstances,
including an event of default or other early termination event, or the decision by a counterparty to request margin in the form of securities
or other forms of collateral under the terms of the derivative contract or applicable laws. The amounts due with respect to a derivative
contract would generally be equal to the unrealized loss of the open positions with the respective counterparty and could also include
other fees and charges. These payments are contingent liabilities and therefore may not appear on the Fund's balance sheet. The Fund's
ability to fund these contingent liabilities will depend on the liquidity of the Fund's assets and access to capital at the time, and
the need to fund these contingent liabilities could adversely impact our financial condition.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Securities Risk.</i> The value of a convertible security
is influenced by both the yield of non- convertible securities of comparable issuers and by the value of the underlying common stock.
The value of a convertible security viewed without regard to its conversion feature (i.e., strictly on the basis of its yield) is sometimes
referred to as its "investment value." A convertible security's investment value tends to decline as prevailing interest rate
levels increase. Conversely, a convertible security's investment value tends to increase as prevailing interest rate levels decline.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, a convertible security's market value tends to reflect the
market price of the common stock of the issuing company when that stock price is greater than the convertible security's "conversion
price." The conversion price is defined as the predetermined price at which the convertible security could be exchanged for the associated
stock. As the market price of the underlying common stock declines, the price of the convertible security tends to be influenced more
by the yield of the convertible security and changes in interest rates. Thus, the convertible security may not decline in price to the
same extent as the underlying common stock. In the event of a liquidation of the issuing company, holders of convertible securities would
be paid before the company's common stockholders. See "Risk Factors &#8212; Fund Risks &#8212; Convertible Securities Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 11 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Counterparty and Settlement Risk.</i> Trading options, futures contracts,
swaps and other derivative financial instruments entails credit risk with respect to the counterparties with whom and through which the
Fund trades. Such instruments when traded over the counter do not include the same protections as may apply to trading derivatives on
organized exchanges. Substantial losses may arise from the insolvency, bankruptcy or default of a counterparty and risk of settlement
default of parties with whom the Fund trades securities. This risk may be heightened during volatile market conditions. Settlement mechanisms
in emerging markets are generally less developed and reliable than those in more developed countries, thus increasing the risks. In the
past, broker-dealers and other financial institutions have experienced extreme financial difficulty, sometimes resulting in bankruptcy
of the institution. Although Calamos monitors the creditworthiness of the Fund's counterparties, there can be no assurance that the Fund's
counterparties will not experience similar difficulties, possibly resulting in losses to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a counterparty becomes bankrupt or otherwise fails to perform its
obligations under a derivative contract due to financial difficulties, such bankruptcy or failure to perform is likely to result in a
default under such derivative contract, unless such default is cured. Default by a party with whom the Fund enters into a hedging transaction
may result in the loss of unrealized profits, leaving the Fund with unsecured exposure and force the Fund to cover its resale commitments,
if any, at the then current market price. It may not always be possible to dispose of or close out a hedging position without the consent
of the hedging counterparty, and the Fund may not be able to enter into an offsetting contract in order to cover its risk. The Fund cannot
assure its shareholders that a liquid secondary market will exist for hedging instruments purchased or sold, and the Fund may be required
to maintain a position until exercise or expiration, which could result in losses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Furthermore, upon the bankruptcy of a counterparty, the Fund may experience
significant delays in obtaining any recovery under the derivative contract in a dissolution, assignment for the benefit of creditors,
liquidation, winding-up, bankruptcy, or other analogous proceeding. In addition, in the event of the insolvency of a counterparty to a
derivative transaction, the derivative transaction would typically be terminated at its fair market value. If the Fund is owed this fair
market value in the termination of the derivative transaction and its claim is unsecured, the Fund will be treated as a general creditor
of such counterparty, and will not have any claim with respect to the underlying security. The Fund may obtain only a limited recovery
or may obtain no recovery in such circumstances and the enforceability of agreements for hedging transactions may depend on compliance
with applicable statutory and other regulatory requirements and, depending on the identity of the counterparty, applicable international
requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain interest rate and credit default swaps are subject to mandatory
clearing, in which case a central clearing counterparty stands between each buyer and seller and effectively guarantees performance of
each derivative contract, to the extent of its available resources for such purpose. As a result, the counterparty risk is now shifted
from bilateral risk between the parties to the individual credit risk of the central clearing counterparty and the futures commission
merchant through which the Fund holds its cleared position. Even in such case, there can be no assurance that a clearing house, or its
members, will satisfy the clearing house's obligations to the Fund. Uncleared derivatives have no such protection; each party bears the
risk that its direct counterparty will default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>"Covenant-Lite" Loans Risk.</i> Some of the loans in which
the Fund may invest may be "covenant-lite" loans, which means the loans contain fewer or no maintenance covenants than other
loans and do not include terms which allow the lender to monitor the performance of the borrower and declare a default if certain criteria
are breached. The Fund may experience delays in enforcing its rights on its holdings of covenant-lite loans.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Credit Risk.</i> An issuer of a fixed income security could be downgraded
or default. If the Fund holds securities that have been downgraded, or that default on payment, the Fund's performance could be negatively
affected.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Currency Risk.</i> To the extent that the Fund invests in securities
or other instruments denominated in or indexed to foreign currencies, changes in currency exchange rates bring an added dimension of risk.
Currency fluctuations could negatively impact investment gains or add to investment losses. Although the Fund may attempt to hedge against
currency risk, the hedging instruments may not always perform as the Fund expects and could produce losses. Suitable hedging instruments
may not be available for currencies of emerging market countries. The Fund's investment adviser may determine not to hedge currency risks,
even if suitable instruments appear to be available.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 12 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cybersecurity Risk.</i> Investment companies, such as the Fund,
and their service providers are exposed to operational and information security risks resulting from cyberattacks, which may result in
financial losses to a fund and its shareholders. Cyber-attacks include, among other behaviors, stealing or corrupting data maintained
online or digitally, denial of service attacks on websites, "ransomware" that renders systems inoperable until ransom is paid,
the unauthorized release of confidential information, or various other forms of cybersecurity breaches. Cyber-attacks affecting the Fund
or the Adviser, custodian, transfer agent, distributor, administrator, intermediaries, trading counterparties, and other third-party service
providers may adversely impact the Fund or the companies in which the Fund invests, causing the Fund's investments to lose value or to
prevent a shareholder redemption or purchase from clearing in a timely manner.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Debt Securities Risk.</i> The Fund may invest in debt securities,
including corporate bonds and high yield securities. In addition to the risks described elsewhere in this prospectus (such as high yield
securities risk and interest rate risk), debt securities are subject to certain additional risks, including issuer risk and reinvestment
risk. Issuer risk is the risk that the value of debt securities may decline for a number of reasons which directly relate to the issuer,
such as management performance, leverage and reduced demand for the issuer's goods and services. Reinvestment risk is the risk that income
from the Fund's portfolio will decline if the Fund invests the proceeds from matured, traded or called bonds at market interest rates
that are below the Fund portfolio's current earnings rate. A decline in income could affect the market price of the Fund's common shares
or the overall return of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Default Risk.</i> Default risk refers to the risk that a company
that issues a convertible or debt security will be unable to fulfill its obligations to repay principal and interest. The lower a debt
security is rated, the greater its default risk. As a result, the Fund may incur cost and delays in enforcing its rights against the defaulting
issuer. See "Risk Factors &#8212; Fund Risks &#8212; Default Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Derivatives Risk.</i> Generally, derivatives are financial contracts
whose value depends on, or is derived from, the value of an underlying asset, reference rate or index, and may relate to individual debt
or equity instruments, interest rates, currencies or currency exchange rates, commodities, related indexes and other assets. The Fund
may utilize a variety of derivative instruments including, but not limited to, interest rate swaps, caps and floors, convertible securities,
synthetic convertible instruments, options on individual securities, index options, long calls, covered calls, long puts, cash-secured
short puts and protective puts for hedging, risk management and investment purposes. The Fund's use of derivative instruments involves
investment risks and transaction costs to which the Fund would not be subject absent the use of these instruments and, accordingly, may
result in losses greater than if they had not been used. The use of derivative instruments may have risks including, among others, leverage
risk, duration mismatch risk, correlation risk, liquidity risk, interest rate risk, volatility risk, credit risk, management risk and
counterparty risk. Derivatives also involve the risk of mispricing or improper valuation and the risk that changes in the value of a derivative
may not correlate perfectly with an underlying asset, interest rate or index. Suitable derivative transactions may not be available in
all circumstances and there can be no assurance that the Fund will engage in these transactions to reduce exposure to other risks when
that would be beneficial. Furthermore, the skills needed to employ derivatives strategies are different from those needed to select portfolio
securities and, in connection with such strategies, the Fund makes predictions with respect to market conditions, liquidity, currency
movements, market values, interest rates and other applicable factors, which may be inaccurate. Thus, the use of derivative instruments
may require the Fund to sell or purchase portfolio securities at inopportune times or for prices below or above the current market values,
may limit the amount of appreciation the Fund can realize on an investment or may cause the Fund to hold a security that it might otherwise
want to sell. Tax rules&#160;governing the Fund's transactions in derivative instruments may also affect whether gains and losses recognized
by the Fund are treated as ordinary or capital, accelerate the recognition of income or gains to the Fund, defer losses to the Fund, and
cause adjustments in the holding periods of the Fund's securities, thereby affecting, among other things, whether capital gains and losses
are treated as short-term or long-term. These rules&#160;could therefore affect the amount, timing and/or character of distributions to
shareholders. In addition, there may be situations in which the Fund elects not to use derivative instruments that result in losses greater
than if they had been used.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amounts paid by the Fund as premiums and cash or other assets held
in margin accounts with respect to the Fund's derivative instruments would not be available to the Fund for other investment purposes,
which may result in lost opportunities for gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 13 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Derivative instruments can be illiquid, may disproportionately increase
losses and may have a potentially large impact on Fund performance. See "Risk Factors &#8212; Fund Risks &#8212; Derivatives Risk"
for a more complete discussion of the risks associated with derivatives transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Duration Risk.</i> Duration measures the time-weighted expected
cash flows of a fixed-income security, which can determine its sensitivity to changes in the general level of interest rates. The value
of securities with longer durations tend to be more sensitive to interest rate changes than securities with shorter durations. The longer
the Fund's dollar-weighted average duration, the more its value can generally be expected to be sensitive to interest rate changes than
a fund with a shorter dollar-weighted average duration. Duration differs from maturity in that it considers a security's coupon payments
in addition to the amount of time until the security matures. Various techniques may be used to shorten or lengthen the Fund's duration.
As the value of a security changes over time, so will its duration.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Emerging Markets Risk.</i> Emerging market countries may have relatively
unstable governments and economies based on only a few industries, which may cause greater instability. The value of emerging market securities
will likely be particularly sensitive to changes in the economies of such countries. These countries are also more likely to experience
higher levels of inflation, deflation or currency devaluations, which could adversely affect the value of the Fund's investments and hurt
those countries' economies and securities markets. See "Risk Factors &#8212; Fund Risks &#8212; Emerging Markets Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities Risk.</i> Equity investments are subject to greater
fluctuations in market value than other asset classes as a result of such factors as the issuer's business performance, investor perceptions,
stock market trends and general economic conditions. Equity securities are subordinated to bonds and other debt instruments in a company's
capital structure in terms of priority to corporate income and liquidation payments. The Fund may invest in preferred stocks and convertible
securities of any rating, including below investment grade. Below investment grade securities or comparable unrated securities are considered
predominantly speculative with respect to the issuer's ability to pay interest and principal and are susceptible to default or decline
in market value due to adverse economic and business developments. The market values for below investment grade securities tend to be
very volatile, and these securities are generally less liquid than investment grade debt securities. For these reasons, your investment
in the Fund is subject to the following specific risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased price
sensitivity to changing interest rates and to a deteriorating economic environment;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> greater risk of loss due to default or declining credit quality;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> adverse company specific events are more likely to render the
issuer unable to make interest and/or principal payments; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if a negative perception of the below investment grade market
develops, the price and liquidity of below investment grade securities may be depressed. This negative perception could last for a significant
period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Foreign Securities Risk.</i> Investments in non-U.S. issuers may
involve unique risks compared to investing in securities of U.S. issuers. These risks are more pronounced to the extent that the Fund
invests a significant portion of its non-U.S investments in one region or in the securities of emerging market issuers. See also "&#8212;
Emerging Markets Risk" below. These risks may include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> less information may be available about non-U.S. issuers or
markets due to less rigorous disclosure or accounting standards or regulatory practices in foreign jurisdictions;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> many non-U.S. markets are smaller, less liquid and more volatile.
In a changing market, Calamos may not be able to sell the Fund's portfolio securities at times, in amounts and at prices it considers
reasonable;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> an adverse effect of currency exchange rate changes or controls
on the value of the Fund's investments;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the economies of non-U.S. countries may grow at slower rates
than expected or may experience a downturn or recession;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 14 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> economic, political and social developments may adversely affect
the securities markets in foreign jurisdictions, including expropriation and nationalization;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the difficulty in obtaining or enforcing a court judgment in
non-U.S. countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> restrictions on foreign investments in non-U.S. jurisdictions;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> difficulties in effecting the repatriation of capital invested
in non-U.S. countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> withholding and other non-U.S. taxes may decrease the Fund's
return;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the ability for the Public Company Accounting Oversight Board,
which regulates auditors of U.S. public companies, is unable to inspect audit work papers in certain foreign countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> often limited rights and few practical remedies to pursue shareholder
claims, including class actions or fraud claims, and the ability of the Commission, the U.S. Department of Justice and other authorities
to bring and enforce actions against foreign issuers or foreign persons is limited; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> dividend income the Fund receives from foreign securities may
not be eligible for the special tax treatment applicable to qualified dividend income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based upon the Fund's test for determining whether an issuer is a "foreign
issuer" as described above, it is possible that an issuer of securities in which the Fund invests could be organized under the laws
of a foreign country, yet still conduct a substantial portion of its business in the U.S. or have substantial assets in the U.S. In this
case, such a "foreign issuer" may be subject to the market conditions in the U.S. to a greater extent than it may be subject
to the market conditions in the country of its organization. See "Risk Factors &#8212; Fund Risks &#8212; Foreign Securities Risk."
See also " &#8212; Non-U.S. Government Obligation Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Forward Currency Exchange Contracts Risk.</i> Forward contracts
are contractual agreements to purchase or sell a specified currency at a specified future date (or within a specified time period) at
a price set at the time of the contract. The Fund may not fully benefit from, or may lose money on, forward foreign currency transactions
if changes in currency exchange rates do not occur as anticipated or do not correspond accurately to changes in the value of the Fund's
holdings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Geographic Concentration Risk.</i> Investments in a particular country
or geographic region may be particularly susceptible to political, diplomatic or economic conditions and regulatory requirements. To the
extent the Fund concentrates its investments in a particular country, region or group of regions, the Fund may be more volatile than a
more geographically diversified fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>High Yield Securities Risk.</i> The Fund may invest in high yield
securities of any rating. Investment in high yield securities involves substantial risk of loss. Below investment grade non-convertible
debt securities or comparable unrated securities are commonly referred to as "junk bonds" and are considered predominantly speculative
with respect to the issuer's ability to pay interest and principal and are susceptible to default or decline in market value due to adverse
economic and business developments. The market values for high yield securities tend to be very volatile, and these securities are less
liquid than investment grade debt securities. For these reasons, your investment in the Fund is subject to the following specific risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased price sensitivity to changing interest rates and to
a deteriorating economic environment;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> greater risk of loss due to default or declining credit quality;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> adverse company specific events are more likely to render the
issuer unable to make interest and/or principal payments; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if a negative perception of the high yield market develops,
the price and liquidity of high yield securities may be depressed. This negative perception could last for a significant period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 15 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Adverse changes in economic conditions are more likely to lead to a
weakened capacity of a high yield issuer to make principal payments and interest payments than an investment grade issuer. The principal
amount of high yield securities outstanding has proliferated in the past decade as an increasing number of issuers have used high yield
securities for corporate financing. An economic downturn could severely affect the ability of highly leveraged issuers to service their
debt obligations or to repay their obligations upon maturity. The Fund may incur additional expenses to the extent it is required to seek
recovery upon a default in payment of principal or interest on its portfolio holdings. In certain circumstances, the Fund may be required
to foreclose on an issuer's assets and take possession of its property or operations. In such circumstances, the Fund would incur additional
costs in disposing of such assets and potential liabilities from operating any business acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The secondary market for high yield securities may not be as liquid
as the secondary market for more highly rated securities, a factor which may have an adverse effect on the Fund's ability to dispose of
a particular security. There are fewer dealers in the market for high yield securities than for investment grade obligations. The prices
quoted by different dealers may vary significantly and the spread between the bid and asked price is generally much larger than for higher
quality instruments. Under adverse market or economic conditions, the secondary market for high yield securities could contract further,
independent of any specific adverse changes in the condition of a particular issuer, and these instruments may become illiquid. As a result,
the Fund could find it more difficult to sell these securities or may be able to sell the securities only at prices lower than if such
securities were widely traded. Prices realized upon the sale of such lower rated or unrated securities, under these circumstances, may
be less than the prices used in calculating the Fund's NAV. See "Risk Factors &#8212; Fund Risks &#8212; High Yield Securities Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Risk.</i> In addition to the risks described above,
debt securities, including high yield securities, are subject to certain risks, including:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if interest rates go up, the value of debt securities in the
Fund's portfolio generally will decline;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> during periods of declining interest rates, the issuer of a
security may exercise its option to prepay principal earlier than scheduled, forcing the Fund to reinvest in lower yielding securities.
This is known as call or prepayment risk. Debt securities frequently have call features that allow the issuer to repurchase the security
prior to its stated maturity. An issuer may redeem an obligation if the issuer can refinance the debt at a lower cost due to declining
interest rates or an improvement in the credit standing of the issuer;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> during periods of rising interest rates, the average life of
certain types of securities may be extended because of slower than expected principal payments. This may lock in a below market interest
rate, increase the estimated period until the security is paid in full, and reduce the value of the security. This is known as extension
risk;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> rising interest rates could result in an increase in the cost
of the Fund's leverage and could adversely affect the ability of the Fund to meet asset coverage requirements with respect to leverage;
and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> variable rate securities generally are less sensitive to interest
rate changes but may decline in value if their interest rates do not rise as much, or as quickly, as interest rates in general. When the
Fund holds variable rate securities, a decrease in market interest rates will adversely affect the income received from such securities
and the net asset value ("NAV") of the Fund's shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Leverage Risk.</i> <span style="color: #231F20">The
derivative instruments in which the Fund may invest will give rise to forms of financial leverage, which may magnify the risk of owning
such instruments. Derivatives generally involve leverage in the sense that the investment exposure created by the derivatives may be significantly
greater than the Fund&#8217;s initial investment in the derivative. Accordingly, if the Fund enters into a derivative transaction, it
could lose substantially more than the principal amount invested.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has issued indebtedness and preferred
shares and may borrow money or issue debt securities as permitted by the 1940 Act. As of January&#160;31, 2025 the Fund has leverage in
the form of borrowings under the SSB Agreement and outstanding MRP Shares. Leverage is the potential for the Fund to participate in gains
and losses on an amount that exceeds the Fund's investment. The borrowing of money or issuance of debt securities and preferred shares
represents the leveraging of the Fund's common shares. As a non-fundamental policy, the Fund may not issue preferred shares or borrow
money and/or issue debt securities with an aggregate liquidation preference and aggregate principal amount exceeding 38% of the Fund's
managed assets as measured at the time of borrowing or issuance of the new securities. However, the Board of Trustees reserves the right
to issue preferred shares or debt securities or borrow to the extent permitted by the 1940 Act and the Fund's policies. See "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 16 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage creates risks which may adversely affect the return for the
holders of common shares, including:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the likelihood of greater volatility in the NAV and market price
of the Fund's common shares;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> fluctuations in the dividend rates on any preferred shares borne
by the Fund or in interest rates on borrowings and short-term debt;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased operating costs, which are effectively borne by common
shareholders, may reduce the Fund's total return; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the potential for a decline in the value of an investment acquired
with borrowed funds, while the Fund's obligations under such borrowing or preferred shares remain fixed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the rights of lenders and the holders of preferred shares
and debt securities issued by the Fund will be senior to the rights of the holders of common shares with respect to the payment of dividends
or to the payment of assets upon liquidation. Holders of preferred shares have voting rights in addition to and separate from the voting
rights of common shareholders. See "Description of Securities &#8212; Preferred Shares" and "Certain Provisions of the
Agreement and Declaration of Trust and By-Laws,&#160;Including Antitakeover Provisions." The holders of preferred shares or debt,
if any, on the one hand, and the holders of the common shares, on the other, may have interests that conflict in certain situations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage is a speculative technique that could adversely affect the
returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the
income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's
return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased
with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less
than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other
distributions will be reduced or potentially eliminated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will pay, and common shareholders will effectively bear, any
costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares or debt securities. Such
costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and
interest and/or dividend expense and ongoing maintenance. These conditions may, directly or indirectly, result in higher leverage costs
to common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain types of borrowings may result in the Fund being subject to
covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and
additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The
Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject
to certain restrictions on investments imposed by guidelines of and covenants with rating agencies which may issue ratings for the preferred
shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition
requirements that are more stringent than those imposed by the 1940 Act. The Board reserves the right to change the amount and type of
leverage that the Fund uses, and reserves the right to implement changes to the Fund's borrowings that it believes are in the long-term
interests of the Fund and its shareholders, even if such changes impose a higher interest rate or other costs or impacts over the intermediate,
or short-term time period. There is no guarantee that the Fund will maintain leverage at the current rate, and the Board reserves the
right to raise, decrease, or eliminate the Fund's leverage exposure. See "Prospectus Summary &#8212; Use of Leverage by the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 17 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Liquidity Risk.</i> The Fund may invest without limit in securities
that, at the time of investment, are illiquid (i.e., any investment that the Fund reasonably expects cannot be sold or disposed of in
current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the
investment). The Fund may also invest without limit in Rule&#160;144A Securities determined to be liquid. Calamos, under the supervision
and oversight of the Board of Trustees, will determine whether Rule&#160;144A Securities are illiquid (that is, not readily marketable).
Illiquid securities may be difficult to dispose of at a fair price at the times when the Fund believes it is desirable to do so. Investment
of the Fund's assets in illiquid securities may restrict the Fund's ability to take advantage of market opportunities. The market price
of illiquid securities generally is more volatile than that of more liquid securities, which may adversely affect the price that the Fund
pays for or recovers upon the sale of illiquid securities. Illiquid securities are also more difficult to value and may be fair valued
in which case Calamos' judgment may play a greater role in the valuation process. The risks associated with illiquid securities may be
particularly acute in situations in which the Fund's operations require cash and could result in the Fund borrowing to meet its short-term
needs or incurring losses on the sale of illiquid securities. See "Risk Factors &#8212; Fund Risks &#8212; Liquidity Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Loan Risk.</i> The Fund may invest in loans which may not be (i)&#160;rated
at the time of investment, (ii)&#160;registered with the SEC or (iii)&#160;listed on a securities exchange. There may not be as much public
information available regarding these loans as is available for other Fund investments, such as exchange-listed securities. As well, there
may not be an active trading market for some loans, meaning they may be illiquid and more difficult to value than other more liquid securities.
Settlement periods for loans are longer than for exchange-traded securities, typically ranging between 1 and 3 weeks, and in some cases
much longer. There is no central clearinghouse for loan trades, and the loan market has not established enforceable settlement standards
or remedies for failure to settle. Because the interest rates of floating-rate loans in which the Fund may invest may reset frequently,
if market interest rates fall, the loans' interest rates will be reset to lower levels, potentially reducing the Fund's income. Because
the adviser may wish to invest in the publicly-traded securities of an obligor, the Fund may not have access to material non-public information
regarding the obligor to which other investors have access.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Management Risk.</i> Calamos' judgment about the attractiveness,
relative value or potential appreciation of a particular sector, security or investment strategy may prove to be incorrect. See "Risk
Factors &#8212; Fund Risks &#8212; Management Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Disruption Risk.</i> Certain events have a disruptive effect
on the securities markets, such as terrorist attacks, war and other geopolitical events, earthquakes, storms and other disasters. The
Fund cannot predict the effects of similar events in the future on the U.S. economy or any foreign economy. See "Risk Factors &#8212;
Fund Risks &#8212; Market Disruption Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Master Limited Partnerships Risk.</i> Investments in MLPs involve
risks that differ from investments in common stock. Holders of MLP common units are subject to certain risks inherent in the structure
of MLPs, including (i)&#160;tax risks, (ii)&#160;risk related to limited control of management or the general partner or managing member,
(iii)&#160;limited rights to vote on matters affecting the MLP, except with respect to extraordinary transactions, (iv)&#160;conflicts
of interest between the general partner or managing member and its affiliates, on the one hand, and the limited partners or members, on
the other hand, including those arising from incentive distribution payments or corporate opportunities, and (v)&#160;cash flow risks.
MLP common units and other equity securities can be affected by macro-economic and other factors affecting the stock market in general,
expectations of interest rates, investor sentiment towards MLPs or the energy sector, changes in a particular issuer's financial condition,
or unfavorable or unanticipated poor performance of a particular issuer (in the case of MLPs, generally measured in terms of distributable
cash flow). Prices of common units of individual MLPs and other equity securities also can be affected by fundamentals unique to the partnership
or company, including cash flow growth, cash generating power and distribution coverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although certain MLPs may trade on national securities exchanges, certain
MLPs may trade less frequently than those of larger companies due to their market capitalizations. Due to limited trading volumes of certain
MLPs, the prices of such MLPs may display abrupt or erratic movements at times. Additionally, it may be more difficult for the Fund to
buy and sell significant amounts of such securities without an unfavorable impact on prevailing market prices. The Fund's investment in
securities that are less actively traded or over time experience decreased trading volume may restrict its ability to dispose of the securities
at a fair price. Such a situation may prevent the Fund from limiting losses or realizing gains. This also may adversely affect the Fund's
ability to make dividend distributions to shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 18 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MLPs are generally treated as partnerships for U.S. federal income
tax purposes. Partnerships do not pay U.S. federal income tax at the partnership level. Rather, each partner is allocated a share of the
partnership's income, gains, losses, deductions and expenses. A change in current tax law, or a change in the business of a given MLP,
could result in an MLP being treated as a corporation for U.S. federal income tax purposes. As a result, the amount of cash available
for distribution by the MLP would be reduced and the after-tax return to the Fund with respect to its investment in such MLPs would be
materially reduced. Thus, if any of the MLPs owned by the Fund were treated as corporations for U.S. federal income tax purposes, it could
result in a reduction in the value of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Maturity Risk.</i> Interest rate risk will generally affect the
price of a fixed income security more if the security has a longer maturity. Fixed income securities with longer maturities will therefore
be more volatile than other fixed income securities with shorter maturities. Conversely, fixed income securities with shorter maturities
will be less volatile but generally provide lower potential returns than fixed income securities with longer maturities. The average maturity
of the Fund's investments may affect the volatility of the Fund's share price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-Convertible Income Securities Risk.</i> The Fund will also invest
in non-convertible income securities. The Fund's investments in non-convertible income securities may have fixed or variable principal
payments and all types of interest rate and dividend payment and reset terms, including fixed rate, adjustable rate, zero coupon, contingent,
deferred, payment in kind and auction rate features. Recent events in the fixed-income markets, including the potential impact of the
Federal Reserve Board tapering its quantitative easing program, may expose the Fund to heightened interest rate risk and volatility as
a result of a rise in interest rates. In addition, the Fund is subject to the risk that interest rates may exhibit increased volatility,
which could cause the Fund's net asset value to fluctuate more. A decrease in fixed-income market maker capacity may act to decrease liquidity
in the fixed-income markets and act to further increase volatility, affecting the Fund's return.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-U.</i>S<i>. Government Obligation Risk</i>. An investment in
debt obligations of non-U.S. governments and their political subdivisions involves special risks that are not present in corporate debt
obligations. The non-U.S. issuer of the sovereign debt or the non-U.S. governmental authorities that control the repayment of the debt
may be unable or unwilling to repay principal or interest when due, and the Fund may have limited recourse in the event of a default.
During periods of economic uncertainty, the market prices of sovereign debt may be more volatile than prices of debt obligations of U.S.
issuers. See "Risk Factors &#8212; Fund Risks &#8212; Non-U.S. Government Obligation Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Selection Risk.</i> The value of your investment may decrease
if the investment adviser's judgment about the attractiveness, value or market trends affecting a particular security, issuer, industry
or sector or about market movements is incorrect.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Turnover Risk.</i> The portfolio managers may actively
and frequently trade securities or other instruments in the Fund's portfolio to carry out its investment strategies. A high portfolio
turnover rate increases transaction costs, which may increase the Fund's expenses. Frequent and active trading may also cause adverse
tax consequences for investors in the Fund due to an increase in short-term capital gains.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Market Events.</i> Since the 2008 financial crisis, financial
markets throughout the world have experienced increased periods of volatility, depressed valuations, decreased liquidity and heightened
uncertainty and turmoil. This turmoil resulted in unusual and extreme volatility in the equity and debt markets, in the prices of individual
securities and in the world economy. Events that have contributed to these market conditions include, but are not limited to, major cybersecurity
events, geopolitical events (such as wars (including Russia&#8217;s military invasion of Ukraine), terror attacks, natural or environmental
disasters, country instability, and public health emergencies), measures to address budget deficits, downgrading of sovereign debt, dramatic
changes in currency exchange rates, and public sentiment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, policy and legislative changes in the United States and
in other countries are changing many aspects of financial regulation. The impact of these changes on the markets, and the practical implications
for market participants, may not be fully known for some time. Widespread disease and virus epidemics and pandemics, such as the coronavirus
outbreak, could likewise be highly disruptive, adversely affecting individual companies, sectors, industries, markets, currencies, interest
and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Fund's investments. See "Risk
Factors &#8212; Fund Risks &#8212; Recent Market Events."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 19 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>REIT Risk.</i> Investing in real estate investment trusts ("REITs")
involves certain unique risks in addition to those risks associated with investing in the real estate industry in general. An equity REIT
may be affected by changes in the value of the underlying properties owned by the REIT. A mortgage REIT may be affected by changes in
interest rates and the ability of the issuers of its portfolio mortgages to repay their obligations. REITs are dependent upon the skills
of their managers and are not diversified.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">REITs are generally dependent upon maintaining cash flows to repay
borrowings and to make distributions to shareholders and are subject to the risk of default by lessees or borrowers. REITs whose underlying
assets are concentrated in properties used by a particular industry, such as health care, are also subject to risks associated with such
industry. REITs (especially mortgage REITs) are also subject to interest rate risks. When interest rates decline, the value of a REIT's
investment in fixed rate obligations can be expected to rise. Conversely, when interest rates rise, the value of a REIT's investment in
fixed rate obligations can be expected to decline. If the REIT invests in adjustable rate mortgage loans the interest rates on which are
reset periodically, yields on a REIT's investments in such loans will gradually align themselves to reflect changes in market interest
rates. This causes the value of such investments to fluctuate less dramatically in response to interest rate fluctuations than would investments
in fixed rate obligations. REITs may have limited financial resources, may utilize significant amounts of leverage, may trade less frequently
and in a limited volume and may be subject to more abrupt or erratic price movements than larger company securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historically, REITs have been more volatile in price than the larger
capitalization stocks included in Standard&#160;&amp; Poor's 500 Stock Index. See "Risk Factors &#8212; Fund Risks &#8212; REIT Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Risks Associated with Options.</i> There are several risks associated
with transactions in options. For example, there are significant differences between the securities markets and options markets that could
result in an imperfect correlation among these markets, causing a given transaction not to achieve its objectives. A decision as to whether,
when and how to use options involves the exercise of skill and judgment, and even a well-conceived transaction may be unsuccessful to
some degree because of market behavior or unexpected events. The Fund's ability to utilize options successfully will depend on Calamos'
ability to predict pertinent market movements, which cannot be assured.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may sell call options on individual securities and securities
indices. All call options sold by the Fund must be "covered." Even though the Fund will receive the option premium to help protect
it against loss, a call option sold by the Fund exposes the Fund during the term of the option to possible loss of opportunity to realize
appreciation in the market price of the underlying security or instrument and may require the Fund to hold a security or instrument that
it might otherwise have sold. In addition, a loss on a call option sold may be greater than the premium received. The Fund may purchase
and sell put options on individual securities and securities indices. In selling put options, there is a risk that the Fund may be required
to buy the underlying security at a disadvantageous price above the market price. See "Risk Factors &#8212; Fund Risks &#8212; Risks
Associated with Options."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Rule&#160;144A Securities Risk.</i> The Fund may invest in securities
that are issued and sold through transactions under Rule&#160;144A of the Securities Act of 1933. Under the supervision and oversight
of the Board, Calamos will determine whether Rule&#160;144A Securities are illiquid. If qualified institutional buyers are unwilling to
purchase these Rule&#160;144A Securities, the percentage of the Fund's assets invested in illiquid securities would increase. Typically,
the Fund purchases Rule&#160;144A Securities only if the Fund's adviser has determined them to be liquid. If any Rule&#160;144A Security
held by the Fund should become illiquid, the value of the security may be reduced and a sale of the security may be more difficult.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sector Risk.</i> To the extent the Fund invests a significant portion
of its assets in a particular sector, a greater portion of the Fund's performance may be affected by the general business and economic
conditions affecting that sector. Each sector may share economic risk with the broader market, however there may be economic risks specific
to each sector. As a result, returns from those sectors may trail returns from the overall stock market and it is possible that the Fund
may underperform the broader market, or experience greater volatility.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 20 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Synthetic Convertible Instruments Risk.</i> The value of a synthetic
convertible instrument may respond differently to market fluctuations than a convertible instrument because a synthetic convertible instrument
is composed of two or more separate securities, each with its own market value. In addition, if the value of the underlying common stock
or the level of the index involved in the convertible component falls below the exercise price of the warrant or option, the warrant or
option may lose all value. See "Risk Factors &#8212; Fund Risks &#8212; Synthetic Convertible Instruments Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tax Risk.</i> The Fund may invest in certain securities, such as
certain convertible securities and high yield securities, for which the federal income tax treatment may not be clear or may be subject
to recharacterization by the Internal Revenue Service ("IRS"). It could be more difficult for the Fund to comply with certain
federal income tax requirements applicable to regulated investment companies if the tax characterization of the Fund's investments is
not clear or if the tax treatment of the income from such investments was successfully challenged by the IRS. Any failure to comply with
the rules&#160;applicable to regulated investment companies could cause the Fund to fail to qualify as such. In addition, the tax treatment
of the Fund may be affected by future interpretations of the Internal Revenue Code of 1986, as amended (the "Code"), and changes
in the tax laws and regulations, all of which may apply with retroactive effect. See "Risk Factors &#8212; Fund Risks &#8212; Tax
Risk" and "Certain Federal Income Tax Matters."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>U.S. Government Security Risk.</i> Some securities issued by U.S.
Government agencies or government sponsored enterprises are not backed by the full faith and credit of the U.S. and may only be supported
by the right of the agency or enterprise to borrow from the U.S. Treasury. There can be no assurance that the U.S. Government will always
provide financial support to those agencies or enterprises.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Risks to Common Shareholders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Additional risks of investing in common shares include the following:</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Diminished Voting Power and Excess Cash Risk.</i> The voting power
of current shareholders will be diluted to the extent that such shareholders do not purchase shares in any future common share offerings
or do not purchase sufficient shares to maintain their percentage interest. In addition, if the Fund is unable to invest the proceeds
of such offering as intended, its per share distribution may decrease (or may consist of return of capital) and the Fund may not participate
in market advances to the same extent as if such proceeds were fully invested as planned.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Transactions Risk.</i> The Fund may enter into an
interest rate swap, cap or floor transaction to attempt to protect itself from increasing dividend or interest expenses on its leverage
resulting from increasing short-term interest rates and to hedge its portfolio securities. A decline in interest rates may result in a
decline in the value of the swap or cap, which may result in a decline in the net asset value of the Fund. See "Risk Factors &#8212;
Interest Rate Transactions Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Discount Risk.</i> The Fund's common shares have traded both
at a premium and at a discount relative to net asset value. Common shares of closed-end investment companies frequently trade at prices
lower than their net asset value. Depending on the premium of the Fund's common shares, the Fund's net asset value may be reduced immediately
following an offering of the Fund's common shares by the offering expenses paid by the Fund. See "Use of Proceeds."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition to net asset value, the market price of the Fund's common
shares may be affected by such factors as the Fund's use of leverage, dividend stability, portfolio credit quality, liquidity, market
supply and demand of the common shares and the Fund's dividends paid (which are, in turn, affected by expenses), call protection for portfolio
securities and interest rate movements. See "Leverage," "Risk Factors" and "Description of Securities."
The Fund's common shares are designed primarily for long-term investors, and you should not purchase common shares if you intend to sell
them shortly after purchase.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whether shareholders will realize a gain or loss upon the sale of the
Fund's common shares depends upon whether the market value of the shares at the time of sale is above or below the price the shareholder
paid, taking into account transaction costs for the shares, and is not directly dependent upon the Fund's net asset value. Because the
market value of the Fund's common shares will be determined by factors such as the relative demand for and supply of the shares in the
market, general market conditions and other factors beyond the control of the Fund, the Fund cannot predict whether its common shares
will trade at, below or above the Fund's net asset value, or below or above the public offering price for the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 21 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Impact Risk.</i> The sale of our common shares (or the perception
that such sales may occur) may have an adverse effect on prices in the secondary market for our common shares. An increase in the number
of common shares available may put downward pressure on the market price for our common shares. These sales also might make it more difficult
for us to sell additional equity securities in the future at a time and price the Fund deems appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reduction of Leverage Risk.</i> We have previously taken, and may
in the future take, action to reduce the amount of leverage employed by the Fund. Reduction of the leverage employed by the Fund, including
by redemption of preferred shares, will in turn reduce the amount of assets available for investment in portfolio securities. This reduction
in leverage may negatively impact our financial performance, including our ability to sustain current levels of distributions on common
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board reserves the right to change the amount and type of leverage
that the Fund uses, and reserves the right to implement changes to the Fund's borrowings that it believes are in the best long-term interests
of the Fund and its shareholders, even if such changes impose a higher interest rate or other costs or impacts over the intermediate,
or short-term time period. There is no guarantee that the Fund will maintain leverage at the current rate, and the Board reserves the
right to raise, decrease, or eliminate the Fund's leverage exposure.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See "Risk Factors &#8212; Additional Risks to Common Shareholders"
for a more detailed discussion of these risks.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Risks to Senior Security Holders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Additional risks of investing in senior securities include the
following:</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Generally, an investment in preferred shares (including exchange-listed
preferred shares) or debt securities (collectively, "senior securities") is subject to the following risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Decline in Net Asset Value Risk.</i> A material decline in the Fund's
NAV may impair our ability to maintain required levels of asset coverage for outstanding borrowings or any debt securities or preferred
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Early Redemption Risk.</i> The Fund may voluntarily redeem preferred
shares or may be forced to redeem preferred shares to meet regulatory requirements and the asset coverage requirements of the preferred
shares. Such redemptions may be at a time that is unfavorable to holders of the preferred shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inflation Risk.</i> Inflation is the reduction in the purchasing
power of money resulting from an increase in the price of goods and services. Inflation risk is the risk that the inflation adjusted or
"real" value of an investment in preferred stock or debt securities or the income from that investment will be worth less in
the future. As inflation occurs, the real value of the preferred stock or debt securities and the dividend payable to holders of preferred
stock or interest payable to holders of debt securities declines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Risk.</i> Rising market interest rates could impact
negatively the value of our investment portfolio, reducing the amount of assets serving as asset coverage for the senior securities. Rising
market interest rates could also reduce the value of the Fund's senior securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Discount Risk.</i> The market price of exchange-listed preferred
shares that the Fund may issue may also be affected by such factors as the Fund's use of leverage, dividend stability, portfolio credit
quality, liquidity, and the Fund's dividends paid (which are, in turn, affected by expenses), call protection for portfolio securities
and interest rate movements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Ratings and Asset Coverage Risk.</i> To the extent that senior securities
are rated, a rating does not eliminate or necessarily mitigate the risks of investing in our senior securities, and a rating may not fully
or accurately reflect all of the credit and market risks associated with that senior security. A rating agency could downgrade the rating
of our shares of preferred stock or debt securities, which may make such securities less liquid in the secondary market, though potentially
with higher resulting interest rates. If a rating agency downgrades the rating assigned to a senior security, we may alter our portfolio
or redeem the senior security. We may voluntarily redeem senior securities under certain circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 22 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Secondary Market Risk.</i> The market value of exchange-listed preferred
shares that the Fund may issue will be determined by factors such as the relative demand for and supply of the preferred shares in the
market, general market conditions and other factors beyond the control of the Fund. It may be difficult to predict the trading patterns
of preferred shares, including the effective costs of trading. There is a risk that the market for preferred shares may be thinly traded
and relatively illiquid compared to the market for other types of securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Leverage Risk.</i> Preferred shares will be junior in liquidation
and with respect to distribution rights to debt securities and any other borrowings. Senior securities representing indebtedness may constitute
a substantial lien and burden on preferred shares by reason of their prior claim against our income and against our net assets in liquidation.
We may not be permitted to declare dividends or other distributions with respect to any series of preferred shares unless at such time
we meet applicable asset coverage requirements and the payment of principal or interest is not in default with respect to any borrowings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See "Risk Factors &#8212; Additional Risks to Senior Security
Holders" for a more detailed discussion of these risks.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SUMMARY OF FUND EXPENSES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table and example contain information about the costs
and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows
our expenses, including interest payments on borrowed funds, and preferred stock dividend payments, as a percentage of our average net
assets as of January&#160;31, 2025, and not as a percentage of gross assets or managed assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By showing expenses as a percentage of average net assets, expenses
are not expressed as a percentage of all of the assets we invest. The table and example are based on our capital structure as of January&#160;31,
2025. As of January&#160;31, 2025, the Fund had utilized $315 million of the $430 million available under the SSB Agreement ($263 million
in advances outstanding, and $62 million in structural leverage consisting of collateral received from counterparties via SSB in connection
with securities on loan), representing 25.6% of the Fund's managed assets as of that date, and had $133 million of MRP Shares outstanding,
representing 10.8% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented
36.4% of the Fund's managed assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><b>Shareholder Transaction Expenses</b></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Sales Load (as a percentage of offering price)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 10%">&#8212;</td>
    <td style="width: 2%"><span style="font-size: 10pt"><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Offering Expenses Borne by the Fund (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td><span style="font-size: 10pt"><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Dividend Reinvestment Plan Fees (per sales transaction fee)<span style="font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">15.00</td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Annual Expenses</td><td style="white-space: nowrap; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percentage of Average Net<br/> Assets Attributable to<br/> Common Shareholders</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt">Management Fee<span style="font-size: 10pt"><sup>(3)</sup></span></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 16%; font-size: 10pt; text-align: right">1.26</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Interest Payments on Borrowed Funds<span style="font-size: 10pt"><sup>(4)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2.18</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Preferred Stock Dividend Payments<span style="font-size: 10pt"><sup>(5)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0.70</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">Other Expenses<span style="font-size: 10pt"><sup>(6)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0.09</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total Annual Expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.23</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 23 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Example:</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following example illustrates the expenses that common shareholders
would pay on a $1,000 investment in common shares, assuming (1)&#160;total annual expenses of 4.23% of net assets attributable to common
shareholders; (2)&#160;a 5% annual return; and (3)&#160;all distributions are reinvested at net asset value:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">1 Year</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">3 Years</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">5 Years</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">10 Years</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-size: 10pt; text-align: left">Total Expenses Paid by Common Shareholders<span style="font-size: 10pt"><sup>(7)</sup></span>.</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">42</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">128</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">216</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">441</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The example should not be considered a representation of future
expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the
hypothetical 5% return shown in the example.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&#160;If the securities to which this prospectus relates are sold
to or through underwriters, the prospectus supplement will set forth any applicable sales load and the estimated offering expenses borne
by us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2)&#160;Shareholders will pay a $15.00 transaction fee plus a $0.02
per share brokerage charge if they direct the Plan Agent (as defined below) to sell common shares held in a Plan account. In addition,
each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in
connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his
or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the
shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3)&#160;The Fund pays Calamos an annual management fee, payable monthly
in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance
with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable
to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage
of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's
average weekly net assets as of January&#160;31, 2025 by dividing the total dollar amount of the management fee by the Fund's average
weekly net assets (managed assets less outstanding leverage).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(4)&#160;Reflects interest expense paid on $254 million in average
borrowings under the SSB Agreement, plus $61 million in additional average structural leverage related to certain securities lending
programs, as described under "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(5)&#160;Reflects estimated dividend expense on $133 million aggregate
liquidation preference of mandatory redeemable preferred shares outstanding. See "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(6)&#160;"Other Expenses" are based on estimated amounts
for the Fund's current fiscal year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(7)&#160;The example does not include sales load or estimated offering
costs, which would cause the expenses shown in the example to increase. In connection with an offering of common shares, the applicable
prospectus supplement will set forth an example including sales load and estimated offering costs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purpose of the table and the example above is to help investors
understand the fees and expenses that they, as common shareholders, would bear directly or indirectly. For additional information with
respect to our expenses, see "Management of the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FINANCIAL HIGHLIGHTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information in the table below for the fiscal years ended October&#160;31,
2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016 and 2015 is derived from the Fund's financial statements for the fiscal year ended
October&#160;31, 2024 audited by Deloitte&#160;&amp; Touche LLP, whose report on such financial statements is contained in the Fund's
<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924132100/tm2424550d2_ncsr.htm" style="-sec-extract: exhibit">October&#160;31, 2024 Annual Report</a> and is incorporated by reference into the Statement of Additional Information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 24 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Selected data for a share outstanding throughout each year was as follows:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 8pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year<br/>
 Ended <br/>
October<br/>
31,
    2024</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year <br/>
Ended <br/>
October<br/>
31,
    2023</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year<br/>
 Ended <br/>
October<br/>
31,
    2022</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year<br/>
 Ended <br/>
October<br/>
31,
    2021</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year<br/>
 Ended <br/>
October<br/>
31,
    2020</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year <br/>
Ended <br/>
October<br/>
31,
    2019</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year <br/>
Ended <br/>
October<br/>
31,
    2018</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year <br/>
Ended <br/>
October<br/>
31,
    2017</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year <br/>
Ended <br/>
October<br/>
31,
    2016</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year<br/>
 Ended <br/>
October<br/>
31,
    2015</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 8pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 1pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="13" style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">PER SHARE OPERATING PERFORMANCE</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Net
    asset value, beginning of year</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">8.99</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">10.26</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">15.49</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">12.54</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">10.64</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">10.46</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">11.35</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">10.73</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">11.68</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-size: 8pt">13.45</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Income
    from investment operations:</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    investment income (loss)<sup>*</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.20</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.10</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.01</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.26</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.49</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.50</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.57</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.57</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.60</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.62</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Net
    realized and unrealized gain (loss)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.39</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.03</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(4.11</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.31</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.37</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.64</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.33</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.19</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.41</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.25</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Total
    from investment operations</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.19</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.13</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(4.10</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.05</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.86</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.24</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.76</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.19</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.63</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Less
    distributions to common shareholders from:</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Net
    investment income</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.42</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.15</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.27</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.31</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.44</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.48</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.13</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.67</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.59</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.81</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Net
    realized gains</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.21</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.99</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.87</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.79</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.52</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.31</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.08</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.02</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in"><span style="font-size: 8pt">Return
    of capital</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.51</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.17</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.39</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.55</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.31</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Total
    distributions</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.10</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.96</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(0.96</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.13</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.14</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Premiums
    from shares sold in at the market offerings</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.01</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt"><sup>(a)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.00</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt"><sup>(a)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.00</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt"><sup>(a)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.00</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt"><sup>(a)</sup></span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Net
    asset value, end of year</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.04</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">8.99</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.26</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">15.49</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">12.54</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.64</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.46</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">11.35</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.73</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">11.68</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">Market
    value, end of year</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">11.43</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">9.99</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.78</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">15.81</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.89</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.67</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">9.91</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">11.59</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">9.89</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">10.41</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="16" style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">TOTAL
    RETURN APPLICABLE TO COMMON SHAREHOLDERS</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    investment return based on:<sup>(b)</sup></span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in"><span style="font-size: 8pt">Net
    asset value</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">24.26</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(2.27</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(27.32</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">33.21</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">29.38</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">11.75</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.81</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">17.48</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3.19</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(4.69</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in"><span style="font-size: 8pt">Market
    value</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">27.31</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3.27</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(25.10</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">56.56</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">12.04</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">18.29</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(5.54</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">30.15</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">6.72</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(16.54</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="28" style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">RATIOS
    TO AVERAGE NET ASSETS APPLICABLE TO COMMON SHAREHOLDERS</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    expenses<sup>(c)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.52</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.40</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.44</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.83</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.20</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.88</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">2.52</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.88</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.74</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1.84</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Net
    investment income (loss)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(2.00</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.03</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.08</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">(1.76</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">)%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.36</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.77</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">5.11</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">5.17</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">5.61</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4.90</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td colspan="5" style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">SUPPLEMENTAL
    DATA</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Net
    assets applicable to common shareholders, end of year (000)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">759,206</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">672,782</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">759,716</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">1,111,526</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">889,577</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">754,310</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">741,306</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">797,968</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">750,773</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">817,491</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="font: 8pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 8pt">Portfolio
    turnover rate</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">50</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">39</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">39</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">46</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">76</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">51</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">58</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">90</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">34</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">36</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">%</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Average
    commission rate paid</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0186</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0188</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0215</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0215</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0213</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0188</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0270</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0282</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0220</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">0.0303</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Mandatory
    Redeemable Preferred Shares, at redemption value ($25 per share liquidation preference) (000's omitted)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">132,750</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">133,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">133,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">133,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">100,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">100,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">100,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">100,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">Notes
    Payable (000's omitted)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">314,650</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">314,400</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">339,400</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">399,400</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">288,400</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">277,400</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">288,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">275,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">306,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">353,000</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Asset
    coverage per $1,000 of loan outstanding<sup>(d)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,835</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,563</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,630</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4,116</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4,431</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4,080</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,921</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">4,265</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,454</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">3,316</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Asset
    coverage per $25 liquidation value per share of Mandatory Redeemable Preferred Shares<sup>(e)</sup></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">227</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">211</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">232</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">309</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">319</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">283</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">282</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">293</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">$</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Net investment income (loss) calculated based on average shares
method.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&#160;Amount is less than $0.005 per common share.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&#160;Total investment return is calculated assuming a purchase
of common stock on the opening of the first day and a sale on the closing of the last day of the period reported. Dividends and distributions
are assumed, for purposes of this calculation, to be reinvested at prices obtained under the Fund's dividend reinvestment plan. Total
return is not annualized for periods less than one year. Brokerage commissions are not reflected. NAV per share is determined by dividing
the value of the Fund's portfolio securities, cash and other assets, less all liabilities, by the total number of common shares outstanding.
The common share market price is the price the market is willing to pay for shares of the Fund at a given time. Common share market price
is influenced by a range of factors, including supply and demand and market conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 25 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&#160;Ratio of net expenses, excluding interest expense on Notes
Payable and interest expense and amortization of offering costs on Mandatory Redeemable Preferred Shares, to average net assets was 1.37%,
1.38%, 1.34%, 1.23%, 1.26%, 1.29%, 1.28%, 1.24%, 1.24%, and 1.50%, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Calculated by subtracting the Fund's total liabilities (not
including Notes payable and Mandatory Redeemable Preferred Shares) from the Fund's total assets and dividing this by the amount of Notes
payable outstanding, and by multiplying the result by 1,000.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&#160;Calculated by subtracting the Fund's total liabilities (not
including Notes payable and Mandatory Redeemable Preferred Shares) from the Fund's total assets and dividing this by the amount of Mandatory
Redeemable Preferred Shares outstanding, and by multiplying the result by 25.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth information regarding the Fund's outstanding
bank loans and MRP Shares as of the end of each of the Fund's last ten fiscal years, as applicable. The information in the table shown
below comes from the Fund's financial statements for the fiscal year ended October&#160;31, 2024, and each of the prior nine years then
ended, all of which have been audited by Deloitte&#160;&amp; Touche LLP, the Fund's independent registered public accounting firm.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">Fiscal&#160;Year&#160;Ended</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total&#160;Amount<br/> Outstanding</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Asset<br/> Coverage</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>Liquidating<br/> Preference&#160;per<br/> Preferred&#160;Share<sup>(c)</sup></b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Average<br/> Market<br/> Value&#160;per<br/> Preferred&#160;Share</td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td style="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Type&#160;of<br/> Senior<br/> Security</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2024</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">314,650,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">3,835</td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">132,750,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">227</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">314,400,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">3,563</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">133,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">211</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">339,400,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,630</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">133,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">232</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">399,400,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,116</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">133,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">309</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2020</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">288,400,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,431</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2020</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">319</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2019</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">277,400,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,080</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2019</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">283</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2018</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">288,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,921</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2018</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">282</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2017</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">275,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,265</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2017</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">293</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(b)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">25</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(d)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">MRPS</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2016</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">306,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,454</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">October&#160;31, 2015</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">353,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,316</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"><sup>(a)</sup></span>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Loan</td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&#160;Calculated by subtracting the Fund's total liabilities (not
including notes payable and MRPS) from the Fund's total assets and dividing this by the amount of notes payable outstanding, and by multiplying
the result by 1,000.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&#160;Calculated by subtracting the Fund's total liabilities (not
including MRPS) from the Fund's total assets and dividing this by the number of MRPS outstanding, and by multiplying the result by 25.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&#160;"Liquidating Preference per Preferred Share" means
the amount to which a holder of preferred shares would be entitled upon the liquidation of the Fund in preference to common shareholders,
expressed as a dollar amount per preferred share.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;The MRPS are not listed on any exchange or automated quotation
system. The MRPS are considered debt of the issuer; and the liquidation preference approximates fair value.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 26 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MARKET AND NET ASSET VALUE INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our common shares are listed on the Nasdaq Global Select Market ("Nasdaq")
under the symbol "CHI." Our common shares commenced trading on the New York Stock Exchange ("NYSE") in June&#160;2002.
On July&#160;2, 2012, the common shares ceased trading on the NYSE and commenced trading on Nasdaq.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our common shares have traded both at a premium and a discount to NAV.
We cannot predict whether our shares will trade in the future at a premium or discount to NAV. The provisions of the 1940 Act generally
require that the public offering price of common shares (less any underwriting commissions and discounts) must equal or exceed the NAV
per share of a company's common stock (calculated within 48 hours of pricing). Our issuance of common shares may have an adverse effect
on prices in the secondary market for our common shares by increasing the number of common shares available, which may put downward pressure
on the market price for our common shares. Shares of common stock of closed-end investment companies frequently trade at a discount from
NAV. See "Risk Factors &#8212; Additional Risks to Common Shareholders &#8212; Market Discount Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth for each of the periods indicated the
high and low closing market prices for our common shares on Nasdaq, the NAV per share and the premium or discount to NAV per share at
which our common shares were trading. NAV is shown for the last business day of each quarter. See "Net Asset Value" for information
as to the determination of our NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Market Price<span style="font-size: 10pt"><sup>(1)</sup></span></b></td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Net Asset<br/> Value at<br/> Quarter</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>Premium/<br/> (Discount)<br/> to Net Asset<br/> Value<span style="font-size: 10pt"><sup>(3)</sup></span></b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Quarter Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">High</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Low</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>End<span style="font-size: 10pt"><sup>(2)</sup></span></b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">High</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Low</b></td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-size: 10pt">January&#160;31, 2025</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">12.28</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">11.19</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">10.25</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">22.85</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">10.59</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">October&#160;31, 2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">12.01</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.91</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.04</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">18.20</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">13.13</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">July&#160;31, 2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">12.02</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.04</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">9.95</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">20.24</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">11.61</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">April&#160;30, 2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.54</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.55</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">9.74</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">14.21</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7.46</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">January&#160;31, 2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.71</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">9.74</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">12.00</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0.41</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">October&#160;31, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.32</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">8.99</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">15.20</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.56</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">July&#160;31, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.36</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">9.90</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.51</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">10.21</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1.53</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">April&#160;30, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">12.34</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.21</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">9.94</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">16.91</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1.49</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">January&#160;31, 2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">12.09</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.51</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.61</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">15.03</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3.89</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source: Fund Accounting Records.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&#160;Based on high and low closing market price per share during
the respective quarter and does not reflect commissions.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2)&#160;Based on the NAV calculated on the close of business on the
last business day of each calendar quarter.&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3)&#160;Premium and discount information is shown for the days when
the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The last reported sale price, NAV per common share and percentage premium
to NAV per common share on January&#160;31, 2025 were $11.37, $10.25 and 10.93%, respectively. As of January&#160;31, 2025, we had 76,312,702
common shares outstanding and managed assets of $1.2 billion.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>USE OF PROCEEDS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to the remainder of this section, and unless otherwise specified
in a prospectus supplement, we currently intend to invest the net proceeds of any sales of our securities pursuant to this prospectus
in accordance with our investment objective and policies as described under "Investment Objective and Principal Investment Strategies"
within approximately three months of receipt of such proceeds. Such investments may be delayed if suitable investments are unavailable
at the time or for other reasons. Pending such investment, we anticipate that we will invest the proceeds in securities issued by the
U.S. government or its agencies or instrumentalities or in high quality, short-term or long-term debt obligations. We may also use proceeds
from the sale of our securities to (i)&#160;retire all or a portion of any short-term debt we incur in pursuit of our investment objective
and policies, (ii)&#160;to redeem any outstanding senior securities, and (iii)&#160;for working capital purposes, including the payment
of interest and operating expenses, although there is currently no intent to issue securities primarily for these purposes. A delay in
the anticipated use of proceeds could lower returns, reduce our distribution to common shareholders and reduce the amount of cash available
to make dividend and interest payments on preferred shares and debt securities, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos Convertible Opportunities and Income Fund is a diversified,
closed-end management investment company which commenced investment operations in June&#160;2002. The Fund was organized as a statutory
trust under the laws of the State of Delaware on April&#160;17, 2002, and has registered under the 1940 Act. On June&#160;28, 2002, the
Fund issued an aggregate of 40,000,000 common shares, no par value, in an initial public offering and commenced its operations. On July&#160;12,
2002 and August&#160;13, 2002, the Fund issued an additional 3,000,000 and 225,000 common shares, respectively, in connection with exercises
by the underwriters of their over-allotment option. The net proceeds of the initial public offering and subsequent exercises of the over-allotment
option were approximately $619,298,400 after the payment of offering expenses. As of January&#160;31, 2019, the Fund had issued an additional
19,077,463 common shares in connection with a continuous, at-the-market offering that commenced in June&#160;2008 and ceased in December&#160;2017
(the "2017 ATM Offering"). The net proceeds of the 2017 ATM Offering were $228,615,606. As of January&#160;31, 2022, the Fund
had issued an additional 1,143,832 common shares in connection with a continuous, at-the-market offering that commenced in March&#160;2019
and ceased in February&#160;2022 (the &#8220;2022 ATM Offering&#8221;). The net proceeds of the 2022 ATM Offering were $18 million. <span style="color: #231F20">As
of January&#160;31, 2025, the Fund had issued an additional 1,944,147 common shares in connection with a continuous, at-the-market offering
that commenced on February&#160;24, 2022.</span> The net proceeds from this ATM offering were $23 million.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of January&#160;31, 2025, the Fund had utilized $315 million of
the $430 million available under the SSB Agreement ($253 million in advances outstanding, and $62 million in structural leverage consisting
of collateral received from counterparties to securities lending transactions through SSB in connection with securities on loan), representing
25.6% of the Fund's managed assets as of that date, and had $133 million of MRP Shares outstanding, representing 10.8% of the Fund's managed
assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 36.4% of the Fund's managed assets.
Structural leverage refers to fundings under the SSB Agreement where the source of funding is the Fund's securities lending activities
as managed by SSB in accordance with the SSB Agreement. See "Leverage." The Fund's common shares are listed on Nasdaq under
the symbol "CHI." The Fund's principal office is located at 2020 Calamos Court, Naperville,&#160;Illinois 60563, and its telephone
number is 800-582-6959.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides information about our outstanding securities
as of January&#160;31, 2025:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Title of Class</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount<br/> Authorized<br/> (shares)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount <br/> Held by the <br/> Fund or for <br/> its Account</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount <br/> Outstanding <br/> (shares)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; font-size: 10pt">Common Shares</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">Unlimited</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">76,312,702</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">MRPS-Series&#160;C</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,340,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,340,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">MRPS-Series&#160;D</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,320,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,320,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">MRPS-Series&#160;E</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,330,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,330,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">MRPS-Series&#160;G</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,320,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,320,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INVESTMENT OBJECTIVE AND PRINCIPAL INVESTMENT
STRATEGIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Objective</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's investment objective is to provide total return through
a combination of capital appreciation and current income. The Fund's investment objective may be changed by the Board of Trustees without
a shareholder vote, although the Fund will give shareholders at least 60 days' written notice of any change to the Fund's investment objective.
The Fund makes no assurance that it will realize its objective. An investment in the Fund may be speculative in that it involves a high
degree of risk and should not constitute a complete investment program. See "Risk Factors."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 28 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principal Investment Strategies</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under normal circumstances, the Fund invests at least 80% of its managed
assets in a diversified portfolio of convertible securities and non-convertible income securities. This is a non-fundamental policy and
may be changed by the Board of Trustees of the Fund provided that shareholders are provided with at least 60 days' prior written notice
of any change as required by the rules&#160;under the 1940 Act. The portion of the Fund's assets invested in convertible securities and
non-convertible income securities will vary from time to time consistent with the Fund's investment objective, changes in equity prices
and changes in interest rates and other economic and market factors, although, under normal circumstances, the Fund will invest at least
35% of its managed assets in convertible securities. The Fund invests in securities with a broad range of maturities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Securities.</i> The Fund is not limited in the percentage
of its assets invested in convertible securities, and investment in convertible securities forms an important part of the Fund's principal
investment strategies. Under normal circumstances, the Fund will invest at least 35% of its managed assets in convertible securities.
A convertible security is a debt security, debenture, note or preferred stock that may be converted into an equity security (typically
common stock of the same issuer) at a predetermined price (the "conversion price"). Depending upon the relationship of the conversion
price to the market value of the underlying security, a convertible security may trade more like an equity security than a debt instrument.
The Fund may invest in convertible securities of any rating.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos typically applies a four-step approach when buying and selling
convertible securities for the Fund, which includes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. Evaluating the default risk of the convertible security using traditional
credit analysis;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Analyzing the convertible's underlying common stock to determine
its capital appreciation potential;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Assessing the risk/return potential of the convertible security;
and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. Evaluating the convertible security's impact on the overall composition
of the Fund and its diversification strategy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In analyzing the appreciation potential of the underlying common stock
and the default risk of the convertible security, Calamos generally considers the issuer's:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> financial soundness;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> ability to make interest and dividend payments;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> earnings and cash-flow forecast; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> quality of management.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Synthetic Convertible Instruments.</i> The Fund may invest in "synthetic"
convertible instruments. A synthetic convertible instrument is a financial instrument (or two or more securities held in tandem) that
is designed to simulate the economic characteristics of another instrument (i.e., a convertible security) through the combined economic
features of a collection of other securities or assets. Calamos may create a synthetic convertible instrument by combining separate securities
that possess the two principal characteristics of a true convertible security, i.e., a fixed-income security ("fixed-income component",
which may be a convertible or non-convertible security) and the right to acquire an equity security ("convertible component").
The fixed-income component is achieved by investing in fixed-income securities such as bonds, preferred stocks and money market instruments.
The convertible component is achieved by investing in warrants or options to buy common stock at a certain exercise price, or options
on a stock index.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 29 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may also invest in synthetic convertible instruments created
by third parties, typically investment banks. Synthetic convertible instruments created by such parties may be designed to simulate the
characteristics of traditional convertible securities or may be designed to alter or emphasize a particular feature. Traditional convertible
securities typically offer the opportunity for stable cash flows with the ability to participate in capital appreciation of the underlying
common stock. Traditional convertible securities are exercisable at the option of the holder. Synthetic convertible instruments may alter
these characteristics by offering enhanced yields in exchange for reduced capital appreciation, additional risk of loss, or any combination
of these features. Synthetic convertible instruments may include structured notes, equity-linked notes, mandatory convertibles and combinations
of securities and instruments, such as a debt instrument combined with a forward contract. The Fund's holdings of synthetic convertible
instruments are considered convertible securities for purposes of the Fund's policy to invest at least 35% of its managed assets in convertible
securities and 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Some examples of these securities include the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred equity redeemable cumulative stock ("PERCS") are
shares that automatically convert into one ordinary share upon maturity. They are usually issued at the prevailing share price, convertible
into one ordinary share, with an enhanced dividend yield. PERCS pay a higher dividend than common shares, but the equity appreciation
is capped. Above a certain share price, the conversion ratio will fall as the stock rises, capping the appreciation at that level. Below
this level, the conversion ratio remains one-for-one, giving the same downside exposure as the ordinary shares, excluding the income difference.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dividend enhanced convertible stock ("DECS") are either preference
shares or subordinated bonds. These, like PERCS, mandatorily convert into ordinary shares at maturity, if not already converted. DECS
give no significant loss protection and involve a risk of loss comparable to investing directly in equity securities, with lower relative
direct bond characteristics and interest rate exposure. As with PERCS, some of the appreciation potential is capped and in return, the
investor receives an enhanced potential yield. Unlike PERCS, however, the investor's appreciation potential is not capped. Instead, the
investor limits its ability to participate in appreciation within a range of prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred Redeemable Increased Dividend Equity Security ("PRIDES")
are synthetic securities consisting of a forward contract to purchase the issuer's underlying security and an interest bearing deposit.
Interest payments are made at regular intervals, and conversion into the underlying security is mandatory at maturity. Similar to convertible
securities, PRIDES allow investors the potential to earn stable cash flows while still participating in the appreciation of an underlying
stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may also purchase convertible structured notes. Convertible
structured notes are fixed income debentures linked to equity. Convertible structured notes have the attributes of a convertible security;
however, the investment bank that issued the convertible note assumes the credit risk associated with the investment, rather than the
issuer of the underlying common stock into which the note is convertible. Different companies may issue the fixed-income and convertible
components, which may be purchased separately and at different times. The Fund remains subject to the credit risk of the issuing investment
bank.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain convertible debt securities include a "put option"
which entitles the Fund to sell the security to the issuer before maturity at a stated price, which may represent a premium over the stated
principal amount of the debt security. Conversely many convertible securities are issued with a "call" feature that allows the
security's issuers to choose when to redeem the security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-Convertible Income Securities.</i> The Fund will also invest
in non-convertible income securities. The Fund's investments in non-convertible income securities may have fixed or variable principal
payments and all types of interest rate and dividend payment and reset terms, including fixed rate, adjustable rate, zero coupon, contingent,
deferred, payment in kind and auction rate features.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 30 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>High Yield Securities.</i> A substantial portion of the Fund's assets
may be invested in below investment grade (high yield, high risk) securities for either current income or capital appreciation or both.
These securities are rated Ba or lower by Moody's or BB or lower by Standard&#160;&amp; Poor's or are unrated securities of comparable
quality as determined by Calamos, the Fund's investment adviser. The Fund may invest in high yield securities of any rating. The Fund
may, but currently does not intend to, invest up to 5% of its managed assets in distressed securities that are in default or the issuers
of which are in bankruptcy. Non-convertible debt securities rated below investment grade are commonly referred to as "junk bonds"
and are considered speculative with respect to the issuer's capacity to pay interest and repay principal. Below investment grade securities
involve greater risk of loss, are subject to greater price volatility and are less liquid, especially during periods of economic uncertainty
or change, than higher rated securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Foreign Securities.</i> Although the Fund primarily invests in securities
of U.S. issuers, the Fund may invest up to 25% of its net assets in securities of foreign issuers in developed and emerging markets, including
debt and equity securities of corporate issuers and debt securities of government issuers. A foreign issuer is a foreign government or
a company organized under the laws of a foreign country. In analyzing the foreign issuers in which the Fund may invest, Calamos will generally
consider a number of factors that may characterize the issuer's economic ties to a particular foreign country or region. Such factors
may include any or all of the following: the characteristics of the economy in the principal country or countries in which the issuer
sells it goods and/or services; the stability of the currency in the issuer's country of organization; the laws with respect to international
trade and property rights in the issuer's country of organization; and the tax, accounting and regulatory requirements of the issuer's
country of organization.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Options Writing.</i> The Fund may seek to generate income from option
premiums by writing (selling) options. The Fund may write (sell) call options (i)&#160;on a portion of the equity securities (including
equity securities obtainable by the Fund through the exercise of its rights with respect to convertible securities it owns) in the Fund's
portfolio and (ii)&#160;on broad-based securities indices (such as the S&amp;P 500 or MSCI EAFE) or certain ETFs (exchange traded funds)
that trade like common stocks but seek to replicate such market indices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, to seek to offset some of the risk of a potential decline
in value of certain long positions, the Fund may also purchase put options on individual securities, broad-based securities indices (such
as the S&amp;P 500 or MSCI EAFE), or certain ETFs that trade like common stocks but seek to replicate market indices. See " &#8212;
Options in General" below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Options in General.</i> The Fund may purchase and sell options on
stocks, indices, rates, credit spreads or currencies. A call option, upon payment of a premium, gives the purchaser of the option the
right to buy, and the seller the obligation to sell, the underlying security, index or other instrument at the exercise price. A put option
gives the purchaser of the option, upon payment of a premium, the right to sell, and the seller the obligation to buy, the underlying
security, index, or other instrument at the exercise price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain options, known as "American style" options, may be
exercised at any time during the term of the option. Other options, known as "European style" options, may be exercised only
on the expiration date of the option. The Fund expects that substantially all of the options written by the Fund will be American style
options.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund is authorized to purchase and sell exchange listed options
and over-the-counter options ("OTC options"). Exchange listed options are issued by a regulated intermediary such as the Options
Clearing Corporation ("OCC"), which guarantees the performance of the obligations of the parties to such options. In addition,
the Fund may purchase instruments structured by broker-dealers or investment banks that package or possess economic characteristics of
options. The discussion below uses the OCC as an example, but is also applicable to other financial intermediaries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With certain exceptions, OCC issued and exchange listed options generally
settle by physical delivery of the underlying security or currency, although in the future cash settlement may become available. Index
options are cash settled for the net amount, if any, by which the option is "in-the-money" (i.e., where the value of the underlying
instrument exceeds, in the case of a call option, or is less than, in the case of a put option, the exercise price of the option) at the
time the option is exercised. Frequently, rather than taking or making delivery of the underlying instrument through the process of exercising
the option, listed options are closed by entering into offsetting purchase or sale transactions that do not result in ownership of the
new option.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 31 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">OTC options are purchased from or sold to securities dealers, financial
institutions or other parties ("Counterparties") through direct bilateral agreement with the Counterparty. In contrast to exchange
listed options, which generally have standardized terms and performance mechanics, all the terms of an OTC option, including such terms
as method of settlement, term, exercise price, premium, guarantees and security, are set by negotiation of the parties. The Fund may sell
OTC options (other than OTC currency options) that are subject to a buy-back provision permitting the Fund to require the Counterparty
to sell the option back to the Fund at a formula price within seven days. The Fund expects generally to enter into OTC options that have
cash settlement provisions, although it is not required to do so. The staff of the Commission currently takes the position that OTC options
purchased by a fund, and portfolio securities "covering" the amount of a fund's obligation pursuant to an OTC option sold by
it (or the amount of assets equal to the formula price for the repurchase of the option, if any, less the amount by which the option is
in-the-money) are illiquid. OTC options purchased by the Fund and any portfolio securities used to cover obligations pursuant to such
options are not considered illiquid by Calamos for the purposes of the Fund's limitation on investments in illiquid securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will write call options and put options only if they are "covered."
For example, a call option written by the Fund will require the Fund to hold the securities subject to the call (or securities convertible
into those securities without additional consideration) or to segregate cash or liquid assets sufficient to purchase and deliver the securities
if the call is exercised.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The principal factors affecting the market value of a put or a call
option include supply and demand, interest rates, the current market price of the underlying security or index in relation to the exercise
price of the option, the volatility of the underlying security or index, and the time remaining until the expiration date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Rule&#160;144A Securities.</i> The Fund may invest without limit
in certain securities, such as convertible and debt securities, that are typically purchased in transactions exempt from the registration
requirements of the 1933 Act pursuant to Rule&#160;144A under that Act. Rule&#160;144A Securities may only be sold to qualified institutional
buyers, such as the Fund. Any resale of these securities must generally be effected through a sale that is registered under the 1933 Act
or otherwise exempted or excepted from such registration requirements. Under the supervision and oversight of the Fund's Board of Trustees,
Calamos will determine whether Rule&#160;144A Securities are liquid. Typically, the Fund purchases Rule&#160;144A Securities only if Calamos
has determined them to be liquid. If any Rule&#160;144A Security held by the Fund should become illiquid, the value of the security may
be reduced and a sale of the security may be more difficult.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Loans.</i> The Fund may invest in loan participations and other
direct claims against a borrower. The corporate loans in which the Fund may invest primarily consist of direct obligations of a borrower
and may include debtor in possession financings pursuant to Chapter 11 of the U.S. Bankruptcy Code, obligations of a borrower issued in
connection with a restructuring pursuant to Chapter 11 of the U.S. Bankruptcy Code, leveraged buy-out loans, leveraged recapitalization
loans, receivables purchase facilities, and privately placed notes. The Fund may invest in a corporate loan at origination as a co-lender
or by acquiring in the secondary market participations in, assignments of or novations of a corporate loan. By purchasing a participation,
the Fund acquires some or all of the interest of a bank or other lending institution in a loan to a corporate or government borrower.
The participations typically will result in the Fund having a contractual relationship only with the lender not the borrower. The Fund
will have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the participation
and only upon receipt by the lender of the payments from the borrower. Many such loans are secured, although some may be unsecured. Such
loans may be in default at the time of purchase. Loans that are fully secured offer the Fund more protection than an unsecured loan in
the event of non-payment of scheduled interest or principal. However, there is no assurance that the liquidation of collateral from a
secured loan would satisfy the corporate borrower's obligation, or that the collateral can be liquidated. Direct debt instruments may
involve a risk of loss in case of default or insolvency of the borrower and may offer less legal protection to the Fund in the event of
fraud or misrepresentation. In addition, loan participations involve a risk of insolvency of the lending bank or other financial intermediary.
The markets in such loans are not regulated by federal securities laws or the Commission.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Preferred Shares.</i> The Fund may invest in preferred stock. The
preferred stock in which the Fund typically will invest will be convertible securities. Preferred shares are equity securities, but they
have many characteristics of fixed income securities, such as a fixed dividend payment rate and/or a liquidity preference over the issuer's
common shares. However, because preferred stocks are equity securities, they may be more susceptible to risks traditionally associated
with equity investments than the Fund's fixed income securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 32 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>REITs.</i> The Fund may invest in securities of REITs, including
debt securities they may issue. REITs primarily invest in income-producing real estate or real estate related loans or interests. REITs
are generally classified as equity REITs, mortgage REITs or a combination of equity and mortgage REITs. Equity REITs invest the majority
of their assets directly in real property and derive income primarily from the collection of rents. Equity REITs can also realize capital
gains by selling properties that have appreciated in value. Mortgage REITs invest the majority of their assets in real estate mortgages
and derive income from the collection of interest payments. REITs are not taxed on income distributed to shareholders provided they comply
with the applicable requirements of the Code. The Fund will indirectly bear its proportionate share of any management and other expenses
paid by REITs in which it invests in addition to the expenses paid by the Fund. Debt securities issued by REITs are, for the most part,
general and unsecured obligations and are subject to risks associated with REITs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>U.S. Government Securities.</i> U.S. government securities in which
the Fund invests include debt obligations of varying maturities issued by the U.S. Treasury or issued or guaranteed by an agency or instrumentality
of the U.S. government, including the Federal Housing Administration, Federal Financing Bank, Farmers Home Administration, Export-Import
Bank of the United States, Small Business Administration, Government National Mortgage Association ("GNMA"), General Services
Administration, Central Bank for Cooperatives, Federal Farm Credit Banks, Federal Home Loan Banks, Federal Home Loan Mortgage Corporation
("FHLMC"), Federal National Mortgage Association ("FNMA"), Maritime Administration, Tennessee Valley Authority, District
of Columbia Armory Board, Student Loan Marketing Association, Resolution Fund Corporation and various institutions that previously were
or currently are part of the Farm Credit System (which has been undergoing reorganization since 1987). Some U.S. government securities,
such as U.S. Treasury bills, Treasury notes and Treasury bonds, which differ only in their interest rates, maturities and times of issuance,
are supported by the full faith and credit of the United States. Others are supported only by: (i)&#160;the right of the issuer to borrow
from the U.S. Treasury, such as securities of the Federal Home Loan Banks; (ii)&#160;the discretionary authority of the U.S. government
to purchase the agency's obligations, such as securities of the FNMA; or (iii)&#160;only the credit of the issuer. No assurance can be
given that the U.S. government will provide financial support in the future to U.S. government agencies, authorities or instrumentalities
that are not supported by the full faith and credit of the United States. Securities guaranteed as to principal and interest by the U.S.
government, its agencies, authorities or instrumentalities include: (i)&#160;securities for which the payment of principal and interest
is backed by an irrevocable letter of credit issued by the U.S. government or any of its agencies, authorities or instrumentalities; and
(ii)&#160;participations in loans made to non-U.S. governments or other entities that are so guaranteed. The secondary market for certain
of these participations is limited and, therefore, may be regarded as illiquid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Zero Coupon Securities.</i> The securities in which the Fund invests
may include zero coupon securities, which are debt obligations that are issued or purchased at a significant discount from face value.
The discount may approximate the total amount of interest the security will accrue and compound over the period until maturity or the
particular interest payment date at a rate of interest reflecting the market rate of the security at the time of issuance. Zero coupon
securities do not require the periodic payment of interest. These investments benefit the issuer by mitigating its need for cash to meet
debt service, but generally require a higher rate of return to attract investors who are willing to defer receipt of cash. These investments
involve greater interest rate risk and may experience greater volatility in market value than U.S. government securities that make regular
payments of interest. The Fund accrues income on these investments for tax and accounting purposes, which is distributable to shareholders
and which, because no cash is received at the time of accrual, may require the liquidation of other portfolio securities to satisfy the
Fund's distribution obligations or to reduce or eliminate tax at the Fund level, in which case the Fund will forgo the purchase of additional
income producing assets with these funds. Zero coupon U.S. government securities include STRIPS and CUBES, which are issued by the U.S.
Treasury as component parts of U.S. Treasury bonds and represent scheduled interest and principal payments on the bonds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities.</i> Consistent with its objective, the Fund may
invest in equity securities, including common and preferred stocks, warrants, rights and depository receipts. Equity securities, such
as common stock, generally represent an ownership interest in a company. Therefore, the Fund participates in the financial success or
failure of any company in which it has an equity interest. Although equity securities have historically generated higher average returns
than fixed income securities, equity securities have also experienced significantly more volatility in those returns. An adverse event,
such as an unfavorable earnings report, may depress the value of a particular equity security held by the Fund. Also, the price of equity
securities, particularly common stocks, are sensitive to general changes in economic conditions and movements in the stock market. A drop
in the stock market may depress the price of equity securities held by the Fund. See also " &#8212; Preferred Shares" below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 33 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other Investment Companies.</i> The Fund may invest in the securities
of other investment companies to the extent that such investments are consistent with the Fund's investment objective and policies and
are permissible under the 1940 Act. Under the 1940 Act, the Fund may not acquire the securities of other domestic or non-U.S. investment
companies if, as a result, (1)&#160;more than 10% of the Fund's total assets would be invested in securities of other investment companies,
(2)&#160;such purchase would result in more than 3% of the total outstanding voting securities of any one investment company being held
by the Fund, (3)&#160;more than 5% of the Fund's total assets would be invested in any one investment company, or (4)&#160;such purchase
would result in more than 10% of the total outstanding voting securities of a registered closed-end investment company being held by the
Fund. These limitations do not apply to, among other things, the purchase of shares of money market funds, of certain related funds or
of funds with exemptive relief, or of any investment company in connection with a merger, consolidation, reorganization or acquisition
of substantially all the assets of another investment company, or to purchases of investment companies made in accordance with SEC exemptive
relief or rule.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund, as a holder of the securities of other investment companies,
will bear its pro rata portion of the other investment companies' expenses, including advisory fees. These expenses are in addition to
the direct expenses of the Fund's own operations. In addition, the Fund's performance may be magnified positively or negatively by virtue
of its investment in other investment companies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Temporary and Defensive Investments.</i> Under unusual market or
economic conditions or for temporary defensive purposes, the Fund may invest in a manner that is inconsistent with its principal investment
strategies described herein. In those situations, the Fund may invest up to 100% of its managed assets in securities issued or guaranteed
by the U.S. government or its instrumentalities or agencies, certificates of deposit, bankers' acceptances and other bank obligations,
commercial paper rated in the highest category by a nationally recognized statistical rating organization ("NRSRO") or other
fixed income securities deemed by Calamos to be consistent with a defensive posture, or may hold cash. The yield on such securities may
be lower than the yield on lower rated fixed income securities. During such periods, the Fund may not be able to achieve its investment
objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Repurchase Agreements.</i> The Fund may enter into repurchase agreements
with broker-dealers, member banks of the Federal Reserve System and other financial institutions. Repurchase agreements are arrangements
under which the Fund purchases securities and the seller agrees to repurchase the securities within a specific time and at a specific
price. The repurchase price is generally higher than the Fund's purchase price, with the difference being income to the Fund. The counterparty's
obligations under the repurchase agreement are typically collateralized with U.S. Treasury and/or agency obligations with a market value
of not less than 100% of the obligations, valued daily. Collateral is typically held by the Fund's custodian in a segregated, safekeeping
account for the benefit of the Fund. Repurchase agreements afford the Fund an opportunity to earn income on temporarily available cash.
In the event of commencement of bankruptcy or insolvency proceedings with respect to the issuer of the repurchase agreement before repurchase
of the security under a repurchase agreement, the Fund may encounter losses and delay and incur costs before being able to sell the security.
Such a delay may involve loss of interest or a decline in price of the security. If the court characterizes the transaction as a loan
and the Fund has not perfected a security interest in the security, the Fund may be required to return the security to the seller's estate
and be treated as an unsecured creditor of the seller. As an unsecured creditor, the Fund would be at risk of losing some or all of the
principal and interest involved in the transaction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Lending of Portfolio Securities.</i> The Fund has authorized SSB
as securities lending agent to lend securities to registered broker-dealers or other institutional investors under agreements which require
that the loans be secured continuously by collateral received in cash under the SSB Agreement. Counterparties to securities lending transactions
through SSB are generally SSB&#8217;s approved counterparty list, subject to a concentration limit imposed by the Fund which precludes
any single counterparty from constituting 25% or more of the Fund&#8217;s securities lending transactions then outstanding. The Fund has
the right to limit or to prohibit altogether securities lending with otherwise eligible counterparties, subject to the potential for an
increase in the Fund&#8217;s borrowing cost of either .25% or .45% per annum if such limits or prohibitions disqualify multiple counterparties
which account for more than 25% or 50%, respectively, of the Fund&#8217;s recent securities lending transactions. Cash collateral received
by SSB on behalf of the Fund is deposited into a custodial account in the name of the Fund before being treated as refinancing a portion
of the amounts borrowed under the SSB Agreement. The interest paid by the Fund under the SSB Agreement is not impacted by whether the
funding is through an advance by SSB or by receipt of collateral for securities lending. Under the terms of the SSB Agreement, the Fund
is required to return the value of the collateral to the borrower at the termination of the selected securities loan(s). The Fund does
not use affiliated agents in managing its lending program. The Fund continues to be entitled to receive the equivalent of the interest
or dividends paid by the issuer on the securities loaned as well as the benefit of an increase and the detriment of any decrease in the
market value of the securities loaned and would also receive compensation based on investment of the collateral, but bears the risk of
loss on any collateral so invested. The Fund would not, however, have the right to vote any securities having voting rights during the
existence of the loan, but could seek to call the loan in anticipation of an important vote to be taken among holders of the securities
or of the giving or withholding of consent on a material matter affecting the investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 34 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As with other extensions of credit, there are risks of delay in recovery
or even loss of rights in the collateral should the borrower of the securities fail financially. The Fund remains liable for the return
of the pledged collateral or cash of an equivalent value. At no time would the value of the securities loaned exceed 33 1/3% of the value
of the Fund's managed assets. The securities lending arrangement with SSB involves characteristics common in arm&#8217;s length relationships
in which one party may benefit at the expense of the other party. See "Description of Securities" for more information on lending
of portfolio securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Turnover.</i> Although the Fund does not purchase securities
with a view to rapid turnover, there are no limitations on the length of time that portfolio securities must be held. Portfolio turnover
can occur for a number of reasons, including calls for redemption, general conditions in the securities markets, more favorable investment
opportunities in other securities, or other factors relating to the desirability of holding or changing a portfolio investment. The portfolio
turnover rates may vary greatly from year to year. A high rate of portfolio turnover in the Fund would result in increased transaction
expense, which must be borne by the Fund. High portfolio turnover may also result in the realization of capital gains or losses and, to
the extent net short-term capital gains are realized, any distributions resulting from such gains will be considered ordinary income for
federal income tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Fundamental Investment Restrictions.</i> As more fully described
in the Fund's statement of additional information, under the Fund's fundamental investment restrictions, the Fund may not: (1)&#160;issue
senior securities, except as permitted by the 1940 Act and the rules&#160;and interpretive positions of the Commission thereunder; (2)&#160;borrow
money, except as permitted by the 1940 Act and the rules&#160;and interpretive positions of the Commission thereunder; (3)&#160;invest
in real estate, except that the Fund may invest in securities of issuers that invest in real estate or interests therein, securities that
are secured by real estate or interests therein, securities of real estate investment funds and mortgage-backed securities; (4)&#160;make
loans, except by the purchase of debt obligations, by entering into repurchase agreements or through the lending of portfolio securities
and as otherwise permitted by the 1940 Act and the rules&#160;and interpretive positions of the Commission thereunder; (5)&#160;invest
in physical commodities or contracts relating to physical commodities; (6)&#160;act as an underwriter, except as it may be deemed to be
an underwriter in a sale of securities held in its portfolio; (7)&#160;make any investment inconsistent with the Fund's classification
as a diversified investment company under the 1940 Act and the rules&#160;and interpretive positions of the Commission thereunder; and
(8)&#160;concentrate its investments in securities of companies in any particular industry as defined in the 1940 Act and the rules&#160;and
interpretive positions of the Commission thereunder. This description of the Fund's fundamental investment restrictions is a summary only
and to the extent it differs from the discussion of fundamental investment restrictions contained in the Fund's statement of additional
information, the description in the statement of additional information controls.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These restrictions may not be changed without the approval of the holders
of a majority of the Fund's outstanding voting securities. All other investment policies of the Fund are considered non-fundamental and
may be changed by the Board of Trustees without prior approval of the Fund's outstanding voting shares, although the Fund will give shareholders
at least 60 days' notice of any changes to the Fund's investment objective. See "Investment Restrictions" on page&#160;S-24
of the Fund's statement of additional information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 35 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conflicts of Interest</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conflicts of interest may arise from the fact that Calamos and its
affiliates carry on substantial investment activities for other clients, in which the Fund does not have an interest, some of which may
have investment strategies similar to those of the Fund. Calamos or its affiliates may have financial incentives to favor certain of these
accounts over the Fund. Any of their proprietary accounts or other customer accounts may compete with the Fund for specific trades. Calamos
or its affiliates may give advice and recommend securities to, or buy or sell securities for, other accounts and customers, which advice
or securities recommended may differ from advice given to, or securities recommended or bought or sold for, the Fund, even though their
investment objectives may be the same as, or similar to, the Fund's investment objective. When two or more clients advised by Calamos
or its affiliates seek to purchase or sell the same publicly traded securities, the securities actually purchased or sold will be allocated
among the clients on a good faith equitable basis by Calamos in its discretion and in accordance with the clients' various investment
objectives and Calamos' procedures. In some cases, this system may adversely affect the price or size of the position the Fund may obtain
or sell. In other cases, the Fund's ability to participate in volume transactions may produce better execution for the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos will evaluate a variety of factors in determining whether a
particular investment opportunity or strategy is appropriate and feasible for a particular entity or account at a particular time, including,
but not limited to, the following: (1)&#160;the nature of the investment opportunity taken in the context of the other investments available
at the time; (2)&#160;the liquidity of the investment relative to the needs of the particular entity or account; (3)&#160;the availability
of the opportunity (i.e., size of obtainable position); (4)&#160;the transaction costs involved; and (5)&#160;the investment or regulatory
limitations applicable to the particular entity or account. Because these considerations may differ when applied to the Fund and relevant
accounts under management in the context of any particular investment opportunity, the Fund's investment activities, on the one hand,
and other managed accounts, on the other hand, may differ considerably from time to time. In addition, the Fund's fees and expenses will
differ from those of the other managed accounts. Accordingly, investors should be aware that the Fund's future performance and future
performance of other accounts of Calamos may vary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Situations may occur when the Fund could be disadvantaged because of
the investment activities conducted by Calamos and its affiliates for their other accounts. Such situations may be based on, among other
things, the following: (1)&#160;legal or internal restrictions on the combined size of positions that may be taken for the Fund or the
other accounts, thereby limiting the size of the Fund's position; (2)&#160;the difficulty of liquidating an investment for the Fund or
the other accounts where the market cannot absorb the sale of the combined position; or (3)&#160;limits on co-investing in negotiated
transactions under the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos and its principals, officers, employees, and affiliates may
buy and sell securities or other investments for their own accounts and may have actual or potential conflicts of interest with respect
to investments made on the Fund's behalf. As a result of differing trading and investment strategies or constraints, positions may be
taken by principals, officers, employees, and affiliates of Calamos that are the same as, different from, or made at a different time
than positions taken for the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos' investment management fee is a percentage of the Fund's managed
assets, and Calamos' investment management fee will be higher if the Fund sells additional common shares or employs leverage. Accordingly,
Calamos will benefit from the sale of additional common shares, preferred shares, or debt securities and may have an incentive to be more
aggressive with respect to the use of leverage by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>LEVERAGE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may issue preferred shares or debt securities or borrow to
increase its assets available for investment. As of January&#160;31, 2025, the Fund had $315 million in borrowings outstanding under the
SSB Agreement, MRP Shares outstanding with an aggregate liquidation preference of $133 million and used approximately $62 million of collateral
obtained through securities lending arrangements as an offset against borrowings under the SSB Agreement, for a total of $448 million
of leverage representing 36.4% of managed assets as of that date. The SSB Agreement provides for additional credit availability for the
Fund, such that it may borrow up to $430 million. Additional information regarding the Fund's preferred shares is included below under
"Mandatory Redeemable Preferred Shares."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 36 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a non-fundamental policy, the Fund may not issue preferred shares,
borrow money and/or issue debt securities with an aggregate liquidation preference and aggregate principal amount exceeding 38% of the
Fund's managed assets measured at the time of borrowing or issuance of the new securities. However, the Board of Trustees reserves the
right to issue preferred shares or debt securities or borrow to the extent permitted by the 1940 Act or under any order issued by the
SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The holders of preferred shares will be entitled to receive a preferential
liquidating distribution, which is expected to equal the original purchase price per preferred share plus accumulated and unpaid dividends,
whether or not declared, before any distribution of assets is made to holders of common shares. The 1940 Act requires that the holders
of any preferred shares, voting separately as a single class, have the right to elect at least two Trustees at all times. The remaining
Trustees will be elected by holders of common shares and preferred shares, voting together as a single class. The holders of any preferred
shares have the right to elect a majority of the Trustees at any time two years' accumulated dividends on any preferred shares are unpaid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund also may borrow money as a temporary measure for extraordinary
or emergency purposes, including the payment of dividends and the settlement of securities transactions, which otherwise might require
untimely dispositions of the Fund's holdings. When the Fund leverages its assets, the fees paid to Calamos for investment management services
will be higher than if the Fund did not leverage because Calamos' fees are calculated based on the Fund's managed assets, which include
the proceeds of the issuance of preferred shares or debt securities or any outstanding borrowings. Consequently, the Fund and Calamos
may have differing interests in determining whether to leverage the Fund's assets. The Fund's Board of Trustees monitors any such potential
conflicts of interest on an ongoing basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's use of leverage is premised upon the expectation that the
Fund's leverage costs will be lower than the return the Fund achieves on its investments with the leverage proceeds. Such difference in
return may result from the Fund's higher credit rating or the short-term nature of its borrowing compared to the lower credit quality,
long-term nature of its investments. Because Calamos seeks to invest the Fund's managed assets (including the assets obtained from leverage)
in a portfolio of potentially higher yielding investments or portfolio investments with the potential for capital appreciation, the holders
of common shares will be the beneficiaries of any incremental return but will bear the risk of loss on investments made with the leverage
proceeds. Should the differential between the Fund's return on its investments made with the proceeds of leverage and the cost of the
leverage narrow, the incremental return "pick up" will be reduced or the Fund may incur losses. If long-term interest rates
rise without a corresponding increase in the yield on the Fund's portfolio investments or the Fund otherwise incurs losses on its investments,
the Fund's net asset value attributable to its common shares will reflect the decline in the value of portfolio holdings resulting therefrom.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage creates risks which may adversely affect the return for the
holders of common shares, including:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the likelihood of greater volatility in the net asset value
and market price of common shares;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> fluctuations in the dividend rates on any preferred shares borne
by the Fund or in interest rates on borrowings and short-term debt;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased operating costs, which are effectively borne by common
shareholders, may reduce the Fund's total return; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the potential for a decline in the value of an investment acquired
with borrowed funds, while the Fund's obligations under such borrowing remains fixed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage is a speculative technique that could adversely affect the
returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the
income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's
return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased
with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less
than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other
distributions will be reduced or potentially eliminated (or, in the case of distributions, will consist of return of capital).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 37 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos may determine to maintain the Fund's leveraged position if
it expects that the long-term benefits to the Fund's common shareholders of maintaining the leveraged position will outweigh the current
reduced return. Capital raised through the issuance of preferred shares or debt securities or borrowing will be subject to dividend payments
or interest costs that may or may not exceed the income and appreciation on the assets purchased. The issuance of preferred shares or
debt or borrowing money may involve offering expenses and other costs and may limit the Fund's freedom to pay dividends on common shares
or to engage in other activities. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan &#8212;
Dividends and Distributions on Common Shares." The Fund also may be required to maintain minimum average balances in connection with
borrowings or to pay a commitment or other fee to maintain a line of credit; either of these requirements would increase the cost of borrowing
over the stated interest rate. The Fund will pay (and common shareholders will bear) any costs and expenses relating to any borrowings
by the Fund, including the financial leverage described above, as well as any additional leverage incurred as a result of this offering
and to the issuance and ongoing maintenance of preferred shares or debt securities (for example, the higher management fee resulting from
the use of any such leverage, and interest and/or dividend expense and ongoing maintenance). Net asset value will be reduced immediately
following any additional offering of preferred shares or debt securities by the costs of that offering paid by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board reserves the right to change the amount and type of leverage
that the Fund uses, and reserves the right to implement changes to the Fund's borrowings that it believes are in the long-term interests
of the Fund and its shareholders, even if such changes impose a higher interest rate or other costs or impacts over the intermediate,
or short-term time period. There is no guarantee that the Fund will maintain leverage at the current rate, and the Board reserves the
right to raise, decrease, or eliminate the Fund's leverage exposure.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the 1940 Act, the Fund is not permitted to issue preferred shares
unless immediately after such issuance the Fund has an asset coverage of at least 200% of the liquidation value of the aggregate amount
of outstanding preferred shares (i.e., such liquidation value may not exceed 50% of the value of the Fund's total assets). Under the 1940
Act, the Fund may only issue one class of senior securities representing equity. So long as preferred shares are outstanding, additional
senior equity securities must rank on a parity with the preferred shares. In addition, the Fund is not permitted to declare any cash dividend
or other distribution on its common shares unless, at the time of such declaration, the net asset value of the Fund's portfolio (determined
after deducting the amount of such dividend or distribution) is at least 200% of such liquidation value. Under the 1940 Act, the Fund
is not permitted to incur indebtedness unless immediately after such borrowing the Fund has an asset coverage of at least 300% of the
aggregate outstanding principal balance of indebtedness (i.e., such indebtedness may not exceed 33 1/3% of the value of the Fund's total
assets). Under the 1940 Act, the Fund may only issue one class of senior securities representing indebtedness other than promissory notes
or other evidences of indebtedness not intended to be publicly distributed. Additionally, under the 1940 Act, the Fund generally may not
declare any dividend or other distribution upon any class of its shares, or purchase any such shares, unless the aggregate indebtedness
of the Fund has, at the time of the declaration of any such dividend or distribution or at the time of any such purchase, an asset coverage
of at least 300% after deducting the amount of such dividend, distribution, or purchase price, as the case may be, except that dividends
may be declared upon any preferred shares if such indebtedness has an asset coverage of at least 200% at the time of declaration thereof
after deducting the amount of the dividend. This limitation does not apply to certain privately placed debt. In general, the Fund may
declare dividends on preferred shares as long as there is asset coverage of 200% after deducting the amount of the dividend. The holders
of preferred shares or debt, if any, on the one hand, and the holders of the common shares, on the other, may have interests that conflict
with each other in certain situations. See "Description of Securities &#8212; Preferred Shares" and "Certain Provisions
of the Agreement and Declaration of Trust and By-Laws,&#160;Including Antitakeover Provisions."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may be subject to certain restrictions on investments imposed
by guidelines of and covenants with one or more rating agencies, which may issue ratings for any debt securities or preferred shares issued
by the Fund in the future. These guidelines and covenants may impose asset coverage and portfolio composition requirements that are more
stringent than those imposed by the 1940 Act. Certain types of borrowings may result in the Fund being subject to covenants in credit
agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and additional covenants
that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The Fund also may be required
to pledge its assets to the lenders in connection with certain types of borrowings. Certain types of borrowing may involve the rehypothecation
of the Fund's securities. Calamos does not anticipate that these covenants or restrictions would adversely affect its ability to manage
the Fund's portfolio in accordance with the Fund's investment objective and policies. Due to these covenants or restrictions, the Fund
may be forced to liquidate investments at times and at prices that are not favorable to the Fund, or the Fund may be forced to forgo investments
that Calamos otherwise views as favorable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 38 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The extent to which the Fund employs leverage will depend on many factors,
the most important of which are investment outlook, market conditions and interest rates. Successful use of a leveraging strategy depends
on Calamos' ability to predict correctly interest rates and market movements. There is no assurance that a leveraging strategy will be
successful during any period in which it is employed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Mandatory Redeemable Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September&#160;6, 2017, the Fund completed a private placement of
1,340,000 Series&#160;C MRP Shares. On August&#160;24, 2021, the Fund completed a private placement of 1,320,000 Series&#160;D MRP Shares.
On March&#160;8, 2022, the Fund completed a private placement of 1,330,000 Series&#160;E MRP Shares. On September&#160;9, 2024, the Fund
completed a private placement of 1,320,000 Series&#160;G MRP Shares. Each MRP Share has a liquidation preference of $25.00, resulting
in an aggregate liquidation preference of $132.75 million for all MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The holders of MRP Shares for the Fund ("MRP Shareholders")
are entitled to receive monthly cash dividends, payable on the first business day (a "Dividend Payment Date") of each month
following issuance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to adjustment as described below under "MRP Shares Dividends,"
the dividend rate per annum (the "Applicable Rate") for each series of MRP Shares is as follows:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">MRP Shares</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Applicable Rate</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 86%; font-size: 10pt; text-align: left">Series&#160;C MRP Shares</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">4.24</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Series&#160;D MRP Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2.45</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Series&#160;E MRP Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2.68</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Series&#160;G MRP Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6.24</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The MRP Shares have a term redemption date of September&#160;6, 2027
for the Series&#160;C MRP Shares, August&#160;24, 2026 for the Series&#160;D MRP Shares, May&#160;24, 2027 for the Series&#160;E MRP Shares,
and September&#160;9, 2029 for the Series&#160;G MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="color: #231F20">During the year ended October&#160;31,
2024, all MRP Shares were rated &#8216;AA-&#8217; by Kroll Bond Rating Agency LLC (&#8220;KBRA&#8221;). </span> If the ratings of the
MRP Shares are downgraded, the Fund's dividend expense may increase, as described below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Liquidation Preference.</i> In the event of any voluntary or involuntary
liquidation, dissolution or winding up of the Fund, the MRP Shareholders will be entitled to receive a preferential liquidating distribution
equal to $25.00 per MRP Share plus accrued and unpaid dividends, after satisfaction of claims of creditors of the Fund, but before any
distribution of assets is made to common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>MRP Shares Dividends.</i> If, on the first day of the monthly dividend
period immediately preceding a Dividend Payment Date (each such period a "Dividend Period"), Series&#160;C MRP Shares, Series&#160;D
MRP Shares, Series&#160;E MRP Shares or Series&#160;G MRP Shares are rated no less than "A" by KBRA (and no less than the equivalent
of such rating by some other NRSRO, if any, other than KBRA, such as Fitch Ratings,&#160;Inc. (&#8220;Fitch&#8221;), providing a rating
for the MRP Shares pursuant to the request of the Fund), then the dividend rate for such period (the "Dividend Rate") will be
equal to the Applicable Rate for such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 39 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, on the first day of a Dividend Period, the credit rating assigned
on any date to the MRP Shares are rated lower than the equivalent &#8220;A&#8221; by KBRA (or lower than the equivalent of such rating
by any Other Rating Agency), the Dividend Rate applicable to such series of outstanding MRP Shares for such Dividend Period shall be the
Applicable Rate plus the enhanced dividend amount (which shall not be cumulative) set opposite the lowest of such ratings in the table
below:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">KBRA Rating (or Equivalent by any Other
    Rating Agency)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Enhanced Dividend Amount</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt">"A-"</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 16%; font-size: 10pt; text-align: right">0.5</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">"BBB+" to "BBB-"</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2.0</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">"BB+" or below</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.0</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A 4.0% premium in addition to the Applicable Rate may apply when the
Fund fails to maintain a current credit rating, and a 5.0% premium may apply when the Fund fails to make timely payments with regard to
the MRP Shares (subject to cure periods in each case).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Limitation on Common Share Distributions.</i> With regard to the
Series&#160;C MRP Shares, so long as any MRP Shares are outstanding, the Fund will not declare, pay or set apart for payment any dividend
or other distribution (other than non-cash distributions) with respect to Fund shares ranking junior to or on parity with the MRP Shares,
unless (1)&#160;the Fund has satisfied the MRP Shares Overcollateralization Test (as defined below) on at least one "valuation date"
in the preceding 65 calendar days, (2)&#160;immediately after such transaction the Fund would satisfy the MRP Shares Asset Coverage Test
(as defined below), (3)&#160;full cumulative dividends on the MRP Shares due on or prior to the date of the transaction have been declared
and paid to the holders of MRP Shares and (4)&#160;the Fund has redeemed the full number of MRP Shares required to be redeemed by any
provision for mandatory redemption or deposited sufficient monies with the Fund's paying agent for that purpose, subject to certain grace
periods and exceptions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">MRP Shares Asset Coverage Test</span>: Asset coverage with respect
to all outstanding senior securities and preferred shares, including the MRP Shares, determined in accordance with Section&#160;18(h)&#160;of
the 1940 Act, on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays) next preceding the time
of determination, must be greater than or equal to 225%.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With regard to Series&#160;D MRP Shares, Series&#160;E MRP Shares,
and series G MRP Shares, for so long as any MRP Shares are Outstanding, the Fund will not declare, pay or set apart for payment any dividend
or other distribution (other than a dividend or distribution paid in shares of, or options, warrants or rights to subscribe for or purchase,
Common Shares or other shares of beneficial interest, if any, ranking junior to the MRP Shares as to dividends or upon liquidation (collectively
&#8220;non-cash distributions&#8221;)) with respect to Common Shares or any other shares of the Series&#160;or Fund ranking junior to
or on a parity with the MRP Shares as to dividends or upon liquidation, or call for redemption, redeem, purchase or otherwise acquire
for consideration any Common Shares or any other such junior shares (except by conversion into or exchange for shares of the Fund ranking
junior to the MRP Shares as to dividends and upon liquidation) or any such parity shares (except by conversion into or exchange for shares
of the Fund ranking junior to or on a parity with the MRP Shares as to dividends and upon liquidation), unless (1)&#160;immediately after
such transaction the Fund would satisfy the MRP Shares Asset Coverage Test, (2)&#160;full cumulative dividends on the MRP Shares due on
or prior to the date of the transaction have been declared and paid to the holders of MRP Shares, and (3)&#160;the Fund has redeemed the
full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained in Section&#160;3(a)&#160;of the
Statement of Preferences (as defined below) or deposited sufficient monies with the Paying Agent for that purpose (without regard to the
provisions of the Special Proviso); <i>provided</i> that the Fund may make any distributions reasonably necessary for the Fund to continue
to qualify as a &#8220;regulated investment company&#8221; under Subchapter M of the Internal Revenue Code and to avoid excise tax under
Section&#160;4982 of the Internal Revenue Code <i>(&#8220;Tax Required Payments&#8221;</i>). For the avoidance of doubt, any such Tax
Required Payments would only be paid to holders of Common Shares after full cumulative dividends due on or prior to the date of the applicable
distribution and any mandatory redemptions occurring on or prior to the date of the applicable distribution have been paid to the holders
of Preferred Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 40 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The terms of the MRP Shares and rights and preferences of the holders
of MRP Shares are set forth in the Statement of Preferences of Series&#160;C Mandatory Redeemable Preferred Shares, Series&#160;D Mandatory
Redeemable Preferred Shares, Series&#160;E Mandatory Redeemable Preferred Shares, and Series&#160;G Mandatory Redeemable Preferred Shares
(the "Statement of Preferences").</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Redemption.</i> The terms of the MRP Shares provide that: (i)&#160;the
Fund may redeem the MRP Shares at its option at the liquidation preference plus accrued and unpaid dividends and plus a make-whole premium,
subject to notice and other requirements; (ii)&#160;the Fund is required to redeem the MRP Shares upon failure to satisfy the MRP Shares
Asset Coverage Test (tested monthly) subject to cure periods; and (iii)&#160;the Fund is required to redeem the MRP Shares on the term
redemption date of September&#160;6, 2027 for the Series&#160;C MRP Shares, August&#160;24, 2026 for the Series&#160;D MRP Shares, May&#160;24,
2027 for the Series&#160;E MRP Shares and September&#160;9, 2029 for the Series&#160;G MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Voting Rights.</i> Except as otherwise required in the prospectus,
the governing documents of the Fund, or as otherwise required by applicable law, the Fund's preferred shareholders, including the holders
of MRP Shares, have one vote per share and vote together with the Fund's common shareholders as a single class. The 1940 Act grants the
holders of preferred stock the right to elect at least two Trustees at all times (the "Preferred Share Trustees") and the remaining
Trustees will be elected by the holders of common stock and preferred stock voting as a single class. Except during any time when the
Fund has failed to make a dividend or redemption payment in respect of MRP Shares outstanding, the holders of MRP Shares have agreed to
vote in accordance with the recommendation of the Board of Trustees on any matter submitted to them for their vote or to the vote of shareholders
of the Fund generally.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to the MRP Shares, William R. Rybak and Virginia G. Breen
were designated by the Board of Trustees as the Preferred Share Trustees of the Fund. As of January&#160;1, 2025, there were five other
Trustees of the Fund, Ms.&#160;Stuckey and Messrs.&#160;Calamos, Neal, Toub and Wennlund. See "Management of the Fund" in the
Fund's statement of additional information. The Fund's preferred shareholders, including the MRP Shareholders, are entitled to elect a
majority of the Trustees of the Fund during any period when (i)&#160;at least two years' accumulated dividends on the preferred stock
are due and unpaid or (ii)&#160;the preferred shares are otherwise entitled under the 1940 Act to elect a majority of the Trustees of
the Fund. The MRP Shareholders have certain additional customary voting rights pursuant to the MRP Shares governing documents and the
1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The summary information regarding the MRP Shares contained herein is
qualified in its entirety by reference to the Statement of Preferences and other documents related to the terms and conditions and the
offering of the MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Effects of Leverage</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SSB Agreement provides for credit availability for the Fund, such
that it may borrow up to $430 million. As of January&#160;31, 2025, the Fund had utilized $315 million of the $430 million available under
the SSB Agreement ($253 million in advances outstanding, and $62 million in structural leverage consisting of collateral received from
counterparties via SSB in connection with securities on loan), representing 25.6% of the Fund's managed assets as of that date, and had
$133 million of MRP Shares outstanding, representing 10.8% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement
and the outstanding MRP Shares represented 36.4% of the Fund's managed assets. Interest on the SSB Agreement is charged on the drawn amount
at the rate of the Overnight Bank Financing Rate (OBFR) plus 0.52%, payable monthly in arrears. Interest on overdue amounts or interest
on the drawn amount paid during an event of default will be charged at OBFR plus 2.52%. These rates represent floating rates of interest
that may change over time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SSB Agreement also provides that if the Fund restricts SSB&#8217;s
ability to lend securities to multiple otherwise eligible counterparties that, on a historical basis, have accounted for more than 25%
up to 50% of the Fund&#8217;s historical securities lending transactions, the borrowing cost under the SSB Agreement will increase by
.25% per annum, and that if the Fund restricts SSB&#8217;s ability to lend securities to multiple otherwise eligible counterparties that,
on a historical basis, have accounted for more than 50% of the Fund&#8217;s historical securities lending transactions, the borrowing
cost under the SSB Agreement will increase by 0.45% per annum, comprising Further, if the Fund restricts securities comprising more than
5% of its total assets from being available to lend for purposes of the securities lending program (excluding certain categories of ordinary
course restrictions or as otherwise agreed by SSB), the costs of leverage to the Fund will be increased by 0.20% per annum. The SSB Agreement
has a commitment fee of 0.10% of any undrawn amount. As of January&#160;31, 2025, the interest rate charged under the SSB Agreement was
5.35%.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 41 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's MRP Shareholders are entitled to receive monthly cash dividends,
at a currently effective dividend rate per annum for each series of MRP Shares as follows (subject to adjustment as described above in
"Mandatory Redeemable Preferred Shares"): 4.24% for Series&#160;C MRP Shares, 2.45% for Series&#160;DMRP Shares, 2.68% for Series&#160;E
MRP Shares and 6.24% for Series&#160;G MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To cover the interest expense on the borrowings under the SSB Agreement
and the dividend payments associated with the MRP Shares, based on rates in effect on January&#160;31, 2025, the Fund's portfolio would
need to experience an annual return of 1.71% (before giving effect to expenses associated with senior securities).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage is a speculative technique that could adversely affect the
returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the
income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's
return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased
with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less
than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other
distributions will be reduced or potentially eliminated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will pay, and common shareholders will effectively bear, any
costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares, including the MRP Shares,
or debt securities. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or
issuance costs, and interest and/or dividend expense and ongoing maintenance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain types of borrowings may result in the Fund being subject to
covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and
additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The
Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject
to certain restrictions on investments imposed by guidelines of and covenants with rating agencies for the preferred shares or short-term
debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition requirements that
are more stringent than those imposed by the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because Calamos' investment management fee is a percentage of the Fund's
managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage
the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional
use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would
require approval by the Board of Trustees of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table illustrates the hypothetical effect on the return
to a holder of the Fund's common shares of the leverage obtained by us (and utilized on January&#160;31, 2025). The purpose of this table
is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders
when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative
or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than
those appearing in the table.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Assumed Portfolio Return (Net of Expenses)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(10.00</td>
    <td>)%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(5.00</td>
    <td>)%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0.00</td>
    <td>%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5.00</td>
    <td>%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">10.00</td>
    <td>%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Corresponding Common Share Return<span style="font-size: 10pt"><sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(18.41</td>
    <td>)%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(10.55</td>
    <td>)%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(2.69</td>
    <td>)%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5.17</td>
    <td>%</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">13.03</td>
    <td>%</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&#160;Includes interest expense on the borrowings under the SSB
Agreement, accrued at interest rates in effect on January&#160;31, 2025 of 5.35%, and dividend expense on the MRP Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For further information about leveraging, see "Risk Factors &#8212;
Fund Risks &#8212; Leverage Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 42 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTEREST RATE TRANSACTIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to reduce the interest rate risk inherent in the Fund's underlying
investments and capital structure, the Fund, if Calamos deems market conditions favorable, may enter into over-the-counter interest rate
swap, cap or floor transactions to attempt to protect itself from increasing dividend or interest expenses on its leverage and to hedge
portfolio securities from interest rate changes. Fixed-for-floating interest rate swaps involve the Fund's agreement with the swap counterparty
to pay a fixed rate payment in exchange for the counterparty agreeing to pay the Fund a payment at a variable rate that is expected to
approximate the rate of any variable rate payment obligation on the Fund's leverage. The payment obligations would be based on the notional
amount of the swap.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may use an interest rate cap, which would require it to pay
a premium to the counterparty and would entitle it, to the extent that a specified variable rate index exceeds a predetermined fixed rate,
to receive from the counterparty payment of the excess amount based on a stated notional amount. There can be no assurance that the Fund
will use interest rate transactions or that, if used, their use will be beneficial to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will usually enter into swaps or caps on a net basis; that
is, the two payment streams will be netted out in a cash settlement on the payment date or dates specified in the instrument, with the
Fund receiving or paying, as the case may be, only the net amount of the two payments. The Fund intends to segregate with its custodian
cash or liquid securities having a value at least equal to the Fund's net payment obligations under any swap transaction, marked-to-market
daily.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The use of interest rate swaps and caps is a highly specialized activity
that involves investment techniques and risks different from those associated with ordinary portfolio security transactions. Depending
on the state of interest rates in general, the Fund's use of interest rate swaps or caps could enhance or harm the overall performance
of the Fund's common shares. To the extent that there is a decline in interest rates for maturities equal to the remaining maturity on
the Fund's fixed rate payment obligation under the interest rate swap or equal to the remaining term of the interest rate cap, the value
of the swap or cap (which initially has a value of zero) could decline, and could result in a decline in the net asset value of the common
shares. If, on the other hand, such rates were to increase, the value of the swap or cap could increase, and thereby increase the net
asset value of the common shares. As interest rate swaps or caps approach their maturity, their positive or negative value due to interest
rate changes will approach zero.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, if the short-term interest rates effectively received
by the Fund during the term of an interest rate swap are lower than the Fund's fixed rate of payment on the swap, the swap will increase
the Fund's operating expenses and reduce common share net earnings. For example, if the Fund were to enter into one or more interest rate
swaps in a notional amount equal to 75% of its outstanding margin loan under which the Fund would receive a short-term swap rate of 0.08%
and pay a fixed swap rate of 0.87% over the term of the swap, the swap would effectively increase Fund expenses and reduce Fund common
share net earnings by approximately 0.24% as a percentage of net assets attributable to common shareholders and less than 0.16% as a percentage
of managed assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, on the other hand, the short-term interest rates effectively received
by the Fund are higher than the Fund's fixed rate of payment on the interest rate swap, the swap would enhance common share net earnings.
The example above is purely for illustrative purposes and is not predictive of the actual percentage of the Fund's leverage that will
be hedged by a swap, the actual fixed rates that the Fund will pay under the swap (which will depend on market interest rates for the
applicable maturities at the time the Fund enters into swaps) or the actual short-term rates that the Fund will receive on any swaps (which
fluctuate frequently during the term of the swap, and may change significantly from initial levels), or the actual impact such swaps will
have on the Fund's expenses and common share net earnings. In either case, the swap would have the effect of reducing fluctuations in
the Fund's cost of leverage due to changes in short term interest rates during the term of the swap.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Buying interest rate caps could enhance the performance of the Fund's
common shares by limiting certain leverage expenses. Buying interest rate caps could also increase the operating expenses of the Fund
and decrease the net earnings of the common shares in the event that interest rates decline or stay the same or the premium paid by the
Fund to the counterparty exceeds the additional amount the Fund would have been required to pay on its preferred shares due to increases
in short-term interest rates during the term of the cap had it not entered into the cap agreement. The Fund has no current intention of
selling an interest rate swap or cap. The Fund will monitor any interest rate swaps or caps with a view to ensuring that it remains in
compliance with the federal income tax requirements for qualification as a regulated investment company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 43 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Interest rate swaps and caps do not involve the delivery of securities
or other underlying assets or principal. Accordingly, the risk of loss with respect to interest rate swaps and caps is limited to the
net amount of interest payments that the Fund is contractually obligated to make or, if applicable, any premium paid by the Fund. If the
counterparty defaults, the Fund would not be able to use the anticipated net receipts under the swap or cap to offset the dividend or
interest payments on the Fund's leverage or offset certain losses in its portfolio. Depending on whether the Fund would be entitled to
receive net payments from the counterparty on the swap or cap, which in turn would depend on the general state of short-term interest
rates at that point in time, such a default could negatively impact the performance of the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will not enter into an interest rate swap or cap transaction
with any counterparty that Calamos believes does not have the financial resources to honor its obligation under the interest rate swap
or cap transaction. Further, Calamos will continually monitor the financial stability of a counterparty to an interest rate swap or cap
transaction in an effort to proactively protect the Fund's investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, at the time the interest rate swap or cap transaction
reaches its scheduled termination date, there is a risk that the Fund will not be able to obtain a replacement transaction or that the
terms of the replacement will not be as favorable as on the expiring transaction. If this occurs, it could have a negative impact on the
performance of the Fund's common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When preferred shares are outstanding, the Fund may choose or be required
to redeem some or all preferred shares or prepay any borrowings. This redemption or prepayment would likely result in the Fund seeking
to terminate early all or a portion of any swap or cap transaction. Such early termination of a swap could result in a termination payment
by or to the Fund. An early termination of a cap could result in a termination payment to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RISK FACTORS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investing in any of our securities involves risk, including the
risk that you may receive little or no return on your investment or even that you may lose part or all of your investment. Therefore,
before investing in any of our securities you should consider carefully the following risks, as well as any risk factors included in the
applicable prospectus supplement.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fund Risks</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The principal risks are presented in alphabetical order to facilitate
finding particular risks and comparing them with other funds. Each risk summarized below, including Management Risk, Portfolio Selection
Risk, Equity Securities Risk, Emerging Market Risk and Foreign Securities Risk, among others, is considered a "principal risk"
of investing in the Fund, regardless of the order in which it appears.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General.</i> The Fund is a diversified, closed-end management investment
company designed primarily as a long-term investment and not as a trading tool. The Fund invests primarily in a diversified portfolio
of convertible securities and non-convertible income securities. An investment in the Fund's common shares may be speculative and it involves
a high degree of risk. The Fund is not a complete investment program. Due to the uncertainty in all investments, there can be no assurance
that the Fund will achieve its investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>American Depositary Receipts Risk.</i> The stocks of most foreign
companies that trade in the U.S. markets are traded as ADRs. U.S. depositary banks issue these stocks. Each ADR represents one or more
shares of foreign stock or a fraction of a share. The price of an ADR corresponds to the price of the foreign stock in its home market,
adjusted to the ratio of the ADRs to foreign company shares. Therefore, while purchasing a security on a U.S. exchange, the risks inherently
associated with foreign investing still apply to ADRs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 44 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Antitakeover Provisions.</i> The Fund's Agreement and Declaration
of Trust and By-Laws include provisions that could limit the ability of other entities or persons to acquire control of the Fund or to
change the composition of its Board of Trustees. Such provisions could limit the ability of shareholders to sell their shares at a premium
over prevailing market prices by discouraging a third party from seeking to obtain control of the Fund. These provisions include staggered
terms of office for the Trustees, advance notice requirements for shareholder proposals, and super-majority voting requirements for certain
transactions with affiliates, converting the Fund to an open-end investment company or a merger, asset sale or similar transaction. Holders
of preferred shares have voting rights in addition to and separate from the voting rights of common shareholders with respect to certain
of these matters. Holders of any preferred shares, voting separately as a single class, have the right to elect at least two Trustees
at all times. See "Description of Securities &#8212; Preferred Shares" and "Certain Provisions of the Agreement and Declaration
of Trust and By-Laws,&#160;Including Antitakeover Provisions." The holders of preferred shares or debt, if any, on the one hand,
and the holders of the common shares, on the other, may have interests that conflict with each other in certain situations, including
conflicts that relate to the fees and expenses of the Fund. For more information on potential conflicts of interest between holders of
common shares and holders of preferred shares, see "Leverage Risk" above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Holdings Risk.</i> To the extent the Fund holds cash positions,
the Fund risks achieving lower returns and potential lost opportunities to participate in market appreciation which could negatively impact
the Fund's performance and ability to achieve its investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Contingent Liabilities Risk.</i> Entering into derivative contracts
in order to pursue the Fund's various hedging strategies could require the Fund to fund cash payments in the future under certain circumstances,
including an event of default or other early termination event, or the decision by a counterparty to request margin in the form of securities
or other forms of collateral under the terms of the derivative contract or applicable laws. The amounts due with respect to a derivative
contract would generally be equal to the unrealized loss of the open positions with the respective counterparty and could also include
other fees and charges. These payments are contingent liabilities and therefore may not appear on the Fund's balance sheet. The Fund's
ability to fund these contingent liabilities will depend on the liquidity of the Fund's assets and access to capital at the time, and
the need to fund these contingent liabilities could adversely impact our financial condition.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Securities Risk.</i> The value of a convertible security
is influenced by both the yield of non-convertible securities of comparable issuers and by the value of the underlying common stock. The
value of a convertible security viewed without regard to its conversion feature (i.e., strictly on the basis of its yield) is sometimes
referred to as its "investment value." A convertible security's investment value tends to decline as prevailing interest rate
levels increase. Conversely, a convertible security's investment value tends to increase as prevailing interest rate levels decline.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, a convertible security's market value tends to reflect the
market price of the common stock of the issuing company when that stock price is greater than the convertible security's "conversion
price." The conversion price is defined as the predetermined price at which the convertible security could be exchanged for the associated
stock. As the market price of the underlying common stock declines, the price of the convertible security tends to be influenced more
by the yield of the convertible security and changes in interest rates. Thus, the convertible security may not decline in price to the
same extent as the underlying common stock. In the event of a liquidation of the issuing company, holders of convertible securities would
be paid before the company's common stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Correlation Risk</i>. Imperfect correlation between the value of
derivative instruments and the underlying assets of the Fund creates the possibility that the loss on such instruments may be greater
than the gain in the value of the underlying assets in the Fund's portfolio.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Counterparty and Settlement Risk.</i> Trading options, futures contracts,
swaps and other derivative financial instruments entails credit risk with respect to the counterparties with whom and through which the
Fund trades. Such instruments when traded over the counter do not include the same protections as may apply to trading derivatives on
organized exchanges. Substantial losses may arise from the insolvency, bankruptcy or default of a counterparty and risk of settlement
default of parties with whom the Fund trades securities. This risk may be heightened during volatile market conditions. Settlement mechanisms
in emerging markets are generally less developed and reliable than those in more developed countries thus increasing the risks.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the past, broker-dealers and other financial institutions have experienced
extreme financial difficulty, sometimes resulting in bankruptcy of the institution. Although Calamos monitors the creditworthiness of
the Fund's counterparties, there can be no assurance that the Fund's counterparties will not experience similar difficulties, possibly
resulting in losses to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 45 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a counterparty becomes bankrupt or otherwise fails to perform its
obligations under a derivative contract due to financial difficulties, such bankruptcy or failure to perform is likely to result in a
default under such derivative contract, unless such default is cured. Default by a party with whom the Fund enters into a hedging transaction
may result in the loss of unrealized profits, leaving the Fund with unsecured exposure and force the Fund to cover its resale commitments,
if any, at the then current market price. It may not always be possible to dispose of or close out a hedging position without the consent
of the hedging counterparty, and the Fund may not be able to enter into an offsetting contract in order to cover its risk. The Fund cannot
assure its shareholders that a liquid secondary market will exist for hedging instruments purchased or sold, and the Fund may be required
to maintain a position until exercise or expiration, which could result in losses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Furthermore, upon the bankruptcy of a counterparty, the Fund may experience
significant delays in obtaining any recovery under the derivative contract in a dissolution, assignment for the benefit of creditors,
liquidation, winding-up, bankruptcy, or other analogous proceeding. In addition, in the event of the insolvency of a counterparty to a
derivative transaction, the derivative transaction would typically be terminated at its fair market value. If the Fund is owed this fair
market value in the termination of the derivative transaction and its claim is unsecured, the Fund will be treated as a general creditor
of such counterparty, and will not have any claim with respect to the underlying security. The Fund may obtain only a limited recovery
or may obtain no recovery in such circumstances and the enforceability of agreements for hedging transactions may depend on compliance
with applicable statutory and other regulatory requirements and, depending on the identity of the counterparty, applicable international
requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain interest rate and credit default swaps are subject to mandatory
clearing, in which case a central clearing counterparty stands between each buyer and seller and effectively guarantees performance of
each derivative contract, to the extent of its available resources for such purpose. As a result, the counterparty risk is now shifted
from bilateral risk between the parties to the individual credit risk of the central clearing counterparty and the futures commission
merchant through which the Fund holds its cleared position. Even in such case, there can be no assurance that a clearing house, or its
members, will satisfy the clearing house's obligations to the Fund. Uncleared derivatives have no such protection; each party bears the
risk that its direct counterparty will default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>"Covenant-Lite" Loans Risk.</i> Some of the loans in which
the Fund may invest may be "covenant-lite" loans, which means the loans contain fewer or no maintenance covenants than other
loans and do not include terms which allow the lender to monitor the performance of the borrower and declare a default if certain criteria
are breached. The Fund may experience delays in enforcing its rights on its holdings of covenant-lite loans.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Credit Risk.</i> An issuer of a fixed income security could be downgraded
or default. If the Fund holds securities that have been downgraded, or that default on payment, the Fund's performance could be negatively
affected.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Currency Risk.</i> To the extent that the Fund invests in securities
or other instruments denominated in or indexed to foreign currencies, changes in currency exchange rates bring an added dimension of risk.
Currency fluctuations could negatively impact investment gains or add to investment losses. Although the Fund may attempt to hedge against
currency risk, the hedging instruments may not always perform as the Fund expects and could produce losses. Suitable hedging instruments
may not be available for currencies of emerging market countries. The Fund's investment adviser may determine not to hedge currency risks,
even if suitable instruments appear to be available.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cybersecurity Risk.</i> Investment companies, such as the Fund,
and their service providers are exposed to operational and information security risks resulting from cyberattacks, which may result in
financial losses to a fund and its shareholders. Cyber-attacks include, among other behaviors, stealing or corrupting data maintained
online or digitally, denial of service attacks on websites, "ransomware" that renders systems inoperable until ransom is paid,
the unauthorized release of confidential information, or various other forms of cybersecurity breaches. Cyber-attacks affecting the Fund
or the Adviser, custodian, transfer agent, distributor, administrator, intermediaries, trading counterparties, and other third-party service
providers may adversely impact the Fund or the companies in which the Fund invests, causing the Fund's investments to lose value or to
prevent a shareholder redemption or purchase from clearing in a timely manner.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 46 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Debt Securities Risk.</i> The Fund may invest in debt securities,
including corporate bonds and high yield securities. In addition to the risks described elsewhere in this prospectus (such as high yield
securities risk and interest rate risk), debt securities are subject to certain additional risks, including issuer risk and reinvestment
risk. Issuer risk is the risk that the value of debt securities may decline for a number of reasons which directly relate to the issuer,
such as management performance, leverage and reduced demand for the issuer's goods and services. Reinvestment risk is the risk that income
from the Fund's portfolio will decline if the Fund invests the proceeds from matured, traded or called bonds at market interest rates
that are below the Fund portfolio's current earnings rate. A decline in income could affect the market price of the Fund's common shares
or the overall return of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Default Risk.</i> Default risk refers to the risk that a company
that issues a convertible or debt security will be unable to fulfill its obligations to repay principal and interest. The lower a debt
security is rated, the greater its default risk. As a result, the Fund may incur cost and delays in enforcing its rights against the defaulting
issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Derivatives Risk.</i> Generally, derivatives are financial contracts
whose value depends on, or is derived from, the value of an underlying asset, reference rate or index, and may relate to individual debt
or equity instruments, interest rates, currencies or currency exchange rates, commodities, related indexes and other assets. The Fund
may utilize a variety of derivative instruments including, but not limited to, interest rate swaps, caps and floors, convertible securities,
synthetic convertible instruments, options on individual securities, index options, long calls, covered calls, long puts, cash-secured
short puts and protective puts for hedging, risk management and investment purposes. The Fund's use of derivative instruments involves
investment risks and transaction costs to which the Fund would not be subject absent the use of these instruments and, accordingly, may
result in losses greater than if they had not been used. The use of derivative instruments may have risks including, among others, leverage
risk, duration mismatch risk, correlation risk, liquidity risk, interest rate risk, volatility risk, credit risk, management risk and
counterparty risk. Derivatives also involve the risk of mispricing or improper valuation and the risk that changes in the value of a derivative
may not correlate perfectly with an underlying asset, interest rate or index. Suitable derivative transactions may not be available in
all circumstances and there can be no assurance that the Fund will engage in these transactions to reduce exposure to other risks when
that would be beneficial.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Furthermore, the skills needed to employ derivatives strategies are
different from those needed to select portfolio securities and, in connection with such strategies, the Fund makes predictions with respect
to market conditions, liquidity, currency movements, market values, interest rates and other applicable factors, which may be inaccurate.
Thus, the use of derivative instruments may require the Fund to sell or purchase portfolio securities at inopportune times or for prices
below or above the current market values, may limit the amount of appreciation the Fund can realize on an investment or may cause the
Fund to hold a security that it might otherwise want to sell. Tax rules&#160;governing the Fund's transactions in derivative instruments
may also affect whether gains and losses recognized by the Fund are treated as ordinary or capital, accelerate the recognition of income
or gains to the Fund, defer losses to the Fund, and cause adjustments in the holding periods of the Fund's securities, thereby affecting,
among other things, whether capital gains and losses are treated as short-term or long-term. These rules&#160;could therefore affect the
amount, timing and/or character of distributions to shareholders. In addition, there may be situations in which the Fund elects not to
use derivative instruments that result in losses greater than if they had been used. Amounts paid by the Fund as premiums and cash or
other assets held in margin accounts with respect to the Fund's derivative instruments would not be available to the Fund for other investment
purposes, which may result in lost opportunities for gain. Derivative instruments can be illiquid, may disproportionately increase losses
and may have a potentially large impact on Fund performance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Duration Risk.</i> Duration measures the time-weighted expected
cash flows of a fixed-income security, which can determine its sensitivity to changes in the general level of interest rates. The value
of securities with longer durations tend to be more sensitive to interest rate changes than securities with shorter durations. The longer
the Fund's dollar-weighted average duration, the more its value can generally be expected to be sensitive to interest rate changes than
a fund with a shorter dollar-weighted average duration. Duration differs from maturity in that it considers a security's coupon payments
in addition to the amount of time until the security matures. Various techniques may be used to shorten or lengthen the Fund's duration.
As the value of a security changes over time, so will its duration.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Duration Mismatch Risk. </i>The duration of a derivative instrument
may be significantly different than the duration of the related liability or asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Emerging Markets Risk.</i> Emerging market countries may have relatively
unstable governments and economies based on only a few industries, which may cause greater instability. The value of emerging market securities
will likely be particularly sensitive to changes in the economies of such countries. These countries are also more likely to experience
higher levels of inflation, deflation or currency devaluations, which could adversely affect the value of the Fund's investments and hurt
those countries' economies and securities markets. Securities issued in these countries may be more volatile and less liquid than securities
issued in foreign countries with more developed economies or markets. Loss may also result from the imposition of exchange controls, confiscations
and other government restrictions, or from problems in share registration, settlement, custody, or other operational risks.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities Risk.</i> Equity investments are subject to greater
fluctuations in market value than other asset classes as a result of such factors as the issuer's business performance, investor perceptions,
stock market trends and general economic conditions. Equity securities are subordinated to bonds and other debt instruments in a company's
capital structure in terms of priority to corporate income and liquidation payments. The Fund may invest in preferred stocks and convertible
securities of any rating, including below investment grade. Below investment grade securities or comparable unrated securities are considered
predominantly speculative with respect to the issuer's ability to pay interest and principal and are susceptible to default or decline
in market value due to adverse economic and business developments. The market values for below investment grade securities tend to be
very volatile, and these securities are generally less liquid than investment grade debt securities. For these reasons, your investment
in the Fund is subject to the following specific risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased price sensitivity to changing interest rates and to
a deteriorating economic environment;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> greater risk of loss due to default or declining credit quality;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> adverse company specific events are more likely to render the
issuer unable to make interest and/or principal payments; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if a negative perception of the below investment grade market
develops, the price and liquidity of below investment grade securities may be depressed. This negative perception could last for a significant
period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Foreign Securities Risk.</i> Investments in non-U.S. issuers may
involve unique risks compared to investing in securities of U.S. issuers. These risks are more pronounced to the extent that the Fund
invests a significant portion of its non-U.S. investments in one region or in the securities of emerging market issuers. See also "
&#8212; Emerging Markets Risk" below. These risks may include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> less information may be available about non-U.S. issuers or
markets due to less rigorous disclosure or accounting standards or regulatory practices in foreign jurisdictions;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> many non-U.S. markets are smaller, less liquid and more volatile.
In a changing market, Calamos may not be able to sell the Fund's portfolio securities at times, in amounts and at prices it considers
reasonable;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> an adverse effect of currency exchange rate changes or controls
on the value of the Fund's investments;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the economies of non-U.S. countries may grow at slower rates
than expected or may experience a downturn or recession;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> economic, political and social developments may adversely affect
the securities markets in foreign jurisdictions, including expropriation and nationalization;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the difficulty in obtaining or enforcing a court judgment in
non-U.S. countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> restrictions on foreign investments in non-U.S. jurisdictions;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> difficulties in effecting the repatriation of capital invested
in non-U.S. countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> withholding and other non-U.S. taxes may decrease the Fund's
return;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 48 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the ability for the Public Company Accounting Oversight Board,
which regulates auditors of U.S. public companies, is unable to inspect audit work papers in certain foreign countries;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> often limited rights and few practical remedies to pursue shareholder
claims, including class actions or fraud claims, and the ability of the Commission, the U.S. Department of Justice and other authorities
to bring and enforce actions against foreign issuers or foreign persons is limited; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> dividend income the Fund receives from foreign securities may
not be eligible for the special tax treatment applicable to qualified dividend income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There may be less publicly available information about non-U.S. markets
and issuers than is available with respect to U.S. securities and issuers. Non-U.S. companies generally are not subject to accounting,
auditing and financial reporting standards, practices and requirements comparable to those applicable to U.S. companies. The trading markets
for most non-U.S. securities are generally less liquid and subject to greater price volatility than the markets for comparable securities
in the United States. The markets for securities in certain emerging markets are in the earliest stages of their development. Even the
markets for relatively widely traded securities in certain non-U.S. markets, including emerging market countries, may not be able to absorb,
without price disruptions, a significant increase in trading volume or trades of a size customarily undertaken by institutional investors
in the United States. Additionally, market making and arbitrage activities are generally less extensive in such markets, which may contribute
to increased volatility and reduced liquidity.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Economies and social and political conditions in individual countries
may differ unfavorably from those in the United States. Non-U.S. economies may have less favorable rates of growth of gross domestic product,
rates of inflation, currency valuation, capital reinvestment, resource self-sufficiency and balance of payments positions. Many countries
have experienced substantial, and in some cases extremely high, rates of inflation for many years. Inflation and rapid fluctuations in
inflation rates have had, and may continue to have, very negative effects on the economies and securities markets of certain emerging
market countries. Unanticipated political or social developments may also affect the values of the Fund's investments and the availability
to the Fund of additional investments in such countries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based upon the Fund's test for determining whether an issuer is a "foreign
issuer" as described above, it is possible that an issuer of securities in which the Fund invests could be organized under the laws
of a foreign country, yet still conduct a substantial portion of its business in the U.S. or have substantial assets in the U.S. In this
case, such a "foreign issuer" may be subject to the market conditions in the U.S. to a greater extent than it may be subject
to the market conditions in the country of its organization. See " &#8212; Non-U.S. Government Obligation Risk."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Forward Currency Exchange Contracts Risk.</i> Forward contracts
are contractual agreements to purchase or sell a specified currency at a specified future date (or within a specified time period) at
a price set at the time of the contract. The Fund may not fully benefit from, or may lose money on, forward foreign currency transactions
if changes in currency exchange rates do not occur as anticipated or do not correspond accurately to changes in the value of the Fund's
holdings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General Derivative Risks.</i> Derivatives also involve the risk
of mispricing or improper valuation and the risk that changes in the value of a derivative may not correlate perfectly with an underlying
asset, interest rate or index. Suitable derivative transactions may not be available in all circumstances and there can be no assurance
that the Fund will engage in these transactions to reduce exposure to other risks when that would be beneficial. Furthermore, the skills
needed to employ derivatives strategies are different from those needed to select portfolio securities and, in connection with such strategies,
the Fund makes predictions with respect to market conditions, liquidity, currency movements, market values, interest rates and other applicable
factors, which may be inaccurate. Thus, the use of derivative investments may require the Fund to sell or purchase portfolio securities
at inopportune times or for prices below or above the current market values, may limit the amount of appreciation the Fund can realize
on an investment or may cause the Fund to hold a security that it might otherwise want to sell. Tax rules&#160;governing the Fund's transactions
in derivative instruments may also affect whether gains and losses recognized by the Fund are treated as ordinary or capital, accelerate
the recognition of income or gains to the Fund, defer losses to the Fund, and cause adjustments in the holding periods of the Fund's securities,
thereby affecting, among other things, whether capital gains and losses are treated as short-term or long-term. These rules&#160;could
therefore affect the amount, timing and/or character of distributions to shareholders. In addition, there may be situations in which the
Fund elects not to use derivative instruments that result in losses greater than if they had been used. Amounts paid by the Fund as premiums
and cash or other assets held in margin accounts with respect to the Fund's derivative instruments would not be available to the Fund
for other investment purposes, which may result in lost opportunities for gain. Derivative instruments can be illiquid, and may disproportionately
increase losses and may have a potentially large impact on Fund performance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 49 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Geographic Concentration Risk.</i> Investments in a particular country
or geographic region may be particularly susceptible to political, diplomatic or economic conditions and regulatory requirements. To the
extent the Fund concentrates its investments in a particular country, region or group of regions, the Fund may be more volatile than a
more geographically diversified fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>High Yield Securities Risk.</i> The Fund may invest in high yield
securities of any rating. Investment in high yield securities involves substantial risk of loss. Below investment grade non-convertible
debt securities or comparable unrated securities are commonly referred to as "junk bonds" and are considered predominantly speculative
with respect to the issuer's ability to pay interest and principal and are susceptible to default or decline in market value due to adverse
economic and business developments. The market values for high yield securities tend to be very volatile, and these securities are less
liquid than investment grade debt securities. For these reasons, your investment in the Fund is subject to the following specific risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased price sensitivity to changing interest rates and to
a deteriorating economic environment;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> greater risk of loss due to default or declining credit quality;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> adverse company specific events are more likely to render the
issuer unable to make interest and/or principal payments; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if a negative perception of the high yield market develops,
the price and liquidity of high yield securities may be depressed. This negative perception could last for a significant period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities rated below investment grade are speculative with respect
to the capacity of the issuer to pay interest and repay principal in accordance with the terms of such securities. A rating of "Ba1"
from Moody's means that the issue so rated can have speculative elements and is subject to substantial credit risk. Standard&#160;&amp;
Poor's assigns a rating of "BB+" to issues that are less vulnerable to nonpayment than other speculative issues, but nonetheless
subject to major ongoing uncertainties or exposure to adverse business, financial, or economic conditions which could lead to the obligor's
inadequate capacity to meet its financial commitment on the obligation. A rating of "C" from Moody's means that the issue so
rated can be regarded as having extremely poor prospects of ever attaining any real investment standing. Standard&#160;&amp; Poor's assigns
a rating of "C" to issues that are currently highly vulnerable to nonpayment, and the "C" rating may be used to cover
a situation in which a bankruptcy petition has been filed or similar action taken, but payments on the obligation are being continued
(a "C" rating is also assigned to a preferred stock issue in arrears on dividends or sinking fund payments, but that is currently
paying). See the statement of additional information for a description of Moody's and Standard&#160;&amp; Poor's ratings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Adverse changes in economic conditions are more likely to lead to a
weakened capacity of a high yield issuer to make principal payments and interest payments than an investment grade issuer. The principal
amount of high yield securities outstanding has proliferated in the past decade as an increasing number of issuers have used high yield
securities for corporate financing. An economic downturn could severely affect the ability of highly leveraged issuers to service their
debt obligations or to repay their obligations upon maturity. Similarly, downturns in profitability in specific industries could adversely
affect the ability of high yield issuers in those industries to meet their obligations. The market values of lower quality debt securities
tend to reflect individual developments of the issuer to a greater extent than do higher quality securities. Factors having an adverse
impact on the market value of lower quality securities may have an adverse effect on the Fund's net asset value and the market value of
its common shares. In addition, the Fund may incur additional expenses to the extent it is required to seek recovery upon a default in
payment of principal or interest on its portfolio holdings. In certain circumstances, the Fund may be required to foreclose on an issuer's
assets and take possession of its property or operations. In such circumstances, the Fund would incur additional costs in disposing of
such assets and potential liabilities from operating any business acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 50 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The secondary market for high yield securities may not be as liquid
as the secondary market for more highly rated securities, a factor which may have an adverse effect on the Fund's ability to dispose of
a particular security. There are fewer dealers in the market for high yield securities than for investment grade obligations. The prices
quoted by different dealers may vary significantly and the spread between the bid and asked price is generally much larger than for higher
quality instruments. Under adverse market or economic conditions, the secondary market for high yield securities could contract further,
independent of any specific adverse changes in the condition of a particular issuer, and these instruments may become illiquid. As a result,
the Fund could find it more difficult to sell these securities or may be able to sell the securities only at prices lower than if such
securities were widely traded. Prices realized upon the sale of such lower rated or unrated securities, under these circumstances, may
be less than the prices used in calculating the Fund's NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because investors generally perceive that there are greater risks associated
with lower quality debt securities of the type in which the Fund may invest a portion of its assets, the yields and prices of such securities
may tend to fluctuate more than those for higher rated securities. In the lower quality segments of the debt securities market, changes
in perceptions of issuers' creditworthiness tend to occur more frequently and in a more pronounced manner than do changes in higher quality
segments of the debt securities market, resulting in greater yield and price volatility.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Fund invests in high yield securities that are rated "C"
or below, the Fund will incur significant risk in addition to the risks associated with investments in high yield securities and corporate
loans. Distressed securities frequently do not produce income while they are outstanding. The Fund may purchase distressed securities
that are in default or the issuers of which are in bankruptcy. The Fund may be required to bear certain extraordinary expenses in order
to protect and recover its investment. The Fund also will be subject to significant uncertainty as to when and in what manner and for
what value the obligations evidenced by the distressed securities will eventually be satisfied.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inflation Risk.</i> Inflation is the reduction in the purchasing
power of money resulting from an increase in the price of goods and services. Inflation risk is the risk that the inflation adjusted or
"real" value of an investment in preferred stock or debt securities or the income from that investment will be worth less in
the future. As inflation occurs, the real value of the preferred stock or debt securities and the dividend payable to holders of preferred
stock or interest payable to holders of debt securities declines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Risk.</i> In addition to the risks described above,
debt securities, including high yield securities, are subject to certain risks, including:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if interest rates go up, the value of debt securities in the
Fund's portfolio generally will decline;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> during periods of declining interest rates, the issuer of a
security may exercise its option to prepay principal earlier than scheduled, forcing the Fund to reinvest in lower yielding securities.
This is known as call or prepayment risk. Debt securities frequently have call features that allow the issuer to repurchase the security
prior to its stated maturity. An issuer may redeem an obligation if the issuer can refinance the debt at a lower cost due to declining
interest rates or an improvement in the credit standing of the issuer;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> during periods of rising interest rates, the average life of
certain types of securities may be extended because of slower than expected principal payments. This may lock in a below market interest
rate, increase the estimated period until the security is paid in full and reduce the value of the security. This is known as extension
risk;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> rising interest rates could result in an increase in the cost
of the Fund's leverage and could adversely affect the ability of the Fund to meet asset coverage requirements with respect to leverage;
and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> variable rate securities generally are less sensitive to interest
rate changes but may decline in value if their interest rates do not rise as much, or as quickly, as interest rates in general. When the
Fund holds variable rate securities, a decrease in market interest rates will adversely affect the income received from such securities
and the NAV of the Fund's shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 51 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Benchmark Rate Risk and LIBOR Cessation.</i> The London Interbank
Offered Rate (&#8220;LIBOR&#8221;) was the offered rate for short-term Eurodollar deposits between major international banks. The terms
of investments, financings or other transactions (including certain derivatives transactions) to which the Fund may be a party have historically
been tied to LIBOR. In connection with the global transition away from LIBOR led by regulators and market participants, LIBOR was last
published on a representative basis at the end of June&#160;2023. Alternative reference rates to LIBOR have been established in most major
currencies and the transition to new reference rates continues. Markets in these new rates are developing, but questions around liquidity
and how to appropriately mitigate any economic value transfer as a result of the transition remain a concern. The transition away from
LIBOR and the use of replacement rates may adversely affect transactions that used LIBOR as a reference rate, financial institutions,
funds and other market participants that engaged in such transactions, and the financial markets generally. The impact of the transition
away from LIBOR on the Fund or the financial instruments in which the Fund invests cannot yet be fully determined.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, interest rates or other types of rates and indices which
are classed as &#8220;benchmarks&#8221; have been the subject of ongoing national and international regulatory reform, including under
the European Union regulation on indices used as benchmarks in financial instruments and financial contracts (known as the &#8220;Benchmarks
Regulation&#8221;). The Benchmarks Regulation has been enacted into United Kingdom law by virtue of the European Union (Withdrawal) Act
2018 (as amended), subject to amendments made by the Benchmarks (Amendment and Transitional Provision) (EU Exit) Regulations 2019 (SI
2019/657) and other statutory instruments. Following the implementation of these reforms, the manner of administration of benchmarks has
changed and may further change in the future, with the result that relevant benchmarks may perform differently than in the past, the use
of benchmarks that are not compliant with the new standards by certain supervised entities may be restricted, and certain benchmarks may
be eliminated entirely. Additionally, there could be other consequences which cannot be predicted.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the transition away from LIBOR as a benchmark reference
for interest rates, certain bonds and loans held by the Fund may have floating interest rates based on SOFR or, if otherwise provided
in the underlying contracts, other alternative benchmark rates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>SOFR Risk.</i> SOFR is a relatively new index rate calculated based
on short-term repurchase agreements backed by U.S. Treasury Instruments. While LIBOR is an unsecured rate, SOFR is a secured rate. SOFR,
unlike LIBOR, reflects actual market transactions. Accordingly, SOFR is not the economic equivalent of LIBOR. Consequently, there can
be no assurance that SOFR will perform in the same way as LIBOR would have at any time, including, without limitation, as a result of
changes in interest and yield rates in the market, monetary policy, bank credit risk, market volatility or global or regional economic,
financial, political, regulatory, judicial or other events.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because SOFR is published by the Federal Reserve Bank of New York (the
&#8220;New York Fed&#8221;) based on data received from other sources, the Adviser will have no control over its determination, calculation,
or publication. There can be no assurance that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse
to the interests of the Fund. If the manner in which SOFR is calculated is changed, that change may result in a reduction of the amount
of interest payable on SOFR-linked floating rate instruments and the trading prices of such instruments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, daily changes in SOFR have, on occasion, been more volatile
than daily changes in other benchmark or market rates. Although occasional, increased daily volatility in SOFR would not necessarily lead
to more volatile interest payments, the return on and value of SOFR-linked floating rate instruments may fluctuate more than floating
rate instruments that are linked to less volatile rates. All of the foregoing risks may affect the performance of the applicable bonds
and loans in which the Fund invests, which in turn may adversely affect the performance of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Alternative Benchmark Rate Risk.</i> As stated above, some of the
bonds and loans held by the Fund may have floating interest rates based on alternative benchmark rates other than SOFR. Such alternative
benchmark rates, like SOFR, may not have been widely used by market participants until relatively recently, and they may not perform exactly
the same as LIBOR because they are calculated and administered differently. Generally, the use of alternative benchmark rates (including
SOFR) may (i)&#160;cause the value of the interest rate on such bonds and loans to be uncertain or to be lower or more volatile than it
would otherwise be, (ii)&#160;result in uncertainty as to the functioning, liquidity or value of such bonds and loans, and/or (iii)&#160;involve
actions of regulators or rate administrators that may adversely affect certain markets or contracts underlying such bonds and loans. All
of the foregoing could adversely affect the return on and value of the related floating rate instruments in which the Fund invests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 52 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><i>Leverage Risk.</i> <span style="color: #231F20">The
derivative instruments in which the Fund may invest will give rise to forms of financial leverage, which may magnify the risk of owning
such instruments. Derivatives generally involve leverage in the sense that the investment exposure created by the derivatives may be significantly
greater than the Fund&#8217;s initial investment in the derivative. Accordingly, if the Fund enters into a derivative transaction, it
could lose substantially more than the principal amount invested.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #231F20">Additionally, as a closed-end investment company registered
with the SEC, the Fund is subject to the federal securities laws, including the 1940 Act, the rules&#160;thereunder, and various SEC and
SEC staff interpretive positions. In accordance with these laws, rules&#160;and positions, the Fund may &#8220;set aside&#8221; liquid
assets (often referred to as &#8220;asset segregation&#8221;), or engage in other SEC or staff-approved measures, to &#8220;cover&#8221;
open positions with respect to certain portfolio management techniques, such as engaging in reverse repurchase agreements, dollar rolls,
entering into credit default swaps or futures contracts, or purchasing securities on a when-issued or delayed delivery basis, that may
be considered senior securities under the 1940 Act. The Fund intends to cover its derivative positions by maintaining an amount of cash
or liquid securities in a segregated account equal to the face value of those positions and by offsetting derivative positions against
one another or against other assets to manage the effective market exposure resulting from derivatives in its portfolio. To the extent
that the Fund does not segregate liquid assets or otherwise cover its obligations under such transactions, such transactions will be treated
as senior securities representing indebtedness for purposes of the requirement under the 1940 Act that the Fund may not enter into any
such transactions if the Fund&#8217;s borrowings would thereby exceed 33 1/3% of its managed assets, less all liabilities and indebtedness
of the Fund not represented by senior securities. However, these transactions, even if covered, may represent a form of economic leverage
and will create risks. In addition, these segregation and coverage requirements could result in the Fund maintaining securities positions
that it would otherwise liquidate, segregating assets at a time when it might be disadvantageous to do so or otherwise restricting portfolio
management. Such segregation and cover requirements will not limit or offset losses on related positions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund has issued indebtedness and preferred shares and may borrow
money or issue debt securities as permitted by the 1940 Act. As of January&#160;31, 2025, the Fund has leverage in the form of borrowings
under the SSB Agreement and outstanding MRP Shares. Leverage is the potential for the Fund to participate in gains and losses on an amount
that exceeds the Fund's investment. The borrowing of money or issuance of debt securities and preferred shares represents the leveraging
of the Fund's common shares. As a non-fundamental policy, the Fund may not issue preferred shares or borrow money and/or issue debt securities
with an aggregate liquidation preference and aggregate principal amount exceeding 38% of the Fund's managed assets as measured at the
time of borrowing or issuance of the new securities. However, the Board of Trustees reserves the right to issue preferred shares or debt
securities or borrow to the extent permitted by the 1940 Act and the Fund's policies. See "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage creates risks which may adversely affect the return for the
holders of common shares, including:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the likelihood of greater volatility in the NAV and market price
of the Fund's common shares;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> fluctuations in the dividend rates on any preferred shares borne
by the Fund or in interest rates on borrowings and short-term debt;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> increased operating costs, which are effectively borne by common
shareholders, may reduce the Fund's total return; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the potential for a decline in the value of an investment acquired
with borrowed funds, while the Fund's obligations under such borrowing or preferred shares remain fixed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the rights of lenders and the holders of preferred shares
and debt securities issued by the Fund will be senior to the rights of the holders of common shares with respect to the payment of dividends
or to the payment of assets upon liquidation. Holders of preferred shares have voting rights in addition to and separate from the voting
rights of common shareholders. See "Description of Securities &#8212; Preferred Shares" and "Certain Provisions of the
Agreement and Declaration of Trust and By-Laws,&#160;Including Antitakeover Provisions." The holders of preferred shares or debt,
if any, on the one hand, and the holders of the common shares, on the other, may have interests that conflict in certain situations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 53 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's use of leverage is premised upon the expectation that the
Fund's preferred share dividends or borrowing cost will be lower than the return the Fund achieves on its investments with the proceeds
of the issuance of preferred shares or debt securities or borrowing. Such difference in return may result from the Fund's higher credit
rating or the short-term nature of its borrowing compared to the lower credit quality, long-term nature of its investments. Because Calamos
seeks to invest the Fund's managed assets (including the assets obtained from leverage) in a portfolio of potentially higher yielding
investments or portfolio investments with the potential for capital appreciation, the holders of common shares will be the beneficiaries
of any incremental return but will bear the risk of loss on investments made with the leverage proceeds. Should the differential between
the Fund's return on its investments made with the proceeds of leverage and the cost of the leverage narrow, the incremental return "pick
up" will be reduced or the Fund may incur losses. If long-term interest rates rise without a corresponding increase in the yield
on the Fund's portfolio investments or the Fund otherwise incurs losses on its investments, the Fund's net asset value attributable to
its common shareholders will reflect the decline in the value of portfolio holdings resulting therefrom.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Leverage is a speculative technique that could adversely affect the
returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the
income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's
return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased
with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less
than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other
distributions will be reduced or potentially eliminated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will pay, and common shareholders will effectively bear, any
costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares or debt securities. Such
costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and
interest and/or dividend expense and ongoing maintenance. These conditions may, directly or indirectly, result in higher leverage costs
to common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain types of borrowings may result in the Fund being subject to
covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and
additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The
Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject
to certain restrictions on investments imposed by guidelines of and covenants with rating agencies which may issue ratings for the preferred
shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition
requirements that are more stringent than those imposed by the 1940 Act. If the Fund's ability to make dividends and distributions on
its common shares is limited, such limitation could, under certain circumstances, impair the ability of the Fund to maintain its qualification
for taxation as a regulated investment company or to reduce or eliminate tax at the Fund level, which would have adverse tax consequences
for common shareholders. To the extent that the Fund is required, in connection with maintaining 1940 Act asset coverage requirements
or otherwise, or elects to redeem any preferred shares or debt securities or prepay any borrowings, the Fund may need to liquidate investments
to fund such redemptions or prepayments. Liquidation at times of adverse economic conditions may result in capital loss and reduce returns
to common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board reserves the right to change the amount and type of leverage
that the Fund uses, and reserves the right to implement changes to the Fund's borrowings that it believes are in the long-term interests
of the Fund and its shareholders, even if such changes impose a higher interest rate or other costs or impacts over the intermediate,
or short-term time period. There is no guarantee that the Fund will maintain leverage at the current rate, and the Board reserves the
right to raise, decrease, or eliminate the Fund's leverage exposure. See "Prospectus Summary &#8212; Use of Leverage by the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 54 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because Calamos' investment management fee is a percentage of the Fund's
managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage
the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional
use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would
require approval by the Board. In considering whether to approve the use of additional leverage, the Board would be presented with all
relevant information necessary to make a determination whether or not additional leverage through those means would be in the best interests
of the Fund, including information regarding any potential conflicts of interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Liquidity Risk.</i> The Fund may invest without limit in securities
that, at the time of investment, are illiquid (i.e., any investment that the Fund reasonably expects cannot be sold or disposed of in
current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the
investment). The Fund may also invest without limit in Rule&#160;144A Securities determined to be liquid. Calamos, under the supervision
and oversight of the Board of Trustees, will determine whether Rule&#160;144A Securities are illiquid (that is, not readily marketable).
Illiquid securities may be difficult to dispose of at a fair price at the times when the Fund believes it is desirable to do so. Investment
of the Fund's assets in illiquid securities may restrict the Fund's ability to take advantage of market opportunities. The market price
of illiquid securities generally is more volatile than that of more liquid securities, which may adversely affect the price that the Fund
pays for or recovers upon the sale of illiquid securities. Illiquid securities are also more difficult to value and may be fair valued
in which case Calamos' judgment may play a greater role in the valuation process. The risks associated with illiquid securities may be
particularly acute in situations in which the Fund's operations require cash and could result in the Fund borrowing to meet its short-term
needs or incurring losses on the sale of illiquid securities. The Fund may also invest without limitation in securities that have not
been registered for public sale, but that are eligible for purchase and sale by certain qualified institutional buyers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Loan Risk.</i> The Fund may invest in loans which may not be (i)&#160;rated
at the time of investment, (ii)&#160;registered with the SEC or (iii)&#160;listed on a securities exchange. There may not be as much public
information available regarding these loans as is available for other Fund investments, such as exchange-listed securities. As well, there
may not be an active trading market for some loans, meaning they may be illiquid and more difficult to value than other more liquid securities.
Settlement periods for loans are longer than for exchange-traded securities, typically ranging between 1 and 3 weeks, and in some cases
much longer. There is no central clearinghouse for loan trades, and the loan market has not established enforceable settlement standards
or remedies for failure to settle. Because the interest rates of floating-rate loans in which the Fund may invest may reset frequently,
if market interest rates fall, the loans' interest rates will be reset to lower levels, potentially reducing the Fund's income. Because
the adviser may wish to invest in the publicly-traded securities of an obligor, the Fund may not have access to material non-public information
regarding the obligor to which other investors have access.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Management Risk.</i> Calamos' judgment about the attractiveness,
relative value or potential appreciation of a particular sector, security or investment strategy may prove to be incorrect.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Disruption Risk.</i> Certain events have a disruptive effect
on the securities markets, such as terrorist attacks, war and other geopolitical events, earthquakes, storms and other disasters. The
Fund cannot predict the effects of similar events in the future on the U.S. economy or any foreign economy. High yield securities tend
to be more volatile than higher rated debt securities so that these events and any actions resulting from them may have a greater impact
on the prices and volatility of high yield securities than on higher rated securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Master Limited Partnerships Risk.</i> Investments in MLPs involve
risks that differ from investments in common stock. Holders of MLP common units are subject to certain risks inherent in the structure
of MLPs, including (i)&#160;tax risks, (ii)&#160;risk related to limited control of management or the general partner or managing member,
(iii)&#160;limited rights to vote on matters affecting the MLP, except with respect to extraordinary transactions, (iv)&#160;conflicts
of interest between the general partner or managing member and its affiliates, on the one hand, and the limited partners or members, on
the other hand, including those arising from incentive distribution payments or corporate opportunities, and (v)&#160;cash flow risks.
MLP common units and other equity securities can be affected by macro-economic and other factors affecting the stock market in general,
expectations of interest rates, investor sentiment towards MLPs or the energy sector, changes in a particular issuer's financial condition,
or unfavorable or unanticipated poor performance of a particular issuer (in the case of MLPs, generally measured in terms of distributable
cash flow). Prices of common units of individual MLPs and other equity securities also can be affected by fundamentals unique to the partnership
or company, including cash flow growth, cash generating power and distribution coverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 55 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although certain MLPs may trade on national securities exchanges, certain
MLPs may trade less frequently than those of larger companies due to their market capitalizations. Due to limited trading volumes of certain
MLPs, the prices of such MLPs may display abrupt or erratic movements at times. Additionally, it may be more difficult for the Fund to
buy and sell significant amounts of such securities without an unfavorable impact on prevailing market prices. The Fund's investment in
securities that are less actively traded or over time experience decreased trading volume may restrict its ability to dispose of the securities
at a fair price. Such a situation may prevent the Fund from limiting losses or realizing gains. This also may adversely affect the Fund's
ability to make dividend distributions to shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MLPs are generally treated as partnerships for U.S. federal income
tax purposes. Partnerships do not pay U.S. federal income tax at the partnership level. Rather, each partner is allocated a share of the
partnership's income, gains, losses, deductions and expenses. A change in current tax law, or a change in the business of a given MLP,
could result in an MLP being treated as a corporation for U.S. federal income tax purposes. As a result, the amount of cash available
for distribution by the MLP would be reduced and the after-tax return to the Fund with respect to its investment in such MLPs would be
materially reduced. Thus, if any of the MLPs owned by the Fund were treated as corporations for U.S. federal income tax purposes, it could
result in a reduction in the value of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Maturity Risk.</i> Interest rate risk will generally affect the
price of a fixed income security more if the security has a longer maturity. Fixed income securities with longer maturities will therefore
be more volatile than other fixed income securities with shorter maturities. Conversely, fixed income securities with shorter maturities
will be less volatile but generally provide lower potential returns than fixed income securities with longer maturities. The average maturity
of the Fund's investments may affect the volatility of the Fund's share price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-Convertible Income Securities Risk.</i> The Fund will also invest
in non-convertible income securities. The Fund's investments in non-convertible income securities may have fixed or variable principal
payments and all types of interest rate and dividend payment and reset terms, including fixed rate, adjustable rate, zero coupon, contingent,
deferred, payment in kind and auction rate features. Recent events in the fixed-income markets, including the potential impact of the
Federal Reserve Board tapering its quantitative easing program, may expose the Fund to heightened interest rate risk and volatility. In
addition, the Fund is subject to the risk that interest rates may exhibit increased volatility, which could cause the Fund's net asset
value to fluctuate more. A decrease in fixed-income market maker capacity may act to decrease liquidity in the fixed-income markets and
act to further increase volatility, affecting the Fund's return.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Non-U.S. Government Obligation Risk.</i> An investment in debt obligations
of non-U.S. governments and their political subdivisions involves special risks that are not present in corporate debt obligations. The
non-U.S. issuer of the sovereign debt or the non-U.S. governmental authorities that control the repayment of the debt may be unable or
unwilling to repay principal or interest when due, and the Fund may have limited recourse in the event of a default. During periods of
economic uncertainty, the market prices of sovereign debt may be more volatile than prices of debt obligations of U.S. issuers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Selection Risk.</i> The value of your investment may decrease
if the investment adviser's judgment about the attractiveness, value or market trends affecting a particular security, issuer, industry
or sector or about market movements is incorrect.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Turnover Risk.</i> The portfolio managers may actively
and frequently trade securities or other instruments in the Fund's portfolio to carry out its investment strategies. A high portfolio
turnover rate increases transaction costs, which may increase the Fund's expenses. Frequent and active trading may also cause adverse
tax consequences for investors in the Fund due to an increase in short-term capital gains.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Market Events.</i> Since the 2008 financial crisis, financial
markets throughout the world have experienced increased periods of volatility, depressed valuations, decreased liquidity and heightened
uncertainty and turmoil. This turmoil resulted in unusual and extreme volatility in the equity and debt markets, in the prices of individual
securities and in the world economy. Events that have contributed to these market conditions include, but are not limited to, major cybersecurity
events, geopolitical events (such as wars (including Russia&#8217;s military invasion of Ukraine), terror attacks, natural or environmental
disasters, country instability, and public health emergencies), measures to address budget deficits, downgrading of sovereign debt, dramatic
changes in currency exchange rates, and public sentiment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 56 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, policy and legislative changes in the United States and
in other countries are changing many aspects of financial regulation. The impact of these changes on the markets, and the practical implications
for market participants, may not be fully known for some time. Widespread disease and virus epidemics and pandemics, such as the coronavirus
outbreak, could likewise be highly disruptive, adversely affecting individual companies, sectors, industries, markets, currencies, interest
and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Fund's investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Regulatory Risk. </i>Derivatives markets are subject to various
risks related to existing as well as new and evolving regulations both within and outside the United States. For example, in the United
States, new or amended regulations may be imposed by the U.S. Commodity Futures Trading Commission (the &#8220;CFTC&#8221;), the SEC,
the Federal Reserve or other financial regulators, other governmental regulatory authorities or self-regulatory organizations that supervise
the financial markets that could adversely affect the Fund. In particular, these agencies are empowered to promulgate a variety of new
rules&#160;pursuant to financial reform legislation in the United States. The Fund also may be adversely affected by changes in the enforcement
or interpretation of existing statues and rules&#160;by these governmental regulatory authorities or self-regulatory organizations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the securities and futures markets are subject to comprehensive
statutes, regulations and margin requirements. For instance, the Dodd &#8212; Frank Wall Street Reform and Consumer Protection Act of
2010 ("Dodd-Frank Act") could have an adverse effect on the Fund's ability to use derivative instruments. The Dodd-Frank Act
is designed to impose stringent regulation on the over-the-counter derivatives market in an attempt to increase transparency and accountability
and provides for, among other things, clearing, execution, margin, reporting, recordkeeping, business conduct, disclosure, position limit,
minimum net capital and registration requirements. Because regulations that are being implemented by these requirements are evolving (and
some of the regulations are not yet final), their ultimate impact remains unclear. Similar requirements are in the process of being implemented
in the European Union, the United Kingdom and other jurisdictions which may impact the Fund&#8217;s transactions with entities domiciled
in such jurisdictions and subject to such requirements. These regulations could, among other things, restrict the Fund's ability to engage
in derivatives transactions (for example, by making certain types of derivatives transactions no longer available to our funds), increase
the costs of using these instruments (for example, by increasing margin, capital or reporting requirements) and/or make them less effective
and, as a result, the Fund may be unable to execute its investment strategy. Limits or restrictions applicable to the counterparties with
which the Fund engages in derivative transactions could also prevent the Fund from using these instruments, affect the pricing or other
factors relating to these instruments or may change availability of certain investments. It is unclear how the regulatory changes will
affect counterparty risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule&#160;18f-4 under the 1940 Act provides for the regulation of registered
investment companies' use of derivatives and certain related instruments. The rule, among other things, limits derivatives exposure through
one of two value-at-risk tests, requires funds to adopt and implement a derivatives risk management program (including the appointment
of a derivatives risk manager and the implementation of certain testing requirements), and subjects funds to certain reporting requirements
in respect of derivatives. Limited derivatives users (as determined by Rule&#160;18f-4) are not, however, subject to the full requirements
under the rule. Rule&#160;18f-4 could restrict the Fund's ability to engage in certain derivatives transactions and/or increase the costs
of such derivatives transactions, which could adversely affect the value or performance of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 57 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>REIT Risk.</i> Investing in real estate investment trusts (&#8220;REITs&#8221;)
involves certain unique risks in addition to those risks associated with investing in the real estate industry in general. An equity REIT
may be affected by changes in the value of the underlying properties owned by the REIT. A mortgage REIT may be affected by changes in
interest rates and the ability of the issuers of its portfolio mortgages to repay their obligations. REITs are dependent upon the skills
of their managers and are not diversified. REITs are generally dependent upon maintaining cash flows to repay borrowings and to make distributions
to shareholders and are subject to the risk of default by lessees or borrowers. REITs whose underlying assets are concentrated in properties
used by a particular industry, such as health care, are also subject to risks associated with such industry.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">REITs (especially mortgage REITs) are also subject to interest rate
risks. When interest rates decline, the value of a REIT's investment in fixed rate obligations can be expected to rise. Conversely, when
interest rates rise, the value of a REIT's investment in fixed rate obligations can be expected to decline. If the REIT invests in adjustable
rate mortgage loans the interest rates on which are reset periodically, yields on a REIT's investments in such loans will gradually align
themselves to reflect changes in market interest rates. This causes the value of such investments to fluctuate less dramatically in response
to interest rate fluctuations than would investments in fixed rate obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">REITs may have limited financial resources, may utilize significant
amounts of leverage, may trade less frequently and in a limited volume and may be subject to more abrupt or erratic price movements than
larger company securities. Historically, REITs have been more volatile in price than the larger capitalization stocks included in Standard&#160;&amp;
Poor's 500 Stock Index.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Risks Associated with Options.</i> The Fund may use options, including
on the Fund's convertible securities or during the creation of synthetic convertible instruments. There are several risks associated with
transactions in options. For example, there are significant differences between the securities markets and options markets that could
result in an imperfect correlation among these markets, causing a given transaction not to achieve its objectives. A decision as to whether,
when and how to use options involves the exercise of skill and judgment, and even a well-conceived transaction may be unsuccessful to
some degree because of market behavior or unexpected events. The Fund's ability to utilize options successfully will depend on Calamos'
ability to predict pertinent market movements, which cannot be assured.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund intends to seek to generate income from option premiums by
writing (selling) options. The Fund may write (sell) call options (i)&#160;on a portion of the equity securities (including securities
that are convertible into equity securities) in the Fund's portfolio, (ii)&#160;on a portion of the equity securities the Fund has a right
to receive upon conversion of a convertible security that it owns at the time it writes the call, and (iii)&#160;on broad-based securities
indices (such as the S&amp;P 500 or MSCI EAFE) or certain ETFs that trade like common stocks but seek to replicable such market indices.
All call options sold by the Fund must be "covered." For example, a call option written by the Fund will require the Fund to
hold the securities subject to the call (or securities convertible into the needed securities without additional consideration) or to
segregate cash or liquid assets sufficient to purchase and deliver the securities if the call is exercised. Even though the Fund will
receive the option premium to help protect it against loss, a call option sold by the Fund exposes the Fund during the term of the option
to possible loss of opportunity to realize appreciation in the market price of the underlying security or instrument and may require the
Fund to hold a security or instrument that it might otherwise have sold. The Fund may purchase and sell put options on individual securities
and securities indices. In selling put options, there is a risk that the Fund may be required to buy the underlying security at a disadvantageous
price above the market price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Rule&#160;144A Securities Risk.</i> The Fund may invest in securities
that are issued and sold through transactions under Rule&#160;144A of the Securities Act of 1933. Under the supervision and oversight
of the Board of Trustees, Calamos will determine whether Rule&#160;144A Securities are illiquid. If qualified institutional buyers are
unwilling to purchase these Rule&#160;144A Securities, the percentage of the Fund's assets invested in illiquid securities would increase.
Typically, the Fund purchases Rule&#160;144A Securities only if the Fund's adviser has determined them to be liquid. If any Rule&#160;144A
Security held by the Fund should become illiquid, the value of the security may be reduced and a sale of the security may be more difficult.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sector Risk.</i> To the extent the Fund invests a significant portion
of its assets in a particular sector, a greater portion of the Fund's performance may be affected by the general business and economic
conditions affecting that sector. Each sector may share economic risk with the broader market, however there may be economic risks specific
to each sector. As a result, returns from those sectors may trail returns from the overall stock market and it is possible that the Fund
may underperform the broader market, or experience greater volatility.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 58 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Synthetic Convertible Instruments Risk.</i> The value of a synthetic
convertible instrument may respond differently to market fluctuations than a convertible instrument because a synthetic convertible instrument
is composed of two or more separate securities, each with its own market value. In addition, if the value of the underlying common stock
or the level of the index involved in the convertible component falls below the exercise price of the warrant or option, the warrant or
option may lose all value. Synthetic convertible instruments created by other parties have the same attributes of a convertible security;
however, the issuer of the synthetic convertible instrument assumes the credit risk associated with the investment, rather than the issuer
of the underlying equity security into which the instrument is convertible. Investing in synthetic convertible instruments also involves
the risk that the Fund does not achieve the investment exposure desired by Calamos. The Fund remains subject to the credit risk associated
with the counterparty creating the synthetic convertible instrument.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tax Risk.</i> The Fund may invest in certain securities, such as
certain convertible securities and high yield securities, for which the federal income tax treatment may not be clear or may be subject
to recharacterization by the IRS. It could be more difficult for the Fund to comply with certain federal income tax requirements applicable
to regulated investment companies if the tax characterization of the Fund's investments is not clear or if the tax treatment of the income
from such investments was successfully challenged by the IRS. Any failure to comply with the rules&#160;applicable to regulated investment
companies could cause the Fund to fail to qualify as such. In addition, the tax treatment of the Fund may be affected by future interpretations
of the Code and changes in the tax laws and regulations, all of which may apply with retroactive effect. See "Certain Federal Income
Tax Matters."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of the Fund's investment practices may be subject to special
and complex federal income tax provisions that may, among other things, (i)&#160;disallow, suspend or otherwise limit the allowance of
certain losses or deductions, (ii)&#160;convert tax-advantaged, long-term capital gains and qualified dividend income into higher taxed
short-term capital gain or ordinary income, (iii)&#160;increase ordinary income distributions, (iv)&#160;convert an ordinary loss or a
deduction into a capital loss (the deductibility of which is more limited), (v)&#160;cause the Fund to recognize income or gain without
a corresponding receipt of cash, (vi)&#160;adversely affect the timing as to when a purchase or sale of stock or securities is deemed
to occur, and (vii)&#160;adversely alter the characterization of certain complex financial transactions. The Fund will monitor its transactions
and may make certain tax elections where applicable in order to mitigate the effect of these provisions, if possible.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>U.S. Government Security Risk.</i> Some securities issued by U.S.
Government agencies or government sponsored enterprises are not backed by the full faith and credit of the U.S. and may only be supported
by the right of the agency or enterprise to borrow from the U.S. Treasury. There can be no assurance that the U.S. Government will always
provide financial support to those agencies or enterprises.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Volatility Risk.</i> Risk may arise in connection with the use of
derivative instruments from volatility of interest rates and the prices of reference instruments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Risks to Common Shareholders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Generally, an investment in common shares is subject to the following
risks:</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Diminished Voting Power and Excess Cash Risk.</i> The voting power
of current shareholders will be diluted to the extent that such shareholders do not purchase shares in any future common share offerings
or do not purchase sufficient shares to maintain their percentage interest. In addition, if the Fund is unable to invest the proceeds
of such offering as intended, its per share distribution may decrease (or may consist of return of capital) and the Fund may not participate
in market advances to the same extent as if such proceeds were fully invested as planned.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Transactions Risk.</i> The Fund may enter into an
interest rate swap, cap or floor transaction to attempt to protect itself from increasing dividend or interest expenses on its leverage
resulting from increasing short-term interest rates and to hedge its portfolio securities. A decline in interest rates may result in a
decline in the value of the swap or cap, which may result in a decline in the net asset value of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depending on the state of interest rates in general, the Fund's use
of interest rate swap or cap transactions could enhance or harm the overall performance of the common shares. To the extent there is a
decline in interest rates, the value of the interest rate swap or cap could decline, and could result in a decline in the net asset value
of the common shares. In addition, if the counterparty to an interest rate swap or cap defaults, the Fund would not be able to use the
anticipated net receipts under the swap or cap to offset the dividend or interest payments on the Fund's leverage or offset certain losses
in its portfolio.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 59 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depending on whether the Fund would be entitled to receive net payments
from the counterparty on the swap or cap, which in turn would depend on the general state of short-term interest rates at that point in
time, such a default could negatively impact the performance of the common shares. In addition, at the time an interest rate swap or cap
transaction reaches its scheduled termination date, there is a risk that the Fund would not be able to obtain a replacement transaction
or that the terms of the replacement would not be as favorable as on the expiring transaction. If either of these events occurs, it could
have a negative impact on the performance of the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Fund fails to maintain a required 200% asset coverage of the
liquidation value of any outstanding preferred shares or if the Fund loses its rating on its preferred shares or fails to maintain other
covenants with respect to the preferred shares, the Fund may be required to redeem some or all of the preferred shares. Similarly, the
Fund could be required to prepay the principal amount of any debt securities or other borrowings. Such redemption or prepayment would
likely result in the Fund seeking to terminate early all or a portion of any swap or cap transaction. Early termination of a swap could
result in a termination payment by or to the Fund. Early termination of a cap could result in a termination payment to the Fund. The Fund
intends to segregate with its custodian cash or liquid securities having a value at least equal to the Fund's net payment obligations
under any swap transaction, marked-to-market daily.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, certain categories of interest rate swaps are subject to
mandatory clearing, and more are expected to be cleared in the future. The counterparty risk for cleared derivatives is generally lower
than for uncleared OTC derivative transactions because generally a clearing organization becomes substituted for each counterparty to
a cleared derivative contract and, in effect, guarantees the parties' performance under the contract as each party to a trade looks only
to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members,
will satisfy the clearing house's obligations to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Discount Risk.</i> The Fund's common shares have traded both
at a premium and at a discount relative to net asset value. Common shares of closed-end investment companies frequently trade at a discount
from net asset value, but in some cases trade above net asset value. The risk of the Fund's common shares trading at a discount is a risk
separate from the risk of a decline in the Fund's net asset value as a result of investment activities. The Fund's net asset value may
be reduced immediately following this offering by the offering costs for common shares or other securities, which will be borne entirely
by all common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whether shareholders will realize a gain or loss upon the sale of the
Fund's common shares depends upon whether the market value of the shares at the time of sale is above or below the price the shareholder
paid, taking into account transaction costs for the shares, and is not directly dependent upon the Fund's net asset value. Because the
market value of the Fund's common shares will be determined by factors such as the relative demand for and supply of the shares in the
market, general market conditions and other factors beyond the control of the Fund, the Fund cannot predict whether its common shares
will trade at, below or above the Fund's net asset value, or below or above the public offering price for the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Impact Risk.</i> The sale of our common shares (or the perception
that such sales may occur) may have an adverse effect on prices in the secondary market for our common shares. An increase in the number
of common shares available may put downward pressure on the market price for our common shares. These sales also might make it more difficult
for us to sell additional equity securities in the future at a time and price the Fund deems appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reduction of Leverage Risk.</i> We have previously taken, and may
in the future take, action to reduce the amount of leverage employed by the Fund. Reduction of the leverage employed by the Fund, including
by redemption of preferred shares, will in turn reduce the amount of assets available for investment in portfolio securities. This reduction
in leverage may negatively impact our financial performance, including our ability to sustain current levels of distributions on common
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 60 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board reserves the right to change the amount and type of leverage
that the Fund uses, and reserves the right to implement changes to the Fund's borrowings that it believes are in the best long-term interests
of the Fund and its shareholders, even if such changes impose a higher interest rate or other costs or impacts over the intermediate,
or short-term time period. There is no guarantee that the Fund will maintain leverage at the current rate, and the Board reserves the
right to raise, decrease, or eliminate the Fund's leverage exposure.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Risks to Senior Security Holders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Additional risks of investing in senior securities include the
following:</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Generally, an investment in preferred shares (including exchange-listed
preferred shares) or debt securities (collectively, "senior securities") is subject to the following risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Decline in Net Asset Value Risk.</i> A material decline in the Fund's
NAV may impair our ability to maintain required levels of asset coverage for outstanding borrowings or any debt securities or preferred
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Early Redemption Risk.</i> The Fund may voluntarily redeem preferred
shares or may be forced to redeem preferred shares to meet regulatory requirements and the asset coverage requirements of the preferred
shares. Such redemptions may be at a time that is unfavorable to holders of the preferred shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inflation Risk.</i> Inflation is the reduction in the purchasing
power of money resulting from an increase in the price of goods and services. Inflation risk is the risk that the inflation adjusted or
"real" value of an investment in preferred stock or debt securities or the income from that investment will be worth less in
the future. As inflation occurs, the real value of the preferred stock or debt securities and the dividend payable to holders of preferred
stock or interest payable to holders of debt securities declines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Risk.</i> Rising market interest rates could impact
negatively the value of our investment portfolio, reducing the amount of assets serving as asset coverage for the senior securities. Rising
market interest rates could also reduce the value of the Fund's senior securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Discount Risk.</i> The market price of exchange-listed preferred
shares that the Fund may issue may also be affected by such factors as the Fund's use of leverage, dividend stability, portfolio credit
quality, liquidity, and the Fund's dividends paid (which are, in turn, affected by expenses), call protection for portfolio securities
and interest rate movements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Ratings and Asset Coverage Risk.</i> To the extent that senior securities
are rated, a rating does not eliminate or necessarily mitigate the risks of investing in our senior securities, and a rating may not fully
or accurately reflect all of the credit and market risks associated with that senior security. A rating agency could downgrade the rating
of our shares of preferred stock or debt securities, which may make such securities less liquid in the secondary market, though potentially
with higher resulting interest rates. If a rating agency downgrades the rating assigned to a senior security, we may alter our portfolio
or redeem the senior security. We may voluntarily redeem senior securities under certain circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Secondary Market Risk.</i> The market value of exchange-listed preferred
shares that the Fund may issue will be determined by factors such as the relative demand for and supply of the preferred shares in the
market, general market conditions and other factors beyond the control of the Fund. It may be difficult to predict the trading patterns
of preferred shares, including the effective costs of trading. There is a risk that the market for preferred shares may be thinly traded
and relatively illiquid compared to the market for other types of securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Leverage Risk.</i> Preferred shares will be junior in liquidation
and with respect to distribution rights to debt securities and any other borrowings. Senior securities representing indebtedness may constitute
a substantial lien and burden on preferred shares by reason of their prior claim against our income and against our net assets in liquidation.
We may not be permitted to declare dividends or other distributions with respect to any series of preferred shares unless at such time
we meet applicable asset coverage requirements and the payment of principal or interest is not in default with respect to any borrowings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 61 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT OF THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustees and Officers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's Board of Trustees provides broad supervision over the affairs
of the Fund. The officers of the Fund are responsible for the Fund's operations. Currently, there are seven Trustees of the Fund, one
of whom is an "interested person" of the Fund (as defined in the 1940 Act) and six of whom are not "interested persons."
The names and business addresses of the trustees and officers of the Fund and their principal occupations and other affiliations during
the past five years are set forth under "Management of the Fund" in the statement of additional information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Adviser</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's investments are managed by Calamos, 2020 Calamos Court,
Naperville,&#160;Illinois 60563. On January&#160;31, 2025, Calamos managed approximately $40.4 billion in assets of individuals and institutions.
Calamos is a wholly owned subsidiary of Calamos Investments LLC ("CILLC"). Calamos Asset Management,&#160;Inc. ("CAM")
is the sole manager of CILLC. As of January&#160;31, 2025, approximately 22% of the outstanding interests of CILLC was owned by CAM and
the remaining approximately 78% of CILLC was owned by Calamos Partners LLC (&#8220;CPL&#8221;) and John P. Calamos,&#160;Sr. CAM was owned
by John P. Calamos,&#160;Sr. and John S. Koudounis, and CPL was owned by John S. Koudounis and Calamos Family Partners,&#160;Inc. (&#8220;CFP&#8221;).
CFP was beneficially owned by members of the Calamos family, including John P. Calamos,&#160;Sr.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Management Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to the overall supervision and review of the Board of Trustees,
Calamos provides the Fund with investment research, advice and supervision and furnishes continuously an investment program for the Fund,
consistent with the investment objective and policies of the Fund. In addition, Calamos furnishes for use of the Fund such office space
and facilities as the Fund may require for its reasonable needs, supervises the Fund's business and affairs and provides the following
other services on behalf of the Fund (not provided by persons not a party to the investment management agreement): (a)&#160;preparing
or assisting in the preparation of reports to and meeting materials for the Trustees; (b)&#160;supervising, negotiating contractual arrangements
with, to the extent appropriate, and monitoring the performance of, accounting agents, custodians, depositories, transfer agents and pricing
agents, accountants, attorneys, printers, underwriters, brokers and dealers, insurers and other persons in any capacity deemed to be necessary
or desirable to Fund operations; (c)&#160;assisting in the preparation and making of filings with the Commission and other regulatory
and self-regulatory organizations, including, but not limited to, preliminary and definitive proxy materials, registration statements
on Form&#160;N-2 and amendments thereto, and reports on Form&#160;N-CEN and Form&#160;N-CSR; (d)&#160;overseeing the tabulation of proxies
by the Fund's transfer agent; (e)&#160;assisting in the preparation and filing of the Fund's federal, state and local tax returns; (f)&#160;assisting
in the preparation and filing of the Fund's federal excise tax returns pursuant to Section&#160;4982 of the Code; (g)&#160;providing assistance
with investor and public relations matters; (h)&#160;monitoring the valuation of portfolio securities and the calculation of net asset
value; (i)&#160;monitoring the registration of shares of beneficial interest of the Fund under applicable federal and state securities
laws; (j)&#160;maintaining or causing to be maintained for the Fund all books, records and reports and any other information required
under the 1940 Act, to the extent that such books, records and reports and other information are not maintained by the Fund's custodian
or other agents of the Fund; (k)&#160;assisting in establishing the accounting policies of the Fund; (l)&#160;assisting in the resolution
of accounting issues that may arise with respect to the Fund's operations and consulting with the Fund's independent accountants, legal
counsel and the Fund's other agents as necessary in connection therewith; (m)&#160;reviewing the Fund's bills; (n)&#160;assisting the
Fund in determining the amount of dividends and distributions available to be paid by the Fund to its shareholders, preparing and arranging
for the printing of dividend notices to shareholders, and providing the transfer and dividend paying agent, the custodian, and the accounting
agent with such information as is required for such parties to effect the payment of dividends and distributions; and (o)&#160;otherwise
assisting the Fund as it may reasonably request in the conduct of the Fund's business, subject to the direction and control of the Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the investment management agreement, the Fund pays to Calamos
a fee based on the average weekly managed assets that is computed weekly and payable monthly in arrears. The fee paid by the Fund is set
at the annual rate of 0.80% of the Fund's average weekly managed assets. Because the fees paid to Calamos are determined on the basis
of the Fund's managed assets, the amount of management fees paid to Calamos when the Fund uses leverage will be higher than if the Fund
did not use leverage. Therefore, Calamos has a financial incentive to use leverage, which creates a conflict of interest between Calamos
and the Fund's common shareholders. A discussion regarding the basis of the approval of the Investment Management Agreement is available
in the Fund's Form&#160;N-CSR for the year ended October&#160;31, 2024.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 62 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of its investment management agreement, except for
the services and facilities provided by Calamos as set forth therein, the Fund shall assume and pay all expenses for all other Fund operations
and activities and shall reimburse Calamos for any such expenses incurred by Calamos. The expenses borne by the Fund shall include, without
limitation: (a)&#160;organizational expenses of the Fund (including out-of-pocket expenses, but not including Calamos' overhead or employee
costs); (b)&#160;fees payable to Calamos; (c)&#160;legal expenses; (d)&#160;auditing and accounting expenses; (e)&#160;maintenance of
books and records that are required to be maintained by the Fund's custodian or other agents of the Fund; (f)&#160;telephone, telex, facsimile,
postage and other communications expenses; (g)&#160;taxes and governmental fees; (h)&#160;fees, dues and expenses incurred by the Fund
in connection with membership in investment company trade organizations and the expense of attendance at professional meetings of such
organizations; (i)&#160;fees and expenses of accounting agents, custodians, subcustodians, transfer agents, dividend disbursing agents
and registrars; (j)&#160;payment for portfolio pricing or valuation services to pricing agents, accountants, bankers and other specialists,
if any; (k)&#160;expenses of preparing share certificates; (l)&#160;expenses in connection with the issuance, offering, distribution,
sale, redemption or repurchase of securities issued by the Fund; (m)&#160;expenses relating to investor and public relations provided
by parties other than Calamos; (n)&#160;expenses and fees of registering or qualifying shares of beneficial interest of the Fund for sale;
(o)&#160;interest charges, bond premiums and other insurance expenses; (p)&#160;freight, insurance and other charges in connection with
the shipment of the Fund's portfolio securities; (q)&#160;the compensation and all expenses (specifically including travel expenses relating
to Fund business) of Trustees, officers and employees of the Fund who are not affiliated persons of Calamos; (r)&#160;brokerage commissions
or other costs of acquiring or disposing of any portfolio securities of the Fund; (s)&#160;expenses of printing and distributing reports,
notices and dividends to shareholders; (t)&#160;expenses of preparing and setting in type, printing and mailing prospectuses and statements
of additional information of the Fund and supplements thereto; (u)&#160;costs of stationery; (v)&#160;any litigation expenses; (w)&#160;indemnification
of Trustees and officers of the Fund; (x)&#160;costs of shareholders' and other meetings; (y)&#160;interest on borrowed money, if any;
and (z)&#160;the fees and other expenses of listing the Fund's shares on Nasdaq or any other national stock exchange.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Managers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>John P. Calamos,&#160;Sr.</b> John P. Calamos,&#160;Sr. has been
President, Trustee and Co-Portfolio Manager of the Fund since inception and Founder of Calamos, Chairman and Global Chief Investment Officer
("CIO") of Calamos since August&#160;2016; Chairman and Global CIO from April&#160;to August&#160;2016; Chairman, Chief Executive
Officer and Global Co-CIO between April&#160;2013 and April&#160;2016; Chief Executive Officer and Global Co-CIO between August&#160;2012
and April&#160;2013; and Chief Executive Officer and Co-CIO prior thereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dennis Cogan.</b> Dennis Cogan joined Calamos in March&#160;2005
and since February&#160;2021 has been a Senior Co-Portfolio Manager. From March&#160;2013 to February&#160;2021, he was Co-Portfolio Manager,
and from March&#160;2005 to March&#160;2013, he was a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>R. Matthew Freund.</b> R. Matthew Freund joined Calamos in November&#160;2016
as a Co-CIO, Head of Fixed Income Strategies, as well as a Senior Co-Portfolio Manager. Previously, he was SVP of Investment Portfolio
Management and Chief Investment Officer at USAA Investments since 2010.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>John Hillenbrand.</b> John Hillenbrand joined Calamos in 2002 and
since September&#160;2015 is a Co-CIO, Head of Multi-Asset Strategies and Co-Head of Convertible Strategies, as well as a Senior Co-Portfolio
Manager. From March&#160;2013 to September&#160;2015 he was a Co-Portfolio Manager. Between August&#160;2002 and March&#160;2013 he was
a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nick Niziolek.</b> Nick Niziolek joined Calamos in March&#160;2005
and has been a Co-CIO, Head of Global Strategies, as well as a Senior Co-Portfolio Manager, since September&#160;2015. Between August&#160;2013
and September&#160;2015, he was a Co-Portfolio Manager, Co-Head of Research. Between March&#160;2013 and August&#160;2013 he was a Co-Portfolio
Manager. Between March&#160;2005 and March&#160;2013 he was a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 63 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Eli Pars.</b> Eli Pars joined Calamos in May&#160;2013 and has been
Co-CIO, Co-Head of Alternative Strategies (since July&#160;2024; previously served as Head of Alternative Strategies from September&#160;2015
to June&#160;2024) and Co-Head of Convertible Strategies, as well as a Senior Co-Portfolio Manager since September&#160;2015. Between
May&#160;2013 and September&#160;2015, he was a Co-Portfolio Manager. Previously, he was a Portfolio Manager at Chicago Fundamental Investment
Partners from February&#160;2009 until November&#160;2012.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Jon Vacko.</b> Jon Vacko joined Calamos in June&#160;2000 and has
been a Senior Co-Portfolio Manager since September&#160;2015. Previously, he was a Co-Portfolio Manager from August&#160;2013 to September&#160;2015;
prior thereto he was a Co-Head of Research and Investments from July&#160;2010 to August&#160;2013.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Joe Wysocki.</b> Joe Wysocki joined Calamos in October&#160;2003
and since February&#160;2021 has been a Senior Co-Portfolio Manager. Previously, Mr.&#160;Wysocki was a Co-Portfolio Manager from March&#160;2015
to January&#160;2021; sector head from March&#160;2014 to March&#160;2015; a Co-Portfolio Manager from March&#160;2013 to March&#160;2014;
and a senior strategy analyst from February&#160;2007 to March&#160;2013.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Chuck Carmody.</b> <span style="color: #212529; ">Chuck
Carmody joined Calamos in 2004 and since February&#160;2016 is a Co-Portfolio Manager (Co-Portfolio Manager of the Fund since December&#160;2023),
as well as a Senior Fixed Income Trader. From January&#160;2010 to February&#160;2016, he was a Senior Trader.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Calamos employs a "team of teams" approach to portfolio management,
led by the Global CIO and our CIO team consisting of 5 Co-CIOs with specialized areas of investment expertise. The Global CIO and Co-CIO
team are responsible for oversight of investment team resources, investment processes, performance and risk. As heads of investment verticals,
Co-CIOs manage investment team members and, along with Co-Portfolio Managers, Managers and Associate Portfolio Managers, have day-to-day
portfolio oversight and construction responsibilities of their respective investment strategies. While investment research professionals
within each Co-CIO's team are assigned specific strategy responsibilities, they also provide support to other investment team verticals,
creating deeper insights across a wider range of investment strategies. The combination of specialized investment teams with cross team
collaboration results in what we call our team of teams approach.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This team of teams approach is further reflected in the composition
of Calamos' Investment Committee, made up of the Global CIO, the Co-CIO team, and the Global Head of Trading. Other members of the investment
team participate in Investment Committee meetings in connection with specific investment related issues or topics as deemed appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The structure and composition of the Investment Committee results in
a number of benefits, as it:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Leads to broader perspective on investment decisions: multiple
viewpoints and areas of expertise feed into consensus;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Promotes collaboration between teams; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Functions as a think tank with the goal of identifying ways
to outperform the market on a risk-adjusted basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The objectives of the Investment Committee are to:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Form&#160;the firm's top-down macro view, market direction,
asset allocation, and sector/country positioning.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Establish firm-wide secular and cyclical themes for review.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Review firm-wide and portfolio risk metrics, recommending changes
where appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Review firm-wide, portfolio and individual security liquidity
constraints.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Evaluate firm-wide and portfolio investment performance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Evaluate firm-wide and portfolio hedging policies and execution.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 64 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> Evaluate enhancements to the overall investment process.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John P. Calamos,&#160;Sr., Founder, Chairman and Global CIO, is responsible
for the day-to-day management of the team, bottom-up research efforts and strategy implementation. R. Matthew Freund, John Hillenbrand,
Nick Niziolek, Eli Pars, Dennis Cogan, Jon Vacko and Joe Wysocki are each Sr. Co-Portfolio Managers. Chuck Carmody is a Co-Portfolio Manager.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For over 20 years, the Calamos portfolio management team has managed
money for their clients in convertible, high yield and global strategies. Furthermore, Calamos has extensive experience investing in foreign
markets through its convertible securities and high yield securities strategies. Such experience has included investments in established
as well as emerging foreign markets. The Fund's statement of additional information provides additional information about the Co-Portfolio
Managers, including other accounts they manage, their ownership in the Calamos Family of Funds and their compensation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fund Administration and Accounting</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the arrangements with State Street to provide fund accounting
services, State Street provides certain administrative and accounting services to the Fund and such other funds advised by Calamos that
may be part of those arrangements (the Fund and such other funds are collectively referred to as the "Calamos Funds") as described
more fully in the statement of additional information. For the services rendered to the Calamos Funds, State Street receives a fee based
on the combined managed assets of the closed-end Calamos Funds and the combined total average daily net assets of the open-end Calamos
Funds ("Combined Assets"). Each fund of the Calamos Funds pays its pro rata share of the fees payable to State Street described
below based on relative managed assets of each fund. State Street receives a fee at the annual rate of 0.005% for the first $20.0 billion
of Combined Assets, 0.004% for the next $10.0 billion of Combined Assets and 0.003% for the Combined Assets in excess of $30.0 billion.
Each fund of the Calamos Funds pays its pro-rata share of the fees payable to State Street based on relative Combined Assets of each fund.
Because the fees payable to State Street are based on the relative Combined Assets of the Calamos Funds, the fees increase as the Calamos
Funds increase their leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CLOSED-END FUND STRUCTURE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund is a diversified, closed-end management investment company
(commonly referred to as a closed-end fund) which commenced investment operations in June&#160;2002. Closed-end funds differ from open-end
management investment companies (which are generally referred to as mutual funds) in that closed-end funds generally list their shares
for trading on a stock exchange and do not redeem their shares at the request of the shareholder. This means that if you wish to sell
your shares of a closed-end fund you must trade them on the market like any other stock at the prevailing market price at that time. In
a mutual fund, if the shareholder wishes to sell shares of the fund, the mutual fund will redeem or buy back the shares at "net asset
value." Also, mutual funds generally offer new shares on a continuous basis to new investors, and closed-end funds generally do not.
From time to time, the Fund may engage in a continuous at the market offering of its common shares as described in the applicable prospectus
supplement. The continuous inflows and outflows of assets in a mutual fund can make it difficult to manage the fund's investments. By
comparison, closed-end funds are generally able to stay more fully invested in securities that are consistent with their investment objectives
and also have greater flexibility to make certain types of investments and to use certain investment strategies, such as financial leverage
and investments in illiquid securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares of closed-end funds frequently trade at a discount to their
net asset value. To the extent the Fund's common shares trade at a discount, the Fund's Board of Trustees may from time to time engage
in open-market repurchases or tender offers for shares after balancing the benefit to shareholders of the increase in the net asset value
per share resulting from such purchases against the decrease in the assets of the Fund and potential increase in the expense ratio of
expenses to assets of the Fund. The Board of Trustees believes that in addition to the beneficial effects described above, any such purchases
or tender offers may result in the temporary narrowing of any discount but may not have any long-term effect on the level of any discount.
We cannot guarantee or assure, however, that the Fund's Board of Trustees will decide to engage in any of these actions. Nor is there
any guarantee or assurance that such actions, if undertaken, would result in the shares trading at a price equal or close to net asset
value per share. The Board of Trustees might also consider converting the Fund to an open-end mutual fund, which would also require a
vote of the shareholders of the Fund. Conversion of the Fund to an open-end mutual fund would require an amendment to the Fund's Agreement
and Declaration of Trust. Such an amendment would require the favorable vote of the holders of at least 75% of the Fund's outstanding
shares (including any preferred shares) entitled to be voted on the matter, voting as a single class (or a majority of such shares if
the amendment were previously approved, adopted or authorized by 75% of the total number of Trustees fixed in accordance with the By-Laws),
and, assuming preferred shares are issued, the affirmative vote of a majority of outstanding preferred shares, voting as a separate class.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 65 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN FEDERAL INCOME TAX MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a summary discussion of certain U.S. federal income
tax consequences affecting the Fund and its shareholders and noteholders (as the case may be). The discussion reflects applicable tax
laws of the United States as of the date of this prospectus, which tax laws may be changed or subject to new interpretations by the courts
or the IRS retroactively or prospectively. No assurance can be given that the IRS would not assert, or that a court would not sustain,
a position different from any of the tax aspects set forth below. The specific terms of preferred shares and debt securities may result
in different tax consequences to holders than those described herein. Tax matters are very complicated, and the tax consequences of an
investment in and holding of our securities will depend on the particular facts of each investor's situation. No attempt is made to present
a detailed explanation of all U.S. federal, state, local and foreign tax concerns affecting the Fund and its shareholders and noteholders
(including shareholders and noteholders subject to special tax rules&#160;and shareholders owning large positions in the Fund), and the
discussion set forth herein does not constitute tax advice. Investors are advised to consult their own tax advisers with respect to the
application to their own circumstances of the general federal income taxation rules&#160;described below and with respect to other federal,
state, local or foreign tax consequences applicable to them before making an investment in our securities. Unless otherwise noted, this
discussion assumes that investors are U.S. persons and hold our securities as capital assets. More detailed information regarding the
U.S. federal income tax consequences of investing in our securities is in the statement of additional information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Taxation of the Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund has elected to be treated, and intends to qualify and to be
eligible to be treated each year, as a "regulated investment company" under Subchapter M of the Code, so that it will not pay
U.S. federal income tax on income and capital gains timely distributed to shareholders. In order to qualify and be eligible for treatment
as a regulated investment company, the Fund must, among other things, satisfy diversification, 90% gross income and distribution requirements.
The Fund's failure to qualify and be eligible for treatment as a regulated investment company would result in corporate level taxation,
and consequently, a reduction in income available for distribution to shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Fund qualifies as a regulated investment company and distributes
to its shareholders at least 90% of the sum of (i)&#160;its "investment company taxable income" as that term is defined in the
Code (which includes, among other things, dividends, taxable interest, the excess of any net short-term capital gains over net long-term
capital losses, taking into account certain capital loss carryforwards and certain net foreign currency exchange gains, less certain deductible
expenses) without regard to the deduction for dividends paid, and (ii)&#160;the excess of its gross tax-exempt interest, if any, over
certain disallowed deductions, the Fund will be relieved of U.S. federal income tax on any income of the Fund, including long-term capital
gains, distributed to shareholders. However, if the Fund retains any investment company taxable income or net capital gain (i.e., the
excess of net long-term capital gain over net short-term capital loss, taking into account certain capital loss carryforwards), it will
be subject to U.S. federal income tax at regular corporate federal income tax rates on the amount retained. The Fund intends to distribute
at least annually all or substantially all of its investment company taxable income, net tax-exempt interest, if any, and net capital
gain. Under the Code, the Fund will generally be subject to a nondeductible 4% federal excise tax on its undistributed ordinary income
and capital gains if it fails to meet certain distribution requirements with respect to each calendar year. The Fund intends to make distributions
in a timely manner in amounts necessary to avoid the excise tax and accordingly does not expect to be subject to this tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, for any taxable year, the Fund were not to qualify as a regulated
investment company for U.S. federal income tax purposes, it would be treated in the same manner as a regular corporation subject to U.S.
federal income tax and distributions to its shareholders would not be deducted by the Fund in computing its taxable income. In such event,
the Fund's distributions, to the extent derived from the Fund's current and accumulated earnings and profits, would generally constitute
ordinary dividends, which would generally be eligible for the dividends received deduction available to corporate shareholders, and noncorporate
shareholders would generally be able to treat such distributions as "qualified dividend income" eligible for reduced rates of
U.S. federal income taxation, provided holding period and other requirements are met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 66 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund could be required to recognize unrealized gains, pay substantial
taxes and interest and make substantial distributions before requalifying as a regulated investment company that is accorded special tax
treatment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">From time to time, a substantial portion of the Fund's investments
in loans and other debt obligations could be treated as having market discount and/or "original issue discount" ("OID")
for U.S. federal income tax purposes, which, in some cases, could be significant and could cause the Fund to recognize income in respect
of these investments before or without receiving cash representing such income. If so, the Fund could be required to pay out as an income
distribution each year an amount which is greater than the total amount of cash interest the Fund actually received. As a result, the
Fund could be required at times to liquidate investments (including at potentially disadvantageous times or prices) in order to satisfy
its distribution requirements or to avoid incurring Fund-level U.S. federal income or excise taxes. If the Fund liquidates portfolio securities
to raise cash, the Fund may realize gain or loss on such liquidations; in the event the Fund realizes net long-term or short-term capital
gains from such liquidation transactions, its shareholders may receive larger capital gain or ordinary dividends, respectively, than they
would in the absence of such transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments in debt obligations that are at risk of or in default present
special tax issues for the Fund. Tax rules&#160;are not entirely clear about issues such as whether or to what extent the Fund should
recognize market discount on such a debt obligation; when the Fund may cease to accrue interest, OID or market discount; when and to what
extent the Fund may take deductions for bad debts or worthless securities; and how the Fund should allocate payments received on obligations
in default between principal and income. These and other related issues will be addressed by the Fund when, as, and if it invests in such
securities in order to seek to ensure that it distributes sufficient income to preserve its status as a regulated investment company and
avoid becoming subject to U.S. federal income or excise tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund is permitted to carry forward net capital losses to one or
more subsequent taxable years without expiration. The Fund must apply such carryforwards first against gains of the same character. Capital
loss carryforwards are reduced to the extent they offset current-year net realized capital gains, whether the Fund retains or distributes
such gains.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of the Fund's investment practices may be subject to special
and complex federal income tax provisions that may, among other things, (i)&#160;disallow, suspend or otherwise limit the allowance of
certain losses or deductions, (ii)&#160;convert tax-advantaged, long-term capital gains and qualified dividend income into higher taxed
short-term capital gain or ordinary income, (iii)&#160;increase ordinary income distributions, (iv)&#160;convert an ordinary loss or a
deduction into a capital loss (the deductibility of which is more limited), (v)&#160;cause the Fund to recognize income or gain without
a corresponding receipt of cash, (vi)&#160;adversely affect the timing as to when a purchase or sale of stock or securities is deemed
to occur, and (vii)&#160;adversely alter the characterization of certain complex financial transactions. The Fund will monitor its transactions
and may make certain tax elections where applicable in order to mitigate the effect of these provisions, if possible.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the tax treatment and the tax rules&#160;applicable to these
types of transactions are in some cases uncertain under current law, an adverse determination or future guidance by the IRS with respect
to these rules&#160;or treatment (which determination or guidance could be retroactive) may affect whether the Fund has made sufficient
distributions, and otherwise satisfied the relevant requirements, to maintain its qualification as a regulated investment company and
avoid a Fund-level tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It is possible that the Fund's use of derivatives and foreign currency-denominated
instruments, and any of the Fund's transactions in foreign currencies and hedging activities, could produce a difference between its book
income and the sum of its taxable income (including realized capital gains) and net tax-exempt income (if any). If such a difference arises,
and the Fund's book income is less than the sum of its taxable income (including realized capital gains) and net tax-exempt income (if
any), the Fund could be required to make distributions exceeding book income to qualify for treatment as a regulated investment company
and to eliminate Fund-level tax. In the alternative, if the Fund's book income exceeds the sum of its taxable income (including realized
capital gains) and its net tax-exempt income (if any), the distribution (if any) of such excess generally will be treated as (i)&#160;a
dividend to the extent of the Fund's remaining current and accumulated earnings and profits (including earnings and profits arising from
tax-exempt income), if any, (ii)&#160;thereafter, as a return of capital to the extent of the recipient's adjusted tax basis in its shares,
and (iii)&#160;thereafter, as gain from the sale or exchange of a capital asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 67 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dividends, interest, proceeds and gains received by the Fund on foreign
securities may be subject to foreign withholding or other taxes, which would reduce the yield on or return from those investments. If
more than 50% of the value of the Fund's assets at the close of the taxable year consists of stock or securities of foreign corporations,
the Fund may make an election under the Code to pass through such taxes to shareholders of the Fund. If the Fund is eligible to and makes
such an election, shareholders will generally be able (subject to applicable limitations under the Code) to claim a credit or deduction
(but not both) on their federal income tax return for, and will be required to treat as part of the amounts distributed to them, their
pro rata portion of the income taxes paid by the Fund to foreign countries. If the Fund makes such an election, it will provide relevant
information to its shareholders. If such election is not made, shareholders will not be required to include such taxes in their gross
incomes and will not be entitled to a tax deduction or credit for such taxes on their own federal income tax returns.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each prospective investor is urged to consult its tax adviser regarding
taxation of foreign securities in the Fund's portfolio and any available foreign tax credits with respect to the prospective investor's
own situation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Taxation of Common and Preferred Shareholders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Federal Income Tax Treatment of Common Share Distributions.</i>
Unless a shareholder is ineligible to participate or elects otherwise, all distributions will be automatically reinvested in additional
shares of common stock of the Fund pursuant to the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). For taxpayers subject
to U.S. federal income tax, all dividends will generally be taxable regardless of whether a shareholder takes them in cash or they are
reinvested pursuant to the Plan in additional shares of the Fund. Distributions of the Fund's investment company taxable income (determined
without regard to the deduction for dividends paid) will generally be taxable at ordinary federal income tax rates to the extent of the
Fund's current and accumulated earnings and profits. However, a portion of such distributions derived from certain corporate dividends,
if any, may qualify for either the dividends received deduction available to corporate shareholders under Section&#160;243 of the Code
or the reduced rates of U.S. federal income taxation for "qualified dividend income" currently available to noncorporate shareholders
under Section&#160;1(h)(11) of the Code, provided certain holding period and other requirements are met at both the Fund and shareholder
levels. Distributions of net capital gains (as defined above), if any, that are properly reported as capital gain dividends are generally
taxable as long-term capital gains for U.S. federal income tax purposes without regard to the length of time a shareholder has held shares
of the Fund. A distribution of an amount in excess of the Fund's current and accumulated earnings and profits, if any, will be treated
by a shareholder as a tax-free return of capital, which is applied against and reduces the shareholder's basis in their shares. Such distributions
represent a return of the investor's capital to the extent of his or her basis in the shares, and thus, could potentially subject the
shareholder to capital gains taxation in connection with a later sale of Fund shares, even if those shares are sold at a price that is
lower than the shareholder's original investment price. To the extent that the amount of any such distribution exceeds the shareholder's
basis in their shares, the excess will be treated by the shareholder as gain from the sale or exchange of shares. The U.S. federal income
tax status of all dividends and distributions will be reported by the Fund to the shareholders annually.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Fund retains any net capital gain, the Fund may report the retained
amount as undistributed capital gains to shareholders who, if subject to U.S. federal income tax on long-term capital gains, (i)&#160;will
be required to include in income as long-term capital gain their proportionate share of such undistributed amount, and (ii)&#160;will
be entitled to credit their proportionate share of the federal income tax paid by the Fund on the undistributed amount against their U.S.
federal income tax liabilities, if any, and to claim refunds to the extent the credit exceeds such liabilities. If the Fund makes this
designation, the tax basis of shares owned by a shareholder of the Fund will, for U.S. federal income tax purposes, generally be increased
by the difference between the amount of undistributed net capital gain included in the shareholder's gross income and the federal income
tax deemed paid by the shareholder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a shareholder's distributions are automatically reinvested pursuant
to the Plan and the Plan Agent invests the distribution in shares acquired on behalf of the shareholder in open-market purchases, for
U.S. federal income tax purposes, the shareholder will be treated as having received a taxable distribution in the amount of the cash
dividend that the shareholder would have received if the shareholder had elected to receive cash. If a shareholder's distributions are
automatically reinvested pursuant to the Plan and the Plan Agent invests the distribution in newly issued shares of the Fund, the shareholder
will generally be treated as receiving a taxable distribution equal to the fair market value of the stock the shareholder receives.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the time of an investor's purchase of the Fund's shares, a portion
of the purchase price may be attributable to realized or unrealized appreciation in the Fund's portfolio or undistributed taxable income
of the Fund. Consequently, subsequent distributions by the Fund with respect to these shares from such appreciation or income may be taxable
to such investor even if the net asset value of the investor's shares is, as a result of the distributions, reduced below the investor's
cost for such shares and the distributions economically represent a return of a portion of the investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dividends declared by the Fund in October, November&#160;or December&#160;with
a record date in such month that are paid during the following January&#160;will be treated for U.S. federal income tax purposes as paid
by the Fund and received by the shareholders on December&#160;31 of the calendar year in which they were declared.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Federal Income Tax Treatment of Preferred Share Distributions.</i>
Under present law, the Fund intends to treat its preferred shares as equity, and, in such case, distributions with respect to preferred
shares (other than distributions in redemption of preferred shares subject to Section&#160;302(b)&#160;of the Code) will generally constitute
dividends to the extent of the Fund's current and accumulated earnings and profits, as calculated for federal income tax purposes. Except
in the case of distributions of net capital gain, such dividends generally will be taxable to holders at ordinary federal income tax rates
but may qualify for the dividends received deduction available to corporate shareholders under Section&#160;243 of the Code or the reduced
rates of U.S. federal income taxation under Section&#160;1(h)(11) of the Code that apply to qualified dividend income received by noncorporate
shareholders. Distributions reported by the Fund as net capital gain distributions will be taxable as long-term capital gain regardless
of the length of time a shareholder has held shares of the Fund. Please see the discussion above on qualified dividend income, dividends
received deductions and net capital gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The IRS currently requires that a regulated investment company that
has two or more classes of stock allocate to each such class proportionate amounts of each type of its income (such as ordinary income
and capital gains). Accordingly, the Fund intends to report distributions made with respect to preferred shares as ordinary income, capital
gain distributions, dividends qualifying for the dividends received deduction, if any, and qualified dividend income, if any, in proportion
to the preferred shares' share of total dividends paid during the year. See "Certain Federal Income Tax Matters" in the statement
of additional information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Earnings and profits are generally treated, for U.S. federal income
tax purposes, as first being used to pay distributions on the preferred shares, and then to the extent remaining, if any, to pay distributions
on the common shares. Distributions in excess of the Fund's earnings and profits, if any, will first reduce a shareholder's adjusted tax
basis in his or her preferred shares and, after the adjusted tax basis is reduced to zero, will constitute capital gains to a shareholder
who holds such shares as a capital asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dividends declared by the Fund in October, November&#160;or December&#160;with
a record date in such month that are paid during the following January&#160;will be treated for federal income tax purposes as paid by
the Fund and received by the shareholders on December&#160;31 of the calendar year in which they were declared.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sale of Shares.</i> Sales and other dispositions of the Fund's shares,
including a repurchase by the Fund of its shares, generally are taxable events for shareholders that are subject to U.S. federal income
tax. Shareholders should consult their own tax advisers with reference to their individual circumstances to determine whether any particular
transaction in the Fund's shares is properly treated as a sale or exchange for federal income tax purposes, as the following discussion
assumes, and the tax treatment of any gains or losses recognized in such transactions. In particular, a repurchase by the Fund of its
shares may be subject to different rules, as discussed in more detail in the statement of additional information. Gain or loss will generally
be equal to the difference between the amount of cash and the fair market value of other property received and the shareholder's adjusted
tax basis in the shares sold or exchanged. Such gain or loss will generally be characterized as capital gain or loss and will be long-term
or short-term depending on the shareholder's holding period in the shares disposed. However, any loss realized by a shareholder upon the
sale or other disposition of shares with a federal income tax holding period of six months or less will be treated as a long-term capital
loss to the extent of any amounts treated as distributions of long-term capital gain with respect to such shares. The ability to deduct
capital losses may be limited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 69 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gain or loss will generally be long-term capital gain or loss if the
shares disposed of were held for more than one year and will be short-term capital gain or loss if the shares disposed of were held for
one year or less. Net long-term capital gain recognized by a noncorporate U.S. shareholder generally will be subject to federal income
tax at a lower rate than net short-term capital gain or ordinary income. For corporate shareholders, capital gain is generally taxed for
federal income tax purposes at the same rate as ordinary income. In addition, losses on sales or other dispositions of shares may be disallowed
under the "wash sale" rules&#160;in the event that substantially identical stock or securities are treated as acquired by a
shareholder (including those made pursuant to reinvestment of dividends) within a period of 61 days beginning 30 days before and ending
30 days after a sale or other disposition of shares by such shareholder. In such a case, the disallowed portion of any loss generally
would be included in the U.S. federal tax basis of the shares acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Backup Withholding.</i> The Fund is required in certain circumstances
to withhold federal income tax ("backup withholding") from reportable payments including dividends, capital gain distributions,
and proceeds of sales or other dispositions of the Fund's shares paid to certain holders of the Fund's shares who do not furnish the Fund
with their correct social security number or other taxpayer identification number and certain other certifications, or who are otherwise
subject to backup withholding. Backup withholding is not an additional tax. Any amounts withheld from payments made to a shareholder may
be refunded or credited against such shareholder's U.S. federal income tax liability, if any, provided that the required information is
furnished to the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Shares Purchased Through Tax-Qualified Plans.</i> Special tax rules&#160;apply
to investments through defined contribution plans and other tax-qualified plans. Shareholders should consult their tax advisers to determine
the suitability of shares of the Fund as an investment through such plans and the precise effect of an investment on their particular
tax situation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Taxation of Non-U.S. Shareholders.</i> The description of certain
federal income tax provisions above relates only to U.S. federal income tax consequences for shareholders who are U.S. persons (i.e.,
U.S. citizens or resident aliens or U.S. corporations, partnerships, trusts or estates who are subject to U.S. federal income tax on a
net income basis). Investors other than U.S. persons, including non-resident alien individuals, may be subject to different U.S. federal
income tax treatment. With respect to such persons, the Fund must generally withhold U.S. federal withholding tax at the rate of 30% (or,
if the Fund receives certain certifications from a non-U.S. shareholder, such lower rate as prescribed by an applicable tax treaty) on
amounts treated as ordinary dividends from the Fund. However, the Fund is not required to withhold tax on any amounts paid to a non-U.S.
person with respect to capital gain distributions (i.e., distributions of net capital gain that are properly reported by the Fund as capital
gain dividends), dividends attributable to "qualified short-term gain" (i.e., the excess of net short-term capital gain over
net long-term capital loss) reported as such by the Fund and dividends attributable to certain U.S. source interest income of types similar
to those not subject to federal withholding tax if earned directly by a non-U.S. person, provided such amounts are properly reported by
the Fund. Shareholders should consult their own tax advisers on these matters and on any specific question of U.S. federal, state, local,
foreign and other applicable tax laws before making an investment in the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Taxation of Holders of Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Federal Income Tax Treatment of Holders of Debt Securities.</i>
Under present law, the Fund intends to treat its debt securities as indebtedness of the Fund for federal income tax purposes, which treatment
the discussion below assumes. The Fund intends to treat all payments made with respect to the debt securities consistent with this characterization.
The following discussion assumes that all interest on the debt securities will be qualified stated interest (which is generally interest
that is unconditionally payable at least annually at a fixed or qualified floating rate), and that the debt securities will have a fixed
maturity date of more than one year from the date of issuance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Taxation of Interest.</i> Payments or accruals of interest on debt
securities generally will be taxable to holders as ordinary interest income at the time such interest is received (actually or constructively)
or accrued, in accordance with their regular method of accounting for federal income tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 70 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Purchase, Sale and Redemption of Debt Securities.</i> Initially,
the tax basis in debt securities acquired generally will be equal to the cost to acquire such debt securities. This basis will be increased
by the amounts, if any, that a holder includes in income under the rules&#160;governing OID (taking into account any acquisition premium
that offsets such OID) and market discount, and will be decreased by the amount of any amortized premium on such debt securities, as discussed
below, and any payments on such debt securities other than stated interest. When a holder sells, exchanges or redeems any of their debt
securities, or otherwise disposes of their debt securities in a taxable transaction, the holder of the debt securities generally will
recognize gain or loss equal to the difference between the amount realized on the transaction (less any accrued and unpaid interest (including
OID), which will be subject to federal income tax as interest in the manner described above) and the tax basis in the debt securities
relinquished.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as discussed below with respect to market discount, the gain
or loss recognized on the sale, exchange, redemption or other taxable disposition of any debt securities generally will be capital gain
or loss. Such gain or loss will generally be long-term capital gain or loss if the disposed debt securities were held for more than one
year and will be short-term capital gain or loss if the disposed debt securities were held for one year or less. A holder's ability to
deduct capital losses may be limited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Amortizable Premium.</i> If a holder purchases debt securities at
a cost greater than their stated redemption price at maturity, plus accrued interest, the holder will be considered to have purchased
the debt securities at a premium, and generally may elect to amortize this premium as an offset to interest income, using a constant yield
method, over the remaining term of the debt securities. If the holder makes the election to amortize the premium, it generally will apply
to all debt instruments held at the beginning of the first taxable year to which the election applies, as well as any debt instruments
subsequently acquired. In addition, the holder may not revoke the election without the consent of the IRS. If the holder elects to amortize
the premium, the holder will be required to reduce its tax basis in the debt securities by the amount of the premium amortized during
its holding period. If the holder does not elect to amortize premium, the amount of premium will be included in its tax basis in the debt
securities. Therefore, if the holder does not elect to amortize the premium and holds the debt securities to maturity, the holder generally
will be required to treat the premium as a capital loss when the debt securities are redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Original Issue Discount.</i> If the stated redemption price at maturity
of the debt securities exceeds their issue price by at least the statutory <i>de minimis</i> amount, the debt securities will be treated
as being issued with OID for U.S. federal income tax purposes. In that case, the holder will be required to include such OID in gross
income (as ordinary income) as it accrues over the term of the debt securities on a constant-yield basis, in advance of the receipt of
cash attributable to that income and regardless of its regular method of accounting for U.S. federal income tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Acquisition Premium.</i> If a holder purchases debt securities that
were issued with OID at a cost greater than their issue price and less than or equal to their stated redemption price at maturity, the
holder will be considered to have purchased the debt securities with acquisition premium. Such holder will generally be permitted to reduce
the daily portions of OID required to be included in income by a fraction, the numerator of which is the excess of the holder's initial
basis in the debt securities over the debt securities' issue price, and the denominator of which is the excess of the redemption price
at maturity of the debt securities over their issue price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market Discount.</i> If the holder purchases debt securities in
the secondary market at a price that reflects a "market discount," any principal payments on, or any gain realized on the disposition
of, the debt securities generally will be treated as ordinary interest income to the extent of the market discount that accrued on the
debt securities during the time the holder held such debt securities. "Market discount" is defined under the Code as, in general,
the excess (subject to a statutory <i>de minimis</i> amount) of the stated redemption price at maturity (or in the case of an obligation
issued with OID, its "revised issue price") over the purchase price of the debt security. In addition, the holder may be required
to defer the deduction of all or a portion of any interest paid on any indebtedness incurred or continued to purchase or carry the debt
securities that were acquired at a market discount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The holder may elect to include market discount in gross income currently
as it accrues (on either a ratable or constant yield basis), in lieu of treating a portion of any gain realized on a sale of the debt
securities as ordinary income. If the holder elects to include market discount on a current basis, the interest deduction deferral rule&#160;described
above will not apply and the holder will increase its basis in the debt security by the amount of market discount it includes in gross
income. If the holder does make such an election, it will apply to all market discount debt instruments that the holder acquires on or
after the first day of the first taxable year to which the election applies. This election may not be revoked without the consent of the
IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 71 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Information Reporting and Backup Withholding.</i> In general, information
reporting requirements will apply to payments of principal, interest, and premium, if any, paid on debt securities and to the proceeds
of the sale of debt securities paid to U.S. holders other than certain exempt recipients (such as certain corporations) provided they
establish such exemption. Information reporting generally will apply to payments of interest on the debt securities to non-U.S. Holders
(as defined below) and the amount of tax, if any, withheld with respect to such payments. Copies of the information returns reporting
such interest payments and any withholding may also be made available to the tax authorities in the country in which the non-U.S. Holder
resides under the provisions of an applicable income tax treaty. In addition, for non-U.S. Holders, information reporting will apply to
the proceeds of the sale of debt securities within the United States or conducted through United States-related financial intermediaries
unless the certification requirements described below have been complied with and the statement described below in "Taxation of Non-U.S.
Holders" has been received (and the payor does not have actual knowledge or reason to know that the holder is a United States person)
or the holder otherwise establishes an exemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may be required to withhold, for U.S. federal income tax purposes,
a portion of all payments (including redemption proceeds) payable to holders of debt securities who fail to provide us with their correct
taxpayer identification number, who fail to make required certifications or who have been notified by the IRS that they are subject to
backup withholding (or if we have been so notified). Certain corporate and other shareholders specified in the Code and the regulations
thereunder are exempt from backup withholding. Backup withholding is not an additional tax. Any amounts withheld may be credited against
the holder's U.S. federal income tax liability provided the appropriate information is furnished to the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A holder who is a non-U.S. Holder may have to comply with certification
procedures to establish its non-U.S. status in order to avoid backup withholding tax requirements. The certification procedures required
to claim the exemption from withholding tax on interest income described below with respect to non-U.S. Holders will satisfy these requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Taxation of Non-U.S. Holders.</i> If a holder is a non-resident
alien individual or a foreign corporation (a "non-U.S. Holder"), the payment of interest on the debt securities generally will
be considered "portfolio interest" and thus generally will be exempt from U.S. federal withholding tax. This exemption will
apply provided that (1)&#160;interest paid on the debt securities is not effectively connected with the holder's conduct of a trade or
business in the United States, (2)&#160;the holder is not a bank whose receipt of interest on the debt securities is described in Section&#160;881(c)(3)(A)&#160;of
the Code, (3)&#160;the holder does not actually or constructively own 10 percent or more of the combined voting power of all classes of
the Fund's stock entitled to vote, (4)&#160;the holder is not a controlled foreign corporation that is related, directly or indirectly,
to the Fund through stock ownership, and (5)&#160;the holder satisfies the certification requirements described below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To satisfy the certification requirements, either (1)&#160;the holder
of any debt securities must certify, under penalties of perjury, that such holder is a non-U.S. person and must provide such owner's name,
address and taxpayer identification number, if any, on IRS Form&#160;W-8BEN or W-8BEN-E, or (2)&#160;a securities clearing organization,
bank or other financial institution that holds customer securities in the ordinary course of its trade or business and holds the debt
securities on behalf of the holder thereof must certify, under penalties of perjury, that it has received a valid and properly executed
IRS Form&#160;W-8BEN or W-8BEN-E from the beneficial holder and comply with certain other requirements. Special certification rules&#160;apply
for debt securities held by a foreign partnership and other intermediaries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Interest on debt securities received by a non-U.S. Holder that is not
excluded from U.S. federal withholding tax under the portfolio interest exemption as described above generally will be subject to withholding
at a 30% rate, except where (1)&#160;the interest is effectively connected with the conduct of a U.S. trade or business, in which case
the interest will generally be subject to U.S. income tax on a net basis at graduated rates as applicable to U.S. holders generally (and,
in the case of corporate non-U.S. Holders, may be subject to an additional 30% branch profits tax) or (2)&#160;a non-U.S. Holder can claim
the benefits of an applicable income tax treaty to reduce or eliminate such withholding tax. To claim the benefit of an income tax treaty
or to claim an exemption from withholding because the interest is effectively connected with a U.S. trade or business, a non-U.S. Holder
must timely provide the appropriate, properly executed IRS forms. These forms may be required to be periodically updated. Also, a non-U.S.
Holder who is claiming the benefits of an income tax treaty may be required to obtain a U.S. taxpayer identification number and to provide
certain documentary evidence issued by foreign governmental authorities to prove residence in the foreign country.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 72 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any capital gain that a non-U.S. Holder realizes on a sale, exchange
or other disposition of debt securities generally will be exempt from United States federal income tax, including withholding tax. This
exemption will not apply to a holder whose gain is effectively connected with their conduct of a trade or business in the U.S. or who
is an individual holder and is present in the U.S. for a period or periods aggregating 183 days or more in the taxable year of the disposition
and, in each case, certain other conditions are met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See "Information Reporting and Backup Withholding" above
for a general discussion of information reporting and backup withholding requirements applicable to non-U.S. Holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Tax Matters</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other Reporting and Withholding Requirements.</i> Sections 1471-1474
of the Code and the U.S. Treasury and IRS guidance issued thereunder (collectively, "FATCA") generally require the Fund to obtain
information sufficient to identify the status of each of its shareholders and holders of its debt securities under FATCA or under an applicable
intergovernmental agreement (an "IGA") between the United States and a foreign government. If a shareholder or holder of debt
securities fails to provide the required information or otherwise fails to comply with FATCA or an IGA, the Fund may be required to withhold
under FATCA at a rate of 30% with respect to that holder on ordinary dividends and interest payments. The IRS and the Department of Treasury
have issued proposed regulations providing that these withholding rules&#160;will not be applicable to the gross proceeds of share redemptions
or capital gains dividends that the Fund pays. If a payment by the Fund is subject to FATCA withholding, the Fund is required to withhold
even if such payment would otherwise be exempt from withholding under the rules&#160;applicable to non-U.S. persons. Each prospective
investor is urged to consult its tax adviser regarding the applicability of FATCA and any other reporting requirements with respect to
the prospective investor's own situation, including investments through an intermediary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Medicare Tax on Certain Investment Income.</i> Certain noncorporate
taxpayers are subject to an additional tax of 3.8% with respect to the lesser of (1)&#160;their "net investment income" (or
undistributed "net investment income" in the case of an estate or trust) or (2)&#160;the excess of their "modified adjusted
gross income" over a threshold amount ($250,000 for married persons filing jointly and $200,000 for single taxpayers). For this purpose,
"net investment income" includes interest, dividends (including dividends paid with respect to shares), annuities, royalties,
rent, net gain attributable to the disposition of property not held in a trade or business (including net gain from the sale, redemption,
exchange or other taxable disposition of shares) and certain other income, but will be reduced by any deductions properly allocable to
such income or net gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Alternative Minimum Tax</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investors may be subject to the federal alternative minimum tax on
their income (including taxable income from the Fund), depending on their individual circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NET ASSET VALUE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net asset value per share is determined no less frequently than the
close of regular session trading on the NYSE (usually 4:00 p.m., Eastern time), on the last business day in each week, or such other time
as the Fund may determine. The NYSE is regularly closed on New Year's Day, the third Mondays in January&#160;and February, Good Friday,
the last Monday in May,&#160;Independence Day, Labor Day, Thanksgiving and Christmas. If the NYSE is closed due to weather or other extenuating
circumstances on a day it would typically be open for business, the Fund reserves the right to treat such day as a Business Day and calculate
the Fund's NAV as of the normally scheduled close of regular trading on the NYSE or such other time that the Fund may determine, in accordance
with applicable law. The Fund reserves the right to close if the primary trading markets of the Fund's portfolio instruments are closed.
On any business day when the Securities Industry and Financial Markets Association ("SIFMA") recommends that the securities
markets close trading early or when the NYSE closes earlier than scheduled, the Fund may (i)&#160;close trading early (as such, the time
as of which the NAV is calculated would be advanced) or (ii)&#160;calculate its NAV as of, the normally scheduled close of regular trading
on the NYSE for that day.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 73 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net asset value is calculated by dividing the value of all of the securities
and other assets of the Fund, less its liabilities (including accrued expenses and indebtedness) and the aggregate liquidation value of
any outstanding preferred shares, by the total number of common shares outstanding. Information that becomes known to the Fund after the
time as of which NAV has been calculated on a particular day will not generally be used to retroactively adjust the price of a security
or the NAV determined earlier that day. If regular trading on the NYSE closes earlier than scheduled, the Fund reserves the right to either
(i)&#160;calculate its NAV as of the earlier closing time or (ii)&#160;calculate its NAV as of the normally scheduled close of regular
trading on the NYSE for that day. The Fund generally does not calculate its NAV on days during which the NYSE is closed. However, if the
NYSE is closed on a day it would normally be open for business, the Fund reserves the right to calculate its NAV as of the normally scheduled
close of regular trading on the NYSE for that day or such other time that the Fund may determine. Because the Fund may invest in securities
that are primarily listed on foreign exchanges and trade on days when the Fund does not price its shares, the Fund's underlying assets
may change in value on days when the NAV is not calculated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The valuation of the Fund's portfolio securities is in accordance with
policies and procedures adopted by and under the ultimate supervision of the Board of Trustees. Securities for which market quotations
are readily available will be valued using the market value of those securities. Securities for which market quotations are not readily
available will be fair valued in accordance with policies and procedures adopted by and under the ultimate supervision of the Board of
Trustees. The method by which a security may be fair valued will depend on the type of security and the circumstances under which the
security is being fair valued.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Portfolio securities that are traded on U.S. securities exchanges,
except option securities, are valued at the last current reported sales price at the time the Fund determines its NAV. Securities traded
in the over-the-counter market and quoted on The Nasdaq Stock Market are valued at the Nasdaq Official Closing Price, as determined by
Nasdaq, or lacking a Nasdaq Official Closing Price, the last current reported sale price on Nasdaq at the time the Fund determines its
NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When a last sale or closing price is not available, equity securities,
other than option securities, that are traded on a U.S. securities exchange and other equity securities traded in the over-the-counter
market are valued at the mean between the most recent bid and asked quotations in accordance with guidelines adopted by the Board of Trustees.
Each option security traded on a U.S. securities exchange is valued at the mid-point of the consolidated bid/ask quote for the option
security, also in accordance with guidelines adopted by the Board of Trustees. Each over-the-counter option that is not traded through
the Options Clearing Corporation is valued based on a quotation provided by the counterparty to such option under the ultimate supervision
of the Board of Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fixed income securities and certain convertible preferred securities
are generally traded in the over-the-counter market and are valued based on evaluations provided by independent pricing services or by
dealers who make markets in such securities. Valuations of such fixed income securities and certain convertible preferred securities consider
yield or price of equivalent securities of comparable quality, coupon rate, maturity, type of issue, trading characteristics and other
market data and do not rely exclusively upon exchange or over-the-counter prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Trading on European and Far Eastern exchanges and over-the-counter
markets is typically completed at various times before the close of business on each day on which the NYSE is open. Each security trading
on these exchanges or over-the-counter markets may be valued utilizing a systematic fair valuation model provided by an independent pricing
service approved by the Board of Trustees. The valuation of each security that meets certain criteria in relation to the valuation model
is systematically adjusted to reflect the impact of movement in the U.S. market after the foreign markets close. Securities that do not
meet the criteria, or that are principally traded in other foreign markets, are valued as of the last reported sale price at the time
the Fund determines its NAV, or when reliable market prices or quotations are not readily available, at the mean between the most recent
bid and asked quotations as of the close of the appropriate exchange or other designated time. Trading of foreign securities may not take
place on every NYSE business day. In addition, trading may take place in various foreign markets on Saturdays or on other days when the
NYSE is not open and on which the Fund's NAV is not calculated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 74 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the pricing committee, whose members are appointed by the Board
of Trustees and which is comprised of officers of the Fund and employees of Calamos, determines that the valuation of a security, in accordance
with the methods described above, is not reflective of a fair value for such security, the security is valued at a fair value by the pricing
committee, under the ultimate supervision of the Board of Trustees, following the guidelines and/or procedures adopted by the Board of
Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund also may use fair value pricing, pursuant to guidelines adopted
by the Board of Trustees and under the ultimate supervision of the Board of Trustees, if trading in a security is halted or if the value
of a security it holds is materially affected by events occurring before the Fund's pricing time but after the close of the primary market
or exchange on which the security is listed. Those procedures may utilize valuations furnished by pricing services approved by the Board
of Trustees, which may be based on market transactions for comparable securities and various relationships between securities that are
generally recognized by institutional traders, a computerized matrix system, or appraisals derived from information concerning the securities
or similar securities received from recognized dealers in those securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When fair value pricing of securities is employed, the prices of securities
used by the Fund to calculate its NAV may differ from market quotations or official closing prices. In light of the judgment involved
in fair valuations, there can be no assurance that a fair value assigned to a particular security is accurate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIVIDENDS AND DISTRIBUTIONS ON COMMON SHARES;<br/>
AUTOMATIC DIVIDEND REINVESTMENT PLAN</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends and Distributions on Common Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund intends to distribute to common shareholders all or a portion
of its net investment income monthly and net realized capital gains, if any, at least annually.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund currently intends to make monthly distributions to common
shareholders at a level rate established by the Board of Trustees. The rate may be modified by the Board of Trustees from time to time.
Monthly distributions may include net investment income, net realized short-term capital gain and, if necessary to maintain a level distribution,
return of capital. The Fund may at times in its discretion pay out less than the entire amount of net investment income earned in any
particular period and may at times pay out such accumulated undistributed income in addition to net investment income earned in other
periods in order to permit the Fund to maintain a more stable level of distributions. As a result, the distributions paid by the Fund
to holders of common shares for any particular period may be more or less than the amount of net investment income earned by the Fund
during such period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will seek to establish a distribution rate that roughly corresponds
to the Adviser's projections of the total return that could reasonably be expected to be generated by the Fund over an extended period
of time, although the distribution rate will not be solely dependent on the amount of income earned or capital gains realized by the Fund.
Calamos, in making such projections, may consider long-term historical returns and a variety of other factors. If, for any monthly distribution,
net investment income and net realized capital gains were less than the amount of the distribution, the difference would be distributed
from the Fund's assets. In addition, in order to make such distributions, the Fund might have to sell a portion of its investment portfolio
at a time when independent investment judgment might not dictate such action. The Fund's final distribution for each calendar year will
include any remaining net investment income undistributed during the year and may include any remaining net realized capital gains undistributed
during the year. The Fund's actual financial performance will likely vary significantly from quarter-to-quarter and from year-to-year,
and there may be extended periods of up to several years when the distribution rate will exceed the Fund's actual total returns. The Fund's
projected or actual distribution rate is not a prediction of what the Fund's actual total returns will be over any specific future period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As portfolio and market conditions change, the rate of distributions
on the common shares and the Fund's distribution policy could change. To the extent that the total return of the Fund exceeds the distribution
rate for an extended period, the Fund may be in a position to increase the distribution rate or distribute supplemental amounts to shareholders.
Conversely, if the total return of the Fund is less than the distribution rate for an extended period of time, the Fund will effectively
be drawing upon its net assets to meet payments prescribed by its distribution policy. The rate may be modified by the Fund's Board from
time to time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 75 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent the Fund distributes an amount in excess of the Fund's
current and accumulated earnings and profits, such excess, if any (the "Excess"), will be treated by a shareholder for federal
income tax purposes as a tax-free return of capital to the extent of the shareholder's adjusted tax basis in their shares and thereafter
as a gain from the sale or exchange of such shares. See "Certain Federal Income Tax Matters." Any such distributions made by
the Fund will reduce the shareholder's adjusted tax basis in their shares to the extent that the distribution constitutes a return of
capital during any calendar year, and thus could potentially subject the shareholder to capital gains taxation in connection with the
sale of Fund shares, even if those shares are sold at a price that is lower than the shareholder's original investment price. To the extent
that the Fund's distributions exceed the Fund's current and accumulated earnings and profits, the distribution payout rate will exceed
the yield generated from the Fund's investments. There is no guarantee that the Fund will realize capital gain in any given year, nor
that the Fund's distribution rates will equal in any period the Fund's net investment income. Pursuant to the requirements of the 1940
Act and other applicable laws, a notice will accompany each monthly distribution with respect to the estimated source of the distribution
made. Distributions are subject to recharacterization for federal income tax purposes after the end of the fiscal year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For U.S. federal income tax purposes, the Fund is required to distribute
substantially all of its net investment income and net realized capital gains each year to both reduce its federal income tax liability
and to avoid a potential excise tax. Accordingly, the Fund intends to distribute all or substantially all of its net investment income
and all net realized capital gains, if any. Therefore, the Fund's final distribution with respect to each calendar year would include
any remaining net investment income and net realized capital gains, if any, undistributed during the year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event the Fund distributed an Excess, such distribution would
decrease the Fund's managed assets and, therefore, have the likely effect of increasing the Fund's expense ratio. There is a risk that
the Fund would not eventually realize capital gains in an amount corresponding to a distribution of the Excess.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November&#160;4, 2008, the Commission granted Calamos, on behalf
of itself and certain registered closed-end funds that it manages, including the Fund, or may manage in the future, an order granting
an exemption from Section&#160;19(b)&#160;of, and Rule&#160;19b-1 under, the 1940 Act to conditionally permit the Fund to make periodic
distributions of long-term capital gains with respect to the Fund's outstanding common shares as frequently as twelve times each year,
so long as it complies with the conditions of the order and maintains in effect a distribution policy with respect to its common shares
calling for periodic distributions of an amount equal to a fixed amount per share, a fixed percentage of market price per share or a fixed
percentage of the Fund's net asset value per share (the "Managed Distribution Policy"). As of the date of this Prospectus, as
supplemented, the Fund is not using a Managed Distribution Policy. Pursuant to and in reliance on the order granted by the Commission,
under the Managed Distribution Policy, the Fund is required to:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> implement certain compliance review and reporting procedures
with respect to the Managed Distribution Policy;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> include in each notice to shareholders that accompanies distributions
certain information in addition to the information currently required by Section&#160;19(a)&#160;of and Rule&#160;19a-1 under the 1940
Act;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> include disclosure regarding the Managed Distribution Policy
on the inside front cover of each annual and semi-annual report to shareholders;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> provide the Fund's total return in relation to changes in NAV
in the financial highlights table and in any discussion about the Fund's total return in each prospectus and annual and semi-annual report
to shareholders; include the information contained in each notice to shareholders that accompanies distributions in: (a)&#160;communications
regarding the Managed Distribution Policy to shareholders, prospective shareholders and third-party information providers; (b)&#160;a
press release issued contemporaneously with the issuance of the notice; (c)&#160;an exhibit to the Fund's next report filed with the Commission
on Form&#160;N-CSR; and (d)&#160;a statement posted prominently on its website; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> take certain steps to ensure the delivery of the notices accompanying
distributions to beneficial owners whose Fund shares are held through a financial intermediary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 76 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, if the Fund's common shares were to trade at a significant
premium to NAV following the implementation of the Managed Distribution Policy, and certain other circumstances were present, the Fund's
Board of Trustees would be required to determine whether to approve or disapprove the continuation, or continuation after amendment, of
the Managed Distribution Policy. Finally, pursuant to the order, the Fund would not be permitted to make a public offering of common shares
other than:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> a rights offering below NAV to holders of the Fund's common
shares;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> an offering in connection with a dividend reinvestment plan,
merger, consolidation, acquisition, spin-off or reorganization of the Fund; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> an offering other than those described above, unless, with respect
to such other offering:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the Fund's average annual distribution rate for the six months
ending on the last day of the month ended immediately prior to the most recent distribution record date, expressed as a percentage of
NAV per share as of such date, is no more than one percentage point greater than the Fund's average annual total return for the five-year
period ending on such date; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the transmittal letter accompanying any registration statement
filed with the Commission in connection with such offering discloses that the Fund has received an order under Section&#160;19(b)&#160;of
the 1940 Act to permit it to make periodic distributions of long-term capital gains with respect to its common stock as frequently as
twelve times each year, and as frequently as distributions are specified in accordance with the terms of any outstanding preferred stock
that such fund may issue.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The relief described above will expire on the effective date of any
amendment to Rule&#160;19b-1 under the 1940 Act that provides relief permitting certain closed-end investment companies to make periodic
distributions of long-term capital gains with respect to their outstanding common stock as frequently as twelve times each year. Under
the Managed Distribution Policy, if, for any distribution, undistributed net investment income and net realized capital gains were less
than the amount of the distribution, the difference would be distributed from the Fund's other assets. In addition, in order to make such
distributions, the Fund might have to sell a portion of its investment portfolio at a time when independent investment judgment might
not dictate such action.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the 1940 Act, the Fund is not permitted to incur indebtedness
unless immediately after such incurrence the Fund has an asset coverage of at least 300% of the aggregate outstanding principal balance
of indebtedness. Additionally, under the 1940 Act, the Fund generally may not declare any dividend or other distribution upon any class
of its shares, or purchase any such shares, unless the aggregate indebtedness of the Fund has, at the time of the declaration of any such
dividend or distribution or at the time of any such purchase, an asset coverage of at least 300% after deducting the amount of such dividend,
distribution, or purchase price, as the case may be, except that dividends may be declared upon any preferred shares if such indebtedness
has an asset coverage of at least 200% at the time of declaration thereof after deducting the amount of the dividend. This limitation
does not apply to certain privately placed debt.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While any preferred shares are outstanding, the Fund may not declare
any dividend or other distribution on its common shares, unless at the time of such declaration, (1)&#160;all accumulated preferred dividends
have been paid and (2)&#160;the net asset value of the Fund's portfolio (determined after deducting the amount of such dividend or other
distribution) is at least 200% of the liquidation value of the outstanding preferred shares (expected to be equal to the original purchase
price per share plus any accumulated and unpaid dividends thereon).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition to the limitations imposed by the 1940 Act described above,
certain lenders may impose additional restrictions on the payment of dividends or distributions on common shares in the event of a default
on the Fund's borrowings. If the Fund's ability to make distributions on its common shares is limited, such limitation could, under certain
circumstances, impair the ability of the Fund to maintain its qualification for federal income taxation as a regulated investment company
and to reduce or eliminate tax at the Fund level, which would have adverse tax consequences for shareholders. See "Leverage"
and "Certain Federal Income Tax Matters."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 77 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See " &#8212; Automatic Dividend Reinvestment Plan" for information
concerning the manner in which dividends and distributions to common shareholders may be automatically reinvested in common shares. Dividends
and distributions are taxable to shareholders for federal income tax purposes whether they are reinvested in shares of the Fund or received
in cash.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The yield on the Fund's common shares may vary from period to period
depending on factors including, but not limited to, market conditions, the timing of the Fund's investment in portfolio securities, the
securities comprising the Fund's portfolio, changes in interest rates including changes in the relationship between short-term rates and
long-term rates, the amount and timing of the use of borrowings and other leverage by the Fund, the effects of leverage on the common
shares discussed above under "Leverage," the timing of the investment of leverage proceeds in portfolio securities, the Fund's
net assets and its operating expenses. Consequently, the Fund cannot guarantee any particular yield on its common shares and the yield
for any given period is not an indication or representation of future yields on the Fund's common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Automatic Dividend Reinvestment Plan</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Plan, unless a common shareholder is ineligible or
elects otherwise, all dividend and capital gains on common shares distributions are automatically reinvested by Computershare Shareowner
Services LLC, a subsidiary of Computershare Limited, as agent for shareholders in administering the Plan ("Plan Agent"), in
additional common shares of the Fund. Shareholders who elect not to participate in the Plan will receive all dividends and distributions
payable in cash paid by check mailed directly to the shareholder of record (or, if the shares are held in street or other nominee name,
then to such nominee) by Plan Agent, as dividend paying agent. Shareholders may elect not to participate in the Plan and to receive all
dividends and distributions in cash by sending written instructions to Plan Agent, as dividend paying agent, at the address set forth
below. Participation in the Plan is completely voluntary and may be terminated or resumed at any time without penalty by giving notice
in writing to the Plan Agent; such termination will be effective with respect to a particular dividend or distribution if notice is received
prior to the record date for the applicable distribution.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whenever the Fund declares a dividend or distribution payable either
in common shares or in cash, non participants in the Plan will receive cash, and participants in the Plan will receive the equivalent
in shares of common shares. The common shares are acquired by the Plan Agent for the participant's account, depending upon the circumstances
described below, either (i)&#160;through receipt of additional common shares from the Fund ("newly issued shares") or (ii)&#160;by
purchase of outstanding common shares on the open market ("open-market purchases") on Nasdaq or elsewhere. If, on the payment
date, the net asset value per share of the common shares is equal to or less than the market price per common share plus estimated brokerage
commissions (such condition being referred to herein as "market premium"), the Plan Agent will receive newly issued common shares
from the Fund for each participant's account. The number of newly issued common shares to be credited to the participant's account will
be determined by dividing the dollar amount of the dividend or distribution by the greater of (i)&#160;the net asset value per common
share on the payment date, or (ii)&#160;95% of the market price per common share on the payment date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, on the payment date, the net asset value per common share exceeds
the market price plus estimated brokerage commissions (such condition being referred to herein as "market discount"), the Plan
Agent has until the last business day before the next date on which the shares trade on an "ex-dividend" basis or in no event
more than 30 days after the payment date ("last purchase date") to invest the dividend or distribution amount in shares acquired
in open-market purchases. It is contemplated that the Fund will pay monthly income dividends. Therefore, the period during which open-market
purchases can be made will exist only from the payment date on the dividend through the date before the next ex-dividend date, which typically
will be approximately ten days. If, before the Plan Agent has completed its purchases, the market price plus estimated brokerage commissions
exceeds the net asset value of the common shares as of the payment date, the purchase price paid by Plan Agent may exceed the net asset
value of the common shares, resulting in the acquisition of fewer common shares than if such dividend or distribution had been paid in
common shares issued by the Fund. The weighted average price (including brokerage commissions) of all common shares purchased by the Plan
Agent as Plan Agent will be the price per common share allocable to each participant. If, before the Plan Agent has completed its open-market
purchases, the market price of a common share exceeds the net asset value per share, the average per share purchase price paid by the
Plan Agent may exceed the net asset value of the Fund's shares, resulting in the acquisition of fewer shares than if the dividend had
been paid in newly issued shares on the payment date. Because of the foregoing difficulty with respect to open-market purchases, the Plan
provides that if the Plan Agent is unable to invest the full dividend amount in open-market purchases during the purchase period or if
the market discount shifts to a market premium during the purchase period, the Plan Agent will cease making open-market purchases and
will invest the uninvested portion of the dividend or distribution amount in newly issued shares at the net asset value per common share
at the close of business on the last purchase date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 78 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Plan Agent maintains all shareholders' accounts in the Plan and
furnishes written confirmation of each acquisition made for the participant's account as soon as practicable, but in no event later than
60 days after the date thereof. Shares in the account of each Plan participant will be held by the Plan Agent in non-certificated form
in the Plan Agent's name or that of its nominee, and each shareholder's proxy will include those shares purchased or received pursuant
to the Plan. The Plan Agent will forward all proxy solicitation materials to participants and vote proxies for shares held pursuant to
the Plan first in accordance with the instructions of the participants then with respect to any proxies not returned by such participant,
in the same proportion as the Plan Agent votes the proxies returned by the participants.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There will be no brokerage charges with respect to common shares issued
directly by the Fund as a result of dividends or distributions payable either in shares or in cash. However, each participant will pay
a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment
of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the
proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold, plus a $15.00 transaction
fee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The automatic reinvestment of dividends and distributions will not
relieve participants of any federal, state or local income tax that may be payable (or required to be withheld) on such dividends. See
"Certain Federal Income Tax Matters."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shareholders participating in the Plan may receive benefits not available
to shareholders not participating in the Plan. If the market price plus commissions of the Fund's shares is higher than the net asset
value, participants in the Plan will receive shares of the Fund at less than they could otherwise purchase them and will have shares with
a cash value greater than the value of any cash distribution they would have received on their shares. If the market price plus commissions
is below the net asset value, participants receive distributions of shares with a net asset value greater than the value of any cash distribution
they would have received on their shares. However, there may be insufficient shares available in the market to make distributions in shares
at prices below the net asset value. Also, since the Fund does not redeem its shares, the price on resale may be more or less than the
net asset value. See "Certain Federal Income Tax Matters" for a discussion of federal income tax consequences of the Plan.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Experience under the Plan may indicate that changes are desirable.
Accordingly, the Fund reserves the right to amend or terminate the Plan if in the judgment of the Board of Trustees such a change is warranted.
The Plan may be terminated by the Plan Agent or the Fund upon notice in writing mailed to each participant at least 60 days prior to the
effective date of the termination. Upon any termination, the Plan Agent will cause a certificate or certificates to be issued for the
full shares held by each participant under the Plan and cash adjustment for any fraction of a common share at the then current market
value of the common shares to be delivered to him or her. If preferred, a participant may request the sale of all of the common shares
held by the Plan Agent in his or her Plan account in order to terminate participation in the Plan. If such participant elects in advance
of such termination to have the Plan Agent sell part or all of his or her shares, the Plan Agent is authorized to deduct from the proceeds
a $15.00 fee plus the brokerage commissions incurred for the transaction. If a participant has terminated his or her participation in
the Plan but continues to have common shares registered in his or her name, he or she may re-enroll in the Plan at any time by notifying
the Plan Agent in writing at the address below. The terms and conditions of the Plan may be amended by the Plan Agent or the Fund at any
time but, except when necessary or appropriate to comply with applicable law or the rules&#160;or policies of the Commission or any other
regulatory authority, only by mailing to each participant appropriate written notice at least 30 days prior to the effective date thereof.
The amendment shall be deemed to be accepted by each participant unless, prior to the effective date thereof, the Plan Agent receives
notice of the termination of the participant's account under the Plan. Any such amendment may include an appointment by the Plan Agent
of a successor Plan Agent, subject to the prior written approval of the successor Plan Agent by the Fund. There is no direct service charge
to participants in the Plan; however, the Fund reserves the right to amend the Plan to include a service charge payable by the participants.
Since investors can participate in the Plan only if their broker or nominee participates in our Plan, you should contact your broker or
nominee to confirm that you are eligible to participate in the Plan.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 79 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information, please direct all correspondence concerning the
Plan to the Plan Agent at P.O.&#160;Box 505000, Louisville, KY 40233-5000</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF SECURITIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a brief description of the capital structure of the
Fund. This description does not purport to be complete and is subject to and qualified in its entirety by reference to the Fund's Agreement
and Declaration of Trust and By-Laws, each as amended and restated through the date hereof. The Agreement and Declaration of Trust and
By-Laws are each exhibits to the registration statement of which this prospectus is a part.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund is authorized to issue an unlimited number of common shares,
without par value. The Fund is also authorized to issue preferred shares and debt securities. As of January&#160;31, 2025, the Fund had
76,312,702 common shares outstanding and MRP Shares outstanding in the following amounts: 1,340,000 Series&#160;C MRP Shares, 1,320,000
Series&#160;D MRP Shares, 1,330,000 Series&#160;E MRP Shares, and 1,320,000 Series&#160;G MRP Shares. As of such date, the Fund had not
issued any debt securities. Subject to the restrictions under the 1940 Act, the Board of Trustees may, from time to time, establish additional
series or classes of Fund shares and set forth the designations, preferences, conversion or other rights, voting powers, restrictions,
limitations as to dividends, qualifications or terms or conditions of redemption of such shares and pursuant to such classification or
reclassification to increase or decrease the number of authorized shares of any existing class or series but the Board may not change
any outstanding shares in a manner materially adverse to such shareholders. The Board of Trustees, without shareholder approval but subject
to the governing documents of the Fund and the MRP Shares, is authorized to amend the Agreement and Declaration of Trust and By-Laws to
reflect the terms of any such class or series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of January&#160;31, 2025, the Fund had total leverage of approximately
$448 million representing approximately 36.4% of the Fund's managed assets as of that date. The Fund will pay, and common shareholders
will effectively bear, any costs and expenses relating to any borrowings by the Fund, including the financial leverage described above,
as well as any additional leverage incurred as a result of this offering. Such costs and expenses include the higher management fee resulting
from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance. Borrowings
under the SSB Agreement are secured by assets of the Fund that are held with the Fund's custodian in a separate account. Interest on the
SSB Agreement is charged on the drawn amount at the rate of OBFR plus 0.52%, payable monthly in arrears. Interest on overdue amounts or
interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.52%. The SSB Agreement has a commitment fee
of 0.10% of any undrawn amount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SSB Agreement also provides that if the Fund restricts SSB&#8217;s
ability to lend securities to multiple otherwise eligible counterparties that, on a historical basis, have accounted for lending comprising
more than 25% up to 50% of the value of securities on loan, the Fund&#8217;s cost of leverage will be increased by 0.25% per annum. If
the Fund restricts SSB&#8217;s ability to lend securities to multiple otherwise eligible counterparties that, on a historical basis, have
accounted for lending comprising over 50% of the value of securities on loan, the Fund&#8217;s cost of leverage will be increased by 0.45%
per annum, Further, if the Fund restricts securities comprising more than 5% of its total assets from being available to lend for purposes
of the securities lending program (excluding ordinary course restrictions and as otherwise agreed by SSB), the costs of leverage to the
Fund will be increased by 0.20% per annum. As of January&#160;31, 2025, the net interest rate charged under the SSB Agreement was 5.35%.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the SSB Agreement, all securities lent or subject
to repurchase transactions through SSB must be secured continuously by collateral received in cash. Cash collateral received by SSB on
behalf of the Fund is deposited into a custodial account in the name of the Fund before being treated as refinancing a portion of the
amounts borrowed under the SSB Agreement. The cost of leverage to the Fund under the SSB Agreement is the same, regardless of whether
funded as an advance from SSB or by securities lending agented by SSB. Any amounts credited against the borrowings under the SSB Agreement
would count against the Fund's leverage limitations under the 1940 Act. Under the terms of the SSB Agreement, the Fund is required to
return the value of the collateral to the borrower upon the return of the lent securities, which will eliminate the credit against the
borrowings under the SSB Agreement and will increase the balance on which the Fund will pay interest. The Fund reserves the right to utilize
sources of borrowings in addition to, or in lieu of, the SSB Agreement. See "Prospectus Summary &#8212; Use of Leverage by the Fund."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 80 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While unsecured and unsubordinated indebtedness may rank equally with
the borrowings under the SSB Agreement in right of payment, the lender under the agreement, together with the holders of other outstanding
secured indebtedness, may, to the exclusion of unsecured creditors, seek recourse against the collateral as security for the borrowings
and such other secured indebtedness until amounts owed under the SSB Agreement and the other secured indebtedness are satisfied in full.
All borrowings under the SSB Agreement and the securities lending agreement rank senior to the Fund's common and preferred shares as to
the payment of interest and distribution of assets upon liquidation. The securities lending arrangement with SSB involves characteristics
common in arm&#8217;s length relationships in which one party may benefit at the expense of the other party.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A declaration of a dividend or other distribution on or purchase or
redemption of any common or preferred shares of the Fund may be prohibited (i)&#160;at any time that an event of default under any borrowings
has occurred and is continuing, or (ii)&#160;if after giving effect to such declaration, purchase or redemption, the Fund would not meet
the 1940 Act asset coverage requirements or any temporary requirements imposed under an order issued by the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common shares, when issued and outstanding, will be legally issued,
fully paid and non-assessable and will have no preemptive or conversion rights or rights to cumulative voting, except as described below.
The Board has not granted such common shares conversion rights. Shareholders are entitled to share pro rata in the net assets of the Fund
available for distribution to common shareholders upon liquidation of the Fund. Common shareholders are entitled to one vote for each
share held.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's Agreement and Declaration of Trust provides that the Trustees
have the power to cause each shareholder to pay directly, in advance or arrears, for charges of the Fund's custodian or transfer, shareholder
servicing or similar agent, an amount fixed from time to time by the Trustees, by setting off such charges due from a shareholder from
declared but unpaid dividends owed to such shareholder and/or by reducing the number of shares in the account of such shareholder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">So long as any preferred shares that may be issued by the Fund are
outstanding, holders of common shares will not be entitled to receive any net income of or other distributions from the Fund unless all
accumulated dividends on preferred shares have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to preferred
shares would be at least 200% after giving effect to such distributions. See "Leverage."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will provide unaudited semi-annual financial statements and
audited annual financial statements to all of its shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other offerings of common shares, if made, will require approval of
the Board of Trustees and will be subject to the requirement of the 1940 Act that common shares may not be sold at a price below the then-current
net asset value, exclusive of underwriting discounts and commissions, except in limited circumstances including in connection with an
offering to existing shareholders. Common shares may be sold in one or more at the market offerings through sales on Nasdaq at a price
equal to or above the Fund's per share NAV plus any sales commissions paid by the Fund to execute such sales.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred shares, when issued and outstanding, will be legally issued,
fully paid and non-assessable. Holders of preferred shares will be entitled to the rights and preferences set out in the documents creating
the preferred shares. As a non-fundamental policy, the Fund may not issue preferred shares or borrow money and/or issue debt securities
with an aggregate liquidation preference and aggregate principal amount exceeding 38% of the Fund's managed assets. However, the Board
of Trustees reserves the right to issue preferred shares to the extent permitted by the 1940 Act, which currently limits the aggregate
liquidation preference of all outstanding preferred shares to 50% of the value of the Fund's total assets less the Fund's liabilities
and indebtedness not represented by senior securities. Under the 1940 Act, the Fund may only issue one class of preferred shares. So long
as any preferred shares are outstanding, additional issuances of preferred shares may not have preference or priority over the outstanding
preferred shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 81 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the Fund, the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which
is expected to equal the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before
any distribution of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which
they are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets by
the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 1940 Act requires that the holders of any preferred shares, voting
separately as a single class, have the right to elect at least two Trustees at all times. The remaining Trustees will be elected by holders
of common shares and preferred shares, voting together as a single class. In addition, subject to the prior rights, if any, of the holders
of any other class of senior securities outstanding, the holders of any preferred shares have the right to elect a majority of the Trustees
at any time two years' accumulated dividends on any preferred shares are unpaid. The 1940 Act also requires that, in addition to any approval
by shareholders that might otherwise be required, the approval of the holders of a majority of any outstanding preferred shares, voting
separately as a class, would be required to (1)&#160;adopt any plan of reorganization that would adversely affect the preferred shares,
and (2)&#160;take any action requiring a vote of security holders under Section&#160;13(a)&#160;of the 1940 Act, including, among other
things, changes in the Fund's subclassification as a closed-end investment company or changes in its fundamental investment restrictions.
See "Certain Provisions of the Agreement and Declaration of Trust and By-Laws,&#160;Including Antitakeover Provisions." As a
result of these voting rights, the Fund's ability to take any such actions may be impeded to the extent that there are any preferred shares
outstanding. Except as otherwise indicated in this prospectus and except as otherwise required by applicable law, holders of preferred
shares have equal voting rights with holders of common shares (one vote per share, unless otherwise required by the 1940 Act) and will
vote together with holders of common shares as a single class.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of the holders of a majority of the outstanding
preferred shares, voting as a separate class, will be required to amend, alter or repeal any of the preferences, rights or powers of holders
of preferred shares so as to affect materially and adversely such preferences, rights or powers, or to increase or decrease the authorized
number of preferred shares. The class vote of holders of preferred shares described above will in each case be in addition to any other
vote required to authorize the action in question.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any redemption or purchase of any preferred shares by the Fund will
reduce the leverage applicable to the common shares, while any resale of shares by the Fund will increase that leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred shares that may be issued by the Fund may or may not be listed
on an exchange or automated quotation system. The details on how to buy and sell such securities, along with the other terms of the securities,
will be described in a prospectus supplement. We cannot assure you that any market will exist for our preferred securities or if a market
does exist, whether it will provide holders with liquidity.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General.</i> Under Delaware law and the Fund's Agreement and Declaration
of Trust, it may borrow money, without prior approval of holders of common and preferred shares. The Fund may issue debt securities, or
other evidence of indebtedness (including bank borrowings or commercial paper) and may secure any such notes or borrowings by mortgaging,
pledging or otherwise subjecting as security our assets to the extent permitted by the 1940 Act or rating agency guidelines. Any borrowings
will rank senior to preferred shares and the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the 1940 Act, the Fund may only issue one class of senior securities
representing indebtedness other than promissory notes or other evidences of indebtedness not intended to be publicly distributed, which
in the aggregate, may represent no more than 33 1/3% of our managed assets. A prospectus supplement and indenture (a summary of the expected
terms of which is attached as Appendix A to the statement of additional information) relating to any debt securities will include specific
terms relating to the offering. These terms are expected to include the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the form and title of the security;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 82 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the aggregate principal amount of the securities;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the interest rate of the securities;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the maturity dates on which the principal of the securities
will be payable;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> any changes to or additional events of default or covenants;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> any optional or mandatory redemption provisions;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> identities of, and any changes in trustees, paying agents or
security registrar; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> any other terms of the securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest.</i> Unless otherwise stated in a prospectus supplement,
debt securities will bear interest as generally determined by the Board of Trustees, as more fully described in the related prospectus
supplement. Interest on debt securities shall be payable when due as described in the related prospectus supplement. If we do not pay
interest when due, it will trigger an event of default and we will be restricted from declaring dividends and making other distributions
with respect to our common shares and preferred shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Limitations.</i> Under the requirements of the 1940 Act, immediately
after issuing any senior securities representing indebtedness, we must have an asset coverage of at least 300%. Asset coverage means the
ratio which the value of our total assets, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate
amount of senior securities representing indebtedness. Other types of borrowings also may result in our being subject to similar covenants
in credit agreements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Events of Default and Acceleration of Maturity of Debt Securities;
Remedies.</i> Unless stated otherwise in the related prospectus supplement, any one of the following events are expected to constitute
an "event of default" for that series under the indenture:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> default in the payment of any interest upon a series of debt
securities when it becomes due and payable and the continuance of such default for 30 days;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> default in the payment of the principal of, or premium on, a
series of debt securities at its stated maturity;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> default in the performance, or breach, of any covenant or warranty
of ours in the indenture, and continuance of such default or breach for a period of 90 days after written notice has been given to us
by the trustee;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> certain voluntary or involuntary proceedings involving us and
relating to bankruptcy, insolvency or other similar laws;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> if, on the last business day of each of twenty-four consecutive
calendar months, the debt securities have a 1940 Act asset coverage of less than 100%; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> any other "event of default" provided with respect
to a series, including a default in the payment of any redemption price payable on the redemption date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the occurrence and continuance of an event of default, the holders
of a majority in principal amount of a series of outstanding debt securities or the trustee may declare the principal amount of that series
of debt securities immediately due and payable upon written notice to us. A default that relates only to one series of debt securities
does not affect any other series and the holders of such other series of debt securities are not entitled to receive notice of such a
default under the indenture. Upon an event of default relating to bankruptcy, insolvency or other similar laws, acceleration of maturity
occurs automatically with respect to all series. At any time after a declaration of acceleration with respect to a series of debt securities
has been made, and before a judgment or decree for payment of the money due has been obtained, the holders of a majority in principal
amount of the outstanding debt securities of that series, by written notice to us and the trustee, may rescind and annul the declaration
of acceleration and its consequences if all events of default with respect to that series of debt securities, other than the non-payment
of the principal of that series of debt securities which has become due solely by such declaration of acceleration, have been cured or
waived and other conditions have been met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 83 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Liquidation Rights.</i> In the event of (a)&#160;any insolvency
or bankruptcy case or proceeding, or any receivership, liquidation, reorganization or other similar case or proceeding in connection therewith,
relative to us or to our creditors, as such, or to our assets, or (b)&#160;any liquidation, dissolution or other winding up of the Fund,
whether voluntary or involuntary and whether or not involving insolvency or bankruptcy, or (c)&#160;any assignment for the benefit of
creditors or any other marshalling of assets and liabilities of ours, then (after any payments with respect to any secured creditor of
ours outstanding at such time) and in any such event the holders of debt securities shall be entitled to receive payment in full of all
amounts due or to become due on or in respect of all debt securities (including any interest accruing thereon after the commencement of
any such case or proceeding), or provision shall be made for such payment in cash or cash equivalents or otherwise in a manner satisfactory
to the holders of the debt securities, before the holders of any common or preferred stock of the Fund are entitled to receive any payment
on account of any redemption proceeds, liquidation preference or dividends from such shares. The holders of debt securities shall be entitled
to receive, for application to the payment thereof, any payment or distribution of any kind or character, whether in cash, property or
securities, including any such payment or distribution which may be payable or deliverable by reason of the payment of any other indebtedness
of ours being subordinated to the payment of the debt securities, which may be payable or deliverable in respect of the debt securities
in any such case, proceeding, dissolution, liquidation or other winding up event.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unsecured creditors of ours may include, without limitation, service
providers including Calamos, the Fund's custodian, the Fund's administrator, broker-dealers and the trustee, pursuant to the terms of
various contracts with us. Secured creditors of ours may include without limitation SSB and other lenders to the Fund, parties entering
into any interest rate swap, floor or cap transactions, or other similar transactions with us that create liens, pledges, charges, security
interests, security agreements or other encumbrances on our assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A consolidation, reorganization or merger of the Fund with or into
any other company, or a sale, lease or exchange of all or substantially all of our assets in consideration for the issuance of equity
securities of another company shall not be deemed to be a liquidation, dissolution or winding up of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Voting Rights.</i> Debt securities have no voting rights, except
to the extent required by law or as otherwise provided in the indenture relating to the acceleration of maturity upon the occurrence and
continuance of an event of default. In connection with any other borrowings (if any), the 1940 Act does in certain circumstances grant
to the lenders certain voting rights in the event of default in the payment of interest on or repayment of principal.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Market.</i> Our debt securities are not likely to be listed on an
exchange or automated quotation system. The details on how to buy and sell such securities, along with the other terms of the securities,
will be described in a prospectus supplement. We cannot assure you that any market will exist for our debt securities or if a market does
exist, whether it will provide holders with liquidity.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Book-Entry, Delivery and Form.</i> Unless otherwise stated in the
related prospectus supplement, the debt securities will be issued in book-entry form and will be represented by one or more notes in registered
global form. The global notes will be deposited with the trustee as custodian for The Depository Trust Company ("DTC") and registered
in the name of Cede&#160;&amp; Co., as nominee of DTC. DTC will maintain the notes in designated denominations through its book-entry
facilities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the expected terms of the indenture, we and the trustee may treat
the persons in whose names any notes, including the global notes, are registered as the owners thereof for the purpose of receiving payments
and for any and all other purposes whatsoever. Therefore, so long as DTC or its nominee is the registered owner of the global notes, DTC
or such nominee will be considered the sole holder of outstanding notes under the indenture. We or the trustee may give effect to any
written certification, proxy or other authorization furnished by DTC or its nominee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 84 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A global note may not be transferred except as a whole by DTC, its
successors or their respective nominees. Interests of beneficial owners in the global note may be transferred or exchanged for definitive
securities in accordance with the rules&#160;and procedures of DTC. In addition, a global note may be exchangeable for notes in definitive
form if:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> DTC notifies us that it is unwilling or unable to continue as
a depository and we do not appoint a successor within 60 days;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> we, at our option, notify the trustee in writing that we elect
to cause the issuance of notes in definitive form under the indenture; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> an event of default has occurred and is continuing.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In each instance, upon surrender by DTC or its nominee of the global
note, notes in definitive form will be issued to each person that DTC or its nominee identifies as being the beneficial owner of the related
notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the expected terms of the indenture, the holder of any global
note may grant proxies and otherwise authorize any person, including its participants and persons who may hold interests through DTC participants,
to take any action which a holder is entitled to take under the indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RATING AGENCY GUIDELINES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Rating Agencies, which may assign ratings to our senior securities,
impose asset coverage requirements, which may limit our ability to engage in certain types of transactions and may limit our ability to
take certain actions without confirming that such action will not impair the ratings. Any agency that may rate our debt securities or
preferred shares is referred to as the "Rating Agency."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may, but are not required to, adopt any modification to the guidelines
that may hereafter be established by any Rating Agency. Failure to adopt any modifications, however, may result in a change in the ratings
described above or a withdrawal of ratings altogether. In addition, any Rating Agency may, at any time, change or withdraw any rating.
The Board may, without shareholder approval, modify, alter or repeal certain of the definitions and related provisions which have been
adopted pursuant to each Rating Agency's guidelines ("Rating Agency Guidelines") only in the event we receive written confirmation
from the Rating Agency or Agencies that any amendment, alteration or repeal would not impair the ratings then assigned to the senior securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may be required to satisfy two separate asset maintenance requirements
with respect to outstanding rated debt securities and with respect to rated preferred shares: (1)&#160;we must maintain assets in our
portfolio that have a value, discounted in accordance with guidelines set forth by each Rating Agency, at least equal to 115% of the aggregate
principal amount/liquidation preference of the debt securities/preferred stock, respectively, plus specified liabilities, payment obligations
and other amounts (the "Basic Maintenance Amount"); and (2)&#160;we must satisfy the 1940 Act asset coverage requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Basic Maintenance Amounts.</i> We may be required to maintain, as
of each valuation date on which senior securities are outstanding, eligible assets having an aggregate discounted value at least equal
to 115% of the applicable Basic Maintenance Amount, which is calculated separately for debt securities and preferred shares for each Rating
Agency that is then rating the senior securities and so requires. If we fail to maintain eligible assets having an aggregated discounted
value at least equal to 115% of the applicable Basic Maintenance Amount as of any valuation date and such failure is not cured, we will
be required in certain circumstances to redeem certain of the senior securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The applicable Basic Maintenance Amount is defined in the Rating Agency's
Guidelines. Each Rating Agency may amend the definition of the applicable Basic Maintenance Amount from time to time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The market value of our portfolio securities (used in calculating the
discounted value of eligible assets) is calculated using readily available market quotations when appropriate, and in any event, consistent
with our valuation procedures. For the purpose of calculating the applicable Basic Maintenance Amount, portfolio securities are valued
in the same manner as we calculate our NAV. See "Net Asset Value."</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 85 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each Rating Agency's discount factors, the criteria used to determine
whether the assets held in our portfolio are eligible assets, and the guidelines for determining the discounted value of our portfolio
holdings for purposes of determining compliance with the applicable Basic Maintenance Amount are based on Rating Agency Guidelines established
in connection with rating the senior securities. The discount factor relating to any asset, the applicable basic maintenance amount requirement,
the assets eligible for inclusion in the calculation of the discounted value of our portfolio and certain definitions and methods of calculation
relating thereto may be changed from time to time by the applicable Rating Agency, without our approval, or the approval of our Board
of Trustees or shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A Rating Agency's Guidelines will apply to the senior securities only
so long as that Rating Agency is rating such securities. In connection with obtaining a rating, we will pay certain fees to Moody's, Fitch,
KBRA and any other Rating Agency that may provide a rating for the senior securities. The ratings assigned to the senior securities are
not recommendations to buy, sell or hold the senior securities. Such ratings may be subject to revision or withdrawal by the assigning
Rating Agency at any time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>1940 Act Asset Coverage.</i> We are also required to maintain, with
respect to senior securities, as of the last business day on any month in which any senior securities are outstanding, asset coverage
of at least 300% for debt securities and 200% for preferred stock (or such other percentage as may in the future be specified in or under
the 1940 Act or in any order granted by the Commission as the minimum asset coverage for senior securities representing shares of a closed-end
investment company as a condition of declaring dividends on its common stock). If we fail to maintain the applicable 1940 Act asset coverage
as of the last business day of any month and such failure is not cured as of the last business day of the following month (the "Asset
Coverage Cure Date"), we may be required to redeem certain senior securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Notices.</i> Under the current Rating Agency Guidelines, in certain
circumstances, we may be required to deliver to any Rating Agency which is then rating the senior securities (1)&#160;a certificate with
respect to the calculation of the applicable Basic Maintenance Amount; (2)&#160;a certificate with respect to the calculation of the applicable
1940 Act asset coverage and the value of our portfolio holdings; and (3)&#160;a letter prepared by our independent accountants regarding
the accuracy of such calculations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding anything herein to the contrary, the Rating Agency
Guidelines, as they may be amended from time to time by each Rating Agency will be reflected in a written document and may be amended
by each Rating Agency without the vote, consent or approval of the Fund, the Board of Trustees or any shareholder of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the current Rating Agency Guidelines will be provided to
any holder of rated, senior securities promptly upon request made by such holder to the Fund by writing the Fund at 2020 Calamos Court,
Naperville,&#160;Illinois 60563.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN PROVISIONS OF THE AGREEMENT<br/>
AND DECLARATION OF TRUST AND BY-LAWS,&#160;<br/>
INCLUDING ANTITAKEOVER PROVISIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's Agreement and Declaration of Trust includes provisions that
could have the effect of limiting the ability of other entities or persons to acquire control of the Fund or to change the composition
of its Board of Trustees and could have the effect of depriving shareholders of an opportunity to sell their shares at a premium over
prevailing market prices by discouraging a third party from seeking to obtain control of the Fund. These provisions, however, have the
advantage of potentially requiring persons seeking control of the Fund to negotiate with our management regarding the price to be paid
and facilitating the continuity of the Fund's investment objective and policies. The Board of Trustees of the Fund has considered these
provisions and concluded that they are in the best interests of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Trustees is divided into three classes. The terms of the
Trustees of the different classes are staggered. A Trustee may be removed from office with or without cause (1)&#160;at any time by a
written instrument signed by at least two-thirds of the then Trustees, specifying the effective date of removal, or (2)&#160;by a vote
of at least a majority of the then Trustees if such removal is approved by the holders of at least two-thirds of the outstanding shares
entitled to vote with respect to the election of such Trustee and present in person or by proxy at a meeting of shareholders called for
such purpose.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 86 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, subject to certain exceptions in the Agreement and Declaration
of Trust, the Agreement and Declaration of Trust requires the affirmative vote of at least 75% of the outstanding shares entitled to vote
on the matter for the Fund to merge or consolidate with any other corporation, association, trust or other organization or to sell, lease
or exchange all or substantially all of the Fund's assets; unless such action has been approved by the affirmative vote of at least 75%
of the Continuing Trustees (as defined in the Agreement and Declaration of Trust) then in office, in which case, the affirmative vote
of a majority of the outstanding shares entitled to vote on the matter is required.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, conversion of the Fund to an open-end investment company
would require an amendment to the Fund's Agreement and Declaration of Trust. Such an amendment would require the favorable vote of a majority
of the then Continuing Trustees (as defined in the Agreement and Declaration of Trust) followed by a favorable vote of the holders of
at least 75% of the shares of each affected class or series outstanding, voting as separate classes or series (or a majority of the shares
outstanding and entitled to vote if the amendment was previously approved by 75% of the Trustees). Such a vote also would satisfy a separate
requirement in the 1940 Act that the change be approved by the shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the 1940 Act, shareholders of an open-end investment company
may require the company to redeem their shares of common stock at any time (except in certain circumstances as authorized by or under
the 1940 Act) at their net asset value, less such redemption charge, if any, as might be in effect at the time of a redemption. If the
Fund is converted to an open-end investment company, it could be required to liquidate portfolio securities to meet requests for redemption,
and the common shares would no longer be listed on Nasdaq. Conversion to an open-end investment company would also require changes in
certain of the Fund's investment policies and restrictions. In addition, if then outstanding, the Fund would be required to redeem all
of its outstanding preferred shares prior to conversion to an open-end investment company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the Agreement and Declaration of Trust requires the affirmative
vote or consent of a majority of the then Continuing Trustees (as defined in the Agreement and Declaration of Trust) followed by the affirmative
vote or consent of the holders of at least 75% of the shares of each affected class or series of the Fund outstanding, voting separately
as a class or series, to approve certain transactions with a Principal Shareholder, unless the transaction has been approved by at least
75% of the Continuing Trustees (as defined in the Agreement and Declaration of Trust), in which case a majority of the outstanding shares
entitled to vote shall be required. For purposes of these provisions, a "Principal Shareholder" refers to any person who, whether
directly or indirectly and whether alone or together with its affiliates and associates, beneficially owns 5% or more of the outstanding
shares of any class or series of shares of beneficial interest of the Fund. The 5% holder transactions subject to these special approval
requirements are:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the merger or consolidation of the Fund or any subsidiary of
the Fund with or into any Principal Shareholder;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the issuance of any securities of the Fund to any Principal
Shareholder for cash (other than pursuant to any automatic dividend reinvestment plan); or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> the sale, lease or exchange to the Fund or any subsidiary of
the Fund in exchange for securities of the Fund, of any assets of any Principal Shareholder, except assets having an aggregate fair market
value of less than $1,000,000, aggregating for the purpose of such computation all assets sold, leased or exchanged in any series of similar
transactions within a 12-month period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund may be terminated by the affirmative vote of not less than
75% of the Trustees then in office by written notice to the shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's Agreement and Declaration of Trust and By-Laws provide that
the Board of Trustees has the power, to the exclusion of shareholders, to make, alter or repeal any of the By-Laws, except for any By-Law
that requires a vote of the shareholders to be amended, adopted or repealed by the terms of the Agreement and Declaration of Trust, By-Laws
or applicable law. Neither this provision of the Agreement and Declaration of Trust, nor any of the foregoing provisions thereof requiring
the affirmative vote of 75% of outstanding shares of the Fund, can be amended or repealed except by the vote of such required number of
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 87 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's By-Laws provide that the affirmative vote of a majority
of the shares outstanding and entitled to vote shall elect a trustee; provided, that if the Fund's Agreement and Declaration of Trust
or applicable law requires that a trustee be elected by individual series or classes, then the affirmative vote of a majority of the shares
outstanding and entitled to vote of that series or class shall elect a trustee. In the case of a failure to elect trustees at a shareholder
meeting, the Fund's Agreement and Declaration of Trust provides that each incumbent Trustee shall hold-over as Trustee until her or she
sooner dies, resigns, retires, or is disqualified or removed from office or until the election at an annual meeting and qualification
of his or her successor.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's By-Laws provide that shareholders may only make proposals
regarding underlying matters on which they are entitled to vote. In addition, nominations of persons for election as a trustee and the
proposal of other business may be made at an annual meeting of shareholders by any shareholder who was a shareholder of record at the
time of giving notice required by the Fund's By-Laws and who held shares continuously until the time of the annual meeting (the "Holding
Period"). Other than nominations of persons for election as a trustee, shareholders proposing other business must hold, together
with any other shareholders proposing such business, at least 5% of the outstanding shares of the Fund or 5% of the outstanding shares
of the series or class to which the proposal relates continuously through the Holding Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to proposals by shareholders submitted outside the process
of Rule&#160;14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Fund's By-Laws generally
require that advance notice be given to the Fund in the event a shareholder desires to nominate a person for election to the Board of
Trustees or to transact any other business at an annual meeting of shareholders. With respect to an annual meeting following the first
annual meeting of shareholders, notice of any such nomination or business must be delivered to the principal executive offices of the
Fund not less than 90 calendar days nor more than 120 calendar days prior to the anniversary date of the mailing of the notice for the
prior year's annual meeting (subject to certain exceptions). Any notice by a shareholder must be accompanied by certain information as
provided in the By-Laws, including (a)&#160;the shareholder giving notice and the beneficial owners, if any, on whose behalf the nomination
is made (i)&#160;the name and address of the shareholder, as they appear in the Fund's books, and of the beneficial owner, (ii)&#160;information
regarding the shares held by the shareholder, (iii)&#160;a description of all arrangements, agreements or understandings between the shareholder
and any other person or persons (including their names) pursuant to which the shareholder recommendation is being made, (iv)&#160;a representation,
which is complied with, that the shareholder is a shareholder of record of the Fund and entitled to vote at such meeting and intends to
appear in person or by proxy at the meeting to propose such business or nomination, (v)&#160;a representation, which is complied with,
that the shareholder or the beneficial owner, if any, intends or is part of a group which intends to deliver a proxy statement and/or
form of proxy to shareholders entitled to cast the requisite number of votes to approve or adopt the proposal or elect the nominee, and
(vi)&#160;any other information relating to the shareholder and beneficial owner, if any, that must be disclosed in solicitation of proxies
for election of trustees in an election contest (even if an election contest is not involved), or otherwise would be required, in each
case pursuant to the Exchange Act and the rules&#160;and regulations promulgated thereunder; (b)&#160;information regarding the candidate's
background and qualifications to serve as trustee; and (c)&#160;as to any other business that the shareholder proposes to bring before
the meeting, a brief description of the business desired to be brought before the meeting, the text of the proposal or business (including
the text of any resolutions proposed for consideration), the reasons for conducting such business at the meeting and any material interest
in such business of such shareholder and the beneficial owner, if any, on whose behalf the proposal is made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's Agreement and Declaration of Trust provides that the chair
of the shareholder meeting may adjourn a meeting for any reason on his or her own motion without setting a new record date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing is intended only as a summary and is qualified in its
entirety by reference to the full text of the Fund's Agreement and Declaration of Trust and By-Laws, both of which have been filed as
exhibits to the Fund's registration statement on file with the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 88 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PLAN OF DISTRIBUTION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer, from time to time, our common shares, preferred shares
or debt securities, and certain of our shareholders may sell our common shares, on an immediate, continuous or delayed basis, in one or
more underwritten public offerings, "at the market" offerings or a combination of both offerings under this prospectus and any
related prospectus supplement. The aggregate amount of securities that may be offered by us in connection with this offering is limited
to $200,000,000. Any underwriter or agent involved in the offer and sale of the securities will be named in the applicable prospectus
supplement. A prospectus supplement or supplements will also describe the terms of the offering of the securities, including as applicable:
the purchase price of the securities and the proceeds, if any, we will receive from the sale; any overallotment options under which underwriters
may purchase additional securities from us; any agency fees or underwriting discounts and other items constituting agents' or underwriters'
compensation; the public offering price; any discounts or concessions allowed or re-allowed or paid to dealers; and any securities exchange
or market on which the securities may be listed. Only underwriters named in the prospectus supplement will be underwriters of the securities
offered by such prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Direct Sales</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may sell our common shares, preferred shares or debt securities,
and certain of our shareholders may sell our common shares, directly to, and solicit offers from, institutional investors or others who
may be deemed to be underwriters as defined in the 1933 Act for any resales of the securities. If such an offering occurs, no underwriters
or agents would be involved. We, or any selling shareholder, may use electronic media, including the Internet, to sell offered securities
directly. The terms of any of those sales will be described in a prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our common shares are to be offered for sale by certain of our shareholders,
each prospectus supplement relating to such offering will indicate the nature of any position, office, or other material relationship
which the selling shareholder has had within the past three years with the Fund or any of its predecessors or affiliates, and will state
the amount of securities of the class owned by such shareholder prior to the offering, the amount to be offered for the shareholder's
account, the amount and (if one percent or more) the percentage of the class to be owned by such shareholder after completion of the offering.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>By Agents</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer our common shares, preferred shares and debt securities
through agents that we or they designate. Any agent involved in the offer and sale will be named and any commissions payable by us to
such agent will be described in the applicable prospectus supplement. Unless otherwise indicated in the prospectus supplement, the agents
will be acting on a commercially reasonable efforts basis for the period of their appointment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of our common shares may be made in transactions that are deemed
to be "at the market" as defined in Rule&#160;415 under the 1933 Act, including sales made directly on Nasdaq or sales made
to or through a market maker other than on an exchange.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>By Underwriters</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer and sell securities from time to time to one or more underwriters
who would purchase the securities as principal for resale to the public, either on a firm commitment or best efforts basis. If we sell
securities to underwriters, we will execute an underwriting agreement with them at the time of the sale and will name them in the prospectus
supplement. In connection with these sales, the underwriters may be deemed to have received compensation from us in the form of underwriting
discounts and commissions. The underwriters also may receive commissions from purchasers of securities for whom they may act as agent.
Unless otherwise stated in the prospectus supplement, the underwriters will not be obligated to purchase the securities unless the conditions
set forth in the underwriting agreement are satisfied, and if the underwriters purchase any of the securities, they will be required to
purchase all of the offered securities. The underwriters may sell the offered securities to or through dealers, and those dealers may
receive discounts, concessions or commissions from the underwriters as well as from the purchasers for whom they may act as agent. Any
public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. Our common
shareholders will indirectly bear such fees and expenses as well as any other fees and expenses incurred by us in connection with any
sale of securities. Underwriters, dealers and agents that participate in the distribution of the securities may be deemed to be underwriters
under the 1933 Act, and any discounts and commissions they receive from us and any profit realized by them on the resale of the securities
may be deemed to be underwriting discounts and commissions under the 1933 Act. Any such underwriter or agent will be identified and any
such compensation received from us will be described in the applicable prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 89 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a prospectus supplement so indicates, we may grant the underwriters
an option to purchase additional shares of common stock at the public offering price, less the underwriting discounts and commissions,
within 45 days from the date of the prospectus supplement, to cover any overallotments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>By Dealers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer and sell securities from time to time to one or more dealers
who would purchase the securities as principal. The dealers then may resell the offered securities to the public at fixed or varying prices
to be determined by those dealers at the time of resale. The names of the dealers and the terms of the transactions with them will be
set forth in the applicable prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General Information</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Agents, underwriters, or dealers participating in an offering of securities
may be deemed to be underwriters, and any discounts and commission received by them and any profit realized by them on resale of the offered
securities for whom they act as agent may be deemed to be underwriting discounts and commissions under the 1933 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may offer to sell securities either at a fixed price or at prices
that may vary, at market prices prevailing at the time of sale, at prices related to prevailing market prices, or at negotiated prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinarily, each series of offered securities will be a new issue of
securities and will have no established trading market.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To facilitate an offering of common stock in an underwritten transaction
and in accordance with industry practice, the underwriters may engage in transactions that stabilize, maintain, or otherwise affect the
market price of the common stock or any other security. Those transactions may include overallotment, entering stabilizing bids, effecting
syndicate covering transactions, and reclaiming selling concessions allowed to an underwriter or a dealer. An overallotment in connection
with an offering creates a short position in the common stock for the underwriter's own account. An underwriter may place a stabilizing
bid to purchase the common stock for the purpose of pegging, fixing, or maintaining the price of the common stock. Underwriters may engage
in syndicate covering transactions to cover overallotments or to stabilize the price of the common stock by bidding for, and purchasing,
the common stock or any other securities in the open market in order to reduce a short position created in connection with the offering.
The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering
when the common stock originally sold by the syndicate member is purchased in syndicate covering transactions or otherwise.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any of these activities may stabilize or maintain the market price
of the securities above independent market levels. The underwriters are not required to engage in these activities, and may end any of
these activities at any time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any underwriters to whom the offered securities are sold for offering
and sale may make a market in the offered securities, but the underwriters will not be obligated to do so and may discontinue any market-making
at any time without notice. The offered securities may or may not be listed on a securities exchange. We cannot assure you that there
will be a liquid trading market for the offered securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under agreements entered into with us, underwriters and agents may
be entitled to indemnification by us against certain civil liabilities, including liabilities under the 1933 Act, or to contribution by
us for payments the underwriters or agents may be required to make.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The underwriters, agents, and their affiliates may engage in financial
or other business transactions with us and our subsidiaries in the ordinary course of business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The maximum commission or discount to be received by any member of
the Financial Industry Regulatory Authority or independent broker-dealer will not be greater than eight percent of the initial gross proceeds
from the sale of any security being sold.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 90 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The aggregate offering price specified on the cover of this prospectus
relates to the offering of the securities not yet issued as of the date of this prospectus.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent permitted under the 1940 Act and the rules&#160;and regulations
promulgated thereunder, the underwriters may from time to time act as a broker or dealer and receive fees in connection with the execution
of our portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act
as a broker while it is an underwriter.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus and any accompanying prospectus supplement in electronic
form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of securities for
sale to their online brokerage account holders. Such allocations of securities for internet distributions will be made on the same basis
as other allocations. In addition, securities may be sold by the underwriters to securities dealers who resell securities to online brokerage
account holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CUSTODIAN, TRANSFER AGENT, DIVIDEND DISBURSING
AGENT AND REGISTRAR</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund's securities and cash are held under a custodian agreement
with State Street Bank and Trust Company, One Lincoln Street, Boston, Massachusetts 02111. The transfer agent, dividend disbursing agent
and registrar for the Fund's common shares is Computershare Investor Services, P.O.&#160;Box 505000, Louisville, KY 40233-5000.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>LEGAL MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ropes&#160;&amp; Gray LLP ("Ropes&#160;&amp; Gray") is counsel
to the Fund. Morris, Nichols, Arsht&#160;&amp; Tunnell LLP (&#8220;Morris Nichols&#8221;) on certain matters of Delaware law relating
to the legality of the securities to be offered hereby. If certain legal matters in connection with an offering of securities are passed
upon by counsel for the underwriters of such offering, such matters will be passed upon by counsel to be identified in a prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial highlights included in this prospectus and the financial
statements and financial highlights, including the notes thereto, provided in the statement of additional information, which is incorporated
by reference in its entirety into this prospectus, have been audited by Deloitte&#160;&amp; Touche LLP, an independent registered public
accounting firm, as stated in their report, which is also included in the statement of additional information and incorporated by reference
herein. Deloitte&#160;&amp; Touche LLP audits and reports on the Fund&#8217;s annual financial statements and performs audit, audit-related
and other services when approved by the Fund's audit committee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="ana_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INCORPORATION BY REFERENCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As noted above, this prospectus is part of a registration statement
filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221; the information filed with the SEC, which means that
the Fund can disclose important information to you by referring you to those documents. The information incorporated by reference is considered
to be part of this prospectus, and later information that the Fund files with the SEC will automatically update and supersede this information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The documents listed below, and any reports and other documents subsequently
filed with the SEC pursuant to Rule&#160;30(b)(2)&#160;under the 1940 Act and Sections 13(a), 13(c), 14 or 15(d)&#160;of the Exchange
Act, prior to the termination of the offering will be incorporated by reference into this Prospectus and deemed to be part of this Prospectus
from the date of the filing of such reports and documents, provided, however, that the information &#8220;furnished&#8221; under Item
2.02 or Item 7.01 of Form&#160;8-K, or other information &#8220;furnished&#8221; to the SEC which is not deemed filed is not deemed incorporated
by reference into this filing, unless the Registrant specifically states that the information is to be considered &#8220;filed&#8221;
under the Exchange Act or incorporates it by reference into a filing under the Securities Act or the Exchange Act.:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#9679;</span> the Fund&#8217;s Statement of Additional
Information, dated February&#160;21, 2025, filed with this Prospectus;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#9679;</span> <span style="color: #0000EE"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924132100/tm2424550d2_ncsr.htm" style="-sec-extract: exhibit">the Fund&#8217;s Annual Report on Form&#160;N-CSR, filed on December&#160;27, 2024;</a></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 91 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#9679;</span> <span style="color: #0000EE"><a href="https://www.sec.gov/Archives/edgar/data/1171471/000119312512287018/d369908d8a12b.htm" style="-sec-extract: exhibit">the Fund&#8217;s description of Common Shares on Form&#160;8-A, filed on June&#160;28, 2012;</a></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#9679;</span> <a href="https://www.sec.gov/Archives/edgar/data/1171471/000110465921109808/tm2122382d2_8k.htm" style="-sec-extract: exhibit">the Fund&#8217;s Form&#160;8-K, filed on August&#160;26, 2021; and</a></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#9679;</span> <span style="color: #0000EE"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924060902/tm2413798d2_8k.htm" style="-sec-extract: exhibit">the Fund&#8217;s Form&#160;8-K, filed on May&#160;14, 2024.</a></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You may obtain copies of any information incorporated by reference
into this prospectus, at no charge, by calling toll-free 800.582.6959 or by writing to the Fund at 2020 Calamos Court, Naperville,&#160;IL
50463. The Fund&#8217;s periodic reports filed pursuant to Section&#160;30(b)(2)&#160;of the 1940 Act and Sections 13 and 15(d)&#160;of
the Exchange Act, as well as this Prospectus and the Statement of Additional Information, are available on the Fund&#8217;s website http://www.calamos.com.
In addition, the SEC maintains a website at www.sec.gov, free of charge, that contains these reports, the Fund&#8217;s proxy and information
statements, and other information relating to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus does not contain all of the information in our registration
statement, including amendments, exhibits, and schedules. Statements in this prospectus about the contents of any contract or other document
are not necessarily complete and in each instance reference is made to the copy of the contract or other document filed as an exhibit
to the registration statement, each such statement being qualified in all respects by this reference.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 92; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></span></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>




</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm256178d2_sai.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm256178-3/tm256178-3_424b5seq1" --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CALAMOS CONVERTIBLE OPPORTUNITIES AND INCOME
FUND STATEMENT OF ADDITIONAL INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos Convertible Opportunities and Income
Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. This Statement of Additional Information relates
to the offering, on an immediate, continuous or delayed basis, of up to $100,000,000 aggregate initial offering price of common shares,
preferred shares or debt securities in one or more offerings. This Statement of Additional Information does not constitute a prospectus,
but should be read in conjunction with the prospectus relating thereto dated the date hereof and any related prospectus supplement. This
Statement of Additional Information does not include all information that a prospective investor should consider before purchasing any
of the Fund&#8217;s securities, and investors should obtain and read the prospectus and any related prospectus supplement prior to purchasing
such securities. A copy of the prospectus and any related prospectus supplement may be obtained without charge by calling 800-582-6959.
You may also obtain a copy of the prospectus and any related prospectus supplement on the Securities and Exchange Commission&#8217;s
website (http://www.sec.gov). Capitalized terms used but not defined in this Statement of Additional Information have the same meanings
ascribed to them in the prospectus and any related prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS FOR STATEMENT OF ADDITIONAL
INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt"><a href="#a_001-0">Use of Proceeds</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_001-0">S-2</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_002-0">Investment Objective and Policies</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_002-0">S-2</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_003-0">Investment Restrictions</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_003-0">S-24</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_004-0">Management of the Fund</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_004-0">S-26</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_005-0">Certain Shareholders</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_005-0">S-45</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_006-0">Portfolio Transactions</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_006-0">S-47</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_007-0">Net Asset Value</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_007-0">S-48</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_008">Repurchase of Common Shares</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_008">S-50</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_009">Certain Federal Income Tax Matters</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_009">S-51</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_010">Custodian, Transfer Agent, Dividend Disbursing Agent and
    Registrar</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_010">S-64</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_011">Independent Registered Public Accounting Firm</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_011">S-64</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt"><a href="#a_012">Additional Information</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_012">S-64</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_013">Additional Information Concerning the Agreement and Declaration
    of Trust</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_013">S-64</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_014">Financial Statements</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_014">S-65</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_015">Incorporation by Reference</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_015">S-65</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_016">Appendix A &#8211; Summary of Certain Provisions of the Indenture
    and Form&#160;of Supplemental Indenture</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_016">A-1</a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding: 0.25pt 0.5pt; text-align: justify"><a href="#a_017">Appendix B &#8211; Description of Ratings</a></td>
    <td style="padding: 0.25pt 0.5pt; text-align: right"><a href="#a_017">B-1</a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This Statement of Additional Information is dated
February&#160;21, 2025.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_001-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>USE OF PROCEEDS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise specified in a prospectus supplement,
we currently intend to use the net proceeds from the sale of our securities primarily to invest in accordance with our investment objective
and policies within approximately three months of receipt of such proceeds. We may also use proceeds from the sale of our securities
(i)&#160;to retire all or a portion of any short-term debt we incur in pursuit of our investment objective and policies, (ii)&#160;to
redeem any outstanding senior securities, and (iii)&#160;for working capital purposes, including the payment of interest and operating
expenses, although there is currently no intent to issue securities primarily for these purposes. Pending such investments, the net proceeds
may be invested in U.S. government securities and high grade, short-term money market instruments. If necessary, the Fund may also purchase,
as temporary investments, securities of other open- or closed-end investment companies that invest primarily in the types of securities
in which the Fund may invest directly.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_002-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INVESTMENT OBJECTIVE AND
POLICIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The prospectus presents the investment objective
and the principal investment strategies and risks of the Fund. This section supplements the disclosure in the Fund&#8217;s prospectus
and provides additional information on the Fund&#8217;s investment policies or restrictions. Restrictions or policies stated as a maximum
percentage of the Fund&#8217;s assets are only applied immediately after a portfolio investment to which the policy or restriction is
applicable (other than the limitations on borrowing). Accordingly, any later increase or decrease resulting from a change in values,
managed assets or other circumstances will not be considered in determining whether the investment complies with the Fund&#8217;s restrictions
and policies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Primary Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under normal circumstances, the Fund invests
at least 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities. The Fund
will provide written notice to shareholders at least 60 days prior to any change to the requirement that it invest at least 80% of its
managed assets as described in the sentence above. The portion of the Fund&#8217;s assets invested in convertible securities and non-convertible
income securities will vary from time to time consistent with the Fund&#8217;s investment objective, changes in equity prices and changes
in interest rates and other economic and market factors, although, under normal circumstances, the Fund will invest at least 35% of its
managed assets in convertible securities. &#8220;Managed assets&#8221; means the total assets of the Fund (including any assets attributable
to any leverage that may be outstanding) minus the sum of accrued liabilities (other than debt representing financial leverage). For
this purpose, the liquidation preference on the preferred shares will not constitute a liability.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Convertible securities include any corporate
debt security or preferred stock that may be converted into underlying shares of common stock. The common stock underlying convertible
securities may be issued by a different entity than the issuer of the convertible securities. Convertible securities entitle the holder
to receive interest payments paid on corporate debt securities or the dividend preference on a preferred stock until such time as the
convertible security matures or is redeemed or until the holder elects to exercise the conversion privilege. As a result of the conversion
feature, however, the interest rate or dividend preference on a convertible security is generally less than would be the case if the
security were a non-convertible obligation. The value of convertible securities is influenced by both the yield of non-convertible securities
of comparable issuers and by the value of the underlying common stock. A convertible security&#8217;s value viewed without regard to
its conversion feature (i.e., strictly on the basis of its yield) is sometimes referred to as its &#8220;investment value.&#8221; A convertible
security&#8217;s investment value typically will fluctuate inversely with changes in prevailing interest rates. However, at the same
time, the convertible security will be influenced by its &#8220;conversion value,&#8221; which is the market value of the underlying
common stock that would be obtained if the convertible security were converted. Conversion value fluctuates directly with the price of
the underlying common stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If, because of a low price of the common stock,
a convertible security&#8217;s conversion value is substantially below its investment value, the convertible security&#8217;s price is
governed principally by its investment value. If a convertible security&#8217;s conversion value increases to a point that approximates
or exceeds its investment value, the convertible security&#8217;s value will be principally influenced by its conversion value. A convertible
security will sell at a premium over its conversion value to the extent investors place value on the right to acquire the underlying
common stock while holding a fixed income security. Holders of convertible securities have a claim on the issuer&#8217;s assets prior
to the common stockholders, but may be subordinated to holders of similar non-convertible securities of the same issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Synthetic Convertible Instruments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos Advisors LLC (&#8220;Calamos&#8221;)
may create a &#8220;synthetic&#8221; convertible instrument by combining fixed income securities with the right to acquire equity securities.
More flexibility is possible in the assembly of a synthetic convertible instrument than in the purchase of a convertible security. Although
synthetic convertible instruments may be selected where the two components are issued by a single issuer, thus making the synthetic convertible
instrument similar to the true convertible security, the character of a synthetic convertible instrument allows the combination of components
representing distinct issuers, when Calamos believes that such a combination would better promote the Fund&#8217;s investment objective.
A synthetic convertible instrument also is a more flexible investment in that its two components may be purchased separately. For example,
the Fund may purchase a warrant for inclusion in a synthetic convertible instrument but temporarily hold short-term investments while
postponing the purchase of a corresponding bond pending development of more favorable market conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of a synthetic convertible instrument
faces the risk of a decline in the price of the security or the level of the index involved in the convertible component, causing a decline
in the value of the call option or warrant purchased to create the synthetic convertible instrument. Should the price of the stock fall
below the exercise price and remain there throughout the exercise period, the entire amount paid for the call option or warrant would
be lost. Because a synthetic convertible instrument includes the fixed-income component as well, the holder of a synthetic convertible
instrument also faces the risk that interest rates will rise, causing a decline in the value of the fixed-income instrument.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may also purchase synthetic convertible
instruments manufactured by other parties, including convertible structured notes. Convertible structured notes are fixed income debentures
linked to equity, and are typically issued by investment banks. Convertible structured notes have the attributes of a convertible security;
however, the investment bank that issued the convertible note assumes the credit risk associated with the investment, rather than the
issuer of the underlying common stock into which the note is convertible.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s holdings of synthetic convertible
instruments are considered convertible securities for purposes of the Fund&#8217;s policy to invest at least 35% of its managed assets
in convertible securities and 80% of its managed assets in a diversified portfolio of convertible and non-convertible income securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Zero Coupon and Payment-in-Kind Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Investments in zero coupon and payment-in-kind
securities are subject to certain risks, including that market prices of zero coupon and payment-in-kind securities generally are more
volatile than the prices of securities that pay interest periodically and in cash, and are likely to respond to changes in interest rates
to a greater degree than other types of debt securities with similar maturities and credit quality. Because zero coupon securities bear
no interest, their prices are especially volatile. And because zero coupon bondholders do not receive interest payments, the prices of
zero coupon securities generally fall more dramatically than those of bonds that pay interest on a current basis when interest rates
rise. However, when interest rates fall, the prices of zero coupon securities generally rise more rapidly in value than those of similar
interest paying bonds. Under many market and other conditions, the market for the zero coupon and payment-in-kind securities may suffer
decreased liquidity making it difficult for the Fund to dispose of them or to determine their current value. In addition, as these securities
may not pay cash interest, the Fund&#8217;s investment exposure to these securities and their risks, including credit risk, will increase
during the time these securities are held in the Fund&#8217;s portfolio. Further, to maintain its qualification for treatment as a regulated
investment company and to avoid Fund-level U.S. federal income and/or excise taxes, the Fund is required to distribute to its shareholders
any income it is deemed to have received in respect of such investments, notwithstanding that cash has not been received currently, and
the value of paid-in-kind interest. Consequently, the Fund may have to dispose of portfolio securities under disadvantageous circumstances
to generate the cash, or may have to leverage itself by borrowing the cash to satisfy this distribution requirement. The required distributions,
if any, would result in an increase in the Fund&#8217;s exposure to these securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 3; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>High Yield Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A substantial portion of the Fund&#8217;s assets
may be invested in below investment grade (high yield) securities. The high yield securities in which the Fund invests are rated &#8220;Ba&#8221;
or lower by Moody&#8217;s Investors Service,&#160;Inc. (&#8220;Moody&#8217;s&#8221;) or &#8220;BB&#8221; or lower by Standard&#160;&amp;
Poor&#8217;s Corporation, a division of The McGraw-Hill Companies (&#8220;S&amp;P&#8221; or &#8220;Standard&#160;&amp; Poor&#8217;s&#8221;)
or are unrated but determined by Calamos to be of comparable quality. Non- convertible debt securities rated below investment grade are
commonly referred to as &#8220;junk bonds&#8221; and are considered speculative with respect to the issuer&#8217;s capacity to pay interest
and repay principal.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Below investment grade non-convertible debt securities
or comparable unrated securities are susceptible to greater risk of default or decline in market value due to adverse economic and business
developments than higher-rated debt securities. The market values for high yield securities tend to be very volatile, and these securities
are less liquid than investment grade debt securities. For these reasons, your investment in the Fund is subject to the following specific
risks:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%"><span>&#9679;</span></td>
    <td style="width: 98%">increased price sensitivity to changing interest rates and to a deteriorating economic environment;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span>&#9679;</span></td>
    <td>greater risk of loss due to default or declining credit quality;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span>&#9679;</span></td>
    <td style="padding-right: 62.3pt">adverse company specific events are more likely to render the issuer unable to make interest and/or
    principal payments; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 62.3pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span>&#9679;</span></td>
    <td style="padding-right: 75.3pt">if a negative perception of the high yield market develops, the price and liquidity of high yield
    securities may be depressed. This negative perception could last for a significant period of time.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Securities rated below investment grade are speculative
with respect to the capacity to pay interest and repay principal in accordance with the terms of such securities. A rating of &#8220;Ba1&#8221;
from Moody&#8217;s means that the issue so rated can have speculative elements and is subject to substantial credit risk. Standard&#160;&amp;
Poor&#8217;s assigns a rating of &#8220;BB+&#8221; to issues that are less vulnerable to nonpayment than other speculative issues, but
nonetheless subject to major ongoing uncertainties or exposure to adverse business, financial, or economic conditions which could lead
to the obligor&#8217;s inadequate capacity to meet its financial commitment on the obligation. A rating of &#8220;C&#8221; from Moody&#8217;s
means that the issue so rated can be regarded as having extremely poor prospects of ever attaining any real investment standing. Standard&#160;&amp;
Poor&#8217;s assigns a rating of &#8220;C&#8221; to issues that are currently highly vulnerable to nonpayment, and the &#8220;C&#8221;
rating may be used to cover a situation where a bankruptcy petition has been filed or similar action taken, but payments on the obligation
are being continued (a &#8220;C&#8221; rating is also assigned to a preferred stock issue in arrears on dividends or sinking fund payments,
but that is currently paying). See Appendix B to this Statement of Additional Information for a description of Moody&#8217;s and Standard&#160;&amp;
Poor&#8217;s ratings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Adverse changes in economic conditions are more
likely to lead to a weakened capacity of a high yield issuer to make principal payments and interest payments than an investment grade
issuer. The principal amount of high yield securities outstanding has proliferated in the past decade as an increasing number of issuers
have used high yield securities for corporate financing. An economic downturn could severely affect the ability of highly leveraged issuers
to service their debt obligations or to repay their obligations upon maturity. Similarly, down-turns in profitability in specific industries
could adversely affect the ability of high yield issuers in that industry to meet their obligations. The market values of lower quality
debt securities tend to reflect individual developments of the issuer to a greater extent than do higher quality securities, which react
primarily to fluctuations in the general level of interest rates. Factors having an adverse impact on the market value of lower quality
securities may have an adverse effect on the Fund&#8217;s net asset value and the market value of its common shares. In addition, the
Fund may incur additional expenses to the extent it is required to seek recovery upon a default in payment of principal or interest on
its portfolio holdings. In certain circumstances, the Fund may be required to foreclose on an issuer&#8217;s assets and take possession
of its property or operations. In such circumstances, the Fund would incur additional costs in disposing of such assets and potential
liabilities from operating any business acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The secondary market for high yield securities
may not be as liquid as the secondary market for more highly rated securities, a factor which may have an adverse effect on the Fund&#8217;s
ability to dispose of a particular security when necessary to meet its liquidity needs. There are fewer dealers in the market for high
yield securities than investment grade obligations. The prices quoted by different dealers may vary significantly and the spread between
the bid and asked price is generally much larger than higher quality instruments. Under adverse market or economic conditions, the secondary
market for high yield securities could contract further, independent of any specific adverse changes in the condition of a particular
issuer, and these instruments may become illiquid. As a result, the Fund could find it more difficult to sell these securities or may
be able to sell the securities only at prices lower than if such securities were widely traded. Prices realized upon the sale of such
lower rated or unrated securities, under these circumstances, may be less than the prices used in calculating the Fund&#8217;s net asset
value.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Because investors generally perceive that there
are greater risks associated with lower quality debt securities of the type in which the Fund may invest a portion of its assets, the
yields and prices of such securities may tend to fluctuate more than those for higher rated securities. In the lower quality segments
of the debt securities market, changes in perceptions of issuers&#8217; creditworthiness tend to occur more frequently and in a more
pronounced manner than do changes in higher quality segments of the debt securities market, resulting in greater yield and price volatility.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund invests in high yield securities
that are rated C or below, the Fund will incur significant risk in addition to the risks associated with investments in high yield securities
and corporate loans. Distressed securities frequently do not produce income while they are outstanding. The Fund may purchase distressed
securities that are in default or the issuers of which are in bankruptcy. The Fund may be required to bear certain extraordinary expenses
in order to protect and recover its investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Distressed Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may, but currently does not intend to,
invest up to 5% of its managed assets in distressed securities, including corporate loans, which are the subject of bankruptcy proceedings
or otherwise in default as to the repayment of principal and/or payment of interest at the time of acquisition by the Fund or are rated
in the lower rating categories (&#8220;Ca&#8221; or lower by Moody&#8217;s or &#8220;CC&#8221; or lower by Standard&#160;&amp; Poor&#8217;s)
or which are unrated investments considered by Calamos to be of comparable quality. Investment in distressed securities is speculative
and involves significant risk of loss. Distressed securities frequently do not produce income while they are outstanding and may require
the Fund to bear certain extraordinary expenses in order to protect and recover its investment. Therefore, to the extent the Fund seeks
capital appreciation through investment in distressed securities, the Fund&#8217;s ability to achieve current income for its shareholders
may be diminished. The Fund also will be subject to significant uncertainty as to when and in what manner and for what value the obligations
evidenced by the distressed securities will eventually be satisfied (e.g., through a liquidation of the obligor&#8217;s assets, an exchange
offer or plan of reorganization involving the distressed securities or a payment of some amount in satisfaction of the obligation). In
addition, even if an exchange offer is made or a plan of reorganization is adopted with respect to distressed securities held by the
Fund, there can be no assurance that the securities or other assets received by the Fund in connection with such exchange offer or plan
of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made. Moreover,
any securities received by the Fund upon completion of an exchange offer or plan of reorganization may be restricted as to resale. As
a result of the Fund&#8217;s participation in negotiations with respect to any exchange offer or plan of reorganization with respect
to an issuer of distressed securities, the Fund may be restricted from disposing of such securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Loans</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in loan participations and
other direct claims against a borrower. The corporate loans in which the Fund may invest primarily consist of direct obligations of a
borrower and may include debtor in possession financings pursuant to Chapter 11 of the U.S. Bankruptcy Code, obligations of a borrower
issued in connection with a restructuring pursuant to Chapter 11 of the U.S. Bankruptcy Code, leveraged buy-out loans, leveraged recapitalization
loans, receivables purchase facilities, and privately placed notes. The Fund may invest in a corporate loan at origination as a co-lender
or by acquiring in the secondary market participations in, assignments of or novations of a corporate loan. By purchasing a participation,
the Fund acquires some or all of the interest of a bank or other lending institution in a loan to a corporate or government borrower.
The participations typically will result in the Fund having a contractual relationship only with the lender not the borrower. The Fund
will have the right to receive payments of principal, interest and any fees to which it is entitled only from the lender selling the
participation and only upon receipt by the lender of the payments from the borrower. Many such loans are secured, although some may be
unsecured. Such loans may be in default at the time of purchase. Loans that are fully secured offer the Fund more protection than an
unsecured loan in the event of non-payment of scheduled interest or principal. However, there is no assurance that the liquidation of
collateral from a secured loan would satisfy the corporate borrower&#8217;s obligation, or that the collateral can be liquidated. Direct
debt instruments may involve a risk of loss in case of default or insolvency of the borrower and may offer less legal protection to the
Fund in the event of fraud or misrepresentation. In addition, loan participations involve a risk of insolvency of the lending bank or
other financial intermediary. The markets in such loans are not regulated by federal securities laws or the Securities and Exchange Commission
(&#8220;SEC&#8221; or the &#8220;Commission&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 5; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As in the case of other high yield investments,
such corporate loans may be rated in the lower rating categories of the established rating services (&#8220;Ba&#8221; or lower by Moody&#8217;s
or &#8220;BB&#8221; or lower by Standard&#160;&amp; Poor&#8217;s), or may be unrated investments considered by Calamos to be of comparable
quality. As in the case of other high yield investments, such corporate loans can be expected to provide higher yields than lower yielding,
higher rated fixed income securities, but may be subject to greater risk of loss of principal and income. There are, however, some significant
differences between corporate loans and high yield bonds. Corporate loan obligations are frequently secured by pledges of liens and security
interests in the assets of the borrower, and the holders of corporate loans are frequently the beneficiaries of debt service subordination
provisions imposed on the borrower&#8217;s bondholders. These arrangements are designed to give corporate loan investors preferential
treatment over high yield investors in the event of a deterioration in the credit quality of the issuer. Even when these arrangements
exist, however, there can be no assurance that the borrowers of the corporate loans will repay principal and/or pay interest in full.
Corporate loans generally bear interest at rates set at a margin above a generally recognized base lending rate that may fluctuate on
a day-to-day basis, in the case of the prime rate of a U.S. bank, or which may be adjusted on set dates, typically 30 days but generally
not more than one year, in the case of the London Interbank Offered Rate. Consequently, the value of corporate loans held by the Fund
may be expected to fluctuate significantly less than the value of other fixed rate high yield instruments as a result of changes in the
interest rate environment. On the other hand, the secondary dealer market for certain corporate loans may not be as well developed as
the secondary dealer market for high yield bonds, and therefore presents increased market risk relating to liquidity and pricing concerns.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Foreign Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest up to 25% of its net assets
in securities of foreign issuers. A foreign security is a security issued by a foreign government or a company whose country of incorporation
is a foreign country. For this purpose, foreign securities do not include American Depositary Receipts (&#8220;ADRs&#8221;) or securities
guaranteed by a U.S. person but which represent underlying shares of foreign issuers, but may include foreign securities in the form
of European Depositary Receipts (&#8220;EDRs&#8221;), Global Depositary Receipts (&#8220;GDRs&#8221;) or other securities representing
underlying shares of foreign issuers. Positions in those securities are not necessarily denominated in the same currency as the common
stocks into which they may be converted. ADRs are receipts typically issued by an American bank or trust company evidencing ownership
of the underlying securities. EDRs are European receipts listed on the Luxembourg Stock Exchange evidencing a similar arrangement. GDRs
are U.S. dollar- denominated receipts issued by international banks evidencing ownership of foreign securities. Generally, ADRs, in registered
form, are designed for the U.S. securities markets and EDRs and GDRs, in bearer form, are designed for use in foreign securities markets.
The Fund may invest in sponsored or unsponsored ADRs. In the case of an unsponsored ADR, the Fund is likely to bear its proportionate
share of the expenses of the depository and it may have greater difficulty in receiving shareholder communications than it would have
with a sponsored ADR.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To the extent positions in portfolio securities
are denominated in foreign currencies, the Fund&#8217;s investment performance is affected by the strength or weakness of the U.S. dollar
against those currencies. For example, if the dollar falls in value relative to the Japanese yen, the dollar value of a Japanese stock
held in the portfolio will rise even though the price of the stock remains unchanged. Conversely, if the dollar rises in value relative
to the yen, the dollar value of the Japanese stock will fall. (See discussion of transaction hedging and portfolio hedging below under
&#8220;Currency Exchange Transactions.&#8221;)</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 6; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Investors should understand and consider carefully
the risks involved in foreign investing. Investing in foreign securities, which are generally denominated in foreign currencies, and
utilization of forward foreign currency exchange contracts involve certain considerations comprising both risks and opportunities not
typically associated with investing in U.S. securities. These considerations include: fluctuations in exchange rates of foreign currencies;
possible imposition of exchange control regulation or currency restrictions that would prevent cash from being brought back to the United
States less public information with respect to issuers of securities; less governmental supervision of stock exchanges, securities brokers,
and issuers of securities; lack of uniform accounting, auditing and financial reporting standards; lack of uniform settlement periods
and trading practices; less liquidity and frequently greater price volatility in foreign markets than in the United States; greater costs
of buying, holding and selling securities, including brokerage, tax and custodial costs; and sometimes less advantageous legal, operational
and financial protections applicable to foreign sub-custodial arrangements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although the Fund intends primarily to invest
in companies and government securities of countries having stable political environments, there is the possibility of expropriation or
confiscatory taxation, seizure or nationalization of foreign bank deposits or other assets, establishment of exchange controls, the adoption
of foreign government restrictions, or other adverse political, social or diplomatic developments that could affect investment in these
nations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in the securities of issuers
located in emerging market countries. The securities markets of emerging countries are substantially smaller, less developed, less liquid
and more volatile than the securities markets of the U.S. and other more developed countries. Disclosure and regulatory standards in
many respects are less stringent than in the U.S. and other major markets. There also may be a lower level of monitoring and regulation
of emerging markets and the activities of investors in such markets, and enforcement of existing regulations has been extremely limited.
Economies in individual emerging markets may differ favorably or unfavorably from the U.S. economy in such respects as growth of gross
domestic product, rates of inflation, currency depreciation, capital reinvestment, resource self-sufficiency and balance of payments
positions. Many emerging market countries have experienced high rates of inflation for many years, which has had and may continue to
have very negative effects on the economies and securities markets of those countries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Currency Exchange Transactions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currency exchange transactions may be conducted
either on a spot (i.e., cash) basis at the spot rate for purchasing or selling currency prevailing in the foreign exchange market or
through forward currency exchange contracts (&#8220;forward contracts&#8221;). Forward contracts are contractual agreements to purchase
or sell a specified currency at a specified future date (or within a specified time period) and price set at the time of the contract.
Forward contracts are usually entered into with banks, foreign exchange dealers and broker-dealers, are not exchange traded, and are
usually for less than one year, but may be renewed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Forward currency exchange transactions may involve
currencies of the different countries in which the Fund may invest and serve as hedges against possible variations in the exchange rate
between these currencies and the U.S. dollar. Currency exchange transactions are limited to transaction hedging and portfolio hedging
involving either specific transactions or portfolio positions, except to the extent described below under &#8220;Synthetic Foreign Money
Market Positions.&#8221; Transaction hedging is the purchase or sale of forward contracts with respect to specific receivables or payables
of the Fund accruing in connection with the purchase and sale of its portfolio securities or the receipt of dividends or interest thereon.
Portfolio hedging is the use of forward contracts with respect to portfolio security positions denominated or quoted in a particular
foreign currency. Portfolio hedging allows the Fund to limit or reduce its exposure in a foreign currency by entering into a forward
contract to sell such foreign currency (or another foreign currency that acts as a proxy for that currency) at a future date for a price
payable in U.S. dollars so that the value of the foreign denominated portfolio securities can be approximately matched by a foreign denominated
liability. The Fund may not engage in portfolio hedging with respect to the currency of a particular country to an extent greater than
the aggregate market value (at the time of making such sale) of the securities held in its portfolio denominated or quoted in that particular
currency, except that the Fund may hedge all or part of its foreign currency exposure through the use of a basket of currencies or a
proxy currency where such currencies or currency act as an effective proxy for other currencies. In such a case, the Fund may enter into
a forward contract where the amount of the foreign currency to be sold exceeds the value of the securities denominated in such currency.
The use of this basket hedging technique may be more efficient and economical than entering into separate forward contracts for each
currency held in the Fund. The Fund may not engage in &#8220;speculative&#8221; currency exchange transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 7; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund enters into a forward contract, its
custodian will segregate liquid assets of the Fund having a value equal to the Fund&#8217;s commitment under such forward contract from
day to day, except to the extent that the Fund&#8217;s forward contract obligation is covered by liquid portfolio securities denominated
in, or whose value is tied to, the currency underlying the forward contract. At the maturity of the forward contract to deliver a particular
currency, the Fund may either sell the portfolio security related to the contract and make delivery of the currency, or it may retain
the security and either acquire the currency on the spot market or terminate its contractual obligation to deliver the currency by purchasing
an offsetting contract with the same currency trader obligating it to purchase on the same maturity date the same amount of the currency.
It is impossible to forecast with absolute precision the market value of portfolio securities at the expiration of a forward contract.
Accordingly, it may be necessary for the Fund to purchase additional currency on the spot market (and bear the expense of such purchase)
if the market value of the security is less than the amount of currency the Fund is obligated to deliver and if a decision is made to
sell the security and make delivery of the currency. Conversely, it may be necessary to sell on the spot market some of the currency
received upon the sale of the portfolio security if its market value exceeds the amount of currency the Fund is obligated to deliver.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund retains the portfolio security and
engages in an offsetting currency transaction, it will incur a gain or a loss to the extent that there has been movement in forward contract
prices. If the Fund engages in an offsetting currency transaction, it subsequently may enter into a new forward contract to sell the
currency. Should forward prices decline during the period between the Fund&#8217;s entering into a forward contract for the sale of a
currency and the date it enters into an offsetting contract for the purchase of the currency, the Fund will realize a gain to the extent
the price of the currency it has agreed to sell exceeds the price of the currency it has agreed to purchase. Should forward prices increase,
the Fund will suffer a loss to the extent the price of the currency it has agreed to purchase exceeds the price of the currency it has
agreed to sell. A default on the contract would deprive the Fund of unrealized profits or force the Fund to cover its commitments for
purchase or sale of currency, if any, at the current market price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Hedging against a decline in the value of a currency
does not eliminate fluctuations in the value of a portfolio security traded in that currency or prevent a loss if the value of the security
declines. Hedging transactions also preclude the opportunity for gain if the value of the hedged currency should rise. Moreover, it may
not be possible for the Fund to hedge against a devaluation that is so generally anticipated that the Fund is not able to contract to
sell the currency at a price above the devaluation level it anticipates. The cost to the Fund of engaging in currency exchange transactions
varies with such factors as the currency involved, the length of the contract period, and prevailing market conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Synthetic Foreign Money Market Positions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in money market instruments
denominated in foreign currencies. In addition to, or in lieu of, such direct investment, the Fund may construct a synthetic foreign
money market position by (a)&#160;purchasing a money market instrument denominated in one currency, generally U.S. dollars, and (b)&#160;concurrently
entering into a forward contract to deliver a corresponding amount of that currency in exchange for a different currency on a future
date and at a specified rate of exchange. For example, a synthetic money market position in Japanese yen could be constructed by purchasing
a U.S. dollar money market instrument, and entering concurrently into a forward contract to deliver a corresponding amount of U.S. dollars
in exchange for Japanese yen on a specified date and at a specified rate of exchange. Because of the availability of a variety of highly
liquid short-term U.S. dollar money market instruments, a synthetic money market position utilizing such U.S. dollar instruments may
offer greater liquidity than direct investment in foreign currency and a concurrent construction of a synthetic position in such foreign
currency, in terms of both income yield and gain or loss from changes in currency exchange rates, in general should be similar, but would
not be identical because the components of the alternative investments would not be identical. The Fund currently does not intend to
invest a significant amount of its assets in synthetic foreign money market positions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 8; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Debt Obligations of Non-U.S. Governments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An investment in debt obligations of non-U.S.
governments and their political subdivisions (sovereign debt) involves special risks that are not present in corporate debt obligations.
The non-U.S. issuer of the sovereign debt or the non-U.S. governmental authorities that control the repayment of the debt may be unable
or unwilling to repay principal or interest when due, and the Fund may have limited recourse in the event of a default. During periods
of economic uncertainty, the market prices of sovereign debt may be more volatile than prices of debt obligations of U.S. issuers. In
the past, certain non-U.S. countries have encountered difficulties in servicing their debt obligations, withheld payments of principal
and interest and declared moratoria on the payment of principal and interest on their sovereign debt.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A sovereign debtor&#8217;s willingness or ability
to repay principal and pay interest in a timely manner may be affected by, among other factors, its cash flow situation, the extent of
its foreign currency reserves, the availability of sufficient non-U.S. currency, the relative size of the debt service burden, the sovereign
debtor&#8217;s policy toward its principal international lenders and local political constraints. Sovereign debtors may also be dependent
on expected disbursements from non-U.S. governments, multilateral agencies and other entities to reduce principal and interest arrearages
on their debt. The failure of a sovereign debtor to implement economic reforms, achieve specified levels of economic performance or repay
principal or interest when due may result in the cancellation of third-party commitments to lend funds to the sovereign debtor, which
may further impair such debtor&#8217;s ability or willingness to service its debts.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Eurodollar Instruments and Samurai and Yankee Bonds</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in Eurodollar instruments
and Samurai and Yankee bonds. Eurodollar instruments are bonds of corporate and government issuers that pay interest and principal in
U.S. dollars but are issued in markets outside the United States, primarily in Europe. Samurai bonds are yen-denominated bonds sold in
Japan by non-Japanese issuers. Yankee bonds are U.S. dollar-denominated bonds typically issued in the U.S. by non-U.S. governments and
their agencies and non-U.S. banks and corporations. The Fund may also invest in Eurodollar Certificates of Deposit (&#8220;ECDs&#8221;),
Eurodollar Time Deposits (&#8220;ETDs&#8221;) and Yankee Certificates of Deposit (&#8220;Yankee CDs&#8221;). ECDs are U.S. dollar-denominated
certificates of deposit issued by non-U.S. branches of domestic banks; ETDs are U.S. dollar-denominated deposits in a non-U.S. branch
of a U.S. bank or in a non-U.S. bank; and Yankee CDs are U.S. dollar-denominated certificates of deposit issued by a U.S. branch of a
non-U.S. bank and held in the U.S. These investments involve risks that are different from investments in securities issued by U.S. issuers,
including potential unfavorable political and economic developments, non-U.S. withholding or other taxes, seizure of non-U.S. deposits,
currency controls, interest limitations or other governmental restrictions which might affect payment of principal or interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Lending of Portfolio Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has authorized State Street Bank and
Trust Company (&#8220;SSB&#8221;) as securities lending agent to lend portfolio securities to broker-dealers and banks. Any such loan
must be continuously secured by collateral received in cash under the terms of the Amended and Restated Liquidity Agreement (&#8220;SSB
Agreement&#8221;) between the Fund and SSB. Cash collateral received by SSB on behalf of the Fund is deposited into a custodial account
in the name of the Fund before being treated as refinancing a portion of the amounts borrowed under the SSB Agreement, such that the
Fund will effectively bear lower interest expense with respect to those borrowed amounts. Any amounts credited against the borrowings
under SSB Agreement would count against the Fund&#8217;s leverage limitations under the Investment Company Act of 1940, as amended (the
&#8220;1940 Act&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the terms of the SSB Agreement, the Fund
is required to return the value of the collateral to the borrower upon the return of the lent securities The Fund continues to be entitled
to receive the equivalent of the interest or dividends paid by the issuer on the securities loaned as well as the benefit of an increase
and the detriment of any decrease in the market value of the securities loaned, and would also receive an additional return that may
be in the form of a fixed fee or a percentage of income earned on the collateral. The Fund may experience losses as a result of a diminution
in value of its cash collateral investments. The Fund may pay reasonable fees to persons unaffiliated with the Fund for services in arranging
these loans. The Fund would have the right to call the loan and obtain the securities loaned at any time on notice of not less than five
business days. The Fund would not have the right to vote the securities during the existence of the loan; however, the Fund may attempt
to call back the loan and vote the proxy if time permits prior to the record date. In the event of bankruptcy or other default of the
borrower, the Fund could experience both delays in liquidating the loaned collateral (or recovering the loaned securities) or losses,
including (a)&#160;possible decline in the value of the collateral or in the value of the securities loaned during the period while the
Fund seeks to enforce its rights thereto, (b)&#160;possible subnormal levels of income and lack of access to income during this period
and (c)&#160;expenses of enforcing its rights. The Fund may also experience losses as a result of the diminution in value of its cash
collateral investments. In an effort to reduce these risks, the Fund&#8217;s securities lending agent will monitor, and report to Calamos
on, the creditworthiness of the firms to which the Fund lends securities. The securities lending arrangement with SSB involves characteristics
common in arm&#8217;s length relationships in which one party may benefit at the expense of the other party.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 9; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Options on Securities,&#160;Indices and Currencies</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may purchase and sell (write) put options
and call options on securities, indices or foreign currencies. The Fund may purchase agreements, sometimes called cash puts, that may
accompany the purchase of a new issue of bonds from a dealer. The successful use of options depends principally on the price movements
of the underlying securities, indices or other reference assets or rates. Investing in options can result in a greater potential for
profit or loss than directly investing in the underlying assets. The value of an option may change because of, including but not limited
to, a change in the value of the underlying assets, the passage of time, changes in the market&#8217;s perception as to the future price
behavior of the underlying assets or rates, or any combination of the foregoing.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A put option gives the purchaser of the option,
upon payment of a premium, the right to sell, and the writer the obligation to buy, the underlying security, commodity, index, currency
or other instrument at the exercise price. For instance, the Fund&#8217;s purchase of a put option on a security might be designed to
protect its holdings in the underlying instrument (or, in some cases, a similar instrument) against a substantial decline in the market
value by giving the Fund the right to sell such instrument at the option exercise price. A call option, upon payment of a premium, gives
the purchaser of the option the right to buy, and the seller the obligation to sell, the underlying instrument at the exercise price.
The Fund&#8217;s purchase of a call option on a security, financial future, index, currency or other instrument might be intended to
protect it against an increase in the price of the underlying instrument that it intends to purchase in the future by fixing the price
at which it may purchase such instrument.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain options, known as &#8220;American style&#8221;
options, may be exercised at any time during the term of the option. Other options, known as &#8220;European style&#8221; options, may
be exercised only on the expiration date of the option. The Fund expects that substantially all of the options written by the Fund will
be American style options.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may purchase and sell (write) exchange
listed options and over-the-counter options (&#8220;OTC options&#8221;). Exchange listed options are issued by a regulated intermediary
such as the Options Clearing Corporation (&#8220;OCC&#8221;), which guarantees the performance of the obligations of the parties to such
options. The discussion below uses the OCC as an example, but is also applicable to other financial intermediaries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">With certain exceptions, OCC issued and exchange
listed options generally settle by physical delivery of the underlying security or currency, although in the future cash settlement may
become available. Index options and Eurodollar instruments are cash settled for the net amount, if any, by which the option is &#8220;in-the-money&#8221;
(i.e., where the value of the underlying instrument exceeds, in the case of a call option, or is less than, in the case of a put option,
the exercise price of the option) at the time the option is exercised. Frequently, rather than taking or making delivery of the underlying
instrument through the process of exercising the option, listed options are closed by entering into offsetting purchase or sale transactions
that do not result in ownership of the new option.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">OTC options are purchased from or sold to securities
dealers, financial institutions or other parties (&#8220;Counterparties&#8221;) through direct bilateral agreement with the Counterparty.
In contrast to exchange listed options, which generally have standardized terms and performance mechanics, all the terms of an OTC option,
including such terms as method of settlement, term, exercise price, premium, guarantees and security, are set by negotiation of the parties.
The Fund may sell (write) OTC options (other than OTC currency options) that are subject to a buy-back provision permitting the Fund
to require the Counterparty to sell the option back to the Fund at a formula price within seven days. The Fund generally is expected
to enter into OTC options that have cash settlement provisions, although it is not required to do so. The staff of the SEC currently
takes the position that OTC options purchased by a fund, and portfolio securities &#8220;covering&#8221; the amount of a fund&#8217;s
obligation pursuant to an OTC option sold by it (or the amount of assets equal to the formula price for the repurchase of the option,
if any, less the amount by which the option is &#8220;in the money&#8221;) are illiquid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 10; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may also purchase and sell (write) options
on securities indices and other financial indices. Options on securities indices and other financial indices are similar to options on
a security or other instrument except that, rather than settling by physical delivery of the underlying instrument, they settle by cash
settlement, i.e., an option or an index gives the holder the right to receive, upon exercise of the option, an amount of cash if the
closing level of the index upon which the option is based exceeds, in the case of a call, or is less than, in the case of a put, the
exercise price of the option (except if, in the case of an OTC option, physical delivery is specified). This amount of cash is equal
to the excess of the closing price of the index over the exercise price of the option, which also may be multiplied by a formula value.
The seller of the option is obligated, in return for the premium received, to make delivery of this amount. The gain or loss on an option
on an index depends on price movements in the instruments making upon the market, market segment, industry or other composite on which
the underlying index is based, rather than primarily on the price movements in individual securities, as is the case with respect to
options on securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund will write call options and put options
only if they are &#8220;covered.&#8221; For example, a call option written by the Fund will require the Fund to hold the securities subject
to the call (or securities convertible into the needed securities without additional consideration) or to segregate cash or liquid assets
sufficient to purchase and deliver the securities if the call is exercised.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">OTC options entered into by the Fund and OCC
issued and exchange listed index options may provide for cash settlement. As a result, when the Fund sells these instruments it will
only segregate an amount of cash or liquid assets equal to its accrued net obligations, as there is no requirement for payment or delivery
of amounts in excess of the net amount. These amounts will equal 100% of the exercise price in the case of a non cash-settled put, the
same as an OCC guaranteed listed option sold by the Fund, or the in-the-money amount plus any sell-back formula amount in the case of
a cash-settled put or call. In addition, when the Fund sells a call option on an index at a time when the in-the-money amount exceeds
the exercise price, the Fund will segregate, until the option expires or is closed out, cash or cash equivalents equal in value to such
excess. OCC issued and exchange listed options sold by the Fund other than those above generally settle with physical delivery, or with
an election of either physical delivery or cash settlement and the Fund will segregate an amount of cash or liquid assets equal to the
full value of the option. OTC options settling with physical delivery, or with an election of either physical delivery or cash settlement,
will be treated the same as other options settling with physical delivery.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If an option written by the Fund expires, the
Fund realizes a capital gain equal to the premium received at the time the option was written. If an option purchased by the Fund expires,
the Fund realizes a capital loss equal to the premium paid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to the earlier of exercise or expiration,
an option may be closed out by an offsetting purchase or sale of an option of the same series (type, exchange, underlying security or
index, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected
when the Fund desires.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund will realize a capital gain from a closing
purchase transaction if the cost of the closing option is less than the premium received from writing the option, or, if it is more,
the Fund will realize a capital loss. If the premium received from a closing sale transaction is more than the premium paid to purchase
the option, the Fund will realize a capital gain or, if it is less, the Fund will realize a capital loss. The principal factors affecting
the market value of a put or a call option include supply and demand, interest rates, the current market price of the underlying security
or index in relation to the exercise price of the option, the volatility of the underlying security or index, and the time remaining
until the expiration date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 11; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A put or call option purchased by the Fund is
an asset of the Fund, valued initially at the premium paid for the option. The premium received for an option written by the Fund is
recorded as a deferred credit. The value of an option purchased or written is marked-to-market daily and is valued at the closing price
on the exchange on which it is traded or, if not traded on an exchange or no closing price is available, at the mean between the last
bid and asked prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Associated with Options</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are several risks associated with transactions
in options. For example, there are significant differences between the securities markets, the currency markets and the options markets
that could result in an imperfect correlation among these markets, causing a given transaction not to achieve its objectives. A decision
as to whether, when and how to use options involves the exercise of skill and judgment, and even a well-conceived transaction may be
unsuccessful because of market behavior or unexpected events. The Fund&#8217;s ability to utilize options successfully will depend on
Calamos&#8217; ability to predict pertinent market investments, which cannot be assured.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s ability to close out its position
as a purchaser or seller (writer) of an OCC or exchange listed put or call option is dependent, in part, upon the liquidity of the option
market. Among the possible reasons for the absence of a liquid option market on an exchange are: (i)&#160;insufficient trading interest
in certain options; (ii)&#160;restrictions on transactions imposed by an exchange; (iii)&#160;trading halts, suspensions or other restrictions
imposed with respect to particular classes or series of options or underlying securities including reaching daily price limits; (iv)&#160;interruption
of the normal operations of the OCC or an exchange; (v)&#160;inadequacy of the facilities of an exchange or OCC to handle current trading
volume; or (vi)&#160;a decision by one or more exchanges to discontinue the trading of options (or a particular class or series of options),
in which event the relevant market for that option on that exchange would cease to exist, although outstanding options on that exchange
would generally continue to be exercisable in accordance with their terms. If the Fund were unable to close out an option that it has
purchased on a security, it would have to exercise the option in order to realize any profit or the option would expire and become worthless.
If the Fund were unable to close out a covered call option that it had written on a security, it would not be able to sell the underlying
security until the option expired. As the writer of a covered call option on a security, the Fund foregoes, during the option&#8217;s
life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium
and the exercise price of the call. As the writer of a covered call option on a foreign currency, the Fund foregoes, during the option&#8217;s
life, the opportunity to profit from any currency appreciation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The hours of trading for listed options may not
coincide with the hours during which the underlying financial instruments are traded. To the extent that the option markets close before
the markets for the underlying financial instruments, significant price and rate movements can take place in the underlying markets that
cannot be reflected in the option markets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless the parties provide for it, there is no
central clearing or guaranty function in an OTC option. As a result, if the Counterparty (as described above under &#8220;Options on
Securities,&#160;Indices and Currencies&#8221;) fails to make or take delivery of the security, currency or other instrument underlying
an OTC option it has entered into with the Fund or fails to make a cash settlement payment due in accordance with the terms of that option,
the Fund will lose any premium it paid for the option as well as any anticipated benefit of the transaction unless the Fund has collected
sufficient collateral from the counterparty to cover its exposure. Accordingly, Calamos must assess the creditworthiness of each such
Counterparty or any guarantor or credit enhancement of the Counterparty&#8217;s credit to determine the likelihood that the terms of
the OTC option will be satisfied.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may purchase and sell (write) call options
on securities indices and currencies. All call options sold by the Fund must be &#8220;covered.&#8221; Even though the Fund will receive
the option premium to help protect it against loss, a call sold by the Fund exposes the Fund during the term of the option to possible
loss of opportunity to realize appreciation in the market price of the underlying security or instrument and may require the Fund to
hold a security or instrument which it might otherwise have sold. In addition, a loss on a call option sold may be greater than the premium
received. The Fund may purchase and sell (write) put options on securities indices and currencies. In selling (writing) put options,
there is a risk that the Fund may be required to buy the underlying index or currency at a disadvantageous price above the market price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 12; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Futures Contracts and Options on Futures Contracts</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may enter into interest rate futures
contracts, index futures contracts, volatility index futures contracts and foreign currency futures contracts. An interest rate, index,
volatility or foreign currency futures contract provides for the future sale by one party and purchase by another party of a specified
quantity of a financial instrument or the cash value of an index at a specified price and time. A public market exists in futures contracts
covering a number of indices (including, but not limited to the Standard&#160;&amp; Poor&#8217;s 500 Index, the Russell 2000 Index, the
Value Line Composite Index, and the New York Stock Exchange (&#8220;NYSE&#8221;) Composite Index) as well as financial instruments (including,
but not limited to U.S. Treasury bonds, U.S. Treasury notes, Eurodollar certificates of deposit and foreign currencies). Other index
and financial instrument futures contracts are available and it is expected that additional futures contracts will be developed and traded.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may purchase and write call and put
futures options. Futures options possess many of the same characteristics as options on securities, indices and foreign currencies (discussed
above). A futures option gives the holder the right, in return for the premium paid, to assume a long position (call) or short position
(put) in a futures contract at a specified exercise price at any time during the period of the option. Upon exercise of a call option,
the holder acquires a long position in the futures contract and the writer is assigned the opposite short position. In the case of a
put option, the opposite is true. The Fund might, for example, use futures contracts to hedge against or gain exposure to fluctuations
in the general level of stock prices, anticipated changes in interest rates or currency fluctuations that might adversely affect either
the value of the Fund&#8217;s securities or the price of the securities that the Fund intends to purchase. Although other techniques
could be used to reduce or increase the Fund&#8217;s exposure to stock price, interest rate and currency fluctuations, the Fund may be
able to achieve its desired exposure more effectively and perhaps at a lower cost by using futures contracts and futures options.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund will only enter into futures contracts
and futures options that are standardized and traded on an exchange, board of trade or similar entity, or quoted on an automated quotation
system.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The success of any futures transaction by the
Fund depends on Calamos correctly predicting changes in the level and direction of stock prices, interest rates, currency exchange rates
and other factors. Should those predictions be incorrect, the Fund&#8217;s return might have been better had the transaction not been
attempted; however, in the absence of the ability to use futures contracts, Calamos might have taken portfolio actions in anticipation
of the same market movements with similar investment results, but, presumably, at greater transaction costs. When the Fund makes a purchase
or sale of a futures contract, the Fund is required to deposit with its custodian (or futures commission merchant (&#8220;FCM&#8221;),
if legally permitted) a specified amount of cash or U.S. Government securities or other securities acceptable to the broker (&#8220;initial
margin&#8221;). The margin required for a futures contract is set by the exchange on which the contract is traded and may be modified
during the term of the contract, although the Fund&#8217;s broker may require margin deposits in excess of the minimum required by the
exchange. The initial margin is in the nature of a performance bond or good faith deposit on the futures contract, which is returned
to the Fund upon termination of the contract, assuming all contractual obligations have been satisfied. The Fund expects to earn interest
income on its initial margin deposits. A futures contract held by the Fund is valued daily at the official settlement price of the exchange
on which it is traded. Each day the Fund pays or receives cash, called &#8220;variation margin,&#8221; equal to the daily change in value
of the futures contract. This process is known as &#8220;marking-to-market.&#8221; Variation margin paid or received by the Fund does
not represent a borrowing or loan by the Fund but is instead settlement between the Fund and the broker of the amount one would owe the
other if the futures contract had expired at the close of the previous day. In computing daily net asset value, the Fund will mark-to-market
its open futures positions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund is also required to deposit and maintain
margin with respect to put and call options on futures contracts written by it. Such margin deposits will vary depending on the nature
of the underlying futures contract (and the related initial margin requirements), the current market value of the option and other futures
positions held by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although some futures contracts call for making
or taking delivery of the underlying securities, usually these obligations are closed out prior to delivery by offsetting purchases or
sales of matching futures contracts (same exchange, underlying security or index, and delivery month). If an offsetting purchase price
is less than the original sale price, the Fund engaging in the transaction realizes a capital gain, or if it is more, the Fund realizes
a capital loss. Conversely, if an offsetting sale price is more than the original purchase price, the Fund engaging in the transaction
realizes a capital gain, or if it is less, the Fund realizes a capital loss. The transaction costs must also be included in these calculations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 13; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Associated with Futures</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are several risks associated with the use
of futures contracts and futures options. A purchase or sale of a futures contract or option may result in losses in excess of the amount
invested in the futures contract or option. In trying to increase or reduce market exposure, there can be no guarantee that there will
be a correlation between price movements in the futures contract or option and in the portfolio exposure sought. In addition, there are
significant differences between the securities and futures markets that could result in an imperfect correlation between the markets,
causing a given transaction not to achieve its objectives. The degree of imperfection of correlation depends on circumstances such as:
variations in speculative market demand for futures, futures options and the related securities, including technical influences in futures
and futures options trading and differences between the securities markets and the securities underlying the standard contracts available
for trading. For example, in the case of index futures contracts, the composition of the index, including the issuers and the weighing
of each issue, may differ from the composition of the Fund&#8217;s portfolio, and, in the case of interest rate futures contracts, the
interest rate levels, maturities and creditworthiness of the issues underlying the futures contract may differ from the financial instruments
held in the Fund&#8217;s portfolio. Futures prices are highly volatile at times, and are influenced by many external economic, governmental
and world events. The low margin deposits normally required in futures trading permits an extremely high degree of leverage, which can
result in the Fund experiencing substantial gains or losses due to relatively small price movements or other factors. A decision as to
whether, when and how to use futures contracts involves the exercise of skill and judgment, and even a well-conceived transaction may
be unsuccessful to some degree because of market behavior or unexpected stock price or interest rate trends.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Futures exchanges may limit the amount of fluctuation
permitted in certain futures contract prices during a single trading day. The daily limit establishes the maximum amount that the price
of a futures contract may vary either up or down from the previous day&#8217;s settlement price at the end of the current trading session.
Once the daily limit has been reached in a futures contract subject to the limit, no more trades may be made on that day at a price beyond
that limit. The daily limit governs only price movements during a particular trading day and therefore does not limit potential losses
because the limit may work to prevent the liquidation of unfavorable positions. For example, futures prices have occasionally moved to
the daily limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of positions and
subjecting some holders of futures contracts to substantial losses. Stock index futures contracts are not normally subject to such daily
price change limitations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The markets for futures positions may be thinly
traded from time to time. In addition, futures positions may become illiquid due to daily price limits taking effect or due to market
disruptions. There can be no assurance that a liquid market will exist at a time when the Fund seeks to close out a futures or futures
option position. The Fund would be exposed to possible loss on the position during the interval of inability to close, and would continue
to be required to meet margin requirements until the position is closed. In addition, many of the contracts discussed above are relatively
new instruments without a significant trading history. As a result, there can be no assurance that an active market will develop or continue
to exist.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Limitations on Options and Futures</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If options, futures contracts or futures options
of types other than those described herein are traded in the future, the Fund may also use those investment vehicles, provided the Board
of Trustees determines that their use is consistent with the Fund&#8217;s investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">When purchasing a futures contract or writing
a put option on a futures contract, the Fund must maintain with its custodian (or FCM, if legally permitted) cash or cash equivalents
(including any margin) equal to the market value of such contract. When writing a call option on a futures contract, the Fund similarly
will maintain with its custodian (or FCM) cash or cash equivalents (including any margin) equal to the amount by which such option is
in-the-money until the option expires or is closed by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 14; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may not maintain open short positions
in futures contracts, call options written on futures contracts or call options written on indices if, in the aggregate, the market value
of all such open positions exceeds the current value of the securities in its portfolio, plus or minus unrealized gains and losses on
the open positions, adjusted for the historical relative volatility of the relationship between the portfolio and the positions. For
this purpose, to the extent the Fund has written call options on specific securities in its portfolio, the value of those securities
will be deducted from the current market value of the securities portfolio.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The use of options and futures contracts is subject
to applicable regulations of the SEC, the several exchanges upon which they are traded and the U.S. Commodity Futures Trading Commission
(the &#8220;CFTC&#8221;). For example, the CFTC, certain foreign regulators and many futures exchanges have established (and continue
to evaluate and monitor) speculative position limits (&#8220;position limits&#8221;) on the maximum net long or net short positions which
any person or entity may hold or control in particular futures and options on futures contracts. In addition, U.S. federal position limits
apply to swaps that are economically equivalent to futures contracts on certain agricultural, metals and energy commodities. Unless an
exemption applies, all positions owned or controlled by the same person or entity, even if in different accounts, must be aggregated
for purposes of determining whether the applicable position limits have been exceeded. Thus, even if the Fund does not intend to exceed
applicable position limits, it is possible that different clients managed by the Adviser and its affiliates may be aggregated for this
purpose. Therefore, the trading decisions of the Adviser may have to be modified and positions held by the Fund liquidated in order to
avoid exceeding such limits. The modification of investment decisions or the elimination of open positions, if it occurs, may adversely
affect the profitability of the Fund. A violation of position limits could also lead to regulatory action materially adverse to the Fund&#8217;s
investment strategy. The Fund may also be affected by other regimes, including those of the EU and UK, and trading venues that impose
position limits on commodity derivatives contracts. In addition, the Fund&#8217;s FCM may limit the Fund&#8217;s ability to invest in
certain futures contracts. Such restrictions may adversely affect the Fund&#8217;s performance and its ability to achieve its investment
objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to CFTC Rule&#160;4.5, Calamos, the
Fund&#8217;s investment adviser, is excluded from the definition of commodity pool operator (&#8220;CPO&#8221;) under the Commodity Exchange
Act (&#8220;CEA&#8221;) and is not subject to registration or regulation as such under the CEA. The terms of the exclusion require the
Fund, among other things, to adhere to certain limits on its investments in &#8220;commodity interests.&#8221; Pursuant to the exemption,
if the Fund uses commodity interests (such as futures contracts, options on futures contracts and most swaps), the aggregate initial
margin and premiums required to establish these positions (after taking into account unrealized profits and unrealized losses on any
such positions and excluding the amount by which options that are &#8220;in-the-money&#8221;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2
</sup></span>at the time of purchase) may not exceed 5% of the Fund&#8217;s NAV, or alternatively, the aggregate net notional value of
those positions, as determined at the time the most recent position was established, may not exceed 100% of the Fund&#8217;s NAV (after
taking into account unrealized profits and unrealized losses on any such positions). If, in the future, the Fund can no longer satisfy
these requirements, Calamos would withdraw its exclusion from the definition of CPO, and Calamos would be subject to registration and
regulation as a CPO with respect to the Fund, in accordance with CFTC rules&#160;that apply to CPOs of registered investment companies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, the Fund&#8217;s ability to use
options and futures contracts may be limited by tax considerations. See &#8220;Certain Federal Income Tax Matters&#8221; below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrants</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in warrants. A warrant is
a right to purchase common stock at a specific price (usually at a premium above the market value of the underlying common stock at time
of issuance) during a specified period of time. A warrant may have a life ranging from less than a year to twenty years or longer, but
a warrant becomes worthless unless it is exercised or sold before expiration. In addition, if the market price of the common stock does
not exceed the warrant&#8217;s exercise price during the life of the warrant, the warrant will expire worthless. Warrants have no voting
rights, pay no dividends and have no rights with respect to the assets of the corporation issuing them. The percentage increase or decrease
in the value of a warrant may be greater than the percentage increase or decrease in the value of the underlying common stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2
</sup></span>A call option is &#8220;in-the-money&#8221; to the extent, if any, that the value of the futures contract that is the subject
of the option exceeds the exercise price. A put option is &#8220;in-the-money&#8221; if the exercise price exceeds the value of the futures
contract that is the subject of the option.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 15; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Turnover</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although the Fund does not purchase securities
with a view to rapid turnover, there are no limitations on the length of time that a portfolio security must be held. Portfolio turnover
can occur for a number of reasons, including calls for redemption, general conditions in the securities markets, more favorable investment
opportunities in other securities, or other factors relating to the desirability of holding or changing a portfolio investment. The portfolio
turnover rates may vary greatly from year to year. A high rate of portfolio turnover in the Fund would result in increased transaction
expense, which must be borne by the Fund. High portfolio turnover may also result in the realization of capital gains or losses and,
to the extent net short-term capital gains are realized, any distributions resulting from such gains will be taxed at ordinary income
tax rates for U.S. federal income tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Short Sales</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A short sale may be effected when Calamos believes
that the price of a security will decline or underperform the market, and involves the sale of borrowed securities, in the hope of purchasing
the same securities at a later date at a lower price. There can be no assurance that the Fund will be able to close out a short position
(i.e., purchase the same securities) at any particular time or at an acceptable or advantageous price. To make delivery to the buyer,
the Fund must borrow the securities from a broker-dealer through which the short sale is executed, and the broker-dealer delivers the
securities, on behalf of the Fund, to the buyer. The broker- dealer may be entitled to retain the proceeds from the short sale until
the Fund delivers to it the securities sold short or the Fund may receive and invest the proceeds. In addition, the Fund is required
to pay to the broker- dealer the amount of any dividends or interest paid on the securities sold short.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To secure its obligation to deliver to the broker-dealer
the securities sold short, the Fund must segregate an amount of cash or liquid securities that are marked to market daily with its custodian
equal to any excess of the current market value of the securities sold short over any cash or liquid securities deposited as collateral
with the broker in connection with the short sale (not including the proceeds of the short sale). As a result of that requirement, the
Fund will not gain any leverage merely by selling short, except to the extent that it earns interest or other income or gains on the
segregated cash or liquid securities while also being subject to the possibility of gain or loss from the securities sold short.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund is said to have a short position in
the securities sold until it delivers to the broker-dealer the securities sold. The Fund will normally close out a short position by
purchasing on the open market and delivering to the broker-dealer an equal amount of the securities sold short.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund will realize a gain if the price of
the securities declines between the date of the short sale and the date on which the Fund purchases securities to replace the borrowed
securities. On the other hand, the Fund will incur a loss if the price of the securities increases between those dates. The amount of
any gain will be decreased and the amount of any loss increased by any premium or interest that the Fund may be required to pay in connection
with the short sale. It should be noted that possible losses from short sales differ from those that could arise from a cash investment
in a security in that losses from a short sale may be limitless, while the losses from a cash investment in a security cannot exceed
the total amount of the investment in the security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is also a risk that securities borrowed
by the Fund and delivered to the buyer of the securities sold short will need to be returned to the broker-dealer on short notice. If
the request for the return of securities occurs at a time when other short sellers of the security are receiving similar requests, a
&#8220;short squeeze&#8221; can occur, meaning that the Fund might be compelled, at the most disadvantageous time, to replace the borrowed
securities with securities purchased on the open market, possibly at prices significantly in excess of the proceeds received from the
short sale.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">It is possible that the market value of the securities
the Fund holds in long positions will decline at the same time that the market value of the securities the Fund has sold short increases,
thereby increasing the Fund&#8217;s potential volatility.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Rule&#160;10a-1 under the Securities Exchange
Act of 1934, as amended (&#8220;Exchange Act&#8221;) provides that exchange-traded securities can be sold short only at a price that
is higher than the last trade or the same as the last trade price if that price is higher than the price of the previous reported trade.
The requirements of Rule&#160;10a-1 can delay, or in some cases prevent, execution of short sales, resulting in opportunity costs and
increased exposure to market action.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 16; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may also make short sales &#8220;against
the box,&#8221; meaning that at all times when a short position is open the Fund owns an equal amount of such securities or securities
convertible into or exchangeable, without payment of further consideration, for securities of the same issue as, and in an amount equal
to, the securities sold short. Short sales &#8220;against the box&#8221; result in a &#8220;constructive sale&#8221; and require the
Fund to recognize any taxable gain unless an exception to the constructive sale rule&#160;applies. The Fund will not make a short sale
of securities (other than a short sale &#8220;against the box&#8221;), if more than 20% of its net assets would be deposited with brokers
as collateral or allocated to segregated accounts in connection with all outstanding short sales (other than short sales &#8220;against
the box&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Short sales also may afford the Fund an opportunity
to earn additional current income to the extent it is able to enter into arrangements with broker-dealers through which the short sales
are executed to receive income with respect to the proceeds of the short sales during the period the Fund&#8217;s short positions remain
open. Calamos believes that some broker-dealers may be willing to enter into such arrangements, but there is no assurance that the Fund
will be able to enter into such arrangements to the desired degree.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC has adopted new rules&#160;require managers to file monthly
confidential reports with the SEC regarding equity short sales and related activity. Under the new rules, the SEC will publicly disclose
aggregated short position information on a monthly basis. The SEC also adopted a rule&#160;that will require reporting and public disclosure
of securities loan transaction information (not including party names); this may include, but is not limited to, information about securities
loans entered into in connection with short sales.&#160; In addition, other non-U.S. jurisdictions (such as the EU and the UK) where
a Portfolio may trade have reporting requirements.&#160; If a Portfolio&#8217;s short positions or its strategy become generally known,
it could have a significant effect on the manager&#8217;s ability to implement its investment strategy.&#160; In particular, it would
make it more likely that other investors could cause a &#8220;short squeeze&#8221; in the securities held short by the Portfolio forcing
the Portfolio to cover its positions at a loss.&#160; Such reporting requirements also may limit the manager&#8217;s ability to access
management and other personnel at certain companies where the manager seeks to take a short position.&#160; In addition, if other investors
engage in copycat behavior by taking positions in the same issuers as the Portfolio, the cost of borrowing securities to sell short could
increase drastically and the availability of such securities to the Portfolio could decrease drastically.&#160; Such events could make
the Portfolio unable to execute its investment strategy.&#160; Short sales are also subject to certain SEC regulations and certain EU
and UK regulations (under which there are restrictions on net short sales in certain securities).&#160; If the SEC or regulatory authorities
in other jurisdictions were to adopt additional restrictions regarding short sales, they could restrict the Fund&#8217;s ability to engage
in short sales in certain circumstances, and a Portfolio may be unable to execute its investment strategy as a result.&#160; In response
to market events, the SEC and regulatory authorities in other jurisdictions may adopt (and in certain cases, have adopted) bans or other
restrictions on short sales of certain securities or on derivatives and other hedging instruments used to achieve a similar economic
effect.&#160; Such bans or other restrictions may make it impossible for a Portfolio to execute certain investment strategies and may
have a material adverse effect on a Portfolio&#8217;s ability to generate returns.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See also &#8220;Risks of transactions in futures contracts and related
options&#8221; for more information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Swaps, Caps, Floors and Collars</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may enter into interest rate, currency,
index, credit default and other swaps and the purchase or sale of related caps, floors and collars. The Fund expects to enter into these
transactions primarily as a hedge to preserve a return or spread on a particular investment or portion of its portfolio, to protect against
currency fluctuations, as a duration management technique or to protect against any increase in the price of securities the Fund anticipates
purchasing at a later date. The Fund will not sell interest rate caps or floors where it does not own securities or other instruments
providing the income stream the Fund may be obligated to pay. Interest rate swaps involve the exchange by the Fund with another party
of their respective commitments to pay or receive interest, e.g., an exchange of floating rate payments for fixed rate payments with
respect to a notional amount of principal. A currency swap is an agreement to exchange cash flows on a notional amount of two or more
currencies based on the relative value differential among them and an index swap is an agreement to swap cash flows on a notional amount
based on changes in the values of the reference indices. A credit default swap is an agreement to transfer the credit exposure of fixed
income products between parties. The purchase of a cap entitles the purchaser to receive payments on a notional principal amount from
the party selling such cap to the extent that a specified index exceeds a predetermined interest rate or amount. The purchase of a floor
entitles the purchaser to receive payments on a notional principal amount from the party selling such floor to the extent that a specified
index falls below a predetermined interest rate or amount. A collar is a combination of a cap and a floor that preserves a certain return
within a predetermined range of interest rates or values for the purchases.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund will usually enter into swaps or caps
on a net basis; that is, the two payment streams will be netted out in a cash settlement on the payment date or dates specified in the
instrument, with the Fund receiving or paying, as the case may be, only the net amount of the two payments. The Fund intends to maintain
in a segregated account with its custodian cash or liquid securities having a value at least equal to the Fund&#8217;s net payment obligations
under any swap transaction, marked-to-market daily.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The use of swaps and caps is a highly specialized
activity that involves investment techniques and risks different from those associated with ordinary portfolio security transactions.
The Fund&#8217;s use of swaps or caps could enhance or harm the overall performance on the common shares. To the extent there is a decline
in interest rates, the value of the interest rate swap or cap could decline, and could result in a decline in the net asset value of
the common shares. In addition, if short-term interest rates are lower than the Fund&#8217;s fixed rate of payment on the interest rate
swap, the swap will reduce common share net earnings. If, on the other hand, short-term interest rates are higher than the fixed rate
of payment on the interest rate swap, the swap will enhance common share net earnings. Buying caps could enhance the performance of the
common shares by limiting certain leverage expenses. Buying caps could also decrease the net earnings of the common shares in the event
that the premium paid by the Fund to the counterparty exceeds the additional amount the Fund would have been required to pay had it not
entered into the cap agreement. The Fund has no current intention of selling swaps or caps.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 17; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Swaps and caps entered into by the Fund typically
do not involve the delivery of securities or other underlying assets or principal. Accordingly, the risk of loss with respect to swaps
usually is expected to be limited to the net amount of payments that the Fund is contractually obligated to make. If the counterparty
defaults, the Fund would not be able to use the anticipated net receipts under the swap or cap to offset the payments on the Fund&#8217;s
leverage or offset certain losses in the portfolio. Depending on whether the Fund would be entitled to receive net payments from the
counterparty on the swap or cap, such a default could negatively impact the performance of the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although this will not guarantee the counterparty
does not default, the Fund will not enter into any swap, cap, floor or collar transaction unless, at the time of entering into such transaction,
the Fund believes that the counterparty has the financial resources to honor its obligation under the transaction. Further, Calamos will
continually monitor the financial stability of a counterparty to a swap or cap transaction in an effort to proactively protect the Fund&#8217;s
investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, at the time the swap or cap transaction
reaches its scheduled termination date, there is a risk that the Fund would not be able to obtain a replacement transaction or that the
terms of the replacement would not be as favorable as on the expiring transaction. If this occurs, it could have a negative impact on
the performance of the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund were to issue preferred shares, the
Fund may choose or be required to redeem some or all of the preferred shares or prepay any borrowings. Such redemption or prepayment
would likely result in the Fund seeking to terminate early all or a portion of any swap or cap transaction. Such early termination of
a swap could result in termination payment by or to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although the swap market has grown substantially
over the years increasing liquidity, some swaps, including caps, floors, and collars may be considered illiquid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, certain categories of interest rate
and credit default swaps are, and more in the future may be, centrally cleared. Swaps that are centrally-cleared are subject to the creditworthiness
of the clearing organizations involved in the transaction. For example, the Fund could lose margin payments deposited with the clearing
organization, as well as the net amount of gains not yet paid by the clearing organization, if the clearing organization breaches the
swap agreement with the Fund or becomes insolvent or goes into bankruptcy. Also, the Fund will be exposed to the credit risk of the FCM
who acts as the Fund&#8217;s clearing member on the clearinghouse for a centrally cleared swap. If the Fund&#8217;s FCM becomes bankrupt
or insolvent, or otherwise defaults on its obligations to the Fund, the Fund may not receive all amounts owed to it in respect of its
trading, even if the clearinghouse fully discharges all of its obligations. In the event of bankruptcy of the Fund&#8217;s FCM, the Fund
may be entitled to the net amount of gains the Fund is entitled to receive, plus the return of margin owed to it, only in proportion
to the amount received by the FCM&#8217;s other customers, potentially resulting in losses to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Associated with Cleared Derivatives</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The CFTC requires that certain interest rate
swaps and index credit default swaps be cleared through a central counterparty (&#8220;CCP&#8221;) (unless an exception or exemption
applies), and the CFTC may expand the types of swaps (e.g., certain foreign currency and commodity swaps) subject to mandatory clearing.
While the SEC has adopted rules&#160;establishing a framework for determining which security-based swaps will be subject to mandatory
clearing, no such clearing determination has been issued.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the Fund enters into swaps subject to mandatory
clearing, it may be required to clear such swaps at a CCP through a FCM acting as clearing broker. The Fund will have to post initial
margin to CCPs through such FCMs (in the U.S.) or other clearing brokers (outside the U.S.), and for swaps cleared at CCPs that are U.S.-registered
derivatives clearing organizations, such initial margin will be held by such CCPs and FCMs in segregated accounts under the CFTC rules.
Such segregation is intended to protect the initial margin of swap clearing customers from the claims of other creditors of a CCP or
FCM. Furthermore, the CFTC rules&#160;implement the so-called &#8220;legally segregated, operationally commingled&#8221; model for the
segregation of swap clearing customer collateral on a customer-by-customer basis, which is intended to protect each customer from the
default of other customers of the FCM. Such segregation, however, will not protect clearing customers like the Fund from any operational
or fraud risk of a CCP or FCM with respect to the initial margin posted to the CCP or FCM. In addition, the initial margin posted to
a non-US CCP through a non-US clearing broker may not even be segregated from the property of such CCP and/or clearing members. The SEC
has no final rules&#160;for the treatment and protection of customer property, including initial margin, held by CCPs and broker-dealers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 18; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, where the Fund enters into certain
swaps subject to mandatory clearing, it may be required to execute such swaps on a registered designated contract market or swap execution
facility (&#8220;SEF&#8221;). The CFTC requires that certain interest rate swaps and index credit default swaps be executed on a registered
designated contract market or SEF, and registered designated contract markets or SEFs may self-certify additional types of interest rate
and index credit default swaps as subject to this requirement. The SEC has adopted registration rules&#160;for security-based swap registered
designated contract markets or SEFs but currently there is not a mandatory trade execution requirement for security-based swaps. In addition,
certain foreign jurisdictions may impose clearing and trade execution requirements that could apply to the Fund&#8217;s transactions
with non-U.S. entities. While the Fund may benefit from reduced counterparty credit and operations risk and pricing transparency resulting
from these requirements, it will incur additional costs in trading these swaps. In addition, while the Fund will attempt to execute,
clear and settle these swaps through entities Calamos believes to be sound, there can be no assurance that a failure by such an entity
will not cause a loss to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Associated with Uncleared Derivatives</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the Fund enters into derivatives contracts
that are not centrally cleared through a CCP, the Fund will become subject to the risk that a counterparty will not perform its obligations
under such contracts, because of for example, a dispute over the terms of the contract (whether or not bona fide) or because of a credit
or liquidity problem of the counterparty, thus causing the Fund to suffer a loss. Such counterparty risk may be accentuated by the fact
that the Fund may concentrate its transactions with a single or small group of counterparties. In addition, in the case of a default,
the Fund could become subject to adverse market movements while seeking replacement transactions. The Fund is not restricted from dealing
with any particular counterparty or from concentrating any or all of its transactions with one counterparty. Certain of the swap counterparties
may be entities that are rated by recognized rating agencies. The Fund&#8217;s ability to transact business with any one or number of
counterparties, the possible lack of a meaningful and independent evaluation of such counterparties&#8217; financial capabilities, and
the absence of a regulated market to facilitate settlement may increase the potential for losses by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The U.S. prudential regulators and the CFTC have
adopted variation margin requirements for non-cleared swaps which apply to entities subject to the jurisdiction of the prudential regulators
and entities registered as swap dealers with the CFTC, respectively. While the Fund will not be directly subject to these margin requirements,
the Fund will be indirectly impacted by the margin requirements where its counterparty is subject to such requirement. These requirements
include restrictions on the types of collateral that may be exchanged and the timing of transferring margin, among other things. Mandatory
initial margin requirements have been implemented, but such requirements apply only to swap dealers when trading with financial end users
with &#8220;material swaps exposure.&#8221; Given the anticipated volume of the Fund&#8217;s swap transactions, the Fund is not likely
to have &#8220;material swaps exposure&#8221; for purposes of these margin rules, and therefore does not expect to be subject to these
initial margin requirements. In addition, the U.S. prudential regulators&#8217; margin rules&#160;apply to non-cleared security-based
swaps entered into by security-based swap dealers that are subject to their jurisdiction. The SEC also finalized margin rules&#160;for
security-based swap dealers that are not subject to the jurisdiction of prudential regulators which generally apply to such dealers and
their security-based swap transactions with their counterparties regardless of their material swaps exposure. Similar requirements have
been adopted in the European Union, United Kingdom and other jurisdictions, which impose similar clearing and margin requirements that
may affect the Fund&#8217;s derivative activities with the Fund&#8217;s counterparties domiciled in such jurisdictions and subject to
such requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To the extent that the Fund&#8217;s swap dealer
counterparty collects margin from the Fund on its uncleared swaps and security-based swaps, such margin is held in an account at the
Fund&#8217;s custodian in which the swap dealer has a security interest. The custodian may fail to segregate such assets or collateral
properly. In either case, in the event of the bankruptcy or insolvency of any custodian or counterparty, the Fund&#8217;s assets and
collateral may be subject to the conflicting claims of the creditors of the relevant custodian or counterparty, and the Fund may be exposed
to the risk of a court treating the Fund as a general unsecured creditor of such custodian or counterparty, rather than as the owner
of such assets or collateral.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 19; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, uncleared OTC derivative instruments
can generally be closed out only by negotiation with the counterparty, which may expose the Fund to liquidity risk. There can be no assurance
that a liquid secondary market will exist for any particular derivative instrument at any particular time, including for those derivative
instruments that were originally categorized as liquid at the time they were acquired by the Fund. In volatile markets, the Fund may
not be able to close out a position without incurring a significant amount of loss. In addition, the Fund may not be able to convince
its counterparty to consent to an early termination of an OTC derivative contract or may not be able to enter into an offsetting transaction
to effectively unwind the transaction. Such OTC derivative contracts generally are not assignable except by agreement between the parties,
and a counterparty typically has no obligation to permit assignments. Even if the Fund&#8217;s counterparty agrees to early termination
of OTC derivatives at any time, doing so may subject the Fund to certain early termination charges.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#8220;When Issued&#8221; and Delayed Delivery Securities and Reverse
Repurchase Agreements</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may purchase securities on a when issued
or delayed delivery basis. Although the payment and interest terms of these securities are established at the time the Fund enters into
the commitment, the securities may be delivered and paid for a month or more after the date of purchase, when their value may have changed.
The Fund makes such commitments only with the intention of actually acquiring the securities, but may sell the securities before settlement
date if Calamos deems it advisable for investment reasons. The Fund may utilize spot and forward foreign currency exchange transactions
to reduce the risk inherent in fluctuations in the exchange rate between one currency and another when securities are purchased or sold
on a when issued or delayed delivery basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may enter into reverse repurchase agreements
with banks and securities dealers. A reverse repurchase agreement is a repurchase agreement in which the Fund is the seller of, rather
than the investor in, securities and agrees to repurchase them at an agreed upon time and price. Use of a reverse repurchase agreement
may be preferable to a regular sale and later repurchase of securities because it avoids certain market risks and transaction costs.
Reverse repurchase agreements involve the risk that the market value of securities and/or other instruments purchased by the Fund with
the proceeds received by the Fund in connection with such reverse repurchase agreements may decline below the market value of the securities
the Fund is obligated to repurchase under such reverse repurchase agreements. They also involve the risk that the counterparty liquidates
the securities delivered to it by the Fund under the reverse repurchase agreement following the occurrence of an event of default under
the applicable master repurchase agreement by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Illiquid Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest without limit in securities
that, at the time of investment, are illiquid (i.e., any investment that the Fund reasonably expects cannot be sold or disposed of in
current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the
investment). Illiquid securities may be difficult to dispose of at a fair price at the times when the Fund believes it is desirable to
do so. The market price of illiquid securities generally is more volatile than that of more liquid securities, which may adversely affect
the price that the Fund pays for or recovers upon the sale of illiquid securities. Illiquid securities are also more difficult to value
and Calamos&#8217; judgment may play a greater role in the valuation process. Investment of the Fund&#8217;s assets in illiquid securities
may restrict the Fund&#8217;s ability to take advantage of market opportunities. The risks associated with illiquid securities may be
particularly acute in situations in which the Fund&#8217;s operations require cash and could result in the Fund borrowing to meet its
short-term needs or incurring losses on the sale of illiquid securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 20; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in bonds, corporate loans,
convertible securities, preferred stocks and other securities that lack a secondary trading market or are otherwise considered illiquid.
Liquidity of a security relates to the ability to easily dispose of the security and the price to be obtained upon disposition of the
security, which may be less than would be obtained for a comparable more liquid security. Such investments may affect the Fund&#8217;s
ability to realize the net asset value in the event of a voluntary or involuntary liquidation of its assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Temporary Defensive Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may make temporary investments without
limitation when Calamos determines that a defensive position is warranted. Such investments may be in money market instruments, consisting
of obligations of, or guaranteed as to principal and interest by, the U.S. Government or its agencies or instrumentalities; certificates
of deposit, bankers&#8217; acceptances and other obligations of domestic banks having total assets of at least $500 million and that
are regulated by the U.S. Government, its agencies or instrumentalities; commercial paper rated in the highest category by a recognized
rating agency; cash; and repurchase agreements. If the Fund temporarily uses a different investment strategy for defensive purposes,
different factors could affect the Fund&#8217;s performance, and the Fund may not achieve its investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Repurchase Agreements</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As part of its strategy for the temporary investment
of cash, the Fund may enter into &#8220;repurchase agreements&#8221; with member banks of the Federal Reserve System or primary dealers
(as designated by the Federal Reserve Bank of New York) in such securities. A repurchase agreement arises when the Fund purchases a security
and simultaneously agrees to resell it to the vendor at an agreed upon future date. The resale price is greater than the purchase price,
reflecting an agreed upon market rate of return that is effective for the period of time the Fund holds the security and that is not
related to the coupon rate on the purchased security. Such agreements generally have maturities of no more than seven days and could
be used to permit the Fund to earn interest on assets awaiting long-term investment. The Fund requires continuous maintenance by the
custodian for the Fund&#8217;s account in the Federal Reserve/Treasury Book Entry System of collateral in an amount equal to, or in excess
of, the repurchase price for the repurchase transaction. Repurchase agreements maturing in more than seven days are considered illiquid
securities. In the event of a bankruptcy or other default of a seller of a repurchase agreement, the Fund could experience both delays
in liquidating the underlying security and losses, including: (a)&#160;possible decline in the value of the underlying security during
the period while the Fund seeks to enforce its rights thereto; (b)&#160;possible subnormal levels of income and lack of access to income
during this period; and (c)&#160;expenses of enforcing its rights.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in preferred shares. The
preferred shares that the Fund will invest in will typically be convertible securities. Preferred shares are equity securities, but they
have many characteristics of fixed income securities, such as a fixed dividend payment rate and/or a liquidity preference over the issuer&#8217;s
common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Real Estate Investment Trusts (&#8220;REITs&#8221;) and Associated
Risk Factors</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">REITs are pooled investment vehicles which invest
primarily in income producing real estate or real estate related loans or interests. REITs are generally classified as equity REITs,
mortgage REITs or a combination of equity and mortgage REITs. Equity REITs invest the majority of their assets directly in real property
and derive income primarily from the collection of rents. Equity REITs can also realize capital gains by selling properties that have
appreciated in value. Mortgage REITs invest the majority of their assets in real estate mortgages and derive income from the collection
of interest payments. REITs are not taxed on income and gains distributed to shareholders provided they comply with the applicable requirements
of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The Fund will indirectly bear its proportionate share of any
management and other expenses paid by REITs in which it invests in addition to the expenses paid by the Fund. Debt securities issued
by REITs are, for the most part, general and unsecured obligations and are subject to risks associated with REITs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 21; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Investing in REITs involves certain unique risks
in addition to those risks associated with investing in the real estate industry in general. An equity REIT may be affected by changes
in the value of the underlying properties owned by the REIT. A mortgage REIT may be affected by changes in interest rates and the ability
of the issuers of its portfolio mortgages to repay their obligations. REITs are dependent upon the skills of their managers and are not
diversified. REITs are generally dependent upon maintaining cash flows to repay borrowings and to make distributions to shareholders
and are subject to the risk of default by lessees or borrowers. REITs whose underlying assets are concentrated in properties used by
a particular industry, such as health care, are also subject to risks associated with such industry.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">REITs (especially mortgage REITs) are also subject
to interest rate risks. When interest rates decline, the value of a REIT&#8217;s investment in fixed rate obligations can be expected
to rise. Conversely, when interest rates rise, the value of a REIT&#8217;s investment in fixed rate obligations can be expected to decline.
If the REIT invests in adjustable rate mortgage loans the interest rates on which are reset periodically, yields on a REIT&#8217;s investments
in such loans will gradually align themselves to reflect changes in market interest rates. This causes the value of such investments
to fluctuate less dramatically in response to interest rate fluctuations than would investments in fixed rate obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">REITs may have limited financial resources, may
utilize significant amounts of leverage, may trade less frequently and in a limited volume and may be subject to more abrupt or erratic
price movements than larger company securities. Historically REITs have been more volatile in price than the larger capitalization stocks
included in Standard&#160;&amp; Poor&#8217;s 500 Stock Index.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Investment Companies (including ETFs)</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest in the securities of other
investment companies, including ETFs, to the extent that such investments are consistent with the Fund&#8217;s investment objective and
policies and permissible under the 1940 Act. Under the 1940 Act, the Fund generally may not acquire the securities of other domestic
or non-U.S. investment companies if, as a result, (i)&#160;more than 10% of the Fund&#8217;s total assets would be invested in securities
of other investment companies, (ii)&#160;such purchase would result in more than 3% of the total outstanding voting securities of any
one investment company being held by the Fund, (iii)&#160;more than 5% of the Fund&#8217;s total assets would be invested in any one
investment company, or (iv)&#160;such purchase would result in more than 10% of the total outstanding voting securities of a registered
closed-end investment company being held by the Fund and other investment companies advised by Calamos. These limitations do not apply
to the purchase of shares of money market funds or any investment company in connection with a merger, consolidation, reorganization
or acquisition of substantially all the assets of another investment company, or to purchases of investment companies made in accordance
with SEC exemptive relief or rule.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund, as a holder of the securities of other
investment companies, will bear its pro rata portion of the other investment companies&#8217; expenses, including advisory fees. These
expenses are in addition to the direct expenses of the Fund&#8217;s own operations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dodd-Frank Act and Other Derivatives Regulations</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial crises in both the U.S. and global
economies over the past several years has resulted, and may continue to result, in an unusually high degree of volatility in the financial
markets and the economy at large. Both domestic and international equity and fixed income markets have experienced heightened volatility
and turmoil, with issuers that have exposure to the real estate, mortgage and credit markets particularly affected.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition to the recent unprecedented turbulence
in financial markets, the reduced liquidity in credit and fixed income markets may negatively affect many issuers worldwide. Reduced
liquidity in these markets may mean there is less money available to purchase raw materials, goods and services, which may, in turn,
bring down the prices of these economic staples. It may also result in some issuers having more difficulty obtaining financing and ultimately
may lead to a decline in their stock prices. The values of some sovereign debt and of securities of issuers that hold that sovereign
debt have fallen. These events, and the potential for continuing market turbulence, may have an adverse effect on the Fund. In addition,
global economies and financial markets have become increasingly interconnected, which increases the possibilities that conditions in
one country or region might adversely impact issuers in a different country or region.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 22; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Continuing uncertainty as to the status of the
Euro and the European Monetary Union (&#8220;EMU&#8221;) and the potential for certain countries to withdraw from the institution has
created significant volatility in currency and financial markets generally. Any partial or complete dissolution of the EMU could have
significant adverse effects on currency and financial markets, and on the values of the Fund&#8217;s portfolio investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The U.S. federal government and certain foreign
central banks have acted to calm credit markets and increase confidence in the U.S. and world economies. Certain of these entities have
injected liquidity into the markets and taken other steps in an effort to stabilize the markets and grow the economy. The ultimate effect
of these efforts is, of course, not yet known. Changes in government policies may exacerbate the market&#8217;s difficulties and the
withdrawal of this support, or other policy changes by governments or central banks, could negatively affect the value and liquidity
of certain securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The situation in the financial markets has led
to calls for increased regulation, and the need of many financial institutions for government help has given lawmakers and regulators
new leverage. The Dodd-Frank Act initiated a dramatic revision of the U.S. financial regulatory framework. The Dodd-Frank Act covers
a broad range of topics, including (among many others) a reorganization of federal financial regulators; a process intended to improve
financial systemic stability and the resolution of potentially insolvent financial firms; new rules&#160;for derivatives trading; the
creation of the Consumer Financial Protection Bureau; the registration and additional regulation of hedge and private equity fund managers;
and new federal requirements for residential mortgage loans. Instruments in which the Fund may invest, or the issuers of such instruments,
may be affected by the legislation and regulations promulgated thereunder in ways that may be unforeseeable. Because these requirements
are evolving (and some of the rules&#160;are not yet final), their ultimate impact remains unclear.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The statutory provisions of the Dodd-Frank Act
significantly change in several respects the ways in which investment products are marketed, sold, settled or terminated. In particular,
the Dodd-Frank Act mandates the elimination of references to credit ratings in numerous securities laws, including the 1940 Act. Transactions
in some types of swaps (including interest rate swaps and credit default index swaps on North American and European indices) are required
to be centrally cleared. Clearinghouses and futures commission merchants have broad rights to increase margin requirements for existing
cleared transactions or to terminate cleared transactions at any time. Any increase in margin requirements or termination by the clearing
member or the clearinghouse may have an effect on the performance of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under rules&#160;adopted under the Dodd-Frank
Act, certain cleared derivatives contracts are required to be executed through swap execution facilities (&#8220;SEFs&#8221;). A SEF
is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other
participants in the platform. Such requirements may make it more difficult and costly for investment funds, such as the Fund, to enter
into highly tailored or customized transactions. Trading swaps on a SEF may offer certain advantages over traditional bilateral over-the-counter
trading, such as ease of execution, price transparency, increased liquidity and/or favorable pricing. Execution through a SEF is not,
however, without additional costs and risks, as parties are required to comply with SEF and CFTC rules&#160;and regulations, including
disclosure and recordkeeping obligations, and SEF rights of inspection, among others. SEFs typically charge fees, and if the Fund executes
derivatives on a SEF through a broker intermediary, the intermediary may impose fees as well. The Fund also may be required to indemnify
a SEF, or a broker intermediary who executes swaps on a SEF on the Fund&#8217;s behalf, against any losses or costs that may be incurred
as a result of the Fund&#8217;s transactions on the SEF. In addition, the Fund may be subject to execution risk if it enters into a derivatives
transaction that is required to be cleared, and no clearing member is willing to clear the transaction on the Fund&#8217;s behalf. In
that case, the transaction might have to be terminated, and the Fund could lose some or all of the benefit of any increase in the value
of the transaction after the time of the trade.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The European Union, the United Kingdom (and some
other countries) are implementing similar requirements that will affect the Fund when it enters into derivatives transactions with a
counterparty organized in that country or otherwise subject to that country&#8217;s derivatives regulations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 23; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The new requirements may result in increased
uncertainty about counterparty credit risk, and they may also limit the flexibility of the Fund to protect its interests in the event
of an insolvency of a derivatives counterparty. In the event of a counterparty&#8217;s (or its affiliate&#8217;s) insolvency, the Fund&#8217;s
ability to exercise remedies, such as the termination of transactions, netting of obligations and realization on collateral, could be
stayed or eliminated under new special resolution regimes adopted in the United States, the European Union and various other jurisdictions.
Such regimes provide government authorities with broad authority to intervene when a financial institution is experiencing financial
difficulty. In particular, with respect to counterparties who are subject to such proceedings, the liabilities of such counterparties
to the Fund could be reduced, eliminated, or converted to equity in such counterparties (sometimes referred to as a &#8220;bail in&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Additionally, U.S. regulators, the European Union,
the United Kingdom, and certain other jurisdictions have adopted minimum margin and capital requirements for uncleared derivatives transactions.
These regulations may have a material impact on the Fund&#8217;s use of uncleared derivatives. These rules&#160;impose minimum initial
and variation margin requirements on derivatives transactions between the Fund and its swap counterparties and may increase the amount
of margin the Fund is required to provide. They impose regulatory requirements on the timing of transferring margin. The Fund is subject
to variation margin requirements under such rules&#160;and the Fund may, but is not expected to, become subject to initial margin requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Rule&#160;18f-4 under the 1940 Act applies to
the Fund&#8217;s use of derivative investments and certain financing transactions (e.g., reverse repurchase agreements). Among other
things, Rule&#160;18f-4 requires funds that invest in derivative instruments beyond a specified limited amount to apply a value-at-risk
based limit to their use of certain derivative instruments and financing transactions and to adopt and implement a derivatives risk management
program. A fund that uses derivative instruments (beyond certain currency and interest rate hedging transactions) in a limited amount
will is not subject to the full requirements of Rule&#160;18f-4.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These and other new rules&#160;and regulations
could, among other things, further restrict the Fund&#8217;s ability to engage in, or increase the cost to the Fund of, derivatives transactions,
for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. This may result in
changes to the Fund&#8217;s principal investment strategies and could adversely affect the Fund&#8217;s performance and its ability to
achieve its investment objective.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_003-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INVESTMENT RESTRICTIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following are the Fund&#8217;s fundamental
investment restrictions. These restrictions may not be changed without the approval of the holders of a majority of the Fund&#8217;s
outstanding voting securities (which for this purpose and under the 1940 Act means the lesser of (i)&#160;67% of the common shares represented
at a meeting at which more than 50% of the outstanding common shares are represented or (ii)&#160;more than 50% of the outstanding common
shares). As long as preferred shares are outstanding, the investment restrictions cannot be changed without the approval of a majority
of the outstanding common and preferred shares, voting together as a class, and the approval of a majority of the outstanding preferred
shares, voting separately by class.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 24; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may not:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>(1)</td>
    <td style="padding-right: 44.2pt">Issue senior securities, except as permitted by the 1940 Act and the rules&#160;and interpretive
    positions of the SEC thereunder.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 44.2pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(2)</td>
    <td style="padding-right: 46.25pt">Borrow money, except as permitted by the 1940 Act and the rules&#160;and interpretive positions
    of the SEC thereunder.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 46.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(3)</td>
    <td>Invest in real estate, except that the Fund may invest in securities of issuers that invest in real estate or interests therein,
    securities that are secured by real estate or interests therein, securities of real estate investment funds and mortgage-backed securities.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(4)</td>
    <td>Make loans, except by the purchase of debt obligations, by entering into repurchase agreements or through the lending of portfolio
    securities and as otherwise permitted by the 1940 Act and the rules&#160;and interpretive positions of the SEC thereunder.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(5)</td>
    <td>Invest in physical commodities or contracts relating to physical commodities.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(6)</td>
    <td style="padding-right: 48.15pt">Act as an underwriter, except as it may be deemed to be an underwriter in a sale of securities
    held in its portfolio.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 48.15pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(7)</td>
    <td>Make any investment inconsistent with the Fund&#8217;s classification as a diversified investment company under the 1940 Act
    and the rules&#160;and interpretive positions of the SEC thereunder.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(8)</td>
    <td style="padding-right: 50.2pt">Concentrate its investments in securities of companies in any particular industry as defined in
    the 1940 Act and the rules&#160;and interpretive positions of the SEC thereunder.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All other investment policies of the Fund are
considered non-fundamental and may be changed by the Board of Trustees without prior approval of the Fund&#8217;s outstanding voting
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently under the 1940 Act, the Fund is not
permitted to issue preferred shares unless immediately after such issuance the net asset value of the Fund&#8217;s portfolio is at least
200% of the liquidation value of the outstanding preferred shares (i.e., such liquidation value may not exceed 50% of the value of the
Fund&#8217;s total assets). In addition, currently under the 1940 Act, the Fund is not permitted to declare any cash dividend or other
distribution on its common shares unless, at the time of such declaration, the net asset value of the Fund&#8217;s portfolio (determined
after deducting the amount of such dividend or distribution) is at least 200% of such liquidation value plus any senior securities representing
indebtedness. Currently under the 1940 Act, the Fund is not permitted to issue senior securities representing indebtedness unless immediately
after such borrowing the Fund has asset coverage of at least 300% of the aggregate outstanding principal balance of indebtedness (i.e.,
such indebtedness may not exceed 33 1/3% of the value of the Fund&#8217;s total assets). Additionally, currently under the 1940 Act,
the Fund generally may not declare any dividend or other distribution upon any class of its shares, or purchase any such shares, unless
the aggregate indebtedness of the Fund has, at the time of the declaration of any such dividend or distribution or at the time of any
such purchase, an asset coverage of at least 300% after deducting the amount of such dividend, distribution, or purchase price, as the
case may be, except that dividends may be declared upon any preferred shares if such indebtedness has an asset coverage of at least 200%
at the time of declaration thereof after deducting the amount of the dividend. This limitation does not apply to certain privately placed
debt.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently under the 1940 Act, the Fund is not
permitted to lend money or property to any person, directly or indirectly, if such person controls or is under common control with the
Fund, except for a loan from the Fund to a company which owns all of the outstanding securities of the Fund, except directors&#8217;
qualifying shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently, under interpretive positions of the
SEC, the Fund may not have on loan at any time securities representing more than one third of its total assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently under the 1940 Act, a &#8220;senior
security&#8221; does not include any promissory note or evidence of indebtedness where such loan is for temporary purposes only and in
an amount not exceeding 5% of the value of the total assets of the issuer at the time the loan is made. A loan is presumed to be for
temporary purposes if it is repaid within sixty days and is not extended or renewed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently, the Fund would be deemed to &#8220;concentrate&#8221;
in a particular industry if it invested 25% or more of its total assets in that industry.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Currently under the 1940 Act, a &#8220;diversified
company&#8221; means a management company which meets the following requirements: at least 75% of the value of its total assets is represented
by cash and cash items (including receivables), government securities, securities of other investment companies, and other securities
for the purposes of this calculation limited in respect of any one issuer to an amount not greater in value than 5% of the value of the
total assets of such management company and not more than 10% of the outstanding voting securities of such issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 25; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the 1940 Act, the Fund
may not acquire the securities of other domestic or non-U.S. investment companies if, as a result, (1)&#160;more than 10% of the Fund&#8217;s
total assets would be invested in securities of other investment companies, (2)&#160;such purchase would result in more than 3% of the
total outstanding voting securities of any one investment company being held by the Fund, (3)&#160;more than 5% of the Fund&#8217;s total
assets would be invested in any one investment company, or (4)&#160;such purchase would result in more than 10% of the total outstanding
voting securities of a registered closed-end investment company being held by the Fund and any other registered investment companies
advised by Calamos, except as permitted under the 1940 Act, the rules&#160;thereunder or SEC exemptive relief. Currently, under the 1940
Act and the rules&#160;thereunder and SEC exemptive relief, a Fund may invest in other investment companies in excess of the above limitations
if the Fund complies with Rule&#160;12d1-4 under the 1940 Act. The Fund may also invest without limitation in money market funds, provided
the Fund complies with Rule&#160;12d1-1 under the 1940 Act. These limitations do not apply, however, in connection with a merger, consolidation,
reorganization or acquisition of substantially all the assets of another investment company, or to purchases of investment companies
made in accordance with SEC exemptive relief or rule. As a shareholder in any investment company, the Fund will bear its ratable share
of that investment company&#8217;s expenses, and would remain subject to payment of the Fund&#8217;s advisory fees and other expenses
with respect to assets so invested. Holders of common shares would therefore be subject to duplicative expenses to the extent the Fund
invests in other investment companies. In addition, the securities of other investment companies may also be leveraged and will therefore
be subject to the same leverage risks described herein and in the prospectus. As described in the prospectus in the section entitled
&#8220;Risks,&#8221; the net asset value and market value of leveraged shares will be more volatile and the yield to shareholders will
tend to fluctuate more than the yield generated by unleveraged shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, to comply with federal income tax
requirements for qualification as a regulated investment company, the Fund&#8217;s investments will be limited by both an income and
an asset test. See &#8220;Certain Federal Income Tax Matters.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a non-fundamental policy, the Fund may not
issue preferred shares, borrow money and/or issue debt securities with an aggregate liquidation preference and aggregate principal amount
exceeding 38% of the Fund&#8217;s managed assets measured at the time of borrowing or issuance of the new securities. Investments of
short sale proceeds and economic leverage through derivatives are not considered borrowings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund presently utilizes leverage through
its outstanding borrowings pursuant to the SSB Agreement, and its issuance of mandatory redeemable preferred shares. See the prospectus
(under the caption &#8220;Leverage&#8221;) for more information about the Fund&#8217;s present activities related to the issuance of
senior securities and the borrowing of money.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_004-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT OF THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustees and Officers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s Board of Trustees provides broad
oversight over the Fund&#8217;s affairs. The officers of the Fund are responsible for the Fund&#8217;s operations. The Fund&#8217;s Trustees
and officers are listed below, together with their year of birth, positions held with the Fund, term of office and length of service
and principal occupations during the past five years. Asterisks indicate those Trustees who are interested persons of the Fund within
the meaning of the 1940 Act, and they are referred to as Interested Trustees. Trustees who are not interested persons of the Fund are
referred to as &#8220;Independent Trustees.&#8221; Each of the Trustees serves as a Trustee of other investment companies (26 U.S. registered
investment portfolios) for which Calamos serves as investment adviser (collectively, the &#8220;Calamos Funds&#8221;). The address for
all Independent and Interested Trustees and all officers of the Fund is 2020 Calamos Court, Naperville,&#160;Illinois 60563.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 26; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustees Who Are Interested Persons of the Fund:</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt 0.5pt; text-align: left; width: 8%"><b>NAME<br/>
    AND <br/>
    YEAR OF<br/>
    BIRTH</b></td>
    <td style="padding: 0.25pt 0.5pt 1.25pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt 0.5pt; text-align: center; width: 20%"><b>POSITION(S)<br/>
    AND LENGTH <br/>
    OF TIME <br/>
    WITH FUND</b></td>
    <td style="padding: 0.25pt 0.5pt 1.25pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt 0.5pt; text-align: center; width: 20%"><b>PORTFOLIOS<br/>
    IN <br/>
    FUND <br/>
    COMPLEX&#x5E;<br/>
    OVERSEEN</b></td>
    <td style="padding: 0.25pt 0.5pt 1.25pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt 0.5pt; text-align: center; width: 49%"><b>PRINCIPAL <br/>
    OCCUPATION(S)<br/>
    DURING THE PAST 5<br/>
    YEARS<br/>
    AND OTHER<br/>
    DIRECTORSHIPS</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">John P. Calamos,&#160;Sr. (1940)*</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Chairman, Trustee and President (since 2002) Term Expires 2026 Co-Portfolio Manager (since inception)</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; text-align: center">68</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Founder, Chairman and Global Chief Investment Officer, Calamos Asset
Management, Inc. (&#8220;CAM&#8221;), Calamos Investments LLC (&#8220;CILLC&#8221;), Calamos Advisors LLC (&#8220;Calamos Advisors&#8221;) and
its predecessor and Calamos Wealth Management LLC (&#8220;CWM&#8221;); Global Chief Investment Officer, Calamos Antetokounmpo Asset Management
LLC, doing business as CGAM (&#8220;CGAM&#8221;); Director, CAM and previously Chief Executive Officer, Calamos Financial Services LLC (&#8220;CFS&#8221;)
and its predecessor; Director, CAM, CILLC, Calamos Advisors, and CWM</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 27; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustees Who Are Not Interested Persons of the Fund:</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt; width: 8%"><p style="margin-top: 0; margin-bottom: 0"><b>NAME</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>AND<br/>
                                            YEAR OF<br/>
                                            BIRTH</b></p></td>
    <td style="padding: 0.25pt 0.5pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt; text-align: center; width: 13%"><b>POSITION(S)&#160;<br/>
    WITH FUND</b></td>
    <td style="padding: 0.25pt 0.5pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt; text-align: center; width: 12%"><b>PORTFOLIOS<br/>
    IN<br/>
    FUND<br/>
    COMPLEX&#x5E;<br/>
    OVERSEEN</b></td>
    <td style="padding: 0.25pt 0.5pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.5pt; text-align: center; width: 32%"><b>PRINCIPAL <br/>
    OCCUPATION(S)<br/>
    DURING THE PAST 5 <br/>
    YEARS AND<br/>
    OTHER<br/>
    DIRECTORSHIPS</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 31%"><b>EXPERIENCE,<br/>
    QUALIFICATIONS,<br/>
    ATTRIBUTES, SKILLS<br/>
    FOR BOARD <br/>
    MEMBERSHIP</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">John E. Neal (1950)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Trustee (since 2002); Lead Independent Trustee (since July&#160;2019) Term Expires 2027</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">69</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&#x5E;&#x5E;Retired;
                                            private investor; Director, Equity Residential Trust (publicly-owned REIT); Director, Creation
                                            Investments (private international microfinance company); Director, Centrust Bank (Northbrook,
                                            Illinois community bank); formerly, Director, Neuro-ID (private company providing prescriptive
                                            analytics for the risk industry) (until 2021); formerly, Partner, Linden LLC (health care
                                            private equity) (until 2018)</p></td>
    <td>&#160;</td>
    <td>Served for multiple years as a trustee of the Funds; more than 25 years of experience in the financial services industry; experience
    serving on boards of other entities, including other investment companies; and earned a Masters of Business Administration degree</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">William R. Rybak (1951)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Trustee (since 2002) Term Expires 2026</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">68</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Private investor; Chairman (since 2016) and Director
    (since 2010), Christian Brothers Investment Services Inc.; Trustee, Jackson Credit Opportunities Fund (Since 2023), Jackson Real
    Assets Fund (since 2024) (interval funds), JNL Series&#160;Trust and JNL Investors Series&#160;Trust (since 2007), JNL Variable Fund
    LLC (2007-2020), Jackson Variable Series&#160;Trust (2018-2020) and JNL Strategic Income Fund LLC (2007-2018) (open-end mutual
    funds)**; formerly Trustee, Lewis University (2012-2024); formerly Director, Private Bancorp (2003-2017); Executive Vice President
    and Chief Financial Officer, Van Kampen Investments,&#160;Inc. and subsidiaries (investment manager) (until 2000)</td>
    <td>&#160;</td>
    <td>Served for multiple years as a trustee of the Funds; more than 25 years of experience in the financial services industry; experience
    serving on boards of other entities, including other investment companies; and earned a Masters of Business Administration degree</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Virginia G. Breen (1964)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Trustee (since 2015) Term Expires 2025</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">68</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Private investor; Trustee, UBS NY Fund Cluster (open-end
    funds) (since 2023)***; Director, Paylocity Holding Corporation (since 2018); Trustee, Neuberger Berman Private Equity Registered
    Funds (registered private equity funds) (since 2015)****; Director, UBS A&amp;Q Fund Complex (closed-end funds) (since 2008)*****;
    Trustee, Jones Lang LaSalle Income Property Trust,&#160;Inc. (REIT) (2004-2023); Director, Tech and Energy Transition Corporation
    (blank check company) (2021-2023</td>
    <td>&#160;</td>
    <td>Served for multiple years as a trustee of the Funds; more than 25 years of experience in the financial services industry; experience
    serving on boards of other entities, including other investment companies; and earned a Masters of Business Administration degree</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 28; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; width: 8%"><p style="margin-top: 0; margin-bottom: 0"><b>NAME</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>AND<br/>
                                            YEAR OF<br/>
                                            BIRTH</b></p></td>
    <td style="padding: 0.25pt 0.5pt 1pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 13%"><b>POSITION(S)<br/>
    WITH FUND</b></td>
    <td style="padding: 0.25pt 0.5pt 1pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 12%"><b>PORTFOLIOS<br/>
    IN<br/>
    FUND<br/>
    COMPLEX&#x5E;<br/>
    OVERSEEN</b></td>
    <td style="padding: 0.25pt 0.5pt 1pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 32%"><b>PRINCIPAL<br/>
    OCCUPATION(S)<br/>
    DURING THE PAST 5 <br/>
    YEARS AND<br/>
    OTHER <br/>
    DIRECTORSHIPS</b></td>
    <td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 31%"><b>EXPERIENCE,<br/>
    QUALIFICATIONS,<br/>
    ATTRIBUTES, SKILLS<br/>
    FOR BOARD <br/>
    MEMBERSHIP</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Lloyd A. Wennlund (1957)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Trustee (since 2018) Term Expires 2025</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">68</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Board Member, Mutual Fund Directors Forum (2023-present);
    Trustee and Chairman of the Board, Datum One Series&#160;Trust (since 2020); Expert Affiliate, Bates Group, LLC (financial services
    consulting and expert testimony firm) (since 2018); Executive Vice President, The Northern Trust Company (1989- 2017); President
    and Business Unit Head of Northern Funds and Northern Institutional Funds (1994-2017); Director, Northern Trust Investments (1998-2017);
    Governor (2004-2017) and Executive Committee member (2011-2017),&#160;Investment Company Institute Board of Governors; Member, Securities
    Industry Financial Markets Association (SIFMA) Advisory Council, Private Client Services Committee and Private Client Steering Group
    (2006- 2017); Board Member, Chicago Advisory Board of the Salvation Army (2011-2019)</td>
    <td>&#160;</td>
    <td>More than 25 years of experience in the financial services industry; experience serving on boards of other entities, including
    other investment companies</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Karen L. Stuckey (1953)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Trustee (since 2019) Term Expires 2027</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">68</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Partner (1990-2012) of PricewaterhouseCoopers LLP
    (professional services firm) (held various positions from 1975-1990); Member of Executive, Nominating, and Audit Committees and
    Chair of Finance Committee (1992-2006); Emeritus Trustee (since 2007) of Lehigh University; formerly, Trustee, Denver Board of
    Oppenheimer Funds (open-end mutual funds) (2012-2019)</td>
    <td>&#160;</td>
    <td>More than 25 years of experience in the financial services industry; experience serving on boards of other entities, including
    other investment companies</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Christopher M. Toub (1959)</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Trustee (since 2019) Term Expires 2026</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">68</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.5pt; padding-left: 0.5pt">Private investor; formerly, Director of Equities, AllianceBernstein
    LP (until 2012)</td>
    <td>&#160;</td>
    <td>More than 25 years of experience in the financial services industry; and earned a Masters of Business Administration degree</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>*</td>
    <td>Mr.&#160;Calamos,&#160;Sr. is an &#8220;interested person&#8221; of the Fund as defined in the 1940 Act because he is an officer
    of the Fund and an affiliate of Calamos and CFS.</td></tr>
  <tr style="vertical-align: top">
    <td>**</td>
    <td style="text-align: justify">Overseeing 131 portfolios in fund complex.</td></tr>
  <tr style="vertical-align: top">
    <td>***</td>
    <td style="text-align: justify">Overseeing thirty-eight portfolios in fund complex.</td></tr>
  <tr style="vertical-align: top">
    <td>****</td>
    <td style="text-align: justify">Overseeing twenty-two portfolios in fund complex.</td></tr>
  <tr style="vertical-align: top">
    <td>*****</td>
    <td style="text-align: justify">&#160;Overseeing three portfolios in fund complex.</td></tr>
  <tr style="vertical-align: top">
    <td>&#x5E;</td>
    <td><span>The Fund Complex consists of Calamos Investment Trust, Calamos Advisors Trust, Calamos
    Convertible Opportunities and Income Fund, Calamos Convertible and High Income Fund, Calamos Strategic Total Return Fund, Calamos
    Global Total Return Fund, Calamos Global Dynamic Income Fund, Calamos Dynamic Convertible and Income Fund, Calamos Long/Short Equity&#160;&amp;
    Dynamic Income Trust, Calamos ETF Trust, Calamos Antetokounmpo Sustainable Equities Trust and Calamos Aksia Alternative Credit and
    Income Fund.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#x5E;&#x5E;</td>
    <td>Mr. Neal is the only Trustee of the Fund who oversees Calamos Aksia Alternative Credit and Income Fund.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Officers</i>. The preceding table gives information
about Mr.&#160;John P. Calamos,&#160;Sr., who is Chairman, Trustee and President of the Fund. The following table sets forth each other
officer&#8217;s name and year of birth, position with the Fund and date first appointed to that position, and principal occupation(s)&#160;during
the past five years. Each officer serves until his or her successor is chosen and qualified or until his or her resignation or removal
by the board of trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 29; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; width: 15%"><b>NAME<br/>
    AND<br/>
    YEAR OF<br/>
    BIRTH</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 16%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 16%"><b>POSITION(S)&#160;WITH
    <br/>
    FUND</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; width: 47%"><b>PRINCIPAL
    OCCUPATION(S)&#160;DURING THE PAST<br/>
    5 YEARS</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Thomas P. Kiley III (1968)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Vice President (since 2024)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Senior Vice President, Chief
                                      Distribution Officer (since 2024), CAM, CILLC, and Calamos Advisors; Principal Executive Officer
                                      and Chief Distribution Officer (since 2024), CFS; Vice President (since 2024), CGAM; prior thereto
                                      Managing Director, RIA Eastern Divisional Sales Manager, Blackrock Investments,&#160;Inc. (2017-2024).</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Thomas E. Herman (1961)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Vice President (since 2016) and Chief Financial Officer (2016-2017 and since 2019)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Executive Vice President (since 2021) and Chief Financial Officer, CAM, CILLC, Calamos
    Advisors, and CWM (since 2016); Chief Financial Officer and Treasurer, CGAM (since 2022); Chief Financial Officer (since 2022), CGAM; prior thereto, Chief Financial Officer
    and Treasurer, Harris Associates (2010-2016)</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Erik D. Ojala (1975)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt"/>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Vice President and Secretary (since 2023)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Senior Vice President, General Counsel and Secretary, CAM, CILLC, Calamos Advisors, CWM (since
    2023); Chief Legal Officer, CGAM (since 2023); General Counsel and Secretary, CFS (since 2023); prior thereto, Executive Vice President
    and General Counsel (2017-2023), Secretary (2010-2023) and Chief Compliance Officer (2022-2023), Harbor Capital Advisors,&#160;Inc.;
    Director and Secretary (2019-2023) and Chief Compliance Officer (2022-2023), Harbor Trust Company,&#160;Inc.; Director, Executive
    Vice President (2017-2023) and Chief Compliance Officer (2017-2021, 2022-2023), Harbor Funds Distributors,&#160;Inc.; Director (2017-2023),
    Assistant Secretary (2014-2023) and Chief Compliance Officer (2022-2023), Harbor Services Group,&#160;Inc.; Chief Compliance Officer,
    Harbor ETF Trust (2021-2023); and Chief Compliance Officer of Harbor Funds (2017-2023).</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">John S. Koudounis (1966)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Vice President (since 2016)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">President (since February&#160;2021) and Chief Executive Officer, CAM, CILLC, Calamos Advisors,
    CWM, and CFS (since 2016); Chairman and Chief Executive Officer, CGAM (since 2022); Director, CAM (since 2016); President and Chief
    Executive Officer (2010-2016), Mizuho Securities USA Inc.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Mark J. Mickey (1951)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Chief Compliance Officer (since 2014)</td>
    <td>&#160;</td>
    <td style="padding: 0.3pt 0.5pt 0.25pt">Chief Compliance Officer, Calamos Funds (since 2005)</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.3pt 0.5pt 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Stephen Atkins (1965)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Treasurer (since 2022)</td>
    <td>&#160;</td>
    <td style="padding: 0.3pt 0.5pt 0.25pt">Senior Vice President, Head of Fund Administration (since 2020); Calamos Advisors;
    prior thereto, Consultant, Fund Accounting and Administration, Vx Capital Partners (2019-2020); Chief Financial
    Officer and Treasurer of SEC Registered Funds, and Senior Vice President, Head of European Special Purpose Vehicles Accounting and
    Administration, Avenue Capital Group (2010-2018)</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.3pt 0.5pt 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.5pt">Daniel Dufresne (1974)</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding: 0.25pt 0.5pt">Vice President (since 2021)</td>
    <td>&#160;</td>
    <td style="padding: 0.3pt 0.5pt 0.25pt">Executive Vice President and Chief Operating Officer, CAM, CILLC, Calamos Advisors, and CWM
    (since 2021); President, CGAM (since 2022); prior thereto Citadel (1999-2020); Partner (2008-2020); Managing Director,
    Global Treasurer (2008-2020); Global Head of Operations (2011-2020); Global Head of Counterparty Strategy (2018-2020); Senior Advisor
    to the COO (2020); CEO, Citadel Clearing LLC (2015-2020).</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 30; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s Board of Trustees consists of
seven members. In accordance with the Fund&#8217;s Agreement and Declaration of Trust, the Board of Trustees is divided into three classes
of approximately equal size. The terms of the trustees of the different classes are staggered. The terms of Virginia G. Breen and Lloyd
A. Wennlund will expire at the annual meeting of shareholders in 2025. The terms of John P. Calamos,&#160;Sr., William R. Rybak, and
Christopher M. Toub will expire at the annual meeting of shareholders in 2026. The terms of John E. Neal and Karen L. Stuckey will expire
at the annual meeting of shareholders in 2027. Such classification of the Trustees may prevent the replacement of a majority of the Trustees
for up to a two-year period. Each of the Fund&#8217;s officers serves until his or her successor is chosen and qualified or until his
or her resignation or removal by the Board of Trustees. In connection with the issuance of the MRP Shares, Mr.&#160;Rybak and Ms.&#160;Breen
were designated as the Trustees who represent the holders of preferred shares of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Committees of the Board of Trustees</i>. The
Fund&#8217;s Board of Trustees currently has five standing committees:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="text-decoration:underline">Executive Committee</span>. Messrs.&#160;John
P. Calamos,&#160;Sr. and John E. Neal are members of the Executive Committee, which has authority during intervals between meetings of
the Board of Trustees to exercise the powers of the Board, with certain exceptions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="text-decoration:underline">Audit Committee</span>. Messrs.&#160;William
R. Rybak (Chair), John E. Neal, Christopher M. Toub and Lloyd A. Wennlund and Mses. Virginia G. Breen and Karen L. Stuckey, each a non-interested
Trustee, serve on the Audit Committee. The Audit Committee operates under a written charter adopted and approved by the Board, a copy
of which is available on the Fund&#8217;s website, <span style="text-decoration:underline">www.calamos.com</span>. The Audit Committee selects independent auditors, approves
services to be rendered by the auditors, monitors the auditors&#8217; performance, reviews the results of the Fund&#8217;s audit, determines
whether to recommend to the Board that the Fund&#8217;s audited financial statements be included in the Fund&#8217;s annual report and
responds to other matters deemed appropriate by the Board of Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="text-decoration:underline">Governance Committee</span>. Mses. Virginia G.
Breen (Chair) and Karen L. Stuckey and Messrs.&#160;John E. Neal, William R. Rybak, Christopher M. Toub and Lloyd A. Wennlund, each a
non-interested Trustee, serve on the Governance Committee. The Governance Committee operates under a written charter adopted by the Board,
a copy of which is available on the Fund&#8217;s website, <span style="text-decoration:underline">www.calamos.com</span>. The Governance Committee oversees the independence
and effective functioning of the Board of Trustees and endeavors to be informed about good practices for investment company boards. The
members of the Governance Committee make recommendations to the Board of Trustees regarding candidates for election as non-interested
Trustees. The Governance Committee will consider shareholder recommendations regarding potential candidates for nomination as Trustees
properly submitted to the Governance Committee for its consideration. A Fund shareholder who wishes to nominate a candidate to the Fund&#8217;s
Board of Trustees must submit any such recommendation in writing via regular mail to the attention of the Fund&#8217;s Secretary, at
the address of the Fund&#8217;s principal executive offices. The shareholder recommendation must include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span>&#9679;</span></td>
    <td>the number and class of all Fund shares owned beneficially and of record by the nominating shareholder at the time the recommendation
    is submitted and the dates on which such shares were acquired, specifying the number of shares owned beneficially;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>a full listing of the proposed candidate&#8217;s education, experience (including knowledge of the investment company industry,
    experience as a director or senior officer of public or private companies, and directorships on other boards of other registered
    investment companies), current employment, date of birth, business and residence address, and the names and addresses of at least
    three professional references;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>information as to whether the candidate is, has been or may be an &#8220;interested person&#8221; (as such term is defined in
    the 1940 Act) of the Fund, Calamos or any of its affiliates, and, if believed not to be or have been an &#8220;interested person,&#8221;
    information regarding the candidate that will be sufficient for the Committee to make such determination;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td style="padding-right: 53.2pt">the written and signed consent of the candidate to be named as a nominee and to serve as a Trustee
    of the Fund, if elected;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 53.2pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>a description of all arrangements or understandings between the nominating shareholder, the candidate and/or any other person
    or persons (including their names) pursuant to which the shareholder recommendation is being made, and if none, so specify;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>the class or series and number of all shares of the Fund owned of record or beneficially by the candidate, as reported by the
    candidate; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>such other information that would be helpful to the Governance Committee in evaluating the candidate.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p><div>


</div><!-- Field: Page; Sequence: 31; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Governance Committee may require the nominating
shareholder to furnish other information it may reasonably require or deem necessary to verify any information furnished pursuant to
the procedures delineated above or to determine the qualifications and eligibility of the candidate proposed by the nominating shareholder
to serve as a Trustee. If the nominating shareholder fails to provide such additional information in writing within seven days of receipt
of a written request from the Governance Committee, the recommendation of such candidate as a nominee will be deemed not properly submitted
for consideration, and the Governance Committee is not required to consider such candidate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise specified by the Governance
Committee&#8217;s chairman or by legal counsel to the non- interested Trustees, the Fund&#8217;s Secretary will promptly forward all
shareholder recommendations to the Governance Committee&#8217;s chairman and the legal counsel to the non-interested Trustees, indicating
whether the shareholder recommendation has been properly submitted pursuant to the procedures adopted by the Governance Committee for
the consideration of trustee candidates nominated by shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Recommendations for candidates as trustees will
be evaluated, among other things, in light of whether the number of Trustees is expected to change and whether the Trustees expect any
vacancies. During periods when the Governance Committee is not actively recruiting new Trustees, shareholder recommendations will be
kept on file until active recruitment is under way. After consideration of a shareholder recommendation, the Governance Committee may
dispose of the shareholder recommendation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except to the extent that such requirements are
waived by a majority of the Continuing Trustees (as defined in the Agreement and Declaration of Trust) then in office at the time of
nomination of such trustee, only persons satisfying the following qualification requirements may be nominated, elected, appointed, qualified
or seated (&#8220;nominated or seated&#8221;) to serve as trustee:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(A)&#160;An individual nominated or seated as
a trustee shall be at least twenty-one years of age and not older than the mandatory retirement age determined from time to time by the
trustees or a committee of the trustees, in each case at the time the individual is nominated or seated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(B)&#160;An individual nominated or seated as
a trustee shall, at the time the individual is nominated or seated, serve as a trustee or director of no more than 5 investment companies
(including the Fund) having securities registered under the Exchange Act (investment companies or individual series thereof having the
same investment adviser or investment advisers affiliated through a control relationship shall all be counted as a single company for
this purpose).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(C)&#160;An individual nominated or seated as
a trustee shall not serve or have served within the past 3 years as a trustee of any closed-end investment company which, while such
individual was serving as a trustee or within one year after the end of such service, ceased to be a closed-end investment company registered
under the 1940 Act, unless such individual was initially nominated for election as a trustee by the board of trustees of such closed-end
investment company or had served as a trustee since the inception of such closed-end investment company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(D)&#160;Except as set forth in Section&#160;4.6
of the By-Laws of the Fund, an individual nominated or seated as a trustee shall not be an employee, officer, partner, member, trustee,
director or 5% or greater shareholder in any investment adviser (other than the Fund&#8217;s investment adviser or any investment adviser
affiliated with the Fund&#8217;s investment adviser), collective investment vehicle primarily engaged in the business of investing in
&#8220;investment securities&#8221; (as defined in the 1940 Act) (an &#8220;investment company&#8221;) or entity controlling or controlled
by any investment adviser (other than the Fund&#8217;s investment adviser or any investment adviser affiliated with the Fund&#8217;s
investment adviser) or investment company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(E)&#160;An individual nominated or seated as
a trustee shall not be and shall not have been subject to any censure, order, consent decree (including consent decrees in which the
respondent has neither admitted nor denied the findings) or adverse final action of any federal, state or foreign governmental or regulatory
authority (including self-regulatory organizations), barring or suspending such individual from participation in or association with
any investment-related business or restricting such individual&#8217;s activities with respect to any investment-related business, nor
shall an individual nominated or seated as a trustee be the subject of any investigation or proceeding that could reasonably be expected
to result in an individual nominated or seated as a trustee failing to satisfy the requirements of this paragraph, nor shall any individual
nominated or seated as a trustee be or have engaged in any conduct that has resulted in, or could have reasonably been expected or would
reasonably be expected to result in, the Commission censuring, placing limitations on the activities, functions, or operations of, suspending,
or revoking the registration of any investment adviser under Section&#160;203(e)&#160;or (f)&#160;of the Investment Advisers Act of 1940,
as amended.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 32; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(F)&#160;An individual nominated or seated as
a trustee shall not have been charged (unless such charges were dismissed or the individual was otherwise exonerated) with a criminal
offense involving moral turpitude, dishonesty or breach of trust, or have been convicted or have pled guilty or nolo contendere with
respect to a felony under the laws of the United States or any state thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(G)&#160;An individual nominated or seated as
a trustee shall not be and shall not have been the subject of any of the ineligibility provisions contained in Section&#160;9(b)&#160;of
the 1940 Act that would permit, or could reasonably have been expected or would reasonably be expected to permit, the Commission by order
to prohibit, conditionally or unconditionally, either permanently or for a period of time, such individual from serving or acting as
an employee, officer, trustee, director, member of an advisory board, investment adviser or depositor of, or principal underwriter for,
a registered investment company or affiliated person (as defined in Section&#160;2(a)(3)&#160;of the 1940 Act) of such investment adviser,
depositor, or principal underwriter.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="text-decoration:underline">Dividend Committee</span>. Mr.&#160;John P. Calamos,&#160;Sr.
serves as the sole member of the dividend committee and Mr.&#160;Rybak serves as the liaison to the Dividend Committee for the non-interested
Trustees. The Dividend Committee is authorized, subject to Board review, to declare distributions on the Fund&#8217;s shares in accordance
with the Fund&#8217;s distribution policies, including, but not limited to, regular dividends, special dividends and short- and long-term
capital gains distributions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="text-decoration:underline">Valuation Committee</span>. Messrs.&#160;Lloyd
A. Wennlund (Chair), John E. Neal, William R. Rybak and Christopher M. Toub and Mses. Virginia G. Breen, and Karen L. Stuckey, each a
non-interested Trustee, serve on the Valuation Committee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Valuation Committee is responsible for overseeing
the implementation of the valuation procedures adopted by the Board of Trustees. The members of the Valuation Committee make recommendations
to the Board of Trustees regarding valuation matters relating to the Fund. The Valuation Committee operates under a written charter approved
by the board. The Valuation Committee oversees valuation matters of the Fund delegated to the valuation designee, including the fair
valuation determinations and methodologies proposed and utilized by the valuation designee, reviews the Fund&#8217;s valuation procedures
and their application by the valuation designee, reviews pricing errors and procedures for calculation of net asset value of each series
of the Fund and responds to other matters deemed appropriate by the Board.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition to the above committees, there is
a Board of Trustees directed pricing committee comprised of officers of the Fund and employees of Calamos.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table identifies the number of
meetings the Board of Trustees and each standing committee held during the fiscal year ended October&#160;31, 2024.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 33; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center"><b>NUMBER OF MEETINGS</b></td>
    <td style="white-space: nowrap; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center"><b>DURING FISCAL YEAR ENDED</b></td>
    <td style="white-space: nowrap; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><b>October&#160;31, 2024</b></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Board of Trustees</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 30%">5</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Executive Committee</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Audit Committee</td>
    <td>&#160;</td>
    <td style="text-align: center">4</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Governance Committee</td>
    <td>&#160;</td>
    <td style="text-align: center">3</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Dividend Committee<span style="font-size: 10pt"><sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Valuation Committee</td>
    <td>&#160;</td>
    <td style="text-align: center">4</td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><sup>(1)</sup></span>&#160;Although
the Dividend Committee held no meetings, it acted by written consent on 12 occasions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s Agreement and Declaration of
Trust provides that the Fund will indemnify the Trustees and officers against liabilities and expenses incurred in connection with any
claim in which they may be involved because of their offices with the Fund, unless it is determined in the manner specified in the Agreement
and Declaration of Trust that they have not acted in good faith in the reasonable belief that their actions were in the best interests
of the Fund or that such indemnification would relieve any officer or Trustee of any liability to the Fund or its shareholders by reason
of willful misfeasance, bad faith, gross negligence or reckless disregard of his or her duties.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Leadership Structure and Qualifications of
the Board of Trustees. </i>The Board of Trustees is responsible for oversight of the Fund. The Fund has engaged Calamos to manage the
Fund on a day-to-day basis. The Board of Trustees oversees Calamos and certain other principal service providers in the operations of
the Fund. The Board of Trustees is currently composed of seven members, six of whom are non-interested trustees. The Board of Trustees
meets in-person at regularly scheduled meetings four times throughout the year. In addition, the Board may meet in-person or by telephone
at special meetings or on an informal basis at other times. As described above, the Board of Trustees has established five standing committees
&#8212; Audit, Dividend, Executive, Governance and Valuation &#8212; and may establish ad hoc committees or working groups from time
to time, to assist the Board of Trustees in fulfilling its oversight responsibilities. The non-interested trustees also have engaged
independent legal counsel to assist them in fulfilling their responsibilities. Such independent legal counsel also serves as counsel
to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The chairman of the Board of Trustees is an &#8220;interested
person&#8221; of the Fund (as such term is defined in the 1940 Act). The non-interested trustees have appointed a lead independent trustee.
The lead independent trustee serves as a liaison between Calamos and the non-interested trustees and leads the non-interested trustees
in all aspects of their oversight of the Fund. Among other things, the lead independent trustee reviews and approves, with the chairman,
the agenda for each board and committee meeting and facilitates communication among the Fund&#8217;s non-interested trustees. The Trustees
believe that the Board&#8217;s leadership structure is appropriate given the characteristics and circumstances of the Fund. The Trustees
also believe that this structure facilitates the exercise of the Board&#8217;s independent judgment in fulfilling its oversight function
and efficiently allocates responsibility among committees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 34; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board of Trustees has concluded that, based
on each Trustee&#8217;s experience, qualifications, attributes or skills on an individual basis and in combination with those of the
other Trustees, each Trustee should serve as a member of the Board. In making this determination, the Board has taken into account the
actual service of the Trustees during their tenure in concluding that each should continue to serve. The Board also has considered each
Trustee&#8217;s background and experience. Set forth below is a brief discussion of the specific experience qualifications, attributes
or skills of each Trustee that led the Board to conclude that he should serve as a Trustee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each of Messrs.&#160;Calamos, Neal and Rybak
has served for more than ten years as a Trustee of the Fund. In addition, each of Mses. Breen and Stuckey and Messrs.&#160;Calamos, Neal,
Rybak, Toub and Wennlund has more than 25 years of experience in the financial services industry. Each of Mses. Breen and Stuckey and
Messrs.&#160;Calamos, Neal, Rybak and Wennlund has experience serving on boards of other entities, including other investment companies.
Each of Ms.&#160;Breen and Messrs.&#160;Calamos, Neal, Rybak and Toub has earned a Masters of Business Administration degree.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Risk Oversight. </i>The operation of a registered
investment company, including its investment activities, generally involves a variety of risks. As part of its oversight of the Fund,
the Board of Trustees oversees risk through various regular board and committee activities. The Board of Trustees, directly or through
its committees, reviews reports from, among others, Calamos, the Fund&#8217;s Compliance Officer, the Fund&#8217;s independent registered
public accounting firm, independent outside legal counsel, and internal auditors of Calamos or its affiliates, as appropriate, regarding
risks faced by the Fund and the risk management programs of Calamos and certain service providers. The actual day-to-day risk management
with respect to the Fund resides with Calamos and other service providers to the Fund. Although the risk management policies of Calamos
and the service providers are designed to be effective, there is no guarantee that they will anticipate or mitigate all risks. Not all
risks that may affect the Fund can be identified, eliminated or mitigated and some risks simply may not be anticipated or may be beyond
the control of the Board of Trustees or Calamos, its affiliates or other service providers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Compensation of Officers and Trustees. </i>John
P. Calamos,&#160;Sr., the trustee who is an &#8220;interested person&#8221; of the Fund, does not receive compensation from the Fund.
Although they are compensated, the non-interested trustees do not receive any pension or retirement benefits from the Fund. Mr.&#160;Mickey
is the only Trust officer who receives compensation from the Fund. The following table sets forth the total compensation (including any
amounts deferred, as described below) paid by the Fund during the periods indicated to each of the current trustees and officers compensated
by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 35; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Name</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Compensation
    from the<br/>
    Fund<br/> 11/1/23-10/31/24</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>Total Compensation
    from Calamos Funds<br/>
    Complex<sup>(2)</sup><br/> 11/1/23-10/31/24</b></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; font-size: 10pt; text-align: left; padding-left: 0.5pt">John P. Calamos, Sr</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Virginia G. Breen</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">8,682</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">261,250</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">John E. Neal<span style="font-size: 10pt"><sup>(1)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,968</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">301,250</td><td style="white-space: nowrap; font-size: 10pt; text-align: left"><sup>(3)</sup>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">William R. Rybak</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,612</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">231,250</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Karen L. Stuckey</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,612</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">231,250</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Christopher M. Toub</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,255</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">221,250</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Lloyd A. Wennlund</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,255</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">221,250</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Mark J. Mickey</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">6,253</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">189,742</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(1)&#160;Includes fees deferred during the relevant
period pursuant to a deferred compensation plan. Deferred amounts are treated as though such amounts have been invested and reinvested
in shares of one or more of the Funds as selected by the trustee. As of October&#160;31, 2024 the value of the deferred compensation
account of Mr.&#160;Neal was $3,153,951.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(2)&#160;The Fund Complex consists of Calamos
Investment Trust, Calamos Advisors Trust, Calamos Convertible Opportunities and Income Fund, Calamos Convertible and High Income Fund,
Calamos Strategic Total Return Fund, Calamos Global Total Return Fund, Calamos Global Dynamic Income Fund, Calamos Dynamic Convertible
and Income Fund, Calamos Long/Short Equity&#160;&amp; Dynamic Income Trust, Calamos ETF Trust, Calamos Antetokounmpo Sustainable Equities
Trust and Calamos Aksia-Alternative Credit and Income Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(3)&#160;Includes compensation received from
the Calamos Aksia Alternative Credit and Income Fund in the amount of $60,000. Such compensation is subject to a different compensation
schedule and allocation.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The compensation paid to the non-interested trustees
of Calamos Funds for their services as such consists of an annual retainer fee in the amount of $210,000, with annual supplemental retainers
of $40,000 to the lead independent trustee, $20,000 to the chair of the audit committee and $10,000 to the chair of any other committee.
Each non-interested trustee receives a meeting attendance fee of $7,000 for any special board meeting attended in person or $3,500 for
any special board meeting attended by telephone. Compensation paid to the non-interested trustees is allocated among the series of the
Calamos Funds in accordance with a procedure determined from time to time by the Board.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has adopted a deferred compensation
plan for non-interested trustees (the &#8220;Plan&#8221;). Under the Plan, a trustee who is not an &#8220;interested person&#8221; of
Calamos Advisors and has elected to participate in the Plan (a &#8220;participating trustee&#8221;) may defer receipt of all or a portion
of his or her compensation from the Fund in order to defer payment of income taxes or for other reasons. The deferred compensation payable
to the participating trustee is credited to the trustee&#8217;s deferred compensation account as of the business day such compensation
otherwise would have been paid to the trustee. The value of a trustee&#8217;s deferred compensation account at any time is equal to what
the value would be if the amounts credited to the account had instead been invested in shares of one or more of the funds as designated
by the trustee. Thus, the value of the account increases with contributions to the account or with increases in the value of the measuring
shares, and the value of the account decreases with withdrawals from the account or with declines in the value of the measuring shares.
If a participating trustee retires, the trustee may elect to receive payments under the plan in a lump sum or in equal annual installments
over a period of five years. If a participating trustee dies, any amount payable under the Plan will be paid to the trustee&#8217;s beneficiaries.
Each Calamos Fund&#8217;s obligation to make payments under the Plan is a general obligation of that Fund. No Fund is liable for any
other Fund&#8217;s obligations to make payments under the Plan.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 36; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Ownership of Shares of the Fund and Other
Calamos Funds</i>. The following table indicates the value of shares that each Trustee beneficially owns in the Fund and the Calamos
Fund Complex in the aggregate. The value of shares of the Calamos Funds is determined on the basis of the net asset value of the class
of shares held as of December&#160;31, 2024. The value of the shares held, are stated in ranges in accordance with the requirements of
the SEC. The table reflects the Trustee&#8217;s beneficial ownership of shares of the Calamos Fund Complex. Beneficial ownership is determined
in accordance with the rules&#160;of the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; width: 29%"><b>NAME OF TRUSTEE</b></td><td style="font-size: 10pt; font-weight: bold; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center; padding-left: 0.5pt; width: 32%"><p style="margin-top: 0; margin-bottom: 0">DOLLAR<br/>
                                            RANGE<br/> OF EQUITY <br/> SECURITIES<br/>
                                            IN THE FUND</p></td><td style="font-size: 10pt; font-weight: bold; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center; padding-left: 0.5pt; width: 35%"><p style="margin-top: 0; margin-bottom: 0">AGGREGATE
                                            DOLLAR RANGE OF EQUITY<br/> SECURITIES IN ALL<br/> REGISTERED<br/> INVESTMENT COMPANIES <br/>
                                            OVERSEEN BY TRUSTEE IN THE</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">CALAMOS FUNDS</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">John P. Calamos,&#160;Sr.<span style="font-size: 10pt"><sup>(1)(2)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Virginia G. Breen</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">None</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">John E. Neal</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">None</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">William R. Rybak</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">$50,001 &#8211; $100,000</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Karen L. Stuckey</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">None</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Christopher M. Toub</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">None</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Lloyd A. Wennlund</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">$10,001 - $50,000</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 0.5pt">Over $100,000</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>(1)</td>
    <td>Pursuant to Rule&#160;16a-1(a)(2)&#160;of the Exchange Act, John P. Calamos,&#160;Sr. may be deemed to have indirect beneficial
    ownership of Fund shares held by Calamos Investments LLC, its subsidiaries, and its parent companies (Calamos Asset Management,&#160;Inc.
    and Calamos Partners LLC, and its parent company, Calamos Family Partners,&#160;Inc.) due to his direct or indirect ownership interest
    in those entities. As a result, these amounts reflect any holdings of those entities in addition to the individual, personal accounts
    of John P. Calamos,&#160;Sr.</td></tr>
  <tr style="vertical-align: top">
    <td>(2)</td>
    <td style="text-align: justify">Indicates an &#8220;interested person&#8221; of the Trust, as defined in the 1940 Act.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Code of Ethics</i>. The Fund and Calamos have
adopted a code of ethics under Rule&#160;17j-1 under the 1940 Act which is applicable to officers, directors/Trustees and designated
employees of Calamos and CFS. Employees of Calamos and CFS are permitted to make personal securities transactions, including transactions
in securities that the Fund may purchase, sell or hold, subject to requirements and restrictions set forth in the code of ethics of Calamos
and CFS. The code of ethics contains provisions and requirements designed to identify and address certain conflicts of interest between
personal investment activities of Calamos and CFS employees and the interests of investment advisory clients such as the Fund. Among
other things, the code of ethics prohibits certain types of transactions absent prior approval, imposes time periods during which personal
transactions may not be made in certain securities, and requires the submission of duplicate broker confirmations and statements and
quarterly reporting of securities transactions. Additional restrictions apply to portfolio managers, traders, research analysts and others
involved in the investment advisory process. Exceptions to these and other provisions of the code of ethics may be granted in particular
circumstances after review by appropriate personnel. Text only versions of the code of ethics can be viewed online or downloaded from
the EDGAR Database on the SEC&#8217;s internet website at <span style="text-decoration:underline">www.sec.gov</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Affiliates of Calamos Advisors and CFS, CAM,
CILLC, Calamos Partners LLC ("CPL"), Calamos Family Partners,&#160;Inc. ("CFP") and the owners of these affiliates,
which include John P. Calamos,&#160;Sr. and members of his family ("Calamos Family"), may invest in and hedge investments made
by them in products managed by Calamos Advisors to support the continued growth of our investment products and strategies, including
investments to seed new products. Notwithstanding any provision to the contrary in the Code of Ethics, investments and corresponding
hedging transactions made by Calamos Advisors, CFS, CAM, CILLC, CPL, CFP and the Calamos Family in Calamos products (excluding Closed-End
Funds and ETFs) are not subject to restrictions of the Code of Ethics, such as the short-term trading ban. However, these hedging transactions
are subject to pre-clearance by the Corporate Investment Committee. Calamos Advisors' Chief Compliance Officer ("CCO") and
the Fund&#8217;s CCO are copied in the approval process. In addition, these entities do not receive preferential treatment over clients.
(They may, however, be traded together with discretionary client transactions.)</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The General Counsel may approve additional strategies
or instruments based on unusual market circumstances and on the determination that the transactions would not impact the broader market
or conflict with any customer activity.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Proxy Voting Procedures</i>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has delegated proxy voting responsibilities
to Calamos, subject to the board of trustees' general oversight. The Fund expects Calamos to vote proxies related to the Fund's portfolio
securities for which the Fund has voting authority consistent with the Fund's best interests. Calamos has adopted its own Proxy Voting
Policies and Procedures (the "Policies"). The Policies address, among other things, conflicts of interest that may arise between
the Fund&#8217;s interests, and the interests of Calamos and its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 37; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of the Policies used
by Calamos in voting proxies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To assist it in voting proxies, Calamos has established
a Proxy Review Committee ("committee") comprised of members of its Portfolio Management (which may include portfolio managers
and/or research analysts), Operations, Legal and Compliance Departments. The committee and/or its members will vote proxies using the
following guidelines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In general, if Calamos believes that a company's
management and board have interests sufficiently aligned with the Fund's interest, Calamos will vote in favor of proposals recommended
by the company's board. More specifically, Calamos seeks to ensure that the board of directors of a company is sufficiently aligned with
security holders' interests and provides proper oversight of the company's management. In many cases this may be best accomplished by
having a majority of independent board members. Calamos generally prefers that key committees such as audit, nominating, and compensation
committees be comprised of independent directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Because of the enormous variety and complexity
of transactions that are presented to shareholders, such as mergers, acquisitions, reincorporations, adoptions of anti-takeover measures
(including adoption of a shareholder rights plan, requiring supermajority voting on particular issues, adoption of fair price provisions,
issuance of blank check preferred stocks and the creation of a separate class of stock with unequal voting rights), changes to capital
structures (including authorizing additional shares, repurchasing stock or approving a stock split), executive compensation and option
plans, that occur in a variety of industries, companies and market cycles, it is extremely difficult to foresee exactly what would be
in the best interests of a Fund in all circumstances. Moreover, voting on such proposals involves considerations unique to each transaction.
Accordingly, Calamos will vote on a case-by-case basis on proposals presenting these transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos has assigned its administrative duties
with respect to the proxy analysis and voting decisions to the "Proxy Group" (the Investment team &#8212; research analysts
and portfolio management), and administrative processing to its Corporate Actions Group within the Operations Department. To assist it
in analyzing proxies, Calamos subscribes to Glass Lewis an unaffiliated third-party corporate governance research service that provides
in-depth analyses of shareholder meeting agendas, and voting recommendations. Glass Lewis facilitates the voting of each proxy by applying
Calamos' custom proxy voting rules&#160;("proxy voting policy") to the proposal(s). Any proxy proposal that is not covered
by the proxy voting guidelines is reviewed and considered by Calamos' proxy group and voted in accordance with that review. Calamos has
two sets of custom proxy voting rules: environmental, social and governance ("ESG") proxy voting rules, and non-ESG proxy voting
rules.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Finally, Calamos has established procedures to
help resolve conflicts of interests that might arise when voting proxies for the Funds. Calamos will generally apply its proxy voting
policy to proxy proposals regardless of whether a conflict has been identified. However, in these situations, the Proxy Group will refer
the proxy proposal, along with the recommended course of action, if any, to the Proxy Review Committee or a subcommittee thereof (each,
a "committee") for evaluation. The committee will independently review the proposals and determine the appropriate action to
be taken. The committee will then memorialize the conflict and the procedures used to address the conflict.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund is required to file with the SEC on
Form&#160;N-PX its complete proxy voting record for the 12-month period ending June&#160;30, by no later than August&#160;31 of each
year. The Fund's proxy voting record for the most recent 12-month period ending June&#160;30 will be available by August&#160;31 of each
year (1)&#160;on the SEC's website at www.sec.gov, and (2)&#160;on the Calamos Funds' website at www.calamos.com, and (3)&#160;without
charge, upon request, by calling 866.363.9219 or emailing <span style="text-decoration:underline">caminfo@calamos.com</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You may obtain a copy of Calamos' Policies by
calling 866.363.9219 or by writing Calamos at: Calamos Investments, Attn: Client Services, 2020 Calamos Court, Naperville,&#160;IL 60563,
and on the SEC's website at www.sec.gov.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 38; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Adviser and Investment Management Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the overall supervision and review
of the Board of Trustees, Calamos provides the Fund with investment research, advice and supervision and furnishes continuously an investment
program for the Fund, consistent with the investment objective and policies of the Fund. In addition, Calamos furnishes for use of the
Fund such office space and facilities as the Fund may require for its reasonable needs, supervises the Fund&#8217;s business and affairs
and provides the following other services on behalf of the Fund and not provided by persons not a party to the investment management
agreement: (i)&#160;preparing or assisting in the preparation of reports to and meeting materials for the Trustees; (ii)&#160;supervising,
negotiating contractual arrangements with, to the extent appropriate, and monitoring the performance of, accounting agents, custodians,
depositories, transfer agents and pricing agents, accountants, attorneys, printers, underwriters, brokers and dealers, insurers and other
persons in any capacity deemed to be necessary or desirable to Fund operations; (iii)&#160;assisting in the preparation and making of
filings with the SEC and other regulatory and self-regulatory organizations, including, but not limited to, preliminary and definitive
proxy materials, registration statements on Form&#160;N-2 and amendments thereto, and reports on Form&#160;N-CEN and Form&#160;N-CSR;
(iv)&#160;overseeing the tabulation of proxies by the Fund&#8217;s transfer agent; (v)&#160;assisting in the preparation and filing of
the Fund&#8217;s federal, state and local tax returns; (vi)&#160;assisting in the preparation and filing of the Fund&#8217;s federal
excise tax returns pursuant to Section&#160;4982 of the Code; (vii)&#160;providing assistance with investor and public relations matters;
(viii)&#160;monitoring the valuation of portfolio securities and the calculation of net asset value; (ix)&#160;monitoring the registration
of shares of beneficial interest of the Fund under applicable federal and state securities laws; (x)&#160;maintaining or causing to be
maintained for the Fund all books, records and reports and any other information required under the 1940 Act, to the extent that such
books, records and reports and other information are not maintained by the Fund&#8217;s custodian or other agents of the Fund; (xi)&#160;assisting
in establishing the accounting policies of the Fund; (xii)&#160;assisting in the resolution of accounting issues that may arise with
respect to the Fund&#8217;s operations and consulting with the Fund&#8217;s independent accountants, legal counsel and the Fund&#8217;s
other agents as necessary in connection therewith; (xiii)&#160;reviewing the Fund&#8217;s bills; (xiv)&#160;assisting the Fund in determining
the amount of dividends and distributions available to be paid by the Fund to its shareholders, preparing and arranging for the printing
of dividend notices to shareholders, and providing the transfer and dividend paying agent, the custodian, and the accounting agent with
such information as is required for such parties to effect the payment of dividends and distributions; and (xv)&#160;otherwise assisting
the Fund as it may reasonably request in the conduct of the Fund&#8217;s business, subject to the direction and control of the Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the investment management agreement, the
Fund pays to Calamos a fee based on the average weekly managed assets that is computed weekly and payable monthly in arrears. The fee
paid by the Fund is set at the annual rate of 0.80% of the Fund&#8217;s average weekly managed assets. Because the management fees paid
to Calamos are based upon a percentage of the Fund&#8217;s managed assets, the amount of management fees paid to Calamos when the Fund
uses leverage will be higher than if the Fund did not use leverage. Therefore, Calamos has a financial incentive to use leverage, which
creates a conflict of interest between Calamos and the Fund&#8217;s common shareholders. Subject to the oversight of the Board, Calamos
intends to use leverage only when it believes it will serve the best interests of the Fund&#8217;s common shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the terms of its investment management
agreement with the Fund, except for the services and facilities provided by Calamos as set forth therein, the Fund shall assume and pay
all expenses for all other Fund operations and activities and shall reimburse Calamos for any such expenses incurred by Calamos. The
expenses borne by the Fund shall include, without limitation: (a)&#160;organization expenses of the Fund (including out-of- pocket expenses,
but not including Calamos&#8217; overhead or employee costs); (b)&#160;fees payable to Calamos; (c)&#160;legal expenses; (d)&#160;auditing
and accounting expenses; (e)&#160;maintenance of books and records that are required to be maintained by the Fund&#8217;s custodian or
other agents of the Fund; (f)&#160;telephone, telex, facsimile, postage and other communications expenses; (g)&#160;taxes and governmental
fees; (h)&#160;fees, dues and expenses incurred by the Fund in connection with membership in investment company trade organizations and
the expense of attendance at professional meetings of such organizations; (i)&#160;fees and expenses of accounting agents, custodians,
subcustodians, transfer agents, dividend disbursing agents and registrars; (j)&#160;payment for portfolio pricing or valuation services
to pricing agents, accountants, bankers and other specialists, if any; (k)&#160;expenses of preparing share certificates; (l)&#160;expenses
in connection with the issuance, offering, distribution, sale, redemption or repurchase of securities issued by the Fund; (m)&#160;expenses
relating to investor and public relations provided by parties other than Calamos; (n)&#160;expenses and fees of registering or qualifying
shares of beneficial interest of the Fund for sale; (o)&#160;interest charges, bond premiums and other insurance expenses; (p)&#160;freight,
insurance and other charges in connection with the shipment of the Fund&#8217;s portfolio securities; (q)&#160;the compensation and all
expenses (specifically including travel expenses relating to Fund business) of Trustees, officers and employees of the Fund who are not
affiliated persons of Calamos; (r)&#160;brokerage commissions or other costs of acquiring or disposing of any portfolio securities of
the Fund; (s)&#160;expenses of printing and distributing reports, notices and dividends to shareholders; (t)&#160;expenses of preparing
and setting in type, printing and mailing prospectuses and statements of additional information of the Fund and supplements thereto;
(u)&#160;costs of stationery; (v)&#160;any litigation expenses; (w)&#160;indemnification of Trustees and officers of the Fund; (x)&#160;costs
of shareholders&#8217; and other meetings; (y)&#160;interest on borrowed money, if any; and (z)&#160;the fees and other expenses of listing
the Fund&#8217;s shares on Nasdaq or any other national stock exchange.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 39; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the fiscal years ended October&#160;31, 2022,
October&#160;31, 2023 and October&#160;31, 2024, the Fund incurred $11,304,501 and $9,659,681 and $9,356,352 respectively, in advisory
fees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The investment management agreement had an initial
term ending August&#160;1, 2003 and continues in effect from year to year thereafter so long as such continuation is approved at least
annually by (1)&#160;the Board of Trustees or the vote of a majority of the outstanding voting securities (as defined in the 1940 Act)
of the Fund, and (2)&#160;a majority of the Trustees who are not interested persons of any party to the investment management agreement,
cast in person at a meeting called for the purpose of voting on such approval. The investment management agreement may be terminated
at any time, without penalty, by either the Fund or Calamos upon 60 days&#8217; written notice, and is automatically terminated in the
event of its assignment as defined in the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos Advisors is a wholly-owned subsidiary
of Calamos Investments LLC (&#8220;CILLC&#8221;). Calamos Asset Management,&#160;Inc. (&#8220;CAM&#8221;) is the sole manager of CILLC.
As of January&#160;31, 2025, approximately 22% of the outstanding interests of CILLC was owned by CAM and the remaining approximately
78% of CILLC was owned by Calamos Partners LLC (&#8220;CPL&#8221;) and John P. Calamos,&#160;Sr. CAM was owned by John P. Calamos,&#160;Sr.
and John S. Koudounis, and CPL was owned by John S. Koudounis and Calamos Family Partners,&#160;Inc. (&#8220;CFP&#8221;). CFP was beneficially
owned by members of the Calamos family, including John P. Calamos,&#160;Sr. In addition, Mr.&#160;Koudounis has the option to purchase
a controlling interest in CPL upon the death or permanent disability of John P. Calamos,&#160;Sr., provided Mr.&#160;Koudounis is then
serving as Chief Executive Officer of CAM and CILLC. John P. Calamos,&#160;Sr. is an affiliated person of the Fund and Calamos Advisors
by virtue of his position as Chairman, Trustee and President of the Fund and Chairman and Global Chief Investment Officer (&#8220;Global
CIO&#8221;) of Calamos Advisors. John S. Koudounis, Thomas Kiley, Thomas E. Herman, Erik D. Ojala, Stephen Atkins, and Daniel Dufresne
are affiliated persons of the Fund and Calamos Advisors by virtue of their positions as Vice President; Vice President; Vice President
and Chief Financial Officer; Vice President and Secretary; Treasurer; and Vice President of the Fund, respectively, and as President
and Chief Executive Officer; Senior Vice President and Chief Distribution Officer; Executive Vice President and Chief Financial Officer;
Senior Vice President, General Counsel and Secretary; Senior Vice President and Head of Fund Administration; and Executive Vice President
and Chief Operating Officer of Calamos Advisors, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A discussion regarding the basis for the Board
of Trustees&#8217; decision to approve the renewal of the Investment Management Agreement is available in the Fund&#8217;s Form&#160;N-CSR
filing for the fiscal year ended October&#160;31, 2024.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The use of the name &#8220;Calamos&#8221; in
the name of the Fund is pursuant to licenses granted by CILLC, and the Fund has agreed to change its name to remove that reference if
Calamos ceases to act as investment adviser to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Managers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>John P. Calamos,&#160;Sr. </b>John P. Calamos,&#160;Sr.
has been President, Trustee and Co-Portfolio Manager of the Fund since inception and Founder of Calamos, Chairman and Global CIO of Calamos
since August&#160;2016; Chairman and Global CIO from April&#160;to August&#160;2016; Chairman, Chief Executive Officer and Global Co-CIO
between April&#160;2013 and April&#160;2016; Chief Executive Officer and Global Co-CIO between August&#160;2012 and April&#160;2013;
and Chief Executive Officer and Co-CIO prior thereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Dennis Cogan. </b>Dennis Cogan joined Calamos
in March&#160;2005 and since February&#160;2021 has been a Senior Co-Portfolio Manager. From March&#160;2013 to February&#160;2021, he
was Co-Portfolio Manager, and from March&#160;2005 to March&#160;2013, he was a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>R. Matthew Freund. </b>R. Matthew Freund joined
Calamos in November&#160;2016 as a Co-CIO, Head of Fixed Income Strategies, as well as a Senior Co-Portfolio Manager. Previously, he
was SVP of Investment Portfolio Management and Chief Investment Officer at USAA Investments since 2010.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 40; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>John Hillenbrand. </b>John Hillenbrand joined
Calamos in 2002 and since September&#160;2015 is a Co-CIO, Head of Multi-Asset Strategies and Co-Head of Convertible Strategies, as well
as a Senior Co-Portfolio Manager.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">From March&#160;2013 to September&#160;2015 he
was a Co-Portfolio Manager. Between August&#160;2002 and March&#160;2013 he was a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Nick Niziolek. </b>Nick Niziolek joined Calamos
in March&#160;2005 and has been a Co-CIO, Head of Global Strategies, as well as a Senior Co-Portfolio Manager, since September&#160;2015.
Between August&#160;2013 and September&#160;2015 he was a Co-Portfolio Manager, Co-Head of Research. Between March&#160;2013 and August&#160;2013
he was a Co-Portfolio Manager. Between March&#160;2005 and March&#160;2013 he was a senior strategy analyst.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Eli Pars. </b>Eli Pars joined Calamos in May&#160;2013
and has been Co-CIO, Co-Head of Alternative Strategies (since July&#160;2024; previously served as Head of Alternative Strategies from
September&#160;2015 to June&#160;2024) and Co-Head of Convertible Strategies, as well as a Senior Co-Portfolio Manager, since September&#160;2015.
Between May&#160;2013 and September&#160;2015, he was a Co-Portfolio Manager. Previously, he was a Portfolio Manager at Chicago Fundamental
Investment Partners from February&#160;2009 until November&#160;2012.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Jon Vacko. </b>Jon Vacko joined Calamos in
June&#160;2000 and has been a Senior Co-Portfolio Manager since September&#160;2015. Previously, he was a Co-Portfolio Manager from August&#160;2013
to September&#160;2015; prior thereto he was a Co-Head of Research and Investments from July&#160;2010 to August&#160;2013.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Joe Wysocki. </b>Joe Wysocki joined Calamos
in October&#160;2003 and since February&#160;2021 has been a Senior Co-Portfolio Manager. Previously, Mr.&#160;Wysocki was a Co-Portfolio
Manager from March&#160;2015 to January&#160;2021; sector head from March&#160;2014 to March&#160;2015; a Co-Portfolio Manager from March&#160;2013
to March&#160;2014; and a senior strategy analyst from February&#160;2007 to March&#160;2013.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Chuck Carmody.</b> <span>Chuck
Carmody joined Calamos in 2004 and since February&#160;2016 is a Co-Portfolio Manager (Co-Portfolio Manager of the Fund since December&#160;2023),
as well as a Senior Fixed Income Trader. From January&#160;2010 to February&#160;2016, he was a Senior Trader.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos employs a &#8220;team of teams&#8221;
approach to portfolio management, led by the Global CIO and our CIO team consisting of 5 Co-CIOs with specialized areas of investment
expertise. The Global CIO and Co-CIO team are responsible for oversight of investment team resources, investment processes, performance
and risk. As heads of investment verticals, Co-CIOs manage investment team members and, along with Co-Portfolio Managers and Associate
Portfolio Managers, have day-to-day portfolio oversight and construction responsibilities of their respective investment strategies.
While investment research professionals within each Co-CIO&#8217;s team are assigned specific strategy responsibilities, they also provide
support to other investment team verticals, creating deeper insights across a wider range of investment strategies. The combination of
specialized investment teams with cross team collaboration results in what we call our team of teams approach.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This team of teams approach is further reflected
in the composition of Calamos&#8217; Investment Committee, made up of the Global CIO, the Co-CIO team, and the Global Head of Trading.
Other members of the investment team participate in Investment Committee meetings in connection with specific investment related issues
or topics as deemed appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The structure and composition of the Investment
Committee results in a number of benefits, as it:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1in">&#160;</td>
    <td style="width: 0.25in"><span>&#9679;</span></td>
    <td style="padding-right: 51.1pt">Leads to broader perspective on investment decisions: multiple viewpoints and areas of expertise
    feed into consensus;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Promotes collaboration between teams; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td style="padding-right: 47.9pt">Functions as a think tank with the goal of identifying ways to outperform the market on a risk-adjusted
    basis.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The objectives of the Investment Committee are
to:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1in">&#160;</td>
    <td style="width: 0.25in"><span>&#9679;</span></td>
    <td style="padding-right: 89.3pt">Form&#160;the firm&#8217;s top-down macro view, market direction, asset allocation, and sector/country
    positioning.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Establish firm-wide secular and cyclical themes for review.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Review firm-wide and portfolio risk metrics, recommending changes where appropriate.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Review firm-wide, portfolio and individual security liquidity constraints.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Evaluate firm-wide and portfolio investment performance.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Evaluate firm-wide and portfolio hedging policies and execution.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span>&#9679;</span></td>
    <td>Evaluate enhancements to the overall investment process.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 41; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">John P. Calamos,&#160;Sr., Founder, Chairman
and Global CIO, is responsible for the day-to-day management of the team, bottom-up research efforts and strategy implementation. R.
Matthew Freund, John Hillenbrand, Nick Niziolek, Eli Pars, Dennis Cogan, Jon Vacko and Joe Wysocki are each Sr. Co-Portfolio Managers.
Chuck Carmody is a Co-Portfolio Manager.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For over 20 years, the Calamos portfolio management
team has managed money for their clients in convertible, high yield and global strategies. Furthermore, Calamos has extensive experience
investing in foreign markets through its convertible securities and high yield securities strategies. Such experience has included investments
in established as well as emerging foreign markets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Global CIO,&#160;Sr. Co-Portfolio Managers
and Co-Portfolio Managers also have responsibility for the day-to-day management of accounts other than the Fund. Information regarding
these other accounts as of October&#160;31, 2024 is set forth below:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Other Accounts Managed and Assets by Account
Type as of October&#160;31, 2024:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Registered <br/> Investment <br/> Companies</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Other Pooled <br/> Investment <br/> Vehicles</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Other <br/> Accounts</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; font-size: 10pt; text-align: left">John P. Calamos Sr.</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 11%; font-size: 10pt; text-align: right">24</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 13%; font-size: 10pt; text-align: right">31,210,097,989</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">5</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 12%; font-size: 10pt; text-align: right">896,426,294</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">5,855</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 13%; font-size: 10pt; text-align: right">5,075,208,287</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">R. Matthew Freund</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">20</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">15,315,388,721</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">751,999,671</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">5,478</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4,856,359,088</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">John Hillenbrand</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">18</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">13,354,445,885</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">5</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">896,426,294</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4,539</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4,029,636,748</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Nick Niziolek</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">11</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">8,707,116,616</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">184,109,235</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3,842</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2,556,885,569</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Eli Pars</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">30</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">29,822,961,767</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">946,433,073</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4,486</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3,904,974,731</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Jon Vacko</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">19</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">13,818,634,156</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">5</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">896,426,294</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4,504</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3,952,335,988</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Joe Wysocki</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">13</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">12,957,637,559</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">4</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">892,795,757</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3,605</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2,649,582,117</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Dennis Cogan</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">11</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">8,707,116,616</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">184,109,235</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">3,842</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2,556,885,569</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Chuck Carmody</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">10</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">9,239,356,808</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">558</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">1,271,170,829</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Number of Accounts and Assets for which Advisory
Fee is Performance Based as of October&#160;31, 2024:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Registered<br/> Investment <br/> Companies</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Other Pooled <br/> Investment <br/> Vehicles</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Other <br/> Accounts</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Accounts</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; font-size: 10pt; text-align: left">John P. Calamos Sr.</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 11%; font-size: 10pt; text-align: right">2</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 13%; font-size: 10pt; text-align: right">376,061,221</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 12%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 13%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">R. Matthew Freund</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">John Hillenbrand</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">376,061,221</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Nick Niziolek</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">376,061,221</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Eli Pars</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">376,061,221</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Jon Vacko</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">376,061,221</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Joe Wysocki</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Dennis Cogan</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">376,061,221</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Chuck Carmody</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each Co-Portfolio Manager may invest for his
own benefit in securities held in brokerage and mutual fund accounts. The information shown in the table does not include information
about those accounts where the Co-Portfolio Manager or members of his family have a beneficial or pecuniary interest because no advisory
relationship exists with Calamos or any of its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s Co-Portfolio Managers are responsible
for managing both the Fund and other accounts, including separate accounts and funds not required to be registered under the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Other than potential conflicts between investment
strategies, the side-by-side management of both the Fund and other accounts may raise potential conflicts of interest due to the interest
held by Calamos in an account and certain trading practices used by the portfolio managers (e.g., cross-trades between the Fund and another
account and allocation of aggregated trades). Calamos has developed policies and procedures reasonably designed to mitigate those conflicts.
For example, Calamos will place cross-trades in securities held by the Fund only in accordance with the rules&#160;promulgated under
the 1940 Act and has adopted policies designed to ensure the fair allocation of securities purchased on an aggregated basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 42; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The allocation methodology employed by Calamos
varies depending on the type of securities sought to be bought or sold and the type of client or group of clients. Generally, however,
orders are placed first for those clients that have given Calamos brokerage discretion (including the ability to step out a portion of
trades), and then to clients that have directed Calamos to execute trades through a specific broker. However, if the directed broker
allows Calamos to execute with other brokerage firms, which then book the transaction directly with the directed broker, the order will
be placed as if the client had given Calamos full brokerage discretion. Calamos and its affiliates frequently use a &#8220;rotational&#8221;
method of placing and aggregating client orders and will build and fill a position for a designated client or group of clients before
placing orders for other clients. A client account may not receive an allocation of an order if: (a)&#160;the client would receive an
unmarketable amount of securities based on account size; (b)&#160;the client has precluded Calamos from using a particular broker; (c)&#160;the
cash balance in the client account will be insufficient to pay for the securities allocated to it at settlement; (d)&#160;current portfolio
attributes make an allocation inappropriate; and (e)&#160;account specific guidelines, objectives and other account specific factors
make an allocation inappropriate. Allocation methodology may be modified when strict adherence to the usual allocation is impractical
or leads to inefficient or undesirable results. Calamos&#8217; head trader must approve each instance that the usual allocation methodology
is not followed and provide a reasonable basis for such instances and all modifications must be reported in writing to Calamos&#8217;
Chief Compliance Officer on a monthly basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Investment opportunities for which there is limited
availability generally are allocated among participating client accounts pursuant to an objective methodology (i.e., either on a pro
rata basis or using a rotational method, as described above). However, in some instances, Calamos may consider subjective elements in
attempting to allocate a trade, in which case the Fund may not participate, or may participate to a lesser degree than other clients,
in the allocation of an investment opportunity. In considering subjective criteria when allocating trades, Calamos is bound by its fiduciary
duty to its clients to treat all client accounts fairly and equitably.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Co-Portfolio Managers advise certain accounts
under a performance fee arrangement. A performance fee arrangement may create an incentive for a Co-Portfolio Manager to make investments
that are riskier or more speculative than would be the case in the absence of performance fees. A performance fee arrangement may result
in increased compensation to the Co-Portfolio Managers from such accounts due to unrealized appreciation as well as realized gains in
the client&#8217;s account.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of October&#160;31, 2024, John P. Calamos,&#160;Sr.,
our Global CIO, aside from distributions arising from his ownership from various entities, receives all of his compensation from Calamos.
He has entered into an employment agreement that provides for compensation in the form of an annual base salary and an annual bonus,
both components payable in cash. Similarly, Mr.&#160;Calamos is eligible for Calamos Advisors&#8217; Long-Term Incentive (&#8220;LTI&#8221;)
program.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of October&#160;31, 2024, R. Matthew Freund,
John Hillenbrand, Nick Niziolek, Eli Pars, Jon Vacko, Dennis Cogan, Joe Wysocki and Chuck Carmody receive all of their compensation from
Calamos. Compensation for portfolio management team members includes a competitive base salary, and an annual cash bonus (driven by investment,
company, and individual performance). Portfolio managers are also eligible for Calamos Advisors' Long-Term Incentive ("LTI")
program, which is an incentive award vesting over time that reflects appreciation and depreciation in the value of both the funds managed
by such professional and the company generally. LTI awards granted in 2024 vest on a three-year schedule (25% on or about the first anniversary
of the award grant, 25% on or about the second anniversary of the award grant, and 50% on or about the third anniversary of the award
grant). Each investment team LTI award will be allocated as follows: (i)&#160;33.3% to track the value of the associate's managed strategies,
(ii)&#160;33.3% to track the Calamos strategy of the associate's choice, and (iii)&#160;33.3% to track the value of the firm; all over
the vesting period. This compensation structure considers annually the performance of the various strategies managed by the Portfolio
Managers, among other factors, including, without limitation, the overall performance of the firm.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The amounts paid to all Co-Portfolio Managers,
together with the criteria utilized to determine such amounts, are benchmarked against industry specific data provided by third party
analytical agencies. This compensation structure considers annually the performance of the various strategies managed by the Co-Portfolio
Managers, among other factors, including, without limitation, the overall performance of the firm.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 43; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At October&#160;31, 2024, each portfolio manager
beneficially owned (as determined pursuant to Rule&#160;16a-1(a)(2)&#160;under the Exchange Act) shares of the Fund having value within
the indicated dollar ranges.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; width: 49%; font-size: 10pt; font-weight: bold; text-align: left">Portfolio Manager</td><td style="width: 2%; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 47%; font-size: 10pt; font-weight: bold; text-align: center"><b>Fund</b></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">John P. Calamos,&#160;Sr.<span style="font-size: 10pt"><sup>(1)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">$100,001 &#8211; $500,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Nick Niziolek</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Dennis Cogan</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">John Hillenbrand</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Jon Vacko</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">Joe Wysocki</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Eli Pars</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">R. Matthew Freund</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">None</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Chuck Carmody</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">$10,001-$50,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>(1)</td>
    <td>Pursuant to Rule&#160;16a-1(a)(2)&#160;of the Exchange Act, John P. Calamos,&#160;Sr. may be deemed to have indirect beneficial
    ownership of Fund shares held by Calamos Investments LLC, its subsidiaries, and its parent companies (Calamos Asset Management,&#160;Inc.
    and Calamos Partners LLC, and its parent company Calamos Family Partners,&#160;Inc.) due to his direct or indirect ownership interest
    in those entities. As a result, these amounts reflect any holdings of those entities in addition to the individual, personal accounts
    of John P. Calamos,&#160;Sr.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fund Accountant and Administration Arrangements</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has entered into an agreement with Ernst&#160;&amp;
Young LLP (&#8220;EY&#8221;) located at 155 N. Wacker Drive, Chicago,&#160;IL 60606 to provide certain tax services to the Fund. The
tax services include the following: calculating, tracking and reporting tax adjustments on all assets of the Fund, including but not
limited to contingent debt and preferred trust obligations; preparing excise tax and fiscal year distribution schedules; preparing tax
information required for financial statement footnotes; preparing state and federal income tax returns; preparing specialized calculations
of amortization on convertible securities; preparing year-end dividend disclosure information providing treaty-based foreign withholding
tax reclaim services; providing certain global compliance and reporting services; providing a match service and analysis of the &#8220;passive
foreign investment company&#8221; status of foreign corporate entities; and providing services related to corporate actions that may
or may not have a tax impact on the Fund&#8217;s holdings. For the fiscal years ended October&#160;31, 2024, October&#160;31, 2023, and
October&#160;31, 2022, the Fund paid EY $72,964, $52,367, and $65,183, respectively, for tax services.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the arrangements with State Street Bank
and Trust Company (&#8220;State Street&#8221;) located at One Iron Street, Boston, MA 02111 to provide fund accounting services, State
Street provides certain administrative and accounting services including providing daily reconciliation of cash, trades and positions;
maintaining general ledger and capital stock accounts; preparing daily trial balance; calculating net asset value; providing selected
general ledger reports; preferred share compliance; calculating total returns; and providing monthly distribution analysis to the Fund.
For the fiscal years ended October&#160;31, 2024, October&#160;31, 2023, and October&#160;31, 2022, the Fund paid State Street $78,292,
$82,304, and $89,833, respectively, for fund accounting services. The Fund has also entered into an agreement with State Street pursuant
to which State Street provides certain administration treasury services to the Fund. These services include: monitoring the calculation
of expense accrual amounts for the Fund and making any necessary modifications; managing the Fund&#8217;s expenses and expense payment
processing; coordinating any expense reimbursement calculations and payment; calculating net investment income dividends and capital
gain distributions; coordinating the audits for the Fund; preparing financial reporting statements for the Fund; preparing certain regulatory
filings; and calculating asset coverage tests for certain Calamos Funds. For the fiscal years ended October&#160;31, 2024, October&#160;31,
2023, and October&#160;31, 2022, the Fund paid State Street $71,047, $76,676, and $78,372, respectively, for administration services.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 44; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_005-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN SHAREHOLDERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At January&#160;31, 2025, the following persons
were known to own beneficially or of record more than 5% of the outstanding securities of the Fund:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Class&#160;of Shares</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Name and Address
    of Beneficial <br/> Owner</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt; font-weight: bold; text-align: center">Number of<br/>
    Shares <br/> Owned</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt; font-weight: bold; text-align: center">Percent<br/>
    of<br/> Class</td>
    <td style="text-align: left; font-size: 10pt; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 29%; font-size: 10pt; padding-left: 0.5pt; vertical-align: top">Common</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 37%; font-size: 10pt; text-align: left; padding-left: 0.5pt">Charles Schwab &amp; Co., Inc.<br/>
 2423 E. Lincoln Drive<br/>
 Phoenix, AZ 85016-1215</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; font-size: 10pt; text-align: right">13,180,347</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; font-size: 10pt; text-align: right">17.3</td>
    <td style="vertical-align: top; width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">National Financial Services LLC<br/>
 499 Washington Blvd.<br/>
 Jersey City, NJ 07310</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">10,875,846</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">14.3</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Merrill Lynch Pierce Fenner&#160;&amp; Smith<br/>
    4804 Deer Lake Dr.&#160;E. <br/> Jacksonville, FL 32246</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">6,977,937</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">9.1</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Morgan Stanley Smith Barney LLC<br/> 1300 Thames Street    <br/> Baltimore, MD 21231</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">6,788,211</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">8.9</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">UBS Financial Services Inc.<br/> 1000 Harbor Blvd<br/> Weehawken, NY 07086</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">6,443,979</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">8.4</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Wells Fargo Clearing Services LLC <br/> 2801 Market
    Street <br/> H0006-09B <br/> St. Louis, MO <br/> 63103</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">5,586,416</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">7.3</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt; text-align: left; padding-left: 0.5pt">Series&#160;C Mandatory Redeemable Preferred
    Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Massachusetts Mutual Life Insurance Company <br/>c/o Barings LLC
    <br/> 1500 Main Street &#8211; Suite&#160;2200 <br/>P.O.&#160;Box 15189<br/> Springfield, MA 0115-5189</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">1,076,000</td><td style="font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: right">80.3</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 45; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 29%; font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 36%; font-size: 10pt; text-align: left; padding-left: 0.5pt">Great-West Life&#160;&amp; Annuity
    <br/> 8525 East Orchard Road <br/> Greenwood Village, CO 80111 Company</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; width: 15%; font-size: 10pt; text-align: right">264,000</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; width: 15%; font-size: 10pt; text-align: right">19.7</td><td style="vertical-align: top; width: 1%; font-size: 10pt; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt; text-align: left; padding-left: 0.5pt">Series&#160;D Mandatory Redeemable Preferred
    Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Northwestern Mutual Life Insurance Company <br/>
    720 East Wisconsin Ave <br/> Milwaukee, WI 53202</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">480,000</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">34.29</td><td style="vertical-align: top; font-size: 10pt; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Metropolitan Life Insurance Company <br/> One MetLife
    Way <br/> Whippany, NJ 07981</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">476,000</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">34</td><td style="vertical-align: top; font-size: 10pt; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Metropolitan Life Insurance Company <br/> One MetLife
    Way <br/> Whippany, NJ 07981</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Thrivent Financial for Lutherans<br/> 901 Marquette
    Ave <br/> Minneapolis, MN 55402</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">400,000</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">28.6</td><td style="vertical-align: top; font-size: 10pt; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Thrivent Financial for Lutherans<br/> 901 Marquette
    Ave <br/> Minneapolis, MN 55402</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt; text-align: left; padding-left: 0.5pt">Series&#160;E Mandatory Redeemable Preferred
    Shares</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Metropolitan Life Insurance Company<br/> One MetLife Way<br/> Whippany,
    NJ 07981</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">740,000</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">50.7</td><td style="vertical-align: top; font-size: 10pt; text-align: right">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0.5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 0.5pt">Northwestern Mutual Life Insurance Company<br/> 720 East Wisconsin
    Ave Milwaukee, WI 53202</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">720,000</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="vertical-align: top; font-size: 10pt; text-align: right">49.3</td><td style="vertical-align: top; font-size: 10pt; text-align: right">%</td></tr>
  </table><div>




</div><p style="margin: 0"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0.25pt 0.5pt; text-align: left; vertical-align: top">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; padding-top: 0.25pt; padding-bottom: 0.25pt; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.25pt 0.5pt; text-align: left; width: 29%; vertical-align: top">Series&#160;G Mandatory Redeemable Preferred
    Shares</td>
    <td style="padding: 0.25pt 0.5pt; width: 1%">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; width: 36%"><p style="margin-top: 0; margin-bottom: 0">Northwestern Mutual Life Insurance Company<br/>
                                            720 East Wisconsin Ave</p>
                                      <p style="margin-top: 0; margin-bottom: 0">Milwaukee, WI 53202</p></td>
    <td style="padding: 0.25pt 0.5pt; width: 1%">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right; width: 15%">640,000</td>
    <td style="padding: 0.25pt 0.5pt; width: 1%">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right; width: 15%">44.4</td>
    <td style="text-align: right; padding-top: 0.25pt; padding-bottom: 0.25pt; width: 1%; vertical-align: top">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; padding-top: 0.25pt; padding-bottom: 0.25pt; vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">Metropolitan Life Insurance Company <br/>
    One MetLife Way <br/>
    Whippany, NJ 07981</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">624,000</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">43.3</td>
    <td style="text-align: right; vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="padding: 0.25pt 0.5pt">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; padding-top: 0.25pt; padding-bottom: 0.25pt; vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom"><span style="font-size: 10pt">Zurich Insurance Company Ltd<br/>
    1299 Zurich Way <br/>
    Schaumburg,&#160;Illinois 60196</span></td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">108,000</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt 0.5pt; vertical-align: top; text-align: right">7.5</td>
    <td style="text-align: right; vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt">%</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 46; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At January&#160;31, 2025, the trustees and officers
as a group owned less than one percent of the Fund&#8217;s outstanding common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_006-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PORTFOLIO TRANSACTIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Portfolio transactions on behalf of the Fund
effected on stock exchanges involve the payment of negotiated brokerage commissions. There is generally no stated commission in the case
of securities traded in the over-the- counter markets, but the price paid by the Fund usually includes an undisclosed dealer commission
or mark-up. In underwritten offerings, the price paid by the Fund includes a disclosed, fixed commission or discount retained by the
underwriter or dealer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In executing portfolio transactions, Calamos
seeks to obtain for the Fund the most favorable combination of price and execution available. In seeking the most favorable combination
of price and execution, Calamos considers all factors it deems relevant, including price, the size of the transaction, the nature of
the market for the security, the amount of commission, the timing of the transaction taking into account market prices and trends, the
execution capability of the broker-dealer and the quality of service rendered by the broker-dealer in other transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustees have determined that portfolio transactions
for the Fund may be executed through CFS, an affiliate of Calamos, if, in the judgment of Calamos, the use of CFS is likely to result
in prices and execution at least as favorable to the Fund as those available from other qualified brokers and if, in such transactions,
CFS charges the Fund commission rates consistent with those charged by CFS to comparable unaffiliated customers in similar transactions.
The Board of Trustees, including a majority of the Trustees who are not &#8220;interested&#8221; trustees, has adopted procedures that
are reasonably designed to provide that any commissions, fees or other remuneration paid to CFS are consistent with the foregoing standard.
The Fund will not effect principal transactions with CFS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In allocating the Fund&#8217;s portfolio brokerage
transactions to unaffiliated broker-dealers, Calamos may take into consideration the research, analytical, statistical and other information
and services provided by the broker- dealer, such as general economic reports and information, reports or analyses of particular companies
or industry groups, market timing and technical information, and the availability of the brokerage firm&#8217;s analysts for consultation.
Although Calamos believes these services have substantial value, they are considered supplemental to Calamos&#8217; own efforts in the
performance of its duties under the management agreement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 47; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Calamos does not guarantee any broker the placement
of a predetermined amount of securities transactions in return for the research or brokerage services it provides. Calamos has adopted
internal procedures which it believes are reasonably designed to allocate transactions in a manner consistent with its execution policies
to brokers that it has identified as providing research, research-related products or services, or execution-related services of a particular
benefit to its clients. Calamos has entered into client commission agreements (&#8220;CCAs&#8221;) with certain broker-dealers under
which the broker-dealers may use a portion of their commissions to pay third parties or other broker-dealers that provide Calamos with
research or brokerage services, as permitted under Section&#160;28(e)&#160;of the Exchange Act. CCAs allow Calamos to direct broker-dealers
to pool commissions that are generated from orders executed at that broker-dealer, and then periodically direct the broker-dealer to
pay third parties or other broker-dealers for research or brokerage services. All uses of CCAs by Calamos are subject to applicable law
and its best execution obligations. Brokerage and research products and services furnished by brokers may be used in servicing any or
all of the clients of Calamos and such research may not necessarily be used by Calamos in connection with the accounts which paid commissions
to the broker providing such brokerage and research products and services.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As permitted by Section&#160;28(e)&#160;of the
Exchange Act, Calamos may cause the Fund to pay a broker-dealer that provides brokerage and research services an amount of commission
for effecting a securities transaction for the Fund in excess of the commission that another broker-dealer would have charged for effecting
that transaction if the amount is believed by Calamos to be reasonable in relation to the value of the overall quality of the brokerage
and research services provided. Other clients of Calamos may indirectly benefit from the provision of these services to Calamos, and
the Fund may indirectly benefit from services provided to Calamos as a result of transactions for other clients.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund paid $0, $0, and $0 in aggregate brokerage
commissions for the fiscal years ended October&#160;31, 2022, October&#160;31, 2023 and October&#160;31, 2024, including $0, $0, and
$0 to CFS, which represented 0%, 0% and 0% of the Fund&#8217;s aggregate brokerage fees paid for the respective fiscal year, and 0%,
0%, and 0% of the Fund&#8217;s aggregate dollar amount of transactions involving brokerage commissions for the respective fiscal year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Turnover</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our annual portfolio turnover rate may vary greatly
from year to year. Although we cannot accurately predict our annual portfolio turnover rate, it is not expected to exceed 100% annually
under normal circumstances. For the fiscal years ended October&#160;31, 2023 and October&#160;31, 2024, the portfolio turnover rate was
39% and 50%, respectively. However, portfolio turnover rate is not considered a limiting factor in the execution of investment decisions
for the Fund, and it is possible that the Fund may exceed this level of turnover in any given year. A higher turnover rate results in
correspondingly greater brokerage commissions and other transactional expenses that are borne by the Fund. High portfolio turnover also
may result in the realization of capital gains or losses and, to the extent net short-term capital gains are realized, any distributions
resulting from such gains will be taxed at ordinary income tax rates for U.S. federal income tax purposes. See &#8220;Certain Federal
Income Tax Matters.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_007-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NET ASSET VALUE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Net asset value per share is determined no less
frequently than the close of regular session trading on the NYSE (usually 4:00 p.m., Eastern time), on the last business day in each
week, or such other time as the Fund may determine. The NYSE is regularly closed on New Year&#8217;s Day, the third Mondays in January&#160;and
February, Good Friday, the last Monday in May,&#160;Independence Day, Labor Day, Thanksgiving and Christmas. If the NYSE is closed due
to weather or other extenuating circumstances on a day it would typically be open for business, the Fund reserves the right to treat
such day as a Business Day and calculate the Fund&#8217;s NAV as of the normally scheduled close of regular trading on the NYSE or such
other time that the Fund may determine, in accordance with applicable law. The Fund reserves the right to close if the primary trading
markets of the Fund&#8217;s portfolio instruments are closed. On any business day when the Securities Industry and Financial Markets
Association (&#8220;SIFMA&#8221;) recommends that the securities markets close trading early or when the NYSE closes earlier than scheduled,
the Fund may (i)&#160;close trading early (as such, the time as of which the NAV is calculated would be advanced) or (ii)&#160;calculate
its NAV as of, the normally scheduled close of regular trading on the NYSE for that day.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 48; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Net asset value is calculated by dividing the
value of all of the securities and other assets of the Fund, less its liabilities (including accrued expenses and indebtedness) and the
aggregate liquidation value of any outstanding preferred shares, by the total number of common shares outstanding. Information that becomes
known to the Fund after the time as of which NAV has been calculated on a particular day will not generally be used to retroactively
adjust the price of a security or the NAV determined earlier that day. If regular trading on the NYSE closes earlier than scheduled,
the Fund reserves the right to either (i)&#160;calculate its NAV as of the earlier closing time or (ii)&#160;calculate its NAV as of
the normally scheduled close of regular trading on the NYSE for that day. The Fund generally does not calculate its NAV on days during
which the NYSE is closed. However, if the NYSE is closed on a day it would normally be open for business, the Fund reserves the right
to calculate its NAV as of the normally scheduled close of regular trading on the NYSE for that day or such other time that the Fund
may determine. Because the Fund may invest in securities that are primarily listed on foreign exchanges and trade on days when the Fund
does not price its shares, the Fund&#8217;s underlying assets may change in value on days when the NAV is not calculated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund's Board of Trustees, including a majority
of the Trustees who are not "interested persons" of the Fund, have designated Calamos Advisors to perform fair valuation determinations
related to all Fund investments under the oversight of the Board. As "valuation designee" Calamos Advisors has adopted procedures
to guide the determination of the NAV on any day on which the Fund's NAVs are determined. The valuation of the Fund's investments is
in accordance with these procedures. Fund securities that are traded on U.S. securities exchanges, except option securities, are valued
at the official closing price, which is the last current reported sales price on its principal exchange at the time the Fund determines
its net asset value ("NAV"). Securities traded in the over-the-counter market and quoted on The NASDAQ Stock Market are valued
at the NASDAQ Official Closing Price, as determined by NASDAQ, or lacking a NASDAQ Official Closing Price, the last current reported
sale price on NASDAQ at the time the Fund determines its NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">When a last sale or closing price is not available,
equity securities, other than option securities, that are traded on a U.S. securities exchange and other equity securities traded in
the over-the-counter market are valued at the mean between the most recent bid and asked quotations on its principal exchange in accordance
with guidelines adopted by the board of trustees. Each option security traded on a U.S. securities exchange is valued at the mid-point
of the consolidated bid/ask quote for the option security, also in accordance with guidelines adopted by the board of trustees. Each
over-the-counter option that is not traded through the Options Clearing Corporation is valued either by an independent pricing agent
approved by the board of trustees or based on a quotation provided by the counterparty to such option under the ultimate supervision
of the board of trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Fixed-income securities, bank loans, certain
convertible preferred securities, and non-exchange traded derivatives are normally valued by independent pricing services or by dealers
or brokers who make markets in such securities. Valuations of such fixed income securities, bank loans, certain convertible preferred
securities, and non-exchange traded derivatives consider yield or price of equivalent securities of comparable quality, coupon rate,
maturity, type of issue, trading characteristics and other market data and do not rely exclusively upon exchange or over-the-counter
prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Trading on European and Far Eastern exchanges
and over-the-counter markets is typically completed at various times before the close of business on each day on which the New York Stock
Exchange ("NYSE") is open. Each security trading on these exchanges or in over-the-counter markets may be valued utilizing
a systematic fair valuation model provided by an independent pricing service approved by the board of trustees. The valuation of each
security that meets certain criteria in relation to the valuation model is systematically adjusted to reflect the impact of movement
in the U.S. market after the foreign markets close. Securities that do not meet the criteria, or that are principally traded in other
foreign markets, are valued as of the last reported sale price at the time the respective Fund determines its NAV, or when reliable market
prices or quotations are not readily available, at the mean between the most recent bid and asked quotations as of the close of the appropriate
exchange or other designated time. Trading of foreign securities may not take place on every NYSE business day. In addition, trading
may take place in various foreign markets on Saturdays or on other days when the NYSE is not open and on which the respective Fund's
NAV is not calculated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the pricing committee determines that the
valuation of a security in accordance with the methods described above is not reflective of a fair value for such security, the security
is valued at a fair value by the pricing committee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund also may use fair value pricing, pursuant
to guidelines adopted by Calamos Advisors, if trading in the security is halted or if the value of a security it holds is materially
affected by events occurring before the Fund's pricing time but after the close of the primary market or exchange on which the security
is listed. Those procedures may utilize valuations furnished by pricing services approved by the Calamos Advisors, which may be based
on market transactions for comparable securities and various relationships between securities that are generally recognized by institutional
traders, a computerized matrix system, or appraisals derived from information concerning the securities or similar securities received
from recognized dealers in those securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 49; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPURCHASE OF COMMON SHARES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund is a closed-end investment company and
as such its shareholders will not have the right to cause the Fund to redeem their shares. Instead, the Fund&#8217;s common shares trade
in the open market at a price that is a function of several factors, including dividend levels (which are in turn affected by expenses),
net asset value, call protection, dividend stability, relative demand for and supply of such shares in the market, general market and
economic conditions and other factors. Because shares of a closed-end investment company may frequently trade at prices lower than net
asset value, the Fund&#8217;s Board of Trustees may consider action that might be taken to reduce or eliminate any material discount
from net asset value in respect of common shares, which may include the repurchase of such shares in the open market or in private transactions,
the making of a tender offer for such shares, or the conversion of the Fund to an open-end investment company. The Board of Trustees
may decide not to take any of these actions. In addition, there can be no assurance that share repurchases or tender offers, if undertaken,
will reduce market discount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notwithstanding the foregoing, at any time when
the Fund&#8217;s preferred shares are outstanding, the Fund may not purchase, redeem or otherwise acquire any of its common shares unless
(1)&#160;all accumulated preferred shares dividends have been paid and (2)&#160;at the time of such purchase, redemption or acquisition,
the net asset value of the Fund&#8217;s portfolio (determined after deducting the acquisition price of the common shares) is at least
200% of the liquidation value of the outstanding preferred shares (expected to equal the original purchase price per share plus any accrued
and unpaid dividends thereon). Any service fees incurred in connection with any tender offer made by the Fund will be borne by the Fund
and will not reduce the stated consideration to be paid to tendering shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to its investment restrictions, the Fund
may borrow to finance the repurchase of shares or to make a tender offer. Interest on any borrowings to finance share repurchase transactions
or the accumulation of cash by the Fund in anticipation of share repurchases or tenders will reduce the Fund&#8217;s net income. Any
share repurchase, tender offer or borrowing that might be approved by the Fund&#8217;s Board of Trustees would have to comply with the
Exchange Act, the 1940 Act and the rules&#160;and regulations thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although the decision to take action in response
to a discount from net asset value will be made by the Board of Trustees at the time it considers such issue, it is not currently anticipated
that the Board of Trustees would authorize repurchases of common shares or a tender offer for such shares if: (1)&#160;such transactions,
if consummated, would (a)&#160;result in the delisting of the common shares from Nasdaq, or (b)&#160;impair the Fund&#8217;s status as
a regulated investment company under the Code (which would make the Fund a taxable entity, causing the Fund&#8217;s income to be taxed
at the corporate level in addition to the taxation of shareholders who receive dividends from the Fund) or as a registered closed-end
investment company under the 1940 Act; (2)&#160;the Fund would not be able to liquidate portfolio securities in an orderly manner and
consistent with the Fund&#8217;s investment objective and policies in order to repurchase shares; or (3)&#160;there is, in the board&#8217;s
judgment, any (a)&#160;material legal action or proceeding instituted or threatened challenging such transactions or otherwise materially
adversely affecting the Fund, (b)&#160;general suspension of or limitation on prices for trading securities on Nasdaq, (c)&#160;declaration
of a banking moratorium by federal or state authorities or any suspension of payment by United States or New York banks, (d)&#160;material
limitation affecting the Fund or the issuers of its portfolio securities by federal or state authorities on the extension of credit by
lending institutions or on the exchange of foreign currency, (e)&#160;commencement of war, armed hostilities or other international or
national calamity directly or indirectly involving the United States, or (f)&#160;other event or condition which would have a material
adverse effect (including any adverse tax effect) on the Fund or its shareholders if shares were repurchased.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 50; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The repurchase by the Fund of its shares at prices
below net asset value will result in an increase in the net asset value of those shares that remain outstanding. However, there can be
no assurance that share repurchases or tender offers at or below net asset value will result in the Fund&#8217;s shares trading at a
price equal to their net asset value. Nevertheless, the fact that the Fund&#8217;s shares may be the subject of repurchase or tender
offers from time to time, or that the Fund may be converted to an open-end investment company, may reduce any spread between market price
and net asset value that might otherwise exist.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, a purchase by the Fund of its common
shares will decrease the Fund&#8217;s total managed assets which would likely have the effect of increasing the Fund&#8217;s expense
ratio. Any purchase by the Fund of its common shares at a time when preferred shares are outstanding will increase the leverage applicable
to the outstanding common shares then remaining.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Before deciding whether to take any action if
the common shares trade below net asset value, the Fund&#8217;s Board of Trustees would likely consider all relevant factors, including
the extent and duration of the discount, the liquidity of the Fund&#8217;s portfolio, the impact of any action that might be taken on
the Fund or its shareholders and market considerations. Based on these considerations, even if the Fund&#8217;s shares should trade at
a discount, the Board of Trustees may determine that, in the interest of the Fund and its shareholders, no action should be taken.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN FEDERAL INCOME
TAX MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary discussion of certain
U.S. federal income tax consequences that may be relevant to a shareholder or a noteholder (as the case may be) that acquires, holds
and/or disposes of the Fund&#8217;s securities. This discussion only addresses certain U.S. federal income tax consequences to U.S. shareholders
and noteholders (as the case may be) who hold their Fund securities as capital assets and does not address all of the U.S. federal income
tax consequences that may be relevant to particular shareholders and noteholders (as the case may be) in light of their individual circumstances.
This discussion also does not address all U.S. federal, state, local and foreign tax concerns affecting the Fund and its shareholders
and noteholders (including shareholders and noteholders subject to special tax rules&#160;and shareholders owning large positions in
the Fund), and the discussion set forth herein does not constitute tax advice. The discussion reflects applicable tax laws of the United
States as of the date of this Statement of Additional Information, which tax laws may be changed or subject to new interpretations by
the courts or the Internal Revenue Service (&#8220;IRS&#8221;) retroactively or prospectively. No assurance can be given that the IRS
would not assert, or that a court would not sustain, a position different from any of the tax aspects set forth below. The specific terms
of preferred shares and debt securities may result in different tax consequences to holders than those described herein. No attempt is
made to present a detailed explanation of all U.S. federal income tax concerns affecting the Fund and its shareholders and noteholders,
and the discussion set forth herein does not constitute tax advice. <b>Investors are urged to consult their own tax advisers to determine
the specific tax consequences to them of investing in the Fund, including the applicable federal, state, local and foreign tax consequences
to them and the effect of possible changes in tax laws.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Taxation of the Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund has elected to be treated, and intends
to qualify and to be eligible to be treated each year, as a &#8220;regulated investment company&#8221; under Subchapter M of the Code,
so that it will not pay U.S. federal income tax on investment company taxable income and capital gains timely distributed to shareholders.
If the Fund qualifies as a regulated investment company and distributes to its shareholders at least 90% of the sum of (i)&#160;its &#8220;investment
company taxable income&#8221; as that term is defined in the Code (which includes, among other things, dividends, taxable interest, the
excess of any net short-term capital gains over net long-term capital losses, taking into account certain capital loss carryforwards,
and certain net foreign currency exchange gains, less certain deductible expenses) without regard to the deduction for dividends paid
and (ii)&#160;the excess of its gross tax-exempt interest, if any, over certain disallowed deductions, the Fund will be relieved of U.S.
federal income tax on any income of the Fund, including long-term capital gains, distributed to shareholders. However, if the Fund retains
any investment company taxable income or &#8220;net capital gain&#8221; (i.e., the excess of net long-term capital gain over the sum
of net short-term capital loss and certain capital loss carryforwards), it will be subject to U.S. federal income tax at regular corporate
rates on the amount retained. The Fund intends to distribute at least annually, all or substantially all of its investment company taxable
income, net tax-exempt interest, if any, and net capital gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 51; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In determining its net capital gain, its taxable
income, and its earnings and profits, a regulated investment company generally may elect to treat part or all of any post-October&#160;capital
loss (defined as any net capital loss attributable to the portion, if any, of the taxable year after October&#160;31 or, if there is
no such loss, the net long-term capital loss or net short-term capital loss attributable to any such portion of the taxable year) or
late-year ordinary loss (generally, the sum of (i)&#160;net ordinary loss, if any, from the sale, exchange or other taxable disposition
of property, attributable to the portion, if any, of the taxable year after October&#160;31, and its (ii)&#160;other net ordinary loss,
if any, attributable to the portion of the taxable year, if any, after December&#160;31) as if incurred in the succeeding taxable year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Capital losses in excess of capital gains (&#8220;net
capital losses&#8221;) are not permitted to be deducted against the Fund&#8217;s net investment income. Instead, potentially subject
to certain limitations, the Fund may carry net capital losses from any taxable year forward to subsequent taxable years without expiration
to offset capital gains, if any, realized during such subsequent taxable years. Capital loss carryforwards are reduced to the extent
they offset current-year net realized capital gains, whether the Fund retains or distributes such gains. The Fund must apply such carryforwards
first against gains of the same character.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If for any taxable year the Fund did not qualify
as a regulated investment company for U.S. federal income tax purposes, it would be treated in the same manner as a regular corporation
subject to U.S. federal income tax and distributions to its shareholders would not be deductible by the Fund in computing its taxable
income. In such event, the Fund&#8217;s distributions, to the extent derived from the Fund&#8217;s current and accumulated earnings and
profits, would generally constitute ordinary dividends, which would generally be eligible for the dividends received deduction available
to corporate shareholders under Section&#160;243 of the Code, and noncorporate shareholders of the Fund would generally be able to treat
such distributions as &#8220;qualified dividend income&#8221; eligible for reduced rates of federal income taxation under Section&#160;1(h)(11)
of the Code, as described below, provided holding period and other requirements are met. The Fund could be required to recognize unrealized
gains, pay substantial taxes and interest and make substantial distributions before re-qualifying as a regulated investment company that
is accorded special tax treatment. If the Fund failed to qualify for a period greater than two taxable years, it would also be required
to elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss
that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized
for a period of five years.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the Code, the Fund will be subject to a
nondeductible 4% federal excise tax on its undistributed ordinary income for a calendar year and its undistributed capital gains for
the one-year period generally ending on October&#160;31 of such calendar year if it fails to meet certain distribution requirements with
respect to that year. Generally, the excise tax applies to the extent the Fund fails to distribute by the end of any calendar year at
least the sum of (i)&#160;98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii)&#160;98.2%
of its capital gains in excess of its capital losses (adjusted for certain ordinary losses). In addition, the minimum amounts that must
be distributed in any year to avoid the excise tax will be increased or decreased to reflect the total amount of any under-distribution
or over-distribution, as the case may be, from the previous year. For purposes of the required excise tax distribution, a regulated investment
company&#8217;s ordinary gains and losses from the sale, exchange, or other taxable disposition of property that would otherwise be taken
into account after October&#160;31 generally are treated as arising on January&#160;1 of the following calendar year. Also, for purposes
of the excise tax, the Fund will be treated as having distributed any amount on which it is subject to corporate income tax for the taxable
year ending within the calendar year. The Fund intends to generally make distributions in a timely manner and in an amount sufficient
to avoid such tax and accordingly does not expect to be subject to this excise tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 52; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In order to qualify as a regulated investment
company under Subchapter M of the Code, the Fund must, among other things, derive at least 90% of its gross income for each taxable year
from (i)&#160;dividends, interest, payments with respect to securities loans, gains from the sale or other disposition of stock, securities
or foreign currencies, or other income (including gains from options, futures and forward contracts) derived with respect to its business
of investing in such stock, securities or currencies and (ii)&#160;net income derived from interests in certain publicly traded partnerships
that derive less than 90% of their gross income from the items described in (i)&#160;above (each, a &#8220;Qualified Publicly Traded
Partnership&#8221;) (the &#8220;90% income test&#8221;). For purposes of the 90% income test, the character of income earned by certain
entities in which the Fund invests that are not treated as corporations for U.S. federal income tax purposes will generally pass through
to the Fund. Consequently, the Fund may be required to limit its equity investments in certain such entities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition to the 90% income test, the Fund
must also diversify its holdings (the &#8220;asset test&#8221;) so that, at the end of each quarter of its taxable year (i)&#160;at least
50% of the market value of the Fund&#8217;s total assets is represented by cash and cash items (including receivables), U.S. government
securities, securities of other regulated investment companies and other securities, with such other securities of any one issuer limited
for the purposes of this calculation to an amount not greater in value than 5% of the value of the Fund&#8217;s total assets and to not
more than 10% of the outstanding voting securities of such issuer, and (ii)&#160;not more than 25% of the market value of its total assets
is invested, including through corporations in which the Fund owns a 20% or more voting stock interest, in the securities (other than
U.S. government securities or securities of other regulated investment companies) of any one issuer or of two or more issuers controlled
by the Fund and engaged in the same, similar or related trades or businesses or in the securities of one or more Qualified Publicly Traded
Partnerships.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Foreign exchange gains and losses realized by
the Fund in connection with certain transactions involving foreign currency-denominated debt securities, certain options and futures
contracts relating to foreign currency, foreign currency forward contracts, foreign currencies, or payables or receivables denominated
in a foreign currency are subject to Section&#160;988 of the Code, which generally causes such gains and losses to be treated as ordinary
income and losses and may affect the amount, timing and character of distributions to shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund acquires any equity interest (generally
including not only stock but also an option to acquire stock such as is inherent in a convertible bond) in certain foreign corporations
that receive at least 75% of their annual gross income from passive sources (such as interest, dividends, certain rents and royalties,
or capital gains) or that hold at least 50% of their assets in investments held for the production of such passive income (&#8220;passive
foreign investment companies&#8221;), the Fund could be subject to U.S. federal income tax and additional interest charges on &#8220;excess
distributions&#8221; received from such companies or on gain from the sale of equity interests in such companies, even if all income
or gain actually received by the Fund is timely distributed to its shareholders. These investments could also result in the treatment
as ordinary income of associated gains on a sale of the investment. The Fund would not be able to pass through to its shareholders any
credit or deduction for such tax. Tax elections may generally be available that would ameliorate these adverse tax consequences, but
any such election could require the Fund to recognize taxable income or gain (which would be subject to the distribution requirements
described above) without the concurrent receipt of cash. The Fund may limit and/or manage its holdings in passive foreign investment
companies to limit its U.S. federal income tax liability or maximize its return from these investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund invests in certain pay-in-kind securities,
zero coupon securities, deferred interest securities or, in general, any other securities with original issue discount (&#8220;OID&#8221;)
(or with market discount if the Fund elects to include market discount in income currently), the Fund must accrue income on such investments
for each taxable year, which generally will be prior to the receipt of the corresponding cash payments. However, the Fund must distribute,
at least annually, all or substantially all of its investment company taxable income, including such accrued income, to shareholders
to avoid U.S. federal income and excise taxes. Therefore, the Fund may have to dispose of its portfolio securities under disadvantageous
circumstances to generate cash, or may have to leverage itself by borrowing the cash, to satisfy distribution requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may acquire market discount bonds. A
market discount bond is a security acquired in the secondary market at a price below its stated redemption price at maturity (or its
adjusted issue price if it is also an OID bond). If the Fund invests in a market discount bond, it will be required to treat any gain
recognized on the disposition of such market discount bond as ordinary income (instead of capital gain) to the extent of the accrued
market discount, unless the Fund elects to include the market discount in income as it accrues as discussed above. Such market discount
will not constitute qualified dividend income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 53; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may invest to a significant extent in
debt obligations that are in the lowest rating categories or are unrated, including debt obligations of issuers not currently paying
interest or who are in default. Investments in debt obligations that are at risk of or in default present special tax issues for the
Fund. The U.S. federal income tax laws are not entirely clear about issues such as when the Fund may cease to accrue interest, OID or
market discount, when and to what extent deductions may be taken for bad debts or worthless securities and how payments received on obligations
in default should be allocated between principal and income. These and other related issues will be addressed by the Fund when, as and
if it invests in such securities, in order to ensure that it distributes sufficient income to preserve its status as a regulated investment
company and does not become subject to U.S. federal income or excise taxes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Very generally, where the Fund purchases a bond
at a price that exceeds the stated redemption price at maturity &#8212; that is, at a premium &#8212; the premium is amortizable over
the remaining term of the bond. In the case of a taxable bond, if the Fund makes an election applicable to all such bonds it purchases,
which election is irrevocable without consent of the IRS, the Fund reduces the current taxable income from the bond by the amortized
premium and reduces its tax basis in the bond by the amount of such offset; upon the disposition or maturity of such bonds, the Fund
is permitted to deduct any remaining premium allocable to a prior period. In the case of a tax-exempt bond, tax rules&#160;require the
Fund to reduce its tax basis by the amount of amortized premium.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The interest on municipal bonds is generally
exempt from U.S. federal income tax. The Fund does not expect to invest 50% or more of its assets in municipal bonds on which the interest
is exempt from U.S. federal income tax, or in interests in other regulated investment companies. As a result, it does not expect to be
eligible to pay &#8220;exempt-interest dividends&#8221; to its shareholders under the applicable tax rules. As a result, interest on
municipal bonds is taxable to shareholders of the Fund when received as a distribution from the Fund. In addition, gains realized by
the Fund on the sale or exchange of municipal bonds are taxable to shareholders of the Fund when distributed to them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain of the Fund&#8217;s other investments
may cause the Fund to recognize income without the corresponding receipt of cash, which could result in the Fund being required to dispose
of its portfolio securities under disadvantageous circumstances to generate cash or leverage itself by borrowing cash to satisfy distribution
requirements and to avoid entity-level tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may engage in various transactions in
options, futures contracts, forward contracts, hedging instruments, straddles, swaps and other similar transactions. In addition to the
special rules&#160;described below, such transactions may be subject to special provisions of the Code that, among other things, affect
the character of any income realized by the Fund from such investments, accelerate recognition of income to the Fund, defer Fund losses,
affect the holding period of the Fund&#8217;s securities, affect whether distributions will be eligible for the dividends received deduction
or be treated as qualified dividend income and affect the determination of whether capital gain and loss is characterized as long-term
or short-term capital gain or loss. These rules&#160;could therefore affect the character, amount and timing of distributions to shareholders.
These provisions may also require the Fund to &#8220;mark-to-market&#8221; certain types of the positions in its portfolio (i.e., treat
them as if they were closed out), which may cause the Fund to recognize income without receiving cash with which to make distributions
in amounts necessary to satisfy the distribution requirements for avoiding U.S. federal income and excise taxes. Because these and other
tax rules&#160;applicable to these types of transactions are in some cases uncertain under current law, an adverse determination or future
guidance by the IRS with respect to these rules&#160;(which determination or guidance could be retroactive) may affect whether the Fund
has made sufficient distributions, and otherwise satisfied the relevant requirements, to maintain its qualification as a regulated investment
company and avoid a Fund-level tax. The Fund will monitor its transactions and will make the appropriate entries in its books and records
when it acquires an option, futures contract, forward contract, hedge instrument, swap or other similar investment, and if the Fund deems
it advisable, will make appropriate elections in order to mitigate the effect of these rules, prevent disqualification of the Fund as
a regulated investment company and minimize the imposition of U.S. federal income and excise taxes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 54; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain of the Fund&#8217;s investments in derivative
instruments and foreign currency denominated instruments, and any of the Fund&#8217;s transactions in foreign currencies and hedging
activities, are likely to produce a difference between its book income and the sum of its taxable income (including realized capital
gains) and net tax-exempt income (if any). If such a difference arises and the Fund&#8217;s book income is less than the sum of its taxable
income (including realized capital gains) and net tax-exempt income (if any), the Fund could be required to make distributions exceeding
book income to qualify as a regulated investment company that is accorded special tax treatment and to avoid a Fund-level tax. If the
Fund&#8217;s book income exceeds the sum of its taxable income (including realized capital gains) and net tax-exempt income (if any),
the distribution (if any) of such excess generally will be treated as (i)&#160;a dividend to the extent of the Fund&#8217;s remaining
current and accumulated earnings and profits (including earnings and profits arising from tax-exempt income), if any, (ii)&#160;thereafter,
as a return of capital to the extent of the recipient&#8217;s adjusted tax basis in its shares and (iii)&#160;thereafter, as gain from
the sale or exchange of a capital asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In general, option premiums received by the Fund
are not immediately included in the income of the Fund. Instead, the premiums are recognized when the option contract expires, the option
is exercised by the holder, or the Fund transfers or otherwise terminates the option (e.g., through a closing transaction). If a call
option written by the Fund is exercised and the Fund sells or delivers the underlying stock, the Fund generally will recognize capital
gain or loss equal to (a)&#160;the sum of the strike price and the option premium received by the Fund minus (b)&#160;the Fund&#8217;s
basis in the stock. Such gain or loss generally will be short-term or long-term depending upon the holding period of the underlying stock.
If securities are purchased by the Fund pursuant to the exercise of a put option written by it, the Fund generally will subtract the
premium received for purposes of computing its cost basis in the securities purchased. The termination of the Fund&#8217;s obligation
under an option other than through the exercise of the option will result in gain or loss, depending on whether the premium income received
by the Fund is greater or less than the amount paid by the Fund (if any) in terminating the transaction. Subject to certain exceptions,
some of which are described below, such gain or loss generally will be short-term. Thus, for example, if an option written by the Fund
expires unexercised, the Fund generally will recognize short-term gain equal to the premium received.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s options activities may include
transactions constituting straddles for U.S. federal income tax purposes, that is, that trigger the U.S. federal income tax straddle
rules&#160;contained primarily in Section&#160;1092 of the Code. Such straddles include, for example, positions in a particular security,
or an index of securities, and one or more options that offset the former position, including options that are &#8220;covered&#8221;
by the Fund&#8217;s long position in the subject security. Very generally, where applicable, Section&#160;1092 requires (i)&#160;that
losses be deferred on positions deemed to be offsetting positions with respect to &#8220;substantially similar or related property,&#8221;
to the extent of unrealized gain in the latter, and (ii)&#160;that the holding period of such a straddle position that has not already
been held for the long-term holding period be terminated and begin anew once the position is no longer part of a straddle. Options on
single stocks that are not &#8220;deep in the money&#8221; may constitute qualified covered calls, which generally are not subject to
the straddle rules; the holding period on stock underlying qualified covered calls that are &#8220;in the money&#8221; although not &#8220;deep
in the money&#8221; will be suspended during the period that such calls are outstanding. These straddle rules&#160;and the rules&#160;governing
qualified covered calls could cause gains that would otherwise constitute long-term capital gains to be treated as short-term capital
gains, and distributions that would otherwise constitute &#8220;qualified dividend income&#8221; or qualify for the dividends received
deduction to fail to satisfy the holding period requirements and therefore to be taxed as ordinary income or to fail to qualify for the
dividends received deduction, as the case may be.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s transactions in certain investments
(including broad based equity index options and certain other futures contracts) are generally considered &#8220;Section&#160;1256 contracts&#8221;
for federal income tax purposes. Any unrealized gains or losses on such Section&#160;1256 contracts are treated as though they were realized
at the end of each taxable year. The resulting gain or loss is treated as sixty percent long-term capital gain or loss and forty percent
short-term capital gain or loss, although certain foreign currency gains and losses from such contracts may be treated as ordinary in
character. Gain or loss recognized on actual sales of Section&#160;1256 contracts is treated in the same manner. As noted below, distributions
of net short-term capital gain are taxable to shareholders as ordinary income while distributions of net long-term capital gain that
are properly reported as capital gain dividends are taxable to shareholders as long-term capital gain, regardless of how long the shareholder
has held shares of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 55; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s entry into a short sale transaction,
an option or certain other contracts could be treated as the constructive sale of an appreciated financial position, causing the Fund
to realize gain, but not loss, on the position.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any investment by the Fund in equity securities
of REITs may result in the Fund&#8217;s receipt of cash in excess of the REIT&#8217;s earnings; if the Fund distributes these amounts,
these distributions could constitute a return of capital to Fund shareholders for U.S. federal income tax purposes. Dividends received
by the Fund from a REIT will not qualify for the corporate dividends-received deduction and generally will not constitute qualified dividend
income. The Fund may invest in REITs that hold residual interests in real estate mortgage investment conduits (&#8220;REMICs&#8221;).
Under a notice issued by the IRS, a portion of the Fund&#8217;s income from a REIT that is attributable to the REIT&#8217;s residual
interest in a REMIC (referred to in the Code as an &#8220;excess inclusion&#8221;) will be subject to U.S. federal income tax in all
events. This notice also provides that excess inclusion income of a regulated investment company, such as the Fund, will be allocated
to shareholders of the regulated investment company in proportion to the dividends received by such shareholders, with the same consequences
as if the shareholders held the related REMIC residual interest directly. In general, excess inclusion income allocated to shareholders
(i)&#160;cannot be offset by net operating losses (subject to a limited exception for certain thrift institutions), (ii)&#160;will constitute
unrelated business taxable income (&#8220;UBTI&#8221;) to entities (including a qualified pension plan, an individual retirement account,
a 401(k)&#160;plan, a Keogh plan or other tax-exempt entity) subject to federal income tax on unrelated business income, thereby potentially
requiring such an entity that is allocated excess inclusion income, and otherwise might not be required to file a federal income tax
return, to file a tax return and pay tax on such income, and (iii)&#160;in the case of a foreign shareholder, will not qualify for any
reduction in U.S. federal withholding tax. In addition, special tax consequences apply to charitable remainder trusts (&#8220;CRTs&#8221;)
that invest in regulated investment companies that invest directly or indirectly in residual interests in REMICs. Under legislation enacted
in December&#160;2006, a CRT, as defined in Section&#160;664 of the Code, that realizes any UBTI for a taxable year, must pay an excise
tax annually of an amount equal to such UBTI. Under IRS guidance issued in 2006, a CRT will not recognize UBTI solely as a result of
investing in a regulated investment company that recognizes &#8220;excess inclusion income.&#8221; Rather, if at any time during any
taxable year a CRT (or one of certain other tax-exempt shareholders, such as the United States, a state or political subdivision, or
an agency or instrumentality thereof, and certain energy cooperatives) is a record holder of a share in a regulated investment company
that recognizes &#8220;excess inclusion income,&#8221; then the regulated investment company will be subject to a tax on that portion
of its &#8220;excess inclusion income&#8221; for the taxable year that is allocable to such shareholders at the highest federal corporate
income tax rate. The extent to which this IRS guidance remains applicable in light of the December&#160;2006 legislation is unclear.
To the extent permitted under the 1940 Act, the Fund may elect to specially allocate any such tax to the applicable CRT, or other shareholder,
and thus reduce such shareholder&#8217;s distributions for the year by the amount of the tax that relates to such shareholder&#8217;s
interest in the Fund. The Fund has not yet determined whether such an election will be made. CRTs and other tax-exempt shareholders are
urged to consult their tax advisers concerning the consequences of investing in the Fund. The Fund does not intend to invest in REITs
in which a substantial portion of the assets will consist of residual interests in REMICs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund may be subject to withholding and other
taxes imposed by foreign countries, including taxes on interest, dividends and capital gains with respect to its investments in those
countries, which would, if imposed, reduce the yield on or return from those investments. If more than 50% of the value of the Fund&#8217;s
assets at the close of the taxable year consists of stock or securities of foreign corporations, the Fund may make an election under
the Code to pass through such taxes to shareholders of the Fund. If the Fund is eligible to and makes such an election, shareholders
will generally be able (subject to applicable limitations under the Code) to claim a credit or deduction (but not both) on their federal
income tax return for, and will be required to treat as part of the amounts distributed to them, their pro rata portion of the income
taxes paid by the Fund to foreign countries. If the Fund makes such an election, it will provide relevant information to its shareholders.
If such an election is not made, shareholders will not be required to include such taxes in their gross incomes and will not be entitled
to a tax deduction or credit for such taxes on their own federal income tax returns. Each prospective investor is urged to consult its
tax adviser regarding taxation of foreign securities in the Fund&#8217;s portfolio and any available foreign tax credits with respect
to the prospective investor&#8217;s own situation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Shares and Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Common Share Distributions</i>. Unless a shareholder
is ineligible to participate or elects otherwise, all distributions on common shares will be automatically reinvested in additional common
shares of the Fund pursuant to the Automatic Dividend Reinvestment Plan (the &#8220;Dividend Reinvestment Plan&#8221;). For U.S. federal
income tax purposes, dividends are generally taxable whether a shareholder takes them in cash or they are reinvested pursuant to the
Dividend Reinvestment Plan in additional shares of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 56; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Distributions of investment company taxable income
(determined without regard to the deduction for dividends paid), which includes dividends, taxable interest, net short-term capital gain
in excess of net long-term capital loss, taking into account certain capital loss carryforwards and certain net foreign currency exchange
gains, are, except as discussed below, taxable as ordinary income to the extent of the Fund&#8217;s current and accumulated earnings
and profits. A portion of such dividends may qualify for the dividends received deduction available to corporations under Section&#160;243
of the Code and the reduced rate of taxation under Section&#160;1(h)(11) of the Code that applies to &#8220;qualified dividend income&#8221;
received by noncorporate shareholders. In general, dividends of net investment income received by corporate shareholders of the Fund
qualify for the dividends received deduction generally available to corporations only to the extent of the amount of eligible dividends
received by the Fund from domestic corporations (other than REITs) for the taxable year. Qualified dividend income received by noncorporate
shareholders is taxed at rates equivalent to long-term capital gain tax rates. Qualified dividend income generally includes dividends
from domestic corporations and dividends from foreign corporations that meet certain specified criteria, although dividends paid by REITs
will not generally be eligible for treatment as qualified dividend income. The Fund generally can pass the tax treatment of dividends
eligible for the dividends received deduction and qualified dividend income it receives through to Fund shareholders. For the Fund to
receive tax-advantaged dividend income, the Fund must meet certain holding period requirements with respect to the stock on which the
dividend is paid. In addition, the Fund cannot be obligated to make payments (pursuant to a short sale or otherwise) with respect to
substantially similar or related property. Similar provisions, including holding period requirements, apply to each shareholder&#8217;s
investment in the Fund. Moreover, the dividends received deduction may otherwise be disallowed or reduced by application of various provisions
of the Code (for instance, the dividends received deduction is reduced in the case of a dividend received on debt-financed portfolio
stock (generally, stock acquired with borrowed funds)).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Distributions of net capital gains &#8212; that
is, the excess, if any, of net long-term gain over net short-term loss &#8212; properly reported by a Fund as capital gain dividends,
generally are taxable to shareholders as long-term capital gains, regardless of how long the shareholder has held a Fund&#8217;s shares,
and are not eligible for the dividends received deduction. The IRS and the Department of the Treasury have issued regulations that impose
special rules&#160;in respect of capital gain dividends received through partnership interests constituting &#8220;applicable partnership
interests&#8221; under Section&#160;1061 of the Code. Distributions of gains from investments that a Fund owned for one year or less
will generally be taxable to shareholders as ordinary income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any distributions in excess of a Fund&#8217;s
current and accumulated earnings and profits will be characterized as a return of capital to shareholders to the extent of their basis
in their Fund shares and, thereafter, as capital gain. A return of capital is not taxable, but it reduces a shareholder&#8217;s tax basis,
thus reducing any loss or increasing any gain on a subsequent taxable disposition of Fund shares. Distributions are taxable to shareholders
as described herein even if they are paid from income or gains earned by a Fund before a shareholder&#8217;s investment (and thus effectively
were included in the price the shareholder paid).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Distributions by the Fund to its shareholders
that the Fund properly reports as &#8220;section 199A dividends,&#8221; as defined and subject to certain conditions described below,
are treated as qualified REIT dividends in the hands of noncorporate shareholders. Noncorporate shareholders are permitted a federal
income tax deduction equal to 20% of qualified REIT dividends received by them, subject to certain limitations. Currently, eligible noncorporate
shareholders can claim the deduction for tax years beginning after December&#160;31, 2017, and ending on or before December&#160;31,
2025. Very generally, a &#8220;section 199A dividend&#8221; is any dividend or portion thereof that is attributable to certain dividends
received by a regulated investment company from REITs, to the extent such dividends are properly reported as such by the regulated investment
company in a written notice to its shareholders. A section 199A dividend is treated as a qualified REIT dividend only if the shareholder
receiving such dividend holds the dividend-paying regulated investment company shares for at least 46 days of the 91-day period beginning
45 days before the shares become ex-dividend, and is not under an obligation to make related payments with respect to a position in substantially
similar or related property. The Fund is permitted to report such part of its dividends as section 199A dividends as are eligible, but
is not required to do so.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund retains any net capital gain, the
Fund may report the retained amount as undistributed capital gains to shareholders who, if subject to U.S. federal income tax on long-term
capital gains, (i)&#160;will be required to include in income, as long-term capital gain, their proportionate share of such undistributed
amount, and (ii)&#160;will be entitled to credit their proportionate share of the federal income tax paid by the Fund on the undistributed
amount against their U.S. federal income tax liabilities, if any, and to claim refunds to the extent the credit exceeds such liabilities.
If the Fund makes this designation, for U.S. federal income tax purposes, the tax basis of shares owned by a shareholder of the Fund
will be increased by the difference between the amount of undistributed net capital gain included in the shareholder&#8217;s gross income
and the federal income tax deemed paid by the shareholder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 57; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If a shareholder&#8217;s distributions are automatically
reinvested pursuant to the Dividend Reinvestment Plan and the plan agent invests the distribution in shares acquired on behalf of the
shareholder in open-market purchases, for U.S. federal income tax purposes, the shareholder will be treated as having received a taxable
distribution in the amount of the cash dividend that the shareholder would have received if the shareholder had elected to receive cash.
If a shareholder&#8217;s distributions are automatically reinvested pursuant to the Dividend Reinvestment Plan and the plan agent invests
the distribution in newly issued shares of the Fund, the shareholder will generally be treated as receiving a taxable distribution equal
to the fair market value of the shares the shareholder receives.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the time of an investor&#8217;s purchase of
the Fund&#8217;s shares, a portion of the purchase price may be attributable to unrealized appreciation in the Fund&#8217;s portfolio
or undistributed taxable income of the Fund. Consequently, subsequent distributions by the Fund with respect to these shares from such
appreciation or income may be taxable to such investor even if the net asset value of the investor&#8217;s shares is, as a result of
the distributions, reduced below the investor&#8217;s cost for such shares and the distributions economically represent a return of a
portion of the investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any dividend declared by the Fund in October,
November&#160;or December&#160;with a record date in such a month and paid during the following January&#160;will be treated for U.S.
federal income tax purposes as paid by the Fund and received by shareholders on December&#160;31 of the calendar year in which it is
declared.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Preferred Share Distributions</i>. Under present
law and based in part on the fact that there is and will be no express or implied agreement between or among a broker-dealer or any other
party, and the Fund or any owners of preferred shares, that the broker-dealer or any other party will guarantee or otherwise arrange
to ensure that an owner of preferred shares will be able to sell his or her shares, the Fund has treated, and intends to continue to
treat, the preferred shares as equity for federal income tax purposes. As such, distributions with respect to the preferred shares (other
than distributions in redemption of the preferred shares subject to Section&#160;302(b)&#160;of the Code) will generally constitute dividends
to the extent of the Fund&#8217;s current and accumulated earnings and profits, as calculated for U.S. federal income tax purposes. Except
in the case of net long-term capital gain distributions, such dividends generally will be taxable at ordinary income tax rates to holders
of preferred shares but may qualify for the dividends received deduction available to corporate shareholders under Section&#160;243 of
the Code and the reduced rates of federal income taxation that apply to qualified dividend income received by noncorporate shareholders
under Section&#160;1(h)(11) of the Code. Distributions reported by the Fund as capital gain dividends will be taxable as long-term capital
gain regardless of the length of time a shareholder has held shares of the Fund. Please see the discussion above on qualified dividend
income, dividends received deductions and net capital gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The character of the Fund&#8217;s income will
not affect the amount of dividends which the holders of preferred shares are entitled to receive. If the preferred shares are auction
rate securities, holders of preferred shares are entitled to receive only the amount of dividends as determined by periodic auctions.
For U.S. federal income tax purposes, the IRS requires that a regulated investment company that has two or more classes of shares allocate
to each such class proportionate amounts of each type of its income (such as ordinary income and net capital gain) for each tax year.
Accordingly, the Fund intends to report distributions made with respect to the common shares and preferred shares as consisting of particular
types of income (e.g., net capital gain and ordinary income), in accordance with each class&#8217;s proportionate share of the total
dividends paid to both classes. Thus, each year the Fund will report dividends qualifying for the corporate dividends received deduction,
qualified dividend income, ordinary income and net capital gains in a manner that allocates such income between the preferred shares
and common shares in proportion to the total dividends made to each class with respect to such taxable year, or otherwise as required
by applicable law. In addition, solely for the purpose of satisfying the 90% distribution requirement and the distribution requirement
for avoiding income taxes, certain distributions made after the close of a taxable year of the Fund may be &#8220;spilled back&#8221;
and treated as paid during such taxable year. In such case, shareholders will be treated as having received such dividends in the taxable
year in which the distribution was actually made. The Fund intends to treat any dividends that are paid following the close of a taxable
year as &#8220;paid&#8221; in the prior year for purposes of determining a class&#8217;s proportionate share of a particular type of
income. The IRS has ruled privately that dividends paid following the close of the taxable year that are treated for federal income tax
purposes as derived from income from the prior year will be treated as dividends &#8220;paid&#8221; in the prior year for purposes of
determining the proportionate share of a particular type of income for each class. The private ruling is not binding on the IRS, and
there can be no assurance that the IRS will respect such treatment. Each shareholder will be notified of the allocation within 60 days
after the end of the year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 58; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although the Fund is required to distribute annually
at least 90% of its investment company taxable income (determined without regard to the deduction for dividends paid), the Fund is not
required to distribute net capital gains to the shareholders. The Fund may retain and reinvest such gains and pay federal income taxes
on such gains (the &#8220;net undistributed capital gain&#8221;). Please see the discussion above on undistributed capital gains. The
Fund intends to distribute its net capital gain for any year during which it has preferred shares outstanding.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although dividends generally will be treated
as distributed when paid, dividends declared in October, November&#160;or December&#160;with a record date in such a month, and paid
in January&#160;of the following year, will be treated as having been distributed by the Fund and received by the shareholders on December&#160;31
of the year in which the dividend was declared.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Earnings and profits are generally treated, for
federal income tax purposes, as first being used to pay distributions on preferred shares, and then to the extent remaining, if any,
to pay distributions on the common shares. Distributions in excess of current and accumulated earnings and profits of the Fund are treated
first as return of capital to the extent of the shareholder&#8217;s basis in the shares and, after the adjusted basis is reduced to zero,
will be treated as capital gain to a shareholder who holds such shares as a capital asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Fund utilizes leverage through borrowings,
or otherwise, asset coverage limitations imposed by the 1940 Act as well as additional restrictions that may be imposed by certain lenders
on the payment of dividends or distributions potentially could limit or eliminate the Fund&#8217;s ability to make distributions on its
common shares and/or preferred shares until the asset coverage is restored. These limitations could prevent the Fund from distributing
at least 90% of its investment company taxable income as is required under the Code and therefore might jeopardize the Fund&#8217;s qualification
as a regulated investment company and/or might subject the Fund to a nondeductible 4% federal excise tax. Upon any failure to meet the
asset coverage requirements imposed by the 1940 Act, the Fund may, in its sole discretion and to the extent permitted under the 1940
Act, purchase or redeem preferred shares in order to maintain or restore the requisite asset coverage and avoid the adverse consequences
to the Fund and its shareholders of failing to meet the distribution requirements. There can be no assurance, however, that any such
action would achieve these objectives. The Fund will endeavor to avoid restrictions on its ability to distribute dividends.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Sales of Fund Shares</i>. Sales and other
dispositions of the Fund&#8217;s shares, including a repurchase by the Fund of its shares, generally are taxable events for shareholders
that are subject to federal income tax. Selling shareholders will generally recognize gain or loss in an amount equal to the difference
between the amount received for such shares and their adjusted tax basis in the shares sold. If such shares are held as a capital asset
at the time of sale, the gain or loss will generally be a long-term capital gain or loss if the shares have been held for more than one
year and, if not held for such period, a short-term capital gain or loss. Similarly, a repurchase by the Fund, including as a result
of a tender offer by the Fund, if any, of all of the shares (common and preferred) actually and constructively held by a shareholder
generally will give rise to capital gain or loss under Section&#160;302(b)&#160;of the Code if the shareholder does not own (and is not
regarded under certain federal income tax law rules&#160;of constructive ownership as owning) any other common or preferred shares of
the Fund and provided that the proceeds from the purchase do not represent declared but unpaid dividends. If the Fund repurchases fewer
than all of a shareholder&#8217;s common shares or a shareholder continues to hold (directly or by attribution) other Fund shares (including
preferred shares if then outstanding) subsequent to a Fund repurchase, in certain circumstances such shareholder may be treated as having
received a distribution under Section&#160;301 of the Code (&#8220;Section&#160;301 distribution&#8221;) unless the repurchase is treated
as being either (i)&#160;&#8220;substantially disproportionate&#8221; with respect to such shareholder or (ii)&#160;otherwise &#8220;not
essentially equivalent to a dividend&#8221; under the relevant rules&#160;of the Code. A Section&#160;301 distribution is not treated
as a sale or exchange giving rise to capital gain or loss, but rather is treated as a dividend to the extent supported by the Fund&#8217;s
current and accumulated earnings and profits, with the excess treated as a return of capital reducing the shareholder&#8217;s tax basis
in its Fund shares, and thereafter as capital gain. Where a selling shareholder is treated as receiving a dividend, there is a risk that
non-selling shareholders whose percentage interests in the Fund increase as a result of such repurchase will be treated as having received
a taxable distribution from the Fund. The extent of such risk will vary depending upon the particular circumstances of the repurchase,
in particular whether such repurchase is a single and isolated event or is part of a plan for periodically repurchasing the common shares
of the Fund; if isolated, any such risk is likely remote.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 59; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Gain or loss will generally be long-term capital
gain or loss if the shares disposed of were held for more than one year and will be short-term capital gain or loss if the shares disposed
of were held for one year or less. Net long-term capital gain recognized by a noncorporate U.S. shareholder generally will be subject
to federal income tax at a lower rate than net short-term capital gain or ordinary income. For corporate holders, capital gain is generally
taxed for federal income tax purposes at the same rate as ordinary income. A holder&#8217;s ability to deduct capital losses may be limited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any loss realized by a shareholder upon the sale
or other disposition of shares with a tax holding period of six months or less will be treated as a long-term capital loss to the extent
of any amounts treated as distributions of long-term capital gain with respect to such shares. Losses on sales or other dispositions
of shares may be disallowed under &#8220;wash sale&#8221; rules&#160;in the event a shareholder acquires, or is treated as acquiring,
substantially identical stock or securities (including Fund shares acquired pursuant to the reinvestment of dividends) within a period
of 61 days beginning 30 days before and ending 30 days after a sale or other disposition of shares. In such a case, the disallowed portion
of any loss generally would be included in the U.S. federal income tax basis of the shares acquired. Shareholders should consult their
own tax advisers regarding their individual circumstances to determine whether any particular transaction in the Fund&#8217;s shares
is properly treated as a sale for U.S. federal income tax purposes and the tax treatment of any gains or losses recognized in such transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the dissolution of the Fund, shareholders
generally will realize capital gain or loss in an amount equal to the difference between the amount of cash or other property received
by the shareholder (including any property deemed received by reason of its being placed in a liquidating trust) and the shareholder&#8217;s
adjusted tax basis in shares of the Fund for U.S. federal income tax purposes. Any such gain or loss will be long-term if the shareholder
is treated as having a holding period in Fund shares of greater than one year, and otherwise will be short-term.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Federal Income Tax Withholding</i>. Federal
law requires that the Fund withhold, as &#8220;backup withholding,&#8221; a percentage of reportable payments, including dividends, capital
gain distributions and the proceeds of sales or other dispositions of the Fund&#8217;s shares paid to shareholders who have not complied
with IRS regulations. In order to avoid this withholding requirement, shareholders must certify on their account applications, or on
a separate IRS Form&#160;W-9, that the social security number or other taxpayer identification number they provide is their correct number
and that they are not currently subject to backup withholding, or that they are exempt from backup withholding. The Fund may nevertheless
be required to backup withhold if it receives notice from the IRS or a broker that the number provided is incorrect or backup withholding
is applicable. Backup withholding is not an additional tax. Any amounts withheld from payments made to a shareholder may be refunded
or credited against such shareholder&#8217;s U.S. federal income tax liability, if any, provided that the required information is furnished
to the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Other Matters</i>. Treasury regulations provide
that if a shareholder recognizes a loss with respect to Fund shares of at least $2 million in any single taxable year or $4 million in
any combination of taxable years for an individual, shareholder, or $10 million in any single taxable year or $20 million in any combination
of taxable years for a corporate shareholder, the shareholder must file with the IRS a disclosure statement on Form&#160;8886. Direct
shareholders of portfolio securities are in many cases excepted from this reporting requirement, but under current guidance, shareholders
of a regulated investment company are not excepted. Future guidance may extend the current exception from this reporting requirement
to shareholders of most or all regulated investment companies. The fact that a loss is reportable under these regulations does not affect
the legal determination of whether the taxpayer&#8217;s treatment of the loss is proper. Shareholders should consult their tax advisers
to determine the applicability of these regulations in light of their individual circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Special tax rules&#160;apply to investments through
defined contribution plans and other tax-qualified plans. Shareholders should consult their tax advisers to determine the suitability
of shares of the Fund as an investment through such plans and the precise effect of an investment on their particular tax situation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 60; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Taxation of Non-U.S. Shareholders. </i>The
description of certain federal income tax provisions above relates only to U.S. federal income tax consequences for shareholders who
are U.S. persons (i.e., U.S. citizens or resident aliens or U.S. corporations, partnerships, trusts or estates who are subject to U.S.
federal income tax on a net income basis). Investors other than U.S. persons, including non-resident alien individuals, may be subject
to different U.S. federal income tax treatment. With respect to such persons, the Fund must generally withhold U.S. federal withholding
tax at the rate of 30% (or, if the Fund receives certain certifications from such non-U.S. shareholder, such lower rate as prescribed
by an applicable tax treaty) on amounts treated as ordinary dividends from the Fund. However, the Fund is not required to withhold tax
on any amounts paid to a non-U.S. person with respect to capital gain dividends (that is, distributions of net capital gain that are
properly reported by the Fund as capital gain dividends), dividends attributable to &#8220;qualified short-term gain&#8221; (i.e., the
excess of net short-term capital gain over net long-term capital loss) reported as such by the Fund and dividends attributable to certain
U.S. source interest income of types similar to those not subject to federal withholding tax if earned directly by a non-U.S. person,
provided such amounts are properly reported by the Fund. <b>Shareholders should consult their own tax advisers on these matters and on
any specific question of U.S. federal, state, local, foreign and other applicable tax laws before making an investment in the Fund.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under present law, the Fund intends to treat
the debt securities as indebtedness for federal income tax purposes, which treatment the discussion below assumes. We intend to treat
all payments made with respect to the debt securities consistent with this characterization. The following discussion assumes that all
interest on the debt securities will be qualified stated interest (which is generally interest that is unconditionally payable at least
annually at a fixed or qualified floating rate), and that the debt securities will have a fixed maturity date of more than one year from
the date of issuance.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Taxation of Interest. </i>Payments or accruals
of interest on debt securities generally will be taxable to holders as ordinary interest income at the time such interest is received
(actually or constructively) or accrued, in accordance with the holder&#8217;s regular method of accounting for federal income tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Purchase, Sale and Redemption of Debt Securities.
</i>Initially, a holder&#8217;s tax basis in debt securities acquired generally will be equal to the cost to acquire such debt securities.
This basis will be increased by the amounts, if any, that the holder includes in income under the rules&#160;governing OID (taking into
account any acquisition premium that offsets such OID) and market discount, and will be decreased by the amount of any amortized premium
on such debt securities, as discussed below, and any payments on such debt securities other than stated interest. When the holder sells,
exchanges or redeems any of its debt securities, or otherwise disposes of its debt securities in a taxable transaction, the holder generally
will recognize gain or loss equal to the difference between the amount realized on the transaction (less any accrued and unpaid interest
(including any OID), which will be subject to federal income tax as interest in the manner described above) and the tax basis in the
debt securities relinquished.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as discussed below with respect to market
discount, the gain or loss recognized on the sale, exchange, redemption or other taxable disposition of any debt securities generally
will be capital gain or loss. Such gain or loss will generally be long-term capital gain or loss if the disposed debt securities were
held for more than one year and will be short-term capital gain or loss if the disposed debt securities were held for one year or less.
Net long-term capital gain recognized by a noncorporate U.S. holder generally will be subject to federal income tax at a lower rate than
net short-term capital gain or ordinary income. For corporate holders, capital gain is generally taxed for federal income tax purposes
at the same rate as ordinary income. A holder&#8217;s ability to deduct capital losses may be limited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Amortizable Premium. </i>If a holder purchases
debt securities at a cost greater than their stated redemption price at maturity, plus accrued interest, the holder will be considered
to have purchased the debt securities at a premium, and generally may elect to amortize this premium as an offset to interest income,
using a constant yield method, over the remaining term of the debt securities. If the holder makes the election to amortize the premium,
it generally will apply to all debt instruments held at the beginning of the first taxable year to which the election applies, as well
as any debt instruments that were subsequently acquired. In addition, the holder may not revoke the election without the consent of the
IRS. If the holder elects to amortize the premium, it will be required to reduce its tax basis in the debt securities by the amount of
the premium amortized during its holding period. If the holder does not elect to amortize premium, the amount of premium will be included
in the holder&#8217;s tax basis in the debt securities. Therefore, if the holder does not elect to amortize the premium and holds the
debt securities to maturity, the holder generally will be required to treat the premium as a capital loss when the debt securities are
redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 61; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Original Issue Discount. </i>If the stated
redemption price at maturity of the debt securities exceeds their issue price by at least the statutory <i>de minimis </i>amount, the
debt securities will be treated as being issued with OID for U.S. federal income tax purposes. The stated redemption price at maturity
includes all payments on the debt securities other than qualified stated interest, which is generally interest that is unconditionally
payable at least annually at a fixed or qualified floating rate. If the debt securities are issued with OID, you will be required to
include such OID in gross income (as ordinary income) as it accrues over the term of the debt securities on a constant-yield basis, in
advance of the receipt of cash attributable to that income and regardless of your regular method of accounting for U.S. federal income
tax purposes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Acquisition Premium. </i>If a holder purchases
debt securities that were issued with OID at a cost greater than their issue price and less than or equal to their stated redemption
price at maturity, the holder will be considered to have purchased the debt securities with acquisition premium. Such holder will generally
be permitted to reduce the daily portions of OID required to be included in income by a fraction, the numerator of which is the excess
of the holder&#8217;s initial basis in the debt securities over the debt securities&#8217; issue price, and the denominator of which
is the excess of the redemption price at maturity of the debt securities over their issue price.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Market Discount. </i>If the holder purchases
debt securities in the secondary market at a price that reflects a &#8220;market discount,&#8221; any principal payments on, or any gain
that the holder realized on the disposition of, the debt securities generally will be treated as ordinary interest income to the extent
of the market discount that accrued on the debt securities during the time such debt securities were held. &#8220;Market discount&#8221;
is defined under the Code as, in general, the excess (subject to a statutory de minimis amount) of the stated redemption price at maturity
(or in the case of an obligation issued with OID, its &#8220;revised issue price&#8221;) over the purchase price of the debt security.
In addition, the holder may be required to defer the deduction of all or a portion of any interest paid on any indebtedness incurred
or continued to purchase or carry the debt securities that were acquired at a market discount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holder may elect to include market discount
in gross income currently as it accrues (on either a ratable or constant yield basis), in lieu of treating a portion of any gain realized
on a sale of the debt securities as ordinary income. If the holder elects to include market discount on a current basis, the interest
deduction deferral rule&#160;described above will not apply and the holder will increase its basis in the debt security by the amount
of market discount included in gross income. If the holder does make such an election, it will apply to all market discount debt instruments
acquired on or after the first day of the first taxable year to which the election applies. This election may not be revoked without
the consent of the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Information Reporting and Backup Withholding</i>.
In general, information reporting requirements will apply to payments of principal, interest, and premium, if any, paid on debt securities
and to the proceeds of the sale of debt securities paid to U.S. holders other than certain exempt recipients (such as certain corporations)
provided they establish such exemption. Information reporting generally will apply to payments of interest on the debt securities to
non-U.S. Holders (as defined below) and the amount of tax, if any, withheld with respect to such payments. Copies of the information
returns reporting such interest payments and any withholding may also be made available to the tax authorities in the country in which
the non-U.S. Holder resides under the provisions of an applicable income tax treaty. In addition, for non-U.S. Holders, information reporting
will apply to the proceeds of the sale of debt securities within the United States or conducted through United States-related financial
intermediaries unless the certification requirements described below have been complied with and the statement described below in &#8220;Taxation
of Non-U.S. Holders&#8221; has been received (and the payor does not have actual knowledge or reason to know that the holder is a United
States person) or the holder otherwise establishes an exemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may be required to withhold, for U.S. federal
income tax purposes, a portion of all payments (including redemption proceeds) payable to holders of debt securities who fail to provide
us with their correct taxpayer identification number, who fail to make required certifications or who have been notified by the IRS that
they are subject to backup withholding (or if we have been so notified). Certain corporate and other shareholders specified in the Code
and the regulations thereunder are exempt from backup withholding. Backup withholding is not an additional tax. Any amounts withheld
may be credited against the holder&#8217;s U.S. federal income tax liability, provided the appropriate information is furnished to the
IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 62; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder who is a non-U.S. Holder may have to
comply with certification procedures to establish its non-U.S. status in order to avoid backup withholding tax requirements. The certification
procedures required to claim the exemption from withholding tax on interest income described below with respect to non-U.S. Holders will
satisfy these requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Taxation of Non-U.S. Holders</i>. If a holder
is a non-resident alien individual or a foreign corporation (a &#8220;non-U.S. Holder&#8221;), the payment of interest on the debt securities
generally will be considered &#8220;portfolio interest&#8221; and thus generally will be exempt from U.S. federal withholding tax. This
exemption will apply to the holder provided that (1)&#160;interest paid on the debt securities is not effectively connected with the
holder&#8217;s conduct of a trade or business in the United States, (2)&#160;the holder is not a bank whose receipt of interest on the
debt securities is described in Section&#160;881(c)(3)(A)&#160;of the Code, (3)&#160;the holder does not actually or constructively own
10 percent or more of the combined voting power of all classes of our stock entitled to vote, (4)&#160;the holder is not a controlled
foreign corporation that is related, directly or indirectly, to us through stock ownership, and (5)&#160;the holder satisfies the certification
requirements described below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To satisfy the certification requirements, either
(1)&#160;the holder of any debt securities must certify, under penalties of perjury, that such holder is a non-U.S. person and must provide
such owner&#8217;s name, address and taxpayer identification number, if any, on IRS Form&#160;W-8BEN or W-8BEN-E, or (2)&#160;a securities
clearing organization, bank or other financial institution that holds customer securities in the ordinary course of its trade or business
and holds the debt securities on behalf of the holder thereof must certify, under penalties of perjury, that it has received a valid
and properly executed IRS Form&#160;W-8BEN or W-8BEN-E from the beneficial holder and comply with certain other requirements. Special
certification rules&#160;apply for debt securities held by a foreign partnership and other intermediaries.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Interest on debt securities received by a non-U.S.
Holder that is not excluded from U.S. federal withholding tax under the portfolio interest exemption as described above generally will
be subject to withholding at a 30% rate, except where (1)&#160;the interest is effectively connected with the conduct of a U.S. trade
or business, in which case the interest will be subject to U.S. income tax on a net basis at graduated rates as applicable to U.S. holders
generally (and, in the case of corporate non-U.S. Holders, may be subject to an additional 30% branch profits tax) or (2)&#160;a non-U.S.
Holder can claim the benefits of an applicable income tax treaty to reduce or eliminate such withholding tax. To claim the benefit of
an income tax treaty or to claim an exemption from withholding because the interest is effectively connected with a U.S. trade or business,
a non-U.S. Holder must timely provide the appropriate, properly executed IRS forms. These forms may be required to be periodically updated.
Also, a non-U.S. Holder who is claiming the benefits of an income tax treaty may be required to obtain a U.S. taxpayer identification
number and to provide certain documentary evidence issued by foreign governmental authorities to prove residence in the foreign country.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any capital gain that a non-U.S. Holder realizes
on a sale, exchange or other disposition of debt securities generally will be exempt from U.S. federal income tax, including withholding
tax. This exemption will not apply to a holder whose gain is effectively connected with the conduct of a trade or business in the U.S.
or who is an individual holder and is present in the U.S. for a period or periods aggregating 183 days or more in the taxable year of
the disposition and, in each case, certain other conditions are met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">See &#8220;Information Reporting and Backup Withholding&#8221;
above for a general discussion of information reporting and backup withholding requirements applicable to non-U.S. Holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Tax Matters</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Medicare Tax on Certain Investment Income.
</i>Certain noncorporate taxpayers are subject to an additional tax of 3.8% with respect to the lesser of (1)&#160;their &#8220;net investment
income&#8221; (or undistributed &#8220;net investment income&#8221; in the case of an estate or trust) or (2)&#160;the excess of their
&#8220;modified adjusted gross income&#8221; over a threshold amount ($250,000 for married persons filing jointly and $200,000 for single
taxpayers). For this purpose, &#8220;net investment income&#8221; includes interest, dividends (including dividends paid with respect
to shares), annuities, royalties, rent, net gain attributable to the disposition of property not held in a trade or business (including
net gain from the sale, redemption, exchange or other taxable disposition of shares) and certain other income, but will be reduced by
any deductions properly allocable to such income or net gain.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 63; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Other Reporting and Withholding Requirements.
</i>Sections 1471-1474 of the Code and the U.S. Treasury and IRS guidance issued thereunder (collectively, &#8220;FATCA&#8221;) generally
require the Fund to obtain information sufficient to identify the status of each of its shareholders and holders of its debt securities
under FATCA or under an applicable intergovernmental agreement (an &#8220;IGA&#8221;) between the United States and a foreign government.
If a shareholder or holder of debt securities fails to provide the required information or otherwise fails to comply with FATCA or an
IGA, the Fund may be required to withhold under FATCA at a rate of 30% with respect to that holder on ordinary dividends and interest
payments. The IRS and the Department of Treasury have issued proposed regulations providing that these withholding rules&#160;will not
be applicable to the gross proceeds of share redemptions or capital gains dividends that the Fund pays. If a payment by the Fund is subject
to FATCA withholding, the Fund is required to withhold even if such payment would otherwise be exempt from withholding under the rules&#160;applicable
to non-U.S. persons. Each prospective investor is urged to consult its tax adviser regarding the applicability of FATCA and any other
reporting requirements with respect to the prospective investor&#8217;s own situation, including investments through an intermediary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Shareholders that are U.S. persons and own, directly
or indirectly, more than 50% of the Fund could be required to report annually their &#8220;financial interest&#8221; in the Fund&#8217;s
&#8220;foreign financial accounts,&#8221; if any, on FinCEN Form&#160;114, Report of Foreign Bank and Financial Accounts (FBAR). Shareholders
should consult a tax adviser regarding the applicability to them of this reporting requirement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Alternative Minimum Tax</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Investors may be subject to the federal alternative
minimum tax on their income (including taxable income from the Fund), depending on their individual circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CUSTODIAN, TRANSFER AGENT,
DIVIDEND DISBURSING AGENT AND REGISTRAR</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s securities and cash are held
under a custodian agreement with State Street Bank and Trust Company, 100 Lincoln Street, Boston, Massachusetts 02111. The transfer agent,
dividend disbursing agent and registrar for the Fund&#8217;s shares is Computershare Investor Services, P.O.&#160;Box 505000, Louisville,
KY 40233- 5000.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Deloitte&#160;&amp; Touche LLP, 111 S. Wacker
Drive, Chicago,&#160;IL 60606, serves as our independent registered public accounting firm. Deloitte&#160;&amp; Touche LLP provides audit
and audit-related services and consultation in connection with the review of our filing with the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADDITIONAL INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A Registration Statement on Form&#160;N-2, including
amendments thereto, relating to the securities offered hereby, has been filed by the Fund with the SEC, Washington, D.C. The prospectus,
any prospectus supplement and this Statement of Additional Information do not contain all of the information set forth in the Registration
Statement, including any exhibits and schedules thereto. For further information with respect to the Fund and the securities offered
hereby, reference is made to the Registration Statement. Statements contained in the prospectus, prospectus supplement and this Statement
of Additional Information as to the contents of any contract or other document referred to are not necessarily complete and in each instance
reference is made to the copy of such contract or other document filed as an exhibit to the Registration Statement, each such statement
being qualified in all respects by such reference. A copy of the Registration Statement may be reviewed on the SEC&#8217;s website at
http://www.sec.gov.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADDITIONAL INFORMATION
CONCERNING THE AGREEMENT AND DECLARATION OF TRUST</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Fund&#8217;s Agreement and Declaration of
Trust provides that the Fund&#8217;s Trustees shall have the power to cause each shareholder to pay directly, in advance or arrears,
for charges of the Fund&#8217;s custodian or transfer, shareholder servicing or similar agent, an amount fixed from time to time by the
Trustees, by setting off such charges due from such shareholder from declared but unpaid dividends owed such shareholder and/or by reducing
the number of shares in the account of such shareholder by that number of full and/or fractional shares which represents the outstanding
amount of such charges due from such shareholder. The Fund has no present intention of relying on this provision of the Agreement and
Declaration of Trust and would only do so if consistent with the 1940 Act or the rules&#160;and regulations or interpretations of the
SEC thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 64; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Financial
Statements</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Fund&#8217;s financial
statements appearing in the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924132100/tm2424550d2_ncsr.htm" style="-sec-extract: exhibit">Fund&#8217;s
annual shareholder report for the year ended October&#160;31, 2024</a> are incorporated by reference in this Statement of Additional
Information and have been so incorporated in reliance upon the reports of Deloitte&#160;&amp; Touche LLP, independent registered public
accounting firm for the Fund, which report is included in such annual shareholder reports and is incorporated by reference herein.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The annual shareholder
report is available without charge on its website at <span style="text-decoration:underline">www.calamos.com</span> or by request in writing to the Fund at 2020 Calamos Court,
Naperville,&#160;IL 60564.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INCORPORATION BY REFERENCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Statement of Additional Information is part
of a registration statement filed with the Commission. The Fund is permitted to &#8220;incorporate by reference&#8221; the information
filed with the Commission, which means that the Fund can disclose important information to you by referring you to those documents. The
information incorporated by reference is considered to be part of this Statement of Additional Information, and later information that
the Fund files with the SEC will automatically update and supersede this information. The documents listed below, and any reports and
other documents subsequently filed with the SEC pursuant to Rule&#160;30(b)(2)&#160;under the 1940 Act and Sections 13(a), 13(c), 14
or 15(d)&#160;of the Exchange Act, prior to the termination of the offering will be incorporated by reference into this Statement of
Additional Information and deemed to be part of this Statement of Additional Information from the date of the filing of such reports
and documents:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span>&#9679;</span></td>
    <td style="text-align: justify">The Fund&#8217;s prospectus, dated February&#160;21, 2025, filed with this Statement of Additional
    Information;</td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify"><span>&#9679;</span></td>
    <td style="text-align: justify"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924132100/tm2424550d2_ncsr.htm" style="-sec-extract: exhibit">the
    Fund&#8217;s Annual Report on Form&#160;N-CSR, filed on December&#160;27, 2024;</a></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify"><span>&#9679;</span></td>
    <td style="text-align: justify">the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1171471/000119312512287018/d369908d8a12b.htm" style="-sec-extract: exhibit">description
    of Common Shares on Form&#160;8-A, filed on June&#160;28, 2012</a>;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span>&#9679;</span></td>
    <td style="text-align: justify">the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1171471/000110465921109808/tm2122382d2_8k.htm" style="-sec-extract: exhibit">Form&#160;8-K,
    filed on August&#160;26, 2021</a>; and</td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify"><span>&#9679;</span></td>
    <td style="text-align: justify">the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1171471/000110465924060902/tm2413798d2_8k.htm" style="-sec-extract: exhibit">Form&#160;8-K,
    filed on May&#160;14, 2024</a>.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You may obtain copies of any information incorporated
by reference into this Statement of Additional Information, at no charge, by calling toll-free 800.582.6959 or by writing to the Fund
at 2020 Calamos Court, Naperville,&#160;IL 50463. The Fund&#8217;s periodic reports filed pursuant to Section&#160;30(b)(2)&#160;of the
1940 Act and Sections 13 and 15(d)&#160;of the Exchange Act, as well as the prospectus and this Statement of Additional Information,
are available on the Fund&#8217;s website http://www.calamos.com. In addition, the Commission maintains a website at www.sec.gov, free
of charge, that contains these reports, the Fund&#8217;s proxy statement and information statements, and other information relating to
the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 65; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPENDIX A &#8211; SUMMARY
OF CERTAIN PROVISIONS OF THE INDENTURE AND FORM&#160;OF SUPPLEMENTAL INDENTURE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of certain provisions
of the indenture (the &#8220;Original Indenture&#8221;) and the supplemental indenture (&#8220;Supplemental Indenture&#8221;) that the
Fund expects to enter into in connection with the issuance of debt securities. This summary does not purport to be complete and is qualified
in its entirety by reference to the indenture, a copy of which will be filed with the Commission in connection with an offering of debt
securities by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DEFINITIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>&#8216;AA&#8217; Composite Commercial
Paper Rate</b>&#8221; on any date means (i)&#160;the interest equivalent of (1)&#160;the 7-day rate, in the case of a Rate Period which
is 7 days or shorter, (2)&#160;the 30-day rate, in the case of a Rate Period which is a Standard Rate Period greater than 7 days but
fewer than or equal to 31 days, or (3)&#160;the 180-day rate, in the case of all other Rate Periods, on financial commercial paper on
behalf of issuers whose corporate bonds are rated &#8220;AA&#8221; by S&amp;P, or the equivalent of such rating by another nationally
recognized rating agency, as announced by the Federal Reserve Bank of New York for the close of business on the Business Day immediately
preceding such date; or (ii)&#160;if the Federal Reserve Bank of New York does not make available such a rate, then the arithmetic average
of the interest equivalent of such rates on financial commercial paper placed on behalf of such issuers, as quoted on a discount basis
or otherwise by the Commercial Paper Dealers to the Auction Agent for the close of business on the Business Day immediately preceding
such date (rounded to the next highest .001 of 1%). If any Commercial Paper Dealer does not quote a rate required to determine the &#8220;AA&#8221;
Composite Commercial Paper Rate, such rate shall be determined on the basis of the quotations (or quotation) furnished by the remaining
Commercial Paper Dealers (or Dealer), if any, or, if there are no such Commercial Paper Dealers, a nationally recognized dealer in commercial
paper of such issues then making such quotations selected by the Issuer. For purposes of this definition, (A)&#160;&#8220;Commercial
Paper Dealers&#8221; shall mean (1)&#160;and; (2)&#160;in lieu of any thereof, its respective Affiliate or successor; and (3)&#160;in
the event that any of the foregoing shall cease to quote rates for financial commercial paper of issuers of the sort described above,
in substitution therefor, a nationally recognized dealer in financial commercial paper of such issuers then making such quotations selected
by the Issuer, and (B)&#160;&#8220;interest equivalent&#8221; of a rate stated on a discount basis for financial commercial paper of
a given number of days&#8217; maturity shall mean a number equal to the quotient (rounded upward to the next higher one-thousandth of
1%) of (1)&#160;such rate expressed as a decimal, divided by (2)&#160;the difference between (x)&#160;1.00 and (y)&#160;a fraction, the
numerator of which shall be the product of such rate expressed as a decimal, multiplied by the number of days in which such commercial
paper shall mature and the denominator of which shall be 360.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Affiliate</b>&#8221; means any person
controlled by, in control of or under common control with the Issuer; provided that no Broker-Dealer controlled by, in control of or
under common control with the Issuer shall be deemed to be an Affiliate nor shall any corporation or any person controlled by, in control
of or under common control with such corporation one of the directors or executive officers of which is also a Director of the Issuer
be deemed to be an Affiliate solely because such director or executive officer is also a Director of the Issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Agent Member</b>&#8221; means a member
of or participant in the Securities Depository that will act on behalf of a Bidder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>All Hold Rate</b>&#8221; means 80%
of the &#8220;AA&#8221; Composite Commercial Paper Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Applicable Rate</b>&#8221; means the
rate determined in accordance with the procedures in Section&#160;2.02(c)(i)&#160;of this Supplemental Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction</b>&#8221; means each periodic
implementation of the Auction Procedures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 66; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Agent</b>&#8221; means unless
and until another commercial bank, trust company, or other financial institution appointed by a resolution of the Board of Directors
enters into an agreement with the Issuer to follow the Auction Procedures for the purpose of determining the Applicable Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Agreement</b>&#8221; means
the agreement between the Auction Agent and the Issuer pursuant to which the Auction Agent agrees to follow the procedures specified
in Appendix A-I to this Supplemental Indenture, as such agreement may from time to time be amended or supplemented.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Date</b>&#8221; means the first
Business Day next preceding the first day of a Rate Period for each series of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Desk</b>&#8221; means the business
unit of a Broker-Dealer that fulfills the responsibilities of the Broker- Dealer under a Broker-Dealer Agreement, including soliciting
Bids for the Notes, and units of the Broker-Dealer which are not separated by information controls appropriate to control, limit and
monitor the inappropriate dissemination of information about Bids.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Period</b>&#8221; means with
respect to the Notes, either a Standard Auction Period or a Special Auction Period, as applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Procedures</b>&#8221; means
the procedures for conducting Auctions set forth in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Auction Rate</b>&#8221; means for each
series of Notes for each Auction Period, (i)&#160;if Sufficient Clearing Bids exist, the Winning Bid Rate, provided, however, if all
of the Notes are the subject of Submitted Hold Orders, the All Hold Rate for such series of Notes and (ii)&#160;if Sufficient Clearing
Bids do not exist, the Maximum Rate for such series of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Authorized Denomination</b>&#8221;
means $25,000 and any integral multiple thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Available Notes</b>&#8221; means for
each series of Notes on each Auction Date, the number of Units of Notes of such series that are not the subject of Submitted Hold Orders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Beneficial Owner</b>,&#8221; with respect
to each series of Notes, means a customer of a Broker-Dealer who is listed on the records of that Broker-Dealer (or, if applicable, the
Auction Agent) as a holder of such series of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Bid</b>&#8221; shall have the meaning
specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Bidder</b>&#8221; means each Beneficial
Owner, Potential Beneficial Owner and Broker Dealer who places an Order.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Board of Directors</b>&#8221; or &#8220;<b>Board</b>&#8221;
means the Board of Directors of the Issuer or any duly authorized committee thereof as permitted by applicable law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Broker-Dealer</b>&#8221; means any
broker-dealer or broker-dealers, or other entity permitted by law to perform the function required of a Broker-Dealer by the Auction
Procedures, that has been selected by the Issuer and that is a party to a Broker-Dealer Agreement with the Auction Agent.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Broker-Dealer Agreement</b>&#8221;
means an agreement between the Auction Agent and a Broker-Dealer, pursuant to which such Broker-Dealer agrees to follow the Auction Procedures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Broker-Dealer Deadline</b>&#8221; means,
with respect to an Order, the internal deadline established by the Broker-Dealer through which the Order was placed after which it will
not accept Orders or any change in any Order previously placed with such Broker-Dealer; provided, however, that nothing shall prevent
the Broker- Dealer from correcting Clerical Errors by the Broker-Dealer with respect to Orders from Bidders after the Broker-Dealer Deadline
pursuant to the provisions herein. Any Broker-Dealer may change the time or times of its Broker-Dealer Deadline as it relates to such
Broker-Dealer by giving notice not less than two Business Days prior to the date such change is to take effect to Bidders who place Orders
through such Broker-Dealer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 67 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Business Day</b>&#8221; means a day
on which the New York Stock Exchange is open for trading and which is not a Saturday, Sunday or other day on which banks in the City
of New York, New York are authorized or obligated by law to close, days on which the Federal Reserve Bank of New York is not open for
business, days on which banking institutions or trust companies located in the state in which the operations of the Auction Agent are
conducted are authorized or required to be closed by law, regulation or executive order of the state in which the Auction Agent conducts
operations with respect to the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Clerical Error</b>&#8221; means a clerical
error in the processing of an Order, and includes, but is not limited to, the following: (i)&#160;a transmission error, including but
not limited to, an Order sent to the wrong address or number, failure to transmit certain pages&#160;or illegible transmission, (ii)&#160;failure
to transmit an Order received from one or more Existing Holders or Potential Beneficial Owners (including Orders from the Broker-Dealer
which were not originated by the Auction Desk) prior to the Broker-Dealer Deadline or generated by the Broker-Dealer&#8217;s Auction
Desk for its own account prior to the Submission Deadline or (iii)&#160;a typographical error. Determining whether an error is a &#8220;Clerical
Error&#8221; is within the reasonable judgment of the Broker-Dealer, provided that the Broker-Dealer has a record of the correct Order
that shows it was so received or so generated prior to the Broker- Dealer Deadline or the Submission Deadline, as applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Code</b>&#8221; means the Internal
Revenue Code of 1986, as amended.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Commercial Paper Dealers</b>&#8221;
has the meaning set forth in the definition of AA Composite Commercial Paper Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Commission</b>&#8221; means the Securities
and Exchange Commission.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Default Rate</b>&#8221; means the Reference
Rate multiplied by three (3).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Deposit Securities</b>&#8221; means
cash and any obligations or securities, including short term money market instruments that are Eligible Assets, rated at least, or by,
except that, such obligations or securities shall be considered &#8220;Deposit Securities&#8221; only if they are also rated at least
P-2 by Moody&#8217;s.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Discount Factor</b>&#8221; means the
Moody&#8217;s Discount Factor (if Moody&#8217;s is then rating the Notes), Discount Factor (if is then rating the Notes) or an Other
Rating Agency Discount Factor, whichever is applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Discounted Value</b>&#8221; means the
quotient of the Market Value of an Eligible Asset divided by the applicable Discount Factor, provided that with respect to an Eligible
Asset that is currently callable, Discounted Value will be equal to the quotient as calculated above or the call price, whichever is
lower, and that with respect to an Eligible Asset that is prepayable, Discounted Value will be equal to the quotient as calculated above
or the par value, whichever is lower.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Eligible Assets</b>&#8221; means Moody&#8217;s
Eligible Assets or &#8217;s Eligible Assets (if Moody&#8217;s or are then rating the Notes) and/or Other Rating Agency Eligible Assets,
whichever is applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Error Correction Deadline</b>&#8221;
means one hour after the Auction Agent completes the dissemination of the results of the Auction to Broker-Dealers without regard to
the time of receipt of such results by any Broker- Dealer; provided, however, in no event shall the Error Correction Deadline extend
past 4:00 p.m., New York City time unless the Auction Agent experiences technological failure or force majeure in disseminating the Auction
results which causes a delay in dissemination past 3:00 p.m., New York City time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Existing Holder</b>,&#8221; with respect
to Notes of a series, shall mean a Broker-Dealer (or any such other Person as may be permitted by the Issuer) that is listed on the records
of the Auction Agent as a holder of Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220; &#8221; means Ratings and its successors
at law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Discount Factor</b>&#8221; means the
discount factors set forth in the Guidelines for use in calculating the Discounted Value of the Issuer&#8217;s assets in connection with
&#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Eligible Asset</b>&#8221; means assets
of the Issuer set forth in the Guidelines as eligible for inclusion in calculating the Discounted Value of the Issuer&#8217;s assets
in connection with &#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Guidelines</b>&#8221; mean the guidelines
provided by, as may be amended from time to time, in connection with &#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Hold Order</b>&#8221; shall have the
meaning specified in Appendix A-I hereto or an Order deemed to have been submitted as provided in paragraph (c)&#160;of Section&#160;1
of Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Holder</b>&#8221; means, with respect
to Notes, the registered holder of notes of each series of Notes as the same appears on the books or records of the Issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Index</b>&#8221; means on any Auction
Date with respect to Notes in any Auction Period of 35 days or less the applicable LIBOR rate. The Index with respect to Notes in any
Auction Period of more than 35 days shall be the rate on United States Treasury Securities having a maturity which most closely approximates
the length of the Auction Period as last published in The Wall Street Journal or such other source as may be mutually agreed upon by
the Trustee and the Broker-Dealers. If either rate is unavailable, the Index shall be an index or rate agreed to by all Broker-Dealers
and consented to by the Issuer. For the purpose of this definition an Auction Period of 35 days or less means a 35-day Auction Period
or shorter Auction Period, i.e., a 35-day Auction Period which is extended because of a holiday would still be considered an Auction
Period of 35 days or less.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Interest Payment Date</b>&#8221; when
used with respect to any Notes, means the date on which an installment of interest on such Notes shall be due and payable which generally
shall be the day next following an Auction Date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>LIBOR</b>&#8221; means, for purposes
of determining the Reference Rate, (i)&#160;the rate for deposits in U.S. dollars for the designated Rate Period, which appears on display
page&#160;3750 of Moneyline&#8217;s Telerate Service (&#8220;Telerate Page&#160;3750&#8221;) (or such other page&#160;as may replace
that page&#160;on that service, or such other service as may be selected by Lehman Brothers Inc. or its successors) as of 11:00 a.m.,
London time, on the day that is the Business Day on the Auction Date or, if the Auction Date is not a Business Day, the Business Day
preceding the Auction Date (the &#8220;LIBOR Determination Date&#8221;), or (ii)&#160;if such rate does not appear on Telerate Page&#160;3750
or such other page&#160;as may replace such Telerate Page&#160;3750, (A)&#160;shall determine the arithmetic mean of the offered quotations
of the reference banks to leading banks in the London interbank market for deposits in U.S. dollars for the designated Rate Period in
an amount determined by reference to requests for quotations as of approximately 11:00 a.m.&#160;(London time) on such date made by to
the reference banks, (B)&#160;if at least two of the reference banks provide such quotations, LIBOR shall equal such arithmetic mean
of such quotations, (C)&#160;if only one or none of the reference banks provide such quotations, LIBOR shall be deemed to be the arithmetic
mean of the offered quotations that leading banks in The City of New York, New York selected by (after obtaining the Issuer&#8217;s approval)
are quoting on the relevant LIBOR Determination Date for deposits in U.S. dollars for the designated Rate Period in an amount determined
by (after obtaining the Issuer&#8217;s approval) that is representative of a single transaction in such market at such time by reference
to the principal London office of leading banks in the London interbank market; provided, however, that if is not a Broker-Dealer or
does not quote a rate required to determine LIBOR, LIBOR will be determined on the basis of the quotation or quotations furnished by
any other Broker-Dealer selected by the Issuer to provide such rate or rates not being supplied by; provided further, that if and/or
a substitute Broker- Dealer are required but unable to determine a rate in accordance with at least one of the procedures provided above,
LIBOR shall be the most recently determinable LIBOR. If the number of Rate Period days shall be (i)&#160;7 or more but fewer than 21
days, such rate shall be the seven-day LIBOR rate; (ii)&#160;more than 21 but fewer than 49 days, such rate shall be one-month LIBOR
rate; (iii)&#160;49 or more but fewer than 77 days, such rate shall be the two-month LIBOR rate; (iv)&#160;77 or more but fewer than
112 days, such rate shall be the three-month LIBOR rate; (v)&#160;112 or more but fewer than 140 days, such rate shall be the four-month
LIBOR rate; (vi)&#160;140 or more but fewer than 168 days, such rate shall be the five-month LIBOR rate; (vii)&#160;168 or more but fewer
189 days, such rate shall be the six-month LIBOR rate; (viii)&#160;189 or more but fewer than 217 days, such rate shall be the seven-
month LIBOR rate; (ix)&#160;217 or more but fewer than 252 days, such rate shall be the eight-month LIBOR rate; (x)&#160;252 or more
but fewer than 287 days, such rate shall be the nine-month LIBOR rate; (xi)&#160;287 or more but fewer than 315 days, such rate shall
be the ten-month LIBOR rate; (xii)&#160;315 or more but fewer than 343 days, such rate shall be the eleven-month LIBOR rate; and (xiii)&#160;343
or more days but fewer than 365 days, such rate shall be the twelve-month LIBOR rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 69 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Market Value</b>&#8221; means the market
value of an asset of the Issuer determined as follows: For equity securities, the value obtained from readily available market quotations.
If an equity security is not traded on an exchange or not available from a Board-approved pricing service, the value obtained from written
broker-dealer quotations. For fixed-income securities, the value obtained from readily available market quotations based on the last
sale price of a security on the day the Issuer values its assets or the market value obtained from a pricing service or the value obtained
from a direct written broker-dealer quotation from a dealer who has made a market in the security. &#8220;Market Value&#8221; for other
securities will mean the value obtained pursuant to the Issuer&#8217;s valuation procedures. If the market value of a security cannot
be obtained, or the Issuer&#8217;s investment adviser determines that the value of a security as so obtained does not represent the fair
value of a security, fair value for that security shall be determined pursuant to the valuation procedures adopted by the Board of Directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Maximum Rate</b>&#8221; means, on any
date on which the Applicable Rate is determined, the rate equal to the applicable percentage of the Reference Rate, subject to upward
but not downward adjustment in the discretion of the Board of Directors after consultation with the Broker-Dealers, provided that immediately
following any such increase the Issuer would be in compliance with the Notes Basic Maintenance Amount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Minimum Rate</b>&#8221; means, on any
Auction Date with respect to a Rate Period of days or fewer, 70% of the AA Composite Commercial Paper Rate at the close of business on
the Business Day next preceding such Auction Date. There shall be no Minimum Rate on any Auction Date with respect to a Rate Period of
more than the Standard Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Moody&#8217;s</b>&#8221; means Moody&#8217;s
Investors Service,&#160;Inc., a Delaware corporation, and its successors at law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Moody&#8217;s Discount Factor</b>&#8221;
means the discount factors set forth in the Moody&#8217;s Guidelines for use in calculating the Discounted Value of the Issuer&#8217;s
assets in connection with Moody&#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Moody&#8217;s Eligible Assets</b>&#8221;
means assets of the Issuer set forth in the Moody&#8217;s Guidelines as eligible for inclusion in calculating the Discounted Value of
the Issuer&#8217;s assets in connection with Moody&#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Moody&#8217;s Guidelines</b>&#8221;
mean the guidelines provided by Moody&#8217;s, as may be amended from time to time, in connection with Moody&#8217;s ratings of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>1940 Act Notes Asset Coverage</b>&#8221;
means asset coverage, as determined in accordance with Section&#160;18(h)&#160;of the Investment Company Act, of at least 300% with respect
to all outstanding senior securities representing indebtedness of the Issuer, including all Outstanding Notes (or such other asset coverage
as may in the future be specified in or under the Investment Company Act as the minimum asset coverage for senior securities representing
indebtedness of a closed-end investment company as a condition of declaring dividends on its common stock), determined on the basis of
values calculated as of a time within 48 hours next preceding the time of such determination.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Notes</b>&#8221; means Securities of
the Issuer ranking on a parity with the Notes that may be issued from time to time pursuant to the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Order</b>&#8221; means a Hold Order,
Bid or Sell Order.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Original Issue Date</b>&#8221; means,
with respect to the Notes, .</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Other Rating Agency</b>&#8221; means
each rating agency, if any, other than Moody&#8217;s or then providing a rating for the Notes pursuant to the request of the Issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 70 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Other Rating Agency Discount Factor</b>&#8221;
means the discount factors set forth in the Other Rating Agency Guidelines of each Other Rating Agency for use in calculating the Discounted
Value of the Issuer&#8217;s assets in connection with the Other Rating Agency&#8217;s rating of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Other Rating Agency Eligible Assets</b>&#8221;
means assets of the Issuer set forth in the Other Rating Agency Guidelines of each Other Rating Agency as eligible for inclusion in calculating
the Discounted Value of the Issuer&#8217;s assets in connection with the Other Rating Agency&#8217;s rating of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Other Rating Agency Guidelines</b>&#8221;
mean the guidelines provided by each Other Rating Agency, as may be amended from time to time, in connection with the Other Rating Agency&#8217;s
rating of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Outstanding</b>&#8221; or &#8220;<b>outstanding</b>&#8221;
means, as of any date, Notes theretofore issued by the Issuer except, without duplication, (i)&#160;any Notes theretofore canceled, redeemed
or repurchased by the Issuer, or delivered to the Trustee for cancellation or with respect to which the Issuer has given notice of redemption
and irrevocably deposited with the Paying Agent sufficient funds to redeem such Notes and (ii)&#160;any Notes represented by any certificate
in lieu of which a new certificate has been executed and delivered by the Issuer. Notwithstanding the foregoing, (A)&#160;in connection
with any Auction, any series of Notes as to which the Issuer or any person known to the Auction Agent to be an Affiliate of the Issuer
shall be the Existing Holder thereof shall be disregarded and deemed not to be Outstanding; and (B)&#160;for purposes of determining
the Notes Basic Maintenance Amount, Notes held by the Issuer shall be disregarded and not deemed Outstanding but Notes held by any Affiliate
of the Issuer shall be deemed Outstanding.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Paying Agent</b>&#8221; means unless
and until another entity appointed by a resolution of the Board of Directors enters into an agreement with the Issuer to serve as paying
agent, transfer agent, registrar, and redemption agent with respect to the Notes, which Paying Agent may be the same as the Trustee or
the Auction Agent.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Person</b>&#8221; or &#8220;<b>person</b>&#8221;
means and includes an individual, a partnership, a trust, a company, an unincorporated association, a joint venture or other entity or
a government or any agency or political subdivision thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Potential Beneficial Owner</b>,&#8221;
with respect to a series of Notes, shall mean a customer of a Broker-Dealer that is not a Beneficial Owner of Notes of such series but
that wishes to purchase Notes of such series, or that is a Beneficial Owner of Notes of such series that wishes to purchase additional
Notes of such series; provided, however, that for purposes of conducting an Auction, the Auction Agent may consider a Broker-Dealer acting
on behalf of its customer as a Potential Beneficial Owner.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Potential Holder</b>,&#8221; with respect
to Notes of such series, shall mean a Broker-Dealer (or any such other person as may be permitted by the Issuer) that is not an Existing
Holder of Notes of such series or that is an Existing Holder of Notes of such series that wishes to become the Existing Holder of additional
Notes of such series; provided, however, that for purposes of conducting an Auction, the Auction Agent may consider a Broker-Dealer acting
on behalf of its customer as a Potential Holder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Rate Period</b>&#8221; means, with
respect to a series of Notes, the period commencing on the Original Issue Date thereof and ending on the date specified for such series
on the Original Issue Date thereof and thereafter, as to such series, the period commencing on the day following each Rate Period for
such series and ending on the day established for such series by the Issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Rating Agency</b>&#8221; means each
of (if is then rating Notes), Moody&#8217;s (if Moody&#8217;s is then rating Notes) and any Other Rating Agency.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Rating Agency Guidelines</b>&#8221;
mean Guidelines (if is then rating Notes), Moody&#8217;s Guidelines (if Moody&#8217;s is then rating Notes) and any Other Rating Agency
Guidelines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Redemption Date</b>,&#8221; when used
with respect to any Note to be redeemed, means the date fixed for such redemption by or pursuant to the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Redemption Price</b>,&#8221; when used
with respect to any Note to be redeemed, means the price at which it is to be redeemed pursuant to the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 71 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Reference Rate</b>&#8221; means, with
respect to the determination of the Maximum Rate and Default Rate, the greater of (i)&#160;the applicable AA Composite Commercial Paper
Rate (for a Rate Period of fewer than 184 days) or the applicable Treasury Index Rate (for a Rate Period of 184 days or more), or (ii)&#160;the
applicable LIBOR Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Securities Act</b>&#8221; means the
Securities Act of 1933, as amended from time to time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Securities Depository</b>&#8221; means
The Depository Trust Company and its successors and assigns or any successor securities depository selected by the Issuer that agrees
to follow the procedures required to be followed by such securities depository in connection with the Notes Series&#160;.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Sell Order</b>&#8221; shall have the
meaning specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Special Auction Period</b>&#8221; means
an Auction Period that is not a Standard Auction Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Special Rate Period</b>&#8221; means
a Rate Period that is not a Standard Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Specific Redemption Provisions</b>&#8221;
means, with respect to any Special Rate Period of more than one year, either, or any combination of a period (a &#8220;Non-Call Period&#8221;)
determined by the Board of Directors after consultation with the Broker-Dealers, during which the Notes subject to such Special Rate
Period are not subject to redemption at the option of the Issuer consisting of a number of whole years as determined by the Board of
Directors after consultation with the Broker-Dealers, during each year of which the Notes subject to such Special Rate Period shall be
redeemable at the Issuer&#8217;s option and/or in connection with any mandatory redemption at a price equal to the principal amount plus
accrued but unpaid interest plus a premium expressed as a percentage or percentages of $25,000 or expressed as a formula using specified
variables as determined by the Board of Directors after consultation with the Broker-Dealers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Standard Auction Period</b>&#8221;
means an Auction Period of days.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Standard Rate Period</b>&#8221; means
a Rate Period of days.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Stated Maturity</b>&#8221; with respect
to Notes Series&#160;, shall mean .</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Submission Deadline</b>&#8221; means
1:00 P.M., New York City time, on any Auction Date or such other time on such date as shall be specified by the Auction Agent from time
to time pursuant to the Auction Agreement as the time by which the Broker-Dealers are required to submit Orders to the Auction Agent.
Notwithstanding the foregoing, the Auction Agent will follow the Securities Industry and Financial Markets Association&#8217;s Early
Market Close Recommendations for shortened trading days for the bond markets (the &#8220;SIFMA Recommendation&#8221;) unless the Auction
Agent is instructed otherwise in writing by the Issuer. In the event of a SIFMA Recommendation with respect to an Auction Date, the Submission
Deadline will be 11:30 A.M., instead of 1:00 P.M., New York City time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Submitted Bid</b>&#8221; shall have
the meaning specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Submitted Hold Order</b>&#8221; shall
have the meaning specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Submitted Order</b>&#8221; shall have
the meaning specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Submitted Sell Order</b>&#8221; shall
have the meaning specified in Appendix A-I hereto.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Sufficient Clearing Bids</b>&#8221;
means for each series of Notes, an Auction for which the number of Units of Notes of such series that are the subject of Submitted Bids
by Potential Beneficial Owners specifying one or more rates not higher than the Maximum Rate is not less than the number of Units of
Notes of such series that are the subject of Submitted Sell Orders and of Submitted Bids by Existing Holders specifying rates higher
than the Maximum Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 72 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Notes Basic Maintenance Amount</b>&#8221;
as of any Valuation Date has the meaning set forth in the Rating Agency Guidelines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Notes Series</b>&#8221; means the Series&#160;Notes
or any other Notes hereinafter designated as Series&#160;of the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Treasury Index Rate</b>&#8221; means
the average yield to maturity for actively traded marketable U.S. Treasury fixed interest rate securities having the same number of 30-day
periods to maturity as the length of the applicable Rate Period, determined, to the extent necessary, by linear interpolation based upon
the yield for such securities having the next shorter and next longer number of 30-day periods to maturity treating all Rate Periods
with a length greater than the longest maturity for such securities as having a length equal to such longest maturity, in all cases based
upon data set forth in the most recent weekly statistical release published by the Board of Governors of the Federal Reserve System (currently
in H.15(519)); provided, however, if the most recent such statistical release shall not have been published during the 15 days preceding
the date of computation, the foregoing computations shall be based upon the average of comparable data as quoted to the Issuer by at
least three recognized dealers in U.S. Government securities selected by the Issuer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Trustee</b>&#8221; means or such other
person who is named as a trustee pursuant to the terms of the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Unit</b>&#8221; means, with respect
to each series of Notes, the principal amount of the minimum Authorized Denomination of the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Valuation Date</b>&#8221; means every
Friday, or, if such day is not a Business Day, the next preceding Business Day; provided, however, that the first Valuation Date may
occur on any other date established by the Issuer; provided, further, however, that such first Valuation Date shall be not more than
one week from the date on which Notes Series&#160;initially are issued.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<b>Winning Bid Rate</b>&#8221; means for
each series of Notes, the lowest rate specified in any Submitted Bid of such series of Notes which if selected by the Auction Agent as
the Applicable Rate would cause the number of Units of Notes of such series that are the subject of Submitted Bids specifying a rate
not greater than such rate to be not less than the number of Units of Available Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTE DETAILS, FORM&#160;OF NOTES AND REDEMPTION
OF NOTES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Interest</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;The Holders of any series of Notes shall
be entitled to receive interest payments on their Notes at the Applicable Rate, determined as set forth in paragraph (c)&#160;of this
Section&#160;2.02, and no more, payable on the respective dates determined as set forth in paragraph (b)&#160;of this Section&#160;2.02.
Interest on the Outstanding Notes of any series issued on the Original Issue Date shall accumulate from the Original Issue Date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;(i)&#160;Interest shall be payable,
subject to subparagraph (b)(ii)&#160;of this Section&#160;2.02, on each series of Notes, with respect to any Rate Period on the first
Business Day following the last day of such Rate Period; provided, however, if the Rate Period is greater than 30 days then on a monthly
basis on the first Business Day of each month within such Rate Period, not including the initial Rate Period, and on the Business Day
following the last day of such Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(ii)&#160;If a day for payment of
interest resulting from the application of subparagraph (b)(i)&#160;above is not a Business Day, then the Interest Payment Date shall
be the first Business Day following such day for payment of interest in the case of a series of Notes designated as &#8220;Series&#8221;.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iii)&#160;The Issuer shall pay to
the Paying Agent not later than 3:00 p.m., New York City time, on the Business Day next preceding each Interest Payment Date for each
series of Notes, an aggregate amount of funds available on the next Business Day in the City of New York, New York, equal to the interest
to be paid to all Holders of such Notes on such Interest Payment Date. The Issuer shall not be required to establish any reserves for
the payment of interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 73 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iv)&#160;All moneys paid to the Paying
Agent for the payment of interest shall be held in trust for the payment of such interest by the Paying Agent for the benefit of the
Holders specified in subparagraph (b)(v)&#160;of this Section&#160;2.02. Any moneys paid to the Paying Agent in accordance with the foregoing
but not applied by the Paying Agent to the payment of interest, including interest earned on such moneys, will, to the extent permitted
by law, be repaid to the Issuer at the end of 90 days from the date on which such moneys were to have been so applied.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(v)&#160;Each interest payment on
a series of Notes shall be paid on the Interest Payment Date therefor to the Holders of that series as their names appear on the security
ledger or security records of the Issuer on the Business Day next preceding such Interest Payment Date. Interest in arrears for any past
Rate Period may be declared and paid at any time, without reference to any regular Interest Payment Date, to the Holders as their names
appear on the books or records of the Issuer on such date, not exceeding 15 days preceding the payment date thereof, as may be fixed
by the Board of Directors. No interest will be payable in respect of any Interest Payment or payments which may be in arrears.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;(i)&#160;The interest rate on Outstanding
Notes of each series during the period from and after the Original Issue Date to and including the last day of the initial Rate Period
therefor shall be equal to %. For each subsequent Rate Period with respect to the Notes Outstanding thereafter, the interest rate shall
be equal to the rate per annum that results from an Auction; provided, however, that if an Auction for any subsequent Rate Period of
a series of Notes is not held for any reason or if Sufficient Clearing Bids have not been made in an Auction (other than as a result
of all series of Notes being the subject of Submitted Hold Orders), then the interest rate on a series of Notes for any such Rate Period
shall be the Maximum Rate (except during a Default Period (as defined below) when the interest rate shall be the Default Rate, as set
forth in Section&#160;2.02(c)(ii)&#160;below). The All Hold Rate will apply automatically following an Auction in which all of the Outstanding
series of Notes are subject (or are deemed to be subject) to Hold Orders. The rate per annum at which interest is payable on a series
of Notes as determined pursuant to this Section&#160;2(c)(i)&#160;shall be the &#8220;Applicable Rate.&#8221; For Standard Rate Periods
or shorter periods only, the Applicable Rate resulting from an Auction will not be less than the Minimum Rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(ii)&#160;Subject to the cure provisions
below, a &#8220;Default Period&#8221; with respect to a particular series will commence on any date the Issuer fails to deposit irrevocably
in trust in same-day funds, with the Paying Agent by 12:00 noon, New York City time, (A)&#160;the full amount of any redemption price
(the &#8220;Redemption Price&#8221;) payable on the date fixed for redemption (the &#8220;Redemption Date&#8221;) (a &#8220;Redemption
Default,&#8221; which shall constitute an Event of Default pursuant to Section&#160;5.1(7)&#160;of the Original Indenture) or (B)&#160;the
full amount of any accrued interest on that series payable on the Interest Payment Date (an &#8220;Interest Default&#8221; and together
with a Redemption Default, hereinafter referred to as &#8220;Default&#8221;). Subject to the cure provisions of Section&#160;2(c)(iii)&#160;below,
a Default Period with respect to an Interest Default or a Redemption Default shall end on the Business Day on which, by 12:00 noon, New
York City time, all unpaid interest and any unpaid Redemption Price shall have been deposited irrevocably in trust in same-day funds
with the Paying Agent. In the case of an Interest Default, the Applicable Rate for each Rate Period commencing during a Default Period
will be equal to the Default Rate, and each subsequent Rate Period commencing after the beginning of a Default Period shall be a Standard
Rate Period; provided, however, that the commencement of a Default Period will not by itself cause the commencement of a new Rate Period.
No Auction shall be held during a Default Period with respect to an Interest Default applicable to that series of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iii)&#160;No Default Period with
respect to an Interest Default or Redemption Default shall be deemed to commence if the amount of any interest or any Redemption Price
due (if such default is not solely due to the willful failure of the Issuer) is deposited irrevocably in trust, in same-day funds with
the Paying Agent by 12:00 noon, New York City time within three Business Days after the applicable Interest Payment Date or Redemption
Date, together with an amount equal to the Default Rate applied to the amount of such non-payment based on the actual number of days
comprising such period divided by 360 for each series. The Default Rate shall be equal to the Reference Rate multiplied by three (3).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 74 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iv)&#160;The amount of interest per
Unit of Notes payable on each Interest Payment Date of each Rate Period of less than one (1)&#160;year (or in respect of interest on
another date in connection with a redemption during such Rate Period) shall be computed by multiplying the Applicable Rate (or the Default
Rate) for such Rate Period (or a portion thereof) by a fraction, the numerator of which will be the number of days in such Rate Period
(or portion thereof) that such Notes were outstanding and for which the Applicable Rate or the Default Rate was applicable and the denominator
of which will be 360, multiplying the amount so obtained by $25,000, and rounding the amount so obtained to the nearest cent. During
any Rate Period of one (1)&#160;year or more, the amount of interest per Unit of Notes payable on any Interest Payment Date (or in respect
of interest on another date in connection with a redemption during such Rate Period) shall be computed as described in the preceding
sentence.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;Any Interest Payment made on any series
of Notes shall first be credited against the earliest accrued but unpaid interest due with respect to such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Redemption</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;(i)&#160;After the initial Rate Period,
subject to the provisions of this Section&#160;2.03 and to the extent permitted under the Investment Company Act, the Issuer may, at
its option, redeem in whole or in part out of funds legally available therefor a series of Notes herein designated as (A)&#160;having
a Rate Period of one year or less, on the Business Day after the last day of such Rate Period by delivering a notice of redemption not
less than 15 days and not more than 40 days prior to the date fixed for such redemption, at a redemption price equal to the aggregate
principal amount, plus an amount equal to accrued but unpaid interest thereon (whether or not earned) to the date fixed for redemption
(&#8220;Redemption Price&#8221;), or (B)&#160;having a Rate Period of more than one year, on any Business Day prior to the end of the
relevant Rate Period by delivering a notice of redemption not less than 15 days and not more than 40 days prior to the date fixed for
such redemption, at the Redemption Price, plus a redemption premium, if any, determined by the Board of Directors after consultation
with the Broker-Dealers and set forth in any applicable Specific Redemption Provisions at the time of the designation of such Rate Period
as set forth in Section&#160;2.04 hereof; provided, however, that during a Rate Period of more than one year no series of Notes will
be subject to optional redemption except in accordance with any Specific Redemption Provisions approved by the Board of Directors after
consultation with the Broker-Dealers at the time of the designation of such Rate Period. Notwithstanding the foregoing, the Issuer shall
not give a notice of or effect any redemption pursuant to this Section&#160;2.03(a)(i)&#160;unless, on the date on which the Issuer intends
to give such notice and on the date of redemption (a)&#160;the Issuer has available certain Deposit Securities with maturity or tender
dates not later than the day preceding the applicable redemption date and having a value not less than the amount (including any applicable
premium) due to Holders of a series of Notes by reason of the redemption of such Notes on such date fixed for the redemption and (b)&#160;the
Issuer would have Eligible Assets with an aggregate Discounted Value at least equal the Notes Basic Maintenance Amount immediately subsequent
to such redemption, if such redemption were to occur on such date, it being understood that the provisions of paragraph (d)&#160;of this
Section&#160;2.03 shall be applicable in such circumstances in the event the Issuer makes the deposit and takes the other action required
thereby.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ii)&#160;If the Issuer fails to maintain, as
of any Valuation Date, Eligible Assets with an aggregate Discounted Value at least equal to the Notes Basic Maintenance Amount or, as
of the last Business Day of any month, the 1940 Act Notes Asset Coverage, and such failure is not cured within ten Business Days following
such Valuation Date in the case of a failure to maintain the Notes Basic Maintenance Amount or on the last Business Day of the following
month in the case of a failure to maintain the 1940 Act Notes Asset Coverage as of such last Business Day (each an &#8220;Asset Coverage
Cure Date&#8221;), the Notes will be subject to mandatory redemption out of funds legally available therefor. The aggregate principal
amount of Notes to be redeemed in such circumstances will be equal to the lesser of (A)&#160;the minimum principal amount of Notes the
redemption of which, if deemed to have occurred immediately prior to the opening of business on the relevant Asset Coverage Cure Date,
would result in the Issuer having Eligible Assets with an aggregate Discounted Value at least equal to the Notes Basic Maintenance Amount,
or sufficient to satisfy 1940 Act Notes Asset Coverage, as the case may be, in either case as of the relevant Asset Coverage Cure Date
(provided that, if there is no such minimum principal amount of Notes the redemption of which would have such result, all Notes then
Outstanding will be redeemed), and (B)&#160;the maximum principal amount of Notes that can be redeemed out of funds expected to be available
therefor on the Mandatory Redemption Date at the Mandatory Redemption Price set forth in subparagraph (a)(iii)&#160;of this Section&#160;2.03.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 75 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(iii)&#160;In determining the Notes required
to be redeemed in accordance with the foregoing Section&#160;2.03(a)(ii), the Issuer shall allocate the aggregate principal amount of
Notes required to be redeemed to satisfy the Notes Basic Maintenance Amount or the 1940 Act Notes Asset Coverage, as the case may be,
pro rata among the Holders of Notes in proportion to the aggregate principal amount of Notes they hold, by lot or by such other method
as the Issuer shall deem equitable, subject to the further provisions of this subparagraph (iii). The Issuer shall effect any required
mandatory redemption pursuant to subparagraph (a)(ii)&#160;of this Section&#160;2.03 no later than 40 days after the Asset Coverage Cure
Date (the &#8220;Mandatory Redemption Date&#8221;), except that if the Issuer does not have funds legally available for the redemption
of, or is not otherwise legally permitted to redeem, the aggregate principal amount of Notes which would be required to be redeemed by
the Issuer under clause (A)&#160;of subparagraph (a)(ii)&#160;of this Section&#160;2.03 if sufficient funds were available, or the Issuer
otherwise is unable to effect such redemption on or prior to such Mandatory Redemption Date, the Issuer shall redeem those Notes, and
other Notes, on the earliest practicable date on which the Issuer will have such funds available, upon notice pursuant to Section&#160;2.03(b)&#160;to
record owners of the Notes to be redeemed and the Paying Agent. The Issuer will deposit with the Paying Agent funds sufficient to redeem
the specified aggregate principal amount of Notes with respect to a redemption required under subparagraph (a)(ii)&#160;of this Section&#160;2.03,
by 1:00 p.m., New York City time, of the Business Day immediately preceding the Mandatory Redemption Date. If fewer than all of the Outstanding
Notes are to be redeemed pursuant to this Section&#160;2.03(a)(iii), the aggregate principal amount of Notes to be redeemed shall be
redeemed pro rata from the Holders of such Notes in proportion to the aggregate principal amount of such Notes held by such Holders,
by lot or by such other method as the Issuer shall deem fair and equitable, subject, however, to the terms of any applicable Specific
Redemption Provisions. &#8220;Mandatory Redemption Price&#8221; means the Redemption Price plus (in the case of a Rate Period of one
year or more only) a redemption premium, if any, determined by the Board of Directors after consultation with the Broker-Dealers and
set forth in any applicable Specific Redemption Provisions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;In the event of a redemption pursuant
to Section&#160;2.03(a), the Issuer will file a notice of its intention to redeem with the Commission so as to provide at least the minimum
notice required under Rule&#160;23c-2 under the Investment Company Act or any successor provision. In addition, the Issuer shall deliver
a notice of redemption to the Auction Agent and the Trustee (the &#8220;Notice of Redemption&#8221;) containing the information set forth
below (i)&#160;in the case of an optional redemption pursuant to subparagraph (a)(i)&#160;above, at least three Business Days prior to
the giving of notice to the Holders and (ii)&#160;in the case of a mandatory redemption pursuant to subparagraph (a)(ii)&#160;above,
on or prior to the 30th day preceding the Mandatory Redemption Date. The Trustee will use its reasonable efforts to provide notice to
each Holder of Notes called for redemption by electronic or other reasonable means not later than the close of business on the Business
Day immediately following the day on which the Trustee determines the Notes to be redeemed (or, during a Default Period with respect
to such Notes, not later than the close of business on the Business Day immediately following the day on which the Trustee receives Notice
of Redemption from the Issuer). The Trustee shall confirm such notice in writing not later than the close of business on the third Business
Day preceding the date fixed for redemption by providing the Notice of Redemption to each Holder of Notes called for redemption, the
Paying Agent (if different from the Trustee) and the Securities Depository. Notice of Redemption will be addressed to the registered
owners of each series of Notes at their addresses appearing on the books or records of the Issuer. Such Notice of Redemption will set
forth (i)&#160;the date fixed for redemption, (ii)&#160;the principal amount and identity of Notes to be redeemed, (iii)&#160;the redemption
price (specifying the amount of accrued interest to be included therein and any redemption premium, if any), (iv)&#160;that interest
on the Notes to be redeemed will cease to accrue on such date fixed for redemption, (v)&#160;applicable cusip number(s)&#160;and (vi)&#160;the
provision under which redemption shall be made. No defect in the Notice of Redemption or in the transmittal or mailing thereof will affect
the validity of the redemption proceedings, except as required by applicable law. If fewer than all Notes held by any Holder are to be
redeemed, the Notice of Redemption mailed to such Holder shall also specify the principal amount of Notes to be redeemed from such Holder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;Notwithstanding the provisions of paragraph
(a)&#160;of this Section&#160;2.03, no Notes may be redeemed unless all interest on the Outstanding Notes and all Notes of the Issuer
ranking on a parity with the Notes, have been or are being contemporaneously paid or set aside for payment; provided, however, that the
foregoing shall not prevent the purchase or acquisition of all Outstanding Notes pursuant to the successful completion of an otherwise
lawful purchase or exchange offer made on the same terms to, and accepted by, Holders of all Outstanding Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 76 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;Upon the deposit of funds sufficient
to redeem any Notes with the Paying Agent and the giving of the Notice of Redemption to the Trustee under paragraph (b)&#160;of this
Section&#160;2.03, interest on such Notes shall cease to accrue and such Notes shall no longer be deemed to be Outstanding for any purpose
(including, without limitation, for purposes of calculating whether the Issuer has maintained the requisite Notes Basic Maintenance Amount
or the 1940 Act Notes Asset Coverage), and all rights of the Holder of the Notes so called for redemption shall cease and terminate,
except the right of such Holder to receive the redemption price specified herein, but without any interest or other additional amount.
Such redemption price shall be paid by the Paying Agent to the nominee of the Securities Depository. The Issuer shall be entitled to
receive from the Paying Agent, promptly after the date fixed for redemption, any cash deposited with the Paying Agent in excess of (i)&#160;the
aggregate redemption price of the Notes called for redemption on such date and (ii)&#160;such other amounts, if any, to which Holders
of the Notes called for redemption may be entitled. Any funds so deposited that are unclaimed at the end of two years from such redemption
date shall, to the extent permitted by law, be paid to the Issuer, after which time the Holders of Notes so called for redemption may
look only to the Issuer for payment of the redemption price and all other amounts, if any, to which they may be entitled. The Issuer
shall be entitled to receive, from time to time after the date fixed for redemption, any interest earned on the funds so deposited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;To the extent that any redemption for
which Notice of Redemption has been given is not made by reason of the absence of legally available funds therefor, or is otherwise prohibited,
such redemption shall be made as soon as practicable to the extent such funds become legally available or such redemption is no longer
otherwise prohibited. Failure to redeem any series of Notes shall be deemed to exist at any time after the date specified for redemption
in a Notice of Redemption when the Issuer shall have failed, for any reason whatsoever, to deposit in trust with the Paying Agent the
redemption price with respect to any Notes for which such Notice of Redemption has been given. Notwithstanding the fact that the Issuer
may not have redeemed any Notes for which a Notice of Redemption has been given, interest may be paid on a series of Notes and shall
include those Notes for which Notice of Redemption has been given but for which deposit of funds has not been made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&#160;All moneys paid to the Paying Agent
for payment of the redemption price of any Notes called for redemption shall be held in trust by the Paying Agent for the benefit of
Holders of Notes to be redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&#160;So long as any Notes are held of record
by the nominee of the Securities Depository, the redemption price for such Notes will be paid on the date fixed for redemption to the
nominee of the Securities Depository for distribution to Agent Members for distribution to the persons for whom they are acting as agent.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&#160;Except for the provisions described
above, nothing contained herein limits any right of the Issuer to purchase or otherwise acquire any Notes outside of an Auction at any
price, whether higher or lower than the price that would be paid in connection with an optional or mandatory redemption, so long as,
at the time of any such purchase, there is no arrearage in the payment of interest on, or the mandatory or optional redemption price
with respect to, any series of Notes for which Notice of Redemption has been given and the Issuer is in compliance with the 1940 Act
Notes Asset Coverage and has Eligible Assets with an aggregate Discounted Value at least equal to the Notes Basic Maintenance Amount
after giving effect to such purchase or acquisition on the date thereof. If fewer than all the Outstanding Notes of any series are redeemed
or otherwise acquired by the Issuer, the Issuer shall give notice of such transaction to the Trustee, in accordance with the procedures
agreed upon by the Board of Directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#160;The Board of Directors may, without
further consent of the holders of the Notes or the holders of shares of capital stock of the Issuer, authorize, create or issue any class
or series of Notes, including other series of Notes, ranking prior to or on a parity with the Notes to the extent permitted by the Investment
Company Act, if, upon issuance, either (A)&#160;the net proceeds from the sale of such Notes (or such portion thereof needed to redeem
or repurchase the Outstanding Notes) are deposited with the Trustee in accordance with Section&#160;2.03(d), Notice of Redemption as
contemplated by Section&#160;2.03(b)&#160;has been delivered prior thereto or is sent promptly thereafter, and such proceeds are used
to redeem all Outstanding Notes or (B)&#160;the Issuer would meet the 1940 Act Notes Asset Coverage, the Notes Basic Maintenance Amount
and the requirements of Section&#160;2.08 hereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 77 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(j)&#160;If any Notes are to be redeemed and
such Notes are held by the Securities Depository, the Issuer shall include in the notice of redemption delivered to the Securities Depository:
(i)&#160;under an item entitled &#8220;Publication Date for Securities Depository Purposes&#8221;, the Interest Payment Date prior to
the Redemption Date, and (ii)&#160;an instruction to the Securities Depository to (x)&#160;determine on such Publication Date after the
Auction held on the immediately preceding Auction Date has settled, the Depository participants whose Securities Depository positions
will be redeemed and the principal amount of such Notes to be redeemed from each such position (the &#8220;Securities Depository Redemption
Information&#8221;), and (y)&#160;notify the Auction Agent immediately after such determination of (A)&#160;the positions of the Depository
Participants in such Notes immediately prior to such Auction settlement, (B)&#160;the positions of the Depository Participants in such
Notes immediately following such Auction settlement and (C)&#160;the Securities Depository Redemption Information. &#8220;Publication
Date&#8221; shall mean three Business Days after the Auction Date next preceding such Redemption Date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Designation of Rate Period</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The initial Rate Period for each series of Notes
is as set forth under &#8220;Designation&#8221; in Section&#160;2.01(a)&#160;above. The Issuer will designate the duration of subsequent
Rate Periods of each series of Notes; provided, however, that no such designation is necessary for a Standard Rate Period and, provided
further, that any designation of a Special Rate Period shall be effective only if (i)&#160;notice thereof shall have been given as provided
herein, (ii)&#160;any failure to pay in a timely manner to the Trustee the full amount of any interest on, or the redemption price of,
Notes shall have been cured as provided above, (iii)&#160;Sufficient Clearing Bids shall have existed in an Auction held on the Auction
Date immediately preceding the first day of such proposed Special Rate Period, (iv)&#160;if the Issuer shall have mailed a Notice of
Redemption with respect to any Notes, the redemption price with respect to such Notes shall have been deposited with the Paying Agent,
and (v)&#160;in the case of the designation of a Special Rate Period, the Issuer has confirmed that as of the Auction Date next preceding
the first day of such Special Rate Period, it has Eligible Assets with an aggregate Discounted Value at least equal to the Notes Basic
Maintenance Amount, and the Issuer has consulted with the Broker-Dealers and has provided notice of such designation and otherwise complied
with the Rating Agency Guidelines.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Issuer proposes to designate any Special
Rate Period, not fewer than 7 (or two Business Days in the event the duration of the Rate Period prior to such Special Rate Period is
fewer than 8 days) nor more than 30 Business Days prior to the first day of such Special Rate Period, notice shall be (i)&#160;made by
press release and (ii)&#160;communicated by the Issuer by telephonic or other means to the Trustee and confirmed in writing promptly
thereafter. Each such notice shall state (A)&#160;that the Issuer proposes to exercise its option to designate a succeeding Special Rate
Period, specifying the first and last days thereof and (B)&#160;that the Issuer will by 3:00 p.m., New York City time, on the second
Business Day next preceding the first day of such Special Rate Period, notify the Auction Agent and the Trustee, who will promptly notify
the Broker-Dealers, of either (x)&#160;its determination, subject to certain conditions, to proceed with such Special Rate Period, subject
to the terms of any Specific Redemption Provisions, or (y)&#160;its determination not to proceed with such Special Rate Period, in which
latter event the succeeding Rate Period shall be a Standard Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No later than 3:00 p.m., New York City time,
on the second Business Day next preceding the first day of any proposed Special Rate Period, the Issuer shall deliver to the Auction
Agent and Trustee, who will promptly deliver to the Broker-Dealers and Existing Holders, either:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(i)&#160;a notice stating (A)&#160;that
the Issuer has determined to designate the next succeeding Rate Period as a Special Rate Period, specifying the first and last days thereof
and (B)&#160;the terms of any Specific Redemption Provisions; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(ii)&#160;a notice stating that the
Issuer has determined not to exercise its option to designate a Special Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Issuer fails to deliver either such notice
with respect to any designation of any proposed Special Rate Period to the Auction Agent or is unable to make the confirmation provided
in clause (v)&#160;of Paragraph (a)&#160;of this Section&#160;2.04 by 3:00 p.m., New York City time, on the second Business Day next
preceding the first day of such proposed Special Rate Period, the Issuer shall be deemed to have delivered a notice to the Auction Agent
with respect to such Rate Period to the effect set forth in clause (ii)&#160;above, thereby resulting in a Standard Rate Period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 78 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Restrictions on Transfer</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notes may be transferred only (a)&#160;pursuant
to an order placed in an Auction, (b)&#160;to or through a Broker-Dealer or (c)&#160;to the Issuer or any Affiliate. Notwithstanding
the foregoing, a transfer other than pursuant to an Auction will not be effective unless the selling Existing Holder or the Agent Member
of such Existing Holder, in the case of an Existing Holder whose Notes are listed in its own name on the books of the Auction Agent,
or the Broker-Dealer or Agent Member of such Broker-Dealer, in the case of a transfer between persons holding Notes through different
Broker-Dealers, advises the Auction Agent of such transfer. The certificates representing the Notes issued to the Securities Depository
will bear legends with respect to the restrictions described above and stop-transfer instructions will be issued to the Transfer Agent
and/or Registrar.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1940 Act Notes Asset Coverage</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Issuer shall maintain, as of the last Business
Day of each month in which any Notes are Outstanding, asset coverage with respect to the Notes which is equal to or greater than the
1940 Act Notes Asset Coverage; provided, however, that Section&#160;2.03(a)(ii)&#160;shall be the sole remedy in the event the Issuer
fails to do so.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes Basic Maintenance Amount</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">So long as the Notes are Outstanding and any
Rating Agency is then rating the Notes, the Issuer shall maintain, as of each Valuation Date, Eligible Assets having an aggregate Discounted
Value equal to or greater than the Notes Basic Maintenance Amount; provided, however, that Section&#160;2.03(a)(ii)&#160;shall be the
sole remedy in the event the Issuer fails to do so.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Other Restrictions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For so long as any Notes are Outstanding and
any Rating Agency is then rating the Notes, the Issuer will not engage in certain proscribed transactions set forth in the Rating Agency
Guidelines, unless it has received written confirmation from each such Rating Agency that proscribes the applicable transaction in its
Rating Agency Guidelines that any such action would not impair the rating then assigned by such Rating Agency to a series of Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For so long as any Notes are Outstanding, the
Issuer will not declare, pay or set apart for payment any dividend or other distribution (other than a dividend or distribution paid
in shares of, or options, warrants or rights to subscribe for or purchase, common shares or other shares of capital stock of the Issuer)
upon any class of shares of capital stock of the Issuer, unless, in every such case, immediately after such transaction, the 1940 Act
Notes Asset Coverage would be achieved after deducting the amount of such dividend, distribution, or purchase price, as the case may
be; provided, however, that dividends may be declared upon any preferred shares of capital stock of the Issuer if the Notes and any other
senior securities representing indebtedness of the Issuer have an asset coverage of at least 200% at the time of declaration thereof,
after deducting the amount of such dividend.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A declaration of a dividend or other distribution
on or purchase or redemption of any common or preferred shares of capital stock of the Issuer is prohibited (i)&#160;at any time that
an Event of Default under the Indenture has occurred and is continuing, (ii)&#160;if after giving effect to such declaration, the Issuer
would not have Eligible Assets with an aggregate Discounted Value at least equal to the Notes Basic Maintenance Amount or the 1940 Act
Notes Asset Coverage, or (iii)&#160;the Issuer has not redeemed the full amount of Notes required to be redeemed by any provisions for
mandatory redemption contained herein.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 79 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compliance Procedures for Asset Maintenance Tests</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For so long as any Notes are Outstanding and
any Rating Agency is then rating such Notes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;As of each Valuation Date, the Issuer
shall determine in accordance with the procedures specified herein (i)&#160;the Market Value of each Eligible Asset owned by the Issuer
on that date, (ii)&#160;the Discounted Value of each such Eligible Asset using the Discount Factors, (iii)&#160;whether the Notes Basic
Maintenance Amount is met as of that date, (iv)&#160;the value of the total assets of the Issuer, less all liabilities, and (v)&#160;whether
the 1940 Act Notes Asset Coverage is met as of that date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;Upon any failure to maintain the required
Notes Basic Maintenance Amount or 1940 Act Notes Asset Coverage on any Valuation Date, the Issuer may use reasonable commercial efforts
(including, without limitation, altering the composition of its portfolio, purchasing Notes outside of an Auction or in the event of
a failure to file a Rating Agency Certificate (as defined below) on a timely basis, submitting the requisite Rating Agency Certificate)
to re-attain (or certify in the case of a failure to file on a timely basis, as the case may be) the required Notes Basic Maintenance
Amount or 1940 Act Notes Asset Coverage on or prior to the Asset Coverage Cure Date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;Compliance with the Notes Basic Maintenance
Amount and 1940 Act Notes Asset Coverage tests shall be determined with reference to those Notes which are deemed to be Outstanding hereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;The Issuer shall deliver to each Rating
Agency which is then rating Notes and any other party specified in the Rating Agency Guidelines all certificates that are set forth in
the respective Rating Agency Guidelines regarding 1940 Act Notes Asset Coverage, Notes Basic Maintenance Amount and/or related calculations
at such times and containing such information as set forth in the respective Rating Agency Guidelines (each, a &#8220;Rating Agency Certificate&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;In the event that any Rating Agency
Certificate is not delivered within the time periods set forth in the Rating Agency Guidelines, the Issuer shall be deemed to have failed
to maintain the Notes Basic Maintenance Amount or the 1940 Act Notes Asset Coverage, as the case may be, on such Valuation Date for purposes
of Section&#160;2.09(b). In the event that any Rating Agency Certificate with respect to an applicable Asset Coverage Cure Date is not
delivered within the time periods set forth in the Rating Agency Guidelines, the Issuer shall be deemed to have failed to have Eligible
Assets with an aggregate Discounted Value at least equal to the Notes Basic Maintenance Amount or to meet the 1940 Notes Asset Coverage,
as the case may be, as of the related Valuation Date, and such failure shall be deemed not to have been cured as of such Asset Coverage
Cure Date for purposes of the mandatory redemption provisions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Delivery of Notes</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the execution and delivery of this Supplemental
Indenture, the Issuer shall execute and deliver to the Trustee and the Trustee shall authenticate the Notes and deliver them to The Depository
Trust Company and as hereinafter in this Section&#160;provided.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to the delivery by the Trustee of any of
the Notes, there shall have been filed with or delivered to the Trustee the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;A resolution duly adopted by the Issuer,
certified by the Secretary or other Authorized Officer thereof, authorizing the execution and delivery of this Supplemental Indenture
and the issuance of the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;Duly executed copies of this Supplemental
Indenture and a copy of the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;Rating letters from each Rating Agency
rating the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;An Opinion of Counsel and an Officers&#8217;
Certificate pursuant to Sections 3.3 and 9.3 of the Original Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 80 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustee&#8217;s Authentication Certificate</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee&#8217;s authentication certificate
upon the Notes shall be substantially in the forms provided in Appendix hereto. No Note shall be secured hereby or entitled to the benefit
hereof, or shall be valid or obligatory for any purpose, unless a certificate of authentication, substantially in such form, has been
duly executed by the Trustee; and such certificate of the Trustee upon any Note shall be conclusive evidence and the only competent evidence
that such Bond has been authenticated and delivered hereunder. The Trustee&#8217;s certificate of authentication shall be deemed to have
been duly executed by it if manually signed by an authorized officer of the Trustee, but it shall not be necessary that the same person
sign the certificate of authentication on all of the Notes issued hereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EVENTS OF DEFAULT; REMEDIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Events of Default</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An &#8220;Event of Default&#8221; means any one
of the following events set forth below (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary
or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule&#160;or regulation of
any administrative or governmental body):</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;default in the payment of any interest
upon a series of Notes when it becomes due and payable and the continuance of such default for thirty (30) days; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;default in the payment of the principal
of, or any premium on, a series of Notes at its Stated Maturity; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;default in the performance, or breach,
of any covenant or warranty of the Company in the Indenture, and continuance of such default or breach for a period of ninety (90) days
after there has been given, by registered or certified mail, to the Company by the Trustee a written notice specifying such default or
breach and requiring it to be remedied and stating that such notice is a &#8220;Notice of Default;&#8221; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;the entry by a court having jurisdiction
in the premises of (A)&#160;a decree or order for relief in respect of the Company in an involuntary case or proceeding under any applicable
Federal or State bankruptcy, insolvency, reorganization or other similar law or (B)&#160;a decree or order adjudging the Company a bankrupt
or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect
of the Company under any applicable Federal or State law, or appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator
or other similar official of the Company or of any substantial part of its property, or ordering the winding up or liquidation of its
affairs, and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period
of 60 consecutive days; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;the commencement by the Company of a
voluntary case or proceeding under any applicable Federal or State bankruptcy, insolvency, reorganization or other similar law or of
any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it to the entry of a decree or order for relief
in respect of the Company in an involuntary case or proceeding under any applicable Federal or State bankruptcy, insolvency, reorganization
or other similar law or to the commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition
or answer or consent seeking reorganization or relief under any applicable Federal or State law, or the consent by it to the filing of
such petition or to the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or
other similar official of the Company or of any substantial part of its property, or the making by it of an assignment for the benefit
of creditors, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate
action by the Company in furtherance of any such action; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&#160;if, pursuant to Section&#160;18(a)(1)(c)(ii)&#160;of
the 1940 Act on the last business day of each of twenty-four(24) consecutive calendar months, the 1940 Act Notes Asset Coverage is less
than 100%; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&#160;any other Event of Default provided
with respect to a series of Notes, including a default in the payment of any Redemption Price payable on the date fixed for redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise noted, an Event of Default that
relates only to one series of Notes will not affect any other series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 81 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Acceleration of Maturity; Rescission and Annulment</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If an Event of Default with respect to Notes
of a series at the time Outstanding occurs and is continuing, then in every such case the Trustee or the holders of not less than a majority
in principal amount of the Outstanding Notes of that series may declare the principal amount of all the Notes of that series to be due
and payable immediately, by a notice in writing to the Company (and to the Trustee if given by holders), and upon any such declaration
such principal amount (or specified amount) shall become immediately due and payable. If an Event of Default specified in paragraphs
(d)&#160;and (e)&#160;above with respect to Notes of any series at the time Outstanding occurs, the principal amount of all the Notes
of that series shall automatically, and without any declaration or other action on the part of the Trustee or any holder, become immediately
due and payable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At any time after such a declaration of acceleration
with respect to Notes of any series has been made and before a judgment or decree for payment of the money due has been obtained by the
Trustee, the holders of a majority in principal amount of the Outstanding Notes of that series, by written notice to the Company and
the Trustee, may rescind and annul such declaration and its consequences if:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;the Company has paid or deposited with
the Trustee a sum sufficient to pay</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(i)&#160;all overdue interest on all
Notes of that series,</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(ii)&#160;the principal of (and premium,
if any, on) any Notes of that series which have become due otherwise than by such declaration of acceleration and any interest thereon
at the rate or rates prescribed therefor in such Notes,</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iii)&#160;to the extent that payment
of such interest is lawful, interest upon overdue interest at the rate or rates prescribed therefor in such Notes,</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(iv)&#160;all sums paid or advanced
by the Trustee and the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;all Events of Default with respect to
Notes of that series, other than the non-payment of the principal of Notes of that series which have become due solely by such declaration
of acceleration, have been cured or waived.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No such rescission shall affect any subsequent
default or impair any right consequent thereon.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Collection of Indebtedness and Suits for Enforcement by Trustee</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company covenants that if:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;default is made in the payment of any
interest on any Notes when such interest becomes due and payable and such default continues for a period of 90 days, or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;default is made in the payment of the
principal of (or premium, if any, on) any Notes at the Maturity thereof, the Company will, upon demand of the Trustee, pay to it, for
the benefit of the holders of such Notes, the whole amount then due and payable on such Notes for principal and any premium and interest
and, to the extent that payment of such interest shall be legally enforceable, interest on any overdue principal and premium and on any
overdue interest, at the rate or rates prescribed therefor in such Notes, and, in addition thereto, such further amount as shall be sufficient
to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If an Event of Default with respect to Notes
of any series occurs and is continuing, the Trustee may in its discretion proceed to protect and enforce its rights and the rights of
the holders of Notes of such series by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and
enforce any such rights, whether for the specific enforcement of any covenant or agreement in the Indenture or in aid of the exercise
of any power granted in the Indenture, or to enforce any other proper remedy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 82 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Application of Money Collected</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any money collected by the Trustee pursuant to
the provisions of the Indenture relating to an Event of Default shall be applied in the following order, at the date or dates fixed by
the Trustee and, in case of the distribution of such money on account of principal or any premium or interest, upon presentation of the
Notes and the notation thereon of the payment if only partially paid and upon surrender thereof if fully paid:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">FIRST: To the payment of all amounts due the
Trustee under the Indenture;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">SECOND: To the payment of the amounts then due
and unpaid for principal of and any premium and interest on the Notes in respect of which or for the benefit of which such money has
been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Notes for principal
and any premium and interest, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Limitation On Suits</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No holder of any Notes of any series shall have
any right to institute any proceeding, judicial or otherwise, with respect to the Indenture, or for the appointment of a receiver or
trustee, or for any other remedy hereunder, unless</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;such holder has previously given written
notice to the Trustee of a continuing Event of Default with respect to the Notes of that series;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;the holders of not less than a majority
in principal amount of the Outstanding Notes of that series shall have made written request to the Trustee to institute proceedings in
respect of such Event of Default in its own name as Trustee hereunder;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;such holder or holders have offered
to the Trustee indemnity reasonably satisfactory to it against the costs, expenses and liabilities to be incurred in compliance with
such request;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;the Trustee for 60 days after its receipt
of such notice, request and offer of indemnity has failed to institute any such proceeding; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;no direction inconsistent with such
written request has been given to the Trustee during such 60-day period by the holders of a majority in principal amount of the Outstanding
Notes of that series;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">it being understood and intended that no one
or more of such holders shall have any right in any manner whatever by virtue of, or by availing of, any provision of the Indenture to
affect, disturb or prejudice the rights of any other of such holders, or to obtain or to seek to obtain priority or preference over any
other of such holders or to enforce any right under the Indenture, except in the manner provided and for the equal and ratable benefit
of all of such holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Unconditional Right of Holders to Receive Principal, Premium and
Interest</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notwithstanding any other provision in the Indenture,
the holder of any Notes shall have the right, which is absolute and unconditional, to receive payment of the principal of and any premium
and (subject to the provisions of any supplemental indenture) interest on such Notes on the respective Stated Maturities expressed in
such Notes (or, in the case of redemption, on the Redemption Date), and to institute suit for the enforcement of any such payment and
such rights shall not be impaired without the consent of such holder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 83 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Restoration of Rights and Remedies</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Trustee or any holder has instituted any
proceeding to enforce any right or remedy under the Indenture and such proceeding has been discontinued or abandoned for any reason,
or has been determined adversely to the Trustee or to such holder, then and in every such case, subject to any determination in such
proceeding, the Company, the Trustee and the holders shall be restored severally and respectively to their former positions and thereafter
all rights and remedies of the Trustee and the holders shall continue as though no such proceeding had been instituted.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Rights and Remedies Cumulative</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as otherwise provided with respect to
the replacement or payment of mutilated, destroyed, lost or stolen Notes, no right or remedy conferred upon or reserved to the Trustee
or to the holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted
by law, be cumulative and in addition to every other right and remedy given or now or hereafter existing at law or in equity or otherwise.
The assertion or employment of any right or remedy, or otherwise, shall not prevent the concurrent assertion or employment of any other
appropriate right or remedy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control By Holders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holders of not less than a majority in principal
amount of the Outstanding Notes of any series shall have the right to direct the time, method and place of conducting any proceeding
for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Notes of such
series, provided that</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&#160;such direction shall not be in conflict
with any rule&#160;of law or with the Indenture, and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&#160;the Trustee may take any other action
deemed proper by the Trustee which is not inconsistent with such direction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Waiver of Past Defaults</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holders of not less than a majority in principal
amount of the Outstanding Notes of any series may on behalf of the holders of all the Notes of such series waive any past default hereunder
with respect to such series and its consequences, except a default</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&#160;in the payment of the principal of or
any premium or interest on any Notes of such series, or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&#160;in respect of a covenant or provision
which cannot be modified or amended without the consent of the holder of each Outstanding Notes of such series affected.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon any such waiver, such default shall cease
to exist, and any Event of Default arising therefrom shall be deemed to have been cured, for every purpose of the Indenture; but no such
waiver shall extend to any subsequent or other default or impair any right consequent thereon.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SATISFACTION AND DISCHARGE OF INDENTURE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Indenture shall upon request of the Company
cease to be of further effect (except as to any surviving rights of registration of transfer or exchange of any Notes expressly provided
for herein or in the terms of such security), and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging
satisfaction and discharge of the Indenture, when</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;Either:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(i)&#160;all Notes theretofore authenticated
and delivered (other than (1)&#160;securities which have been destroyed, lost or stolen and which have been replaced or paid as provided
in the Indenture; and (2)&#160;Notes for whose payment money has theretofore been deposited in trust or segregated and held in trust
by the Company and thereafter repaid to the Company or discharged from such trust, as provided in the Indenture) have been delivered
to the Trustee for cancellation; or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 84 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(ii)&#160;all such Notes not theretofore
delivered to the Trustee for cancellation have become due and payable, or will become due and payable at their Stated Maturity within
one year, or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice
of redemption by the Trustee in the name, and at the expense, of the Company, and the Company, in the case of this subsection (ii)&#160;has
deposited or caused to be deposited with the Trustee as trust funds in trust money in an amount sufficient to pay and discharge the entire
indebtedness on such securities not theretofore delivered to the Trustee for cancellation, for principal and any premium and interest
to the date of such deposit (in the case of Securities which have become due and payable) or to the Stated Maturity or Redemption Date,
as the case may be;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;the Company has paid or caused to be
paid all other sums payable hereunder by the Trust; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;the Company has delivered to the Trustee
an Officers&#8217; Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to
the satisfaction and discharge of the Indenture have been complied with.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notwithstanding the satisfaction and discharge
of the Indenture, the obligations of the Company to the Trustee under the Indenture and, if money shall have been deposited with the
Trustee pursuant to subparagraph (ii)&#160;of paragraph (a)&#160;above, the obligations of the Trustee under certain provisions of the
Indenture shall survive.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE TRUSTEE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Duties and Responsibilities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&#160;Except during the continuance of an
Event of Default,</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(A)&#160;the Trustee undertakes to
perform such duties and only such duties as are specifically set forth in the Indenture and as required by the Trust Indenture Act, and
no implied covenants or obligations shall be read into the Indenture against the Trustee; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(B)&#160;in the absence of bad faith
on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein,
upon certificates or opinions furnished to the Trustee and conforming to the requirements of the Indenture; but in the case of any such
certificates or opinions which by any provision of the Indenture are specifically required to be furnished to the Trustee, the Trustee
shall be under a duty to examine the same to determine whether or not they conform to the requirements of the Indenture (but need not
confirm or investigate the accuracy of mathematical calculations or other facts stated therein).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&#160;In case an Event of Default has occurred
and is continuing, the Trustee shall exercise such of the rights and powers vested in it by the Indenture, and use the same degree of
care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of his or her own
affairs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&#160;In no event shall the Trustee be responsible
or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit)
irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&#160;In no event shall the Trustee be responsible
or liable for any failure or delay in the performance of its obligations arising out of or caused by, directly or indirectly, forces
beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances,
nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software
and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices
in the banking industry to resume performance as soon as practicable under the circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 85 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(5)&#160;No provision of the Indenture shall
be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful
misconduct, except that:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(A)&#160;this Subsection shall not
be construed to limit the effect of Subsection (1)(A)&#160;of this Section;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(B)&#160;the Trustee shall not be liable
for any error of judgment made in good faith by a Responsible Officer, unless it shall be proved that the Trustee was negligent in ascertaining
the pertinent facts;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(C)&#160;the Trustee shall not be liable
with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the holders of a majority
in principal amount of the Outstanding securities of any series, determined as provided in the Indenture, relating to the time, method
and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee,
under the Indenture with respect to the Securities of such series; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(D)&#160;no provision of the Indenture
shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its
duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds
or adequate indemnity against such risk or liability is not reasonably assured to it.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notice of Defaults</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If a default occurs hereunder with respect to
Notes of any series, the Trustee shall give the Holders of Notes of such series notice of such default as and to the extent provided
by the Trust Indenture Act; provided, however, that in the case of any default with respect to Notes of such series, no such notice to
Holders shall be given until at least 90 days after the occurrence thereof. For the purpose hereof, the term &#8220;default&#8221; means
any event which is, or after notice or lapse of time or both would become, an Event of Default with respect to Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Rights of Trustee</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the provisions under &#8220;Certain
Duties and Responsibilities&#8221; above:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;the Trustee may conclusively rely and
shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice,
request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to
be genuine and to have been signed or presented by the proper party or parties;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;any request or direction of the Company
shall be sufficiently evidenced by a Company Request or Company Order, and any resolution of the Board of Directors shall be sufficiently
evidenced by a Board Resolution;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;whenever in the administration of the
Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action
hereunder, the Trustee may, in the absence of bad faith on its part, rely upon an Officers&#8217; Certificate;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;the Trustee may consult with counsel
of its selection and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection
in respect of any action taken, suffered or omitted by it in good faith and in reliance thereon;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;the Trustee shall be under no obligation
to exercise any of the rights or powers vested in it by the Indenture at the request or direction of any of the holders pursuant to the
Indenture, unless such holders shall have offered to the Trustee security or indemnity reasonably satisfactory to it against the costs,
expenses and liabilities which might be incurred by it in compliance with such request or direction;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 86 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&#160;the Trustee shall not be bound to make
any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request,
direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its
discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine
to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally
or by agent or attorney;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&#160;the Trustee may execute any of the trusts
or powers or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible
for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&#160;the Trustee shall not be liable for
any action taken, suffered or omitted to be taken by it in good faith and reasonably believed by it to be authorized or within the discretion
or rights or powers conferred upon it by the Indenture;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#160;the Trustee shall not be deemed to have
notice of any default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written
notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such
notice references the Notes and the Indenture;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(j)&#160;the rights, privileges, protections,
immunities and benefits given to the Trustee, including its rights to be indemnified, are extended to, and shall be enforceable by, the
Trustee in each of its capacities hereunder; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(k)&#160;the Trustee may request that the Company
deliver an Officers&#8217; Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take
specified actions pursuant to the Indenture, which Officers&#8217; Certificate may be signed by any person authorized to sign an Officers&#8217;
Certificate, including any person specified as so authorized in any such certificate previously delivered and not superseded.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation and Reimbursement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company agrees:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;to pay to the Trustee from time to time
such compensation as shall be agreed in writing between the parties for all services rendered by it (which compensation shall not be
limited by any provision of law in regard to the compensation of a trustee of an express trust);</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;except as otherwise expressly provided,
to reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in
accordance with any provision of the Indenture (including the reasonable compensation and the expenses and disbursements of its agents
and counsel), except any such expense, disbursement or advance as may be attributable to its negligence or bad faith; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;to indemnify each of the Trustee or
any predecessor Trustee for, and to hold it harmless against, any and all losses, liabilities, damages, claims or expenses including
taxes (other than taxes imposed on the income of the Trustee) incurred without negligence or bad faith on its part, arising out of or
in connection with the acceptance or administration of the trust or trusts hereunder, including the costs and expenses of defending itself
against any claim (whether asserted by the Company, a holder or any other Person) or liability in connection with the exercise or performance
of any of its powers or duties hereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">When the Trustee incurs expenses or renders services
in connection with an Event of Default, the expenses (including the reasonable charges and expenses of its counsel) and the compensation
for the services are intended to constitute expenses of administration under any applicable Federal or State bankruptcy, insolvency or
other similar law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The provisions hereof shall survive the termination
of the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 87 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conflicting Interests</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Trustee has or shall acquire a conflicting
interest within the meaning of the Trust Indenture Act, the Trustee shall either eliminate such interest or resign, to the extent and
in the manner provided by, and subject to the provisions of, the Trust Indenture Act and the Indenture. To the extent not prohibited
by the Trust Indenture Act, the Trustee shall not be deemed to have a conflicting interest by virtue of being a trustee under the Indenture
with respect to Notes of more than one series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Resignation and Removal; Appointment of Successor</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No resignation or removal of the Trustee and
no appointment of a successor Trustee shall become effective until the acceptance of appointment by the successor Trustee in accordance
with the applicable requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee may resign at any time with respect
to the Notes of one or more series by giving written notice thereof to the Company. If the instrument of acceptance by a successor Trustee
shall not have been delivered to the Trustee within 60 days after the giving of such notice of resignation, the resigning Trustee may
petition, at the expense of the Company, any court of competent jurisdiction for the appointment of a successor Trustee with respect
to the Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee may be removed at any time with respect
to the Notes of any series by Act of the holders of a majority in principal amount of the Outstanding Notes of such series, delivered
to the Trustee and to the Company. If the instrument of acceptance by a successor Trustee shall not have been delivered to the Trustee
within 30 days after the giving of a notice of removal pursuant to this paragraph, the Trustee being removed may petition, at the expense
of the Company, any court of competent jurisdiction for the appointment of a successor Trustee with respect to the Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If at any time:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;the Trustee shall fail to comply after
written request therefor by the Company or by any holder who has been a bona fide holder of Notes for at least six months, or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;the Trustee shall cease to be eligible
and shall fail to resign after written request therefor by the Company or by any such holder, or</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;the Trustee shall become incapable of
acting or shall be adjudged a bankrupt or insolvent or a receiver of the Trustee or of its property shall be appointed or any public
officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or
liquidation, then, in any such case, (i)&#160;the Company by a Board Resolution may remove the Trustee with respect to all Notes, or
(ii)&#160;any holder who has been a bona fide holder of Notes for at least six months may, on behalf of himself and all others similarly
situated, petition any court of competent jurisdiction for the removal of the Trustee with respect to all Notes and the appointment of
a successor Trustee or Trustees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Trustee shall resign, be removed or become
incapable of acting, or if a vacancy shall occur in the office of Trustee for any cause, with respect to the Notes of one or more series,
the Company, by a Board Resolution, shall promptly appoint a successor Trustee or Trustees with respect to the Notes of that or those
series (it being understood that any such successor Trustee may be appointed with respect to the Notes of one or more or all of such
series and that at any time there shall be only one Trustee with respect to the Notes of any particular series) and shall comply with
the applicable requirements. If, within one year after such resignation, removal or incapability, or the occurrence of such vacancy,
a successor Trustee with respect to the Notes of any series shall be appointed by Act of the holders of a majority in principal amount
of the Outstanding Notes of such series delivered to the Company and the retiring Trustee, the successor Trustee so appointed shall,
forthwith upon its acceptance of such appointment in accordance with the applicable requirements, become the successor Trustee with respect
to the Notes of such series and to that extent supersede the successor Trustee appointed by the Company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If no successor Trustee with respect to the Notes
of any series shall have been so appointed by the Company or the holders and accepted appointment in the manner required, any holder
who has been a bona fide holder of Notes of such series for at least six months may, on behalf of himself and all others similarly situated,
petition any court of competent jurisdiction for the appointment of a successor Trustee with respect to the Notes of such series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 88 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company shall give notice of each resignation
and each removal of the Trustee with respect to the Notes of any series and each appointment of a successor Trustee with respect to the
Notes of any series to all holders of Notes of such series in the manner provided. Each notice shall include the name of the successor
Trustee with respect to the Notes of such series and the address of its Corporate Trust Office.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Acceptance of Appointment by Successor</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case of the appointment hereunder of a successor
Trustee with respect to all Notes, every such successor Trustee so appointed shall execute, acknowledge and deliver to the Company and
to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall
become effective and such successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers,
trusts and duties of the retiring Trustee; but, on the request of the Company or the successor Trustee, such retiring Trustee shall,
upon payment of its charges, execute and deliver an instrument transferring to such successor Trustee all the rights, powers and trusts
of the retiring Trustee and shall duly assign, transfer and deliver to such successor Trustee all property and money held by such retiring
Trustee hereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case of the appointment hereunder of a successor
Trustee with respect to the Notes of one or more (but not all) series, the Company, the retiring Trustee and each successor Trustee with
respect to the Notes of one or more series shall execute and deliver a supplemental indenture wherein each successor Trustee shall accept
such appointment and which (1)&#160;shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and
to vest in, each successor Trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the Notes of that
or those series to which the appointment of such successor Trustee relates, (2)&#160;if the retiring Trustee is not retiring with respect
to all Notes, shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts
and duties of the retiring Trustee with respect to the Notes of that or those series as to which the retiring Trustee is not retiring
shall continue to be vested in the retiring Trustee, and (3)&#160;shall add to or change any of the provisions of the Indenture as shall
be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that
nothing in the Indenture shall constitute such Trustees co-trustees of the same trust and that each such Trustee shall be trustee of
a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee; and upon the
execution and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the
extent provided therein and each such successor Trustee, without any further act, deed or conveyance, shall become vested with all the
rights, powers, trusts and duties of the retiring Trustee with respect to the Notes of that or those series to which the appointment
of such successor Trustee relates; but, on request of the Company or any successor Trustee, such retiring Trustee shall duly assign,
transfer and deliver to such successor Trustee all property and money held by such retiring Trustee hereunder with respect to the Notes
of that or those series to which the appointment of such successor Trustee relates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon request of any such successor Trustee, the
Company shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor Trustee all such
rights, powers and trusts referred to in the first or second preceding paragraph, as the case may be.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No successor Trustee shall accept its appointment
unless at the time of such acceptance such successor Trustee shall be qualified and eligible.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Merger, Conversion, Consolidation or Succession to Business</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any corporation into which the Trustee may be
merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to
which the Trustee shall be a party, or any corporation succeeding to all or substantially all the corporate trust business of the Trustee,
shall be the successor of the Trustee hereunder, provided such corporation shall be otherwise qualified and eligible, without the execution
or filing of any paper or any further act on the part of any of the parties hereto. In case any Notes shall have been authenticated,
but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee
may adopt such authentication and deliver the Notes so authenticated with the same effect as if such successor Trustee had itself authenticated
such Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 89 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER
OR LEASE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Company May&#160;Consolidate, Etc., Only On Certain Terms</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company shall not consolidate with or merge
into any other Person or convey, transfer or lease its properties and assets substantially as an entirety to any Person, and the Company
shall not permit any Person to consolidate with or merge into the Company, unless:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;in case the Company shall consolidate
with or merge into another Person or convey, transfer or lease its properties and assets substantially as an entirety to any Person,
the Person formed by such consolidation or into which the Company is merged or the Person which acquires by conveyance or transfer, or
which leases, the properties and assets of the Company substantially as an entirety shall be a corporation, partnership or trust, shall
be organized and validly existing under the laws of any domestic or foreign jurisdiction and shall expressly assume, by an indenture
supplemental hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, the due and punctual payment of the
principal of and any premium and interest on all the Notes and the performance or observance of every covenant of the Indenture on the
part of the Company to be performed or observed;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;immediately after giving effect to such
transaction and treating any indebtedness which becomes an obligation of the Company or any subsidiary as a result of such transaction
as having been incurred by the Company or such Subsidiary at the time of such transaction, no Event of Default, and no event which, after
notice or lapse of time or both, would become an Event of Default, shall have happened and be continuing;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;the Company has delivered to the Trustee
an Officers&#8217; Certificate and an Opinion of Counsel, each stating that such consolidation, merger, conveyance, transfer or lease
and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture comply and that all conditions
precedent in the Indenture provided for relating to such transaction have been complied with.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Successor Substituted</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon any consolidation of the Company with, or
merger of the Company into, any other Person or any conveyance, transfer or lease of the properties and assets of the Company substantially
as an entirety, the successor Person formed by such consolidation or into which the Company is merged or to which such conveyance, transfer
or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under the Indenture
with the same effect as if such successor Person had been named as the Company in the Indenture, and thereafter, except in the case of
a lease, the predecessor Person shall be relieved of all obligations and covenants under the Indenture and the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DEFEASANCE AND COVENANT DEFEASANCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Defeasance and Discharge</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the Company&#8217;s exercise of its option
(if any) to have the provisions of the Indenture relating to Defeasance applied to any Notes or any series of Notes, as the case may
be, the Company shall be deemed to have been discharged from its obligations, with respect to such Notes as provided in the Indenture
on and after the date the conditions set forth are satisfied (hereinafter called &#8220;Defeasance&#8221;). For this purpose, such Defeasance
means that the Company shall be deemed to have paid and discharged the entire indebtedness represented by such Notes and to have satisfied
all its other obligations under such Notes and the Indenture insofar as such Notes are concerned (and the Trustee, at the expense of
the Company, shall execute proper instruments acknowledging the same), subject to the following which shall survive until otherwise terminated
or discharged hereunder: (1)&#160;the rights of holders of such Notes to receive, solely from the trust fund, payments in respect of
the principal of and any premium and interest on such Notes when payments are due, (2)&#160;the Company&#8217;s obligations with respect
to such Notes, (3)&#160;the rights, powers, trusts, duties and immunities of the Trustee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 90 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Covenant Defeasance</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the Company&#8217;s exercise of its option
(if any) to have provisions of the Indenture relating to Covenant Defeasance applied to any Notes or any series of Notes, as the case
may be, (1)&#160;the Company shall be released from its obligations under certain provisions of the Indenture for the benefit of the
holders of such Notes and (2)&#160;the occurrence of any event specified in the Indenture, and any such covenants provided pursuant to
certain provisions of the Indenture shall be deemed not to be or result in an Event of Default, in each case with respect to such Notes
as provided in the Indenture on and after the date the conditions are satisfied (hereinafter called &#8220;Covenant Defeasance&#8221;).
For this purpose, such Covenant Defeasance means that, with respect to such Notes, the Company may omit to comply with and shall have
no liability in respect of any term, condition or limitation set forth in any such specified section of the Indenture, whether directly
or indirectly by reason of any reference elsewhere in the Indenture, or by reason of any reference in any such section or article of
the Indenture to any other provision in the Indenture or in any other document, but the remainder of the Indenture and such Notes shall
be unaffected thereby.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conditions to Defeasance or Covenant Defeasance</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#160;The Company shall irrevocably have deposited
or caused to be deposited with the Trustee (or another trustee which satisfies the requirements and agrees to comply with the provisions
of the relevant Article&#160;of the Indenture applicable to it) as trust funds in trust for the purpose of making the following payments,
specifically pledged as security for, and dedicated solely to, the benefits of the holders of such Notes, (i)&#160;money in an amount,
or (ii)&#160;U.S. Government Obligations which through the scheduled payment of principal and interest in respect thereof in accordance
with their terms will provide, not later than one day before the due date of any payment, money in an amount, or (iii)&#160;such other
obligations or arrangements as may be specified with respect to such Notes, or (iv)&#160;a combination thereof, in each case sufficient,
in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered
to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or any such other qualifying trustee) to pay and discharge,
the principal of and any premium and interest on such Notes on the respective Stated Maturities, in accordance with the terms of the
Indenture and such Notes. As used in the Indenture, &#8220;U.S. Government Obligation&#8221; means (x)&#160;any security which is (i)&#160;a
direct obligation of the United States of America for the payment of which the full faith and credit of the United States of America
is pledged or (ii)&#160;an obligation of a Person controlled or supervised by and acting as an agency or instrumentality of the United
States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America,
which, in either case (i)&#160;or (ii), is not callable or redeemable at the option of the Company thereof, and (y)&#160;any depositary
receipt issued by a bank (as defined in Section&#160;3(a)(2)&#160;of the Notes Act) as custodian with respect to any U.S. Government
Obligation which is specified in Clause (x)&#160;above and held by such bank for the account of the holder of such depositary receipt,
or with respect to any specific payment of principal of or interest on any U.S. Government Obligation which is so specified and held,
provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder
of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment
of principal or interest evidenced by such depositary receipt.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#160;In the event of an election to have
Defeasance and Discharge apply to any Notes or any series of Notes, as the case may be, the Company shall have delivered to the Trustee
an Opinion of Counsel stating that (i)&#160;the Company has received from, or there has been published by, the Internal Revenue Service
a ruling or (ii)&#160;since the date of this instrument, there has been a change in the applicable Federal income tax law, in either
case (i)&#160;or (ii)&#160;to the effect that, and based thereon such opinion shall confirm that, the holders of such Notes will not
recognize gain or loss for Federal income tax purposes as a result of the deposit, Defeasance and discharge to be effected with respect
to such Notes and will be subject to Federal income tax on the same amount, in the same manner and at the same times as would be the
case if such deposit, Defeasance and discharge were not to occur.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 91 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#160;In the event of an election to have
Covenant Defeasance apply to any Notes or any series of Notes, as the case may be, the Company shall have delivered to the Trustee an
Opinion of Counsel to the effect that the holders of such Notes will not recognize gain or loss for Federal income tax purposes as a
result of the deposit and Covenant Defeasance to be effected with respect to such Notes and will be subject to Federal income tax on
the same amount, in the same manner and at the same times as would be the case if such deposit and Covenant Defeasance were not to occur.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#160;The Company shall have delivered to
the Trustee an Officers&#8217; Certificate to the effect that neither such Notes nor any other Notes of the same series, if then listed
on any Notes exchange, will be delisted as a result of such deposit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&#160;No event which is, or after notice or
lapse of time or both would become, an Event of Default with respect to such Notes or any other Notes shall have occurred and be continuing
at the time of such deposit or, with regard to any such event specified, at any time on or prior to the 90th day after the date of such
deposit (it being understood that this condition shall not be deemed satisfied until after such 90th day).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&#160;Such Defeasance or Covenant Defeasance
shall not cause the Trustee to have a conflicting interest within the meaning of the Trust Indenture Act (assuming all Notes are in default
within the meaning of such Act).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&#160;Such Defeasance or Covenant Defeasance
shall not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which the Company is
a party or by which it is bound.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&#160;Such Defeasance or Covenant Defeasance
shall not result in the trust arising from such deposit constituting an investment company within the meaning of the Investment Company
Act unless such trust shall be registered under the Investment Company Act or exempt from registration thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#160;No event or condition shall exist that
would prevent the Company from making payments of the principal of (and any premium) or interest on the Notes of such series on the date
of such deposit or at any time on or prior to the 90th day after the date of such deposit (it being understood that this condition shall
not be deemed satisfied until after such 90th day).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(j)&#160;The Company shall have delivered to
the Trustee an Officers&#8217; Certificate and an Opinion of Counsel, each stating that all conditions precedent with respect to such
Defeasance or Covenant Defeasance have been complied with.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(k)&#160;The Company shall have delivered to
the Trustee an Opinion of Counsel substantially to the effect that (i)&#160;the trust funds deposited pursuant hereto will not be subject
to any rights of any holders of indebtedness or equity of the Company, and (ii)&#160;after the 90th day following the deposit, the trust
funds will not be subject to the effect of any applicable bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217;
rights generally, except that if a court were to rule&#160;under any such law in any case or proceeding that the trust funds remained
property of the Company, no opinion is given as to the effect of such laws on the trust funds except the following: (A)&#160;assuming
such trust funds remained in the possession of the trustee with whom such funds were deposited prior to such court ruling to the extent
not paid to holders of such Notes, such trustee would hold, for the benefit of such holders, a valid and perfected security interest
in such trust funds that is not avoidable in bankruptcy or otherwise and (B)&#160;such holders would be entitled to receive adequate
protection of their interests in such trust funds if such trust funds were used.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 92; Options: NewSection; Value: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPENDIX B &#8212; DESCRIPTION
OF RATINGS<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A rating of a rating service represents the service&#8217;s
opinion as to the credit quality of the security being rated. However, the ratings are general and are not absolute standards of quality
or guarantees as to the creditworthiness of an issuer. Consequently, Calamos believes that the quality of debt securities in which the
Fund invests should be continuously reviewed. A rating is not a recommendation to purchase, sell or hold a security, because it does
not take into account market value or suitability for a particular investor. When a security has received a rating from more than one
service, each rating should be evaluated independently. Ratings are based on current information furnished by the issuer or obtained
by the ratings services from other sources that they consider reliable. Ratings may be changed, suspended or withdrawn as a result of
changes in or unavailability of such information, or for other reasons.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a description of the characteristics
of ratings used by Moody&#8217;s Investors Service (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Corporation, a
division of The McGraw-Hill Companies (&#8220;S&amp;P&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Moody&#8217;s Global Short-Term Rating Scale</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">P-1</span>: </i>Ratings of Prime-1 reflect
a superior ability to repay short-term obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">P-2</span>: </i>Ratings of Prime-2 reflect
a strong ability to repay short-term obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">P-3</span>: </i>Ratings of Prime-3 reflect
an acceptable ability to repay short-term obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">NP</span>: </i>Issuers (or supporting institutions)
rated Not Prime do not fall within any of the Prime rating categories.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Moody&#8217;s Global Long-Term Rating Scale</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Aaa</span>: </i>Obligations rated Aaa are
judged to be of the highest quality, subject to the lowest level of credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Aa</span>: </i>Obligations rated Aa are judged
to be of high quality and are subject to very low credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">A</span>: </i>Obligations rated A are judged
to be upper-medium grade and are subject to low credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Baa</span>: </i>Obligations rated Baa are
judged to be medium-grade and subject to moderate credit risk and as such may possess certain speculative characteristics.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Ba</span>: </i>Obligations rated Ba are judged
to be speculative and are subject to substantial credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">B</span>: </i>Obligations rated B are considered
speculative and are subject to high credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Caa</span>: </i>Obligations rated Caa are
judged to be speculative of poor standing and are subject to very high credit risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Ca</span>: </i>Obligations rated Ca are highly
speculative and are likely in, or very near, default, with some prospect of recovery of principal and interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>3</sup> The ratings indicated herein are believed to be the most
recent ratings available at the date of this prospectus for the securities listed. Ratings are generally given to securities at the time
of issuance. While the rating agencies may from time to time revise such ratings, they undertake no obligation to do so, and the ratings
indicated do not necessarily represent ratings which will be given to these securities on the date of the Fund&#8217;s fiscal year-end.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 93; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">C</span>: </i>Obligations rated C are the
lowest rated and are typically in default, with little prospect for recovery of principal or interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">Note</span>: </i>Moody&#8217;s appends numerical
modifiers 1, 2, and 3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in
the higher end of its generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in
the lower end of that generic rating category. Additionally, a &#8220;(hyb)&#8221; indicator is appended to all ratings of hybrid securities
issued by banks, insurers, finance companies, and securities firms.*</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">* By their terms, hybrid securities allow for
the omission of scheduled dividends, interest, or principal payments, which can potentially result in impairment if such an omission
occurs. Hybrid securities may also be subject to contractually allowable write-downs of principal that could result in impairment. Together
with the hybrid indicator, the long-term obligation rating assigned to a hybrid security is an expression of the relative credit risk
associated with that security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>S&amp;P Short-Term Issue Credit Ratings</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">A-1</span>: </i>A short-term obligation rated
&#8216;A-1&#8217; is rated in the highest category by S&amp;P Global Ratings. The obligor&#8217;s capacity to meet its financial commitments
on the obligation is strong. Within this category, certain obligations are designated with a plus sign (+). This indicates that the obligor&#8217;s
capacity to meet its financial commitments on these obligations is extremely strong.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">A-2</span>: </i>A short-term obligation rated
&#8216;A-2&#8217; is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations
in higher rating categories. However, the obligor&#8217;s capacity to meet its financial commitments on the obligation is satisfactory.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">A-3</span>: </i>A short-term obligation rated
&#8216;A-3&#8217; exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely
to weaken an obligor&#8217;s capacity to meet its financial commitments on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">B</span>: </i>A short-term obligation rated
&#8216;B&#8217; is regarded as vulnerable and has significant speculative characteristics.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The obligor currently has the capacity to meet
its financial commitments; however, it faces major ongoing uncertainties that could lead to the obligor&#8217;s inadequate capacity to
meet its financial commitments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">C</span>: </i>A short-term obligation rated
&#8216;C&#8217; is currently vulnerable to nonpayment and is dependent upon favorable business, financial, and economic conditions for
the obligor to meet its financial commitments on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">D</span>: </i>A short-term obligation rated
&#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217; rating category
is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such payments will be
made within any stated grace period. However, any stated grace period longer than five business days will be treated as five business
days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of a similar action and where
default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation is lowered to
&#8216;D&#8217; if it is subject to a distressed debt restructuring.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>S&amp;P Long-Term Issue Credit Ratings*</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Issue credit ratings are based, in varying degrees,
on S&amp;P Global Ratings analysis of the following considerations:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.15in"><span>&#9679;</span></td>
    <td>The likelihood of payment &#8211; the capacity and willingness of the obligor to meet its financial
    commitments on an obligation in accordance with the terms of the obligation;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.15in"><span>&#9679;</span></td>
    <td>The nature and provisions of the financial obligation, and the promise we impute; and</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Ratings from &#8216;AA&#8217; to &#8216;CCC&#8217; may be modified by the addition of a plus (+) or minus (-) sign to show relative
standing within the rating categories.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.15in"><span>&#9679;</span></td>
    <td>The protection afforded by, and relative position of, the financial obligation in the event of
    a bankruptcy, reorganization, or other arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An issue rating is an assessment of default risk
but may incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations are typically
rated lower than senior obligations, to reflect lower priority in bankruptcy, as noted above. (Such differentiation may apply when an
entity has both senior and subordinated obligations, secured and unsecured obligations, or operating company and holding company obligations.)</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">AAA</span>: </i>An obligation rated &#8216;AAA&#8217;
has the highest rating assigned by S&amp;P Global Ratings. The obligor&#8217;s capacity to meet its financial commitments on the obligation
is extremely strong.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">AA</span>: </i>An obligation rated &#8216;AA&#8217;
differs from the highest rated obligations only to a small degree. The obligor&#8217;s capacity to meet its financial commitments on
the obligation is very strong.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">A</span>: </i>An obligation rated &#8216;A&#8217;
is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations in higher rated
categories. However, the obligor&#8217;s capacity to meet its financial commitments on the obligation is still strong.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">BBB</span>: </i>An obligation rated &#8216;BBB&#8217;
exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to weaken the
obligor&#8217;s capacity to meet its financial commitments on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">BB, B, CCC, CC, and C:</span></i> Obligations
rated &#8216;BB&#8217;, &#8216;B&#8217;, &#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant
speculative characteristics. &#8216;BB&#8217; indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations
will likely have some quality and protective characteristics, these may be outweighed by large uncertainties or major exposure to adverse
conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">BB</span>: </i>An obligation rated &#8216;BB&#8217;
is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing uncertainties or exposure to adverse
business, financial, or economic conditions that could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments
on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">B</span>: </i>An obligation rated &#8216;B&#8217;
is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;, but the obligor currently has the capacity to meet its financial
commitments on the obligation. Adverse business, financial, or economic conditions will likely impair the obligor&#8217;s capacity or
willingness to meet its financial commitments on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">CCC</span>: </i>An obligation rated &#8216;CCC&#8217;
is currently vulnerable to nonpayment, and is dependent upon favorable business, financial, and economic conditions for the obligor to
meet its financial commitments on the obligation. In the event of adverse business, financial, or economic conditions, the obligor is
not likely to have the capacity to meet its financial commitments on the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">CC</span>: </i>An obligation rated &#8216;CC&#8217;
is currently highly vulnerable to nonpayment. The &#8216;CC&#8217; rating is used when a default has not yet occurred but S&amp;P Global
Ratings expects default to be a virtual certainty, regardless of the anticipated time to default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">C</span>: </i>An obligation rated &#8216;C&#8217;
is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative seniority or lower ultimate recovery
compared with obligations that are rated higher.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i><span style="text-decoration:underline">D</span>: </i>An obligation rated &#8216;D&#8217;
is in default or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217; rating category is used when
payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such payments will be made within
the next five business days in the absence of a stated grace period or within the earlier of the stated grace period or the next 30 calendar
days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of similar action and where
default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation is lowered to
&#8216;D&#8217; if it is subject to a distressed debt restructuring.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">NR indicates that a rating has not been assigned
or is no longer assigned.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Local Currency and Foreign Currency Ratings</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">S&amp;P Global Ratings&#8217; issuer credit ratings
make a distinction between foreign currency ratings and local currency ratings. A foreign currency rating on an issuer can differ from
the local currency rating on it when the obligor has a different capacity to meet its obligations denominated in its local currency versus
obligations denominated in a foreign currency.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 96; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>chi-20250221.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:chi="http://www.calamos.com/20250221" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" targetNamespace="http://www.calamos.com/20250221" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef-pre/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.calamos.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and entity information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/EffectsOfLeverage" id="EffectsOfLeverage">
        <link:definition>0002 - Disclosure - Effects of Leverage</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/FUNDEXPENSES" id="FUNDEXPENSES">
        <link:definition>0003 - Disclosure - FUND EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/OutstandingSecurities" id="OutstandingSecurities">
        <link:definition>0004 - Disclosure - Outstanding securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/GeneralDescriptionOfRegistrant" id="GeneralDescriptionOfRegistrant">
        <link:definition>0004 - Disclosure - General Description of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="chi-20250221_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="chi-20250221_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="chi-20250221_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AmericanDepositaryReceiptsRiskMember" id="chi_AmericanDepositaryReceiptsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AntitakeoverProvisionsRiskMember" id="chi_AntitakeoverProvisionsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashHoldingsRiskMember" id="chi_CashHoldingsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonSharesMember" id="chi_CommonSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingentLiabilitiesRiskMember" id="chi_ContingentLiabilitiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleHedgingAndShortSalesRiskMember" id="chi_ConvertibleHedgingAndShortSalesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleSecuritiesRiskMember" id="chi_ConvertibleSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorrelationRiskMember" id="chi_CorrelationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CovenantLiteLoansRiskMember" id="chi_CovenantLiteLoansRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditRisksMember" id="chi_CreditRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrencyRiskMember" id="chi_CurrencyRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CybersecurityRiskMember" id="chi_CybersecurityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtSecuritiesRiskMember" id="chi_DebtSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeclineInNetAssetValueRiskMember" id="chi_DeclineInNetAssetValueRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefaultRiskMember" id="chi_DefaultRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativesRiskMember" id="chi_DerivativesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DiminishedVotingPowerAndExcessCashRiskMember" id="chi_DiminishedVotingPowerAndExcessCashRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DurationMismatchRiskMember" id="chi_DurationMismatchRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DurationRiskMember" id="chi_DurationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarlyRedemptionRiskMember" id="chi_EarlyRedemptionRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmergingMarketsRiskMember" id="chi_EmergingMarketsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquitySecuritiesRiskMember" id="chi_EquitySecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FixedIncomeSecuritiesRiskMember" id="chi_FixedIncomeSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignSecuritiesRiskMember" id="chi_ForeignSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForwardCurrencyExchangeContractsRiskMember" id="chi_ForwardCurrencyExchangeContractsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FuturesAndForwardContractsRiskMember" id="chi_FuturesAndForwardContractsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralDerivativeRiskMember" id="chi_GeneralDerivativeRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeographicConcentrationRisksMember" id="chi_GeographicConcentrationRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeographicFocusRiskMember" id="chi_GeographicFocusRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighYieldSecuritiesRiskMember" id="chi_HighYieldSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InflationRiskMember" id="chi_InflationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestRateRisksMember" id="chi_InterestRateRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestRateTransactionsRiskMember" id="chi_InterestRateTransactionsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestingInRealEstateInvestmentTrustsRiskReitMember" id="chi_InvestingInRealEstateInvestmentTrustsRiskReitMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeverageRiskForAllFundsExceptCpzMember" id="chi_LeverageRiskForAllFundsExceptCpzMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeverageRiskMember" id="chi_LeverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LimitedTermRiskMember" id="chi_LimitedTermRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiquidityRiskMember" id="chi_LiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoanRiskMember" id="chi_LoanRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementRiskMember" id="chi_ManagementRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesCMember" id="chi_MandatoryRedeemablePreferredSharesSeriesCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesDMember" id="chi_MandatoryRedeemablePreferredSharesSeriesDMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesEMember" id="chi_MandatoryRedeemablePreferredSharesSeriesEMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesGMember" id="chi_MandatoryRedeemablePreferredSharesSeriesGMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketDiscountRisk1Member" id="chi_MarketDiscountRisk1Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketDiscountRiskMember" id="chi_MarketDiscountRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketDisruptionRiskMember" id="chi_MarketDisruptionRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketImpactRiskMember" id="chi_MarketImpactRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MasterLimitedPartnershipsRiskMember" id="chi_MasterLimitedPartnershipsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaturityRiskMember" id="chi_MaturityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonConvertibleIncomeSecuritiesRiskMember" id="chi_NonConvertibleIncomeSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PortfolioLevelRisksMember" id="chi_PortfolioLevelRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PortfolioSelectionRiskMember" id="chi_PortfolioSelectionRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PortfolioTurnoverRiskMember" id="chi_PortfolioTurnoverRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredShareLiquidationPreferenceRiskMember" id="chi_PreferredShareLiquidationPreferenceRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RatingsAndAssetCoverageRiskMember" id="chi_RatingsAndAssetCoverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecentMarketEventsRiskMember" id="chi_RecentMarketEventsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReductionOfLeverageRiskMember" id="chi_ReductionOfLeverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RegulatoryRiskMember" id="chi_RegulatoryRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithOptionsAllFundsExceptCpzMember" id="chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithOptionsCpzMember" id="chi_RisksAssociatedWithOptionsCpzMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecondaryMarketRiskMember" id="chi_SecondaryMarketRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SectorRiskMember" id="chi_SectorRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorLeverageRiskMember" id="chi_SeniorLeverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortSellingRiskMember" id="chi_ShortSellingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SyntheticConvertibleInstrumentsRiskMember" id="chi_SyntheticConvertibleInstrumentsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxRiskMember" id="chi_TaxRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsGovernmentSecurityRiskMember" id="chi_UsGovernmentSecurityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VolatilityRiskMember" id="chi_VolatilityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>chi-20250221_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#RiskOnly"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#SecurityOnly"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CommonSharesMember" xlink:label="loc_chi_CommonSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_3"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_4"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesGMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_CommonSharesMember_1" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_3" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_4" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_5" order="5" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>chi-20250221_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_AmericanDepositaryReceiptsRiskMember" xlink:label="loc_chi_AmericanDepositaryReceiptsRiskMember_1"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_AntitakeoverProvisionsRiskMember" xlink:label="loc_chi_AntitakeoverProvisionsRiskMember_2"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CashHoldingsRiskMember" xlink:label="loc_chi_CashHoldingsRiskMember_3"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CommonSharesMember" xlink:label="loc_chi_CommonSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CommonSharesMember" xlink:label="loc_chi_CommonSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ContingentLiabilitiesRiskMember" xlink:label="loc_chi_ContingentLiabilitiesRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ConvertibleHedgingAndShortSalesRiskMember" xlink:label="loc_chi_ConvertibleHedgingAndShortSalesRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ConvertibleSecuritiesRiskMember" xlink:label="loc_chi_ConvertibleSecuritiesRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CorrelationRiskMember" xlink:label="loc_chi_CorrelationRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CovenantLiteLoansRiskMember" xlink:label="loc_chi_CovenantLiteLoansRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CreditRisksMember" xlink:label="loc_chi_CreditRisksMember_11"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CurrencyRiskMember" xlink:label="loc_chi_CurrencyRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CybersecurityRiskMember" xlink:label="loc_chi_CybersecurityRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DebtSecuritiesRiskMember" xlink:label="loc_chi_DebtSecuritiesRiskMember_14"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DeclineInNetAssetValueRiskMember" xlink:label="loc_chi_DeclineInNetAssetValueRiskMember_15"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DefaultRiskMember" xlink:label="loc_chi_DefaultRiskMember_16"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DerivativesRiskMember" xlink:label="loc_chi_DerivativesRiskMember_17"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DiminishedVotingPowerAndExcessCashRiskMember" xlink:label="loc_chi_DiminishedVotingPowerAndExcessCashRiskMember_18"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DurationMismatchRiskMember" xlink:label="loc_chi_DurationMismatchRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_DurationRiskMember" xlink:label="loc_chi_DurationRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_EarlyRedemptionRiskMember" xlink:label="loc_chi_EarlyRedemptionRiskMember_21"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_EmergingMarketsRiskMember" xlink:label="loc_chi_EmergingMarketsRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_EquitySecuritiesRiskMember" xlink:label="loc_chi_EquitySecuritiesRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_FixedIncomeSecuritiesRiskMember" xlink:label="loc_chi_FixedIncomeSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ForeignSecuritiesRiskMember" xlink:label="loc_chi_ForeignSecuritiesRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ForwardCurrencyExchangeContractsRiskMember" xlink:label="loc_chi_ForwardCurrencyExchangeContractsRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_FuturesAndForwardContractsRiskMember" xlink:label="loc_chi_FuturesAndForwardContractsRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_GeneralDerivativeRiskMember" xlink:label="loc_chi_GeneralDerivativeRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_GeographicConcentrationRisksMember" xlink:label="loc_chi_GeographicConcentrationRisksMember_29"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_GeographicFocusRiskMember" xlink:label="loc_chi_GeographicFocusRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_HighYieldSecuritiesRiskMember" xlink:label="loc_chi_HighYieldSecuritiesRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_InflationRiskMember" xlink:label="loc_chi_InflationRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_InterestRateRisksMember" xlink:label="loc_chi_InterestRateRisksMember_33"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_InterestRateTransactionsRiskMember" xlink:label="loc_chi_InterestRateTransactionsRiskMember_34"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_InvestingInRealEstateInvestmentTrustsRiskReitMember" xlink:label="loc_chi_InvestingInRealEstateInvestmentTrustsRiskReitMember_35"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LeverageRiskForAllFundsExceptCpzMember" xlink:label="loc_chi_LeverageRiskForAllFundsExceptCpzMember_36"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LeverageRiskForAllFundsExceptCpzMember" xlink:label="loc_chi_LeverageRiskForAllFundsExceptCpzMember_37"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LeverageRiskMember" xlink:label="loc_chi_LeverageRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LimitedTermRiskMember" xlink:label="loc_chi_LimitedTermRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LiquidityRiskMember" xlink:label="loc_chi_LiquidityRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_LoanRiskMember" xlink:label="loc_chi_LoanRiskMember_41"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ManagementRiskMember" xlink:label="loc_chi_ManagementRiskMember_42"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_43"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_44"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_45"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_46"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_47"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_48"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_49"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_50"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_51"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesGMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_52"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesGMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_53"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesGMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_54"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MarketDiscountRisk1Member" xlink:label="loc_chi_MarketDiscountRisk1Member_55"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MarketDiscountRisk1Member" xlink:label="loc_chi_MarketDiscountRisk1Member_56"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MarketDiscountRiskMember" xlink:label="loc_chi_MarketDiscountRiskMember_57"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MarketDisruptionRiskMember" xlink:label="loc_chi_MarketDisruptionRiskMember_58"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MarketImpactRiskMember" xlink:label="loc_chi_MarketImpactRiskMember_59"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MasterLimitedPartnershipsRiskMember" xlink:label="loc_chi_MasterLimitedPartnershipsRiskMember_60"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MaturityRiskMember" xlink:label="loc_chi_MaturityRiskMember_61"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_NonConvertibleIncomeSecuritiesRiskMember" xlink:label="loc_chi_NonConvertibleIncomeSecuritiesRiskMember_62"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_NonConvertibleIncomeSecuritiesRiskMember" xlink:label="loc_chi_NonConvertibleIncomeSecuritiesRiskMember_63"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_PortfolioLevelRisksMember" xlink:label="loc_chi_PortfolioLevelRisksMember_64"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_PortfolioSelectionRiskMember" xlink:label="loc_chi_PortfolioSelectionRiskMember_65"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_PortfolioTurnoverRiskMember" xlink:label="loc_chi_PortfolioTurnoverRiskMember_66"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_PreferredShareLiquidationPreferenceRiskMember" xlink:label="loc_chi_PreferredShareLiquidationPreferenceRiskMember_67"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RatingsAndAssetCoverageRiskMember" xlink:label="loc_chi_RatingsAndAssetCoverageRiskMember_68"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RecentMarketEventsRiskMember" xlink:label="loc_chi_RecentMarketEventsRiskMember_69"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ReductionOfLeverageRiskMember" xlink:label="loc_chi_ReductionOfLeverageRiskMember_70"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RegulatoryRiskMember" xlink:label="loc_chi_RegulatoryRiskMember_71"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember" xlink:label="loc_chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember_72"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RisksAssociatedWithOptionsCpzMember" xlink:label="loc_chi_RisksAssociatedWithOptionsCpzMember_73"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_RisksAssociatedWithOptionsCpzMember" xlink:label="loc_chi_RisksAssociatedWithOptionsCpzMember_74"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_SecondaryMarketRiskMember" xlink:label="loc_chi_SecondaryMarketRiskMember_75"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_SectorRiskMember" xlink:label="loc_chi_SectorRiskMember_76"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_SeniorLeverageRiskMember" xlink:label="loc_chi_SeniorLeverageRiskMember_77"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_ShortSellingRiskMember" xlink:label="loc_chi_ShortSellingRiskMember_78"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_SyntheticConvertibleInstrumentsRiskMember" xlink:label="loc_chi_SyntheticConvertibleInstrumentsRiskMember_79"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_TaxRiskMember" xlink:label="loc_chi_TaxRiskMember_80"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_UsGovernmentSecurityRiskMember" xlink:label="loc_chi_UsGovernmentSecurityRiskMember_81"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_UsGovernmentSecurityRiskMember" xlink:label="loc_chi_UsGovernmentSecurityRiskMember_82"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_VolatilityRiskMember" xlink:label="loc_chi_VolatilityRiskMember_83"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_AmericanDepositaryReceiptsRiskMember_0" xml:lang="en-US">American Depositary Receipts Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_AntitakeoverProvisionsRiskMember_0" xml:lang="en-US">Antitakeover Provisions Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CashHoldingsRiskMember_0" xml:lang="en-US">Cash Holdings Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CommonSharesMember_0" xml:lang="en-US">Common Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chi_CommonSharesMember_1" xml:lang="en-US">This member stands for Common Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ContingentLiabilitiesRiskMember_0" xml:lang="en-US">Contingent Liabilities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ConvertibleHedgingAndShortSalesRiskMember_0" xml:lang="en-US">Convertible Hedging And Short Sales Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ConvertibleSecuritiesRiskMember_0" xml:lang="en-US">Convertible Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CorrelationRiskMember_0" xml:lang="en-US">Correlation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CovenantLiteLoansRiskMember_0" xml:lang="en-US">Covenant Lite Loans Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CreditRisksMember_0" xml:lang="en-US">Credit Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CurrencyRiskMember_0" xml:lang="en-US">Currency Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_CybersecurityRiskMember_0" xml:lang="en-US">Cybersecurity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DebtSecuritiesRiskMember_0" xml:lang="en-US">Debt Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DeclineInNetAssetValueRiskMember_0" xml:lang="en-US">Decline In Net Asset Value Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DefaultRiskMember_0" xml:lang="en-US">Default Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DerivativesRiskMember_0" xml:lang="en-US">Derivatives Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DiminishedVotingPowerAndExcessCashRiskMember_0" xml:lang="en-US">Diminished Voting Power And Excess Cash Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DurationMismatchRiskMember_0" xml:lang="en-US">Duration Mismatch Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_DurationRiskMember_0" xml:lang="en-US">Duration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_EarlyRedemptionRiskMember_0" xml:lang="en-US">Early Redemption Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_EmergingMarketsRiskMember_0" xml:lang="en-US">Emerging Markets Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_EquitySecuritiesRiskMember_0" xml:lang="en-US">Equity Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_FixedIncomeSecuritiesRiskMember_0" xml:lang="en-US">Fixed Income Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ForeignSecuritiesRiskMember_0" xml:lang="en-US">Foreign Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ForwardCurrencyExchangeContractsRiskMember_0" xml:lang="en-US">Forward Currency Exchange Contracts Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_FuturesAndForwardContractsRiskMember_0" xml:lang="en-US">Futures And Forward Contracts Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_GeneralDerivativeRiskMember_0" xml:lang="en-US">General Derivative Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_GeographicConcentrationRisksMember_0" xml:lang="en-US">Geographic Concentration Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_GeographicFocusRiskMember_0" xml:lang="en-US">Geographic Focus Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_HighYieldSecuritiesRiskMember_0" xml:lang="en-US">High Yield Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_InflationRiskMember_0" xml:lang="en-US">Inflation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_InterestRateRisksMember_0" xml:lang="en-US">Interest Rate Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_InterestRateTransactionsRiskMember_0" xml:lang="en-US">Interest Rate Transactions Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_InvestingInRealEstateInvestmentTrustsRiskReitMember_0" xml:lang="en-US">Investing In Real Estate Investment Trusts Risk Reit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_LeverageRiskForAllFundsExceptCpzMember_0" xml:lang="en-US">Leverage Risk (for all Funds except CPZ) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_LeverageRiskForAllFundsExceptCpzMember_1" xml:lang="en-US">Leverage Risk (for all Funds except CPZ) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_LeverageRiskMember_0" xml:lang="en-US">Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_LimitedTermRiskMember_0" xml:lang="en-US">Limited Term Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_LiquidityRiskMember_0" xml:lang="en-US">Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_LoanRiskMember_0" xml:lang="en-US">Loan Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ManagementRiskMember_0" xml:lang="en-US">Management Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_0" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_1" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series C.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2" xml:lang="en-US">MRPS-Series C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_0" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series D. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_1" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series D.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_2" xml:lang="en-US">MRPS-Series D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_0" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series E [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_1" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series E.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_2" xml:lang="en-US">MRPS-Series E [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_0" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series G [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_1" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series G.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_2" xml:lang="en-US">MRPS-Series G [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_MarketDiscountRisk1Member_0" xml:lang="en-US">Market Discount Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MarketDiscountRisk1Member_1" xml:lang="en-US">Market Discount Risk1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MarketDiscountRiskMember_0" xml:lang="en-US">Market Discount Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MarketDisruptionRiskMember_0" xml:lang="en-US">Market Disruption Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MarketImpactRiskMember_0" xml:lang="en-US">Market Impact Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MasterLimitedPartnershipsRiskMember_0" xml:lang="en-US">Master Limited Partnerships Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_MaturityRiskMember_0" xml:lang="en-US">Maturity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_NonConvertibleIncomeSecuritiesRiskMember_0" xml:lang="en-US">Non-Convertible Income Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_NonConvertibleIncomeSecuritiesRiskMember_1" xml:lang="en-US">Non-Convertible Income Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_PortfolioLevelRisksMember_0" xml:lang="en-US">Portfolio Level Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_PortfolioSelectionRiskMember_0" xml:lang="en-US">Portfolio Selection Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_PortfolioTurnoverRiskMember_0" xml:lang="en-US">Portfolio Turnover Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_PreferredShareLiquidationPreferenceRiskMember_0" xml:lang="en-US">Preferred Share Liquidation Preference Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_RatingsAndAssetCoverageRiskMember_0" xml:lang="en-US">Ratings And Asset Coverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_RecentMarketEventsRiskMember_0" xml:lang="en-US">Recent Market Events Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ReductionOfLeverageRiskMember_0" xml:lang="en-US">Reduction Of Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_RegulatoryRiskMember_0" xml:lang="en-US">Regulatory Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember_0" xml:lang="en-US">Risks Associated with Options (All Funds Except CPZ) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_RisksAssociatedWithOptionsCpzMember_0" xml:lang="en-US">Risks Associated with Options (CPZ) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_RisksAssociatedWithOptionsCpzMember_1" xml:lang="en-US">Risks Associated with Options (CPZ) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_SecondaryMarketRiskMember_0" xml:lang="en-US">Secondary Market Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_SectorRiskMember_0" xml:lang="en-US">Sector Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_SeniorLeverageRiskMember_0" xml:lang="en-US">Senior Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_ShortSellingRiskMember_0" xml:lang="en-US">Short Selling Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_SyntheticConvertibleInstrumentsRiskMember_0" xml:lang="en-US">Synthetic Convertible Instruments Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_TaxRiskMember_0" xml:lang="en-US">Tax Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_UsGovernmentSecurityRiskMember_0" xml:lang="en-US">US Government Security Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chi_UsGovernmentSecurityRiskMember_1" xml:lang="en-US">US Government Security Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chi_VolatilityRiskMember_0" xml:lang="en-US">Volatility Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_AmericanDepositaryReceiptsRiskMember_1" xlink:to="lab_chi_AmericanDepositaryReceiptsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_AntitakeoverProvisionsRiskMember_2" xlink:to="lab_chi_AntitakeoverProvisionsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CashHoldingsRiskMember_3" xlink:to="lab_chi_CashHoldingsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CommonSharesMember_4" xlink:to="lab_chi_CommonSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CommonSharesMember_5" xlink:to="lab_chi_CommonSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ContingentLiabilitiesRiskMember_6" xlink:to="lab_chi_ContingentLiabilitiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ConvertibleHedgingAndShortSalesRiskMember_7" xlink:to="lab_chi_ConvertibleHedgingAndShortSalesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ConvertibleSecuritiesRiskMember_8" xlink:to="lab_chi_ConvertibleSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CorrelationRiskMember_9" xlink:to="lab_chi_CorrelationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CovenantLiteLoansRiskMember_10" xlink:to="lab_chi_CovenantLiteLoansRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CreditRisksMember_11" xlink:to="lab_chi_CreditRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CurrencyRiskMember_12" xlink:to="lab_chi_CurrencyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_CybersecurityRiskMember_13" xlink:to="lab_chi_CybersecurityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DebtSecuritiesRiskMember_14" xlink:to="lab_chi_DebtSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DeclineInNetAssetValueRiskMember_15" xlink:to="lab_chi_DeclineInNetAssetValueRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DefaultRiskMember_16" xlink:to="lab_chi_DefaultRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DerivativesRiskMember_17" xlink:to="lab_chi_DerivativesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DiminishedVotingPowerAndExcessCashRiskMember_18" xlink:to="lab_chi_DiminishedVotingPowerAndExcessCashRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DurationMismatchRiskMember_19" xlink:to="lab_chi_DurationMismatchRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_DurationRiskMember_20" xlink:to="lab_chi_DurationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_EarlyRedemptionRiskMember_21" xlink:to="lab_chi_EarlyRedemptionRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_EmergingMarketsRiskMember_22" xlink:to="lab_chi_EmergingMarketsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_EquitySecuritiesRiskMember_23" xlink:to="lab_chi_EquitySecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_FixedIncomeSecuritiesRiskMember_24" xlink:to="lab_chi_FixedIncomeSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ForeignSecuritiesRiskMember_25" xlink:to="lab_chi_ForeignSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ForwardCurrencyExchangeContractsRiskMember_26" xlink:to="lab_chi_ForwardCurrencyExchangeContractsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_FuturesAndForwardContractsRiskMember_27" xlink:to="lab_chi_FuturesAndForwardContractsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_GeneralDerivativeRiskMember_28" xlink:to="lab_chi_GeneralDerivativeRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_GeographicConcentrationRisksMember_29" xlink:to="lab_chi_GeographicConcentrationRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_GeographicFocusRiskMember_30" xlink:to="lab_chi_GeographicFocusRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_HighYieldSecuritiesRiskMember_31" xlink:to="lab_chi_HighYieldSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_InflationRiskMember_32" xlink:to="lab_chi_InflationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_InterestRateRisksMember_33" xlink:to="lab_chi_InterestRateRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_InterestRateTransactionsRiskMember_34" xlink:to="lab_chi_InterestRateTransactionsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_InvestingInRealEstateInvestmentTrustsRiskReitMember_35" xlink:to="lab_chi_InvestingInRealEstateInvestmentTrustsRiskReitMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LeverageRiskForAllFundsExceptCpzMember_36" xlink:to="lab_chi_LeverageRiskForAllFundsExceptCpzMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LeverageRiskForAllFundsExceptCpzMember_37" xlink:to="lab_chi_LeverageRiskForAllFundsExceptCpzMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LeverageRiskMember_38" xlink:to="lab_chi_LeverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LimitedTermRiskMember_39" xlink:to="lab_chi_LimitedTermRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LiquidityRiskMember_40" xlink:to="lab_chi_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_LoanRiskMember_41" xlink:to="lab_chi_LoanRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ManagementRiskMember_42" xlink:to="lab_chi_ManagementRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_43" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_44" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_45" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_46" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_47" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_48" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesDMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_49" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_50" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_51" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesEMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_52" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_53" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_54" xlink:to="lab_chi_MandatoryRedeemablePreferredSharesSeriesGMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MarketDiscountRisk1Member_55" xlink:to="lab_chi_MarketDiscountRisk1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MarketDiscountRisk1Member_56" xlink:to="lab_chi_MarketDiscountRisk1Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MarketDiscountRiskMember_57" xlink:to="lab_chi_MarketDiscountRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MarketDisruptionRiskMember_58" xlink:to="lab_chi_MarketDisruptionRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MarketImpactRiskMember_59" xlink:to="lab_chi_MarketImpactRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MasterLimitedPartnershipsRiskMember_60" xlink:to="lab_chi_MasterLimitedPartnershipsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_MaturityRiskMember_61" xlink:to="lab_chi_MaturityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_NonConvertibleIncomeSecuritiesRiskMember_62" xlink:to="lab_chi_NonConvertibleIncomeSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_NonConvertibleIncomeSecuritiesRiskMember_63" xlink:to="lab_chi_NonConvertibleIncomeSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_PortfolioLevelRisksMember_64" xlink:to="lab_chi_PortfolioLevelRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_PortfolioSelectionRiskMember_65" xlink:to="lab_chi_PortfolioSelectionRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_PortfolioTurnoverRiskMember_66" xlink:to="lab_chi_PortfolioTurnoverRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_PreferredShareLiquidationPreferenceRiskMember_67" xlink:to="lab_chi_PreferredShareLiquidationPreferenceRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RatingsAndAssetCoverageRiskMember_68" xlink:to="lab_chi_RatingsAndAssetCoverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RecentMarketEventsRiskMember_69" xlink:to="lab_chi_RecentMarketEventsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ReductionOfLeverageRiskMember_70" xlink:to="lab_chi_ReductionOfLeverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RegulatoryRiskMember_71" xlink:to="lab_chi_RegulatoryRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember_72" xlink:to="lab_chi_RisksAssociatedWithOptionsAllFundsExceptCpzMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RisksAssociatedWithOptionsCpzMember_73" xlink:to="lab_chi_RisksAssociatedWithOptionsCpzMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_RisksAssociatedWithOptionsCpzMember_74" xlink:to="lab_chi_RisksAssociatedWithOptionsCpzMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_SecondaryMarketRiskMember_75" xlink:to="lab_chi_SecondaryMarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_SectorRiskMember_76" xlink:to="lab_chi_SectorRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_SeniorLeverageRiskMember_77" xlink:to="lab_chi_SeniorLeverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_ShortSellingRiskMember_78" xlink:to="lab_chi_ShortSellingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_SyntheticConvertibleInstrumentsRiskMember_79" xlink:to="lab_chi_SyntheticConvertibleInstrumentsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_TaxRiskMember_80" xlink:to="lab_chi_TaxRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_UsGovernmentSecurityRiskMember_81" xlink:to="lab_chi_UsGovernmentSecurityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_UsGovernmentSecurityRiskMember_82" xlink:to="lab_chi_UsGovernmentSecurityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chi_VolatilityRiskMember_83" xlink:to="lab_chi_VolatilityRiskMember_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>chi-20250221_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_CommonSharesMember" xlink:label="loc_chi_CommonSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_3"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_4"/>
    <loc xlink:type="locator" xlink:href="chi-20250221.xsd#chi_MandatoryRedeemablePreferredSharesSeriesGMember" xlink:label="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllCoregistrantsMember" xlink:label="loc_cef_AllCoregistrantsMember_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_CommonSharesMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesCMember_2" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesDMember_3" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesEMember_4" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_chi_MandatoryRedeemablePreferredSharesSeriesGMember_5" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46162784066656">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001171471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">424B5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Calamos Convertible Opportunities and Income Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
                <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font-size:10pt">&#160;</td>
                <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="white-space:nowrap;width:87%;font:10pt Times New Roman, Times, Serif;text-align:left">Sales Load (<span style="font-size:10pt;font-family:Times New Roman">as a percentage of offering price</span>)</td>
                <td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="white-space:nowrap;width:9%;font:10pt Times New Roman, Times, Serif;text-align:right">1.00</td>
                <td style="white-space:nowrap;width:2%;font:10pt Times New Roman, Times, Serif;text-align:left">%(1)</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Offering Expenses Borne by the Fund (as a percentage of offering price)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8212;</span></td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%(2)</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Dividend Reinvestment Plan Fees (per sales transaction fee)(3)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.00</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>

          </table>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(1)&#160;Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(2)&#160;&#160;Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(3)&#160;Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#8220;Plan Agent&#8221;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page&#160;72 of the accompanying prospectus.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Annual Expenses</td>
                <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Percentage of Average Net<br/>Assets Attributable to<br/>Common Shareholders</td>
                <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:82%;font:10pt Times New Roman, Times, Serif">Management Fee(4)</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">1.26</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Interest Payments on Borrowed Funds(5)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">2.18</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Preferred Stock Dividend Payments(6)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0.70</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif">Other Expenses(7)</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0.09</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Total Annual Expenses</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4.23</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
              </tr>

          </table>

            <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(4)&#160;The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(5)&#160;Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(6)&#160;Reflects estimated dividend expense on $<span style="color:#212529;background-color:white">133 </span>million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(7)&#160;<span style="font-size:10pt;font-family:Times New Roman">"Other Expenses" are based on estimated amounts for the current fiscal year.</span></p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendExpenseOnPreferredSharesPercent', window );">Dividend Expenses on Preferred Shares [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Example:</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares (including an assumed total sales load or commission of 1.00%), assuming (1)&#160;total annual expenses of 4.23% of net assets attributable to common shareholders; (2)&#160;a 5% annual gross return; and (3)&#160;all distributions are reinvested at net asset value:</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="font-size:10pt">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">1 Year</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">3 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">5 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">10 Years</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left">Total Expenses Paid by Common Shareholders(8)</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">52</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">137</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">223</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">445</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></p>
          </div>
        </div>

          <div>&#160;</div>

        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(8) The example includes sales load and estimated offering costs.</p>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">$ 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds and preferred stock dividend payments, as a percentage of our average net assets as of January&#160;31, 2025, and not as a percentage of gross assets or managed assets.</p>
        <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">as a percentage of offering price</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">"Other Expenses" are based on estimated amounts for the current fiscal year.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
          <div>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table sets forth for each of the periods indicated the high and low closing market prices for our common shares on the Nasdaq, the NAV per share and the premium or discount to NAV per share at which our common shares were trading. NAV is shown for the last business day of each quarter. See "Net Asset Value" on page&#160;70 of the accompanying prospectus for information as to the determination of our NAV.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

                <tr style="vertical-align:bottom">
                  <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Market Price</strong></span><strong><span style="font-size:10pt"><sup>(1)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">Net Asset<br/>Value at<br/>Quarter</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Premium/<br/>(Discount)<br/>to Net Asset<br/>Value</strong></span><strong><span style="font-size:10pt"><sup>(3)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom">
                  <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Quarter Ended</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">High</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Low</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>End</strong></span><strong><span style="font-size:10pt"><sup>(2)</sup></span></strong></td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">High</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                  <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Low</td>
                  <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="width:35%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2025</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">12.28</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">11.19</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">10.25</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">22.85</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">10.59</td>
                  <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">October 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.01</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.91</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.04</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">18.20</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.13</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">July 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.02</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.04</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">9.95</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">20.24</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.61</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">April 30, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.54</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.55</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">9.74</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">14.21</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">7.46</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2024</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.71</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">9.74</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0.41</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">October 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.32</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.00</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">8.99</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.20</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4.56</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">July 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">11.36</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">9.90</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.51</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.21</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1.53</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:White">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">April 30, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.34</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.21</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">9.94</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">16.91</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1.49</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>
                <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                  <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">January 31, 2023</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">12.09</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.51</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">10.61</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">15.03</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                  <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:right">3.89</td>
                  <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
                </tr>

            </table>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">Source: Fund Accounting Records.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(1)&#160;Based on high and low closing market price per share during the respective quarter and does not reflect commissions.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(2)&#160;Based on the NAV calculated on the close of business on the last business day of each calendar quarter.</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
            <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">(3)&#160;Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</p>
          </div>
        <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.19<span></span>
</td>
<td class="nump">$ 10.91<span></span>
</td>
<td class="nump">$ 11.04<span></span>
</td>
<td class="nump">$ 10.55<span></span>
</td>
<td class="nump">$ 9.74<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 10.21<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.28<span></span>
</td>
<td class="nump">$ 12.01<span></span>
</td>
<td class="nump">$ 12.02<span></span>
</td>
<td class="nump">$ 11.54<span></span>
</td>
<td class="nump">$ 10.71<span></span>
</td>
<td class="nump">$ 11.32<span></span>
</td>
<td class="nump">$ 11.36<span></span>
</td>
<td class="nump">$ 12.34<span></span>
</td>
<td class="nump">$ 12.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.85%<span></span>
</td>
<td class="nump">18.20%<span></span>
</td>
<td class="nump">20.24%<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="nump">10.21%<span></span>
</td>
<td class="nump">16.91%<span></span>
</td>
<td class="nump">15.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.59%<span></span>
</td>
<td class="nump">13.13%<span></span>
</td>
<td class="nump">11.61%<span></span>
</td>
<td class="nump">7.46%<span></span>
</td>
<td class="nump">0.41%<span></span>
</td>
<td class="nump">4.56%<span></span>
</td>
<td class="nump">1.53%<span></span>
</td>
<td class="nump">1.49%<span></span>
</td>
<td class="nump">3.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.37<span></span>
</td>
<td class="nump">$ 11.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.25<span></span>
</td>
<td class="nump">$ 10.25<span></span>
</td>
<td class="nump">$ 10.04<span></span>
</td>
<td class="nump">$ 9.95<span></span>
</td>
<td class="nump">$ 9.74<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
<td class="nump">$ 9.94<span></span>
</td>
<td class="nump">$ 10.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">The following table provides information about our outstanding securities as of January&#160;31, 2025:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

              <tr style="vertical-align:bottom">
                <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Authorized</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Held by the<br/>Fund or for<br/>its Account</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
                <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount<br/>Outstanding</td>
                <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="width:61%;font:10pt Times New Roman, Times, Serif"><span style="font-size:10pt;font-family:Times New Roman">Common Shares</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Unlimited</span></td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">76,312,702</td>
                <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series C</span></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,340,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,340,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series D</span></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,320,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,320,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:White">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series E</span></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,330,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,330,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>
              <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series G</span></td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,320,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,320,000</td>
                <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              </tr>

          </table>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=chi_CommonSharesMember', window );">Common Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">Common Shares</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,312,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesCMember', window );">MRPS-Series C [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series C</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesDMember', window );">MRPS-Series D [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series D</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesEMember', window );">MRPS-Series E [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series E</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesGMember', window );">MRPS-Series G [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">MRPS-Series G</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#8220;Plan Agent&#8221;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 72 of the accompanying prospectus.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Reflects estimated dividend expense on $133 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">"Other Expenses" are based on estimated amounts for the current fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">The example includes sales load and estimated offering costs.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Based on high and low closing market price per share during the respective quarter and does not reflect commissions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Based on the NAV calculated on the close of business on the last business day of each calendar quarter.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendExpenseOnPreferredSharesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendExpenseOnPreferredSharesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=chi_CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=chi_CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=chi_MandatoryRedeemablePreferredSharesSeriesGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MK_)6KPMXF1VGZU/I2F0@WIK#@5A[OJ]6MX(\[1MEXX0L%JV+-1CVXF<AU,0
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M'8'N\'D.H.JZEAY<_=F-E^Z?>L+B\]F_2X>H9X?:;_@H[>TZ/<-;'VF>A/7
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MYIS4F_U&V.BYE[W"::K?[M5D\X[_Y-7CDQT'[3VG?T@OE<M^T[E]1N^T7U=
MJ/<4E#:!TJ90F@6ES:"T.91F0VD.BE:U[,)[JM]^U%YZ&[N^F^-(V&%P]^MW
M&:W%I;Q)M..R]H7Z5AR?W^Y>T8<>Q >E74%I8RAM J5-H30+2IM!:7,HS8;2
M'!2M:MR%IU1_QT%\I4M RO:[GZ<%U$WJ-;0F9XY-%/+^C+AA=PK[&)2O/2E=
M^-&\+^/]F^]>XJL5V0O?C?D.$[626OEX4[E57/R+1%][O*C;$\>CH[YA'AWW
MS#?.UR_??OW&ZZFQN!#&47_04P<=]8KOE3"7_-PLA3&?AKGBY_U2F/[3,)-F
MCFAL_*"^95#:!$J;0FD6E#:#TN90F@VE.2A:I?$;%+YE@W97L*K=7CMR?2.C
MQI:N'?32E@Y*NX+2QE#:!$J;0FD6E#:#TN90F@VE.2A:U6@+SX:!\3>_C@R@
M[@Q0VA64-H;2)E#:%$JSH+09E#:'TFPHS4'1JL9=N(P,VGT]&EY''H^$'H/O
MVK#5CGZQ&;<+6ADZ-!HN]* W*&T"I4VA- M*FT%I<RC-AM(<%*UJN(6'S6#'
MM>*-ACN5_E)<:R-IMEFH4\S@Z3%PM167*VB"8RAM J5-H30+2IM!:7,HS8;2
M'!2M:I:%#]&@W;&GV2P_A\D>I@GU_4EI9=,\'O4-\[CNQG@%37<,I4V@M"F4
M9D%I,RAM#J794)J#HE4MM/"6&NRX1;8R+=PZ!P7U@(+2KJ"T,90V@=*F4)H%
MI<V@M#F49D-I#HI6-=K"GVHP^KOGH*">5%#:%90VAM(F4-H42K.@M!F4-H?2
M;"C-0=&JQEUXL@W:G<W^TAP4U"%MAZ"5H4.CX4(=U:"T"90VA=(L*&T&I<VA
M-!M*<U"TJN$6CFJ#'<=\-1KNV399A9'W'[GC=1?JDY;2JA<2#'KT7_UM%^IN
M!J5-H+0IE&9!:3,H;0ZEV5":@Z)53;1P-QN\V-ULKVEBJ*-92FN=)H8Z0D%I
M$RAM"J594-H,2IM#:3:4YJ!H%;,<%HY0PW9'J+\P3=Q.?JEIIK3=_28TV3&4
M-H'2IE":!:7-H+0YE&9#:0Z*5C70PNEIV'X02]4QN&V6N!WT8GN$.C-!:6,H
M;0*E3:$T"TJ;06ES*,V&TAP4K6JTA3/3T/R;9XF'4!<G*.T*2AM#:1,H;0JE
M65#:#$J;0VDVE.:@:%7C+AR>AJ]Q>-IOEK@=_6(S;A>T,G1H-%RH2Q24-H'2
MIE":!:7-H+0YE&9#:0Z*5C7<PB5J^!J7J#UGB=O9+[;<ITY11M]L>MN%^D1!
M:1,H;0JE65#:#$J;0VDVE.:@:%43+7RBANT^4:^<)6ZGOM@XASMGB:$)CJ&T
M"90VA=(L*&T&I<VA-!M*<U"TJED67D_#]E.@_LHL,=2]*:7MT6]"/9>@M F4
M-H72+"AM!J7-H30;2G-0M*J!%IY+P_T=@J[:9XFA?DI0VA64-H;2)E#:%$JS
MH+09E#:'TFPHS4'1JD9;>"T-_^[CM8905R8H[0I*&T-I$RAM"J594-H,2IM#
M:3:4YJ!H5>,N_)V&K_%WVG.6&.KTM$/0RM"AT7"A'E%0V@1*FT)I%I0V@]+F
M4)H-I3DH6L5P1X5'U.@U'E%[SA*WLU]JN:,FGZA^P]LN--DQE#:!TJ90F@6E
MS:"T.91F0VD.BE8UT<(G:M3N$_7*6>)VZHN-T]@Y2PQ-< RE3:"T*91F06DS
M*&T.I=E0FH.B5<VR\'H:O>8(I[UFB=O)+S9-<]]^$^JY!*5-H+0IE&9!:3,H
M;0ZEV5":@Z)5#;3P7!KM[Q T:9TE;@>]V!ZA5Y9!:6,H;0*E3:$T"TJ;06ES
M*,V&TAP4K6JTA=?2:/ WSQ*/H*Y,4-H5E#:&TB90VA1*LZ"T&90VA])L*,U!
MT:K&7?@[C5[C[[3?+'$[^L5FO/]A59-&PX5Z1$%I$RAM"J594-H,2IM#:3:4
MYJ!H5<,M/*)&K_&(VG>6&.H3-=K7)PJ:[!A*FT!I4RC-@M)F4-H<2K.A- =%
MJYIHX1,U>LUI3KNGHJ .4BFM=988ZO4$I4V@M"F49D%I,RAM#J794)J#HE7-
MLO!Z&KWFK*;]9HFA[DVCII.:&OM-J.<2E#:!TJ90F@6ES:"T.91F0VD.BE8U
M4/9<JCPY+EPBCMM=(JZ-/[Y*E5:0Q")922'CQ%N[?-/=(EROO3CFF_8>O&0E
M*-1&+A*^^Y<#CK?!\K]B%8I"Q/J^K1NIKN +R=R]@()Y? /?+;U<!G==\7TE
M(RGH41"*NZT;N4$B)05R$P;23P^>[Q-"N,&CB%U?JNO[GDUKLXWB+3&T0(3=
M1*&2<!N+>+O9^')-N5+3:,QP%Q1]0VB6L C:%6?TX?I[)$C/9/07DCH2WBWG
M[4BLW4?.)R7(A>X&?%-A+!-Q&T94T#J=3CH]Z/U'W7;8X>L.[V576!1ZN?3X
MV9%*;1-Y"_J7HB@Y.0NJ +>+E<I4EMI=)*E>(Q%&I80+P'[I'XFEW$C=QH<Z
M^MJ-?E!<36DK/UW/@O3KJ9#=:_,/U3^L2'=D%&M=V)#DKGAK#+N]GDA(86)W
MH:Y^O"7%V?A4^O1KK]LS2]F_B<(?,G+OI%C0W_3A*9$>Q=*+6'TOJ&JV5 XZ
MM$HS? C4+&MT3UF(A6U?B .6])__.#'-WH<O/A74V1W5L'I@?%#W7\>2!*QF
M<"6UWG.%+M1-V;7RH+?(D"^O7(A+C^^S)'WY2A9S3T:G%$BEI)+N\-?.8:VZ
MI4O%M7$C(G@;5OU2*9&>B<A-W$(+2B61FS+?H$D]<T3VW634159)VI J^M>L
M=K<1%6>L;N D7!!(71$*PC&C<CXH\66:P9CU;>G%2>3=;#D*69QUR_*6LB%]
MPL4LQ,J]ES5)=$ES<$:Y])WPJF6)!,^.UY2,RI3O*T]2U0X74B[)])2F/2FZ
MFTQ+EF7BOD69&D":,K=Z7=(BJKS+//,LSF4Y]QRI<M'0A[VTHL/Q-BS L9DI
MU7,MVG7_CPO7=]=AR8I4T_Z3*C0N&KFL918'H5IFR!L$EUHT;Z$N7BUEEY1Q
M&C[(>QD=B8S/34LD_]SR-?&D >L;:I-U6W@;A>M<]3E%ZF7NO7 ;^X\DD+<L
M4B^+]=;HF4=#,G:VY[<G_%5=;.JE]:M;Z:-4[4)>/:DDRWV+4F;YD^M=">"3
MT)&"F[TAT;B6=?&I=C]/GJ52G91P(VIJ[G0^/#9K5F[WEAO/2)+4;#V4AJM[
MS$XUX^JJ6BZP;D><Y66]I*97?W]][_&D4E-;J-2M&\?APE,=>&Z;+Z]HZS8S
MZJ:<<:&01M_=22X)3[-NM\DVDJFAY>*HWCTSM9LP"NC?1ZT3\9/F_J;<"Z78
M3JE7$-]+7<!5FD0GO2)8=X_7@S^^9TI'113GA<9M<A!PA:_=P$TKE[J1(PZF
M &22R8JTDQMPJF(WHB(G4827<*.76V,I>ISU&&F;KR\0)G.@5$@_>MV3WB^U
M'H":-]6,/$CY@]+2L"77FDQBW=I3]4=+-UC(<N/ZYY9Z+ZWA*? BKS ]#"B5
M A5M^!"7DZWFF37791-;T .6AGOC5+" *D!+0_VU;K84F/)3;FC3>NN*\T>5
MFKJJ60T&=B54)'#4%,/3)DP*1&UCK(KFJ:R%WJ>BY@V-1V-*;G=)7%UG73&F
M.J3N:Q.6FCZ5I\;TJ9,C/92JDZ,B2;2I&UUSM*,JRP77>.\T*[[J%;.RTNW7
M,O1]-\J4)TVB)M3-XWX)'U3U28_SRI=C^U+'/>Q>#VGD?ZO[72ZTB)OPU&S3
M!CJ@%G,X$&LR367T09XR&7*DZKP8%!=C'))ZR2*H;HQ2YB*T/5)@&L4\4I<>
M29TQI=W?^'?ZEQXFXMP-?JAXWZ-MK$=J:KBL1GIO1T9%E'101"68246][)9:
MRH@>9?DDR_'=M X75)LN=R3%:KJ?CF2I9;N+W#5I)%7=4L8+TONB97NF0<[&
MR<).$^MVKD=%H18O4ME0*"]>+EFCW\^SX]Y1H=QQ0?BJG/3UYAO5U\A CZJI
M9NEY&'%_NZ023*]%S[JC= QRT'&^?DD'%IW#<M6G(Y,OA?C?MNLUZR</:@WS
M@_A7K!+*<E-6NHZJE4[V4V=7R7"S6:J@TJ7MW>OC/SK:JZ%HP-6PW65CIVP7
MY:9-0M,X-35N98OPX@51'ZF)[EZ?J/9>_G37U(_RX-;?\CWQ^FW.#UVMB 4T
M[PL784PM[O7I'^=9RBOO;J5"TXA!+/PPYF"5MYOB+6.YC3(S3H?0'K6[U/)'
M/$I@R#*4NBF+M$:4>]CNM='[XPL/4[=K'9BRI.R_?+\]-87<M 9Y 2RY0WM8
MR:!H[UBE(H^59*DZJIUY(!TO!/;9N/;+$XEL%$7%83Z?_5M0/2RVVL+2IYRF
M'C)O*6W5_N@??)=,.G](6>% ZH6&(&0=U 9F235-=KR+5]1$7-*H_-/'M:01
M^P6]%? ;)I4:SV^4GG*)_]8Y,]Z?FYUW3YY?&>\=H^'YV>CTO3TZ;?KEN/?>
M/N[Q+^^*I#]]Y.&X0R\/7L MR2V)T>L>#SN"1D:K_(\DW/S6,3K49"8TRE=?
M5]*EAH,#T.^W89AD?W "#V'T0V7UT_\!4$L#!!0    ( #2 6%I;*T5S*0,
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M#W>/VD+KW)-B[^&-;#D&'#]G^0-02P,$%     @ -(!86B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( #2 6%IED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  T@%A:._2\3N\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  T@%A:
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( #2 6%ILGTAQBR(  -4C 0 8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  T@%A:
M6RM%<RD#  !&$@  #0              @ '/*@  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( #2 6%J7BKL<P    !,"   +              "  2,N  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( #2 6%JV0E<F,@$  " "   /
M      "  0PO  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  T@%A:)!Z;
MHJT   #X 0  &@              @ %K,   >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  T@%A:99!YDAD!  #/ P  $P
M    @ %0,0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  ":
%,@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>25</ContextCount>
  <ElementCount>35</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="tm256178d3_424b5.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>chi-20250221.xsd</File>
    <File>chi-20250221_def.xml</File>
    <File>chi-20250221_lab.xml</File>
    <File>chi-20250221_pre.xml</File>
    <File doctype="424B5" isUsgaap="true" original="tm256178d3_424b5.htm">tm256178d3_424b5.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="11">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="77">http://xbrl.sec.gov/cef/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm256178d3_424b5.htm": {
   "nsprefix": "chi",
   "nsuri": "http://www.calamos.com/20250221",
   "dts": {
    "schema": {
     "local": [
      "chi-20250221.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "chi-20250221_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "chi-20250221_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "chi-20250221_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm256178d3_424b5.htm"
     ]
    }
   },
   "keyStandard": 35,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 5,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 25,
   "entityCount": 1,
   "segmentCount": 5,
   "elementCount": 199,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2024": 77,
    "http://fasb.org/us-gaap/2024": 11,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20250221to20250221",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm256178d3_424b5.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20250221to20250221",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm256178d3_424b5.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r169",
      "r170",
      "r172"
     ]
    },
    "chi_CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calamos.com/20250221",
     "localname": "CommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares [Member]",
        "documentation": "This member stands for Common Shares."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r3",
      "r4",
      "r6",
      "r7",
      "r13",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r171",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r13",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r171",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r156"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r156"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r153",
      "r154",
      "r155"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "chi_MandatoryRedeemablePreferredSharesSeriesCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calamos.com/20250221",
     "localname": "MandatoryRedeemablePreferredSharesSeriesCMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mandatory Redeemable Preferred Shares Series C [Member]",
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series C.",
        "terseLabel": "MRPS-Series C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "chi_MandatoryRedeemablePreferredSharesSeriesDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calamos.com/20250221",
     "localname": "MandatoryRedeemablePreferredSharesSeriesDMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mandatory Redeemable Preferred Shares Series D. [Member]",
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series D.",
        "terseLabel": "MRPS-Series D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "chi_MandatoryRedeemablePreferredSharesSeriesEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calamos.com/20250221",
     "localname": "MandatoryRedeemablePreferredSharesSeriesEMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mandatory Redeemable Preferred Shares Series E [Member]",
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series E.",
        "terseLabel": "MRPS-Series E [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "chi_MandatoryRedeemablePreferredSharesSeriesGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calamos.com/20250221",
     "localname": "MandatoryRedeemablePreferredSharesSeriesGMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mandatory Redeemable Preferred Shares Series G [Member]",
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series G.",
        "terseLabel": "MRPS-Series G [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r63",
      "r64",
      "r66",
      "r67",
      "r70",
      "r81"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r153",
      "r154",
      "r155"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r5",
      "r170",
      "r176"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r129",
      "r135"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r135"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128",
      "r135"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r169",
      "r170",
      "r172"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-25-016492-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-016492-xbrl.zip
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M4/\$&LCFT:D0;F,K!1+PMEFK 'I+1P4B^.ZIK" -9WL%(CK 6%<0_V9'!2+
MAB&P(&BXMP(-\(;S82$^S1HOT-"TSIB%2-GZ+)!2J#^5@>$7;+)  MDZR!9
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MDHY EFP96X:M@[3,W1[:1L"0_YA[/K2$0(7?D-(8^S[0P@<GP-L(0.T?""E
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M<2IUWOXF_R/_O0QR\?;_4$L#!!0    ( #2 6%I]'S[]A@(  %$.   4
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M>B6"LX4@\CR.YF(0VF3V3#^=<9P:'=V)OOD/?(Z'GD#E4K>&^9L"\@VOR^,
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M.EMDA\KO[&B7@DSZWS:N!>G7@9K9/2$!SFE>?C _?+YX;Y[][]79Q<V97J9
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M^<8XC(N G>#8%R45E/-%@E<) ][ >OUOJY)QXTE.CAZ[9^1)"/_OJ>N[DU!
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M_BM1UR%O8\N/BZ->V% ZY;7K\ ]EG:N6=F&1?@ [5'4YCM?M)C%&X),DRD"
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M$C=N$Z"X]H(W5B'#D?<LO63-.7XTWMLJF#>MK]TS,<JH;):[W1WE=E]]/+E
MO_O]^<WM]?F[S[?GEQ<[[WO?2D#+,1@;-%,RHLBC8^9[7?Z<@"_#[6FR83X
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MZ^88E#IH@3HU9R"%57N+.O9&BT(+<PN/T9LER[6")L@ C ".<5Q TI5#*R&
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M4-Q)PEBI-GU#4[V4MX-7\%'1<SV<?1R)Y=3V&VD5<?%IR&_JY!<+':\H3<;
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MI14<1D&A7C#FAJJ[BDMMO&QD0F,BNM%W.E8!_^E5RVJTE*V*\^<6!+2'18Q
M>:2N+UTY=<4;-)9&?A<4)=A'LX/P'CW!..V#J^F)BW?RN8R1Q>K73L_A7S!1
MU2,\[3C+HL\2"ANDSL:$",C$3"+46-3&"@+D)^PXRI3038^L_I)LE=#C^(Q
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MVWL&X-Z*K*9CM5X19_4SJH-ZM1BX_BXQ6OF:WB:A5D\>3P4PUWDRB'4B,;N
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M_@0A".,(G/1RCZLE\"H&0$*0(RO12)*%:V]TK/-,B$?19>QPN#?.-0[JX;'
MF7J93R80N"O1UO=JS<S**/4S(%EB-R7:=@X/(N,-M5VN7K)^'6&LT\F9S.WX
MRG;%"ILQ2XH$\*C;K'1A\%9KLK$B]WJ-9?$9TQ^U37_]UC"?=VO4C]%-O H@
MED=O&!P=G:T.?2OC1$HZ$5,':TKF2!_/.RL?#">$G';Z>&UCFG-NB<I8RG($
MI]D$8GSV3)_9CKFZI<).%P+I,-Y,83-FNIMPJ(S4>8G?D"MF:@T7*\2V X)J
M]3_[?J%/CRZ,XUG-R85D@DPGN(.Z"DLT_O2Q3S4L9TC2("5J5=T_GX%\(MW*
M4R9)P7K@Q%UO4+H#WQ8H&XT".DLZ2,@]#\CJ:0!9_ [IQ*4,#-NY<CS[C+Y&
MV-L"I1\ D(9HK1RS7X#S" ,AC4BJ%S?"-(OSN(&_ 6,;*T>>/"ATGOH0.:.%
MXH\R(TNFO.894I\CC;@,O7[[K!G3T,B;7I/#WO[()0&:-$\0U_ ,$Z)=FHJ[
M!Q\(8'H!!F_H)0F)]T4MC<8G2=LWG4P $U#=USEWV\^M/DLV\61\D\?9]7@Y
MT/-4  @J7!0\NB$J[F@TC5-  6-Y*J!X2+Y2PD/>PX*GH?,6"E7J=WK?DN'U
M1-V []'J[WC]RWM,G08&#MF<:%T)0H;EE!2 @SR\/@Q?7,9S"%P,!K+DT'G]
MR85^HA?Y&"!(J]XNG/WVK&Z6XT+\A1 +&.3XC/>*",\83M0G>"O!,.H_V-&A
M$"A7CAK^!%4"Q@A]<";.)!ZQ+%&/*VGM1Y 6&+7=&$*Q,K(7U^83DCQ<"DSR
MFR5^Y G4/8/F&89%"?RFU+M+B/&,(> I4@'A&DL!5U(",LC=9@BW^Z0G(&R(
M'3IW<V+Y=?C,GG'+C:%X)1N51:A)SC$SFF+0]'5<Q2*$JNXY&A$<!PCFJ2;9
M;RG_W^T(JET).^LO?BXG!G8X[7=!>IRZ)/"2!3)Q:*ATAE]G]!(-/L9/X<=P
M/^))C6]RFA .I2BUHYXP=^)CAKTPH@@WPR2A$GK:T"D!RT&G!837L4W.5.$V
ML?=,-0IZ'.@JA:\@&%PXJ?EZX6_S++GFN:?[+KZ-A3J CIM80+B0KG=$:3CU
M?*4L,OX[\5W3[E%D*Q(L#DBL)VY']2,\1[TA-UE@/3\]4\'/:#?EE":M^)P@
M='GF&T&K"0R_2Y%X :J^/'NBZ)_+T:6],4G=7A9LH:*[ODZX4E7L=D<M"N2M
M<E7L=$,[$)O2C<:AC4W0*F(X*^W'R\F2@<2RX&4&@!K '94DIR O4T^'.N.A
M?SV,_4LZY6M(*Y(PD5!T' 2AN8R9Z'U\1-]^&3Z<C9:R7MQ1+1<%30J%I),+
M%.;P,^)+RF43RC2821$OT':<I:4338N)#RWP8-LNSF8GFBV5,R8\>332'.RU
M!)-%=)APQ!.#IN&JA^UO#5JF&1DN'9F %G?&N".MSQ=."V+CH@=W2ZP__8H3
MZ\==8GU]06G<S+<)0 @+;9B#, ",RQ<E@]]"LIYZ.>HJ(6#(9$+A6J!?)(D<
ME=T'5FFRBU3Q(--MK509[D/^(*H2J 8$ZPZ <AE*BGE-@\#L'R=8+XB735JI
M4D']>%\JJ"H3\70UWGH+2AP;!:B>%-)7GN(UXHC+0$L(67H045!>8@#W$_#W
M5.5SO%9(I ;@3DR>\=+3X@I=<*U[3+KJM#FI2.*:N?F US6=WN0\I"-A\I,)
MI_QY2;=>$$TR;-K6Z&/I>+^V8EH+A6K(1CT11MQS'I(O;8% Y$4.Z2J[  P:
M.6F&-)GT3KI''6C3GIO@=:2?)"_?6(G@ 91_)O-E;NG;[] E'TCL$0GDZC<S
MP<".<V> '95M,Z/P\&H(-N]*=7H^;T1-5BVJ3>16< >MAYDL2G&#9U[3A.E'
M%\#YTR*&:]QS((!&B3@((C8^Z1-^/BIY?OY3='91)+1:R&688NF)S^'E;*^*
MYNC1X;ZU-TGQ/,RZ23Q48""B S@AC9R"#[FW[]\QH0V')>QS+FPC+M!W5AX
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MWT(_.Z6LQB45ED,O>\;KS_O*K=SAL&RG\99PA']$#R@A+C1?X(]P_DV3D-O
MY2"02PY'3L+E/4;<P>TB":CITM1O=L=<Z(YC^]\ILNA.,9J.D[)Q)ZU=Q2L
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M/U,LQ:#JU1X_(,^:H]9Y!?%JHD^'ZK'%'!MGO=;812[!&LD0U@%&27H!X$(
M4]D;$-J%Z3H:(7DKQ)J2H?658&AW(%R1SZYL(W<$4Y_A,)9+^_H9-!)'D"0K
M(#)*WP"O$; :!-]>9/'"WD]420QLPRRC"8AZBDR$\E5H_@@>N(Z)#=8&V[.-
ML2.[1X?N#=O29W0S](@O9IS">L2H#-# 0#6V-;#&(,N>#B'D @4^P$J-:&3X
M46EB4I:+$[#U[)>/U&!YTA.."=!H&[\>\9ZN S7=]>JXZ*32L<DPQ'8/T"DN
M2MWCX$;$Q8=Y 88:8M$7@.+PN@S*E)3V#521.2UG7/7BUV(4%C*,4PC"9UE2
M;-YMF/[X$G0 5N)'6X02:\(!&D.NU6DA\(.%']9K8@27SF^_#NNB7(Y8*5XE
MTS(AZI06Q;A=.?/\\XUF*I)"^B9+Z%ZO(691"WR)WZCXO)D;0S%TDU_DWF,M
M9K?2#"5V7JN/I*7KHC?:'>2UWAZRV0B,-L$"M6P!81:TI.W1@9ARW ,4Z,#T
MKZ[TH=;UC R2XM=7_I+7-.<N@-4*OO2,DWGJ678K7>0YSRGO83N-[U6W5_24
M_$53Y][P_)X<F&'LW:3ISQ"0D&5G\#DH*HE!=@:2 .W=%/29>>&Y_&$(!31.
M-!K9'/RK7&N^*UT&TF[S##U\^*IU,#0^D)U@1ID3F_(JI&0;B;*<Q<+ QQ3,
MNAYK(\\2<M7]&2*_P>6 T.I2;W<77"00HV&NT!*)8P,H9$VQ9.FR*O9FY33L
M9#&=P"^1'2F,-18)4%\J"1=U,I #1:54,;[$N)>D-/F<S1%,+T885<=:@LCJ
MW 1NKU'.E8DWQ);8.^64$[X!JOIH"]X1S!E,QN:A-V$U^6"P7U'_$*Q2+X@6
MHQ"\+NS@BJNK2W_C4TZHC-B\0D1UX32^>N&9C!KQ+IF&I2J]R(L#$6,MATV\
MI*4_AE78']<4I,F)!49YU;W:^=0+O/YB5:BE1X?)F"Y@?NF80S@:224Z(7*5
M8[2!Q=B8J#>AE)A*JVBOWUUXO<@:@Q@^D)0A$/.UT$?WB#L:;Q"@M5:%V2&D
MV=Y.RZQ"1OK@$\'P,-X1@ZY^0-5#J-,>%SD%1P'N GSO)RAAEQ_Q3_,%&8KE
MY1/.U)K2VN45_H%**#G5@"+*8?*R)X@\=YMZ?62Z7%EU.0C*,%OKRA$F^FQ3
MNT@YM:J2S7"(X&E6,W^O'$?6T)LQ\;"4RE)^?X7E4D%(!R671B/DW+Z '667
MAZF#-L)2!KJ?EZA%1Z],,N2_I2Y?WU=7[RQL&6YQA;1&3L^ @G/C!5-(S=+2
MWOS,S=0CPI I_8E^XRO-Z.>F]==3Q%CR&)^5Z^FY%=O.-#*" ,921P^5[.$T
M^IL-J%K2$@P!T?>: ?E!4N 1$SOX0'@5JC!K>!KIZD0)&4K_*3U"=J"PB#7/
MKG LY.A2T<EVC(./@0812B3AFK:# 6[/ I=D%V!]4F_+I$&!SW3_#F0&X0K*
M_>," BPQV0R>X]M1+O>C +V#6.*/]J4E5A%2[,,Z>=-\&5PD6OR\2&JD]0Q_
M]0\HB1/!F8_:!XE)TP<.MXS9P'!VT"CWKPD,AH\)UFF-4TURH3 >#:BO6O/N
M\EB:F3WY^ 35 )?&?:.O"H^ F)!QH4,Z6)P3 T\IVL*^H.;:#<]8PV;1,M*?
M:,^ZP?:?$B4*!%>HA#T1MCN,A#@J%#3CP44:BD)4#4#('<>F*&H6QPX>U+Z[
M-L+Z93 D\=('9>P452<F5MTMU*I79$&<C[8' ?+D"E;57&'>GH;!#F;\1U0L
MIJ*%2]1XM3!&L#'0"5]YP.)QQ"Z)"%11_@2ER^A,!U3/!<+CC18)(YHH!U-R
M8@Q$*PZA,[PP[*(O''4_/<E1Y9!CE,L[5:(?##8(,37!R53@2^/IQ7C=*<BI
M5CCETGQ<!UUK8Z!BSE<7_ I#A\)4*\,BM<;UX3&U<4 +X0E$O:!C8$?@#U*(
MK2:/',+*55PKUY"67 ^6,>7)4*,2:KKMO))O[Z)N?/Z9,#@:X.[HG.6]J:AZ
MF^$Q/*)*2?W &*]8/1S>;+_^3>/Z]U?_ICD79\P#0+5T>OV70L$D,BCEI4)#
M4KWZ)<2:B#P#Z P\S6\+'H_7Z(H!#RPW?[=J:0U/L=YB9O9,2]"]C?ECPOMQ
MXV;JCNFZPZ\X73?8[_)UZUFD+]MW-]O 0!X,%AK1/4&= G"@%1A81NXMJ=$W
M?.!*+('@OI[2!\JS@ #$<5ED'+OT$=T[AXC"",N.H6@SUG8A&A<D#X!K;E$*
MDL-'ZNL,A]J*WFBI)H@]B<NI0IG."R4U9XI+@U'ZY(IJ\\9.X\C@Q3&QMFFI
MH%-/:M I5RP19PJB@4E10,Z(R%9>]PH%.XZ\#4W5F+YG_C !OPY-$Y@O4&K)
MW2FQ E^+W<K+.8P5* %Q0] 6J#\8K23]9(FLPOLT<=082'T*/VHQ)R'DB^19
M$!595;(3#(,4\O H/:GAK5MM./U,?K)O\PU-ZOOI#\C$,1%!03UG[0LC<ZE<
M 2H.G'L,&Q9CUC-@2HK*+BM.)Z/CZJD*$ C<C_[)N6&EM,:VX(+S^M0U3&!.
MK9]=:7D)F 3IF6&2!Q5K\-@^'CDJU$4JGI(3-A@$EV=LX ZO46\'1%ZKL%8J
M@(5Q)P08+NR1CV:;YS1GECV[$/)9BA6+K%#%51<3V\PT&X-&)[HMWHHC'\@E
M&O#13.+^0<]1'0X6Z-O;V>%"Q&&B&-!!Q4]ODMJIXIL;E*(XC%F9J(% K"TX
MFKA+?=FCJG=B!6XFE\%3:C+E_6T=08[;Z2#W.'&AL3(L)//P .50!=Q"+>E^
MS#XOBHJ5!EWCOU-=I6RF2KSB6KCC-=J^E#8QY=+.4\^[0K(7:H3#O+EXB@&Z
MT[,,,OV.0X8SVRK2C28EE46Q%R,KD"-1@FURJ>@AX#R@5C;(9E/3B/879!J(
M/9%H:;@-59$(,$%N45X,HZ!^GCO;Q A02$2N'8=R$,:%854+[OOD)E1YU]5&
M<>\)F]W<GNB%W/@.2<$V P8G%).,7"/]53 -Q;))W.&$3W5Y%AVI9*)8.,RI
MR$=0#A1>TT!<R+?WHY]:?Q\P@Q6:&6R181JU/IY*NP""GHA(!O)LU-1:T G;
MZE:[A:"HZ>;8?;[W*9&CT[TT?R6N"ZD9]C2'G-HW]=7*A>%\_OBU@A1GL@B9
M!4'-1Q![1.^[?20#*+PSPPS6VPF]@RO2+9/Z^-5X&[@TF (U]3?5,"9$]TI/
M94A)KZZ@8E9JQ5!1DF@]>0DT= Q^V+B##[WCO_[EV<GIL^?L*SNOC)FU3)M)
MWJ!2XQ0(L4E"S4E.>\HOG"3[E!8Y6@D/TYDO/4YBJTC2"\D$>-LT-AB"Q"C=
M!BR:=BRW8Q#D?'": K(A$%Q(F[5F*16)E'@SO$,A62 /%)QEWU/&@X\S.?N?
MPY^V8OR ",)5@*CKV]5ZM9^>=,P:/G\#RCE_7W+-[\T',/M/8]2XX(PVE'ZV
M-(N9_F,F6XBU ).A-(5X<9OH&ZU0'ZI#T-&^ 7I0U,,0]D_ $$@V?(&N*<>+
MR!Y(5 $/HVA#2T0_S&58G P4[J*Y/4&M-3_R2A]M]5!&\(/!]$0<>Y,J86Y_
M8-=B?3S<BQ?LHO!%&#:T[H.Y-H/S@,[1#GL(IM5#V*$U&?:1,6, >]^.>Q0M
M$UU3P-O,ISOB88[0HMHZRH6<P5TG^*@BO<@+B'Q 6')*L(#<B2T2;384KA=C
M-$(52< <A6A&Y/%*C=M_[(26DF[?CLMH!C>0&T[-\U7. "1;] )S$</-L*O$
MX.R;U^BVB(7#ZCJ>$:O)@"-R)DUP;YC.KZ@SX!;-O&YM[)1-=/3,D%D*K]B.
M><'*2/8C*(H!Q1RM"#\?>"M$N*44W?L;PA[;,5:-@)1;SV$P[J*PESJP[[(4
M@H"\,Q\>9K2&*O".L<Z8 -<%ZLYC=F/S1NYNR=&CKSDY.NB2HX]H>XL[#/R%
M0-@_XB -)A2G04"E5AY&\5]3L\;DDEMUL>N8ECT(4/_=0S"%["?]+_YC\\Z!
M52>HTK .J,8 B^[*#Y">JZCL@(TO6!W6-$_;[1B4NO!X*,K7]&FVT#K4S)98
MAQ+4B4*A3"5[ \P3CEC3 "6(>]K6Q0&!9H$:^IB^ZVT5_^%+\TA4P5M@A@JX
MMF,@,!7-@76I GRW&$[34?2" UQGWMWZ#74* ."*$HF"26/'"^S^!9$/.N=^
M3L]2!>S(G"?.1)I1K!^_%UWEQ4=[T<Z)U=359GH5SZU:@_D$4O:.E8^KP@ '
M:)_*#BR4HR90?TT@6M:14E!1@_R P:6'2;9( ,2 H2[L\$;R02E$4/1]\.,+
M1S=&H36<O9>@&LA Z$GT/XNRDG@;9_6HT!UST9#.*&0_,46@:X44N[E#V#G^
M[E>BWXG4NC@FVQ/SQ&HF$J7$#)_+M(!#@B J1)@XU=L@4&G8 4^L=9T*8PP:
M11!Y!GVJ^ ]",%.9D@?WVRG!T/LD18Z>H T;%ZO\"1,TCIA5P/()QV4%5 4K
M4##?L>.T2B$RN"-2RO3+'4@U^Q)TK"KH05@"JL\=W3 6K6IN+#4Y*^D)/#N5
MIZ;W-*\@4F8(*A:<;,M>M 1\!VH%0X9Z,4*R D5D7PMHNK2DUH&&&C; K>CO
M,9Q9?^PU%=H;X@2DZG$W1)$,D8#.PW1@HS0E>#+FQ"17Y*.U&99'!,\S-SV/
M!T;ZRZ/),*T[ 3=6Q;EWC _AN@__*H; /QS.)_K-E1EO+N;##L(52&DY<JY7
M$HEZ(56T*OHOG_85MJ(^!S]!<:;B?:7;B2I\@'@3HH2Q),>@,%->B47@_O>L
M7#B&2-BN_2)89@BE\!]!@!QE6O;LUTW,>1] E"CI.*4:A VLP27@%)TL"%!(
M;,E4"<PQ(V0+F>59LL2:X0GWO<:/M@S0KD!J?@NR-.9"S*&D"J$OF>AR8L2*
M_^PET2,IOIJV(4);8H)&" HW[E"W:_(?27Y1Q/-+M#@SXDBMP7%K::A8 =WD
MA(":ZPO_)$[G\&D3XN)"8(@+2@ 1SGR:0^9BA%YS$RO$U!FM5,1]INLS=9W7
MD>M44M9$4E?VIJ?R41=%OI@3&\@%Q3<"T@%!\CJ%$#QI8X._]"."R!$[:6"_
M\[[;3-Z)7X #YM_(,7,7)IMVZI@ #-77C%O!5\([GVJX@^M5 R)6(J; N]2@
MK#H3S"UA5, L@B0P@7;ASG\6V4<"J>TX#)3'7$4K,5?F2V*N&@C!$'-E/A]S
MU3Y9"NY^6YP5I,O,?:.KH@Y=Y=!5K04/*]%5ID-7=>BJ#EUU;^@J=4[R(>H0
M5>8:1%7[\7I/**IHTU%4=\O-'G_-N=F#+C>[GD5Z)@>K]R9;/9SF^3I-8K(R
MS94==%0E',7S>"3:+_IPX -83M[F21L2-;K?DM/28FP)'=J'2_4TXXOGV@^F
M?%$A,@PE*;#0W^Z)25((!SJ>=' 6V<L4WH).>:1T##T'HT2J,:2&]7;MKL2$
M>&FYDH/IR<"I.%,#[; H=!R6P'U4JW1287EX$>+]J4!Q[-J"*"PBLJV ^)=<
M"<V#AX2G3(6''PG^BD%4*6=L5)5@E,+380*8)E,D'NS?4IQ4],.H2<E'XU6M
MX!U*HL&5L7#Y"Z\+!%SR:F"U!0\H<V$-"%8ZA0=-0]1TAK6B&9P.+ ^7^2#N
M=Z6$0]'$Q'6*U=BEBJP2?U.%="B.-9D:TE1&T@)0.+'U033$YP5D+JA=AXGY
MB7 YN[:X\N\(9#AA':22&N VL':8<XWB$?5VX^[,#P3J"'7M5CMR&H<H:$;#
ME6*MC\$SC#=0W9$&]7BJ-E/5F"RXU8#M!=D&Y0Y[$4(31' "*2ZHG 2R0M10
M$?%3/G]N[#.>B9.\:!Z*:B^[D]$N0_._BQQZ.EPJ*BMY*_3Q$PR2,KRF7G6H
MM"8<\KQX;:,A T;C\J/SW4#MWA4BS6#Y(DU!X1M+I:"&G1)=(0?B/RC+R2/,
M ] >:NNMGMKVT:(3U<GF38@/#!B+B0I2--JU3Q$W[T0.((\=R5$PN<RUJZ('
M=48F$BYU1! A7:@7YZ'6VEMBC$F1O%  '@VR+>N%=H*HKH-Q]:>P\-CA; DM
M*8P^<.3H:^L*UNA5.L:['@EV^]$[^J(3"'4Y-U3UE'/+HS QBMV,5_5\R@O&
M.#PP(:\YI&A+Q&+#LHSIEH63/IY2E"KDQ_KU[)]WS/U<$S/<Q"S.:[DPWX.I
MH</D-_)L4Y*S'GK4Z('6W=5;19M=Y\K>DHA5G68CNL@C$,X,\B_U^"V='J8!
MB_<'IF:_WHYP#<N3*[8V'YZJT]WZP#*>JYYYF2#;+#&+:=ZYK.%YG<TYB8MI
M*N=9">)>BREP-@O"T9VP:/[Z^#^=5KBNE6 FA&\-QBSL_WW,K'4.Y@4D2Y"Q
M$%_N^$$!#A/.^*1 _Q7N430?\(N3A'@[&#K@Q,Z\:V0?*YE23?AAL"@<45%
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MK)AQ#@DW:E5?O7B$ Y3/8#Z<=#U)D?)//94J50H2=(!"8\R*<W;35NB+.A)
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M5AF4-E;Q" [4J[A0+.472>ZE1^B%/2@DK2[_=V&-;7A4A7472MTW+6.XB77
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ML94+,ABR'LESV]88-2/4%J*:6B%&LWG7#40>B&,K"#-HB!4ZZ$36X0EE?%4
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MNU0+ZW%7Z*S<U"/I=SQQSNU/UTDMPF>(_S*(%#1)[R=>P?G"/<T5V((+[])
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M ;EX"JI&&HIDCD%C)-2AL52U"RPXJ["6<;KD>"?(^J'WH[-F\%CP76;6R+]
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M5YR.%1D;=\ YF Q,#Z+F23=RKEC@7$BG%A=6^'+X$"+BS^I/0%(:C>J;+;"
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M-A#267BHOLX1$RI)1+\VVW+FD'-+3O1=??QDC?YG@5^!I B.%?JN.)!UK<D
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M=S?/(^_AYZ'6.OMPFR;TJ(,A;M6$'O7WUV))=,?N@]ZE3]>"0NPF]6%=\RZ
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M%\WA'@!--UU^&9VS,98U?VFLIB7HP6%=@GHD7>PO$[X"S.40;\!U%7G]29N
MJMMMPHU6<S.>E,6L_2995+[]^:+CNUVNI(2-*]A&WGU]L;F,>#WA\[/%M,Y
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MMPIQ;:O*URYT\]Z9MF)M,P,CJ]+%3(%3;$=N]-X?';\\Z6VB6$="74 >2+(
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M\8W=%U$"<70103ASM/+.<@K=PVV']SF":&H)7$B&']&0(+#VUF<6O)*4@;N
M<)?'X*&/F-*XX:63\4J'3@E+68-$_!6:?\M\"4A&*<*A$D=\6_0X6:4*)4MN
MR!5Q>W<*Y;F"Q66B.YX#F4'$]U,%RL$_1+0#EE#[+3J'*<'R]D7*^4D( 5HY
M$,*.BDK V!ML4F,<A-6H&)6QTDP-7J 4RQ[9PIB>M3ME_NXY]I?.FQR=%V0K
M<X?PB"7LQ,>!WA^_>74$9R_"L^>-,',[>YXGCGDU33I:Y$4)DEBE0?*E"^-
M@I08E-0P3<C6'J>4,AM$;UH4N3BR&:(?$N3'/R.7A[Y_ 5YB7XQ7IY7IH*]
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MBYRH04QZU)M/DP7NI3S3T"_Q:2JX'X=2"3"9>^X'P=($RH3,V@L!/6 QEL%
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MX!:#NYO3O$2CHSFK*P9.,&A#A>L-<C1 D;2B41&+B!+L(/5HFWH+_8*K*P
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MT/[6 15Q3/,%^+\C+/+"/1X'L95&@)6[(@0]BW2!-+(&ORY&1"?-F5Q*S\B
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MU?I=6GK(3)Y2LSL6?DS_2[RAF #,G/36Z5Y72?W%[HNQ*^#FY10,W'(8BL
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M'-^$2989V!<6'PGM/-_95@DQX[GU@O5JB3BZ2( UAN&(@<ERQ!0@/^WO;>O
M052ZD\W,%^[ZAXA)V93:S)'$CIGAD%<OZOT!^TA.<7R<(G*#I+35_:^W;B?Y
MEHG 1S]R(G#O(1'XS6HFDA9J@9 .S3)\JFWLO(_ZD:@,IF$3B@O^;/.>NK&N
M)X/;?<A4T#/!/1<KD-)\HK4*46@\JO:<$?5&F^+;%^?*:!-3<);#^EE$B&V_
MVX'=*)F@A6"&D2M]N]OU;4%(JY%[1:DE[)B0PS,?TFM')T<OU\YO./7P'8I^
M-%=.[?NN0L_$20_ZH)$-5EC MN&-Q[C?2#K%I5A8S6$^[GT^;=#*4)5V8T#Q
M?+K /-5H,9.>O-PUC>I(75EI/](T0<$=O)%X(Z'NU5+'W 25DR,A/%N^7XA9
MF$8/UU,K&%+<6_F HP5$Y<L.1\0AH.9)R284@16USA]QC%V5G53L&SLT$68-
MW8% /Q?S?KC;2NV#I4Y8/&,03[*=4C4\7*Z<9).,/!RY*_1OC9O?;9X:K$ D
M#U\YMQ9^+)@@/(I#S9=<,,&L9$X8?&&Q5-2VY!EEB,5E+8\JYQ*P$L/8C7()
MX$9X\CO1P61Z@FHK$RV$H%H[(L\DDA['C!>VI#.-//RB>DJJ&G2!_M[F_DW\
M3X^]!T7/:*N5[P.[2\Q0\N$<MH"H<J](Z4VE67)= 37F*^-O2208)86T 8B4
M!A!"_\N&,"KM4->(8U" R 8SQME8B*'4QY>0N(N1<'(#\_?)=*0-P[4RO!UH
M<:,6Y<AV>L2Y9R).<HMA;\H;7FUT11F'SSM0 VI?0.9>/;46APGX1"X@XF-_
M'M>_(B-+?#&R.#;E;2H6Y4?MRQPD.*,4#E6M$^6=AC:C[M FG6_X/W>B(WS!
MVAYH6))F!"DC;VY&^ _J \(6"MZ>B2 0^*I1"\Q]D_.C*LX-"D)#/2%=88@S
MD-1E$Y'NX!?NT2J7DJ@Q7&]9'LFCN7D+A8Y=I$X/,Q\M\8\=G2-K%%\+YC/C
M61WRN<SF2>G3JCPU>1J1M-3+?C0%D>AZCIF9S^:J?D 0#2&S3(_=;LMV(]22
MRAJL00Z:LJ[79D2%#[Y@A+)+(M:>6X]H(?F$^<4ORLX"0[,K(2V.%M"Y3L(N
M]6I,D?!Z5Q'!#W%P%;Y7&K9MBFF)?R*[BR@'S]?+U[>CXJI""@PQHUIB%!DQ
M\L7<+D"/,QJF]66:!EI3!M AI^%;K.YT@JOWEE("X;EQOX0[$22L+VB(UI1[
M\PS<^<6\YQ:,&P9I M 67F$^E6L>B<G-RV+8D3(BD*2"SY$9JL2 <B%L-0UZ
M(T<;&B0/NV0C2 FZ6Y>&56DM9GL!^Y%Y,-9EDE!+Z3JVR[)]GO"['6(DW<9X
M)SW)'?[3E<#[,>NM;@HY*6N*IV?ME/CO3O$2*5(E+ <.8=H-+Q/ATKC@*AO<
M6&5_7K>%H9@5O.#IH\=/GTE,B15!]B&=9N>($X3Y=C=#XX! ((L19VHHD^W8
M$X/5^C+S^-I+-)DN1@X!(4NA)K@4DJ]R;JBBV_9 8/A#0_T0/Y@/J%-NVE^_
M:$Q^'POIB^&%M5U(X8+ND2GS!3$%NQ;$LU1%MH1'V](1&-,H3,XW\'$F,-IW
ML71M R-9J==#7(HT-1D+X[(2OTF'"%CW:;!\;=Y?LOZ]U:=T+<23O;Z7 Y<_
M@OF^4(QE.CK/LW\O!*7&N*NNJT(,:S)/K;83N1S$_@)*D -S83L3HD^&>#H7
M)J8/<3<"UA(L_VKRJ?%RVFBFDVKWPA6F)@A'232<3,C@75$/)"=YX")O1]H9
MF,L28*X"2TU_:6&$ZFJH/:8WB/KL[H&80.4J1NQ;7B&3&OB^LL1]=>^OF9G'
M&W3,BJ6<1):G)HR$U0(1+9G0J(Y<04=S6J2?+4<CVVHZ$-Z.OK48;"6D<_+2
M2GK:73G[OMK!W,&/'1B.[8>IZB PVBUV5'D<Q(48E!<2=718S-8!<OTVQ_$&
MUE\H^%6+]^VS^OPP*?YF'@%=$%FNS;53#[?,5S[^D?.5^P_YRF^+@>0FC!SW
M(U\0+V:J8#/WN6H?CR(%G11EM<2N3(K$.\>"[&I6/W=I'0)J\%LU!-/Q1M(4
MX%I?IIG49H-6Q=A"I(J(=0>6N[&B+1.*M%G*CSL$7;W5HHK/4!D[$UZ[XT:&
M+$6B=@YQ+/U&4'T+1YRYJ2A/:Z\HB0U(,,I=3L*J>_4\N)]V,'AM[>79[ L-
M OL&2JYV@$>N*#JFA3:[."EA]'B#8L73,DS0!,Y;Q%S2:7Y&]E+NT,R*+U<*
MN>#6>17<-_"PE_Q,1K \BP\7<((3;**GWXN/4V.NOI^"GI*VH-%M'CWHF=[:
M+A\3\N:[ X*1\MEBYOK0#N%(41>==F.SR"*\2ETVZL +*ZM5+4)@EH;G,(G)
M0'?<B\^4^UI+3'5T$DHDF].%FZQ]X@81.=.%B /&H2MIF6E1XG&H&]+COG5V
M7=QP4[AN56Z<4%EF&FIFYY8B[.L7QF!]E:TS?7P;IF188$MF0QV,#S9H+1]Q
MSTE)C&TC15ZXK'('P)*6N(-%9T$2$;07:7X;Q;'!&;ID-I^*F2N!X0;2-F0]
MBPSNU"5-O+4<=#T0>(C30$K3N&+@FP.X&\(P8-.0RV8S$#!*7$>N]J*YM$YK
MW' A9(]9,!1]YQ[2) 5?.V/OU,%8+'3%Y[^9 R2PRE'8P"JR'D,4$GXM*H7*
M=S\T0ZEBPJ-.BA&C;120.,2NA!>I:Y(77M8N#6AY15Q]1!@QH2IJ)=AW#:*I
MY0'V"Q3$N%4HII*=I: 4<G=3%$]?$/'K4]6M#UX1-H"[94FO<O;(?).T.%P_
M$FRG0'W"H+9F PW->4\=F^CQ1V1(]!W7."'.G9O392CA82PP4;]V\OSWJWK<
M9JX)C8"I5F*SHD5.S9:,2HF32:V1(*=EW:.E13RK)W*MI9C!P6)V3<LFBW4+
MV'@]THU/&[47-AGSEL;2LE7N%M%\:L-<._ C"-X:1 W98-MLM@N.VNV"D3!+
MU@_K-PEGP]"+!EUBB&[F]NA@.!5T@HF\L L08^;=M]18\OAVEW6B$"VI\5_.
MA='X 9.$"U^RHB*T4TH$JL4V A(NZ[45.=T0 K?RCJ04RU2_B3^DO>,7F QI
M,^?5K-/3M-6&\W[&$4OH&*]#5^0G6MN]1Z_;1D1EDX*!35GM%JNK.TE'G:>,
MLI!9CK=K.L[Q:%U]PKSA?XLCMN>/6.1/4GA^%#\JUB[#-\RP[($*?M$X2UWT
MV%WG*5IQGCK:;]_Q/ 6CU$[)6$D&!AD\#?'T,&[I8D"_3DD&1FG5FCV!>]'D
M&BMMHF?J<.*"3IRO ,"@9;NHTDS-=RB2)8SL:;("V7&0"&9"ITY7P]WH7#GE
M>3+5WM1?BH"%:M7.-C 6SI/VR=3$L1S,P*I==9 (YQ0^QL.'9*S]MAQ'+3F^
MQ6'N-Y"M=EFD%Z*T)Z$H)CN%(5FK<X&5ID[!J7X'VH4<DXYC<L.+L+%$=I4I
M%EQ,KM%F-@$I7)">2L&S+6DG<4=L!.MQP=IF/DW0:\"QTU4@<AH>2B>K08R@
M?5]5[BZKU<!K+\'N]?O:G%8 E5GEKU#6@%N!-^@4G'G8Z&W2R.=;8H6^+SRT
MK+F4#F+,&^<7TD1AE!0PD.7U=?+7D>MK@*-5X=.C0?=>RA/?8T43]6_0\^JK
MG;A/<W! ";U'OWBQW/H]N:SZ;&V^<>[Y(8+&DP\IV>[^Z>M76'1J+X\PKN<[
MWH?D @&Y*[=YPRC&&5SP*89I!&8U)K$%OUNQ72A0R@0E26O?H]FC2OCRX@](
M"1KU.&H%)3N*PK!F(4 )B)?'1!C:+-V,-!PFO5Z\N/#@$6+<V4L(V-.0;!!X
M<O7;5%N+RY9SQT&&*>*#&XWQ'(% K+**?G$5A*HJBSVT)/G<L\QNF9L*'B<*
ME46>^SF,+Q44-3-QJ6#&?6,]#;7[U U6@$*XMFY9!A2Y"+#!"G5Q1RT;V;=Q
M,U@9VL-&;6 ])04?!U<',)$O@-N@V)I6Q5ZBV5)VQ2_=>SHVZ*K="^+-G.\\
M7\Y1Z0F9<X/&U!0*:8+"WT2Y8]92;Y](>W37B1;(G-;+[N0[3=LO.H?C+%C.
MHO ZB<NNX'T326%^6^SVK41$5XW4F/ZR6W#P1VP_JN^0!IHG8<(#D3@!3ID3
MB,OE&VF8V%"_!6\,W@9_.PO AU' \NC1A]B=A"YM]Y:U"W3<,DO[Y$?.TAX\
M9&F_G86B<)VBR8C:Y-G@L.<XG9-71<T?ETJXQW#@&2:"?!L_1YG*,6&OSA;U
MM"@^]!W#D&_?$V0@"'=(90.@?:K)8NI2%SHFNJ*5K(]'!E9H[LMK[/6'5_:H
M9MST"!OI- ".!BDZ UTJJ'\;#X;K;%%*7)$(8KJ&(5F/J/+#EHZ)Y*11F-GS
MSV;4CU0(;-8O/?'K\/F-6 '6D>'C70Z_F-<IMJ7BUSQ"MHV=Q\8#15MMFG*_
M=/%<V6^5,K=HI[^WO]W?WMZFEVA/A9>&8F,0PXL.%V?@%O$O=_>)U&/G%J^)
MX36[[=>\LJ^)X#5_).7HG'_WA%ZR>\N7[+5?<M2<2V/1GM*+]HT5<L?9_!:\
MZ C=6_<##FM<Q4>R>S#8WN[[?"B5V=R8RV1W\-@SJI#?!(?<#&?=9/LT##D8
MPI> (FZCYWXCG^YM4B>?KL)N\!SJ\VDC_HZ$2LF2=(($,299B=PLBRJC>-28
MLO\>H0%V =>0OH)-Z6WBZ"B204\W:6--\:S=TI^8]N[C?RT4 5T9_(%A78E[
M9F\<U*3?BVP@BK.@OCWY!OZR=^C92H]Y+0DS@(M9I5JR99Z>L<5-*UQ]Y<(1
M+A4:I=/I'#W<_.POO>T>_1OLOY'^6^T\-G*)+VA>@:FG?WL&E^^X/L>A;?_\
M++[I,'MHT_U:E_I\N--K[&^DYC';BCVQ_.KQ"N.77[A%^+$:OS4=7V^0^_7_
M]4_U^/DMGRZ+Y:U9:[7"X]R(8870D/Y+;[=WF^=W.0G7S:@A=LUI=0Q97GWE
M6()IP?_*&^T9C!9&=U86<)907HKRSW%Y-MS8W=[O[^X]Z>\>'&RV]U6$Z,FC
MGSM&9I=DFDY@O5==[,V9RV-WVT_MWK/P:SLW&XQ=I?8SMJ]["$$2>L_W![O[
MJYYQLW'\?-N-NL'QNGKI7UVQ]+=9[SLO\DT6=G>P?W"K[]UQ->\B]K=<[Z/U
M6.]'3[[&>G_R:OZV#JOYJ$,MW'XU_T27_5K9;&@N&TN)63]C H_Y?L3$^<<Y
MM+;7N/LX4LMZU7W1[_("'\5=7WL5?.V/9!E\YW'G=^QY91KW3D?M:>>7?UMG
M9R>(6(HZ_*_=O9W7N_#+5QR;P0E33V6&5KP;U85;F+V=?L0N;.CUQ9<II]O@
M"Y0L??3L\'!+6J)C$NJ_2S!,XQ<%XL<Y%W3(_#F___XRWL /[FX_^^\7QX?T
MUYUGFX-8:RG?<.)"4W4"FC'OIIQW<9F?47^6@#"_!=D5G@$!%[9=C?7;T>SY
M[\9=?^_<=>Y8_$:83RZT8UV^I%8I.35 8EH?_6=D_'[":8 9ZX BX&DR4^K<
M0H=XL9N>\2U(S^)5I&>1T)L5$J\@G\X'.93&K%RLHC!3B!8\NII([PM$]D^3
M;%9YC'_AD08\(:3H\"1GT?4D9UU%I6LH15W.M<C0I!]&+#!0(6NFD0X',M2H
MKL'*8:4-$Q\F<6=L(]Y@5YR 1_S]( Q"/^IM]J^X+X(K(5KUFZ. S[=<J=>Y
M@SIIL[R(!9L%BK-WV"-E!GJ*ZS2"W])! VF^2*8IXV%I1@)"@.]Q]S3"H;P]
M/CE^9\ P'@N'#Q=0'ZBGUUD-?V&5:? A Z<SZ0.J-/M"JLMKS2]VEZV9WGQ1
M8LC(\6]CSCIUU"YT$#;I:'>P)W#?,[-5'&+QY4$<8-'8OSO&!(<)'6+_*(["
MK-^QN5UF\^F/G-E\])#9_#9"NDI]6V5,)YDO\Y!>#/N!GR%@6Y"59-C+:>[4
MEPW"-*\/8U%8:N%Y15J45WPKU**(NL)AO"-]&5B2K+#B0 \UVE0951,WJA4:
M87_Z9&-Y\(9WC%]14Y6104)CS\\Q&.]-$85,;G":DY^BS:&9>1/LHDTDA:26
M5%4FE2ZX*%5S!1RE#;F.$1FM#Q'JKQ.A)G$5H4.I/?)B:N627AW*YM>.:(.H
MU>D6;@>\(2\NRV1^D]#RW<+<1RKQ[L <DL2O<;R[(SK<>]X[W.K=PTCVM;%Y
M"5EM#UKQUOL8R.Z]>/'B_^VANL:_M5?\WH0 =P?;:QR_[M$J(V\!WB#W=I'W
M/\<B-\*LZV&V'<8P]Y^9Q78Q(X2L )Y7>5,$>Z8B$NU)&'&CZB2;5@VB ZW,
M#:P]Z1D6']@7MY\:-Y_Z@:MCT-47;@[M\H1-5K"]3\-<W+!@<FDI"186V384
M"L#BGS6D(\)8G"OL:3!>A'P8'%GY9[!*M&.K0QR5+T)%4Z-A?0<EJ&Z3R LW
M!/X$0>$6UUAPE)3<"%')RFV5VXIRT0T3JL F' )Q,5/;;+7XXFYF/%8L>D7#
MZ%\+JA2LJ6TWXHP:); V0B_E<4'_7U=GR0&^3"A>S*J\ XWJ&REE_^%=.463
M>H,"OQ.B'";]MTEUN%KVA24D/6ZJK,F,7B1FMP]F/3I IG)8J:1$EPIVR#6B
M7%$I:MOP^BTB\#S/8MF<PR%52[S4^A <?-0>?-]WF9PLD.3+>15A+5CCX6.J
MWN0:%]D+BO9([H:<##-B2O40&9H6W%'J1+GB&Z5;5CP1/K7?M7<EP21EZVCH
M^0*S,(T'6$X8)M'@;['1'<VU,(ID>>9 F"8?1=5G[%J-+;D<\J:G5:O@ ,Z#
MU@UIIU#$_C/5?[^K>NFL!%,[4C7&K"Q8LBAG?<WTF(W^T.T*.UYPX=J?"8N%
M94T6L=,EJ!+6^;/\SA4Y-9MJ)DPVY5SQ=@UQ=R.-D,7&:DI?9]Y56'+"U3:\
M?CM/-LY%,J4WKR\+EA-#W/@HD50X7=GV!-SE+.':4'PXO&[_"1P#)"'<X IE
M'>0)=BM:4MCY'/TF^/MFG&.3:J]2M,XTHCI3GH2D8X@QH$G6R-P"'%_=W3WX
M>>TDK7$!KD[L7IV^E9C.;\%7*(YSY9WY[AO<F<GJ<FS2I)GO[SFA&J)BKOR-
MU.9/BIK0.JXXIC7D!"8-RI13]Z. ;\L7K;O'>];ZJ2L \"F)]D7=C/E5EI:-
M7D %V!8]O($7L/(#1Q(![#8;-(?1-A]:\Z#F'(VY--/T\#':S=8T(K8WVJ0;
MMYM:GPE/I\SNZZ^:OEQ/?5_7KBM/]5S"[TM9&=<&OLXDO'K55-&"D%DHHXJ4
MQ1/C,O&R<I=+-JK@E\R(-"F:"V57)KKQ!E.:M;$,FSI(S@CQDMYU>%''\%J&
MXJTVKG/(CF_!&90M>RWZ?/::,0MO;YQ%=S?.XAL99^SR.?-QI746W=4ZBV]@
MG8%T2/^/+ ^OY[V-Q-W.[!XABYX61WBP0]5ITM_0Z'O/UMYAI[47;VB?B=!/
M<]/RVF>>DBKE.OUB\UD,_J T.1V3NQ=29Z%C3;YSLY<:+FE2%3EX]DNP$+!T
M"L$:03D"X0Z05&61H@U%[5LFTL-*U"R,5\P44W!&36#RI>9@&%A_LAC"69RC
M6?&'SN8-7@A86WV,V!$0QI?%6!J!@,EV461DX:)&JY./TA8UV+K]IT]VKWX8
M+(]FL4_A&<<J1P(-T!L!EVYS$+^6Z=.[E0]G7"R04\(I('A.U'J.'%GBK$&6
M&#D3YCR$:I<]MM6']09^D\\[A0 2BJ_DR\YC ",985B&&/]N^OC0@O!:H./@
M1^[$F!:UZV8PWB[C#I;\#YQQ?_R0<?]V&%ETWMS5T B&B/7NW5K'<-4XK@U_
M!6T+V(7Z7'/ *V]#@MX&@<2;E*;VFPZ8?BFZ\9>.;OHF1MT&\*N;?#%BM-&J
MB??6,FA\[.X #@M?)3]B4) M\>=X(_.&6^2L"C;!6I+'C!SL3RJKU8I2SVOA
ME2R\]"DR8K8N06Q331KT(Q,B U<Z4Y9?\F0LD\LSF$+6-#ZST*CLG@Z9]9B$
MP/P!.L*=%GG489''&S7\'YXMX,7->$4ZXAD;Q]D=1RA&/>YD=&-L?"?F_+-C
MXZ,;8>/C'PH:GSW_![?F/2;US$?QB%W8Q%*RN)UW*8&"8A4+X7XX0V$C?OUQ
M 08DMY:S$..B7/' X=*:=M/D,@"S-T*@CB8X#(1V7A_2"QD3&Q>%%,C20VB+
MZ4>N(7$S&+ZB>TE7TV+7T?F,(U5UV)K-3* NP((BZ.EM6S,+WK1Q,;C/]C8=
MD=S-VC<W7&.=+0VP$7BFGTG_YHX5$%DQ%!<<%PZ2L>=$Y9--E>$>_;\@)&@T
MA888F1UM+GV&K(9I!C"[$S!<I(,$792,I>U>P;A4IK@ F-12P#O^M-UP5N)5
MLZ3F[-;0$ZC"%V:J'K*2A<N[,?S/22!.0=S'<7"NG0;Y9R-NV4Q+_!-)$Y)9
M?#R(CY?#A,7K'QD^(TOBWP;Q"]BA/*)2FG&*N,O$R&A[#X0H<]5)L#IG$!_2
MO_^6Y(NDE'M@AU3Y 4D.?(_>.T%7EUL1=3T';I%JP-\^J1>C#](4ZX^TJDK]
MA3#.]&'=D*+R%%QT^M _TSR?TEB(;?$/S\YO7M 3I:IM>2MKZ!G&MRP'"9N1
MD :MD6^F(YL%*_VXR>0@VBA:V4S=BFR;U(;.O#/. J5V7==U23);G4,\$QAU
M,)88G*C0<NHFIG9WC)M<FP#W1LWC)3O&PG3:5?1#6D;SH9:<#YX IZ=<JNH4
M]Z=9A& 45M<-*EH]<E2&ZZ8><-&JQ8Q6PHBOQ!7;>4P3%L7SB=2#5<2!OHR-
M#S3G<5_+%#9LB':_VN^RI"O]0V^,^P4FED;?'IH=$&:N#$BI<!-L:XIPU&NW
M+;\.GQ\17R&=:6T&N(XL32A@)R<O#.FL.(N,:1>HE[2J8S(P&U/FHJ-(VU@0
M92&Q2V+-'];A[>]M*_%/YWVR9R\432. PL&NM/\!P?II;\<S!XG@V(>:+GH<
M3ZY;$]KX:?=@SWV>],P%=P(**?CAU3\]VK4?K.H2V\*6MF6--,,3.?98H;#!
M8C1",'-:8N87\P87<%GCJ#JX.RUS;!Y/BP2330$#^N[!X-'/]O)HMTA/?/.6
ML>N; 0L9_;2SMV?7;Y4A&+QP9WOPY.H78E/'V1#U#&^<(83U=T6P#9%:V"LJ
M*-P D'S^T6#_NO>_4?8YN?["/0=?>P3/Q2_([\=E<IEKVPD)9)0F//Z.;@_T
M*UY@BX77W. (/3LJ-GSWXO7Q)@<OM@<'NS][7B:M9D3!@JLT*1N#PVN)[F%Z
M-;=7D5]''6/C*+RS#GP5[CB=),BRJ^Z(S@_F@H/CL>WBV)1,F'GYW,+&$Q N
MODRY(_'$#\11X$I^E1N_@.)8.]7<5FA$M.NT&JLJFS,6KM<*OR;5YU5DF \1
MKF=/*;I@2((VGP:VTC0[RZC&)3SY^+X^YZ#/06^ H32B]@R@1,3!1I=J07(_
M40YJ0GWL'OP<L18UC4UPR#I(^T S/APO608^U5LU3BGW'%MQ4EG"7(NRX3(:
MP% \/Y:RKM]D'>//NX[17=;QLZ]>=*O5 WVQ'RX?YE/+#., ,*"R)E+Z[I4T
MXS)?<E.+#G[6EA&VN0VWSV4&;G\]Z@Y,&.^#>6KGD73,'P[,60F.)P(RQ M2
M.WV$3)V%JXA#.Q29 $:(8$L;G.R-J)4$%&!58-&D^L[U'G-WK*%$=NK.-Q:G
M)=W=-DO*SD5XW3"CH>G@A^W<X"7;@QV6!_2\X 5&]=[ 0 D;9ZD*7BD*214=
M#/;6$&-WRY3ISH^<,GWRD#+]M@TBP#IL!19NR;(9$1^Q%+A@EVSR[BR$HTD2
M>349I&>"#.I65C%64L=,4"Y1[T8)S=XFG+G!+MC(DP8A19CTV:6;I_F95^%'
M'CUI?^0H:B1T'G6^;:US-Z>V1[S3Z\KYHSCNF_LU3E!</1/<Q@6V"T['G24J
MU+R"_!.VQ[&.B9L@P(^N<9*#1@@$58KR5**0'S&>F'*35!)6<DZU;_O.X/'.
MS_&&L-6<P:"Q9YTTOBA,L^'&X%L(^_7+FO_NVLY2'F:>CA2G5:>C\SS[]T*8
MR4?=O2DPB,4+6:WB\'&Q(% P:"@M*M-$$2TP1 =RKV>*DB7( W^69Y*#UOUG
MZP0^7%'+$#:'E&D>1B%-J0E-S,VT@][4,!07B;"VG>M2S5LZ66#X.(A;V!:9
MV >N<A::-="L',J*.#LMJ#7(C%&'81UF,$AS9*(?8PPAER5V!O U,Z,Q-BQ6
M-RMNW$28/IZ:M.HS,,[:'OKFM,@U-W8X=?6KW$!X._J2\M+SU#)4$24<73][
MU[NJY).(S]$6M,YFGS3A_MUB1Y=)@++@;$P($&WV$T8_H*B94@NO/.V8NGXT
M^J?!'H#^[<=7-L1VMSN!.Y.2P*#1K9IC*ZJ59/8.3:FO*$6*VFV:J8O#>5?[
M;GX*B\]-6EC3!U>WL'8Q>FY?';FIT:L_K<7UVHG59VA[%76TO8J_>MNKJ*OM
M5?RUVUYYK!E%Y$S;J_A+M+UR2B%L'Q?=KGU<?)/V<8V6<2Y#TM70T#?.CNB0
MXQJ5DDWC+G%!P_6[]X4C]7ZCMG"4*J:@TJW:PJW;<7Z1LCWFNMN8$H>&SB0#
M$<QH#"U(<TMC\82IB+Y_('Y5;UGMM&[M"=\,B &2VKF+OL,Q3!1"?"M9I71(
M:&.HST95:0\STYA>Y01LJ8I"#S5:4^Z=]C6N\>4X4S7O6V!FN:L>Q5]<GC.P
MBZ*&&I8S"D*R,(=PA9C>U7*QN&_8?H=\Z5)E4%DLSL[C/+VTC:\Y,:)!/E&5
MDV2$FDC:*@:7;5?#4/:$1,#)<BPN,$J\"@UCT2[K)LZHWWP_#^;7 CE:<"<E
M-MREFQ]QQ!CGTENP5$LM"+!&PBW4ZO([;RH/!68 :[NHF-C2)6U7^:^;K)6U
M2HJ>"8>"6<FR2NX\N%[B9;% B22?VV4+O8<4A(LI;$OH UH#4+"7L&ANI+X_
MLTI794WX;HLZ(C".UY_RX0S=;E2C<@X#9Z?3I: +,^UXKR-&Z7I)CCUUX"5H
M"H9<H<T7\(I.LK,%A6KF<S!G^6";)4']'H@"E12-:A\9J/26U!G9%T=\#W0_
M_"N?FUOQR-W\]0&MW$KZN9OQR'71+_W7RY='1Z]?>]:EYX>@Q[#B\;W;_F/>
M_HVW*>WPD9CXFP&!4A>ITE5$2QWT2!L[VX/M[? )FS]_]K<<?(67M"?RV5_1
MGL9G?T7'?GP";=KSE]BAKYH7K#0#.B$6L6MR(-5B#C("8H=_<2F,SRV#3P;[
M.U]<!F%E#PZ^^%MV!X^>?NF7' QV'G]I,=P;;.]=*88!)]HZV$BN6)_;HY-W
M>KM ?^0"_7U?VU0W>U]>'[I'C4ZIX+[XT(V82:N8?^WL4:RUGC"<(8"J)D,L
MA/>M/OMQA5#NXZSZ$+_F]J?<_F'W&4<(\#?N1SZ@CC]>OR;VMTRD[_[(B?2G
M#XGTNP@I_2^)L_%?>DF>_._V#HE=\OPSO;F+WY<0T&_>GAX='YV<QL>'IT?Q
MZ?'AVY/#EZ=OWKT]64<@]!MD3QASQ(,S)!V GQ*55I:?4R<2&_C]1:Z-Z9)[
MHYIF\)3FXPR2XHE- HT27QJ@P80_>F+-MLZNC7N?W#3: N'$ >6X!<_:$K1<
M.-ZHNDSF?7P]^G.3:8$Q%(-K(X>[KK%TC%L\%S7>85E=I=,)IPO$9^9.*[[@
MK'F-<OBTKD+'%PDS,*H;>1_7Y.WD^0U 57Z&X>+7V<=TO 4G>,N!5L-/XLPJ
M;D1S$4:F#!!/<N[X60LG7$82UT[ <8;W"+3#%\X%-$/L=?LO\QLD1(]/\;$V
MS^^%:)(+<);)6Z7',UZRH@7C,%@148#J8S9+A+Q=\<C4<"?XMCZX&,(Q3)0J
MU$P[C >T/ZZ$)L/4PP[PZUAH3:$[R3TJ(!"6;.TLD"#BOZ@DFAK(%QX'IM3G
MY=!085;+;D:)([&5_$.X]X[,2<!%\,V^?M(EZ&G[$5_ 53?A5F:@)SZZ]#J]
MSG />H'L1P:VY%)WP6C<-D_D_4C[HUEDM\T)%\2-W5X[N.,IU? A"&&8=C1H
M5_&**#Z-"QJN9J!*A *)]!GGMVLJY<2O:4S<<,<9B.?ZRIFLRX+SYUXKLW)B
M# .7O<9Y6C-8^1FG7#(!$F!UGVXC7 ]I,O.)>O@.;AN:S\R_C)BU"GXXE?HL
M"2#*UYDCH*0_*R-^<DWY1%/?J<9(\,8H9%314@J-:5\+19%466*#?69#(JV!
MK(:!PC#SL+DW2OZ.F70PU5;A]':\+*C*;YPE>413PY@C44O86^(\N>#.1,2D
MZ6N]@QY!H@1Q6%VJCSTZ2G?C56#DML^W[1@LPRV^=Z-QDJUA'?&I3^MW791B
MA7"7:LI-P4Y63#Y&(7M<CHL,KT:ZI_A>K6R*S&&DE(\&O33.)%':C#64)"(#
MZ)@BQ..6&; ,=,@@?I7.&7ZNE3&DN5J3(H=;XOH!)NZ*%=#3.!+M?<Y)I!($
MK&352HE3Q(^D)7FO\/OHBI1(&Y?%*K.4]"%RZH%*IYK+</#,:5>KA >2[/@'
M]!-+9/0S8^BP6(Q1X&,7[34(F%_#=U$KSF+2\46Z,?''=/PB8Q[(BFJ+&GB0
M (D8><_'%3[_G[0L-F7994T4GL,WL((H@B5S6H:2VNYA? 7B+D2Z"Z95$5>G
MPLY*7:*L-Q6IPYQ]#T<WH;AC0CPNT_!1<5I#GT+2\44KQ^>DY+"Z4A[)!D0<
M,5^7NNMZ?;IT$WQ>LT+R.BPJHUE)#9>UH/D.<<_&/5@[E?;&5X0[>*!'3S0/
ME<5T*:0QLOGGL>]4JN+>L@])##!0WN@MU3Y[F'W6XY<[$>I[80K*@.P!+N:I
MX$4\UI8N8?(YK?#0 4@3*FJOF,PP_9C,YN@'6ER!RK?U"W.2&,(.M%W"BH];
MPQ[TRN&QKRNRU9J\/U2B*HJ&C[X?B)QH;=II=HO61%=N>[#]Y&<A@O=>6.,C
M3Q[_'#NHIE50S85FA6ZVWQU2QAUTK#+]PNJ18*F%4D==LRG5&^W_S/0M(2K$
MJ2CDFV%4E!9;=>(T";NA^=SMP<ZCUE-1Q39J7=?NX'9KY$\\OY3$9E#-K<YE
M^X2WA4>L@=6'+SJEBYX.GU9K$/(8AXOWN4->H.2[\KJ$43\(_$4W+^.2$B7D
MY 3\*IB1Q=TD7%88(:X( RK,^F0F(\_R"U&%+IQ#QAH+@19 ;F_Z]9BL+UPW
M"4%UV"WH-!BZ*6/&R-N(OLB#?O )E?&*-A7'(R,V K%RV*I0A#^(-1@//)I,
M,:)&?4%+A3]UJ7JO.!()$$B(!RESP$\")QB_*3&IC-L,PP9,J\U^8\C9; Y_
MD\: -!;:&R'+LCL8J)XK-#O<=&E&)V7DS!,CGO1D#W[!Z9 >(TROS)_\G"RP
M%%M8%#$8U$0@UGA8_;CK.%ZQA&NGCUXLENT 8H<S0,ZT-_X;J+\0#P7G#_'R
MM:V+-;43O.^#^+I7$Q(V,"H[S ,SCLCBB9R1["ZN+@M4K6DF$A#W+MQK,;L1
MG5I+0+-*N JC/G<$C<Q,P"HYTH*65DS*UHT8<)^8& U3P7,/!U!@;)W X>06
MPL\9O0*IBE2*.R^5%5*,5CX69&0UJ6924A0HT0FA%:AQ9!/-0,\F+UP?+ IN
M".595*73J5 V=+M>\%#S*%)L2"I>"Q?^53X">='@4F4@\&3G53HOIEUA1X[.
M/P)]IUG(SS9)Q\10(K4UR+T=8(!1KPM'T$ARMFB37,4%OG8ZX)9YV+T?. ^[
MO_V0A_U6'N\5D;LQL>(&*2\L"8 KAXC7?,C4-Y3Q*4EU4I@@/A]E\V0ZB ^)
MS!'Y* 4R3OE--!F*RK7C<]2$U\45Z3YT7&!1&"-V7W;5L:&AES%U6<DV%EAB
M$M0RE)<%TV1XZ[,OO2):MY- XM]P^X?@>A(6G:K?O(JDN;)Z;UJX"69AAJM%
M^9.T9EMT7E=-.UIB1^AZ3R88$J+]\1G3J+T W0D\ZEC"CW!V!14>*GF;"Z*:
M<"D^RR'VPWD-@SKX2&UI$RJO5F273%Q#IJ>Y,[0H",,L03UU&_#C$I;UD=N.
MVSGBVSD1<V1>9))-A\,AD;O$\1VQH:2QK^E2[>\5UEH8?5NW:RJT#YQQPJ;)
M5::%#:1S'2R>C6 _::T5:C $U9%BA']<I.R@.B]CPM17A VOBD4Y8JZ>\R)'
M/Q<%]V;QYJ@]LH$GO EJ7Z0M"1U\-8K"H8 X24T:QNT:$[MZ:2+;\P8#7P36
M(\>', ^)AAT4_V!.I4%RK)TL!?'3IG=^,T$JD>$"50]R$<'?Q@M2([['G+#-
MF;0'72$=3GQ#OW+]"%F9<["*.*%I-TI;ZJ &#WCM[1>")QN<#)$.B=OS<9Z5
M#4(GN1HRZ9Z"99BJ9[@*RX?:1=GPPZ*5WN&:JYU_4K5+)QEL9[L[CI\4!3<J
M,Y6<D2>VKZ2.GU)J'860\#.*_@9EU>@A956C"R=_DC><-FF:?> P8:O^MDI3
MZD^&-HA(:8KN,9(X3*G$+*$+5-@074JX2U51R35_UTH\Z1^%%#426/9S,F2,
M87HF:^%5SE<]=W33QWY# $4+;[CS=?"&QV]._CM^??CR]-WQ6B(,?\U )>-U
M(B54U*9O B<LZ%OJ4N^H2!LL 9%7KE@@QS7H;,_!U8AH),P2ND(RD)8E/MVX
M[YA"NJ#",_,,(B6A'I5R7&%4C2\*5@A=N7XDW#'9]9/!-X#]A_*L?0M!Q.$Y
MBZD@27P%(P$*"'=RF6+NDKMOTHPG A,7L@.%M-A M.^G /8C_)A#-]B.8>W$
M9/C<P^#74<Y/*60H3J;@1/ J\?RN*"_3^7DRE')$![R5<E_,4X+IQSR$R/^(
M1#VE/HICZ?-$0WLS09F0]T/$+X/X"+/>)#O,GDT8%VKQ9X^4H9,_IM/FB_%.
MB-P<;2#^S1'<;V!JGGC9EI_/4IP\/HM2)E36@$-\#4<$-%C[&V#UHL.&HT7#
MHW(G Q-^<2]<N5Y$OK,Y:*KT^\(!3NE$L45X';-<W;1::C;7SR !7?D;.Y*^
MNY'&":CU!38&171;/QZA^AIOI626N/WTJBN2D*6T1TBQ.T>&(C&5UH?8[%?]
M4Z<H<0O1L*1/@%G *K@HI@&X[8)*Y_WSLCP<G7?6(R*+SJE\CZJ4PT[5U-[6
M_%I"M98!YM#R4S2PYV' 7PDO#,$5)2(]KBMB#!@L"4:Y*:&$U37!,M/LZ:1-
MTSJU[Q9JT$'\:N&X.A>Y1"MJ7@4"/SC?23V$#JAIU.$KP.%%YY3<#GMY$8$'
M3&<=Q?D0% 5F&3%H@YB>A"C^))A$M4U.T*E_ QWJ&:;P)JQ)1(Z5"Y>$TD&E
M_CXX&4C6EI4M_9::C1^^.@;IH0^,_:N'2?Y!"$?P 96^550G?,D31U<63A)Y
M0@ 9F/2X(=MZ4JK[1E8R?E00Z64V$FP[/7SDBE0=T8O["-L%]MD2^CK',\&S
M[$?,I>A[#U!'9/TZ3IHN%'F,Z@ 'W7/6#.K*::HD8@PU=>A$@N[2TFE)@(^3
M5JX09+J,FI!'?:]7W?!_1F1-*6!!N[)V8GR[),K^CYQ$V7E(HGP[78L![^1#
M2O"Q]Z[I<FA*P+5I..+AZGE%3;#)RXZ4)(9^\6*Y]7MRZ;G63!MG0Q=)Z0_.
M&?A()1NE%( 7#ILYV 9:>L5MW3GQ44P#-D%N.R\8%8EK.P8GP>:U^&PD9F'&
M=\70 F :X?.Q6QJ!3C7^4\>N&B:BM81_(#>A@ '1WB6E37"(<58A SC5^*+-
M=)Z5XY@#M,)#2:$9$_SKF+?R79DIZ*I7=7)VEE*,2<.!!?(Z^BHM78:^=OC0
M-I*M;+>9.[X*%C:9"KL=>(^@;%Q+(VT_U'R"6#M14 /#<7<8U!2O@JKO+#[!
M("AH G1-,4]SLEG;N76^2=&OP#@Y XQA?(S/@)U$5R@(5/W5=T1K!=HHGAGV
M4#*=EG@P&#:;)R6#J"03%'ZEF,1=<,9FAE 7A3>4"D>PU5OEAJ@QMS8;HKQ/
M!Z*VN6V6U_<IBILT (QL T#I'_:*&)?G>HB,;Z;EYBVJ95J?GE(!OF]U<+^=
M#NE;.@)J(+]"5?5(3W7W070AU/^?O7==<N.XLD;_YU,@>L8C,DYU#R^2;%ES
M'$%1E$V/+@R1MN/[=:(:*'27"53U5 %LPD__Y5[[DCNS"DW2Q[8&E"(FQB(:
MJ,K*RMRY+VNO101R7!/M#@ERV34,N#1F8G>5284L1VI6B2,L,8.)C>O6FW8I
M794@OF;;YNC^HG42))H+LH/^4B[$BE'JM*V;IB"TS(S!-PG#G @%* FJO*6+
M='5?9+YL=K>$*DI/7L"W((]S?'*%HR#C'CACW.?I.6WM[YY2=Q5M08#$7+!1
M$@L+S"E^<^1N,SUR1*64V\4X#8,8C98P8^651XI9*?7U;(!!O*$P>-^9[ ?G
M=%!5I_4C1TE&],L9C".U7X]R]"49T%HEZLJ/,8Q\BDHI*!J_;?E9-;4DXK.T
M!P1SV#,3-*< %%X!R)QEW""HES504[=JOQ\!-.; A0SR%6N0^)Y9?Z*M :C'
MBE%0@42FZSTUO$NAV!1$VF&YWPHY:!521FY.\,C@+-.:";YK^-Q57#UD/1D<
M79:( 0\>=]K%H,/K&18X!Y^AOXV%RE<J>&=%R9EYQC&>"?-*8Z0*01&4L3Q!
M:W>E8%?BJE<BLB-,AV_DVG<Q2N ^/B!W-!UX PX[V<%>KQ7WX\$6S<TY+)4<
MKR"3H9::14]&\]2,[5X\65F=&[<Z<Z9K.F*07$)NLH#!7-8;;.7QNFD<]/*3
M3)$)JXT]C"-W+/#L= -N+74RE1F5I5#BH8&:/!DE'T]E<[B'L#S*M/_N891$
M\EI-W@\.VF!$#R=JCRQI6:2Z4[AE[7'U7 [T0-2/\8#?($(&ABM&LKQ4#Q2(
MHM&F2)!ZU;RUU .8 I-26M)J(VBPK#O/8>*\;#,S%+]CH$#@2HJ'NK(Y P]L
MW&Z47\  K9L:5N]>>]%<5 MF&=X8I J-X!K%X1'O4\:5*N;P5H.Y(V#$Q-?.
MW F&8487\<GL*#/8BCR\=6$KUKL>?3"7MXAQWX-AK'.>_OF9N?.>AF^_XZ;2
M;*'C.[FM\(?H!+U!O'9L?L3+*>8FONF-:DOXD+ITUCG%*AVZ<8G+^D6\*%2B
M]4Z^QA>("VJ&GG1V:&=IZ0;\6,(/MZ+MFO%4!E&%\ /D[!7\+>I6LL; V7VT
M-&BBI%57%L2G3&J0C2GLKG.S<V0SZRH2E&<QH3/CL=<!H3&S1,AWBQ$Q2W3T
M(G(X:F]-WHI ]F4_5L=_K:>BZX'F<0N<%@T9XJG+W!\U9<]]QP>L&1]^!C29
M6455+F@_:VF97OFR$:QM$JZ0:[A*% U$15%.;2_C6!N8B3\^"YUE=)3%>=U2
MM$';=>G^KL&F/VJ"<P@]P[N&Y#/(;)?\6V+?R@:+#EVKKH^6RMC+ZQ@JZZ^?
ML_@&V_A7=7)YCQV',I"\LIC0QB?Y%@OO]F4B3W$>BE1W^QO)77#(D@#I,4))
M:'=1P$ZO-SER_D501V<;SS/A,0<4H73V=SGBFOW6^)7;ZWXK*X69TLV:2ML5
MU?8TV>MOR@<!5_Z<R@TS@UG_0!(,@4T1U"M+=?,*LBJ5%K[3X]*RBQ'25=TA
MW%#[C=%<4D"G8?\HA>@838XNKQB'2Q7H;GFH4(,<]C>[Y8&361+N3?"]2C?"
M<9J^P>!^,)V^%)QBLK)*.D,,Z8*R7:X;RB<V=())Q]B;GC;WQDZ=1,9VX1?1
MMJ'';\<M@NI&L2"^$)NB-B U5N3FQ,!L)>WH&V:&\G(+':>\TC<Q&0,7?O?F
MEVE2&>F8D]N=SY6[:(SQ^^70OVZ&\U4,8M5UEZ SVUOM3C1'D*!,.F>K$,]%
M2LZ[[Q,Q#<&&B$G#_&JGA1-GV2\_I3ZQFT2W8T-.?MQ])I_ P'3A1<*^OHW6
M\9H<#:08,T"&W]9WP!]RJ/3DEZX/(,FZ:1' GA&WX(-B<PC90\I./&6ZK0^L
M.G_V<ZXZ/_JEZOQ3<5Z4I]9E0Q"NT<R,Y3$AA+R&=T )6,Y?4XP?9CC+9C.+
MT@0]8^U@"> 5YH<KW6[/+#%VPU%Q] A##6UNYRJ/ !>;&405_XX33;[ OR$X
M8[S/BGK3^!/D8GE&9DYGSP]16\K9MZ!,A;8TQ>FRGM&'6;<[J'XP79S#D\5[
M[CL<__!7HIFDB: S)D[#,D]CLS8@I5OB+>M-X_2C*4TMA39-"I*WI;W@/CJ-
M@<(N93DWM_6!^JW40.,EK-I1)5"HF P$-F64TAQ8L5^331(Y$B!+:;CTNW[=
M&5]5ZM0H6F_RCC+N-60> UU?OD#@IB2'",;#+%XXX"3C&DN.*& 6S$3H%STH
M I[)1+$.W]N6\6WV)-Z;36J55/B.EYUYM*+U!&ISW%=D\Q>GIJ5;-<.RY7X5
MM 35W!?EZTQIF8GRYJF=E-)<MP6N;7]CV4;OY]3%:LFF,SD9P?&B4)\QK6%:
M%D!N<*4&S0<]^H]3563.7 DJ=HSO<"_=:"-=GN6V)._#W*#PYMFWBIY6%5S>
M@E@K 0D_W]_XV*%*!:*ZJS?]%16OHD$@&HKX;61#'(]8D1K)8Y(CS84^FL_(
M(XLG]OUK7+/9'6X(X<XU&^M(8@D!0I+4H'Q+B4%M6C84;G\+Q:R6OQNR)*+*
M\.1-1'>,B5' (\$I6AP 9AA].[2PC^Z00U@Q#D.[>O75D 4:69*R-#WFL8J@
MV4%N-Q?]NNR#)L(*X3Z!"H%YM+86<UUX 4R*]BVTOLB2;"4[DI4:S8 T'8R_
M[RDU4<;,(&7X'KI5*BHEJ@UIN$W%/FI^WD/%.\4R0J=!'Y;ZC)5<53JYL297
M (T=4L8QF^=T*Z09^>W7F^"O?'+FZZG)1OK"0-V9&IQZ&9*-&1JGM$G@?U9.
M#\L-ZU15J14"-+8UW',L8_E&OM71Z#A:/@\@E\O] 89E!7R<_*?G*KO:UW&)
M0$TN[PX-^/VLYY3S14L=**G^IK9K8-4 Z6-&,23#:SFHJLG"$'YZPN[?QM.X
M75,6':F7N,ZE@(VO^)2E1IHJ9MN!M6!OF]U2+[C;G1.HNRLET*+W-**LL&WH
M, ?*I,AI><P)&Z=X:;1.\ %^L7A&'6NVGY4AZZYXNDX#C+X3_8!;U^,PMI?H
MNX&5&N.+&45Z.__!)V-&()QU;_ZITR'ZM!BL71S)* A,R:E]R<M(0X*:TP>N
MD8\>>16W+)+*;BZE@HT%?W([^;_:WYT]%8W2\V^CR3Y;?-M'0^JRKB_1'BRJ
M@OB;;M:0N21<5E1G[TR53\\WN"I^J5[<MJF[T5V0-AS9DW5SRXIVG7B((LN<
M2>%VHIG-/P7-5I$P!=Z#[U13TR+?J>G$4?:\!3-]XMSC+ 9D!9A@XU@N8FQA
MX)AX#,99K2'+>LDM^*OB6'39H.2<\:$&-QKN.D,WM75"T%^H[K@YY+DZQ17V
ME,U36E+4(87J/[MQ3(:8=U*YTN.JO^VND"L/*?N<^U]LE%P!##LVD9:E2U3&
M5V!9:6O5SABJ_<JPH22 6ZA%)?4D7PABX>A%'T<89I0_TCY'EGT&?>5#P>@,
M]>HZ(SA=0$5!8#C:X\.W1PK$U6&7.BI3]6#VF4O1.:?@@&QY?+AN%!\:H6ZP
MY\E(%H_QT3C\PQ78V C_M6)T2/J31)8INYP9.R?& I[/Z)72I7;!'H*[PGWP
M7Y;_7-)!4SU2+S8ZW*7JTN!1XF$%4EP=VLM]RR2V,W<(/I]@#@L \3;[-(%%
M*225,#RD*^NW7+V)T?D@+K8 "G GFXML#F)LB$;VEN(0&6]6:&5P&9?T;:0G
MN:L.Y+&H^4I;ZWG9.)!R?^Y]&PJ<VCJ:X0TA"M!<P7S$0\,I,=Y)PCW)A(W8
MH0EU;2-@^&\J,L"_7-(@X^JMEZ_3<>PS=R$E*U-)HF8(G8:E/G]TL<!SG\LU
M]13.VJ?CJR5U"$H4Q(FF7"!+6%!Q?G^#P<6(H+:L$%GZ3IDN5^T5(?P(TA2M
M"XT+U46>(;TKQ?'-9?1#:6K/*!3LM[=QD&<+P;*S-/UXB+??TB Q@[06.>O$
MOP!5<-VN&$.][^I]W/O<DCXT&R"C&'.QYJ@/Y2Z;>1PM"LHM@:G9VA!?83)W
M?*;XM&@0/^4)[[HJ*7%4'/&NR5&YPN&U:D<FMB;^M7I%^N" !(..C?S5;3R&
MZX'+7%(O+LM?*0I&6]"YQ%L\VR&M1]C $BUIILO$F+0/UL*[\DPAS:O]Z)\X
MYW*"K#GE7 4+@68K@J;!%&7M0045C>0D9=5ODB!R#9 H\5?57=<,IV=I/JS*
M]OG/N<KV^)<JVT]V''[=7.Z.(XW+L#%N3&J2<@ZF[S:(!\5-CR33)1K1T15$
MO @,]O.8D>=YTYP!+XA5(@9LEU1;VHS-+1.A=9RR=:0T]_1@3M</+K 8E#9D
MJC=XORH?H<Q\:>#HZ):%3"<]J@1&=I_H,B>&#*[L/'=?:4=[Q.2U&W"L' \[
M;8Q;7*-[L=M3GH69RFOTN[*AYDP'N+M\&QB/K@HZ28[(PP5,5:XNR%H.%$QO
MI9KGKA7M_57?RSN5@R:^QA_=8Q]Y4@X8@R&62B"<9F8$IKF>!C2,.>V9!QO7
M 4T^LNP"SB(:I UQZ<G"LP)BCAIE<@SD 1K-..!6-II/1BM!&@LX_31&&+D"
M$:)@Z4=@&OECH-HY3A%U&%0C21FF7+/>R1UX9$LX5D\V1#_!<@ *?_3;W;*+
MC'<5L2Q:<&,!_);NS.0V:UDENG]2AUWO-VN(Q.PFR4:FQDM40-XR< 3%37<U
M;A+L)BV_?"GG*/P;*4;W8#-99&<WXZ58.H 357<FER0\E9H3[@#]4VS!TUP1
M*:.;5L7O%<-792E?VI=9&X_TU]U>)]>2"SL427 .>N0K$. ]&H9"B4IU=1P>
MM^)5"/]B$($_Y#Z2D$4RI2YWCW7!@E]8&"DTK@H;4V6A^W L7U*Q05CQ(2HW
M74D>QF/V1+3&CF.D#/8Q&HI>EZBB-ES7.H*1MD.K6L2H SF 1"U=C)Y+095(
M:=$I0"*WKO,^1[#'$^;0Q5'NVF7VC6QZ! >,S&F:4'<1?NB$%R8"*=ASW/<-
MF+SDG_C3S9XCDO'Z7,JM@84WZ _<,"OU FC'Y!7(2I&J=B+6.6N BLUDF141
MPCLZPT(#51R&4A]U%6,R!+!(LTI/D@A25Z2^'+6/6.Z_0W-< 8"OJ,\N\8['
MY1%*Y$7>N<)G[ &2#7S+IH/&*#_RW<]J#>W*V6.+*R=B4]<B<(9MM>=,R&+;
MCO'T%C:Y*@/^\R>IKU 9&TL/KE(X<?J2*ZU5_MVJ?Q8F93U"5#G3PPV:B0I>
MBW1QN'282R8D1M #I21@8FK# .3'F<N5YM;(]Z)JWD^?GVL<[,L)W?2,[<KG
M0DV72S'. Q52(C-+,[9=(-]CMJ+_/NA: 1UU5^1!\M..S4006R3"#"E&>3$N
MX&,!$<:>S_TDJ&RRMB=WY&6((;0$O(YS-*+%E7."S?9FTQ^R<\]UA,<C,,QJ
M@*8+C,S1,2L!#FO 3#!=LS2XFV@KV6TR'^5U,YJ8EK4U"ZZ$,6 %8M]MT2J=
M;MMHJ,7@>U#-Y'CT)UM"70@CJ4]UHG6L)CYI<K]#:O=ZMWV:ZZ@''8_/.,U/
MX Y)1^97X#YE'.)K%GJ(&R1PY$!1&63+D$'+08OZX.""351!IMV0$3/8&&F[
M"0"3E;DRC@7.Y%,6KG&-*SU*:IYA325LMF!T2?C8VYHYCFD:HIDGR9K]IAEY
M*US1(=L5Z;UL'R/NGYMO&#)83XF"5#:!:S80Z.,CB)!$5]SE4LK0.6B4:=LR
M@S2EE'&^Q44_F*P[7\FHFSC [/6>#EQ _B6E7J>H?9%,Q7PR\UW&LB#E73+*
M+46]>2CG?9>=*)E:4K@*/J5.[0Q76-<\+=H(/YF>8AZ<R@/)."NEIK($N)?'
M,>C.Z !2-"H:]!4M8Z[-K?Z3IC5&H/&]<CK!LM%JKO.B08;UXV-!V3!;)Y-6
MNC,P4:.4FP+-\9'=*FG_]_56G*?R1%@?2ID2:8HFCBV54X$4=O#>='0&(4FK
MY!7D0.%J<Z Z>>E'GB!7.[&SU?T6QD-KL)8C4C=SMKHSQ_.RE@7N'9=L)')>
MQ_,&YIGM#P&CB9 +%.U,!&7MXSS;0>,>H>HWLAEJL2)J"L?9S[F2E$$ZN?.9
M0E+U1%V6PIS3."] 6@$'&B]T?LNM;%KGC:$&UE,,BVY'!XLX+V 1!H2N.U=^
M15&.JN*L#5Z(!R+%(+A0=.]G%$S6]>RDHWTK,2U<,A/4F2B/,Z(/6VJVZ('3
MFV="QXM,Z!A[KKPPK)&_LB9-Z'Z^3VM%S"Y#FK7:I!(5((XL62\(=_:-:9)R
M,A:9:QGZ>XXZ2/E3U-ULS.\8TD5Z_>QY^1PCQ_IVJBJU].B.7.XQNTGX%/0N
MELGM=/K3LI)R)AS$U+ .D-_%XL]2FW0"\6)S]U)7YD=# 6T3W>_==9/U&-N3
M!6GU=R%(PNW(S'%?*_A81LG%(K^EUSCE'?Z=QIK8Z@O:Z[1L+18M@C)G38.=
M<E[--'GFU@CNK\6^">=QE+6&V0?IT#F]F?RP"N:O?\X5S$]_J6#^9-N]D S(
MR-N.P:9<&JO9*%9PWXV<1>%X*#%,4+-5OVW1?(C^*6N@6,=AMMV*I*K;W)?C
MT,)*!IT);EWD%$XELLM!]V",I:?PLG'*#9M#?B863D0:;M958G"QL7$3 =@L
MQ6\XE%,'HVM=$I5P812"4[+>R'$>XRO)WOE4]ZJQ!-F8]X0E-(JKFF4,&C/H
M$M21]P/Q%/9^\)^X1^6ZI"NA8BU<^-(VRBBKE*G*5X/Z2$958.+RTG-7>$8A
M72ZQHNL%X8,4M /NM0QI?-]2]Z4%T1(!)'J'C*38*@C"],MY^74[LLPLN_(<
M::0E3-<$7Q:_#$IFT-5C5!"7^E9DJVD5#,T5(Y'P8A,QA**9?&>81[:=)F$"
M&8Y9#1*Q'%KG<:LP1PDH)TRA&%[P4AD07HB'P;S;C*H(/ KA!G:IRO((W- *
M[Y<$O:*%F-7N>6C,@+ULI';"'$\ZAMW0* Q# PM9A,N,@4,>=HJ(X&R,>N*&
MZ5#.ELM=409)I5P2^)94!WUA"?HVVGG*\G@3G=Q!@R##C4@8A:WG*);4L[XX
M!DIQA+,L]L!P7*M(>6R(<":S*KC'='!FS^.."5UPL?AJ]O.,,F_PE'G[#D7C
M<CZ3+@U!XU8 8,.M],(B<PD(6PB.LO&F=A+77/+RQ6U^?R/6A;9()_I/ 3*$
M<K5*'[S8Z+16P/VGBU ,FGL?6=H3>8KYF<R0_Q:9!K07JM6UGN2Q*>>O8'[Q
M5GERIP)1P\S'?%4!T%2E)%?PNG?$'IBV.GV<A+7HW5!,P(;OMR=G^."/_L>_
M??'YK[_X4KQ3RPDIY=Q<EF+",2C%HC[4G.-H>]Y3:>$TW9MVZ'$,_7,>YE\]
M3^K/9<+.LFTF&PR0."Y,0@Y^=_@X)D'M@XG Z(8 WI<W:^%-#HUVM N8Q>%V
M($;M;=E_>E5ML_U?TI\^BODCWHNDB)J.;VMMF[>>;&:#V-^,BS&=E]+B_&X#
M+"[O"J)$4ONG3M>988GH12W<$K7/B@2ND&ABZQ3=P"/*<F57"/P;HLV%?I'2
MXA+:0G$#>V3KI*[-_D#C^I4$V)Y[(OYB5MPQB3_LHNBI=_T>!)J[X^U?0=&2
MV>OQXJPM*C(Z_ORY2.2 _/]>FL%\:O)("Y(-FI0@$+R<!55]F W)SWA5YD\I
M&#GJ1?DX3E+X)K[11S9:*@W5ESU@6,5*ZI6-P@X47&IHK_J!TL&D![-A" 5M
M0JY8,:$\=>H/*[BACA7A!MIA2\X+:(CZU_A&1ZWU?QS'T9;.()M.SQ4X;@D4
M/%29PXAREP_T+\)S!"[JX_ 5DJ+Z#.6/:OM,P<PYEF#'#T.!D90KX9R;S(\O
M*01V3.D6'\=[02NH1!*<ZZ$.JUDT9*I&#);;"/T,O>HT.?1QS-4D;6?K.4]2
M70WQ6"=B:A$)45![EVIF A5Q'>TU&JL98#Y X1@<$A_'S&FL082-I!*PE @8
MK->;+%HMVN$X 1F*DT[MQS&;Z1,&<8Z'/F[EA 14XICV;_B/CV.*4><R_L]%
M1EM%D&A#LH/J:=C%"5M=B:IJF"[DCV-2?%:5"@*Y0N748?P(#U[/DHB6AJPO
MEGHN=KHWR/)+.I GJ"&'=<;*?1PS0UD\A9"EA*D][:Y^F[J\&(N3#K? O4"G
M-Q$?5B[^S<^Y7/S9+^7B_T6[%?@<2:UKU^.+_>6F72Z>2HKK20JW?H"$!Z%K
MH1=:!2YO2N!%?O^>V18MO+_A:SE6"5 %:C#1=ISMQ^\6M_WP.K[*&Z9QM5[4
M28GQ].S#W-3W:\(Q&0VA=,$19C)>50)8*C$V1(K "%Y16',XU0!"Q,PS0YEM
MH>AEU#SC]"[TB]JTX?@*Z9]/C5^-DVMX>U^3A*:@L->+/^['G6;<I*['[!,H
M"5-!8U"C+YR(-@IM[C-/P0)_^TC%;,$EC#GY>+*>Z/QBA5;4^*S60@$)^B!0
MES:A\BQ5&20 ;Z+];I4B!YX[Y9Y)N:U^R_!I;NE*G07QE2#YOFY!2I2-X>2R
ME:\\ AM)#;8M%,VXMIZ4?"IR31+< ">@RX\+:)XOL:Q!XJ=YETG*_GV?7#BE
M$4F%.DK"T)MSM;24N*H"+)YNE]3Y&3W'?LA36Y7+9G&ONF/\=*57)$@)(Y*O
M@'R 7+54;A6=DS6T44<W6^]5?V2-XQ(5('EYUZ=FB$$-,-=YT=@#2_B+?^I@
M%%_N$O+7_]:-SIT3LYH9B@NJATU+-1:2?FZTJ:$=?) L[) [D\_BFR645%P=
M*Q1UN/-^?A3E@LN"YF.8K&HNTU9?COUP605E[>9Y7;4C&(D0C^<);T.WMYV]
MXO@:]ENFI6'U$H;"4J<-H"UQ).U&6)=)/!B*ETZ\PJ*6>*H?>3M/C"N">S#Q
M:-OZM:[N>KAL=TRUL$1=]<BJ0FI_9# JHT)L"AVVC%)DU+31!"<'M_++S1,Z
M6&7HY.S=LQS>Q2D=5L357$_"L3 OP\K85G5=!>Z#(.AN?,7K^DU/.^[@N^OF
MWZF9MI29,]@@7I9>2RGPXK*B!%VTGOQ?5!LFS0)JCV96N%T5[*L.16=948/-
M518O>V:1RKAL*06]/A_W%(&W^"E &J+V"0D?T1$UP=*+Q7=@C[9Y*65?R(ZI
MY% E;=$0>P%)+-8FF=PX=80(K!;3)X&M0#[^0-2LU#^D?\&"C(^T6A2 J9!^
MS1?$L*[K5>K(9S50+HK07ZL%,"-6J^3$PZA<S^\"!2(;4=C+4%HCXJ6EJ6!9
M9;_BP)Y_)+GH&N$L=UUVCY7(1CBB?/AB[P;?.T26*M'0%,FE MMY:KO[*Q@M
MX]77OL-&ZLS:-T,F5-OG:J,D)8]E<2;>HH *S@@ZEPB$T*!949&E'9U:!"A'
M/+5I?H;-,Z E<M$DUI58^DF,.' W4!:GQ:/@0)C>'2%YR5+ME^!#<])>18'6
M8%9JDLC^$'L!;0K_NUQ=#E][SC1)@2F=F?O'IFBA4Z2=#3F\:=+EFUT9W(+J
MVJ3J<X=.T^QZX5W7DXG1YY79K+D3ATK)9PNM(IO]_7T"L_Y@Q"Y<I#\[M47/
M@(-;TKDU/M1G6@M[JIPG#H&@WTY\**H,3?^BD\Y1[7-\S W.\!'CNJL5H$,T
M&GI+T.ZDST55?$6UN'OQA^1N <Z9OH*^)49[W(\_#[5!Q79>UME)>F* !623
MW+OUGON\6*"">5ND:@42P6W?-0<PO*SEV0M*VD/6G$PZ,N_!3ROTTSUUE -^
MZXQ[;W)^X&,8HTF">C5ZSS=SC7HS5<F@G- G9XCCFA1*'M];^J/@ND'C] ZJ
MC/#/H\JP9?-^5!GAGT25L?A JHSPSZ'*6!RERE@<X9X('\ ]L?@7<$]X.OJ[
MN"<6_R+NB?!.[HG%W=P3R27[_\4]$=[-/;'X%W!/A'=R3RS^M=P3X2CWQ,3E
M_N=R3X2CW!.+GX9[(DRY)Q8_ ?=$F..>6/P$W!-ARCVQ^,FX)X+CGEC\9-P3
M88Y[8O$OX)[0T'W*/Q$*_@G[ZL^"?^+#BN1?_)R+Y)__4B3_"<.!_FJH;ZY1
M N]8I:H@32F0\;7K3]8@'YQ,Z4H",!<CGK<SY[UJEFPCNOSHLU(U:PFLV;1]
M45+=LV)P%R*8$BQGH0Z//53#*EGMNY^F<@CYJZ'?WS =\Q7[I3L?Y4YZB7&:
MU $?IAF!C8LOC0 %$H:?)O'O'XB$^_^ Y/M#J,3GN;NS_LP+K\N1_21/VS$!
M9Y8A\SU:1YLXJ5+E^T1+*N[W[.PD:F>P<$L7*B7,QL797_?=:^Z;/;.VS-0&
MNCC:!AK^E6V@DZ;EO TT_/UMH/,ORY$2O6_K)U5;PC^ZX5/][5\:/G]I^/RE
MX?.7AL^?KN'3V4DQHM;D&>YH\IPWK_^@QL[%B3=V.C^$S^PC+;$X(H\0,&@Q
M:UG' -3A!&5%SYV_I=* !/C#"G5Y7!R5$J7!X.RH.[>>B.-#?SS[JGYXQLH9
MW_7]BJCF5)-3<LL8"1&W\3-2&,Z50O=$S28I(Q?GG'>7'(7V!4$@ +SB%_0?
M]?;FR_"B[^%]0&L<]"5NH%_]/V? LK)V@\EL ";Q9K_I&L-G18]+=KAG1_$#
MYHLH6WU'R2LX )DX\5\IL=%=]30":HY%.5]=-I]!5^.EGDN5D&;5L9#",Q9M
MFMH:;R$K0;,0XB56,=! [YJN#AI7TX@2N=,QV&Y;R:1VZ2I2\<Q>]].SQ?N\
M[)!>]B7:=N.+XLP=R;>A+TF!&C<]3"O+YG ;+_']D9*9EYW/H 6,NH/O/;,,
M%ODR"'7Q #.+0%+4@AN)_W-L021@+EU)KEMP'T(0(-0I!YA2@+53L8_F:\=9
MVNMZY-S=NMUPJ6]LMRW%=<+)#\07KS8#S4S>E(C&L,H1HU%6X5[M!]I*;8QG
M1H* DIE&7B*9A?@AR1>#=Y)AJ2./K@-J#%R6.B >GLBCI D-\>_QN_>Y<HZ:
M#V&7%*R<(4<2*)1M/>,D[!S2-4=OX([7SL]Z>B7.)^K"I(KC;"YAZLGH_J_#
M;4,K!3LOG0>U/X;3P0 ?9^K3Y)I4]BFG!V;"&E%^07QE5PNIG#/O O3[G>YA
M+/]H #;MNAE4[Q4^!9WZT6W%&3CRS1$2T(^2W)2BA'&J8 _.!^V,9E4:)[%^
M9$*>N(FV-E2VK"/9HH(*SB'RQ5BHD(1#+/<F+ G\*@?M7O(' H1R%C/$U?\5
MB".E=XU;A\T!U&AD@"-S2O7K5EG[ +=2MS<Q_I6L=N'XHV1+1(H]C#VTB^D!
M,AGR7("-8(2:@"74*$/@H'%V-$"HVF9J-@ZX-G%JYJ$^JWXA1(!ZPRS<%NXR
M.8%2[W=(V?M=\0S31RC<6*X(3-O(,[Q81_@3<*OQ1?4(*>X4VEVAP36M,)6R
M3<Y^$DRR<W4\F1G&EDG*46J]S6M4"9';P%)SJN1=4-^'*=#$/ ">($9!!,93
MB=A@)31>$S7W2(1I]M&/B!+?2P!KI+0K>:0@]2A,&,P5ZC&JV8Q! ,+!)+9&
M^<<#8>SAD5%P86HRB:Q^0_7<=B18*KP&%:FSL5@!R$AT6VT.D3&(WV*YJ'K)
M3WMRI]*'E8,^>_!S+@?]^I=RT$_6=$2&N2>7\*!F]7AZU^.GM$LF"*7E[&7@
M;\EA7Z;7J;N#\3FN5/U>QX)+DK.UP2&0U744N(+3=>!4P+JY!;5EO;%#NGGW
M,^. 7/?#U(&;'.*B(O,_^W[':)0$N=*[TC.^H4G*V<?U8!MC2 $\PNZV$>+W
M2VE$JL?7EM%M?2/6EFPLJNE#&BP?YT$/7U?/)_ [I>]TAF4"YJ/EZOBKG9\M
M]ID4(!H#'>#62$B6U?TT>O&9QGKJOPO*=&5@G.SEB@2JJRF4R*'+!M@=Q2SD
M*HX)I<:CC1[M"MBF?G!D&)X+:"P9097XJ>0,\M\"B[31 ;$SI,@3.A>]BWU+
M:S3KOKI8O. ?"G;+@>G'>M-8?BF1Q2#^G5:QJH1EISG.3W5JO]1V0^MBDQ$C
M(B!WI-YP^B;'<7W_Y,\G=R9_U3 RRSJ^W#9"[A2(4<G)B-7P50*D1J@_A#@N
M1);C#C==W>]=//UFV@]<P;0N>P789^+MATVFXH=X-=/D(AJA-"K0+AR)=^7%
MDIE,IF%BCJ7'H)FX[5=9*#'5,V9&+=F\A.ASI,4NS/Q$LI"W\4&OV;?3\3)N
M&V-=#SC\U2:B7%\RY;%JO$4NSFSD04QXW[&S71 ./WW?;-ILTET#WLDM^^<S
MPLM'Z^V6VN,%<O;T+"CKKX\"(":"(, 7%E@F^IC^=]H\G"TO@!GSXV&V9\D^
MA$U?TVG[-<$+40+Q7W6+1R#_W)EGW--Q P*PT7#[LLNE%*T,AN9=S=TH24T#
MOVJ5PA1J8\E)YI*_EM*7Q:V*B.ZR(52*=K"]C8>!05<M3B66)G+SJ88A<JA2
MH$!H6H!>W/V0PU1U95\K<*\P)=P/8"OO&9LNN_'V&OK;V("B)![PF7*B9V[1
MHD'R<YFPN;/S*0AZ*CCN52=HC%<8"3AS<KOMO]K?I=9(CZG2SU1&G3H"-,N-
M<Y<7'34ZW, &4^,%^F62@4*HG!)ZUMYJJN1S2N[IUL<%ZU.G)L.6X4Z$,_(^
MSC+5Y1QD4:; "RUO<9?X!MB"TGL 0+Q=2)<DS@:EV82;QLU+\-_2"'%>R.&(
M D?6L?,>0U)WVS@C;NJ#^G*"4>8DCEPIV)5\?G?F%^6-!(9S>CEU+&)YU!_)
MD_ +^8AY+[LS2\"59PJ8M?55J<.@=A#7=S__2' ZI01<W+S1RR^$SLLEQ1L^
M3-A)DR>+W20K[^, J:SV0]$UD4 YI4*[RW>3P=(HZ[!@YLSHFU+?"OI3;W0-
MWY2E?:;3$!]S7%Y'4[UI5FA:7/HXB'/P"?7(OC/6-=!ER;L.0&K$_WO=];<=
MG:P$$47G$&YNDM:$P\_?N'-KD![!#]<-:\J)OT9XMB+5'R^K7HP+30\!ZARH
MY9)DX0[N6*J8/+'N:>X<6#4-#AQ7+FVSH@+W%W%5J$EN-II0>3HH-9QP5?+>
M0K'T>VX I\Y";OBR- !C%ZSHE94T/M;E'1?"L;6M&H=4]:.TE]I("C+'HN5=
M_$L4-%; R7#\2]]R"0GCEYT6-05AQ/V[2_;M!6XCN2 =(Y +57),4$D9=^V6
M*188<32CC=A*KPT1H>TW&\=NDMM!_R,9E=]-0J[2=Q"E_SC6Q>PJD*15ZNF9
M\09IQX6\MTQ+K1)/'=7K*FC3U,BA=BDR1[U<*2-J*E'->K\OP\>"]'M3#ZT1
MPOA=EG-BP7N=E34-&1TV@3Z$)E21VKS66Z5N*MZ[A+0#'5]QP5/:MV(%RD5\
M#\O75.2NQ_)7K>FO7BS^(F*BW$Q';NMX]*DJE#;3LBIVNUP=KL;L.A)W7PC@
M5NSWETDK]<._?_+GLA62R[@GMW ^K.CW\.=<]/O-+T6_GRRV^RI.]35MZ13<
MX6#X]OE7/_RX>!I-6"T*P=+A\VW?K:+KAYB04EGA!U2V5OS[>T3K\NC!E_@Y
M_OOAE_<7MU(9[.6K#!\B&%QJ0GZV'WI6<294,]%9C5;]8B H+(YRKR.-IB1_
MA+,-:-2V-&*5X$EC:L[-N!CN.291<9T\:8+_[GW.?DV2]I>-U*/$(8^^R*X?
MN.<K (^X:SF;APEA<$=!G4 7O-KTE\1O2;?D>+J^K86\C-_$AC-GU@*G';6P
MQ5P1B^X:'IQ_0'-.H.\ \LCQFA5-J?1%D/$X10S#O:S'=E1JEX:YJ/ZX[QI>
M=8\>/'H<(X&-3#R45%''7"KABCX:/S\>N8' *M^2S@MR^O$&@W Y^,2+>V1"
MB<:%6]Y!D9B@-C/:?BYBX?O<LY)4.-$B3X<JJ6HKXJ_?>V ]SIMK"I1ZD"4P
MOS\=7-LXEBM:GE28M#JHY#1IK.MF*'4=B^>(CE M*HF40>V,B7+R;@-/G<Z%
M..3Q#46[S:$//]R<I$'!*T*Q'^IT<DD>H9])!XE>.-K#L0H$0O6T&3.KBF_
MU";,&$<'N!]"@O6FVR@5F_E%/!4*%BMG+I2+WK-72/(P?P8G2GF,T:ONR%<B
M@J[+1DB)E'/L!%/*&9AM&CB+E=, ,+5S$2R0ZH68)>:6@D8I .5BLR_U*!C%
M<+L]C9A+TG'QPHK)-VMLB%?[)&O6)5BR3_JA$(VT+IG]FR9Z%'_J>._@5\CM
M=C;JO0PTC1!!XNQ2R%EFC4]K<<\"1+JM/+*=?F/XT>ZLQQ8OUO251?I*PILW
M7;UDP"TQT#*UY'_'1US%1;RI;\EFOVF'78I<BP>^]Y=X!JR&N/(W]Q=/EKOP
MZ,'#WRSNT?[=(E2_7V7$NO2AHAM6C193W"#O/=&O8"I>V>Z*L_%BZ-^T%!K?
M7]Q[]J?%L[?M[KY[JG$1;_[%XM[+YS2*+_[S\\]^?=^9!<H0[?%",Q#)-]9"
MN>.]S9THM>M]0G\FK0')7$C9".!UXOY306(6M;-'B9,<.$A:&7^$X$@D>-(P
MEXL#53I0Q3@+^T<,0:F@Y2Z-TAY33"1LSD8(?!UXV@B!0CXTJ_LQ9U5\Z+9&
M^4+N3P=3DNR*;TD]C'%_0]486M"$?_3)&14;:90[1GZ2#SLP0?96)'OI(@2O
M+LEI&;:0^ QYTN([%N_:VE_8/EXV2M%T@D;QR9W'<7FHX&BT.4V'9%CW9:1=
MI7=@LLBH.S.]BR>%,<C:.GYA-Y.L,5'YES]\$T^VH:+P/M$G4;:S7;%@"I:<
M<9TE&U8IQ8SSQ]R#@,_VU-Y=#$$P(:FJA'^V_$J-CYKV$[C=1$E,D$CD%-.\
M!N"]+99P"6]'FW@9@V'VHL$W^8HR&OMHS9Y[:_87  -XI;0CL\XA3R%A2^7&
MYS^_P.=5V'?45,(7J!25#Y&"O3E$F=]T =D)JNQ?T;[5JX/9Z-K),U.*+;JA
M IN3<.*I;NB=V_-U%PJ:.C97N#3R-&KY5 *R)D1$C2J_! ^P&PS!W,$5IO90
M=X*SJ26N;O"/U>R0Y'YQ<'B<K'V2JWV6E4K@RPI5[AU!'(@<9!F?B<(\W[68
MR-\2#391=7  Q=J( N97S;#@6@$=YTAR4"K2L@*_7O*AN.GYY+:3XMIT&:7@
M3XU5LP(%Y(\-H0*BYT#S&Q<4W>#_D"K)/4H+BGMD'\9?63!OAFQ5[^HBK2>.
M LBKY:Q_LJ+3;N"%AQ75]2K_MS"0BKKDM=)B"](P_B. 4X\$$*2;\M4Q-L9R
MF<O!1IJ:VLT'JKUH6VNX*,C4DC%M%&!F@#*T?%#%8F"2*FUT49H.6<\9<5L,
M[]?>O[&H1-^&,UOT+W9MJH5CR5SD+%VUPX;(C;@MC+,=!0)!#I?S3=N1H;.3
M"":S])'EE&02NAQ,Z-V[4]L N1>TJHGRW]DAO EF%V?X2,U",/#E,S8?%ER<
M7(!7>#IU>PN7!]$(V)!=O+JVBY.M240<?$%GO'10B>:M@W8CJQ507R*MN9QH
M:-);J @8EG]DC);5R]YO3<"YGH&+ZB_"Y!>I_YNOK6*V-DR;D8TN7DK-<N28
MA(%=J<"1OMER3Q(?\,%"\L&.!OW*>$=G"TW(?/ID_G[?G"@YD\_1S>1TV;5Z
M8F5^84T'[S\_>?@'NKAW.*C&6EGSNB>N7L)&IE^$XA<5VG39O;*^DY29$*P\
M4@27UI>0Y:ZXUNR\23JTV&422WBP"ZMKU+RMB7LXF']DOI&6S@T\ZJPZVC,D
MI,6IXF++B\7O-0V6T<S>-5DI11WH^>]CF/?:^T+,:62M66V\($667%WY>IF;
MR3">TDU[J:AO;=G)R<W:76 [E0*7R[B,[K4ZI'1T3=&C'*AW.,W@0CJ>DR$]
MPMQH*R60B7?26PD=6##]K[7/CO>,:_<)AGX0FS5K#W0>-&>I(L5('KEH;&YX
ML'%A8N/N**X?,=7\)UY+QTWU4<-W>H;KPZJDCW[.5=(O?JF2_A2+],L%%D&+
MCK7X6=OAO/U6433I=,W>^;+?],-O%__VZ/'#;QYQ?V4X0O![9S\0 IDK5-[(
MVG*G-[,*I2RW0FP\U>^V)B3_(0&\*6U_"\#=Q,G/J/\3B$7Y_PTQI/D":C[P
M@'&#;QLESU*(IA7L[ZYO],ZN[3%DA,PZ#Y (^?67-$/MKLWI:V0HZ<)%'J5U
MJ"5LW)%3])GH@,O#D(),$"X@ZH]RI$E4%73=4Y[Q0S@Z5.WXPN_$$UKAY6+-
M@RAD=< ML#IO[+#!6U"N.$JZL,<3+ 7^\ME3UR8T0[THF0B'GR*%'5\FHJ\]
M_.+3!U08D1 GT9(CVX6#N9)#=&C[_4CWI7\'^M_X"M<2*-_$(Q?,:$DIZ_DL
M;=?8R#C<O9BQ8/2ML+91)5<"A13B_-3BF35%@_/@'HN@%MRA\EN&TXW-U=!<
M924HYJXR00GVG>G!^H&?[1S5:\J_;)'-1-:EU^L"H"?7"OU-O+\]Q 2FI_Y/
MPI''=1/ORQQ>S?*Z:_\'A%W"Y,##DE:YH>'&W=G$*S&N -<QQ/\9JX#M*.%#
MK[D];9X:;^L;%D38,ZK99[\'UQF3=]C&%4K-2><  [/42W2C#N2!-YL6+!U
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MSSTBZ1<FO//L+=J5GQ):H$BU]4FCA_QTI<[/P.]*HKV*\4EB)TOE$[!94!G
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MEFI']4AHPIM^Q._1>$\-2VMR(Z\L"4-E09H=_;5<L.9_Q-AWZ)I#_$_R3'?
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MSX1< A'5QU'\54<A2$+NS#>!938 ^D=IRD\1,A4(J!V^ BWWL!JSQ9[G^5W
M:G#%D!KO-=XO36]J;GO'G:9WT42!&WZ^4\PF!\O BPUV\QHGZ?7<!FH(*[&)
MY[XA:)+1GW,>XG4VQS8B2<UO]JK.YBZ$:F'BL1?RX#E"ETGB1DCM.JTSFWFU
M@#7UO&;'RZ:YJC>!/HA&MD1X9+-4C^EL*!B-8?WHEO&QM_+8["KJ=*G7$@-4
M6HC=9&YVRAZ#*@/72:=HI51%@2'/"BBIEXO7,4 I7G60NBHF70[FF_ "AF]
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M7<8B=-GLXKQV:7WD!GR.RX)8=MLQVIN1#^>K>C!KA5DU]0"*@][4MO'>D?9
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MS=#XK,LD7Q,OO[MS@W/M86?)N^C/5OG=XX&U8;:R'@FZO>X 7SLX!N69 )
M\V^RBD(<X]X4&6521W8OFH%,E(HGTGQNN+V'+NV6^ZWMFFA).C95DGQ\]2Y<
M5/SYV\GMW11^XG:,GBSQ-X=RHU*]$?C@9L6-MY#+(",+PW_O;VZ#V,'#E_6O
M9E,DGSX9S9!T,< 85_7_:(,[_[A3CXO[?[2%X_3BRLO?O;#-PM'W:2(?XX/<
M 06Y_-T=&)AKH%":+KR(+YQV=+3<LH 9X=*?3^8H+\ZWK(PG5'I2C..J1+)R
MU>+I==U2?1=?^/VFOXSKY^EUVZQ]"D3@IX$ 4#^<W?<8*;[/D_U5'!L/_]&#
MAY]_.7_=YS]PX_:3:%<VL@GZ.WY<R5">O8TFDS)'04:27;4_IPMK=LA=.U[L
M,;<?9I_A!MEE%^]QV7R0C\+TNH\YDWS7M>6BW(TA5N\4]^?734=8JZ=]=*=Y
M*?M/%G_M$=88WJZCIK/EM<[4@\^XTHVE\TUS.23HVZ,'CQ[:XE_4VC<SM]PO
M%M_06LJN'-\W^0B32U:+N"\(V35WH8IQ*Y.+/?B,+E9<WZZ4&A.IIME<49JY
MWAS&W2F^SQ\OH+Q]'7_QS= P>W9\J9./9][L]]2C;,E,VEX!L\-+O5K\ 7'Z
M>O%-^S;^D*6^%R]YSKC;E@3PD!%YU_M^89R-]A9>_OD%7=S9*OM=<(G;M"^G
M5HVBQC^]?/(D@WORVHQ/\^ 47R?.E3\0]+:[C+[^RITV[M.9EQD7/> >@9__
M93P\\I?[&8-GRY?['95BSQD,F]ZMFCS]UE.6V08L_T-60'CGCI\;J.W3^<7T
MU:QAY\>?W(*O%3ZJ/?]]&YW$[]N_M?VF><TK)/OH/:VX,];EJI"3]._9[-7B
MZ H\]NH>/L9X9GY1W;T6*K]&?Q2H9KI+N19P\!=WGK]!F"RV\GPYOM8^IO/E
MP^I$CW_&=:+/'_Q2)_K)#.*S34NM B/;0OW7K!D\%/; PC4U@<ZB/"&>BHZI
M#MS9>(\-W!_WF^2G?OJEYZ4&:R<P)^^X%%S7&;M'^;(_[KLF7?_^/^I(MICS
MW68Z3*?KPVWTK/-7+Z;CB<Y<=/26]16G"FNI723?+E@C"Z:MC!4>?+&@G/]F
MZM<^.CW#2YY@M_ASM'R]NH#RSYE5[5?*@P>ZK,.[ [&[UL#L6YN]""<&RG-U
MWK?[,F01=';E\B#'@WC7'C?RV^[A@\4T"_'X--]VL_C+8>R7KUM]W_;!S!O/
M8"CQI3_^QX3E_IU_-USP%704[UH!N3?$)LSWQM%(OJ04.E5S4 .>^=FGT\#]
MLR\_X+:/I[__E).W1[VR(];DUS,IA%-<64^O]]%]>EH/VWYUX+65>3_+?M,/
MOUW\VZ.'CSY[],67BS/^19!?S(>:GRZ.K[>'GUND.7UE]]XS_?EUL\PLQZ/'
M]ZLP=[1ER8E75'?68+-8?&PKIH-UUDTN*5?Q;ML)O7)]45Q%H\>*;G*]Q1S'
M_QW/&#%'.G)4?[9WD< T5=BD&JU+ */8L1_PW[BD-*])J>PSB2*E:T9+U7]K
MT-E?.PXWY'"H8!+=EU%TPHK[\*4";C/'"X >%!"BYU?%#PBZOA^6S.?D&_"6
M:+>OLMXH5/2)<8CZ><DLE0.%E[6DOIN@#\AS-;FOMIG6Q#A0$Y\]3\7<FH^C
MT/]2GCUFF9MZ1O&K$#Y9U0=2GHS_$])K2Q.AV/K=L%>]8)DSA3P9IY#@]"&?
MFYYA-"_R8O&7ZW:3_5$;(3.8!G>F4>,!+2>>'>KVT;=F='!:+D[&MQP<8%;"
M&BE5?10:XX-"H%CJY/F$NU<#!"KH!9OFADOJ3/94+P>2#JOCJZ *"KKJBC?L
M'_P5U[XOG;"I7\G%"&2M\RWH@T#4XG6,8+6IA%H=8#5O"4QTVS"I)&VC;%?:
MICRY(P92,_//0N? >C](KQP(%Q.9!@$,J.-0:KR&$'-I7C3=[79-0\*K<3WL
M;_2D2-:BDEZK<[5*J3-!OJ1NY2ME;OM!ZL!93WAZL6QT@"8A@HT=*);G1I5
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MW8?5=3_].==U'_Y2U_W?N%.;[IKLCZ#0<SZP:=+OY';H47QQI5C@(P!@RHB
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M<^(,Y8[U*E]K5F98)9.4/O\?3-X5N1[BJK?UAXB4[;P&85VN=PZ<U*^(%_U
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M9L7)ECH&Y<=[.-29J<R*Z9,)5,F!V TE:BA=(J062L21_M*_R,%0\XGCX3M
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M^999:S?@V_4N9.,B\@[.^U)??%7LN%7L:1);"[4SK CC'R91-BNGN,(V+EW
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MI,"SKY 3 /3#33",1 _" 4:N+UJ+:H;]B?A]R ]R/898&Z)>1FIK^:FFX^@
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MF6M*>XW9Z:@ZZ2W\JKY=; 5L3]\Y.(JEI2=;IW4,X"<<[7V4%C?0CV%O_O
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M>3:^'W:L55! 6/O3:8JTIWW3L^HLKU2N=BQJ[3]E4A?3K_7T^>^+S34\P?-
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MU*VVS-Y)+7*JMD%?EWC,5UZUR="15DV3@D5+[CZGUDG$NSP^?.+0+FJQ>&.
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M.Y"+D969KB-]L#BK\-J$::A*A3WWUM@RX\&IA/&?<P?7^4:[0(<-O5;L.\9
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M$]<BRT4-^%@EMSJW6%CX:OP:QM$OOID!1=-56C@^-(0I?/$YY6?.P*W1A05
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ME<BYRSG"')3P%PAE83$6@4YNO3 <R**85UMS#0^24?TA,\\'/8ORB69E7X"
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MG)QLP#5 ^&'TZOZ@U92$M:L[)?)AYTUVQZW?7I/V>N75'ESK!P39% G#E"/
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MN.V=X\2=B-%]\"I'A,^4BU'"\9R7,=GM'J[OI8$6T<1LJ[,Y&\/RE73\]^/
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M2(3=WTU-21?(0/*;LTK?C$EN*T"$(RX+R^]Y'M5D32ZTK7H<]'55GU_ SA;
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M6]M0$JX2M&-[:2A8)45W1;^'^0U (B0W-!F[#3_T\N1')'4&,$';R-6+6#$
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M][87QP)\C41X%<^L8Y"P,5L5W/>!&=XU;AAN4L?E\C/$G"G*+N<W7J+T7,&
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M\O^P'OI8QF=TD6Y?R7V5<4H:D -X#[Y31C;%IGB9/R%VSA Y:;(B5G$KV@?
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MJO2;C"[FV-$8(:,9!5[JX+G@9/ @S/E!/(F_J;"%X/!S5 Q=1&C)F7>IH$@
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M]]B\(@PBC)0HA)N)"M2;#M2%6X)$M-T&-B%-4(&@5][^5NI0H1U]__/M,,L
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M#5')XQ>KZ4<$<#Q.)0F&6ZPK0;S%0&_-X&7CTA-%7;Q'R+ZLF^2807&LO)W
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M2"!2[]D2SN;<&7-KL?:,R]8[C1X29H=Q\?)[YT4VKOJ,O%BDI@/1LG-* M
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M0]:KC.E-16:4L0+((HOI:S*+NAUB2)PJ<^6J''9!]#= >E3AS9F9HP/5,$F
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ME<8J*$<IQJC Y$E:]GU+]\E7Y<U9PZE%&$BVI2M)0.$#81V2@/\P":H:I3K
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MZK<(VF+MF)'&H+!WTJ&ISHV "EG ?,G/,#T:%R R;0QZVDCE< CC1(TPV"3
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MH/00!WW4Z]0M%!PJPS6@ZZ):?LD$B@G*M\/G*R)DF*_&T"Y14[TH P@!Z"Z
MT>CI=;*D$$;1LVK2*MS>W-ZT3=XK&A :>1?/8!J:!D:T=QP PVAAKGZ\^>CQ
MSAVS3FZ<(7E\GR&A#,GC^PS)CS<1_FDVRUVS6:K%?=3=*'_Y_M;#MR_DM2L'
MN0UGE9D]\J^K:GQI'CWH5)BTEN+07XK/0_X4,F:@ P;VO[YIFB63VC;VZ9]Q
MS-[M'N[_.BQ_IK?NOGL5NI_^M;][;"Q7]XN7!\>GO]&H+:Z$:;5C"W_HLY%=
MO_WYP;)*J:_V_:W7;F]2%QR]/SD CI:UDW6_)][NOWMS^IOJ$+#B#P[WU6_^
M>6 N<%;]2O7*\>GK]V\/WI^XKSUXISX=OEK]N/?^\.CM_O_^Y?]\>K3_7'79
M[_O')_O[[U:F?QX^X_XY/GBW=W"T^U;/C[V]#T>[G;GTZH.Y]@TZ@$>[)Z?A
M(W^)G?BS[KVY[EC=?'"\OW?Z_OCDMX.C$]N+-RU?6]K;#U[\K3C/PZ.!3?Y1
MOYZ4@W -C.?UOUY_Z)8.RH([]LZ-JT3[*MNX8 (>B0A4N%:E<(AO;VYNKX>G
MX(OL?YHAA9TQ!1\;$W#CR-:&')+(E-P#_\&0R-+JO2_]A/X0P..GW[;;7A<8
M^(E"Z3_LMC>D$+QW#BDO%_\3GSVREO,NQ!F#0XM+BB!T/+"B)GN[AV+*NWMT
M//'MVSUW\8'YJ7OY+J6L6M>V_J@E0C&F-H, &"1F"TKWR@W_3.+,N)RNQ?YC
M_VG;^_P&G6"&JBX^FIZ<S@KJ$O6"P+P@"L<%1O<:,Z/ E3'>T=Z;W4/WXC>[
MZLVO&,EM7F&N8?ZB"Z 8SN;<'M8%,3YPISE.B^V$);K];WQ](F\*)(:H>JOU
M=O.? _R =H^3(VPZ[-L7?-XF)^G)O9-$3M*3>R?I]CA)[XKZWE'Z<8Z2[Q#-
M^C: S>[2=+X3#PVVY6O^[V9-,8:C,QFO^[^.?W?=_RD_<'8#J_Z[F_/+7[C3
M<?_X_5_JW=VR[]Q>YM#Y_MPW<N=N5X?L;'^Y!]>*DIR$W@*\E@O7_M!OUT7+
M^F*+^F+_?X_VCP_VW^WM1Z[=__BP^_;@]<$>]L>)^L/NZ>GQP<L/I_LG9F?_
MN[$QU91Z_?XX?/E^]UC'!@[W#U_NX^=_+0>6=T..$K0X6'@*R&\A[/6+Y^GN
M#\P196QLX]P^VEQ.Z_*Y[[FY-R>NKW9VGX=ODW@<]N2-Y+*_-=F<WK6]N?6L
MZQT_^4%?]YF/7N!(/[M;7[' P(73^[JV$K0.ME[Z[W%2@X;$\QN=TB+!3:D\
MWSO<)TV68R6SC1,K7)LUPRP=9?.-XA*HAH[W#TY]KY9EQ&_4%!TV6'/M,H-+
M(D*@')&.RH*X_A-!SODOAII":.)+T$]>0Z7A85D4'Z.;-47R@@!_;7+HA:%Y
MX#H,33E-2DAMNI>^2YJRV#AXY5HMN'N" S#/"Z!"9Y8*\[K_B\UWS\V65]G4
M/TDP<G'C>KC6F*')8!EO>>T[BLLZA[#!6\0Q4(C@G*(C(T@_WZ05OE*[>ND6
M,%ZU[+M>6BT(59BI@M@BT9_%[#[EK6N7MQ:/IGJNT*?;C_AJU%]E"20KM.C4
MDBJ)B$@'/5>7,V-@B?+I(*H,^ T%)$8X+I:ON)K$Q5GTYX2*BTM8 G%X&%<U
MYZ%?2A1H=PPR-$BEC_0.":"[?NC1]@VWL_M'7^.4NHM?TOOHK\V=][6:^D]0
MC8VGX?$@/)X/XX]HOUU!A7P+>[S/T.MF->[65WU. N3V?<6#%T<=F\GF5NQP
M;3W&5(6U$K -[J^;D/\X-R>YL:KR\&5)@M@Z"6%#^Y!O>2X6?13^S?AMP%:S
M1^J3[V< U@(3!7!="'Y:.^&W;.^LN^N/S<E/?ADAQ^E2:=#VPW4HQ <10G.(
M8ED9W/ON+1J:4F%'UA]\%OSE@#^_ZKG&3=LG_)S?06P,XH58_@,-08,$KM@
MK)9JJKVTY[E@<=#UMATGK%0SDJH&_#3]=&.DA&N%<8ZP/G+:U WW!7WH7__J
M[";7T6^32V, ?LB)4,%8@/#N[0WL*W6],P-E6AC3<U24,WS[#KS]B;G>I7-^
M!W"D35M: E3*^KC4CLWZ_&XFR-_CJ6F]MI %P ;).!11;H;F@6E<(KQ/F2M4
M,% JDVVSY<W>FVOWYMK]H^_-M1\RP7]/(?*1QN&;@3D&06+3V&N/']Y]>VWK
M4==>>W2WOFIU[35[R']X>1*^^Q=9#'L9_+)TEH(R$92EM&/LA;_JF--1/,^*
M$5@(4#<-A]">.?X+/D3<A'BZKE[\+FF&6#(?ODS0<I1&VJ";!>9#*_" #=<4
M18,?D>DTTTR_O[;:"=^Z^Q=C23S_!W\PE+0FG\(U11[1?L[F4WS.7RFJZ*S0
M(@?426P^]FU\$F=9(L;7D9 PXK7:3%G#,"&:10\WL"-UZTZ3$5%#[>>F7^#V
M.&>: -6=9$8/,XCNC<Z3T4<;!83G;F_A<^^MF\^U;NX^F_MM@A(]O8<2$93H
MZ3V4Z!Y?XZ?B/]LDN0?B?"<@#@S:=\!D?$7;=!EJYRM48]S=[OCQX)X[W'L=
M)- W 0*%-T4"R6?8@^[;=O ]/,CYDV^S8CX.=P?A/Y,\SS".OO7LT9,5B%D\
MO8]9W(JO -50H)8X3*9#R $<8LJ"O'9QF:OP=5$V4_1[=S:8AV7=\],YL<"Y
M*?9F\<E1^"JNS<WO\]XLBPUV;&+J ASZ<'<R2;,4M3A?FO]6X9NR:&81)5JZ
M/B^V TB P+\&T7!P3^E)P$Z53HM\;ESE<KK>"I$LRI1$2!6 B)ZDS!F)M,=
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M\$=1 KMKZ\X B$N-\6SF3AS6E\4&@EFA=J@86RQI=\8ROK3Z2@#38"G -&2
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M"A\X"'<ID:.;"+[&95J=TQG!;T_@M)-VR8OT! VZG3L%T ZU+H2AK,"K]#L
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M2]4XZDMXR:KVX!&*S?V4>)0E=+Q+]*]5^_=[18Y;)*1HWL\ :-/DKB35S"/
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M7:8L E)9LD^>CJUN;[&%80><=B\#R !JIR/E566EBKV7:T(Q9O,B:DFS 92
M[A!B-?.TB1DZPLS)PA+*\L!V9B^;7]^@N/&47)"5.J$WN.<0NF<>CK(4VTS
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M@!35'C2$YU022P*PI[77^*RUW%C=!<A84?9IB)X>,T+0'N%=1MX"'N_H_.S
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MB](NWX4 5O>RVN6_^,E/!",GJ<3HRQ&?1Y1J!&]JSYR*W<&F$/N@H%^68G'
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M,X>4\F%"13CT]13%'K>C+%[,5<)X)I)([2''17P,71Y2_?0]]T+=C5Y+CDP
MI6M3';?7R.<I]\GIFY5/YNS)4G.7(;ADW!>02\A@5\JFG&-K:(+%4O$O4_3L
ML1!)%KMN'\+$@N,/X2J1WUUSK=*X6.!I^83%A@WIO/GS5U@*_?<^SG[I;C6$
MG!F"%C-'-&5Q^=_?[7U'/V/=0?WYUM, ]M5,\-&]'[Y#M_Q?FDH_HFQ08QQ
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M/II)SA?5<$( ])*/W&^Q-HUZ2%?SUGTP#C9],+@/QL&F#\8]DB4HS<V=G67
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M)7ODE=O=&.;/TZO!]@>=E2T):H-(D5-23)L)<)@=;!L:U\-)-EK )FT='/^
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M7U[_^O.SM^\>C:OBHHG_EA8+$'0!QSM.0FM??%IU=(4YJ1\*K"<&DMF7*U/
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M%^B%(4K@)H1<M9"?S$ NYQ)'\R]R^J.4(T<E3]CIJA"FMO.3-BB+ 9#5'/%
M+W7W,;*91'49:Y<;AV?!A@K+& .%N3OA0HV!RH-<Z=)6^44?P-24]N6]"0 P
MT0MCV&A_1E>H?T6PEIBL^W"MX).0/6F_R'./90)5&?_IZECA2ZXMHHX2]2]1
MMS?5-"HL;$PE8\>$O1(&8J/'VJ8WP=+P&-)F\WW"_7U=Z#8Q(['%IVU0M:D$
MSF9E266JXHQ/3&&<\ $NTISTMF%UJ:+F6?BAJJZ!G5V!J2I<79\KF)T'02T?
M\:*I2+$X?4.P:!0M5_0P!7O+!7IR+]$<%N>./"K=-7Q@&U%4- M?04P";;([
M>(J7%4X=]G$G^\1RT6UE3ON7\!ZY>6'^"\)X1WY<6Y%+D1J5=MB <?""1/T7
M! ](?A-40O*"I'LPLEVK+DBGXIA4"\,EH(I\O<;-A+T4$L?3LX,K16_EN]EN
M$H>;VD],EZGD2NMUBN31'LHD8K+4LYS*MA/'C09!UZ%E/(G" )?2S%&0%!$7
M_I;XHC1CT+;7IB:<L&-N]*1[;]K+2KG\A"VWRK9:1"N4S;D6UJVU]Q%/-:&M
M64F4Z@ZW&_S O)>WCG/N;^*<'.?<W\0Y[Y$Z]\)7GR-!*37&[,U,Z+?M2Z[6
M$6AK!:%/":%4E>.<RA"L5F5\<B>UEY@*XR,]D'P^Y'9CIH//@]'0[ 2--V2"
M$;'5+55'TMII#2%#;ICCV>[9TLG/B$IG#]-CU+N$L>6MEA\P.95-A*W"D"L!
MG7"LQ,5T^[427-E*V=&:*@.*AI-6Y\%@F@A\BW"S=VC2KC\$;X[;[*17'2RR
M)GS#[XA#UV')B"3N5E302;"/,U?P%!9A /&'G/Z+;KRG.J\5\42ZBXB<L%D^
MA;Z1C92B*?R<#;.9F<,V$ED^#A#WO*U#1<;9SSTPL;:TX:I5J\/>;Z%.ON75
MKBA4QIU'3&N"^#YY; 6R2HJWF#[5 P%@"+GC)HHF=]F$\Q(C<*RRB#Y%)65%
M%?-8NKJ54T-Z68=M*/36ZI=$G*+!<7FQ 7L]FN"1VJG[8 #D BN$Q\OQN&ZQ
M5W/?M#^,%.45P/&2$; WZC+54KK-(#;!61H<GD0OT;6;!H.HF6O@ZMT$6A-T
M0=B6-AYS?,.9I+YKC5$]9UCI.:5<1_I[,--HG%?X9SER,>S$< 75P5>U>APW
MZ<58\C];).5V=I2S$U><)M'-?H%UFOXDOCRS\;<HZ\)]5H2R'\Y;&4B\Z]@G
MUD&A#7&[V<,63&TLY5;B"9=S4)TDU#XH:9%HB8";/7']8!KM/DU!_8?.JUIS
ME.H.F:0XJ^A$3M'AU7A]QGAXG3PR/@^+4PG*I#N/F%9\]*X K3)A? 6NC!*Q
M-X>J#_:YKS'PT6'@%=-B=DN^8"/P/5-V M4TA E./W5^)G5S^6RVEG\I6+XR
M+C%MQSVTEIIZCL$2][<FVUO[^]M1N$Y;Q8="&XFO5(;+I70^:D=L4JDQ%3JO
M,M^O998UAJ\-]3K)<Y+N+D5 8'+*32/AHNAO-'8UY4;4SEE*H <&:7S(@N?"
M796",U6V(RR"BW[?Q"70?8<59+C2$89N3*"0CA ?=WV':(5CCJ<8%R[Q+MTI
M[=G&49NK,I1/AN50,-5L%%*M4_K]CI$%006SG'L)A=)@D4^1D;(?9BOTV/C.
M"F*J.-]3WF2S6E!?9+%PTS??B0&D)B<,&9 W9;8Z*6C]3Q/"]F6%S_N@?!-T
MF A('>-Y2<N5X]-9A&&%B_$E8Z)@9Y'F,>N#!?VC$'Q_#U*->IR.MNTV6%2%
M$0U'/S@6 ">?U]Y%S]70C3.QW1N/MW6(%3='(-'8MA C(GPSU&/A/:Y87(A1
MI33O.*!D1, L.N;A6!4=.RK:# U=*9*+5/3/.&;=#0_9CC:$GRM!(<%RD\6_
MAG:=V1F*W;F8GXJ]X%JW/8$B?3-&..+5:^U9$[&GL,^$/#_[0=V#[?W?D@IZ
M'2\\#V$=K-Q:<=M)P.ZA>:OO_&SWX(=(L9C!R07&B?VSJ/1;KL@CE:R2$PB,
MQZS>[M9%B-%%,H.5LY-5,2OPJ6B0!0YM:8BIS4_3CV4^:A^14KV"0 F,H*#7
M3OU)QKSZ5KLN=6W'4DZD%5OM+Y.X"XU);#?J["-5YF*:PHZHJC.J_'?BS4R_
M-4*OZ(E,B(XT*[?'TA$32[ 8,ZOK:$A6>AIBXVF(#2/W:&K% T8AY?7Z=/S%
MYKKGK"&C7*WR6BYZT!%P7_?'(],"BL5^MW69$)7IEJI6XG>RAQ&:L4$F<<4:
M3UP4"11"T"PE3HLU#-0K=$8]UWNENC319Z: 9 S0=:]=?P3!NN\^9"W]!*E?
MXZ ^[5%R'V3F]8(J_V=<X8\O"*<*BAG!6@JWAG7H":ZN(-X"*V01#N2W](')
MRUM'$@XVD02.)!QL(@GW2,%[89*2'>)CF5GBX 8WX#:,FVZ!$<1>2 &9\QWH
M@P^0&U60$";63.$*4DZ3,::Z#UM*!B\K8[%1Q@S:3>K(B_)HQ9FI/QS*KAJK
M>2?F(RB_6T"#7/)5-1^6=2IOY)CQN,<!/#Y>- L%Y:FG<@A'C6XT4*_4^]%>
M#.Z75C2.VB@Q]D2V)TP9LVZB+17-U_MH%]SD?25)H>K7?#&8YD-?X!IC0" Y
MJ$PH&VERRH2S((/3(USRJG70NOUL GK+'\U'G1[7\MU"@D@\U.A_.T?%&YW1
M>YI1],;/R'FRR1:5-W$Z*FQA=?I,OTK5>IC)W'DZO=%*3B<N=*+0=BJ_($4
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MVOVYI<KY(%'?Y2/[RD5_I&U@1>[\EBM*:P!+28:5]1+9,8T94R,L1@"\HUR
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M7C@3K'DG,A#F1_>1%&4I+J90<]P1>J4,?'&E2 25E:Q%KA:2Y7"@+7.I;'M
MCS7UTND+"0T7EN,PWI J0$2*M'.P*S2A23(T%V'RV4_L$20BXM]S7F,$(LZ7
M&PA38(S"$MX=Q'3 1048/,JQ#D.;LM@YY.>*?77T//QFGO_$9/6F;IO,T;#(
M8>,8?]=(S^#%BX.=R>[.T>[.\5"WQ#_.T?!Q @?,:,\.]'FZ@WVAE"L$<\S7
M)H(A_S0W+8;)UXC+98\95; IP(;J,K&M@@N[F)$1\C^")WNZ9J"0KJ0%27F7
MVP>"$^ HL2RL(@AL)/I7"7=;*AF*$+^*K KE;':>#9^#C%939^)+MRZ^W Z3
M]KDMC-5>$UZ7G-]VNAEMW)G'U%LBOI+3&=>U=\47G)3Q2^['92?-0+TI-L=G
M,'>X5T(F(-$4_@+G6#?RW#M:)7C]'76"3.\,KE2Q:#X@_WOQW<D[6&;TOYZ<
M8%U0=WUEC>MD5E=88VN[BVK.C9\E60'M1] ,!V:0F\4RK' ",D[\V_GSM\O4
M/36Y/_$[C2I="!Q-;96+8)$YP,E9?5G-SF5_\X!CS 6)]?O-&6L4&XF;&W_$
M31W+E5 /NC?X$Q2YO6M\ UO"F3]D_$S!4 D/-&I#Q8X78O]Q9&,?B=F37+*<
M4QXE%+=.QB?H38DQ,J0>)K2-4U3;80Q.U_266A;<L#/=/V7UD)%F+C4JQ=SI
M#]@,Y\#O,%YK98TOU99B)\3%+27V-EC+!/:0#LD'B+<-(+S^A(M,F6UU7>\[
MQ,X"OB#N0F=V8:DI7JI+1W?(=,'@57+T+U04JP!,5'F'$0OBF &L^H@P(2X6
M&%]OAP3CXAIY2-8,4\,Q*0Q&)U$:!0;S#&0C+U5?V#_Q;F(:TQ4"JI,A(J'M
MO=@DG6VP19$&+-K^H8/9#N\":/EJGKDR2532]VV2=!@FG=63:IE.X_J%8E>&
MM<^ERP278'0!F#$+!+%)\J@<,:>04>I%CQ;_D4N-$E@K"/PLKZ&E?KKGCF=]
M6V;"78Z#<6P$.9),VG \,S=NS]!(RV#DCV+'G+!<*9,1$ L_;2=8:X7#KT9B
MEHFB[LY6:J>I,1B_.(MJ+WS)6DB<D+*%*K+J;V)99CNL^#%2:@Y8?#)E)H06
M] %:$-HI1T4([L8UC0:#8;U8BJJ$]TEJWG&(&$ $"!X*N9J^UD:^^]CL\0 /
M+%8;TD!1J&X<$>KCZ@T+#;TJ(7A8[4-$M?QU+BX BXOQT\&+(Q)]D#B++Q!S
MO5)_CQU\,>-UQ6=*F;A "J,FK//5MFB??ZI5.O ^.  !JY&_0#/#J]42L&!,
MGBMVPU4S";DH)(P/X/0H?6##CX1$1,,,-/9*Q;PEE$0 /ZWA_.N(IM]/MI2N
M3@.G%/'X$[N&?!SU-<L1UJ?%LT&M"6GK]E[\+<LC! 5M"IRM$]JH6 XQ_\EC
M<?U2&='\8O:NLZIF3_._*N)?#6&21$N(;A!I55@7;@!H;CHG>%KO1V A3_4K
M+.1*[H<(R@H2,G6/;':,Y=CYZ^&S_7)_?Y_:VZNN0R9:)F \)T7S']N&8'9^
M%_[U<#]\GYBQG4[#+G5Z4VLME7;+#8=#^48$UF-(\C+B"91TM).IW,X]\A_-
METRBT;4KBI>!E0"Z?.!!\)P:=FP,R E4?D0%GHEF8W!D&:U;O;[&SW2<A^)U
M[F@?84?@-Z* .SIAN#,9";A#UPRXYN"(.4H!,4#0*.Z ,I$:24;9$%%>IR/S
M\&SE_>J>1X]U3ZI['CW6/?]8AR*=^+$W9=PH_XG)K.&YR#6)OCAX^O7!$_\?
M3R/-:D%TH"ND&@[P5XA7E5B? SB#]=B90!6 ?7@UXF^./[\Z5EA^Z#]B1PQO
MA;R"(=JT#EV_/(<\(JM+<]RY4@#8$D\W]*DYH1IA5B27R@B?# F2HV?'IRSH
M7,88(<YI^$T7AZ<^'B#LV4ZE8+/3?X3WM+Q',: .\8B9H'?/G:9J&/YQ0H(^
MC=P 3]3;<)M0.!GID8@32G]F<['Z]M7<^;>PW+_C,*W"CAQ&J);L=^@T<9(<
MWF:>8]JMYH;B*4! /S/J29;E:U#Z43D#79]8V^<UB:KG/;:>I,(CE LA>%Y?
MQY%!2"]+T IYR3A&@"<@9RF268)),Z<UP29-#-^;]XR5H_R+]EQTEE*P9;-M
M>LON3&,="0;9;V9G"309H49BD;4L(QA611+WVV')DKB%07$V<&(G<*\XJ2B[
MB-/?P,PP[35V#'<7C'!@NEHAT&"BVEAB<*@NP2N.<;WX$FX4%SYTW7./I>4G
MX,Q5'0*;Y\@(-E!Z0<L(6Y)^BGB%A4 Z)EG'*LKM/)1R75+*#9Q7S[PIL#H2
M$]&OC'E48/)"HW@42=F:6XQHR A&2H0CYC7\F-ND>VT>-&7#-\W\U<D[4]DZ
M.'A:\I&*"XZO]AT4 ^'EW^AEC_FRQ<Z;[XX_[L9D^2ZA9:XV7N6T5+GK?$R:
MYH&M-\Q/',_\'()NC=]\;Z%M<'D%T?S69"D"O?^P#(,9:TZF5F$<W!6/ ]>-
M%BR/0SP%P0))N,>?1,3T0-1>7[,JK;G&](\@L8/_47G?[3__4OV?_0,,OJJ_
M_[KS$,5'N-)>_?#I\_O7I\?O_,\_'K_[].;D8W'\CY-WGTOW^O2_3E^?O'M=
MO#[]]-T/'S^=OOL'?50<^S]^//G'Z2?_DX];LR@_7Z8RCZ;M$(PRDE%P\S [
MQ!5A&?S!-C?>+IZGZ,CZ__1_7 2;^!E24#Z"0&&NTC_[?O$]+-79G+]:%M^U
M_HK^#=Y6?>\=A&5?+[SEW#\\.#@@/P^I0*&]UL=G\T7IQ&F"%,?9LB-"M0O$
MX1$]!J30@&B:VRAR6I;>>L)#+2$9BFZ:;%$8P9MF F/Y8>_]'DW*=^T7?V8]
MV]_?+XOOVV73WWA7L"[=__[OXNG^X='1DP(^^WTWT,%OLX%.W[T^^>!W">P+
MVA,G'T]>NP\_?/?]Z:OB^-6K]S^\^PQ;Y\WIQ[=;LU=>U[,6.#'HOO]/=77]
M;?&Y];YS77S__0>_K@\."N\*_:N:_.3=SM>=-^!E\>K2']T7;4D_.OV^>+[O
M_Z_T^ZR[X=;>)9ICM-$UDN#"VJU)KOS,G_P1CTO37>T5ZY]$PCY_=7\\+!"P
M@_]+V[%Z7MZ,O$$7I!*E;:ZP"54>!X\WC1\ZQ@)R(E<__73RZO==]H>_S;(_
M?OWZ]//I^W?'WQ>G[]Z\__CV&/ZU->O[V/NU9#9Q\C_E!2'?/3DTP8^K_#>F
M$OOX1;MH2\)SHE]"GHW%J"']\[2 KY[YLT [[$"=,I:>L<NK]+NJO_27Q$/B
M]=XK.A0D7EL"](+TO?G?WKGR7C,]/J4'O+$W;W1>'(>*CJT]3EL6,9X3N@&X
M&P8MI@40>_I_+2XETK CY_0^-DJ$YZN_7#9G#7>>]GZ[3B%NEH&C<L?YLN.,
M?+A=+E9519O\"#L9X:X6PNTFZ.&FCQR&9B_\SUY&(?1UF0'?>+#=^&!7?6"C
M!\T. :"L"#E<D6PPHQ48*D(OQ.&AB'QZ@U5[QZ%K$"%PY1^&F]6DJM[,R<%U
MH\,Q::\QA8#)D#6WIX5:<>\ESN?Z$2WI"4A06 >%:-\"TQFO-9YD) 7%7^CS
M O6P/./XS4)6#@QV8(WQ>TB]G]OZK&]@?!;N<K&X_N:KKVYO;_?\$MJ[:&]^
M7T-^]'L:<O?J_;M7)Q_?@>/R^9\GWN__>'+R5GS_UR>OOC_^B%\LWK_Q@8,/
M(K;&] _"@&/UZV$7O:XGLZJ3[AA'_KQZ&5'64J^ 7ZIK=+9%(8;@H+?4&$6P
M.]H;)K--I -%R!C!SA"R/.@:[4#_N(2& E3CN0@D -']0XR"17"*'B(587:#
M"-FMBEX47V":GXK:1$M(,77#S$T-49I!FX>\9XE;UH<MQ(@LAH2?<+JLC6:=
M?0C\ZQ0'& Y %$#&<G1("[>WH@-F?^@GYBLH&J^H4(LHJTL580]:K6RZ14%#
M3)R]%+Y*M3"_/5]"^P[=06C;O/'F2Q+ZM:L9*$5P]':Y !O+7D%TKSM'P8C5
M@T<P;PT&"\X%KE][QV*E:8RF#^0)L@*B9>OB9<MA*#+L4XX;-";]>=^WD/$;
MRCW5Q<'+I_O%,1T#:9I['M<06L:-^^=>R)^(5-J;7E,*>WB9N?M5PY\^5L.I
M&O[TL1K^*S@$3W\+A\!./WZ!C@OOIGY3>,^V[@!8A8Z#9O>#C\\PNC"E#V9O
M9WV!;XN,-Q#H6_H0'%1^9*@OBD\8/VV7WEW]S[^ 5]G';N57S9?_U[O0__G5
M<3>Y!&'7K^KI1=5]-:T6U5<'!U\#WN"K_?W]@X/]I\^?O3Q\>G!T>+"__]7B
MZO#IX=-GS_:GA_]G/NF[O<O%U5_DO9_XBS_QKP#GTS?BC/_E[U'5ARI'T6G'
M-27)#"(J%W(OT^+]9-&>0<<9C/C105D<[A\^A?5'%,,!*SBE8U=#B?G: --%
M,0^><89P([HL\L+-&O1VEM?LO-,#]Z05MCX'M3:1Y))$4I0<+<.I#J.#=&V!
M>(TIU4;&LA?D]/@0P0'XX+!@:W?(<#1<&+O &B5R$^0#84?^PL9@Q=#\>&^0
M6V2_09]AYD/PO_P==M.DFGG7JM_S,2Z;G$)<0!1GQ=8D2 2$Y OE"1:PE/>+
M5_3[XE6[[!:E>U==@PL,:6R3GWSV_.GO&P4^^ZVRV*_>?_SPGF.Z[_Z[^'CR
MYN3CB8\!MR"NX[!NPZP7^-)5AZF:2HLGE.G27U/B0WWC5^W558- >^.\-WW,
M',TU=V,6(JL@!?<DO>9&;R5&ZJJNYBE<!MK0 /T_@]:1Y@IV8H4!1'A-_T1
M"R^/@(<7_$%5G"7+0^ B%['ZC%O_/N'EAI:LJEMHB7Z#&: F]AERBD=/S(1.
M](HP+GV4&&6>A:7W^_P/; <8Y1B7 ,RHIRQ09*Y,DZ;O6\P:1'LGPH7&O+LX
M#];'DCS)C,&372\[D'3%[-A'91(]VM\YVU4D>D 0::@%MPXPQ*.=:K>$_YK
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M'.W?ZY)D>SX!ZJ?JIM'GD4 FW_9LN7#G]:W\U<IB'AW@5XB%TY+='KQ8]TB
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MA 1PJ+D[0;5T\D3%E'(K8D/0=+K6-5#)MLL>@*ETR0 IB9[FVUPPR<B:Q65
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M=7)N/X\H[SOIY9Y2E14M]0][G_:*J1]7.%.%86-:]\T%@;H,/XJ(PYH3V,>
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M-7_/IPC" 1^ 56E[X)?;+==4&!TG'VRS,S\.;CTF+GKZ IM'^YR"DK1U$J3
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MHA'7UG6EVN\1%Q.ZD&9[ PCF>N]J'->5[K@TB,,]GI]^*=VZ7.FVNK@ GC$
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M-OY TZ.,&!/+J!RD^#'S),C+,D4= 'P43B/ATYCN!^GIMW6DRI2QC)AX.&1
ME]M[3J)R8/DG<=B5IP&V,8A#=&ZJ_%4&+DX/L$KP/F;#6*>X8M41M6\WU6R9
M:V)DV[P38"3Q-G1L!W8E+6G[Q8:(A0"5H-5BGBD/\DX,>?(;U-\^,R4O'F%J
M#\62R,FLN6A0*Z7O@4U3<XB*<7_=]!-X27^+_\)1J& 0X.3E$^GR+NWNHKFZ
M\D/N+S:S6!(G#JTUL9+;-6\AX$1MF#:8KF;!, ]T@_I%*S3V0]_*0$>G=W3&
M'9FR1U@@$AE/FFZRO((-.JE["82("C1RM7ZJ65R,5RYZ<?I7BM$H3E?P/8&+
MSK9$/B_J\LE5RZ]@J?C_!^B*R[(WE;_& FTW6:-M)T^AGF7:$U81EGAQ26;X
MX*5W(D"@AJZ,S^<];R(<H00#]>-S]8'+%%"1G6HYH)XGQ0#%V)#[D;3Q#WJ)
MY.)F-#=[6S'*V3>E0T<>A-K@-K[UVG$IJM"O,KSU#F;R0OT\_JU[!;>S&(/2
MO*LD@XQ[D*73WS"HH0I%6&7JG[N0QZ$;)_IU>3.1K=["6<(*5A;.(00>.8(/
MON4E*0Z$LX%KZ-Y\AEH;&GBTFK#BK!&.O-[VNI;R[YE,AO8 LQ^>3*).1.GH
M+"&DDJP1/<CQ]/R-=G")V*H +H33!6B)SE=W[M0^K&R"VV+AC\0ZZ,]5'X[D
M.X;$[8C[BR>1M*J* 6#<_2937&2FV)[=?%#V"#6 \TI_.7<632IK3Y;H+ADG
M"X;Q[_WES@?RLS*IYM%BCS93_>6:J"IH1^B>"I#95C@X95\FV"'QF+-?8#B'
M#4'BCI#*(EE&LRD/[&R]=ZWPV6.M<,-:X<'^8['PC^4N!BH#S9=(I$9&*#C*
M@T-W;0O72)S;[ XC:K"D[40 GAD'(%A&%S]4Z@F8$V@SEVP3KW)X5OD8LP5<
M= 4/QJ-EPDR&Y4-*JM4B7GOWRX739%5<^LL1PV.+#RKZ?13$7-6+2\H/#<82
M4\LP/,AK619)]IMIK')9\-BTP]+(]"Y'20Y>&5FGS^8],H?&76<&G-LFER#)
MPY")SC@#CDIUBP"4'3WV@CO+R2OIQ3#C.6TYIX%'_YCW.DP".&A@@IP^_3JH
M6\B/0RF!A;OJJW+CU6%]DJ2)W.Z$LY4SKT(EB\D,D7[J^0Z8'#:;&4P8J-/'
M&"WPMG102ME:='MG!#YZ_RP"]..UE&8?J&]%'6;\>'0B,]:$RRM^A_1UX!"8
M.D.IJPDVK0M>8P%_(ER5^:P;NG7!$4P8"$KBP.0LW"AV&DVAIHA:1XUT14L$
M\:VA"DSG5"KS,2KV<_)\DOS( ]WIF6.GG6Z ZR5T_VZT%@=H?C.-NC)I\?V,
ME59"V]_!':03Y\-R51QWV>3CZ#+:*TXC#>*1SIK03[-60GTTRZO'WT;G0'R+
M1/@.;BJGD/8;Y_DI?L9)9'Z-Z%XY?O@&.#-K3J9B]&0ZKQKB%QX>4;9VD="2
MCE1:7+:DL+?6^MO:FB'B'D0]6&#:&:1@AO539W$GV%JT^^\I3(T7/;QQ^_F%
MJ0<6G=U%SC44BLHX)2YKE*O8-R4=KF86%WJ@D(^>I&PF/FYT<D#UG"72>NP;
M\=_A_$3(LIBDD^-K)_;RXW)6\[,=39X<WHDZ&(I+JXN'G1/5=-H$A%JR,;'&
MZT8*O#E9,SV+F)$X\KK>Z57"@M,>);^B(6\9^+M S9+6MZYA:B8+(O/I+IQG
MRY#K/4[+4%7:B1BBP\7UP!/QHKGA5!T/3MHM#WF=9NQ)\PG1S7QC>E27N$-P
M^:/]Q66FM+;F=/MLI@K7-3B"L)2I^H5FPKMC?O"C]:JO3-2K],[AA((>U6&G
MFK=IR*#:M7-O<R 'A2>#N1.9W4RY<(+Z=)FTJ$R02\_WF-)M:MJ;HN6I)K<?
M=Z]VH""Q21N+EM'8E_PY+S)P5#9\$6:R[ O:9"[:9,$1X(:+>.*UY^^\Z:ZB
MDK'1W;O/RWA/QQ];T=S$*W*\G?%LQ8O,9!L&1J,0-NZ-%AY:-A=YN]"X,FW.
ML:%A$4:'!V17K9@I<7/5V^^BO?PS26[7&U06Y14Z@/JBZ0$5Y$,-=>9S)(Z<
M<P5'B*\A;"2D"X576T^T 5V'M !''C"TI:OI6SLAI3%B5,E-G$*D;I@BJ>IJ
MS$<M"Y-12H)B@F+M&"+CQ:5%Z X:0>G25.;'S#X!W*3Y<-S!VH7'N-&G@+A>
M&-W:^?CVI[9C5%)0R-=8U3\:-[F5\;@F?DM<,\Y[IY?/X:2X,</C](3FTYVV
MNWDS+8H#_A6I3J8UQLRAYCB<?X(3XO[LO)V%5(.?1G!0?:"J7!=0WD#6 0S"
M\:B[J69^/RZT'AD-<<LT+KVF3"J3ASN+',Y9=9L+J.)X B:1][4&5"ZLI-'7
M@[<0]=5@&B21Z%TN7F)%=AF/15=H&\P%M\0K%LZ7',9I!*SA%"$T'IA#=HZ&
MD<ER=!Q9\A4F(V[ISI$.XU[6A1$9..>7[D]L#I$D -:E^MA\\(868V:U(&0*
MN)A^M;3^$G6[["$+@!Q2'7J850^>C:$.7=M1ZT)".Y W>H.CX!/ORTTNT=T#
M;(G?#GTCY4/X^O"E4^T-=MBA:Q* _[-:?SX/N4/GMQ1\P][-;T._LU!IY1SA
M+U-MDT=5(HJ>%RW5'KU!\YL6MVH98:)R#_G 5O^]*W;/'RMVFU;L#AXK=G\D
M@RY NA]$;DG2O8H)"+E=%[(3<-B:G.T@+2R.<(AVU_GD-B ASV6<CGX(]2NC
MD\%D&CD^25PP1779+T%UB+3)SA(N(VO+E$]OV?E!JET C0:RO%GC':2*7#D\
M%.B[:!M]F ',-!@7";P_0MOTBL,B#Y4<(FAOOZ/VZ#:I/3)J!&L:S<7E0H_(
M$ X%;]8[/OEPW(XJ3C,&PH@DTMI733?0S"_?P"@G#/Q!1(9HM8"<\Q([)&1D
M4WH!QE]R'DI=LCWW*2D 71L6$2& 7$, BFV*M>*]1V*Y024SEHAP\J(:)-I;
ME> B^*>;V5Z8-3$!O/JDZB\-VT%^WS6$GN]Q:FVDYD)^?C RT;SG)SV*6^(4
ME4G6TP3T(3/M1Y1B$'80W :W8@]0QI((8-D4M68 5.EFZ3=AU6!!*V)/7=RV
MV(G0&V?<!)!3I2P8I6LM#%WKD*RUY+GCI JT""0UDSMV$FA(S7Q8CDG^A @V
MH:+/;A?9S'<-_@(  (-A#0O8Y1:P[-225S"^7DO_O?&:S9#E+B[KS&P^, =Q
M[#2MI4$^6D^T4N,< W0GJ4#7\%"$HP #$>C&F$OI'UWR08M!==83L]EY#DZ
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M'-I0_P/Z@W/O)[2EN.JFG3_+>A,H\$4'R$7JV:SJ$YO"5Z'H5NP@E.N<-)I
MC&:7^"*X1^?,/T*/^%I@AI!'#^2OHQ?>)7Z")]4"IPOP\E3K6PVKC^GS9AY@
MJ$VY&RV!,<_;W6,)I.(S8RK,6[+-I S_*L/?<\=H@M5:/YP+<#TL&DO!@EP
MP_JQH+!"39S+:=T:KF,X?C!HW))Y$*+K0472X(OQV*.]YGBO:;G0>C69' UV
M;J_,\9U+--N<+I$HF[*\\MG:9+7C>OHU0RE&+P<!=(<3=P?5R!U&G$OK74VT
M*\I8#9WF%?-[+G ZN)-$Q+?P$ZN^5672[IN\R0[, N!.N.%TU/9)A_F6+%#A
MCCV-ZU^<W8D+%O9H86[8 +V$K2^"+9 3NN8&VO5%D,(603: >A+/J4N=A?NE
M9C:72%8^AMA[B"C6788.YZ7W<U"O[JXQC8[K(6K8EF[&3BR>"O?[3(7^4UQV
M]QNDV=J$XB@[GRXWGP'^(;8F]0N5E$D<E_3]&1"?:3^6?'3\("[,5,K,#\^1
ME]9[J+J6S&Z *S$(;&U-FD+U*NHO]62IC;=3\\($HU_Z?8NL&M7,:>H[LZWH
M.K6]2JYWTOZ;-:*6X!HL&A6<#]Z!7N<2]*-;A.(9-!U>1S4WT9WH.>RG;#L:
MA[070$I2#VP]CLSC!QL*Z.QQ]D(&FBLG/NJ*$0%J$X().$=3B"8/"JTIKU%$
M?R \+-N6FH*3JYW1II@NH>8Z;:\';<.E8_>SMI127;VHF/(4W=ICX5"<%N^!
MMZ'NM""H_(H2K]YC*X8JE!+;"<EA1/ZX'8M<<RVO83;8TH#W?-W(\3-JJL@N
MP'=51T\_VY+1D1"9G:!9#4V]O4'7Q,YO"@[:DE&0 /5X7KR_]C$5Y:M>>5>K
MKV<<;,H>1+JT@Z^_C0(!B\GG$Z,OCO:.\+<O_7_S\GG?>?]P;O?@ QO!^Q8=
M7^P_%ATW+3H^>RPZ_F[>.CLGO+=[/'O9LP1K8/;ZUKCQGX-/IJ]=Q:]MDF2$
M3@L^M@:$ (=;>-/7H-0,Q]20BC*4/?ZOQ]?7]7S:?"F(%A@%<.%*YD(UQ9#<
M2PH,:482":[*$A5.G*#6Q.4H>(N^TYG?^Y7*(!C-. 685O;%T,.-7KL<OA/%
MPOZE2B6,=]/(H8C=YF]#!)W<RGK"BE>+!V+20HVEATQ=C9"G28A_L'L-ZBHU
M\EG+YPX3*]0(U3)A$OKD-D*:6M^0!YK2S$5N+:P=H[&$B".ZK'1H0&[G'*+\
M)8YH ,=6\T 5#J3EY.;&XT12=/X20;7UK#9<<DHV@U*IU-?EX!:4^5C[&BV1
MW$>DY]S_],"S\-$1B#;NY+].WGW^5+Q_4[P^>7/\P_>?ORT^GKP]>7UZ\NGA
M&35ZHQNAXF:LW<-[CS'\XUQR\"F<4)@?B6(*8_-Y+>)^@=^TIJ$)V4XL?18[
M((95<V)$!+)4EV8 702#(8 "W8!@;7V,.Y=HM9GK/Z%G4_M/:8>W?D,JBG-6
MW3)*T[2PKHH?E],+(GR=0AA,^B@=ZV(2<'/9+:2!%C\IBVXYJYFW 8HF%UPK
MP0(QY'2F5]Z3AQY%8G_LB@O(1<XY"#YKIZO=+<L^3'G6AB(KEE^2<>8#H104
M5FL6+![7>R-.QXZ_#*;>Y0ABF*KD"QB%2G<F_9P&RG$[1_N[2$?S\)AD[DHE
MC(\S(8J8^]FQC\*(]*MF>87<GAF1M06"(SXM\)1^6RT :[[:GH&;C Q<W6'-
M$N4UP')T6']TNNEOH.J!^YY;,30/(YE;OI+)+DMM=&R)ZGV8@Y;J0O"U>3.O
M8>&^Y(7KE(Z9 =M600_93J '&ETIQ7Y 1@]82E775!XT2:M6VM4D1$2!UBEY
M7,>/"R]&8!!L/%@H\AD:/-BYB^B,+'D@\ K+B1)$/]C,?RMGRK:LMZF!K_E/
M**M=\2G"79D_^CW63ZD)T,F"A%W*92FE]:H&AQ(IL\V:&M2KM%8Y7)G(A!^.
MR@GW)3#3'CR$</FO3(W3O:G]'TF("RU"<5;-?^J6UXO)"GI\^G9V \DX?P+6
M;7=1S9O_J00IQ?U&S54S Z( .FV5 FSX)M44CEY)Z6DY1._H\'BG.R[(F%UC
M5$<(52 MJCO@56=>7A^6-,RH7J-*3_R(98';^(+9W>'N)+Z#&RA&BQ'NBP?7
M)8.;&[=B,&ZH'TS/W#;4K^,7@;]E.VU@97&'(4 7&[^OL )92N\>%*HD_D!2
M;'0E_'8<##-&+0"22QZR5??%Q),(5E$T'([?8E7JC,A4>!^.%L@U*KOQXP4@
MG;=-YU73]>78L:PMBVL6+Y]-1D4Z_?)R[I][)2TJ<VD^L983IN;Y/JE)00D"
MJ*BVZM2OC3%!1*0?85RS;-)UNOV@NWOO]N&J_86[G=U?^BSS$'1JX,:7K(#>
MLAAL=UY9/;]OHXP.9%:I,6MTA;E_@WG\N0,VW+<\8/Q"T=3R!@I7MB,SR3YK
M=5$!FXH?(ATXX/GQG]"XX5")?72X]?I;(K21 <X;S2)LV/N9O=&YX^?R*X6H
MY\1HA\%@BREC 1]4I+K6]OY\!% &'ZF_T)J"?_-OL::$*ODI'G]IS+[*"-^"
M'?/K>-H0HIX_A"A27Y=$HX6UF>_:S GLOE(! &38/?/_>>&OW&'"BU X*Q'F
M]J&5WH$'%N[>=M=M![E6;C-/#(R_-ZLA#(P\_6![;.ZY-C^6N=H:?7CP E@M
M#G9]>!':*ABHH"@W3EHCS\V9L#).#<\-++-;?_?5DW/O'NX</MV-SK))-:N!
MQ)#X</JX67JT=0'2S Z[SP_V]_^V/?,BFLGAA!FDC)1V<P#D6R?V6!7KDQ<1
M1RU$+Y*5N$LW^6$F;P>0*RI<!&T#']9!9WRNW1C[D G8UU.] ,AEYO4PX2.T
M"Q5Y=6%2Z9L/;.CN79H^>"Q-;UJ:?OY8FO[=BAS'DTD],SGTD![\6/<3]DX@
M/CN>SY<S,)I;4P4Y/<]:N/1D(>DL=+!%D-IP:MC.&J1<Z'.$"]AC,B10B;&0
M S5DL)Y,L(E,,U?5CRW,C4-"I*$&(&* <F+:E+"CAP>8-G.:Q EE*Q@UFYF*
M97(!"O&\D^EL_MXPP93DO$MN,/BT2=)R!Y,+,7RS.6=E+'\)'@D6&M1R=DI,
MP6%&^AJHB:Q-._3'7:TQH:-LV6N2>@1JE>=61]0'="TLW[W3K"!VI$I43\R8
MV16E'O8F:ZK<;*I<,E6*8VZA=6<"P0(-IC17$FFZH4*1*)9CA%;<I4X7F%FN
M\.M+IFX=#JE+AW0KC,:QX60QC$?5@%'&V-6!LYI; %H"0,T@&#<ZR?REI8!)
MP&=,AUC&*NER\%X8K6.]5'O&%"04ZSF%/"2&)IB6XA>8%MSW2>$AV?) +1!A
M+\ :=7#0S*>,A/2GS&"+DTE=D* 7NP<^-C[?L@JK'2D4):L(=!3KP]D!1)&E
M*___JKQ':8*'-2[WT4<!.(T_1&&9&TE#,(,NNR:W;R0LQ4/8JE!30F-+I>#2
M-6A=H+UNUW!]) <$-<%RDX4DCTP@B(['V?#,32V<MLSJG% OP=SQN=8A0*K#
M_X9<FG)'X_?.J1P3.$6V<=ITWCC%_66A/8MLR94874<1DCW5[?ER5H:_H2,T
MV ./X\SC?&,LA;>-P8I6TQO(;$Y=6BSG$E=,37%=SWNN*M9?X!_P3-.F/_/>
M&&;QN4V<+MHGWE&)IU5UH=^;$-H?D9L/:\SO@JO . ^0<JG+F[?-5G< !F_>
MSI^,P5U"8FDC$P:\P[-5SG2YQ'25@S93!(0 -^QV>*SOF,NO"_$\QP4A,6>D
MF0V2A>EGX0M(4!K<+[7O#VR(F )L-JLG<HR=6HY-V*J?EK!WP52> .E!*,?R
MWMZ:_,=GXVX*&HK9*K;.M=;\?T_Q5;8.X"*/4GTFA"[&Y_(Z%&,$L.(D4-T/
M\& O]Q')4&Y-]6: 7QP=:@A%8\^5.%/1<2WRCBO[-Y*>#+VJ-FB"FD-)#M*T
MOD*]YN18AA*J=\"@C [,G:9"*U\U8;'QDP@V<PEL]AP48THOG?_6.E<4I(=@
MFEUD 6L2Z(51LRA+/^X9%@//4,'2L_H"B\ U&2MXC+)(%[*XB_'3V">A+[K4
MKRQ_KF-9X!L!#F-*>K3TQ45;<KL+U9IE-*NHYT>B62 A06IC1AOT[$V)1T9U
M;;'FMN+WJSMT+N_0/;#S[]?*A(>TU=J<M_K8D.9AC28_Y-"+SA0<* I,^L +
M<D:FLI+QVTR,KCXZ_9/+\&:KJFN(BXN?3;P_1!7ZI0]+&(%)B.U0<$TOM#0Q
M_0.T'A57+7"GH*/$_"GF29T\J::EZ?E*[6H0%$@O:JBU<2DR0.3JHJOIPQ1Z
MS(A%C&7.I2D?Y4)E0JY; /Q< ) YL%09Z#+A;^PC,[\5 EM8I..!K>=[5V4/
M'ZNRFU9EOWZLROY^55D"X&E1%E/['+?4TZV)0(Z]$:*RQ43>+6UE,/@L1PD!
MI5Y/23.(;XH+C=G:G8K%P_ &(QGZVKCYBWV>*?L\4_1Y"/]SMHKS[^SE"!DG
M_LR*@,B11*_9$DTP%U6,#YST\73& 4-WED4A=$6 "QWHB"AYPI]R9*X9%/8@
MO5N-<!VHY5'G,2;&M+3:@UJ : F :PV_ ')\^N)VQ(-O3C]^^NPM:#N(_F92
M[:*@SE3+<@H+_YZ-_UN/QK;D(C^=O'K_[G5N6A%DR],J 1O"%I9S7/UQA(:.
MU'B0)M5P[N..P.>4A6R[%/<;/C-6X++JJ9-=K5X)<96/5%:!]_@Z<+P*L6Y#
M'6KP?#\U8'B(<MQ *^P2WC N=>M>N33$GK,'Z!R>_?U[I8\NWL\IM[<UQZ=W
MU"Y99?<\KO&9 "WPJ+F0R(44R+Q?- LBQEN9:*@,(9*@0: 46&:5-^/P0M9^
M@N^O%+P/>'P%ZO,/0B#",H'*C"",&ELQ5YJ)Q'W(TX9%_JZ^:=IE[\]90CXQ
M@L+%" K+F&?"[+N#]C$<UW8<84$V^S> SAE*0LQL"M:EHY:3 16AW60VW=#,
MG3DZ\MP(J:*U7RER7=T@6S*%D\S.\(9!9A/'NT7!;&0ECN""_EI7<S@7-=GG
M#9\W]_TYBE=PLE?;IS2-&)* >-X930G&-_HE0O)9X-S'#.^.RVDXZ5LR![:G
M6087K/-SJE(PU TS<F#+KP-6@<Q4J9N LN[G="B%^0%3%^B,X\.' 9RR0;:H
M2"XXT'GKH\*N%E%0J*-"<_^<S34,@$NM2<P)D!J7Z;+3;O[G^T^@YXAK2QQ
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M]658SDMLR,!"/;$+,TN@;;&BEE(@ .FS<P$&BI!D!8!.<%! (S;*A@CM7(P
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MK) @!9W56)S=)<13/)C(WF5]#O%02_7[VK5-'-MHMYM1!C(ZW2Q4O!!F PQ
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MC2E=QDX/10I<\4@F.!,WBW ::5*G:'KY/H")<N"WIO<X]] !X5AJ$8/4K&R
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MT$,JHK1J'#A!U36H>R',QSLP"@,^P(CY;R@P/21L(1T/D"NH(>1%IA+QQ(0
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M*DR$39B<RI4'D7A(V"S'5+W4@(07'&^3!$Q3(;M4["A^]+POQ89(-$PS'>+
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M              "  :4*  !C:&DM,C R-3 R,C%?;&%B+GAM;%!+ 0(4 Q0
M   ( #2 6%I]'S[]A@(  %$.   4              "  049  !C:&DM,C R
M-3 R,C%?<')E+GAM;%!+ 0(4 Q0    ( #2 6%K +/90*W,$ /]R&@ 4
M          "  ;T;  !T;3(U-C$W.&0S7S0R-&(U+FAT;5!+!08     !0 %
+ $8!   :CP0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm256178d3_424b5_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2024"
  xmlns:chi="http://www.calamos.com/20250221"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="chi-20250221.xsd" xlink:type="simple"/>
    <context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">chi:MandatoryRedeemablePreferredSharesSeriesGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20240801to20241031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20241031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20240501to20240731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_20240731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="C_20240201to20240430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="C_20240430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="C_20231101to20240131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="C_20230801to20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="C_20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="C_20230501to20230731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_20230731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="C_20230201to20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="C_20221101to20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="C_20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_20241101to20250131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="C_20250131to20250131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20250221to20250221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171471</identifier>
        </entity>
        <period>
            <startDate>2025-02-21</startDate>
            <endDate>2025-02-21</endDate>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="SHARES">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Usd_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType
      contextRef="C_20250221to20250221"
      id="Fxbrl_20240919125318801">424B5</dei:DocumentType>
    <dei:EntityCentralIndexKey
      contextRef="C_20250221to20250221"
      id="Fdei_EntityCentralIndexKey20250220111616860">0001171471</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20250221to20250221"
      id="Fdei_AmendmentFlag20250220111629827">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="C_20250221to20250221"
      id="Fxbrl_20240919013421858">Calamos Convertible Opportunities and Income Fund</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20250220173537613">
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds and preferred stock dividend payments, as a percentage of our average net assets as of January&#160;31, 2025, and not as a percentage of gross assets or managed assets.&lt;/p&gt;
        </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20240919014218635">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;Shareholder Transaction Expenses&lt;/td&gt;
                &lt;td style="font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="white-space:nowrap;width:87%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Sales Load (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/td&gt;
                &lt;td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="white-space:nowrap;width:9%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.00&lt;/td&gt;
                &lt;td style="white-space:nowrap;width:2%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%(1)&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Offering Expenses Borne by the Fund (as a percentage of offering price)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%(2)&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Dividend Reinvestment Plan Fees (per sales transaction fee)(3)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.00&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(1)&#160;Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(2)&#160;&#160;Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(3)&#160;Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#x201c;Plan Agent&#x201d;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page&#160;72 of the accompanying prospectus.&lt;/p&gt;
        &lt;/div&gt;
      </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20250220101540204">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20240919013753357"
      unitRef="Pure">0.01</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="C_20250221to20250221"
      decimals="2"
      id="Fxbrl_20240919014039282"
      unitRef="Pure">0</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20250221to20250221"
      decimals="2"
      id="Fxbrl_20240919014057551"
      unitRef="USD">15</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20240919014335769">
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Annual Expenses&lt;/td&gt;
                &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Percentage of Average Net&lt;br/&gt;Assets Attributable to&lt;br/&gt;Common Shareholders&lt;/td&gt;
                &lt;td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:82%;font:10pt Times New Roman, Times, Serif"&gt;Management Fee(4)&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.26&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Interest Payments on Borrowed Funds(5)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;2.18&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Preferred Stock Dividend Payments(6)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.70&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;Other Expenses(7)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.09&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Total Annual Expenses&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.23&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

            &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(4)&#160;The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(5)&#160;Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(6)&#160;Reflects estimated dividend expense on $&lt;span style="color:#212529;background-color:white"&gt;133 &lt;/span&gt;million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#x2014; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(7)&#160;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;"Other Expenses" are based on estimated amounts for the current fiscal year.&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20250220100703613_xbrl_20240919014412199"
      unitRef="Pure">0.0126</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20250220100708341_xbrl_20240919014500055"
      unitRef="Pure">0.0218</cef:InterestExpensesOnBorrowingsPercent>
    <cef:DividendExpenseOnPreferredSharesPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20240919014525346"
      unitRef="Pure">0.007</cef:DividendExpenseOnPreferredSharesPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20240919014544330"
      unitRef="Pure">0.0009</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20250221to20250221"
      decimals="4"
      id="Fxbrl_20240919014558478"
      unitRef="Pure">0.0423</cef:TotalAnnualExpensesPercent>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20250220130952583">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Example:&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares (including an assumed total sales load or commission of 1.00%), assuming (1)&#160;total annual expenses of 4.23% of net assets attributable to common shareholders; (2)&#160;a 5% annual gross return; and (3)&#160;all distributions are reinvested at net asset value:&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;1 Year&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;3 Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;5 Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;10 Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Total Expenses Paid by Common Shareholders(8)&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;52&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;137&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;223&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;445&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/strong&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(8) The example includes sales load and estimated offering costs.&lt;/p&gt;
      </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20250221to20250221"
      decimals="0"
      id="Fxbrl_20250220100757437_xbrl_20240919020758346"
      unitRef="USD">52</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20250221to20250221"
      decimals="0"
      id="Fxbrl_20250220100757437_xbrl_20240919020804439"
      unitRef="USD">137</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20250221to20250221"
      decimals="0"
      id="Fxbrl_20250220100757437_xbrl_20240919020814123"
      unitRef="USD">223</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20250221to20250221"
      decimals="0"
      id="Fxbrl_20250220100757437_xbrl_20240919020822143"
      unitRef="USD">445</cef:ExpenseExampleYears1to10>
    <cef:OtherExpensesNoteTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20250220173700770">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;"Other Expenses" are based on estimated amounts for the current fiscal year.&lt;/span&gt;</cef:OtherExpensesNoteTextBlock>
    <cef:SharePriceTableTextBlock
      contextRef="C_20250221to20250221"
      id="Fxbrl_20250220173742357">
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;The following table sets forth for each of the periods indicated the high and low closing market prices for our common shares on the Nasdaq, the NAV per share and the premium or discount to NAV per share at which our common shares were trading. NAV is shown for the last business day of each quarter. See "Net Asset Value" on page&#160;70 of the accompanying prospectus for information as to the determination of our NAV.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Market Price&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Net Asset&lt;br/&gt;Value at&lt;br/&gt;Quarter&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Premium/&lt;br/&gt;(Discount)&lt;br/&gt;to Net Asset&lt;br/&gt;Value&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Quarter Ended&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;High&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Low&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;End&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;High&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Low&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:35%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;January 31, 2025&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.28&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.19&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.25&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;22.85&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.59&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;October 31, 2024&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.01&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.91&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.04&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;18.20&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;13.13&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;July 31, 2024&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.02&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.04&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.95&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;20.24&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.61&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;April 30, 2024&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.54&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.55&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.74&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;14.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.46&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;January 31, 2024&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.71&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.74&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.00&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.41&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;October 31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.32&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.99&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.20&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.56&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;July 31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.36&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.90&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.51&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.53&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;April 30, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.34&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.94&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16.91&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.49&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt"&gt;January 31, 2023&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.09&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.51&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.61&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15.03&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;3.89&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;Source: Fund Accounting Records.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(1)&#160;Based on high and low closing market price per share during the respective quarter and does not reflect commissions.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(2)&#160;Based on the NAV calculated on the close of business on the last business day of each calendar quarter.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;(3)&#160;Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.&lt;/p&gt;
          &lt;/div&gt;
        </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74"
      unitRef="Usd_per_Share">12.28</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75"
      unitRef="Usd_per_Share">11.19</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20250131"
      decimals="2"
      id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76"
      unitRef="Usd_per_Share">10.25</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241101to20250131"
      decimals="4"
      id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77"
      unitRef="Pure">0.2285</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241101to20250131"
      decimals="4"
      id="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78"
      unitRef="Pure">0.1059</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20250220110000597_20241227085021719_74"
      unitRef="Usd_per_Share">12.01</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20250220110000597_20241227085021721_75"
      unitRef="Usd_per_Share">10.91</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20241031"
      decimals="2"
      id="Fxbrl_20250220110000597_20241227085021722_76"
      unitRef="Usd_per_Share">10.04</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240801to20241031"
      decimals="4"
      id="Fxbrl_20250220110000597_20241227085021723_77"
      unitRef="Pure">0.182</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240801to20241031"
      decimals="4"
      id="Fxbrl_20250220110000597_20241227085021723_78"
      unitRef="Pure">0.1313</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74"
      unitRef="Usd_per_Share">12.02</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75"
      unitRef="Usd_per_Share">11.04</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20240731"
      decimals="2"
      id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76"
      unitRef="Usd_per_Share">9.95</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240501to20240731"
      decimals="4"
      id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77"
      unitRef="Pure">0.2024</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240501to20240731"
      decimals="4"
      id="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78"
      unitRef="Pure">0.1161</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74"
      unitRef="Usd_per_Share">11.54</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75"
      unitRef="Usd_per_Share">10.55</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20240430"
      decimals="2"
      id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76"
      unitRef="Usd_per_Share">9.74</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240201to20240430"
      decimals="4"
      id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77"
      unitRef="Pure">0.1421</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240201to20240430"
      decimals="4"
      id="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78"
      unitRef="Pure">0.0746</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74"
      unitRef="Usd_per_Share">10.71</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75"
      unitRef="Usd_per_Share">9.74</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20240131"
      decimals="2"
      id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76"
      unitRef="Usd_per_Share">10</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231101to20240131"
      decimals="4"
      id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77"
      unitRef="Pure">0.12</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231101to20240131"
      decimals="4"
      id="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78"
      unitRef="Pure">0.0041</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230801to20231031"
      decimals="2"
      id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74"
      unitRef="Usd_per_Share">11.32</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230801to20231031"
      decimals="2"
      id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75"
      unitRef="Usd_per_Share">10</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20231031"
      decimals="2"
      id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76"
      unitRef="Usd_per_Share">8.99</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230801to20231031"
      decimals="4"
      id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77"
      unitRef="Pure">0.152</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230801to20231031"
      decimals="4"
      id="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78"
      unitRef="Pure">0.0456</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230501to20230731"
      decimals="2"
      id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74"
      unitRef="Usd_per_Share">11.36</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230501to20230731"
      decimals="2"
      id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75"
      unitRef="Usd_per_Share">9.9</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20230731"
      decimals="2"
      id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76"
      unitRef="Usd_per_Share">10.51</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230501to20230731"
      decimals="4"
      id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77"
      unitRef="Pure">0.1021</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230501to20230731"
      decimals="4"
      id="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78"
      unitRef="Pure">0.0153</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230201to20230430"
      decimals="2"
      id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74"
      unitRef="Usd_per_Share">12.34</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230201to20230430"
      decimals="2"
      id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75"
      unitRef="Usd_per_Share">10.21</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20230430"
      decimals="2"
      id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76"
      unitRef="Usd_per_Share">9.94</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230201to20230430"
      decimals="4"
      id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77"
      unitRef="Pure">0.1691</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230201to20230430"
      decimals="4"
      id="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78"
      unitRef="Pure">0.0149</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20221101to20230131"
      decimals="2"
      id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74"
      unitRef="Usd_per_Share">12.09</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20221101to20230131"
      decimals="2"
      id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75"
      unitRef="Usd_per_Share">10.51</cef:LowestPriceOrBid>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20230131"
      decimals="2"
      id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76"
      unitRef="Usd_per_Share">10.61</us-gaap:NetAssetValuePerShare>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221101to20230131"
      decimals="4"
      id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77"
      unitRef="Pure">0.1503</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221101to20230131"
      decimals="4"
      id="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78"
      unitRef="Pure">0.0389</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:SharePrice
      contextRef="C_20250131"
      decimals="2"
      id="Fxbrl_20250220173816108"
      unitRef="Usd_per_Share">11.37</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20250131"
      decimals="2"
      id="Fxbrl_20250220173757676"
      unitRef="Usd_per_Share">10.25</us-gaap:NetAssetValuePerShare>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="C_20250131to20250131"
      decimals="4"
      id="Fxbrl_20250220173824060"
      unitRef="Pure">0.1093</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember"
      decimals="0"
      id="Fxbrl_20250220173807622"
      unitRef="SHARES">76312702</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20250131to20250131"
      id="Fxbrl_20250220125827307">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;The following table provides information about our outstanding securities as of January&#160;31, 2025:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Title of Class&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Held by the&lt;br/&gt;Fund or for&lt;br/&gt;its Account&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Outstanding&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:61%;font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;76,312,702&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series C&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,340,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,340,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series D&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,320,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,320,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series E&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,330,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,330,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series G&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,320,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,320,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember"
      id="Fxbrl_20250220104219855">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember"
      decimals="0"
      id="Fxbrl_20240919023157161"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiCommonSharesMember"
      decimals="0"
      id="Fxbrl_20240919023219489"
      unitRef="SHARES">76312702</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember"
      id="Fxbrl_20250220104257935">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series C&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20240919023628137"
      unitRef="SHARES">1340000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20240919023450849_xbrl_20240919023157161"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20240919023450849_xbrl_20240919023219489"
      unitRef="SHARES">1340000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember"
      id="Fxbrl_20250220104319367">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series D&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="0"
      id="Fxbrl_20240919023652285_xbrl_20240919023628137"
      unitRef="SHARES">1320000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="0"
      id="Fxbrl_20240919023652285_xbrl_20240919023450849_xbrl_20240919023157161"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="0"
      id="Fxbrl_20240919023652285_xbrl_20240919023450849_xbrl_20240919023219489"
      unitRef="SHARES">1320000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember"
      id="Fxbrl_20250220104346871">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series E&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20240919023654297_xbrl_20240919023628137"
      unitRef="SHARES">1330000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20240919023654297_xbrl_20240919023450849_xbrl_20240919023157161"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20240919023654297_xbrl_20240919023450849_xbrl_20240919023219489"
      unitRef="SHARES">1330000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember"
      id="Fxbrl_20250220104402295">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series G&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20240919023655942_xbrl_20240919023628137"
      unitRef="SHARES">1320000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20240919023655942_xbrl_20240919023450849_xbrl_20240919023157161"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20250131to20250131_usgaapStatementClassOfStockAxis_chiMandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20240919023655942_xbrl_20240919023450849_xbrl_20240919023219489"
      unitRef="SHARES">1320000</cef:OutstandingSecurityNotHeldShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20250220110000597_20241227085021723_78"
          xlink:label="Fxbrl_20250220110000597_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnote id="FN20241227085021755_187" xlink:label="FN20241227085021755_187" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Premium and discount information is shown for the days when the Fund experienced its high and low closing market prices, respectively, per share during the respective quarter.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110000597_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110000597_20241227085021723_77"
          xlink:label="Fxbrl_20250220110000597_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110000597_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110000597_20241227085021722_76"
          xlink:label="Fxbrl_20250220110000597_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnote id="FN20241227085021755_186" xlink:label="FN20241227085021755_186" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based on the NAV calculated on the close of business on the last business day of each calendar quarter.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110000597_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110000597_20241227085021721_75"
          xlink:label="Fxbrl_20250220110000597_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnote id="FN20241227085021754_184" xlink:label="FN20241227085021754_184" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based on high and low closing market price per share during the respective quarter and does not reflect commissions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110000597_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110000597_20241227085021719_74"
          xlink:label="Fxbrl_20250220110000597_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110000597_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78"
          xlink:label="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77"
          xlink:label="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76"
          xlink:label="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75"
          xlink:label="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74"
          xlink:label="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110006934_xbrl_20241227102550813_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78"
          xlink:label="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77"
          xlink:label="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76"
          xlink:label="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75"
          xlink:label="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74"
          xlink:label="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110012102_xbrl_20241227102553277_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78"
          xlink:label="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77"
          xlink:label="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76"
          xlink:label="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75"
          xlink:label="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74"
          xlink:label="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110017918_xbrl_20241227102557493_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78"
          xlink:label="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77"
          xlink:label="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76"
          xlink:label="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75"
          xlink:label="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74"
          xlink:label="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110022949_xbrl_20241227102559613_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78"
          xlink:label="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77"
          xlink:label="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76"
          xlink:label="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75"
          xlink:label="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74"
          xlink:label="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110032789_xbrl_20241227102601884_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78"
          xlink:label="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77"
          xlink:label="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76"
          xlink:label="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75"
          xlink:label="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74"
          xlink:label="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110039662_xbrl_20241227102609453_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78"
          xlink:label="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77"
          xlink:label="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76"
          xlink:label="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75"
          xlink:label="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74"
          xlink:label="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110045238_xbrl_20241227102611605_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78"
          xlink:label="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_78"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77"
          xlink:label="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021723_77"
          xlink:to="FN20241227085021755_187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76"
          xlink:label="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021722_76"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75"
          xlink:label="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021721_75"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74"
          xlink:label="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220110057650_xbrl_20241227102621365_20241227085021719_74"
          xlink:to="FN20241227085021754_184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220173757676"
          xlink:label="Fxbrl_20250220173757676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220173757676"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220173816108"
          xlink:label="Fxbrl_20250220173816108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220173816108"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220173824060"
          xlink:label="Fxbrl_20250220173824060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220173824060"
          xlink:to="FN20241227085021755_186"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240919013753357"
          xlink:label="Fxbrl_20240919013753357"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102555114" xlink:label="FN20250220102555114" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240919013753357"
          xlink:to="FN20250220102555114"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240919014039282"
          xlink:label="Fxbrl_20240919014039282"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102606193" xlink:label="FN20250220102606193" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calamos will pay the expenses of the offering (other than the applicable commissions). However, Calamos may request reimbursement from the Fund of previously paid offering expenses of $102,500 per $8,500,000 in share sales, with total reimbursements not to exceed the lower of $205,00 or the actual expenses paid. The arrangement is hereinafter referred to as the "reimbursement provision." As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the reimbursement provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240919014039282"
          xlink:to="FN20250220102606193"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240919014057551"
          xlink:label="Fxbrl_20240919014057551"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102621370" xlink:label="FN20250220102621370" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#x201c;Plan Agent&#x201d;) to sell common shares held in an account of the Fund's Automatic Dividend Reinvestment Plan (the "Plan"). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 72 of the accompanying prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240919014057551"
          xlink:to="FN20250220102621370"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100703613_xbrl_20240919014412199"
          xlink:label="Fxbrl_20250220100703613_xbrl_20240919014412199"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102635233" xlink:label="FN20250220102635233" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 0.80% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.26% of the Fund's average weekly net assets as of January 31, 2025 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100703613_xbrl_20240919014412199"
          xlink:to="FN20250220102635233"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100708341_xbrl_20240919014500055"
          xlink:label="Fxbrl_20250220100708341_xbrl_20240919014500055"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102650866" xlink:label="FN20250220102650866" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects interest expense paid on $254 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $61 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under " Leverage."</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100708341_xbrl_20240919014500055"
          xlink:to="FN20250220102650866"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240919014525346"
          xlink:label="Fxbrl_20240919014525346"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102706306" xlink:label="FN20250220102706306" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects estimated dividend expense on $133 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares") outstanding. See "Prospectus Summary &#x2014; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240919014525346"
          xlink:to="FN20250220102706306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240919014544330"
          xlink:label="Fxbrl_20240919014544330"
          xlink:type="locator"/>
        <link:footnote id="FN20250220102723737" xlink:label="FN20250220102723737" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">"Other Expenses" are based on estimated amounts for the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240919014544330"
          xlink:to="FN20250220102723737"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100757437_xbrl_20240919020822143"
          xlink:label="Fxbrl_20250220100757437_xbrl_20240919020822143"
          xlink:type="locator"/>
        <link:footnote id="FN20250220103616902" xlink:label="FN20250220103616902" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example includes sales load and estimated offering costs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100757437_xbrl_20240919020822143"
          xlink:to="FN20250220103616902"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100757437_xbrl_20240919020814123"
          xlink:label="Fxbrl_20250220100757437_xbrl_20240919020814123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100757437_xbrl_20240919020814123"
          xlink:to="FN20250220103616902"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100757437_xbrl_20240919020804439"
          xlink:label="Fxbrl_20250220100757437_xbrl_20240919020804439"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100757437_xbrl_20240919020804439"
          xlink:to="FN20250220103616902"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250220100757437_xbrl_20240919020758346"
          xlink:label="Fxbrl_20250220100757437_xbrl_20240919020758346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250220100757437_xbrl_20240919020758346"
          xlink:to="FN20250220103616902"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
